CC01802
     RDKit          3D

  9  9  0  0  0  0  0  0  0  0999 V2000
    0.0020   -0.0040    0.0020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.0220    1.7320    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1670    2.4400    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1490    3.8220    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0570    4.4980    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2480    3.7900    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2290    2.4070    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0800    6.2340    0.0380 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.7620    4.6380    0.0550 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  7  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  8  1  0
  6  7  2  0
  6  9  1  0
M  END
>  <Name>  (1) 
1,2,4-Trichlorobenzene

>  <InChIKey>  (1) 
PBKONEOXTCPAFI-UHFFFAOYSA-N

>  <PubChem_CID>  (1) 
13

>  <CYP1A2>  (1) 
<3,H;Hydroxylation;R1>
<4,H;Hydroxylation;R2>

>  <CYP2A6>  (1) 


>  <CYP2B6>  (1) 


>  <CYP2C8>  (1) 


>  <CYP2C9>  (1) 


>  <CYP2C19>  (1) 


>  <CYP2D6>  (1) 
<2,H;Hydroxylation;R1>

>  <CYP2E1>  (1) 
<2,H;Hydroxylation;R1>
<3,H;Hydroxylation;R2>

>  <CYP3A4>  (1) 
<2,H;Hydroxylation;R1>
<8,H;Hydroxylation;R2>

>  <References>  (1) 
Bogaards JJ, van Ommen B, Wolf CR, van Bladeren PJ: Human cytochrome P450 enzyme selectivities in the oxidation of chlorinated benzenes. Toxicol Appl Pharmacol. 1995 May;132(1):44-52. (PMID: 7747284)

>  <Comments>  (1) 
<4,H;Hydroxylation> for CYP1A2 cannot be identified.

$$$$
CC01803
     RDKit          3D

 19 22  0  0  0  0  0  0  0  0999 V2000
   -0.0390    1.3600   -0.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0400   -0.0010   -0.6780 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1410    2.0400    0.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2820    2.0300   -0.3210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1220   -0.6970   -1.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2830   -0.6680   -0.6590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3610    1.3650    0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0860    3.3850    0.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4220    1.3080   -0.7240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2860    3.3880    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3460   -0.0350   -1.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0330   -2.0400   -1.4340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4320    0.0210   -0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3500   -2.0120   -1.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1260    4.0670    0.4330 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1980   -2.6940   -1.4120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5130    4.1530    0.0820 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5330    5.2010   -0.5780 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4450    3.7150    0.7680 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  4 10  2  0
  5 11  1  0
  5 12  2  0
  6 13  2  0
  6 14  1  0
  7 13  1  0
  8 15  2  0
  9 11  2  0
 10 15  1  0
 10 17  1  0
 12 16  1  0
 14 16  2  0
 17 18  1  0
 17 19  2  0
M  CHG  2  17   1  18  -1
M  END
>  <Name>  (2) 
1-Nitropyrene

>  <InChIKey>  (2) 
ALRLPDGCPYIVHP-UHFFFAOYSA-N

>  <PubChem_CID>  (2) 
21694

>  <CYP1A2>  (2) 
<12,H;Hydroxylation;R1>
<10,H;Hydroxylation;R2>
<1,2;Reduction;R3>
<0,1;Reduction;R3>

>  <CYP2A6>  (2) 


>  <CYP2B6>  (2) 


>  <CYP2C8>  (2) 


>  <CYP2C9>  (2) 


>  <CYP2C19>  (2) 


>  <CYP2D6>  (2) 


>  <CYP2E1>  (2) 


>  <CYP3A4>  (2) 
<5,H;Hydroxylation;R1>
<7,8;EpOxidation;R2>
<10,H;Hydroxylation;R3>

>  <References>  (2) 
Chae YH, Thomas T, Guengerich FP, Fu PP, El-Bayoumy K: Comparative metabolism of 1-, 2-, and 4-nitropyrene by human hepatic and pulmonary microsomes. Cancer Res. 1999 Apr 1;59(7):1473-80. (PMID: 10197616)
Hatanaka N, Yamazaki H, Oda Y, Guengerich FP, Nakajima M, Yokoi T: Metabolic activation of carcinogenic 1-nitropyrene by human cytochrome P450 1B1 in Salmonella typhimurium strain expressing an O-acetyltransferase in SOS/umu assay. Mutat Res. 2001 Oct 18;497(1-2):223-33. doi: 10.1016/s1383-5718(01)00254-6. (PMID: 11525925)

>  <Comments>  (2) 
Mainly considered the second reference. The observed metabolite is 1-AP.

$$$$
CC01804
     RDKit          3D

 17 19  0  0  0  0  0  0  0  0999 V2000
   -6.8360   -1.5590    1.1320 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3310   -0.7930    2.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4640   -2.7850    1.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8530   -3.2700   -0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7010   -3.4360    2.2390 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7320    0.4240    1.8600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2280    1.1940    2.8910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3100    0.7760    4.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9020   -0.4280    4.5680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4130   -1.2100    3.5300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5390    2.5390    2.7910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2400    2.8310    4.2460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7020    1.7830    5.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6090    3.9430    4.7710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4430    3.9940    6.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9010    2.9540    6.9800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5380    1.8340    6.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  6  2  0
  2 10  1  0
  3  4  1  0
  3  5  2  0
  6  7  1  0
  7  8  2  0
  7 11  1  0
  8  9  1  0
  8 13  1  0
  9 10  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 13 17  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
M  END
>  <Name>  (3) 
2-Acetylaminofluorene

>  <InChIKey>  (3) 
CZIHNRWJTSTCEX-UHFFFAOYSA-N

>  <PubChem_CID>  (3) 
5897

>  <CYP1A2>  (3) 
<3,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>
<5,H;Hydroxylation;R3>
<10,H;Hydroxylation;R4>
<14,H;Hydroxylation;R5>
<15,H;Hydroxylation;R6>

>  <CYP2A6>  (3) 


>  <CYP2B6>  (3) 


>  <CYP2C8>  (3) 


>  <CYP2C9>  (3) 


>  <CYP2C19>  (3) 


>  <CYP2D6>  (3) 


>  <CYP2E1>  (3) 


>  <CYP3A4>  (3) 


>  <References>  (3) 
McManus ME, Burgess WM, Veronese ME, Huggett A, Quattrochi LC, Tukey RH: Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. Cancer Res. 1990 Jun 1;50(11):3367-76. (PMID: 2334931)

>  <Comments>  (3) 
Some minor metabolites are not recorded.

$$$$
CC01805
     RDKit          3D

 12 13  0  0  0  0  0  0  0  0999 V2000
    1.3680   -0.0260    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4670   -1.0630    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8970   -0.6570    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9960    0.7350    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5590    1.4760    0.0020 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0860   -1.4150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3260   -0.7760   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3980    0.6090   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2410    1.3870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8120   -0.1330    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4080   -1.2100    0.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6040    1.1440    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  5  1  0
  1 10  1  0
  2  3  1  0
  3  4  2  0
  3  6  1  0
  4  5  1  0
  4  9  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
 10 11  2  0
 10 12  1  0
M  END
>  <Name>  (4) 
2-Acetylbenzothiophene

>  <InChIKey>  (4) 
SGSGCQGCVKWRNM-UHFFFAOYSA-N

>  <PubChem_CID>  (4) 
89805

>  <CYP1A2>  (4) 
<11,S;S-Oxidation;R1>

>  <CYP2A6>  (4) 
<11,S;S-Oxidation;R1>

>  <CYP2B6>  (4) 
<11,S;S-Oxidation;R1>

>  <CYP2C8>  (4) 
<11,S;S-Oxidation;R1>

>  <CYP2C9>  (4) 
<11,S;S-Oxidation;R1>

>  <CYP2C19>  (4) 


>  <CYP2D6>  (4) 
<11,S;S-Oxidation;R1>

>  <CYP2E1>  (4) 
<11,S;S-Oxidation;R1>

>  <CYP3A4>  (4) 
<11,S;S-Oxidation;R1>

>  <References>  (4) 
Joshi EM, Heasley BH, Chordia MD, Macdonald TL: In vitro metabolism of 2-acetylbenzothiophene: relevance to zileuton hepatotoxicity. Chem Res Toxicol. 2004 Feb;17(2):137-43. doi: 10.1021/tx0341409. (PMID: 14967000)

>  <Comments>  (4) 
Rate of metabolites in other CYPs is low, so they are not recorded.

$$$$
CC01806
     RDKit          2D

 11 12  0  0  0  0  0  0  0  0999 V2000
    1.7860    0.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0
  2  3  2  0
  2 11  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6 11  2  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
M  END
>  <Name>  (5) 
2-Naphthylamine

>  <InChIKey>  (5) 
JBIJLHTVPXGSAM-UHFFFAOYSA-N

>  <PubChem_CID>  (5) 
7057

>  <CYP1A2>  (5) 
<0,H;Hydroxylation;R1>

>  <CYP2A6>  (5) 


>  <CYP2B6>  (5) 


>  <CYP2C8>  (5) 


>  <CYP2C9>  (5) 


>  <CYP2C19>  (5) 


>  <CYP2D6>  (5) 


>  <CYP2E1>  (5) 


>  <CYP3A4>  (5) 


>  <References>  (5) 
Butler MA, Iwasaki M, Guengerich FP, Kadlubar FF: Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci U S A. 1989 Oct;86(20):7696-700. doi: 10.1073/pnas.86.20.7696. (PMID: 2813353)

>  <Comments>  (5) 


$$$$
CC01807
     RDKit          2D

 19 22  0  0  0  0  0  0  0  0999 V2000
    0.3570    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7870    0.6180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    1.0300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    1.0310    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    1.8560    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    0.6190    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1 14  1  0
  2  3  1  0
  2 17  1  0
  3  4  2  0
  4  5  1  0
  4 15  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7 16  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 16  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 17 18  2  0
 17 19  1  0
M  CHG  2  17   1  19  -1
M  END
>  <Name>  (6) 
2-Nitropyrene

>  <InChIKey>  (6) 
MAZCGYFIOOIVHE-UHFFFAOYSA-N

>  <PubChem_CID>  (6) 
13090

>  <CYP1A2>  (6) 
<9,H;Hydroxylation;R1>
<6,7;EpOxidation;R2>
<1,2;Reduction;R3>
<0,1;Reduction;R3>
<13,14;EpOxidation;R4>

>  <CYP2A6>  (6) 


>  <CYP2B6>  (6) 


>  <CYP2C8>  (6) 


>  <CYP2C9>  (6) 


>  <CYP2C19>  (6) 


>  <CYP2D6>  (6) 


>  <CYP2E1>  (6) 


>  <CYP3A4>  (6) 


>  <References>  (6) 
Chae YH, Thomas T, Guengerich FP, Fu PP, El-Bayoumy K: Comparative metabolism of 1-, 2-, and 4-nitropyrene by human hepatic and pulmonary microsomes. Cancer Res. 1999 Apr 1;59(7):1473-80. (PMID: 10197616)

>  <Comments>  (6) 
Xenosite reports 17 is a SoM but cannot be identified.

$$$$
CC01808
     RDKit          3D

 26 30  0  0  1  0  0  0  0  0999 V2000
    0.5560   -0.9440    1.7110 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4780    2.2140   -0.6820 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2590   -2.9630    2.5790 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0450    1.2880   -0.3330 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8650    4.0800   -0.2220 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3640   -0.3470    0.3960 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.7420   -1.4670   -0.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0910    0.0500    0.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2980    0.8400    0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1180   -2.5640    0.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4170    1.2920   -0.2870 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8220    2.0350   -0.2770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0040   -2.2330    1.6430 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7640   -1.5300   -1.9060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1400   -0.8080    0.6370 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6500    0.7700    0.6620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5310   -3.7550   -0.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7520    1.6620   -0.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6700    3.1310   -0.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4760   -0.4340    0.4590 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1750   -2.7220   -2.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4970    1.8650    0.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7870    0.8040   -0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5570   -3.8280   -1.7310 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0020    3.0350   -0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1330    0.4510    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
  6  1  1  1
  1 13  1  0
  2 11  1  0
  2 12  1  0
  3 13  2  0
  4 23  1  0
  4 26  1  0
  5 25  1  0
  6  7  1  0
  6  8  1  0
  6  9  1  0
  7 10  2  0
  7 14  1  0
  8 11  2  0
  8 15  1  0
  9 12  2  0
  9 16  1  0
 10 13  1  0
 10 17  1  0
 11 18  1  0
 12 19  1  0
 14 21  2  0
 15 20  2  0
 16 22  2  0
 17 24  2  0
 18 23  2  0
 19 25  2  0
 20 23  1  0
 21 24  1  0
 22 25  1  0
M  END
>  <Name>  (7) 
3-O-Methylfluorescein

>  <InChIKey>  (7) 
KDXNYSZNOWTPLE-OAQYLSRUSA-N

>  <PubChem_CID>  (7) 
26369045

>  <CYP1A2>  (7) 
<26,H;Oxidation;R1>
<26,4;Cleavage;R1>

>  <CYP2A6>  (7) 


>  <CYP2B6>  (7) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2C8>  (7) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2C9>  (7) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2C19>  (7) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2D6>  (7) 


>  <CYP2E1>  (7) 


>  <CYP3A4>  (7) 


>  <References>  (7) 
Sudsakorn S, Skell J, Williams DA, O'Shea TJ, Liu H: Evaluation of 3-O-methylfluorescein as a selective fluorometric substrate for CYP2C19 in human liver microsomes. Drug Metab Dispos. 2007 Jun;35(6):841-7. doi: 10.1124/dmd.106.014472. Epub 2007 Mar 1. (PMID: 17332142)

>  <Comments>  (7) 


$$$$
CC01809
     RDKit          3D

 16 17  0  0  0  0  0  0  0  0999 V2000
    1.3100    0.6530    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1280    1.3740   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0770    0.6830   -0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2000    1.4530   -0.3410 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3710    0.6510   -0.4520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5570    1.5720   -0.5980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0800   -0.7150   -0.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1140   -1.4240   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3160   -0.7340    0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5750   -1.4310    0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7190   -0.7520    0.3420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7390    0.7200    0.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7830    1.3540    0.4150 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5140    1.3700    0.1700 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9410   -1.4600    0.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9280   -2.0590    0.6060 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  9  1  0
  1 14  1  0
  2  3  1  0
  3  4  1  0
  3  7  2  0
  4  5  1  0
  5  6  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 15  1  0
 12 13  2  0
 12 14  1  0
 15 16  3  0
M  END
>  <Name>  (8) 
3-Cyano-7-ethoxycoumarin

>  <InChIKey>  (8) 
YAFGHMIAFYQSCF-UHFFFAOYSA-N

>  <PubChem_CID>  (8) 
164045

>  <CYP1A2>  (8) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <CYP2A6>  (8) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <CYP2B6>  (8) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <CYP2C8>  (8) 


>  <CYP2C9>  (8) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <CYP2C19>  (8) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <CYP2D6>  (8) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <CYP2E1>  (8) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <CYP3A4>  (8) 


>  <References>  (8) 
Donato MT, Jimenez N, Castell JV, Gomez-Lechon MJ: Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes. Drug Metab Dispos. 2004 Jul;32(7):699-706. doi: 10.1124/dmd.32.7.699. (PMID: 15205384)
Ekins S, Vandenbranden M, Ring BJ, Gillespie JS, Yang TJ, Gelboin HV, Wrighton SA: Further characterization of the expression in liver and catalytic activity of CYP2B6. J Pharmacol Exp Ther. 1998 Sep;286(3):1253-9. (PMID: 9732386)
Ghosal A, Hapangama N, Yuan Y, Lu X, Horne D, Patrick JE, Zbaida S: Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes. Biopharm Drug Dispos. 2003 Dec;24(9):375-84. doi: 10.1002/bdd.374. (PMID: 14689466)

>  <Comments>  (8) 


$$$$
CC01811
     RDKit          3D

 18 19  0  0  0  0  0  0  0  0999 V2000
    1.2810    0.6620    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1060    1.3820   -0.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0910    0.6950   -0.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2040    1.4650   -0.5690 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3670    0.6630   -0.7360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5450    1.5830   -0.9460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0970   -0.7000   -0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0890   -1.4050   -0.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2970   -0.7310    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5660   -1.4230    0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6140   -2.9130    0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8410   -3.4170    1.2990 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.8700   -3.3870    0.5160 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1840   -3.4690   -0.8570 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.6670   -0.6850    0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6810    0.7770    0.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7240    1.4010    0.5360 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4630    1.4080    0.1760 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  9  1  0
  1 18  1  0
  2  3  1  0
  3  4  1  0
  3  7  2  0
  4  5  1  0
  5  6  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 10 15  2  0
 11 12  1  0
 11 13  1  0
 11 14  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
M  END
>  <Name>  (9) 
3-Ethoxy-4-trifluoromethylcoumarin

>  <InChIKey>  (9) 
OLHOIERZAZMHGK-UHFFFAOYSA-N

>  <PubChem_CID>  (9) 
130779

>  <CYP1A2>  (9) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <CYP2A6>  (9) 


>  <CYP2B6>  (9) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <CYP2C8>  (9) 


>  <CYP2C9>  (9) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <CYP2C19>  (9) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <CYP2D6>  (9) 


>  <CYP2E1>  (9) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <CYP3A4>  (9) 


>  <References>  (9) 
Code EL, Crespi CL, Penman BW, Gonzalez FJ, Chang TK, Waxman DJ: Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation. Drug Metab Dispos. 1997 Aug;25(8):985-93. (PMID: 9280407)

>  <Comments>  (9) 


$$$$
CC01812
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    1.2810    0.6620    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1060    1.3820   -0.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0920    0.6950   -0.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2040    1.4660   -0.5690 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3670    0.6630   -0.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0980   -0.7000   -0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0880   -1.4050   -0.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2970   -0.7310    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5660   -1.4230    0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6140   -2.9130    0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8410   -3.4180    1.2990 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.8700   -3.3870    0.5160 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1840   -3.4700   -0.8570 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.6670   -0.6850    0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6810    0.7770    0.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7240    1.4010    0.5360 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4630    1.4080    0.1760 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  8  1  0
  1 17  1  0
  2  3  1  0
  3  4  1  0
  3  6  2  0
  4  5  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 14  2  0
 10 11  1  0
 10 12  1  0
 10 13  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
M  END
>  <Name>  (10) 
3-Methoxy-4-trifluoromethylcoumarin

>  <InChIKey>  (10) 
HAZHUELNIGDYQH-UHFFFAOYSA-N

>  <PubChem_CID>  (10) 
688586

>  <CYP1A2>  (10) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2A6>  (10) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2B6>  (10) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2C8>  (10) 


>  <CYP2C9>  (10) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2C19>  (10) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2D6>  (10) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2E1>  (10) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP3A4>  (10) 


>  <References>  (10) 
Stresser DM, Turner SD, Blanchard AP, Miller VP, Crespi CL: Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4. Drug Metab Dispos. 2002 Jul;30(7):845-52. doi: 10.1124/dmd.30.7.845. (PMID: 12065444)
Ghosal A, Hapangama N, Yuan Y, Lu X, Horne D, Patrick JE, Zbaida S: Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes. Biopharm Drug Dispos. 2003 Dec;24(9):375-84. doi: 10.1002/bdd.374. (PMID: 14689466)

>  <Comments>  (10) 
Metabolite of <5,4;Cleavage> in CYP2C8 is low. Not recorded in this file.

$$$$
CC01813
     RDKit          3D

 21 24  0  0  0  0  0  0  0  0999 V2000
   -5.1060   -0.2400   -0.5040 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8210    0.3440    0.1670 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7220   -0.7280   -0.1280 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.1130    0.6730   -0.4640 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.6390    0.8410   -0.0130 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.1760   -0.4320   -0.3320 C   0  0  2  0  0  0  0  0  0  0  0  0
   -4.1050   -0.4050    0.4980 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.8410   -1.4680    0.9050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0370    1.7100    0.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3760   -1.6220    0.4830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8920    0.9290    1.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0140    2.0570   -0.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8700   -1.5930   -1.3940 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6820   -0.2450   -0.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4080    2.2860   -0.1080 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2530    1.0380   -0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5420   -1.3580   -0.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6480    1.1730    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9300   -1.2110   -0.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4890    0.0580    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7150   -0.7620    0.2230 C   0  0  0  0  0  0  0  0  0  0  0  0
  7  1  1  6
  2 20  1  0
  2 21  1  0
  3  4  1  0
  3  7  1  0
  3  8  1  0
  3 13  1  6
  4  5  1  0
  4  9  1  1
  5  6  1  0
  5 12  1  6
  6 10  1  1
  6 14  1  0
  7 11  1  0
  8 10  1  0
  9 11  1  0
 12 15  1  0
 14 16  2  0
 14 17  1  0
 15 16  1  0
 16 18  1  0
 17 19  2  0
 18 20  2  0
 19 20  1  0
M  END
>  <Name>  (11) 
3-Methylether-estradiol

>  <InChIKey>  (11) 
ULAADVBNYHGIBP-UJWQCDCRSA-N

>  <PubChem_CID>  (11) 
101235253

>  <CYP1A2>  (11) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2A6>  (11) 


>  <CYP2B6>  (11) 


>  <CYP2C8>  (11) 


>  <CYP2C9>  (11) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2C19>  (11) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2D6>  (11) 


>  <CYP2E1>  (11) 


>  <CYP3A4>  (11) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <References>  (11) 
Stresser DM, Kupfer D: Prosubstrates of CYP3A4, the major human hepatic cytochrome P450: transformation into substrates by other P450 isoforms. Biochem Pharmacol. 1998 Jun 1;55(11):1861-71. doi: 10.1016/s0006-2952(98)00060-4. (PMID: 9714305)

>  <Comments>  (11) 


$$$$
CC01814
     RDKit          2D

 10 11  0  0  0  0  0  0  0  0999 V2000
    0.8640    0.9810    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3490    0.3140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8640   -0.3540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0800   -0.0990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6350   -0.5110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3490   -0.0990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3490    0.7260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6350    1.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0800    0.7260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1190   -1.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  9  1  0
  2  3  2  0
  3  4  1  0
  3 10  1  0
  4  5  1  0
  4  9  2  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
M  END
>  <Name>  (12) 
3-Methylindole

>  <InChIKey>  (12) 
ZFRKQXVRDFCRJG-UHFFFAOYSA-N

>  <PubChem_CID>  (12) 
6736

>  <CYP1A2>  (12) 
<0,H;Oxidation;R1>
<1,2;Reduction;R2>
<2,H;Oxidation;R2>

>  <CYP2A6>  (12) 
<0,H;Oxidation;R1>
<1,2;Reduction;R2>
<2,H;Oxidation;R2>

>  <CYP2B6>  (12) 
<1,2;Reduction;R2>
<2,H;Oxidation;R2>

>  <CYP2C8>  (12) 
<1,2;Reduction;R2>
<2,H;Oxidation;R2>

>  <CYP2C9>  (12) 
<1,2;Reduction;R2>
<2,H;Oxidation;R2>

>  <CYP2C19>  (12) 


>  <CYP2D6>  (12) 
<1,2;Reduction;R2>
<2,H;Oxidation;R2>

>  <CYP2E1>  (12) 
<1,2;Reduction;R2>
<2,H;Oxidation;R2>

>  <CYP3A4>  (12) 
<1,2;Reduction;R2>
<2,H;Oxidation;R2>

>  <References>  (12) 
Thornton-Manning J, Appleton ML, Gonzalez FJ, Yost GS: Metabolism of 3-methylindole by vaccinia-expressed P450 enzymes: correlation of 3-methyleneindolenine formation and protein-binding. J Pharmacol Exp Ther. 1996 Jan;276(1):21-9. (PMID: 8558432)

>  <Comments>  (12) 


$$$$
CC01815
     RDKit          2D

 13 14  0  0  0  0  0  0  0  0999 V2000
    0.0000   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4290   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4290   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1430   -1.4440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4 13  1  0
  5  6  2  0
  7  8  2  0
  7 12  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
M  END
>  <Name>  (13) 
4-Aminobiphenyl

>  <InChIKey>  (13) 
DMVOXQPQNTYEKQ-UHFFFAOYSA-N

>  <PubChem_CID>  (13) 
7102

>  <CYP1A2>  (13) 
<0,H;Hydroxylation;R1>

>  <CYP2A6>  (13) 


>  <CYP2B6>  (13) 


>  <CYP2C8>  (13) 


>  <CYP2C9>  (13) 


>  <CYP2C19>  (13) 


>  <CYP2D6>  (13) 


>  <CYP2E1>  (13) 


>  <CYP3A4>  (13) 


>  <References>  (13) 
Hammons GJ, Milton D, Stepps K, Guengerich FP, Tukey RH, Kadlubar FF: Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes. Carcinogenesis. 1997 Apr;18(4):851-4. doi: 10.1093/carcin/18.4.851. (PMID: 9111224)

>  <Comments>  (13) 


$$$$
CC01816
     RDKit          3D

 16 17  0  0  0  0  0  0  0  0999 V2000
    1.3010    0.6480    0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1110    1.3590   -0.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0940    0.6630   -0.1470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2220    1.4250   -0.2790 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3910    0.6150   -0.3390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5840    1.5260   -0.4840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0910   -0.7310   -0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1100   -1.4280    0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3230   -0.7430    0.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6060   -1.4210    0.2600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6680   -2.9040    0.3660 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5540   -3.6600   -1.2370 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.7160   -0.6880    0.3540 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7200    0.7750    0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7670    1.4060    0.3690 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4900    1.3980    0.1190 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  9  1  0
  1 16  1  0
  2  3  1  0
  3  4  1  0
  3  7  2  0
  4  5  1  0
  5  6  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 10 13  2  0
 11 12  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
M  END
>  <Name>  (14) 
4-Chloromethyl-7-ethoxycoumarin

>  <InChIKey>  (14) 
RWMRBNNWQLUEFX-UHFFFAOYSA-N

>  <PubChem_CID>  (14) 
71339287

>  <CYP1A2>  (14) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <CYP2A6>  (14) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <CYP2B6>  (14) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <CYP2C8>  (14) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <CYP2C9>  (14) 


>  <CYP2C19>  (14) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <CYP2D6>  (14) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <CYP2E1>  (14) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <CYP3A4>  (14) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>

>  <References>  (14) 
Ekins S, Vandenbranden M, Ring BJ, Gillespie JS, Yang TJ, Gelboin HV, Wrighton SA: Further characterization of the expression in liver and catalytic activity of CYP2B6. J Pharmacol Exp Ther. 1998 Sep;286(3):1253-9. (PMID: 9732386)

>  <Comments>  (14) 


$$$$
CC01817
     RDKit          3D

 11 11  0  0  0  0  0  0  0  0999 V2000
   -0.0580    3.4920   -0.9100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9940    4.1700   -0.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0320    3.4740    0.5070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1330    2.0870    0.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2030    1.3990   -0.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1910    0.0510   -0.6710 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2200   -0.7200   -0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1700    2.1080   -1.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8870    5.6220    0.0430 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7350    6.1850    0.7500 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0440    6.2020   -0.5330 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  8  1  0
  2  3  1  0
  2  9  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5  8  2  0
  6  7  1  0
  9 10  2  0
  9 11  1  0
M  CHG  2   9   1  11  -1
M  END
>  <Name>  (15) 
4-Nitroanisole

>  <InChIKey>  (15) 
BNUHAJGCKIQFGE-UHFFFAOYSA-N

>  <PubChem_CID>  (15) 
7485

>  <CYP1A2>  (15) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2A6>  (15) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2B6>  (15) 


>  <CYP2C8>  (15) 


>  <CYP2C9>  (15) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2C19>  (15) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2D6>  (15) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2E1>  (15) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP3A4>  (15) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <References>  (15) 
Jones BC, Tyman CA, Smith DA: Identification of the cytochrome P450 isoforms involved in the O-demethylation of 4-nitroanisole in human liver microsomes. Xenobiotica. 1997 Oct;27(10):1025-37. doi: 10.1080/004982597240000. (PMID: 9364740)

>  <Comments>  (15) 


$$$$
CC01818
     RDKit          3D

 19 22  0  0  0  0  0  0  0  0999 V2000
   -0.0260    1.3410   -0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0030   -0.0350    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1700    2.0900   -0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2620    1.9540   -0.6170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2030   -0.7750    0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2180   -0.6730    0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3670    1.4130   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0890    3.4500   -0.6840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4380    1.2060   -0.5870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3010    3.3040   -0.9550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4100   -0.1480   -0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1720   -2.1300    0.3780 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4030    0.0560    0.3100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2270   -2.0290    0.6580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1290    4.0520   -0.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0370   -2.7540    0.6800 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6360    2.1060   -0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5350    1.6380   -0.7210 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7360    3.1040    0.7150 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  4 10  2  0
  5 11  1  0
  5 12  2  0
  6 13  2  0
  6 14  1  0
  7 13  1  0
  7 17  1  0
  8 15  2  0
  9 11  2  0
 10 15  1  0
 12 16  1  0
 14 16  2  0
 17 18  1  0
 17 19  2  0
M  CHG  2  17   1  18  -1
M  END
>  <Name>  (16) 
4-Nitropyrene

>  <InChIKey>  (16) 
UISKIUIWPSPSAV-UHFFFAOYSA-N

>  <PubChem_CID>  (16) 
62134

>  <CYP1A2>  (16) 
<17,19;UnspReduction;R1>
<17,18;UnspReduction;R1>
<9,11;Epoxidation;R2>

>  <CYP2A6>  (16) 


>  <CYP2B6>  (16) 


>  <CYP2C8>  (16) 


>  <CYP2C9>  (16) 


>  <CYP2C19>  (16) 


>  <CYP2D6>  (16) 


>  <CYP2E1>  (16) 


>  <CYP3A4>  (16) 
<0,1;Reduction;R1>
<1,2;Reduction;R1>
<11,H;Hydroxylation;R2>
<10,H;Hydroxylation;R3>
<10,11;Epoxidation;R4>
<6,H;Hydroxylation;R5>
<8,H;Hydroxylation;R6>

>  <References>  (16) 
Chae YH, Thomas T, Guengerich FP, Fu PP, El-Bayoumy K: Comparative metabolism of 1-, 2-, and 4-nitropyrene by human hepatic and pulmonary microsomes. Cancer Res. 1999 Apr 1;59(7):1473-80. (PMID: 10197616)

>  <Comments>  (16) 
One of the metabolites is 4-AP.

$$$$
CC01820
     RDKit          3D

 19 22  0  0  0  0  0  0  0  0999 V2000
    3.9590   -0.3410    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9710   -1.7600    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7300    0.3610   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1470    0.4000    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7200    1.7790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7470   -2.4650   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1580   -2.5120    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9400    2.4970    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1550    1.7960    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4000    2.4610    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5400   -0.3830   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5430   -1.7730   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7310   -3.8600   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1380   -3.9060    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5190    2.5120   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9080    3.9000    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9220   -4.5790   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5060    3.9040   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7050    4.6010    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  6  2  0
  2  7  1  0
  3  5  2  0
  3 11  1  0
  4  9  1  0
  5  8  1  0
  5 15  1  0
  6 12  1  0
  6 13  1  0
  7 14  2  0
  8  9  2  0
  8 16  1  0
  9 10  1  0
 11 12  2  0
 13 17  2  0
 14 17  1  0
 15 18  2  0
 16 19  2  0
 18 19  1  0
M  END
>  <Name>  (17) 
6-Aminochrysene

>  <InChIKey>  (17) 
KIVUHCNVDWYUNP-UHFFFAOYSA-N

>  <PubChem_CID>  (17) 
17534

>  <CYP1A2>  (17) 
<0,H;Hydroxylation;R1>
<7,8;Epoxidation;R2>

>  <CYP2A6>  (17) 
<0,H;Hydroxylation;R1>

>  <CYP2B6>  (17) 
<0,H;Hydroxylation;R1>
<7,8;Epoxidation;R2>

>  <CYP2C8>  (17) 


>  <CYP2C9>  (17) 


>  <CYP2C19>  (17) 


>  <CYP2D6>  (17) 
<0,H;Hydroxylation;R1>
<7,8;Epoxidation;R2>

>  <CYP2E1>  (17) 


>  <CYP3A4>  (17) 
<0,H;Hydroxylation;R1>
<7,8;Epoxidation;R2>

>  <References>  (17) 
Yamazaki H, Mimura M, Oda Y, Inui Y, Shiraga T, Iwasaki K, Guengerich FP, Shimada T: Roles of different forms of cytochrome P450 in the activation of the promutagen 6-aminochrysene to genotoxic metabolites in human liver microsomes. Carcinogenesis. 1993 Jul;14(7):1271-8. doi: 10.1093/carcin/14.7.1271. (PMID: 8330339)
Yun CH, Shimada T, Guengerich FP: Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol Pharmacol. 1991 Nov;40(5):679-85. (PMID: 1944238)
Koehl W, Amin S, Staretz ME, Ueng YF, Yamazaki H, Tateishi T, Guengerich FP, Hecht SS: Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes. Cancer Res. 1996 Jan 15;56(2):316-24. (PMID: 8542586)

>  <Comments>  (17) 


$$$$
CC01821
     RDKit          2D

 21 24  0  0  0  0  0  0  0  0999 V2000
    1.7860    2.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    2.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.6500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570   -2.0620    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -2.0620    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1 18  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5 18  2  0
  6  7  2  0
  6 15  1  0
  7  8  1  0
  8  9  2  0
  8 19  1  0
  9 10  1  0
  9 14  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 19 20  2  0
 19 21  1  0
M  CHG  2  19   1  21  -1
M  END
>  <Name>  (18) 
6-Nitrochrysene

>  <InChIKey>  (18) 
UAWLTQJFZUYROA-UHFFFAOYSA-N

>  <PubChem_CID>  (18) 
24121

>  <CYP1A2>  (18) 
<9,10;EpOxidation;R1>

>  <CYP2A6>  (18) 


>  <CYP2B6>  (18) 


>  <CYP2C8>  (18) 


>  <CYP2C9>  (18) 


>  <CYP2C19>  (18) 


>  <CYP2D6>  (18) 


>  <CYP2E1>  (18) 
<0,1;UnspReduction;R1>
<1,2;UnspReduction;R1>

>  <CYP3A4>  (18) 
<9,10;EpOxidation;R1>
<0,1;UnspReduction;R2>
<1,2;UnspReduction;R2>

>  <References>  (18) 
Chae YH, Yun CH, Guengerich FP, Kadlubar FF, el-Bayoumy K: Roles of human hepatic and pulmonary cytochrome P450 enzymes in the metabolism of the environmental carcinogen 6-nitrochrysene. Cancer Res. 1993 May 1;53(9):2028-34. (PMID: 8481905)

>  <Comments>  (18) 


$$$$
CC01822
     RDKit          3D

 19 22  0  0  0  0  0  0  0  0999 V2000
   -0.0120    1.4320    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0320    0.0250   -0.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2160    2.1090    0.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    2.1260   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2590   -0.6530   -0.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1830   -0.6670   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4240    1.3760    0.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2790    3.5050    0.4290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4370    1.4680   -0.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4600    0.0880   -0.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3430   -2.0470   -0.4620 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3960   -0.0150    0.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6350   -0.8460    0.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6310    2.0590    0.5570 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4850    4.1680    0.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6800   -0.5540   -0.5830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5640   -2.6850   -0.6730 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6650    3.4420    0.7060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7330   -1.9370   -0.7330 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  7 12  1  0
  7 14  1  0
  8 15  2  0
  9 10  2  0
 10 16  1  0
 11 17  2  0
 12 13  1  0
 14 18  2  0
 15 18  1  0
 16 19  2  0
 17 19  1  0
M  END
>  <Name>  (19) 
6-Methylchrysene

>  <InChIKey>  (19) 
ASVDRLYVNFOSCI-UHFFFAOYSA-N

>  <PubChem_CID>  (19) 
15564

>  <CYP1A2>  (19) 
<5,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>
<7,8;EpOxidation;R3>

>  <CYP2A6>  (19) 


>  <CYP2B6>  (19) 


>  <CYP2C8>  (19) 


>  <CYP2C9>  (19) 


>  <CYP2C19>  (19) 


>  <CYP2D6>  (19) 
<0,H;Hydroxylation;R1>
<7,8;EpOxidation;R2>

>  <CYP2E1>  (19) 
<0,H;Hydroxylation;R1>
<7,8;EpOxidation;R2>

>  <CYP3A4>  (19) 
<5,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>
<7,H;Hydroxylation;R3>
<6,H;Hydroxylation;R4>
<7,8;EpOxidation;R5>

>  <References>  (19) 
Koehl W, Amin S, Staretz ME, Ueng YF, Yamazaki H, Tateishi T, Guengerich FP, Hecht SS: Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes. Cancer Res. 1996 Jan 15;56(2):316-24. (PMID: 8542586)

>  <Comments>  (19) 
Metabolites lower than 0.02 are not considered.

$$$$
CC01823
     RDKit          3D

 20 21  0  0  0  0  0  0  0  0999 V2000
    1.2810    0.6620    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1060    1.3820   -0.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0910    0.6950   -0.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2040    1.4660   -0.5690 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3670    0.6630   -0.7360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5440    1.5820   -0.9480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7980    0.7630   -1.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9750    1.6820   -1.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0980   -0.7000   -0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0880   -1.4050   -0.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2970   -0.7310    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5660   -1.4230    0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6140   -2.9130    0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8410   -3.4180    1.2990 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.8700   -3.3870    0.5160 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1840   -3.4700   -0.8570 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.6670   -0.6850    0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6810    0.7770    0.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7240    1.4010    0.5360 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4630    1.4080    0.1760 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1 11  1  0
  1 20  1  0
  2  3  1  0
  3  4  1  0
  3  9  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 17  2  0
 13 14  1  0
 13 15  1  0
 13 16  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
M  END
>  <Name>  (20) 
7-Benzyloxy-4-trifluoromethylcoumarin

>  <InChIKey>  (20) 
BXGYIRIVTYGQAU-UHFFFAOYSA-N

>  <PubChem_CID>  (20) 
2267955

>  <CYP1A2>  (20) 
<3,4;Cleavage;R1>
<3,H;Oxidation;R1>

>  <CYP2A6>  (20) 


>  <CYP2B6>  (20) 
<3,4;Cleavage;R1>
<3,H;Oxidation;R1>

>  <CYP2C8>  (20) 
<3,4;Cleavage;R1>
<3,H;Oxidation;R1>

>  <CYP2C9>  (20) 
<3,4;Cleavage;R1>
<3,H;Oxidation;R1>

>  <CYP2C19>  (20) 
<3,4;Cleavage;R1>
<3,H;Oxidation;R1>

>  <CYP2D6>  (20) 


>  <CYP2E1>  (20) 


>  <CYP3A4>  (20) 
<3,4;Cleavage;R1>
<3,H;Oxidation;R1>

>  <References>  (20) 
Donato MT, Jimenez N, Castell JV, Gomez-Lechon MJ: Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes. Drug Metab Dispos. 2004 Jul;32(7):699-706. doi: 10.1124/dmd.32.7.699. (PMID: 15205384)

>  <Comments>  (20) 
Rate of metabolite for CYP2C8 is low and not recorded in Xenosite.

$$$$
CC01824
     RDKit          3D

 18 20  0  0  0  0  0  0  0  0999 V2000
    0.1470    0.4260   -0.4390 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0110   -0.6010    0.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4140    0.9480   -0.6840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9600    0.9200   -1.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2620   -1.1050    0.7410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0690   -1.0870    1.1860 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5120    0.4550    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2240    0.3960   -0.8800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3790   -0.6200    0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5750   -1.2020    0.3740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6440   -0.6360   -0.3790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9200   -1.3020    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2850   -0.5550    0.9210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6890   -0.7850    1.0520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8810   -1.4080    1.4160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3050   -2.5490    0.7390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5380   -3.0670   -0.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3470   -2.4450   -0.6670 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  4  8  2  0
  5  9  2  0
  6 13  1  0
  7 13  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 14  2  0
 12 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
M  END
>  <Name>  (21) 
7-Benzyloxyquinoline

>  <InChIKey>  (21) 
SIDLHXXVIBTSJZ-UHFFFAOYSA-N

>  <PubChem_CID>  (21) 
3035604

>  <CYP1A2>  (21) 
<4,H;Oxidation;R1>
<4,5;Cleavage;R1>

>  <CYP2A6>  (21) 


>  <CYP2B6>  (21) 


>  <CYP2C8>  (21) 


>  <CYP2C9>  (21) 


>  <CYP2C19>  (21) 


>  <CYP2D6>  (21) 


>  <CYP2E1>  (21) 


>  <CYP3A4>  (21) 
<4,H;Oxidation;R1>
<4,5;Cleavage;R1>

>  <References>  (21) 
Stresser DM, Turner SD, Blanchard AP, Miller VP, Crespi CL: Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4. Drug Metab Dispos. 2002 Jul;30(7):845-52. doi: 10.1124/dmd.30.7.845. (PMID: 12065444)

>  <Comments>  (21) 
Xenosite reported wrong SoMs.

$$$$
CC01825
     RDKit          3D

 23 26  0  0  0  0  0  0  0  0999 V2000
    5.1790    1.2130    0.5290 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8540    1.3000    0.0400 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4990    1.0090    0.9630 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0240   -1.3890   -0.6930 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3040    0.5560    0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2400   -0.7100   -0.5070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9680    0.5580    0.3550 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9540   -0.7820   -0.2820 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5240    1.2060    0.2600 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7010    0.5940   -0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4250   -1.3130   -0.9290 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6480   -0.6670   -0.7600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8360    1.1300    0.7560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6450   -1.4340   -0.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5350    0.4730    0.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5210   -0.8530   -0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9940    0.5850   -0.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2160    1.4010   -0.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9130    1.2670    1.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0550    2.0300    1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5020    2.9270    0.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8080    3.0620   -0.9150 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6660    2.3000   -1.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  1  7  1  0
  2 10  1  0
  2 17  1  0
  3 15  2  0
  4  6  1  0
  4  8  2  0
  5  6  2  0
  5  9  1  0
  6 11  1  0
  7  8  1  0
  7 13  2  0
  8 14  1  0
  9 10  2  0
 10 12  1  0
 11 12  2  0
 13 15  1  0
 14 16  2  0
 15 16  1  0
 17 18  1  0
 18 19  2  0
 18 23  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
M  END
>  <Name>  (22) 
7-Benzyloxyresorufin

>  <InChIKey>  (22) 
XNZRYTITWLGTJS-UHFFFAOYSA-N

>  <PubChem_CID>  (22) 
114982

>  <CYP1A2>  (22) 
<11,H;Oxidation;R1>
<10,11;Cleavage;R1>

>  <CYP2A6>  (22) 


>  <CYP2B6>  (22) 
<11,H;Oxidation;R1>
<10,11;Cleavage;R1>

>  <CYP2C8>  (22) 
<11,H;Oxidation;R1>
<10,11;Cleavage;R1>

>  <CYP2C9>  (22) 


>  <CYP2C19>  (22) 


>  <CYP2D6>  (22) 


>  <CYP2E1>  (22) 


>  <CYP3A4>  (22) 
<11,H;Oxidation;R1>
<10,11;Cleavage;R1>

>  <References>  (22) 
Waxman DJ, Lapenson DP, Aoyama T, Gelboin HV, Gonzalez FJ, Korzekwa K: Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch Biochem Biophys. 1991 Oct;290(1):160-6. doi: 10.1016/0003-9861(91)90602-f. (PMID: 1898086)
Niwa T, Shiraga T, Yamasaki S, Ishibashi K, Ohno Y, Kagayama A: In vitro activation of 7-benzyloxyresorufin O-debenzylation and nifedipine oxidation in human liver microsomes. Xenobiotica. 2003 Jul;33(7):717-29. doi: 10.1080/0049825031000121617. (PMID: 12893521)

>  <Comments>  (22) 


$$$$
CC01826
     RDKit          3D

 14 15  0  0  0  0  0  0  0  0999 V2000
    1.3350    0.6350    0.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1530    1.3550   -0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0500    0.6620   -0.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1730    1.4310   -0.3300 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3420    0.6270   -0.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5300    1.5460   -0.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0530   -0.7360   -0.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1400   -1.4460   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3410   -0.7550    0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5980   -1.4580    0.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7280   -0.7630    0.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7550    0.7030    0.3280 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8120    1.3130    0.4350 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5360    1.3580    0.1850 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  9  1  0
  1 14  1  0
  2  3  1  0
  3  4  1  0
  3  7  2  0
  4  5  1  0
  5  6  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
M  END
>  <Name>  (23) 
7-Ethoxycoumarin

>  <InChIKey>  (23) 
LIFAQMGORKPVDH-UHFFFAOYSA-N

>  <PubChem_CID>  (23) 
35703

>  <CYP1A2>  (23) 
<1,2;Cleavage;R1>
<1,H;Oxidaiton;R1>
<8,H;Hydroxylation;R2>

>  <CYP2A6>  (23) 
<1,2;Cleavage;R1>
<1,H;Oxidaiton;R1>
<8,H;Hydroxylation;R2>

>  <CYP2B6>  (23) 
<1,2;Cleavage;R1>
<1,H;Oxidaiton;R1>

>  <CYP2C8>  (23) 
<1,2;Cleavage;R1>
<1,H;Oxidaiton;R1>

>  <CYP2C9>  (23) 
<1,2;Cleavage;R1>
<1,H;Oxidaiton;R1>

>  <CYP2C19>  (23) 
<1,2;Cleavage;R1>
<1,H;Oxidaiton;R1>

>  <CYP2D6>  (23) 
<1,2;Cleavage;R1>
<1,H;Oxidaiton;R1>

>  <CYP2E1>  (23) 
<1,2;Cleavage;R1>
<1,H;Oxidaiton;R1>

>  <CYP3A4>  (23) 
<1,2;Cleavage;R1>
<1,H;Oxidaiton;R1>

>  <References>  (23) 
Kim KH, Isin EM, Yun CH, Kim DH, Guengerich FP: Kinetic deuterium isotope effects for 7-alkoxycoumarin O-dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. Rate-limiting C-H bond breaking in cytochrome P450 1A2 substrate oxidation. FEBS J. 2006 May;273(10):2223-31. doi: 10.1111/j.1742-4658.2006.05235.x. (PMID: 16649998)
Shimada T, Tsumura F, Yamazaki H: Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes. Drug Metab Dispos. 1999 Nov;27(11):1274-80. (PMID: 10534312)
Yun CH, Kim KH, Calcutt MW, Guengerich FP: Kinetic analysis of oxidation of coumarins by human cytochrome P450 2A6. J Biol Chem. 2005 Apr 1;280(13):12279-91. doi: 10.1074/jbc.M411019200. Epub 2005  Jan 22. (PMID: 15665333)

>  <Comments>  (23) 


$$$$
CC01827
     RDKit          2D

 18 20  0  0  0  0  0  0  0  0999 V2000
    5.5300    1.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0600    1.0240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000    1.0240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5300   -1.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3960    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3960   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6640    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6640   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2900    1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1960    0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2900   -1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1960   -0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7700    1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7700   -1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8640    0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8640   -0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9280    0.5280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7920    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  1  7  1  0
  2 10  1  0
  2 17  1  0
  3 15  2  0
  4  6  1  0
  4  8  2  0
  5  6  2  0
  5  9  1  0
  6 11  1  0
  7  8  1  0
  7 13  2  0
  8 14  1  0
  9 10  2  0
 10 12  1  0
 11 12  2  0
 13 15  1  0
 14 16  2  0
 15 16  1  0
 17 18  1  0
M  END
>  <Name>  (24) 
7-Ethoxyresorufin

>  <InChIKey>  (24) 
CRCWUBLTFGOMDD-UHFFFAOYSA-N

>  <PubChem_CID>  (24) 
3294

>  <CYP1A2>  (24) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2A6>  (24) 


>  <CYP2B6>  (24) 


>  <CYP2C8>  (24) 


>  <CYP2C9>  (24) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2C19>  (24) 


>  <CYP2D6>  (24) 


>  <CYP2E1>  (24) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP3A4>  (24) 


>  <References>  (24) 
Lee QH, Fantel AG, Juchau MR: Human embryonic cytochrome P450S: phenoxazone ethers as probes for expression of functional isoforms during organogenesis. Biochem Pharmacol. 1991 Nov 27;42(12):2377-85. doi: 10.1016/0006-2952(91)90244-y. (PMID: 1764121)

>  <Comments>  (24) 


$$$$
CC01829
     RDKit          2D

 13 14  0  0  0  0  0  0  0  0999 V2000
    6.3580   -1.0350    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660   -1.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1280   -1.0240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4640    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4640   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5980   -1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5980    1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3580    1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2640    0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2640   -0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  1 12  1  0
  2  8  1  0
  2 13  1  0
  3 12  2  0
  4  5  2  0
  4  7  1  0
  4 10  1  0
  5  6  1  0
  6  8  2  0
  7  9  2  0
  8  9  1  0
 10 11  2  0
 11 12  1  0
M  END
>  <Name>  (25) 
7-Methoxycoumarin

>  <InChIKey>  (25) 
LIIALPBMIOVAHH-UHFFFAOYSA-N

>  <PubChem_CID>  (25) 
10748

>  <CYP1A2>  (25) 
<7,H;Hydroxylation;R1>
<0,H;Oxidation;R2>
<0,1;Cleavage;R2>

>  <CYP2A6>  (25) 
<7,H;Hydroxylation;R1>
<0,H;Oxidation;R2>
<0,1;Cleavage;R2>

>  <CYP2B6>  (25) 


>  <CYP2C8>  (25) 


>  <CYP2C9>  (25) 


>  <CYP2C19>  (25) 


>  <CYP2D6>  (25) 


>  <CYP2E1>  (25) 


>  <CYP3A4>  (25) 


>  <References>  (25) 
Kim KH, Isin EM, Yun CH, Kim DH, Guengerich FP: Kinetic deuterium isotope effects for 7-alkoxycoumarin O-dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. Rate-limiting C-H bond breaking in cytochrome P450 1A2 substrate oxidation. FEBS J. 2006 May;273(10):2223-31. doi: 10.1111/j.1742-4658.2006.05235.x. (PMID: 16649998)
Yun CH, Kim KH, Calcutt MW, Guengerich FP: Kinetic analysis of oxidation of coumarins by human cytochrome P450 2A6. J Biol Chem. 2005 Apr 1;280(13):12279-91. doi: 10.1074/jbc.M411019200. Epub 2005  Jan 22. (PMID: 15665333)

>  <Comments>  (25) 


$$$$
CC01830
     RDKit          2D

 17 19  0  0  0  0  0  0  0  0999 V2000
    5.5300    1.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0600    1.0240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000    1.0240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5300   -1.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3960    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3960   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6640    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6640   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2900    1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1960    0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2900   -1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1960   -0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7700    1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7700   -1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8640    0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8640   -0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9280    0.5280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  1  7  1  0
  2 10  1  0
  2 17  1  0
  3 15  2  0
  4  6  1  0
  4  8  2  0
  5  6  2  0
  5  9  1  0
  6 11  1  0
  7  8  1  0
  7 13  2  0
  8 14  1  0
  9 10  2  0
 10 12  1  0
 11 12  2  0
 13 15  1  0
 14 16  2  0
 15 16  1  0
M  END
>  <Name>  (26) 
7-Methoxyresorufin

>  <InChIKey>  (26) 
KNYYMGDYROYBRE-UHFFFAOYSA-N

>  <PubChem_CID>  (26) 
119220

>  <CYP1A2>  (26) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (26) 


>  <CYP2B6>  (26) 


>  <CYP2C8>  (26) 


>  <CYP2C9>  (26) 


>  <CYP2C19>  (26) 


>  <CYP2D6>  (26) 


>  <CYP2E1>  (26) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP3A4>  (26) 


>  <References>  (26) 
Lee QH, Fantel AG, Juchau MR: Human embryonic cytochrome P450S: phenoxazone ethers as probes for expression of functional isoforms during organogenesis. Biochem Pharmacol. 1991 Nov 27;42(12):2377-85. doi: 10.1016/0006-2952(91)90244-y. (PMID: 1764121)

>  <Comments>  (26) 


$$$$
CC01831
     RDKit          3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    5.2650    1.2870   -0.3200 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.9660    1.2130   -0.3450 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5630    1.2360   -0.2660 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1490   -1.5190    0.3120 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4070    0.5370   -0.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3620   -0.8290    0.1460 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0580    0.6230   -0.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0640   -0.8250    0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6240    1.1950   -0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8180    0.4910   -0.1730 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5620   -1.5240    0.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7830   -0.8690    0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9110    1.2820   -0.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7570   -1.4820    0.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6110    0.6200   -0.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6170   -0.8130    0.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1220    0.4000   -0.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3390    1.2660   -0.3800 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5860    0.4360   -0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8040    1.3010   -0.4110 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0500    0.4700   -0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  1  7  1  0
  2 10  1  0
  2 17  1  0
  3 15  2  0
  4  6  1  0
  4  8  2  0
  5  6  2  0
  5  9  1  0
  6 11  1  0
  7  8  1  0
  7 13  2  0
  8 14  1  0
  9 10  2  0
 10 12  1  0
 11 12  2  0
 13 15  1  0
 14 16  2  0
 15 16  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
M  END
>  <Name>  (27) 
7-Pentoxyresorufin

>  <InChIKey>  (27) 
ZPSOKQFFOYYPKC-UHFFFAOYSA-N

>  <PubChem_CID>  (27) 
107683

>  <CYP1A2>  (27) 
<4,H;Oxidation;R1>
<4,5;Cleavage;R1>

>  <CYP2A6>  (27) 


>  <CYP2B6>  (27) 
<4,H;Oxidation;R1>
<4,5;Cleavage;R1>

>  <CYP2C8>  (27) 


>  <CYP2C9>  (27) 


>  <CYP2C19>  (27) 


>  <CYP2D6>  (27) 
<4,H;Oxidation;R1>
<4,5;Cleavage;R1>

>  <CYP2E1>  (27) 


>  <CYP3A4>  (27) 
<4,H;Oxidation;R1>
<4,5;Cleavage;R1>

>  <References>  (27) 
Hanna IH, Reed JR, Guengerich FP, Hollenberg PF: Expression of human cytochrome P450 2B6 in Escherichia coli: characterization of catalytic activity and expression levels in human liver. Arch Biochem Biophys. 2000 Apr 1;376(1):206-16. doi: 10.1006/abbi.2000.1708. (PMID: 10729207)
Lee QH, Fantel AG, Juchau MR: Human embryonic cytochrome P450S: phenoxazone ethers as probes for expression of functional isoforms during organogenesis. Biochem Pharmacol. 1991 Nov 27;42(12):2377-85. doi: 10.1016/0006-2952(91)90244-y. (PMID: 1764121)

>  <Comments>  (27) 


$$$$
CC01832
     RDKit          2D

 19 22  0  0  0  0  0  0  0  0999 V2000
    1.0720   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    0.6190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1 14  1  0
  2  3  1  0
  3  4  2  0
  3 18  1  0
  4  5  1  0
  4 15  1  0
  5  6  1  0
  5 14  2  0
  6  7  2  0
  7  8  1  0
  7 12  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 19  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
M  END
>  <Name>  (28) 
7MBAC

>  <InChIKey>  (28) 
LZUFUDJVBHLHFC-UHFFFAOYSA-N

>  <PubChem_CID>  (28) 
76861

>  <CYP1A2>  (28) 
<11,12;EpOxidation;R1>
<3,4;EpOxidation;R2>
<14,15;EpOxidation;R3>
<4,H;Hydroxylation;R4>
<12,H;Hydroxylation;R5>
<0,H;Hydroxylation;R6>

>  <CYP2A6>  (28) 


>  <CYP2B6>  (28) 


>  <CYP2C8>  (28) 


>  <CYP2C9>  (28) 


>  <CYP2C19>  (28) 


>  <CYP2D6>  (28) 


>  <CYP2E1>  (28) 


>  <CYP3A4>  (28) 
<11,12;EpOxidation;R1>
<3,4;EpOxidation;R2>
<14,15;EpOxidation;R3>
<4,H;Hydroxylation;R4>
<12,H;Hydroxylation;R5>
<0,H;Hydroxylation;R6>

>  <References>  (28) 
Roberts-Thomson SJ, McManus ME, Tukey RH, Gonzalez FJ, Holder GM: Metabolism of polycyclic aza-aromatic carcinogens catalyzed by four expressed human cytochromes P450. Cancer Res. 1995 Mar 1;55(5):1052-9. (PMID: 7866988)

>  <Comments>  (28) 


$$$$
CC01833
     RDKit          3D

 21 21  0  0  0  0  0  0  0  0999 V2000
   12.4990    1.0310    1.0610 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8230   -1.7510    0.2600 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3690   -3.1400   -0.1700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5050   -4.1340   -0.2070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1130   -1.3120   -0.4120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6130   -3.6580   -1.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9010   -2.1920   -1.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6680   -0.8150   -0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0300   -1.7590    1.7640 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3810    0.1120   -0.3320 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1350   -1.8110   -1.8100 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5710    0.6880   -0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8160    2.1040   -0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6550    3.0250   -0.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0310    2.6280    0.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2560    1.9020    0.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4190    2.5280    0.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6980    1.8960    0.6630 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7500    0.4060    0.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7670    2.6730    0.8480 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1380    2.1950    1.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 21  2  0
  2  3  1  0
  2  5  1  0
  2  8  1  0
  2  9  1  0
  3  4  1  0
  4  6  1  0
  5  7  2  0
  5 10  1  0
  6  7  1  0
  7 11  1  0
 10 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 20 21  1  0
M  END
>  <Name>  (29) 
9-cis-Retinal

>  <InChIKey>  (29) 
NCYCYZXNIZJOKI-MKOSUFFBSA-N

>  <PubChem_CID>  (29) 
6436082

>  <CYP1A2>  (29) 
<13,H;Hydroxylation;R1>

>  <CYP2A6>  (29) 


>  <CYP2B6>  (29) 


>  <CYP2C8>  (29) 


>  <CYP2C9>  (29) 


>  <CYP2C19>  (29) 
<13,H;Hydroxylation;R1>

>  <CYP2D6>  (29) 


>  <CYP2E1>  (29) 


>  <CYP3A4>  (29) 
<13,H;Hydroxylation;R1>

>  <References>  (29) 
Zhang QY, Dunbar D, Kaminsky L: Human cytochrome P-450 metabolism of retinals to retinoic acids. Drug Metab Dispos. 2000 Mar;28(3):292-7. (PMID: 10681373)

>  <Comments>  (29) 


$$$$
CC01834
     RDKit          3D

 22 23  0  0  0  0  0  0  0  0999 V2000
    1.2550    0.6470   -0.3760 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0710    1.3510   -0.5820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1430    0.7520   -0.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2610    1.5030   -0.4840 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4440    0.7980   -0.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1550   -0.5400    0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0400   -1.2310    0.4720 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2630   -0.6410    0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5380   -1.3210    0.3390 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5100   -2.7090    0.8830 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6750   -0.6910    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0160   -1.3320    0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8780   -0.5930    1.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2660   -1.1700    1.2510 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9520   -1.2620   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9940    0.1000   -0.7490 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2950   -2.4960    1.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7040   -3.5890    1.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0600   -0.2420    2.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6790    0.6770   -0.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7370    1.2400   -0.7950 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4530    1.2960   -0.7200 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  8  1  0
  1 22  1  0
  2  3  1  0
  3  4  1  0
  3  6  2  0
  4  5  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11 12  1  0
 11 20  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 17  1  0
 14 19  1  0
 15 16  1  0
 17 18  1  0
 20 21  2  0
 20 22  1  0
M  CHG  1  14   1
M  END
>  <Name>  (30) 
AMMC

>  <InChIKey>  (30) 
IWAUXKQGXMTXLR-UHFFFAOYSA-N

>  <PubChem_CID>  (30) 
15487106

>  <CYP1A2>  (30) 
<15,16;Cleavage;R1>
<16,H;Oxidation;R1>

>  <CYP2A6>  (30) 


>  <CYP2B6>  (30) 
<15,16;Cleavage;R1>
<16,H;Oxidation;R1>

>  <CYP2C8>  (30) 


>  <CYP2C9>  (30) 


>  <CYP2C19>  (30) 


>  <CYP2D6>  (30) 
<15,16;Cleavage;R1>
<16,H;Oxidation;R1>

>  <CYP2E1>  (30) 


>  <CYP3A4>  (30) 


>  <References>  (30) 
Chauret N, Dobbs B, Lackman RL, Bateman K, Nicoll-Griffith DA, Stresser DM, Ackermann JM, Turner SD, Miller VP, Crespi CL: The use of 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a specific CYP2D6 probe in human liver microsomes. Drug Metab Dispos. 2001 Sep;29(9):1196-200. (PMID: 11502727)

>  <Comments>  (30) 


$$$$
CC01835
     RDKit          3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -0.1100    1.2610   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0110   -0.1270   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0270    2.0910   -0.0250 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3510    1.8940    0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3440   -0.7250   -0.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1580   -0.8880    0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3040    1.5500   -0.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5080    1.1200    0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4010    0.0910   -0.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4090   -0.2710    0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3110    2.2480   -0.0650 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5040   -2.2080   -0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8080   -2.5900   -0.0520 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.9560   -2.7790    1.0730 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.9170   -2.7810   -1.1100 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6900    1.8070    0.0580 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8030    0.9170    0.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0630    1.7130    0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6730    2.0820   -1.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8500    2.8260   -1.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4190    3.2030    0.1260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8120    2.8360    1.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6350    2.0910    1.3090 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  2  0
  5 12  1  0
  6 10  2  0
  7  9  1  0
  7 11  2  0
  8 10  1  0
  8 16  1  0
 12 13  1  0
 12 14  1  0
 12 15  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 23  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
M  END
>  <Name>  (31) 
BFC

>  <InChIKey>  (31) 
WVKLERKKJXUPIK-UHFFFAOYSA-N

>  <PubChem_CID>  (31) 
848780

>  <CYP1A2>  (31) 
<12,13;Cleavage;R1>
<13,H;Oxidation;R1>

>  <CYP2A6>  (31) 


>  <CYP2B6>  (31) 
<12,13;Cleavage;R1>
<13,H;Oxidation;R1>

>  <CYP2C8>  (31) 


>  <CYP2C9>  (31) 
<12,13;Cleavage;R1>
<13,H;Oxidation;R1>

>  <CYP2C19>  (31) 
<12,13;Cleavage;R1>
<13,H;Oxidation;R1>

>  <CYP2D6>  (31) 


>  <CYP2E1>  (31) 


>  <CYP3A4>  (31) 
<12,13;Cleavage;R1>
<13,H;Oxidation;R1>

>  <References>  (31) 
Renwick AB, Surry D, Price RJ, Lake BG, Evans DC: Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms. Xenobiotica. 2000 Oct;30(10):955-69. doi: 10.1080/00498250050200113. (PMID: 11315104)

>  <Comments>  (31) 


$$$$
CC01836
     RDKit          3D

 19 20  0  0  0  0  0  0  0  0999 V2000
   -0.0780    1.4220   -0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0270    0.0360   -0.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1000    2.1910   -0.3790 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2850    2.1100   -0.4170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2740   -0.6170   -0.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2310   -0.6660   -0.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3480    1.5840   -0.3620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4800    1.3960   -0.3870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3730    0.1290   -0.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4500    0.0070   -0.2640 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3870    2.2260   -0.4650 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3970   -2.0990    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3590   -2.6270    1.3790 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0190   -2.8000    1.8010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1030   -3.3390    3.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6140   -4.6600    3.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4900   -5.1360    4.7930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6250    2.1360   -0.4890 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7820    1.3100   -0.4490 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  2  0
  5 12  1  0
  6 10  2  0
  7  9  1  0
  7 11  2  0
  8 10  1  0
  8 18  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 18 19  1  0
M  END
>  <Name>  (32) 
BMAMC

>  <InChIKey>  (32) 
AHKHKMDMRHPLNJ-UHFFFAOYSA-N

>  <PubChem_CID>  (32) 
85782015

>  <CYP1A2>  (32) 
<3,4;Cleavage;R1>
<3,H;Oxidation;R1>
<14,15;Cleavage;R2>
<15,H;Oxidation;R2>

>  <CYP2A6>  (32) 


>  <CYP2B6>  (32) 


>  <CYP2C8>  (32) 


>  <CYP2C9>  (32) 
<14,15;Cleavage;R1>
<15,H;Oxidation;R1>

>  <CYP2C19>  (32) 
<14,15;Cleavage;R1>
<15,H;Oxidation;R1>

>  <CYP2D6>  (32) 
<14,15;Cleavage;R1>
<15,H;Oxidation;R1>

>  <CYP2E1>  (32) 


>  <CYP3A4>  (32) 


>  <References>  (32) 
Venhorst J, Onderwater RC, Meerman JH, Commandeur JN, Vermeulen NP: Influence of N-substitution of 7-methoxy-4-(aminomethyl)-coumarin on cytochrome P450 metabolism and selectivity. Drug Metab Dispos. 2000 Dec;28(12):1524-32. (PMID: 11095593)

>  <Comments>  (32) 


$$$$
CC01838
     RDKit          3D

 18 20  0  0  0  0  0  0  0  0999 V2000
   -0.0160    1.3460    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1410    2.0430    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1940    2.0020    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5380   -0.6750    0.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5860   -0.7260   -1.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9940    1.9420    0.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4440    2.9240   -1.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2160    3.3490    0.0260 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2340    1.3780    0.0200 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5960   -2.1490    0.9380 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0400    0.0180    2.1870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5470   -2.0400   -1.1860 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2760    2.6700    0.9390 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6690    1.1490    2.1870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5810    3.5840   -1.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0860   -2.7920   -0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5530    3.4430   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  4 10  2  0
  5 11  1  0
  5 12  1  0
  6 13  2  0
  7 14  1  0
  7 15  1  0
  8 16  2  0
 11 17  2  0
 12 15  2  0
 13 17  1  0
 14 18  2  0
 16 18  1  0
M  END
>  <Name>  (33) 
Carbamazepine

>  <InChIKey>  (33) 
FFGPTBGBLSHEPO-UHFFFAOYSA-N

>  <PubChem_CID>  (33) 
2554

>  <CYP1A2>  (33) 
<15,H;Hydroxylation;R1>
<14,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<7,H;Hydroxylation;R4>

>  <CYP2A6>  (33) 
<15,H;Hydroxylation;R1>
<14,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<7,H;Hydroxylation;R4>

>  <CYP2B6>  (33) 
<15,H;Hydroxylation;R1>
<14,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<7,H;Hydroxylation;R4>

>  <CYP2C8>  (33) 
<10,11;EpOxidation;R1>
<15,H;Hydroxylation;R2>
<14,H;Hydroxylation;R3>
<6,H;Hydroxylation;R4>
<7,H;Hydroxylation;R5>

>  <CYP2C9>  (33) 


>  <CYP2C19>  (33) 


>  <CYP2D6>  (33) 
<15,H;Hydroxylation;R1>
<14,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<7,H;Hydroxylation;R4>

>  <CYP2E1>  (33) 
<15,H;Hydroxylation;R1>
<14,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<7,H;Hydroxylation;R4>

>  <CYP3A4>  (33) 
<10,11;EpOxidation;R1>
<15,H;Hydroxylation;R2>
<14,H;Hydroxylation;R3>
<6,H;Hydroxylation;R4>
<7,H;Hydroxylation;R5>

>  <References>  (33) 
Pearce RE, Vakkalagadda GR, Leeder JS: Pathways of carbamazepine bioactivation in vitro I. Characterization of human cytochromes P450 responsible for the formation of 2- and 3-hydroxylated metabolites. Drug Metab Dispos. 2002 Nov;30(11):1170-9. doi: 10.1124/dmd.30.11.1170. (PMID: 12386121)
Parkinson A (2001). Biotransformation of xenobiotics. In Casarett and Doull's Toxicology: The Basic Science of Poisons (6th ed., pp. 172). New York: McGraw-Hill Education / Medical. (ISBN: 9780071347211)

>  <Comments>  (33) 


$$$$
CC01839
     RDKit          3D

 19 21  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.3910    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1450   -0.6580   -0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3060   -0.0320   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3720    1.3500   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2000    2.0840    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3000    2.1260    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3910    1.8440   -0.7640 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3800    2.7220   -0.4760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9310    3.5780    0.5010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6010    3.1890    0.8110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5550    3.9320    1.9810 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -4.7360    2.7270   -1.1390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5000    0.7730   -1.7620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6500    1.8760   -2.4120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9810    0.5390   -2.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6860    4.6870    1.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3620    4.4910    2.1010 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6270    5.9190    0.5660 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  7  8  1  0
  7 11  2  0
  8  9  1  0
  8 14  1  0
  9 10  2  0
  9 13  1  0
 10 11  1  0
 10 17  1  0
 11 12  1  0
 13 15  1  0
 14 16  1  0
 15 16  1  0
 17 18  2  0
 17 19  1  0
M  END
>  <Name>  (34) 
CMV423

>  <InChIKey>  (34) 
KNGXENHWYNLKBU-UHFFFAOYSA-N

>  <PubChem_CID>  (34) 
489128

>  <CYP1A2>  (34) 
<15,H;Hydroxylation;R1>

>  <CYP2A6>  (34) 


>  <CYP2B6>  (34) 


>  <CYP2C8>  (34) 
<11,N;N-Oxidation;R1>
<15,H;Hydroxylation;R2>

>  <CYP2C9>  (34) 
<15,H;Hydroxylation;R1>

>  <CYP2C19>  (34) 


>  <CYP2D6>  (34) 


>  <CYP2E1>  (34) 


>  <CYP3A4>  (34) 
<15,H;Hydroxylation;R1>

>  <References>  (34) 
Bournique B, Lambert N, Boukaiba R, Martinet M: In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide). Br J Clin Pharmacol. 2001 Jul;52(1):53-63. doi: 10.1046/j.0306-5251.2001.01413.x. (PMID: 11453890)

>  <Comments>  (34) 


$$$$
CC01840
     RDKit          3D

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.8370    0.6700   -1.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4420    1.2230   -1.2360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2500    1.1140   -0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6340    1.6900   -0.0550 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.7660    0.4380    1.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5120   -0.1160    1.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3130    0.0020   -0.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7090    3.2000   -0.3090 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.0000    4.0160    0.6700 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6120    4.1550    0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1560    5.0480    1.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1430    3.6880   -0.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0570    2.8440   -1.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8980    1.3690   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5250    0.9120   -0.9120 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9930    4.5450    2.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1390    3.1990    2.3250 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7010    5.3950    3.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5700    6.7730    2.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7380    7.2990    1.8660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6750    8.6620    1.8000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1970    9.1930    0.8100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4720    8.8030    1.0190 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.1960    8.8320   -0.4300 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1570   10.5420    0.8830 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0390    6.4310    1.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  7  1  0
  2  3  1  0
  4  3  1  6
  3  5  2  0
  4  8  1  0
  4 15  1  0
  5  6  1  0
  6  7  2  0
  8  9  1  1
  8 12  1  0
  9 10  1  0
 10 11  1  0
 11 16  2  0
 11 26  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 20 26  2  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 22 25  1  0
M  END
>  <Name>  (35) 
CP-125-611

>  <InChIKey>  (35) 
IZRHKURJIQCXMT-AEFFLSMTSA-N

>  <PubChem_CID>  (35) 


>  <CYP1A2>  (35) 
<14,H;Oxidation;R1>
<13,14;Cleavage;R1>
<5,6;Cleavage;R2>

>  <CYP2A6>  (35) 
<14,H;Oxidation;R1>
<13,14;Cleavage;R1>

>  <CYP2B6>  (35) 
<14,H;Oxidation;R1>
<13,14;Cleavage;R1>

>  <CYP2C8>  (35) 
<14,H;Oxidation;R1>
<13,14;Cleavage;R1>

>  <CYP2C9>  (35) 
<14,H;Oxidation;R1>
<13,14;Cleavage;R1>

>  <CYP2C19>  (35) 
<14,H;Oxidation;R1>
<13,14;Cleavage;R1>
<5,6;Cleavage;R2>

>  <CYP2D6>  (35) 
<14,H;Oxidation;R1>
<13,14;Cleavage;R1>

>  <CYP2E1>  (35) 
<14,H;Oxidation;R1>
<13,14;Cleavage;R1>

>  <CYP3A4>  (35) 
<14,H;Oxidation;R1>
<13,14;Cleavage;R1>
<5,6;Cleavage;R2>

>  <References>  (35) 
Obach RS, Margolis JM, Logman MJ: In vitro metabolism of CP-122,721 ((2S,3S)-2-phenyl-3-[(5-trifluoromethoxy-2-methoxy)benzylamino]piperidine), a non-peptide antagonist of the substance P receptor. Drug Metab Pharmacokinet. 2007 Oct;22(5):336-49. (PMID: 17965517)

>  <Comments>  (35) 
Quinone is not observed.

$$$$
CC01841
     RDKit          3D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -1.8080    3.8640    0.5460 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4930    4.1910    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2830    5.0800    0.9350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2670    4.5630    1.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4880    3.2130    1.7300 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4910    2.8110    2.6570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9700    5.4250    2.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7010    6.7920    2.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7250    7.3130    1.7770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5390    8.6650    1.8480 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4560    9.2040    0.9890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6730    8.6930    1.2710 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1560    8.9780   -0.3070 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5090   10.5410    1.1800 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0220    6.4530    0.9370 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3 15  1  0
  4  5  1  0
  4  7  1  0
  5  6  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 15  2  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 11 14  1  0
M  END
>  <Name>  (36) 
CP-677-623

>  <InChIKey>  (36) 
JGFONUZHXXBGTF-UHFFFAOYSA-N

>  <PubChem_CID>  (36) 
23192118

>  <CYP1A2>  (36) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (36) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2B6>  (36) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C8>  (36) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C9>  (36) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (36) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2D6>  (36) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (36) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP3A4>  (36) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (36) 
Obach RS, Margolis JM, Logman MJ: In vitro metabolism of CP-122,721 ((2S,3S)-2-phenyl-3-[(5-trifluoromethoxy-2-methoxy)benzylamino]piperidine), a non-peptide antagonist of the substance P receptor. Drug Metab Pharmacokinet. 2007 Oct;22(5):336-49. (PMID: 17965517)

>  <Comments>  (36) 


$$$$
CC01842
     RDKit          2D

 22 26  0  0  0  0  0  0  0  0999 V2000
    1.4290    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.4440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4290   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1430   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1430   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4290    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8580    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8580    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4290    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1430    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1 14  2  0
  1 18  1  0
  2  3  2  0
  2 15  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5 14  1  0
  6  7  2  0
  7  8  1  0
  7 12  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 22  1  0
 11 12  1  0
 11 19  1  0
 12 13  2  0
 13 14  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
M  END
>  <Name>  (37) 
DBAJAC

>  <InChIKey>  (37) 
ANUCHZVCBDOPOX-UHFFFAOYSA-N

>  <PubChem_CID>  (37) 
9177

>  <CYP1A2>  (37) 
<11,12;EpOxidation;R1>
<6,7;EpOxidation;R2>
<14,15;EpOxidation;R3>
<0,5;EpOxidation;R4>
<16,17;EpOxidation;R5>
<1,2;EpOxidation;R6>
<9,N;N-Oxidation;R7>
<20,H;Oxidation;R8>
<19,20;Reduction;R8>
<19,10;Oxidation;R8>
<9,10;Reduction;R8>
<8,9;Reduction;R8>
<8,21;Oxidation;R8>
<20,21;Reduction;R8>

>  <CYP2A6>  (37) 


>  <CYP2B6>  (37) 


>  <CYP2C8>  (37) 


>  <CYP2C9>  (37) 


>  <CYP2C19>  (37) 


>  <CYP2D6>  (37) 


>  <CYP2E1>  (37) 


>  <CYP3A4>  (37) 
<11,12;EpOxidation;R1>
<6,7;EpOxidation;R2>
<14,15;EpOxidation;R3>
<0,5;EpOxidation;R4>
<16,17;EpOxidation;R5>
<1,2;EpOxidation;R6>
<9,N;N-Oxidation;R7>
<20,H;Oxidation;R8>
<19,20;Reduction;R8>
<10,19;Oxidation;R8>
<9,21;Reduction;R8>
<8,9;Reduction;R8>
<8,21;Oxidation;R8>
<20,21;Reduction;R8>

>  <References>  (37) 
Roberts-Thomson SJ, McManus ME, Tukey RH, Gonzalez FJ, Holder GM: Metabolism of polycyclic aza-aromatic carcinogens catalyzed by four expressed human cytochromes P450. Cancer Res. 1995 Mar 1;55(5):1052-9. (PMID: 7866988)

>  <Comments>  (37) 
<6,N;N-Oxidation> and <13,H;Oxidation> should also be considered as BoM for CYP3A4 but they are not reported in Xenosite.

$$$$
CC01843
     RDKit          3D

  9  8  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4610    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2410    2.2100    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0360    1.8580   -1.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0230   -0.5220    1.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1940    2.1190    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2390    1.4960    0.0210 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2180    3.8800    0.0290 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0040    4.1710    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  6  1  0
  2  5  1  0
  3  4  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
M  END
>  <Name>  (38) 
DDTC-Me

>  <InChIKey>  (38) 
JYRXPFCUABYLPD-UHFFFAOYSA-N

>  <PubChem_CID>  (38) 
12704

>  <CYP1A2>  (38) 
<5,6;Desulfuration;R1>
<7,S;S-Oxidation;R2>

>  <CYP2A6>  (38) 
<5,6;Desulfuration;R1>
<7,S;S-Oxidation;R2>

>  <CYP2B6>  (38) 
<5,6;Desulfuration;R1>

>  <CYP2C8>  (38) 


>  <CYP2C9>  (38) 


>  <CYP2C19>  (38) 


>  <CYP2D6>  (38) 
<5,6;Desulfuration;R1>
<7,S;S-Oxidation;R2>

>  <CYP2E1>  (38) 
<5,6;Desulfuration;R1>

>  <CYP3A4>  (38) 
<5,6;Desulfuration;R1>
<7,S;S-Oxidation;R2>

>  <References>  (38) 
Madan A, Parkinson A, Faiman MD: Identification of the human P-450 enzymes responsible for the sulfoxidation and thiono-oxidation of diethyldithiocarbamate methyl ester: role of P-450 enzymes in disulfiram bioactivation. Alcohol Clin Exp Res. 1998 Sep;22(6):1212-9. (PMID: 9756035)

>  <Comments>  (38) 
<7,6;UnspOxidation> and <8,S;S-Oxidation> are also reported in the reference but Xenosite did not record them.

$$$$
CC01844
     RDKit          2D

 20 23  0  0  0  0  0  0  0  0999 V2000
    1.0720    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1 14  2  0
  1 18  1  0
  2  3  2  0
  2 15  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5 14  1  0
  6  7  2  0
  6 20  1  0
  7  8  1  0
  7 12  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 19  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
M  END
>  <Name>  (39) 
DMBA

>  <InChIKey>  (39) 
ARSRBNBHOADGJU-UHFFFAOYSA-N

>  <PubChem_CID>  (39) 
6001

>  <CYP1A2>  (39) 
<12,13;EpOxidation;R1>
<3,4;EpOxidation;R2>
<1,14;EpOxidation;R3>
<9,H;Hydroxylation;R4>
<0,H;Hydroxylation;R5>
<17,H;Hydroxylation;R6>
<15,H;Hydroxylation;R7>

>  <CYP2A6>  (39) 


>  <CYP2B6>  (39) 
<12,13;EpOxidation;R1>
<3,4;EpOxidation;R2>
<1,14;EpOxidation;R3>
<9,H;Hydroxylation;R4>
<0,H;Hydroxylation;R5>
<17,H;Hydroxylation;R6>
<15,H;Hydroxylation;R7>

>  <CYP2C8>  (39) 
<12,13;EpOxidation;R1>
<3,4;EpOxidation;R2>
<1,14;EpOxidation;R3>
<9,H;Hydroxylation;R4>
<0,H;Hydroxylation;R5>
<17,H;Hydroxylation;R6>
<15,H;Hydroxylation;R7>

>  <CYP2C9>  (39) 
<12,13;EpOxidation;R1>
<3,4;EpOxidation;R2>
<1,14;EpOxidation;R3>
<9,H;Hydroxylation;R4>
<0,H;Hydroxylation;R5>
<17,H;Hydroxylation;R6>
<15,H;Hydroxylation;R7>

>  <CYP2C19>  (39) 


>  <CYP2D6>  (39) 


>  <CYP2E1>  (39) 
<12,13;EpOxidation;R1>
<3,4;EpOxidation;R2>
<9,H;Hydroxylation;R3>
<0,H;Hydroxylation;R4>
<17,H;Hydroxylation;R5>
<15,H;Hydroxylation;R6>

>  <CYP3A4>  (39) 
<12,13;EpOxidation;R1>
<3,4;EpOxidation;R2>
<1,14;EpOxidation;R3>
<9,H;Hydroxylation;R4>
<0,H;Hydroxylation;R5>
<17,H;Hydroxylation;R6>
<15,H;Hydroxylation;R7>

>  <References>  (39) 
Shou M, Korzekwa KR, Krausz KW, Buters JT, Grogan J, Goldfarb I, Hardwick JP, Gonzalez FJ, Gelboin HV: Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthracene. Mol Carcinog. 1996 Dec;17(4):241-9. doi: 10.1002/(SICI)1098-2744(199612)17:4<241::AID-MC8>3.0.CO;2-G. (PMID: 8989918)

>  <Comments>  (39) 


$$$$
CC01845
     RDKit          3D

 21 23  0  0  0  0  0  0  0  0999 V2000
   -0.3550   -0.2020    0.2630 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5960    3.7040   -0.4820 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9050   -3.2550   -0.2190 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1860   -1.5800   -1.7380 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9530    0.1760    0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3380    1.4910   -0.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3350    0.7580    0.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0730    2.1030   -0.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9300   -0.8260    0.1390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6580    0.3400    0.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3120    2.5330   -0.2660 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2770   -0.4930   -0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6760    1.8250   -0.3800 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6440    0.8290   -0.3080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1070    3.0360   -0.1360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9970   -1.0910    0.6430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6940    1.2750    0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5360   -2.2420    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4200    2.6180    0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3540   -1.5250    0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0310   -1.9540   -0.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  1  7  1  0
  2 11  2  0
  3 21  1  0
  4 21  2  0
  5  6  2  0
  5  9  1  0
  6 11  1  0
  6 13  1  0
  7  8  2  0
  7 10  1  0
  8 11  1  0
  8 15  1  0
  9 12  2  0
  9 18  1  0
 10 16  1  0
 10 17  2  0
 12 14  1  0
 12 20  1  0
 13 14  2  0
 15 19  2  0
 16 21  1  0
 17 19  1  0
M  END
>  <Name>  (40) 
DMXAA

>  <InChIKey>  (40) 
XGOYIMQSIKSOBS-UHFFFAOYSA-N

>  <PubChem_CID>  (40) 
123964

>  <CYP1A2>  (40) 
<0,H;Hydroxylation;R1>

>  <CYP2A6>  (40) 


>  <CYP2B6>  (40) 


>  <CYP2C8>  (40) 


>  <CYP2C9>  (40) 


>  <CYP2C19>  (40) 


>  <CYP2D6>  (40) 


>  <CYP2E1>  (40) 


>  <CYP3A4>  (40) 


>  <References>  (40) 
Zhou S, Paxton JW, Tingle MD, Kestell P: Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acid. Drug Metab Dispos. 2000 Dec;28(12):1449-56. (PMID: 11095582)

>  <Comments>  (40) 


$$$$
CC01847
     RDKit          3D

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.1410    1.5410   -0.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6190    1.7140   -0.4590 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1160    0.0520   -0.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3090    2.3140   -0.3030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3570    4.2450    0.2480 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    2.2130   -0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2810    3.7010   -0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3580    2.1900   -1.3300 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9030    0.7820    0.3010 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1220    3.6010    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1090   -0.4180   -0.8400 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.9720   -0.3770   -1.4370 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.4400   -0.6190    0.6650 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0590    4.3410    0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0
  1  4  2  0
  1  6  1  0
  2  4  1  0
  2  8  2  0
  2  9  1  0
  3 11  1  0
  3 12  1  0
  3 13  1  0
  4  7  1  0
  5 10  1  0
  6 10  2  0
  7 14  2  0
 10 14  1  0
M  CHG  2   2   1   9  -1
M  END
>  <Name>  (41) 
FLU-1

>  <InChIKey>  (41) 
UTKUVRNVYFTEHF-UHFFFAOYSA-N

>  <PubChem_CID>  (41) 
94955

>  <CYP1A2>  (41) 
<0,H;Hydroxylation;R1>

>  <CYP2A6>  (41) 
<0,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>

>  <CYP2B6>  (41) 


>  <CYP2C8>  (41) 
<2,H;Hydroxylation;R1>

>  <CYP2C9>  (41) 
<0,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>

>  <CYP2C19>  (41) 
<2,H;Hydroxylation;R1>

>  <CYP2D6>  (41) 
<2,H;Hydroxylation;R1>

>  <CYP2E1>  (41) 
<2,H;Hydroxylation;R1>

>  <CYP3A4>  (41) 
<0,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>

>  <References>  (41) 
Goda R, Nagai D, Akiyama Y, Nishikawa K, Ikemoto I, Aizawa Y, Nagata K, Yamazoe Y: Detection of a new N-oxidized metabolite of flutamide, N-[4-nitro-3-(trifluoromethyl)phenyl]hydroxylamine, in human liver microsomes and urine of prostate cancer patients. Drug Metab Dispos. 2006 May;34(5):828-35. doi: 10.1124/dmd.105.008623. Epub 2006  Feb 28. (PMID: 16507648)

>  <Comments>  (41) 
Rate of metabolite FLU-3 for CYP2C8, 2C19, 2D6, 2E1 is low.

$$$$
CC01848
     RDKit          3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -1.3480    0.4550    2.0780 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2390   -0.9250   -0.3110 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3280    1.8680    0.0210 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5370   -2.8250    0.2630 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5010    2.1630    0.5070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2930    3.2700   -0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0930    0.8430    0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7250    3.1610    0.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5810    0.8150   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3490   -0.2160   -0.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2690   -0.4780   -0.2390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1010   -0.3620   -0.1460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9310   -0.0350    0.9380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6760   -0.9230   -1.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3790   -0.5250   -1.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9000   -1.6410    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3130   -0.2400    0.8350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0520   -1.1250   -1.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8790   -0.7750   -0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0610   -1.7220   -1.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6010   -2.8340   -0.5720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3120    0.7330    3.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7060   -1.4870   -1.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 13  1  0
  1 22  1  0
  2 19  1  0
  2 23  1  0
  3  8  1  0
  3  9  2  0
  4 16  2  0
  4 21  1  0
  5  6  1  0
  5  7  1  0
  6  8  1  0
  7  9  1  0
  7 10  2  0
  9 11  1  0
 10 12  1  0
 11 15  2  0
 11 16  1  0
 12 13  2  0
 12 14  1  0
 13 17  1  0
 14 18  2  0
 15 20  1  0
 17 19  2  0
 18 19  1  0
 20 21  2  0
M  END
>  <Name>  (42) 
GTS-21

>  <InChIKey>  (42) 
RPYWXZCFYPVCNQ-RVDMUPIBSA-N

>  <PubChem_CID>  (42) 
5310985

>  <CYP1A2>  (42) 
<21,H;Oxidation;R1>
<21,1;Cleavage;R1>
<0,H;Oxidation;R2>
<0,1;Cleavage;R2>

>  <CYP2A6>  (42) 


>  <CYP2B6>  (42) 


>  <CYP2C8>  (42) 


>  <CYP2C9>  (42) 


>  <CYP2C19>  (42) 


>  <CYP2D6>  (42) 


>  <CYP2E1>  (42) 
<21,H;Oxidation;R1>
<21,1;Cleavage;R1>
<0,H;Oxidation;R2>
<0,1;Cleavage;R2>

>  <CYP3A4>  (42) 
<21,H;Oxidation;R1>
<21,1;Cleavage;R1>
<0,H;Oxidation;R2>
<0,1;Cleavage;R2>

>  <References>  (42) 
Azuma R, Komuro M, Korsch BH, Andre JC, Onnagawa O, Black SR, Mathews JM: Metabolism and disposition of GTS-21, a novel drug for Alzheimer's disease. Xenobiotica. 1999 Jul;29(7):747-62. doi: 10.1080/004982599238362. (PMID: 10456692)

>  <Comments>  (42) 
Xenosite reported metabolite for CYP3A4. However, the paper reports 3A (3A3, 3A4, and 3A5) not 3A4.

$$$$
CC01849
     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.3570    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -1.0310    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    1.4440    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2150    1.4440    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -1.0310    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2150   -1.4440    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1 11  1  0
  2  3  1  0
  2 12  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  5 10  2  0
  6  7  2  0
  6 19  1  0
  7  8  1  0
  8  9  2  0
  8 18  1  0
  9 10  1  0
 10 11  1  0
 12 13  2  0
 12 17  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 20  1  0
 16 17  2  0
M  END
>  <Name>  (43) 
Genistein

>  <InChIKey>  (43) 
TZBJGXHYKVUXJN-UHFFFAOYSA-N

>  <PubChem_CID>  (43) 
5280961

>  <CYP1A2>  (43) 
<16,H;Hydroxylation;R1>
<13,H;Hydroxylation;R2>
<5,H;Hydroxylation;R3>
<8,H;Hydroxylation;R4>

>  <CYP2A6>  (43) 


>  <CYP2B6>  (43) 


>  <CYP2C8>  (43) 


>  <CYP2C9>  (43) 


>  <CYP2C19>  (43) 


>  <CYP2D6>  (43) 


>  <CYP2E1>  (43) 
<5,H;Hydroxylation;R1>
<8,H;Hydroxylation;R2>

>  <CYP3A4>  (43) 


>  <References>  (43) 
Roberts-Kirchhoff ES, Crowley JR, Hollenberg PF, Kim H: Metabolism of genistein by rat and human cytochrome P450s. Chem Res Toxicol. 1999 Jul;12(7):610-6. doi: 10.1021/tx9802320. (PMID: 10409400)

>  <Comments>  (43) 


$$$$
CC01850
     RDKit          2D

 15 17  0  0  0  0  0  0  0  0999 V2000
   -1.4240   -1.6290    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1390   -1.2160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1390   -0.3910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4240    0.0210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7100   -0.3910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0040    0.0210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7190   -0.3910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7190   -1.2160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0040   -1.6290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7100   -1.2160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9960    0.9140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1760    0.8280    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3320    0.1610    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1390   -0.0110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4090    1.6290    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1 10  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5 10  2  0
  6  7  2  0
  6 12  1  0
  7  8  1  0
  7 13  1  0
  8  9  2  0
  9 10  1  0
 11 12  2  0
 11 13  1  0
 11 15  1  0
 13 14  1  0
M  END
>  <Name>  (44) 
IQ

>  <InChIKey>  (44) 
ARZWATDYIYAUTA-UHFFFAOYSA-N

>  <PubChem_CID>  (44) 
53462

>  <CYP1A2>  (44) 
<3,H;Hydroxylation;R1>

>  <CYP2A6>  (44) 


>  <CYP2B6>  (44) 


>  <CYP2C8>  (44) 


>  <CYP2C9>  (44) 


>  <CYP2C19>  (44) 


>  <CYP2D6>  (44) 


>  <CYP2E1>  (44) 


>  <CYP3A4>  (44) 


>  <References>  (44) 
Hammons GJ, Milton D, Stepps K, Guengerich FP, Tukey RH, Kadlubar FF: Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes. Carcinogenesis. 1997 Apr;18(4):851-4. doi: 10.1093/carcin/18.4.851. (PMID: 9111224)

>  <Comments>  (44) 


$$$$
CC01851
     RDKit          3D

 33 36  0  0  0  0  0  0  0  0999 V2000
    1.0150    1.1300   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2220    1.7620    0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3090    1.0890    0.7100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5460    1.7390    0.8530 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1570   -0.2340    1.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0750   -0.8700    0.9890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1590   -0.1840    0.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3390   -0.8740    0.3750 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5270   -0.0540    0.2840 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.6600   -1.0050   -0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8100    0.6000    1.6570 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9170   -0.4100    2.6570 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3930    0.1030    3.8710 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9870    1.3930    1.6100 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8750    2.4350    2.5650 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3710    0.9490   -0.8510 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.5380    1.7130   -1.0970 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1730    1.8490   -0.6210 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.8230    2.6560   -1.7830 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4620    2.1370   -3.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8320    4.1040   -1.6190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8250    4.7500   -0.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3980    0.7570   -3.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0320    0.2260   -4.4810 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7190    1.0870   -5.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2660    0.4480   -7.0470 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.7700    2.4620   -5.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1380    2.9710   -4.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8250    4.5820    0.6260 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8540    5.2830    1.0850 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4040    5.8260   -0.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5740    6.6630    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8060    5.5510   -1.1760 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  7  1  0
  1 18  1  0
  2  3  1  0
  3  4  1  0
  3  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  6
  9 11  1  0
  9 16  1  0
 11 12  1  0
 11 14  1  0
 12 13  1  0
 14 15  1  0
 16 17  1  1
 16 18  1  0
 18 19  1  6
 19 20  1  0
 19 21  1  0
 20 23  2  0
 20 28  1  0
 21 22  1  0
 22 29  1  0
 22 33  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 25 27  1  0
 27 28  2  0
 29 30  2  0
 30 31  1  0
 31 32  1  0
 31 33  1  0
M  END
>  <Name>  (45) 
KR-31543

>  <InChIKey>  (45) 
URYBOPNIACOOED-VWPQPMDRSA-N

>  <PubChem_CID>  (45) 
9891080

>  <CYP1A2>  (45) 
<15,H;Oxidation;R1>
<15,16;Cleavage;R1>

>  <CYP2A6>  (45) 


>  <CYP2B6>  (45) 
<15,H;Oxidation;R1>
<15,16;Cleavage;R1>

>  <CYP2C8>  (45) 
<15,H;Oxidation;R1>
<15,16;Cleavage;R1>

>  <CYP2C9>  (45) 
<15,H;Oxidation;R1>
<15,16;Cleavage;R1>

>  <CYP2C19>  (45) 
<15,H;Oxidation;R1>
<15,16;Cleavage;R1>

>  <CYP2D6>  (45) 
<15,H;Oxidation;R1>
<15,16;Cleavage;R1>

>  <CYP2E1>  (45) 
<15,H;Oxidation;R1>
<15,16;Cleavage;R1>

>  <CYP3A4>  (45) 
<15,H;Oxidation;R1>
<15,16;Cleavage;R1>
<10,H;Hydroxylation;R2>

>  <References>  (45) 
Ji HY, Lee SS, Yoo SE, Kim H, Lee DH, Lim H, Lee HS: In vitro metabolism of a new neuroprotective agent, KR-31543 in the human liver microsomes: identification of human cytochrome P450. Arch Pharm Res. 2004 Feb;27(2):239-45. (PMID: 15022728)

>  <Comments>  (45) 


$$$$
CC01852
     RDKit          3D

 15 16  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4030    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1450    2.0910    0.0020 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2340    2.0670    0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2930   -0.6960   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2000   -0.7210    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3310    1.4630   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4140    1.3420    0.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4240    0.0560   -0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3890   -0.0520    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3530    2.1250   -0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3640   -2.2010   -0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2800   -2.7030    1.3550 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6050    1.9940    0.0650 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6240    0.9920    0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  2  0
  5 12  1  0
  6 10  2  0
  7  9  1  0
  7 11  2  0
  8 10  1  0
  8 14  1  0
 12 13  1  0
 14 15  1  0
M  END
>  <Name>  (46) 
MAMC

>  <InChIKey>  (46) 
JTWMBPZRYBLNNG-UHFFFAOYSA-N

>  <PubChem_CID>  (46) 
8758226

>  <CYP1A2>  (46) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2A6>  (46) 


>  <CYP2B6>  (46) 


>  <CYP2C8>  (46) 


>  <CYP2C9>  (46) 


>  <CYP2C19>  (46) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2D6>  (46) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2E1>  (46) 


>  <CYP3A4>  (46) 


>  <References>  (46) 
Venhorst J, Onderwater RC, Meerman JH, Commandeur JN, Vermeulen NP: Influence of N-substitution of 7-methoxy-4-(aminomethyl)-coumarin on cytochrome P450 metabolism and selectivity. Drug Metab Dispos. 2000 Dec;28(12):1524-32. (PMID: 11095593)

>  <Comments>  (46) 


$$$$
CC01853
     RDKit          3D

 15 16  0  0  0  0  0  0  0  0999 V2000
    3.6900    1.4860   -0.3990 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3880   -0.5360    0.7140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2280   -0.7890    0.6660 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9130    0.1540   -0.3960 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.8110   -0.3000   -1.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6550    1.5460    0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5640   -0.3930   -0.7670 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4440    0.6850   -0.8990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8210    2.0830    0.9360 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9790   -1.5740   -0.1260 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7100    0.5470   -0.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1070   -0.6060    0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2650   -1.6900    0.4030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6470   -2.0520    0.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7440    0.7980    0.3010 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 11  1  0
  1 15  1  0
  2 12  1  0
  2 15  1  0
  3  4  1  0
  3 14  1  0
  4  5  1  1
  4  6  1  0
  5  7  1  0
  6  9  1  0
  7  8  1  0
  7 10  2  0
  8 11  2  0
 10 13  1  0
 11 12  1  0
 12 13  2  0
M  END
>  <Name>  (47) 
MBDB

>  <InChIKey>  (47) 
USWVWJSAJAEEHQ-JTQLQIEISA-N

>  <PubChem_CID>  (47) 
44290645

>  <CYP1A2>  (47) 
<14,H;Oxidation;R1>
<14,13;Cleavage;R1>
<11,H;Oxidation;R2>
<11,12;Cleavage;R2>
<11,10;Cleavage;R2>

>  <CYP2A6>  (47) 


>  <CYP2B6>  (47) 
<14,H;Oxidation;R1>
<14,13;Cleavage;R1>
<11,H;Oxidation;R2>
<11,12;Cleavage;R2>
<11,10;Cleavage;R2>

>  <CYP2C8>  (47) 


>  <CYP2C9>  (47) 


>  <CYP2C19>  (47) 
<14,H;Oxidation;R1>
<14,13;Cleavage;R1>
<11,H;Oxidation;R2>
<11,12;Cleavage;R2>
<11,10;Cleavage;R2>

>  <CYP2D6>  (47) 
<14,H;Oxidation;R1>
<14,13;Cleavage;R1>
<11,H;Oxidation;R2>
<11,12;Cleavage;R2>
<11,10;Cleavage;R2>

>  <CYP2E1>  (47) 


>  <CYP3A4>  (47) 
<14,H;Oxidation;R1>
<14,13;Cleavage;R1>
<11,H;Oxidation;R2>
<11,12;Cleavage;R2>
<11,10;Cleavage;R2>

>  <References>  (47) 
Maurer HH, Bickeboeller-Friedrich J, Kraemer T, Peters FT: Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy'). Toxicol Lett. 2000 Mar 15;112-113:133-42. (PMID: 10720722)
Meyer MR, Peters FT, Maurer HH: Stereoselective differences in the cytochrome P450-dependent dealkylation and demethylenation of N-methyl-benzodioxolyl-butanamine (MBDB, Eden) enantiomers. Biochem Pharmacol. 2009 Jun 1;77(11):1725-34. doi: 10.1016/j.bcp.2009.03.001. Epub 2009 Mar 14. (PMID: 19428327)

>  <Comments>  (47) 


$$$$
CC01854
     RDKit          3D

 14 15  0  0  0  0  0  0  0  0999 V2000
   -0.1980    0.9860    0.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1170   -0.2320   -0.4890 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9720    1.5920    0.6870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5450    1.6170    0.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1290   -0.8050   -0.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2220    0.9960    0.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6740    2.6530    1.4460 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.2650   -0.2080   -0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8970    3.5000    1.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8140    1.9920    2.7370 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7820    2.9920    3.7910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3910   -1.9790   -1.2730 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8220   -2.0540   -1.1180 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3850   -0.9320   -0.4110 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  3  6  2  0
  4  7  1  0
  5  8  2  0
  5 12  1  0
  6  8  1  0
  7  9  1  6
  7 10  1  0
  8 14  1  0
 10 11  1  0
 12 13  1  0
 13 14  1  0
M  END
>  <Name>  (48) 
MDMA

>  <InChIKey>  (48) 
SHXWCVYOXRDMCX-MRVPVSSYSA-N

>  <PubChem_CID>  (48) 
667458

>  <CYP1A2>  (48) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>
<12,H;Oxidation;R2>
<12,13;Cleavage;R2>
<11,12;Cleavage;R2>

>  <CYP2A6>  (48) 


>  <CYP2B6>  (48) 


>  <CYP2C8>  (48) 


>  <CYP2C9>  (48) 


>  <CYP2C19>  (48) 


>  <CYP2D6>  (48) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>
<12,H;Oxidation;R2>
<12,13;Cleavage;R2>
<11,12;Cleavage;R2>

>  <CYP2E1>  (48) 


>  <CYP3A4>  (48) 
<12,H;Oxidation;R1>
<11,12;Cleavage;R1>
<12,13;Cleavage;R1>

>  <References>  (48) 
Maurer HH, Bickeboeller-Friedrich J, Kraemer T, Peters FT: Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy'). Toxicol Lett. 2000 Mar 15;112-113:133-42. (PMID: 10720722)

>  <Comments>  (48) 


$$$$
CC01856
     RDKit          3D

 16 17  0  0  0  0  0  0  0  0999 V2000
   -0.0490    1.3470   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0050   -0.0450    0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1270    2.1180   -0.0910 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2570    2.0400   -0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3070   -0.7020    0.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2000   -0.7460    0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3740    1.5100   -0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4510    1.3260    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4010    0.0490   -0.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4190   -0.0680    0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4090    2.1560   -0.2810 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4300   -2.1880    0.0560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4590   -2.7940    1.3760 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1060   -2.9960    1.8560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5970    2.0710    0.0150 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7540    1.2440    0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  2  0
  5 12  1  0
  6 10  2  0
  7  9  1  0
  7 11  2  0
  8 10  1  0
  8 15  1  0
 12 13  1  0
 13 14  1  0
 15 16  1  0
M  END
>  <Name>  (49) 
MMAMC

>  <InChIKey>  (49) 
GWMGUFTYUOYYQV-UHFFFAOYSA-N

>  <PubChem_CID>  (49) 
8931837

>  <CYP1A2>  (49) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>
<12,H;Oxidation;R2>
<11,12;Cleavage;R2>

>  <CYP2A6>  (49) 


>  <CYP2B6>  (49) 


>  <CYP2C8>  (49) 


>  <CYP2C9>  (49) 


>  <CYP2C19>  (49) 
<12,H;Oxidation;R1>
<11,12;Cleavage;R1>

>  <CYP2D6>  (49) 
<12,H;Oxidation;R1>
<11,12;Cleavage;R1>

>  <CYP2E1>  (49) 


>  <CYP3A4>  (49) 


>  <References>  (49) 
Venhorst J, Onderwater RC, Meerman JH, Commandeur JN, Vermeulen NP: Influence of N-substitution of 7-methoxy-4-(aminomethyl)-coumarin on cytochrome P450 metabolism and selectivity. Drug Metab Dispos. 2000 Dec;28(12):1524-32. (PMID: 11095593)

>  <Comments>  (49) 


$$$$
CC01857
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.6300    0.6530    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8220    0.9230    0.8570 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9070    0.4360    0.5480 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6150    1.7930    2.0820 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.4170    0.9410    3.2480 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7150    2.8380    2.1450 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4970    3.8750    3.2190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5990    1.2280    0.3510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7130    0.9660   -0.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5980    0.1340   -1.5540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7900   -0.1450   -2.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3680   -0.4390   -1.8740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7480   -0.1800   -1.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7410    1.6620    4.3290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0910    0.7500    5.4830 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5890    0.7250    5.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6890    0.4390    3.7950 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  8  2  0
  1 13  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  4  6  1  1
  5 14  1  0
  5 17  1  0
  6  7  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
M  END
>  <Name>  (50) 
MPBP

>  <InChIKey>  (50) 
NXNPGAAZKYDOPW-AWEZNQCLSA-N

>  <PubChem_CID>  (50) 
96365834

>  <CYP1A2>  (50) 
<9,H;Hydroxylation;R1>

>  <CYP2A6>  (50) 


>  <CYP2B6>  (50) 


>  <CYP2C8>  (50) 


>  <CYP2C9>  (50) 


>  <CYP2C19>  (50) 
<9,H;Hydroxylation;R1>

>  <CYP2D6>  (50) 
<9,H;Hydroxylation;R1>

>  <CYP2E1>  (50) 


>  <CYP3A4>  (50) 


>  <References>  (50) 
Peters FT, Meyer MR, Theobald DS, Maurer HH: Identification of cytochrome P450 enzymes involved in the metabolism of the new designer drug 4'-methyl-alpha-pyrrolidinobutyrophenone. Drug Metab Dispos. 2008 Jan;36(1):163-8. doi: 10.1124/dmd.107.017293. Epub 2007 Oct 25. (PMID: 17962373)

>  <Comments>  (50) 


$$$$
CC01858
     RDKit          2D

 16 18  0  0  0  0  0  0  0  0999 V2000
   -1.0670   -1.6290    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7820   -1.2160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7820   -0.3910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0670    0.0210    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3530   -0.3910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3620    0.0210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0760   -0.3910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0760   -1.2160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3620   -1.6290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3530   -1.2160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3540    0.9140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5330    0.8280    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6890    0.1610    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4960    0.0210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4960   -0.0110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7660    1.6290    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1 10  1  0
  2  3  1  0
  3  4  2  0
  3 14  1  0
  4  5  1  0
  5  6  1  0
  5 10  2  0
  6  7  2  0
  6 12  1  0
  7  8  1  0
  7 13  1  0
  8  9  2  0
  9 10  1  0
 11 12  2  0
 11 13  1  0
 11 16  1  0
 13 15  1  0
M  END
>  <Name>  (51) 
MeIQx

>  <InChIKey>  (51) 
DVCCCQNKIYNAKB-UHFFFAOYSA-N

>  <PubChem_CID>  (51) 
62275

>  <CYP1A2>  (51) 
<11,H;Hydroxylation;R1>

>  <CYP2A6>  (51) 


>  <CYP2B6>  (51) 


>  <CYP2C8>  (51) 


>  <CYP2C9>  (51) 


>  <CYP2C19>  (51) 


>  <CYP2D6>  (51) 


>  <CYP2E1>  (51) 


>  <CYP3A4>  (51) 


>  <References>  (51) 
Hammons GJ, Milton D, Stepps K, Guengerich FP, Tukey RH, Kadlubar FF: Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes. Carcinogenesis. 1997 Apr;18(4):851-4. doi: 10.1093/carcin/18.4.851. (PMID: 9111224)

>  <Comments>  (51) 


$$$$
CC01859
     RDKit          2D

 21 23  0  0  0  0  0  0  0  0999 V2000
    1.1660    1.4920    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6510    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1660    0.1580    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3820    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0470    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0470    1.2380    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3820    1.2380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7620    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330    2.4750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0470   -1.2380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0470   -2.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7620   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4760   -2.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4760   -1.2380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7620   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4760    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7620    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4210    2.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  9  1  0
  1 21  1  0
  2  3  2  0
  2 19  1  0
  3  4  1  0
  4  5  1  0
  4  9  2  0
  5  6  1  0
  5 12  1  0
  6  7  1  0
  6 10  2  0
  7  8  1  0
  7 20  1  0
  8  9  1  0
  8 11  2  0
 12 13  1  0
 13 14  1  0
 13 18  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
M  END
>  <Name>  (52) 
N7-Methylcyclohexylline

>  <InChIKey>  (52) 
ARGFHYICTJBMFD-UHFFFAOYSA-N

>  <PubChem_CID>  (52) 
102123104

>  <CYP1A2>  (52) 
<13,H;Hydroxylation;R1>
<14,H;Hydroxylation;R2>
<15,H;Hydroxylation;R3>
<16,H;Hydroxylation;R4>
<17,H;Hydroxylation;R5>
<18,H;Hydroxylation;R6>
<0,H;Hydroxylation;R7>
<20,19;Cleavage;R8>
<20,H;Oxidation;R8>

>  <CYP2A6>  (52) 


>  <CYP2B6>  (52) 


>  <CYP2C8>  (52) 


>  <CYP2C9>  (52) 


>  <CYP2C19>  (52) 


>  <CYP2D6>  (52) 


>  <CYP2E1>  (52) 


>  <CYP3A4>  (52) 


>  <References>  (52) 
Racha JK, Rettie AE, Kunze KL: Mechanism-based inactivation of human cytochrome P450 1A2 by furafylline: detection of a 1:1 adduct to protein and evidence for the formation of a novel imidazomethide intermediate. Biochemistry. 1998 May 19;37(20):7407-19. doi: 10.1021/bi973011m. (PMID: 9585555)

>  <Comments>  (52) 


$$$$
CC01860
     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    1.1050    1.3700    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5900    0.7020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1050    0.0350    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3200    0.2900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3940   -0.1230    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1090    0.2900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1090    1.1150    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3940    1.5270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3200    1.1150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8230   -0.1230    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3940    2.3520    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4150    0.7020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8230    1.5270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3940   -0.9480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8630   -1.0250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1090   -1.3600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1950   -2.1810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0020   -2.3520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4150   -1.6380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3600    2.1540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  9  1  0
  1 20  1  0
  2  3  2  0
  2 12  1  0
  3  4  1  0
  4  5  1  0
  4  9  2  0
  5  6  1  0
  5 14  1  0
  6  7  1  0
  6 10  2  0
  7  8  1  0
  7 13  1  0
  8  9  1  0
  8 11  2  0
 14 16  1  0
 15 16  1  0
 15 19  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
M  END
>  <Name>  (53) 
N7-Methylfurafylline

>  <InChIKey>  (53) 
VACPENDPPYPFPY-UHFFFAOYSA-N

>  <PubChem_CID>  (53) 
102123094

>  <CYP1A2>  (53) 
<15,H;Hydroxylation;R1>
<16,H;Hydroxylation;R2>
<14,H;Hydroxylation;R3>
<0,H;Hydroxylation;R4>
<18,19;Cleavage;R5>
<19,H;Oxidation;R5>

>  <CYP2A6>  (53) 


>  <CYP2B6>  (53) 


>  <CYP2C8>  (53) 


>  <CYP2C9>  (53) 


>  <CYP2C19>  (53) 


>  <CYP2D6>  (53) 


>  <CYP2E1>  (53) 


>  <CYP3A4>  (53) 


>  <References>  (53) 
Racha JK, Rettie AE, Kunze KL: Mechanism-based inactivation of human cytochrome P450 1A2 by furafylline: detection of a 1:1 adduct to protein and evidence for the formation of a novel imidazomethide intermediate. Biochemistry. 1998 May 19;37(20):7407-19. doi: 10.1021/bi973011m. (PMID: 9585555)

>  <Comments>  (53) 
The rate of demethyl metabolite is low.

$$$$
CC01861
     RDKit          3D

  7  6  0  0  0  0  0  0  0  0999 V2000
   -1.4200    2.1290    0.5220 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3850    1.7790    1.2100 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3770    3.4350    0.4020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0280    3.8820    0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4090    3.6260   -1.3550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2950    3.9590   -0.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7110    4.0650   -0.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  3  4  1  0
  3  6  1  0
  4  5  1  0
  6  7  1  0
M  END
>  <Name>  (54) 
NDEA

>  <InChIKey>  (54) 
WBNQDOYYEUMPFS-UHFFFAOYSA-N

>  <PubChem_CID>  (54) 
5921

>  <CYP1A2>  (54) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2A6>  (54) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2B6>  (54) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2C8>  (54) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2C9>  (54) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2C19>  (54) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2D6>  (54) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2E1>  (54) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP3A4>  (54) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <References>  (54) 
Bellec G, Dreano Y, Lozach P, Menez JF, Berthou F: Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes. Carcinogenesis. 1996 Sep;17(9):2029-34. doi: 10.1093/carcin/17.9.2029. (PMID: 8824531)

>  <Comments>  (54) 


$$$$
CC01862
     RDKit          3D

  5  4  0  0  0  0  0  0  0  0999 V2000
   -1.3690    2.2250    0.6680 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4320    1.6420    0.7580 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3220    3.4600    0.1290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5280    4.0510   -0.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0640    4.2100    0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  3  4  1  0
  3  5  1  0
M  END
>  <Name>  (55) 
NDMA

>  <InChIKey>  (55) 
UMFJAHHVKNCGLG-UHFFFAOYSA-N

>  <PubChem_CID>  (55) 
6124

>  <CYP1A2>  (55) 
<2,H;Oxidation;R1>
<1,2;Cleavage;R1>
<0,H;Oxidation;R2>
<0,1;Cleavage;R2>

>  <CYP2A6>  (55) 
<2,H;Oxidation;R1>
<1,2;Cleavage;R1>
<0,H;Oxidation;R2>
<0,1;Cleavage;R2>

>  <CYP2B6>  (55) 


>  <CYP2C8>  (55) 
<2,H;Oxidation;R1>
<1,2;Cleavage;R1>
<0,H;Oxidation;R2>
<0,1;Cleavage;R2>

>  <CYP2C9>  (55) 
<2,H;Oxidation;R1>
<1,2;Cleavage;R1>
<0,H;Oxidation;R2>
<0,1;Cleavage;R2>

>  <CYP2C19>  (55) 


>  <CYP2D6>  (55) 
<2,H;Oxidation;R1>
<1,2;Cleavage;R1>
<0,H;Oxidation;R2>
<0,1;Cleavage;R2>

>  <CYP2E1>  (55) 
<2,H;Oxidation;R1>
<1,2;Cleavage;R1>
<0,H;Oxidation;R2>
<0,1;Cleavage;R2>

>  <CYP3A4>  (55) 
<2,H;Oxidation;R1>
<1,2;Cleavage;R1>
<0,H;Oxidation;R2>
<0,1;Cleavage;R2>

>  <References>  (55) 
Bellec G, Dreano Y, Lozach P, Menez JF, Berthou F: Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes. Carcinogenesis. 1996 Sep;17(9):2029-34. doi: 10.1093/carcin/17.9.2029. (PMID: 8824531)
Kushida H, Fujita K, Suzuki A, Yamada M, Endo T, Nohmi T, Kamataki T: Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase. Carcinogenesis. 2000 Jun;21(6):1227-32. (PMID: 10837014)

>  <Comments>  (55) 


$$$$
CC01863
     RDKit          3D

  8  7  0  0  0  0  0  0  0  0999 V2000
   -1.4650    2.1740    0.6830 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6120    1.8440    1.0100 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3880    3.4570    0.4440 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0270    3.8870    0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2740    3.9110   -0.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4850    3.5250   -1.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9000    4.0240   -1.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4100    3.6640   -2.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  3  4  1  0
  3  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
M  END
>  <Name>  (56) 
NMBA

>  <InChIKey>  (56) 
PKTSCJXWLVREKX-UHFFFAOYSA-N

>  <PubChem_CID>  (56) 
23471

>  <CYP1A2>  (56) 
<5,H;Oxidation;R1>
<5,4;Cleavage;R1>
<3,H;Oxidation;R2>
<4,3;Cleavage;R2>

>  <CYP2A6>  (56) 
<5,H;Oxidation;R1>
<5,4;Cleavage;R1>
<3,H;Oxidation;R2>
<4,3;Cleavage;R2>

>  <CYP2B6>  (56) 
<5,H;Oxidation;R1>
<5,4;Cleavage;R1>
<3,H;Oxidation;R2>
<4,3;Cleavage;R2>

>  <CYP2C8>  (56) 
<5,H;Oxidation;R1>
<5,4;Cleavage;R1>
<3,H;Oxidation;R2>
<4,3;Cleavage;R2>

>  <CYP2C9>  (56) 
<5,H;Oxidation;R1>
<5,4;Cleavage;R1>
<3,H;Oxidation;R2>
<4,3;Cleavage;R2>

>  <CYP2C19>  (56) 
<5,H;Oxidation;R1>
<5,4;Cleavage;R1>
<3,H;Oxidation;R2>
<4,3;Cleavage;R2>

>  <CYP2D6>  (56) 
<5,H;Oxidation;R1>
<5,4;Cleavage;R1>
<3,H;Oxidation;R2>
<4,3;Cleavage;R2>

>  <CYP2E1>  (56) 
<5,H;Oxidation;R1>
<5,4;Cleavage;R1>
<3,H;Oxidation;R2>
<4,3;Cleavage;R2>

>  <CYP3A4>  (56) 
<5,H;Oxidation;R1>
<5,4;Cleavage;R1>
<3,H;Oxidation;R2>
<4,3;Cleavage;R2>

>  <References>  (56) 
Bellec G, Dreano Y, Lozach P, Menez JF, Berthou F: Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes. Carcinogenesis. 1996 Sep;17(9):2029-34. doi: 10.1093/carcin/17.9.2029. (PMID: 8824531)

>  <Comments>  (56) 


$$$$
CC01865
     RDKit          3D

 14 14  0  0  0  0  0  0  0  0999 V2000
   -0.1290    1.5810    1.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0030    1.2190    2.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1550    0.6120    2.9330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1900    0.3630    2.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0710    0.7200    0.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9180    1.3260    0.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3690    2.2250    0.6680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4320    1.6420    0.7580 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3220    3.4600    0.1290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5280    4.0510   -0.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0640    4.2100    0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1280    4.8880    1.4860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2880    4.8280    0.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2940    0.2200    4.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  3 14  1  0
  4  5  1  0
  5  6  2  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
  9 11  1  0
 10 13  1  0
 11 12  1  0
M  END
>  <Name>  (57) 
N,N-Dimethyl-m-toluamide

>  <InChIKey>  (57) 
MMOXZBCLCQITDF-UHFFFAOYSA-N

>  <PubChem_CID>  (57) 
4284

>  <CYP1A2>  (57) 
<12,H;Hydroxylation;R1>

>  <CYP2A6>  (57) 
<2,3;Cleavage;R1>
<3,H;Oxidation;R1>
<1,2;Cleavage;R2>
<1,H;Oxidation;R2>

>  <CYP2B6>  (57) 
<12,H;Hydroxylation;R1>

>  <CYP2C8>  (57) 


>  <CYP2C9>  (57) 


>  <CYP2C19>  (57) 
<2,3;Cleavage;R1>
<3,H;Oxidation;R1>
<1,2;Cleavage;R2>
<1,H;Oxidation;R2>

>  <CYP2D6>  (57) 
<12,H;Hydroxylation;R1>

>  <CYP2E1>  (57) 
<12,H;Hydroxylation;R1>

>  <CYP3A4>  (57) 
<2,3;Cleavage;R1>
<3,H;Oxidation;R1>
<1,2;Cleavage;R2>
<1,H;Oxidation;R2>

>  <References>  (57) 
Usmani KA, Rose RL, Goldstein JA, Taylor WG, Brimfield AA, Hodgson E: In vitro human metabolism and interactions of repellent N,N-diethyl-m-toluamide. Drug Metab Dispos. 2002 Mar;30(3):289-94. doi: 10.1124/dmd.30.3.289. (PMID: 11854147)

>  <Comments>  (57) 


$$$$
CC01866
     RDKit          3D

 24 27  0  0  1  0  0  0  0  0999 V2000
    0.2250    0.2970    0.9730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0440   -0.2360    1.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1530   -1.5360    0.8860 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2510   -2.1190    0.1360 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.0340   -0.5980    0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4060   -0.3790   -0.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8090   -0.8920   -1.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2140    0.2190    0.5970 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0840   -1.3630   -1.7570 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1740   -1.7480   -3.0270 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9430   -1.5070   -3.5490 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0870   -0.9570   -2.5820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4910   -1.7250   -4.8640 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3370   -2.3350   -5.9020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2360   -1.3810   -5.2020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4330   -0.7800   -4.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8120   -0.5750   -2.8870 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1240   -3.4550   -5.6160 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9340   -4.0550   -6.5870 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6900   -5.1790   -6.2240 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5030   -5.7300   -7.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9430   -3.5030   -7.8710 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1670   -2.3880   -8.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3680   -1.8090   -7.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  2  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  7  9  1  0
  7 12  2  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 12 17  1  0
 13 14  1  0
 13 15  2  0
 14 18  2  0
 14 24  1  0
 15 16  1  0
 16 17  2  0
 18 19  1  0
 19 20  1  0
 19 22  2  0
 20 21  1  0
 22 23  1  0
 23 24  2  0
M  END
>  <Name>  (58) 
N-Desacetyl-indiplon

>  <InChIKey>  (58) 
QBXROYPDQTVONF-UHFFFAOYSA-N

>  <PubChem_CID>  (58) 
58070549

>  <CYP1A2>  (58) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2A6>  (58) 


>  <CYP2B6>  (58) 


>  <CYP2C8>  (58) 


>  <CYP2C9>  (58) 


>  <CYP2C19>  (58) 


>  <CYP2D6>  (58) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2E1>  (58) 


>  <CYP3A4>  (58) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <References>  (58) 
Madan A, Fisher A, Jin L, Chapman D, Bozigian HP: In vitro metabolism of indiplon and an assessment of its drug interaction potential. Xenobiotica. 2007 Jul;37(7):736-52. doi: 10.1080/00498250701433054. (PMID: 17620220)

>  <Comments>  (58) 


$$$$
CC01867
     RDKit          3D

 13 12  0  0  0  0  0  0  0  0999 V2000
   -0.0150    1.2860    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0440   -0.6270    0.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2430    2.0350    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2940    2.0010    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6950    2.2890    1.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7460    2.2580   -1.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0100    3.0720    1.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0810    3.0050   -1.4100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4620    3.3250    2.8720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5330    3.2620   -2.8480 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7760    4.1080    2.8640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8680    4.0080   -2.8380 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  1  5  1  0
  2  3  2  0
  4  6  1  0
  5  7  1  0
  6  8  1  0
  7  9  1  0
  8 10  1  0
  9 11  1  0
 10 12  1  0
 11 13  1  0
M  END
>  <Name>  (59) 
N-Nitrosodiamylamine

>  <InChIKey>  (59) 
OELWBYBVFOLSTA-UHFFFAOYSA-N

>  <PubChem_CID>  (59) 
252237

>  <CYP1A2>  (59) 
<1,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>
<2,H;Hydroxylation;R3>
<8,H;Hydroxylation;R4>
<3,H;Hydroxylation;R5>
<7,H;Hydroxylation;R6>
<0,H;Hydroxylation;R7>
<10,H;Hydroxylation;R8>

>  <CYP2A6>  (59) 
<1,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<8,H;Hydroxylation;R4>
<3,H;Hydroxylation;R5>
<7,H;Hydroxylation;R6>
<4,5;Cleavage;R7>
<3,H;Oxidation;R7>
<5,6;Cleavage;R8>
<6,H;Oxidation;R8>

>  <CYP2B6>  (59) 
<1,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>
<2,H;Hydroxylation;R3>
<8,H;Hydroxylation;R4>
<3,H;Hydroxylation;R5>
<7,H;Hydroxylation;R6>
<0,H;Hydroxylation;R7>
<10,H;Hydroxylation;R8>

>  <CYP2C8>  (59) 


>  <CYP2C9>  (59) 
<1,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>
<2,H;Hydroxylation;R3>
<8,H;Hydroxylation;R4>
<3,H;Hydroxylation;R5>
<7,H;Hydroxylation;R6>
<0,H;Hydroxylation;R7>
<10,H;Hydroxylation;R8>

>  <CYP2C19>  (59) 
<1,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>
<2,H;Hydroxylation;R3>
<8,H;Hydroxylation;R4>
<3,H;Hydroxylation;R5>
<7,H;Hydroxylation;R6>
<0,H;Hydroxylation;R7>
<10,H;Hydroxylation;R8>

>  <CYP2D6>  (59) 
<1,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>
<2,H;Hydroxylation;R3>
<8,H;Hydroxylation;R4>
<3,H;Hydroxylation;R5>
<7,H;Hydroxylation;R6>
<0,H;Hydroxylation;R7>
<10,H;Hydroxylation;R8>

>  <CYP2E1>  (59) 
<1,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>
<2,H;Hydroxylation;R3>
<8,H;Hydroxylation;R4>
<3,H;Hydroxylation;R5>
<7,H;Hydroxylation;R6>
<0,H;Hydroxylation;R7>
<10,H;Hydroxylation;R8>

>  <CYP3A4>  (59) 
<1,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>
<2,H;Hydroxylation;R3>
<8,H;Hydroxylation;R4>
<3,H;Hydroxylation;R5>
<7,H;Hydroxylation;R6>

>  <References>  (59) 
Bellec G, Dreano Y, Bail JP, Menez JF, Berthou F: Cytochrome P450 hydroxylation of carbon atoms of the alkyl chain of symmetrical N-nitrosodialkylamines by human liver microsomes. Mutat Res. 1997 Jul 3;377(2):199-209. doi: 10.1016/s0027-5107(97)00073-0. (PMID: 9247615)

>  <Comments>  (59) 


$$$$
CC01868
     RDKit          2D

 18 20  0  0  0  0  0  0  0  0999 V2000
    1.2220   -1.1890    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7060   -1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2220   -2.5240    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4370   -2.2690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2780   -2.6810    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9920   -2.2690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7060   -2.6810    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9920   -1.4440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2780   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2780   -0.2060    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4370   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9920    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9920    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7060    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7060    2.2690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9920    2.6810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2780    2.2690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2780    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1 11  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4 11  2  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 13 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
M  END
>  <Name>  (60) 
O6-Benzylguanine

>  <InChIKey>  (60) 
KRWMERLEINMZFT-UHFFFAOYSA-N

>  <PubChem_CID>  (60) 
4578

>  <CYP1A2>  (60) 
<14,H;Oxidation;R1>
<14,15;Reduction;R1>

>  <CYP2A6>  (60) 


>  <CYP2B6>  (60) 


>  <CYP2C8>  (60) 


>  <CYP2C9>  (60) 


>  <CYP2C19>  (60) 


>  <CYP2D6>  (60) 


>  <CYP2E1>  (60) 


>  <CYP3A4>  (60) 
<14,H;Oxidation;R1>
<14,15;Reduction;R1>

>  <References>  (60) 
Roy SK, Korzekwa KR, Gonzalez FJ, Moschel RC, Dolan ME: Human liver oxidative metabolism of O6-benzylguanine. Biochem Pharmacol. 1995 Oct 26;50(9):1385-9. doi: 10.1016/0006-2952(95)02019-5. (PMID: 7503788)

>  <Comments>  (60) 


$$$$
CC01869
     RDKit          3D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -0.0780    1.4220   -0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0270    0.0360   -0.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1000    2.1910   -0.3790 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2850    2.1100   -0.4170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2740   -0.6160   -0.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2310   -0.6660   -0.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3480    1.5840   -0.3620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4800    1.3960   -0.3870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3730    0.1290   -0.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4500    0.0070   -0.2640 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3880    2.2260   -0.4660 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3970   -2.0990    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3590   -2.6270    1.3790 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0180   -2.8000    1.8010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1030   -3.3400    3.2110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6140   -4.6600    3.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6250    2.1360   -0.4890 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7820    1.3100   -0.4490 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  2  0
  5 12  1  0
  6 10  2  0
  7  9  1  0
  7 11  2  0
  8 10  1  0
  8 17  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 17 18  1  0
M  END
>  <Name>  (61) 
PMAMC

>  <InChIKey>  (61) 
SWLDVJDYIJBAMP-UHFFFAOYSA-N

>  <PubChem_CID>  (61) 
85782014

>  <CYP1A2>  (61) 
<14,H;Oxidation;R1>
<13,14;Cleavage;R1>
<2,H;Oxidation;R2>
<2,3;Cleavage;R2>

>  <CYP2A6>  (61) 


>  <CYP2B6>  (61) 


>  <CYP2C8>  (61) 


>  <CYP2C9>  (61) 


>  <CYP2C19>  (61) 
<14,H;Oxidation;R1>
<13,14;Cleavage;R1>
<2,H;Oxidation;R2>
<2,3;Cleavage;R2>

>  <CYP2D6>  (61) 
<14,H;Oxidation;R1>
<13,14;Cleavage;R1>
<2,H;Oxidation;R2>
<2,3;Cleavage;R2>

>  <CYP2E1>  (61) 


>  <CYP3A4>  (61) 


>  <References>  (61) 
Venhorst J, Onderwater RC, Meerman JH, Commandeur JN, Vermeulen NP: Influence of N-substitution of 7-methoxy-4-(aminomethyl)-coumarin on cytochrome P450 metabolism and selectivity. Drug Metab Dispos. 2000 Dec;28(12):1524-32. (PMID: 11095593)

>  <Comments>  (61) 


$$$$
CC01870
     RDKit          2D

 17 19  0  0  0  0  0  0  0  0999 V2000
    0.7390   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7390   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0240    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6900   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6900   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0240   -1.4440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0080   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5240   -1.2860    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5240    0.0490    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4040    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1190   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8330    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8330    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1190    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4040    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7780    0.8330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8330   -0.6190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  1  8  1  0
  2  3  2  0
  2  9  1  0
  3  4  1  0
  4  5  2  0
  4 10  1  0
  5  6  1  0
  7  8  2  0
  7  9  1  0
  7 17  1  0
  9 16  1  0
 10 11  2  0
 10 15  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
M  END
>  <Name>  (62) 
PhIP

>  <InChIKey>  (62) 
UQVKZNNCIHJZLS-UHFFFAOYSA-N

>  <PubChem_CID>  (62) 
1530

>  <CYP1A2>  (62) 
<3,H;Hydroxylation;R1>
<12,H;Hydroxylation;R2>

>  <CYP2A6>  (62) 


>  <CYP2B6>  (62) 


>  <CYP2C8>  (62) 


>  <CYP2C9>  (62) 


>  <CYP2C19>  (62) 


>  <CYP2D6>  (62) 


>  <CYP2E1>  (62) 


>  <CYP3A4>  (62) 


>  <References>  (62) 
Crofts FG, Sutter TR, Strickland PT: Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1. Carcinogenesis. 1998 Nov;19(11):1969-73. doi: 10.1093/carcin/19.11.1969. (PMID: 9855011)

>  <Comments>  (62) 


$$$$
CC01871
     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.7140    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140   -0.4120    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4290   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1430   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1430    0.4120    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5720   -2.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2870   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2870   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5720   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0010   -2.0620    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.8580    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8580    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5720    2.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2870    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2870    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5720    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0010    2.0620    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  3 19  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 12 17  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 18  1  0
 16 17  2  0
 19 20  2  0
 19 24  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 22 25  1  0
 23 24  2  0
M  CHG  1   6   1
M  END
>  <Name>  (63) 
RHP+

>  <InChIKey>  (63) 
CESYFZMRVQIRNB-UHFFFAOYSA-N

>  <PubChem_CID>  (63) 
177961

>  <CYP1A2>  (63) 
<0,1;Oxidation;R1>

>  <CYP2A6>  (63) 


>  <CYP2B6>  (63) 


>  <CYP2C8>  (63) 


>  <CYP2C9>  (63) 


>  <CYP2C19>  (63) 


>  <CYP2D6>  (63) 


>  <CYP2E1>  (63) 


>  <CYP3A4>  (63) 
<0,1;Oxidation;R1>

>  <References>  (63) 
Fang J, McKay G, Song J, Remillrd A, Li X, Midha K: In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes. Drug Metab Dispos. 2001 Dec;29(12):1638-43. (PMID: 11717183)

>  <Comments>  (63) 


$$$$
CC01872
     RDKit          3D

 16 17  0  0  0  0  0  0  0  0999 V2000
    1.1200    0.6730    0.5590 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1570    1.3320    0.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8980    0.8330   -0.9410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9890   -0.6110   -0.9250 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1780   -1.2640   -1.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2530   -1.3250   -0.7130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9740   -0.7810    0.5130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3710   -0.5640   -1.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5840   -1.2210   -1.5480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6260   -2.6100   -1.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4590   -3.3440   -1.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4910   -4.8380   -1.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3840   -5.4060   -1.8740 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5520   -5.3700   -1.9880 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5670   -5.3310   -0.0500 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2560   -2.6620   -1.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  7  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  5  8  2  0
  5 16  1  0
  6  7  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 16  2  0
 12 13  1  0
 12 14  1  0
 12 15  1  0
M  END
>  <Name>  (64) 
TFMPP

>  <InChIKey>  (64) 
KKIMDKMETPPURN-UHFFFAOYSA-N

>  <PubChem_CID>  (64) 
4296

>  <CYP1A2>  (64) 
<6,H;Hydroxylation;R1>
<5,H;Hydroxylation;R2>

>  <CYP2A6>  (64) 


>  <CYP2B6>  (64) 


>  <CYP2C8>  (64) 


>  <CYP2C9>  (64) 


>  <CYP2C19>  (64) 


>  <CYP2D6>  (64) 
<6,H;Hydroxylation;R1>
<5,H;Hydroxylation;R2>

>  <CYP2E1>  (64) 


>  <CYP3A4>  (64) 
<6,H;Hydroxylation;R1>
<5,H;Hydroxylation;R2>

>  <References>  (64) 
Staack RF, Paul LD, Springer D, Kraemer T, Maurer HH: Cytochrome P450 dependent metabolism of the new designer drug 1-(3-trifluoromethylphenyl)piperazine (TFMPP). In vivo studies in Wistar and Dark Agouti rats as well as in vitro studies in human liver microsomes. Biochem Pharmacol. 2004 Jan 15;67(2):235-44. doi: 10.1016/j.bcp.2003.08.029. (PMID: 14698036)

>  <Comments>  (64) 


$$$$
CC01874
     RDKit          3D

 20 21  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3780    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2080   -0.6790   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3960    0.0280   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770    1.4110   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1710    2.0860    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3320    2.1140    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7640    2.3510    1.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7620    1.3160    2.5010 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7490    2.3520    3.9550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9870    3.4140    3.5380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4880    3.4050    2.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3720    2.1320    5.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8830    1.9520    6.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5240    1.7260    7.5730 C   0  0  2  0  0  0  0  0  0  0  0  0
   -4.2220    2.9060    8.5000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0010    0.4930    8.1660 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7400   -0.1900    9.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8410    0.2180    9.3790 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2600   -1.3240    9.6090 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  7  8  1  0
  8  9  1  0
  8 12  2  0
  9 10  1  0
 10 11  2  0
 10 13  1  0
 11 12  1  0
 13 14  3  0
 14 15  1  0
 15 16  1  1
 15 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
M  END
>  <Name>  (65) 
ABT-438

>  <InChIKey>  (65) 
XRXFSKOKCIPNGH-LBPRGKRZSA-N

>  <PubChem_CID>  (65) 
66833621

>  <CYP1A2>  (65) 
<8,H;Hydroxylation;R1>

>  <CYP2A6>  (65) 


>  <CYP2B6>  (65) 


>  <CYP2C8>  (65) 


>  <CYP2C9>  (65) 
<8,H;Hydroxylation;R1>

>  <CYP2C19>  (65) 
<8,H;Hydroxylation;R1>

>  <CYP2D6>  (65) 
<8,H;Hydroxylation;R1>

>  <CYP2E1>  (65) 
<8,H;Hydroxylation;R1>

>  <CYP3A4>  (65) 
<8,H;Hydroxylation;R1>

>  <References>  (65) 
Machinist JM, Mayer MD, Shet MS, Ferrero JL, Rodrigues AD: Identification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193. Drug Metab Dispos. 1995 Oct;23(10):1163-74. (PMID: 8654206)

>  <Comments>  (65) 


$$$$
CC01875
     RDKit          3D

 21 22  0  0  0  0  0  0  0  0999 V2000
   -0.1040    1.2970    0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0510   -0.0830    0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3070   -0.6640    0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4110    0.1350   -0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2590    1.5130   -0.4070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0030    2.0930   -0.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4520    1.9200    0.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7600    2.3130    1.6130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7580    1.3120    2.5780 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6430    2.3780    3.9110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8700    3.4740    3.6140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3660    3.4390    2.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2780    2.1490    5.1650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8090    1.9580    6.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4600    1.7290    7.5130 C   0  0  2  0  0  0  0  0  0  0  0  0
   -4.3350    2.9420    8.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0200    0.5360    8.2000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6670    0.2090    8.0530 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8170   -0.2210    9.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0050    0.0430    9.2060 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1960   -1.3040    9.5950 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  7  8  1  0
  8  9  1  0
  8 12  2  0
  9 10  1  0
 10 11  2  0
 10 13  1  0
 11 12  1  0
 13 14  3  0
 14 15  1  0
 15 16  1  1
 15 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 19 21  1  0
M  END
>  <Name>  (66) 
ABT-761

>  <InChIKey>  (66) 
JONJCOZHGBDTBN-LBPRGKRZSA-N

>  <PubChem_CID>  (66) 


>  <CYP1A2>  (66) 
<8,H;Hydroxylation;R1>

>  <CYP2A6>  (66) 


>  <CYP2B6>  (66) 


>  <CYP2C8>  (66) 


>  <CYP2C9>  (66) 
<8,H;Hydroxylation;R1>

>  <CYP2C19>  (66) 
<8,H;Hydroxylation;R1>

>  <CYP2D6>  (66) 
<8,H;Hydroxylation;R1>

>  <CYP2E1>  (66) 
<8,H;Hydroxylation;R1>

>  <CYP3A4>  (66) 
<8,H;Hydroxylation;R1>

>  <References>  (66) 
Machinist JM, Mayer MD, Roberts EM, Surber BW, Rodrigues AD: Identification of the human liver cytochrome P450 enzymes involved in the in vitro metabolism of a novel 5-lipoxygenase inhibitor. Drug Metab Dispos. 1998 Oct;26(10):970-6. (PMID: 9763401)

>  <Comments>  (66) 


$$$$
CC01876
     RDKit          3D

 26 28  0  0  0  0  0  0  0  0999 V2000
   -0.8310   -1.1120   -0.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3890   -1.4210    1.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7150   -0.8230    1.5110 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.8400   -0.3330    2.9400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9080   -1.6020    1.0530 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4030   -1.6360   -0.4710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6950   -2.2680    2.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0740   -2.4750    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5400   -2.7990    1.6590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3630   -3.0230    0.0320 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9350   -3.7630    0.8440 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8100   -2.7160   -1.0810 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9790    0.8760    3.1670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2770    0.9380    4.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8930    1.7870    2.3480 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2890   -2.8170    1.8020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3980   -3.5260    1.3500 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1460   -3.0960    0.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6640   -3.1860    2.7900 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7960   -1.9390   -0.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6360   -1.1930    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3260   -0.0550   -0.7000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5720   -1.5510   -1.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6740   -2.3130   -1.9240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0080   -3.4700   -1.2230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2420   -3.8690   -0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  2  7  1  0
  3  4  1  1
  3  5  1  0
  4 13  1  0
  5 16  1  0
  5 21  2  0
  6  8  2  0
  7  9  2  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 10 12  2  0
 13 14  1  0
 13 15  2  0
 16 17  1  0
 16 19  2  0
 17 18  1  0
 18 20  2  0
 18 26  1  0
 20 21  1  0
 20 23  1  0
 21 22  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
M  CHG  2  10   1  11  -1
M  END
>  <Name>  (67) 
Acenocoumarol

>  <InChIKey>  (67) 
VABCILAOYCMVPS-HNNXBMFYSA-N

>  <PubChem_CID>  (67) 
54683745

>  <CYP1A2>  (67) 
<19,H;Hydroxylation;R1>

>  <CYP2A6>  (67) 


>  <CYP2B6>  (67) 


>  <CYP2C8>  (67) 


>  <CYP2C9>  (67) 
<19,H;Hydroxylation;R1>
<20,H;Hydroxylation;R2>
<21,H;Hydroxylation;R3>

>  <CYP2C19>  (67) 
<19,H;Hydroxylation;R1>
<20,H;Hydroxylation;R2>
<21,H;Hydroxylation;R3>

>  <CYP2D6>  (67) 


>  <CYP2E1>  (67) 


>  <CYP3A4>  (67) 


>  <References>  (67) 
Thijssen HH, Flinois JP, Beaune PH: Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes. Drug Metab Dispos. 2000 Nov;28(11):1284-90. (PMID: 11038154)

>  <Comments>  (67) 


$$$$
CC01877
     RDKit          3D

 11 11  0  0  0  0  0  0  0  0999 V2000
    2.4050   -3.6550   -0.0050 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2420    2.2160   -0.0110 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9270    1.8530   -0.0200 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8460    0.4550   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5710   -0.1110   -0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9720   -0.3690   -0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4180   -1.4950   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8280   -1.7540   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5510   -2.3000   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0810    2.6090   -0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7400    4.0660   -0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  1  0
  2 10  2  0
  3  4  1  0
  3 10  1  0
  4  5  2  0
  4  6  1  0
  5  7  1  0
  6  8  2  0
  7  9  2  0
  8  9  1  0
 10 11  1  0
M  END
>  <Name>  (68) 
Acetaminophen

>  <InChIKey>  (68) 
RZVAJINKPMORJF-UHFFFAOYSA-N

>  <PubChem_CID>  (68) 
1983

>  <CYP1A2>  (68) 
<7,8;Oxidation;R1>
<3,4;Oxidation;R1>

>  <CYP2A6>  (68) 
<6,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>
<7,8;Oxidation;R3>
<3,4;Oxidation;R3>

>  <CYP2B6>  (68) 


>  <CYP2C8>  (68) 
<7,8;Oxidation;R1>
<3,4;Oxidation;R1>

>  <CYP2C9>  (68) 
<7,8;Oxidation;R1>
<3,4;Oxidation;R1>

>  <CYP2C19>  (68) 


>  <CYP2D6>  (68) 
<7,8;Oxidation;R1>
<3,4;Oxidation;R1>

>  <CYP2E1>  (68) 
<6,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>
<7,8;Oxidation;R3>
<3,4;Oxidation;R3>

>  <CYP3A4>  (68) 
<7,8;Oxidation;R1>
<3,4;Oxidation;R1>

>  <References>  (68) 
Dong H, Haining RL, Thummel KE, Rettie AE, Nelson SD: Involvement of human cytochrome P450 2D6 in the bioactivation of acetaminophen. Drug Metab Dispos. 2000 Dec;28(12):1397-400. (PMID: 11095574)
Raucy JL, Lasker JM, Lieber CS, Black M: Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch Biochem Biophys. 1989 Jun;271(2):270-83. doi: 10.1016/0003-9861(89)90278-6. (PMID: 2729995)
Patten CJ, Thomas PE, Guy RL, Lee M, Gonzalez FJ, Guengerich FP, Yang CS: Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol. 1993 Jul-Aug;6(4):511-8. (PMID: 8374050)
Chen W, Koenigs LL, Thompson SJ, Peter RM, Rettie AE, Trager WF, Nelson SD: Oxidation of acetaminophen to its toxic quinone imine and nontoxic catechol metabolites by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A6. Chem Res Toxicol. 1998 Apr;11(4):295-301. doi: 10.1021/tx9701687. (PMID: 9548799)

>  <Comments>  (68) 


$$$$
CC01878
     RDKit          2D

 10 10  0  0  0  0  0  0  0  0999 V2000
    4.5980    0.7500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    0.7500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660   -0.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -1.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -1.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660   -2.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    1.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    2.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  2  0
  2  3  1  0
  2  9  1  0
  3  4  2  0
  3  5  1  0
  4  6  1  0
  5  7  2  0
  6  8  2  0
  7  8  1  0
  9 10  1  0
M  END
>  <Name>  (69) 
Acetanilide

>  <InChIKey>  (69) 
FZERHIULMFGESH-UHFFFAOYSA-N

>  <PubChem_CID>  (69) 
904

>  <CYP1A2>  (69) 
<5,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>
<7,H;Hydroxylation;R3>

>  <CYP2A6>  (69) 


>  <CYP2B6>  (69) 


>  <CYP2C8>  (69) 


>  <CYP2C9>  (69) 


>  <CYP2C19>  (69) 


>  <CYP2D6>  (69) 


>  <CYP2E1>  (69) 


>  <CYP3A4>  (69) 


>  <References>  (69) 
Liu G, Gelboin HV, Myers MJ: Role of cytochrome P450 IA2 in acetanilide 4-hydroxylation as determined with cDNA expression and monoclonal antibodies. Arch Biochem Biophys. 1991 Feb 1;284(2):400-6. doi: 10.1016/0003-9861(91)90315-a. (PMID: 1989524)

>  <Comments>  (69) 


$$$$
CC01879
     RDKit          3D

 23 27  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3860    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2040   -0.6810   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4070    0.0130   -0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4210    1.3960   -0.0810 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2070    2.0940    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1520    3.5010    0.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0740    4.1330    0.3230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2890    3.3080    0.4900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2020    2.0440   -0.0060 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2320    4.5270   -0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5420    5.8930    0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0780    5.5710    0.3630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1490   -0.9870    0.0490 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.5000   -2.3480    0.4360 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.9510   -2.1740   -0.0480 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9880   -0.6960    1.2830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5620   -1.4860    2.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5390   -2.2880    1.8730 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8110    6.3780    0.5410 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2940    3.7290    1.0310 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5960    2.0690   -0.1410 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6320    1.0880   -0.2170 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1 10  1  0
  2  3  1  0
  2 14  1  0
  3  4  2  0
  3 16  1  0
  4  5  1  0
  5  6  2  0
  5 22  1  0
  6  7  1  0
  7  8  2  0
  7 11  1  0
  8  9  1  0
  8 13  1  0
  9 10  1  0
  9 21  2  0
 11 12  1  0
 12 13  1  0
 13 20  2  0
 14 15  1  0
 14 17  1  1
 15 16  1  1
 15 19  1  0
 17 18  2  0
 18 19  1  0
 22 23  1  0
M  END
>  <Name>  (70) 
Aflatoxin B1

>  <InChIKey>  (70) 
OQIQSTLJSLGHID-WNWIJWBNSA-N

>  <PubChem_CID>  (70) 
186907

>  <CYP1A2>  (70) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>
<13,H;Hydroxylation;R2>
<18,19;Epoxidation;R3>
<17,H;Hydroxylation;R4>

>  <CYP2A6>  (70) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>
<13,H;Hydroxylation;R2>
<17,H;Hydroxylation;R3>

>  <CYP2B6>  (70) 


>  <CYP2C8>  (70) 


>  <CYP2C9>  (70) 


>  <CYP2C19>  (70) 


>  <CYP2D6>  (70) 


>  <CYP2E1>  (70) 


>  <CYP3A4>  (70) 
<13,H;Hydroxylation;R1>
<18,19;Epoxidation;R2>

>  <References>  (70) 
Gallagher EP, Kunze KL, Stapleton PL, Eaton DL: The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicol Appl Pharmacol. 1996 Dec;141(2):595-606. doi: 10.1006/taap.1996.0326. (PMID: 8975785)
He XY, Tang L, Wang SL, Cai QS, Wang JS, Hong JY: Efficient activation of aflatoxin B1 by cytochrome P450 2A13, an enzyme predominantly expressed in human respiratory tract. Int J Cancer. 2006 Jun 1;118(11):2665-71. doi: 10.1002/ijc.21665. (PMID: 16385575)

>  <Comments>  (70) 


$$$$
CC01880
     RDKit          3D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -0.0160    1.3040    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2610    1.7870    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1600    2.0840    0.0190 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2880   -0.4440   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0600    3.4280    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1130    0.6930   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8660   -1.7150   -0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0350    3.9560    0.0220 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4920    0.5510   -0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2440   -1.8420   -0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1720    4.1860    0.0350 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9770   -3.4440   -0.0570 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.0540   -0.7080   -0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7320   -2.9870   -0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0640    5.6340    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5890   -4.2540   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0700   -3.8690   -0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  3  7  1  0
  4  6  1  0
  5  7  2  0
  5  8  1  0
  6  9  2  0
  6 12  1  0
  7 10  1  0
  8 11  2  0
 10 14  2  0
 11 13  1  0
 11 14  1  0
 12 16  1  0
 13 15  1  0
 15 17  1  0
 17 18  1  0
M  END
>  <Name>  (71) 
Albendazole

>  <InChIKey>  (71) 
HXHWSAZORRCQMX-UHFFFAOYSA-N

>  <PubChem_CID>  (71) 
2082

>  <CYP1A2>  (71) 
<3,S;S-Oxidation;R1>

>  <CYP2A6>  (71) 


>  <CYP2B6>  (71) 


>  <CYP2C8>  (71) 


>  <CYP2C9>  (71) 


>  <CYP2C19>  (71) 


>  <CYP2D6>  (71) 


>  <CYP2E1>  (71) 


>  <CYP3A4>  (71) 
<3,S;S-Oxidation;R1>

>  <References>  (71) 
Rawden HC, Kokwaro GO, Ward SA, Edwards G: Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes. Br J Clin Pharmacol. 2000 Apr;49(4):313-22. doi: 10.1046/j.1365-2125.2000.00170.x. (PMID: 10759686)

>  <Comments>  (71) 


$$$$
CC01881
     RDKit          3D

 21 21  0  0  0  0  0  0  0  0999 V2000
   -0.5970    2.1490   -0.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5530    0.7000   -0.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2910    2.8540   -1.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2560    2.8410    0.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5710   -0.1380   -0.6080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2520   -6.2510   -1.2870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6130   -7.6700   -1.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6980   -3.7120   -0.7720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0340   -5.7750   -1.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5010   -1.5730   -0.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8460   -4.3490   -1.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6100   -2.2820   -0.7900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8620   -8.6110   -1.1330 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3340    4.3490   -1.3810 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5090    4.3110    0.2950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0820    2.2340   -2.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4460    2.7510    1.9480 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6240    2.1990    0.7470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7370    5.0270   -0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8520   -6.6330   -0.7270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1870   -2.2040   -0.2390 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  3 14  1  0
  3 16  1  0
  4 15  1  0
  4 17  1  0
  4 18  1  0
  5 10  1  0
  6  7  1  0
  6  9  2  0
  7 13  2  0
  8 11  2  0
  8 12  1  0
  9 11  1  0
  9 20  1  0
 10 12  2  0
 10 21  1  0
 14 19  1  0
 15 19  1  0
M  END
>  <Name>  (72) 
all-trans-Retinal

>  <InChIKey>  (72) 
NCYCYZXNIZJOKI-OVSJKPMPSA-N

>  <PubChem_CID>  (72) 
638015

>  <CYP1A2>  (72) 
<13,H;Hydroxylation;R1>

>  <CYP2A6>  (72) 


>  <CYP2B6>  (72) 


>  <CYP2C8>  (72) 
<13,H;Hydroxylation;R1>

>  <CYP2C9>  (72) 
<13,H;Hydroxylation;R1>

>  <CYP2C19>  (72) 
<13,H;Hydroxylation;R1>

>  <CYP2D6>  (72) 
<13,H;Hydroxylation;R1>

>  <CYP2E1>  (72) 


>  <CYP3A4>  (72) 
<13,H;Hydroxylation;R1>

>  <References>  (72) 
Zhang QY, Dunbar D, Kaminsky L: Human cytochrome P-450 metabolism of retinals to retinoic acids. Drug Metab Dispos. 2000 Mar;28(3):292-7. (PMID: 10681373)
Chen H, Howald WN, Juchau MR: Biosynthesis of all-trans-retinoic acid from all-trans-retinol: catalysis of all-trans-retinol oxidation by human P-450 cytochromes. Drug Metab Dispos. 2000 Mar;28(3):315-22. (PMID: 10681376)

>  <Comments>  (72) 


$$$$
CC01883
     RDKit          3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4020    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3850    1.8260   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2360    2.0820    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3230   -0.3920   -0.0130 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2010   -0.7020    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1320    0.7110   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8930    3.2450    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4060    1.3770    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3930   -0.0110    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9600    3.7610    1.4400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7220    2.1120    0.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4550    5.1440    1.4420 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2740    2.4160   -1.6360 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.2670    5.6570    2.8060 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9040    5.0740    1.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7080    3.2180   -1.4300 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4620    3.3860   -2.2840 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6740    1.2140   -2.2800 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8680    4.6750   -1.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0370    2.5880   -1.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3700    4.9580   -1.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9020    3.6120   -0.5520 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  5  7  1  0
  6 10  2  0
  8 11  1  0
  9 10  1  0
  9 12  1  0
 11 13  1  0
 12 14  1  0
 13 15  1  0
 13 16  1  0
 14 17  1  0
 14 18  2  0
 14 19  2  0
 17 20  1  0
 17 21  1  0
 20 22  1  0
 21 23  1  0
 22 23  1  0
M  END
>  <Name>  (73) 
Almotriptan

>  <InChIKey>  (73) 
WKEMJKQOLOHJLZ-UHFFFAOYSA-N

>  <PubChem_CID>  (73) 
123606

>  <CYP1A2>  (73) 
<20,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>

>  <CYP2A6>  (73) 


>  <CYP2B6>  (73) 


>  <CYP2C8>  (73) 
<20,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>

>  <CYP2C9>  (73) 


>  <CYP2C19>  (73) 
<20,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>

>  <CYP2D6>  (73) 
<20,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>
<1,2;Cleavage;R4>
<2,H;Oxidation;R4>

>  <CYP2E1>  (73) 


>  <CYP3A4>  (73) 
<20,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>
<1,2;Cleavage;R4>
<2,H;Oxidation;R4>

>  <References>  (73) 
Salva M, Jansat JM, Martinez-Tobed A, Palacios JM: Identification of the human liver enzymes involved in the metabolism of the antimigraine agent almotriptan. Drug Metab Dispos. 2003 Apr;31(4):404-11. doi: 10.1124/dmd.31.4.404. (PMID: 12642466)

>  <Comments>  (73) 


$$$$
CC01884
     RDKit          3D

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0540   -1.5120   -0.0240 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1190   -0.7170   -0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9630    0.6030   -0.0800 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2590    1.1280   -0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3240    0.3330   -0.0230 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1680   -0.9870   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2730   -1.8130    0.0330 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6190   -1.2340    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6560   -2.3580    0.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3870   -1.2620   -0.0810 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5600   -0.3870   -0.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0010   -0.0580    1.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7000   -1.0950   -0.8570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4660    2.8780   -0.0840 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2730    2.9810   -0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  2 10  1  0
  3  4  2  0
  4  5  1  0
  4 14  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 14 15  1  0
M  END
>  <Name>  (74) 
Ametryne

>  <InChIKey>  (74) 
RQVYBGPQFYCBGX-UHFFFAOYSA-N

>  <PubChem_CID>  (74) 
13263

>  <CYP1A2>  (74) 
<12,S;S-Oxidation;R1>
<1,2;Cleavage;R2>
<1,H;Oxidation;R2>
<6,7;Cleavage;R3>
<7,H;Oxidation;R3>
<8,H;Hydroxylation;R4>
<9,H;Hydroxylation;R5>

>  <CYP2A6>  (74) 


>  <CYP2B6>  (74) 
<12,S;S-Oxidation;R1>
<7,H;Oxidation;R2>
<6,7;Cleavage;R2>

>  <CYP2C8>  (74) 


>  <CYP2C9>  (74) 


>  <CYP2C19>  (74) 


>  <CYP2D6>  (74) 


>  <CYP2E1>  (74) 


>  <CYP3A4>  (74) 
<12,S;S-Oxidation;R1>
<1,2;Cleavage;R2>
<1,H;Oxidation;R2>
<6,7;Cleavage;R3>
<7,H;Oxidation;R3>

>  <References>  (74) 
Lang DH, Rettie AE, Bocker RH: Identification of enzymes involved in the metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in human liver microsomes. Chem Res Toxicol. 1997 Sep;10(9):1037-44. doi: 10.1021/tx970081l. (PMID: 9305587)

>  <Comments>  (74) 


$$$$
CC01885
     RDKit          3D

 16 17  0  0  0  0  0  0  0  0999 V2000
    1.2340    0.6640   -0.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0720    1.3640    0.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1000    0.6680    0.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1030   -0.7260    0.4220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0540   -1.4490    0.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0150   -2.8580    0.0910 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2180   -0.7300   -0.1530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0970   -3.6770    0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2410   -3.3550    0.6360 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6270   -5.1190    0.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4300   -6.2220    0.3620 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8290   -6.1260    0.7110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9350   -7.5700    0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6750   -5.0000   -0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0860   -3.6910   -0.1960 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4120   -3.2500   -0.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  6  8  1  0
  6 15  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 10 14  2  0
 11 12  1  0
 11 13  1  0
 14 15  1  0
 15 16  1  0
M  END
>  <Name>  (75) 
Aminopyrine

>  <InChIKey>  (75) 
WOEUPEKLVDSCQN-UHFFFAOYSA-N

>  <PubChem_CID>  (75) 


>  <CYP1A2>  (75) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2A6>  (75) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2B6>  (75) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2C8>  (75) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2C9>  (75) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2C19>  (75) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2D6>  (75) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2E1>  (75) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP3A4>  (75) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <References>  (75) 
Niwa T, Sato R, Yabusaki Y, Ishibashi F, Katagiri M: Contribution of human hepatic cytochrome P450s and steroidogenic CYP17 to the N-demethylation of aminopyrine. Xenobiotica. 1999 Feb;29(2):187-93. doi: 10.1080/004982599238731. (PMID: 10199594)

>  <Comments>  (75) 


$$$$
CC01886
     RDKit          3D

 31 33  0  0  0  0  0  0  0  0999 V2000
   -6.5630    1.6000    1.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4340    1.7120    2.8180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4150    1.0520    3.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5170    0.2730    2.7910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6380    0.1520    1.4100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6710    0.8140    0.7300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5540    0.5170   -0.5810 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8830   -0.5730    0.3690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5180   -0.2980   -0.8050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1050   -0.8230   -2.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8270   -2.1440   -2.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4080   -2.6770   -3.8040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1300   -3.9980   -4.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7020   -1.4260    0.5610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3480   -0.8510    0.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2260   -1.6330    0.7330 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0360   -1.0920    0.6220 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1950    0.2310    0.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0820    1.0130   -0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1830    0.4770    0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8400   -2.6080    0.8160 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7180   -2.2640    1.0540 I   0  0  0  0  0  0  0  0  0  0  0  0
    0.3290    3.0050   -0.6610 I   0  0  0  0  0  0  0  0  0  0  0  0
    2.4400    0.7600    0.1160 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8990    0.4710   -1.2060 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2910    1.0740   -1.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2380    0.4360   -0.4820 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5310   -0.8950   -1.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5170   -1.6190   -0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4860    1.2080   -0.5570 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3160    2.5290    0.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  8  1  0
  6  7  1  0
  7  9  1  0
  8  9  2  0
  8 14  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 14 15  1  0
 14 21  2  0
 15 16  2  0
 15 20  1  0
 16 17  1  0
 17 18  2  0
 17 22  1  0
 18 19  1  0
 18 24  1  0
 19 20  2  0
 19 23  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 27 30  1  0
 28 29  1  0
 30 31  1  0
M  END
>  <Name>  (76) 
Amiodarone

>  <InChIKey>  (76) 
IYIKLHRQXLHMJQ-UHFFFAOYSA-N

>  <PubChem_CID>  (76) 
2157

>  <CYP1A2>  (76) 
<23,24;Cleavage;R1>
<24,H;Oxidation;R1>
<23,26;Cleavage;R2>
<26,H;Oxidation;R2>

>  <CYP2A6>  (76) 


>  <CYP2B6>  (76) 


>  <CYP2C8>  (76) 
<23,24;Cleavage;R1>
<24,H;Oxidation;R1>
<23,26;Cleavage;R2>
<26,H;Oxidation;R2>

>  <CYP2C9>  (76) 
<23,24;Cleavage;R1>
<24,H;Oxidation;R1>
<23,26;Cleavage;R2>
<26,H;Oxidation;R2>

>  <CYP2C19>  (76) 
<23,24;Cleavage;R1>
<24,H;Oxidation;R1>
<23,26;Cleavage;R2>
<26,H;Oxidation;R2>

>  <CYP2D6>  (76) 
<23,24;Cleavage;R1>
<24,H;Oxidation;R1>
<23,26;Cleavage;R2>
<26,H;Oxidation;R2>

>  <CYP2E1>  (76) 


>  <CYP3A4>  (76) 
<23,24;Cleavage;R1>
<24,H;Oxidation;R1>
<23,26;Cleavage;R2>
<26,H;Oxidation;R2>

>  <References>  (76) 
Ohyama K, Nakajima M, Nakamura S, Shimada N, Yamazaki H, Yokoi T: A significant role of human cytochrome P450 2C8 in amiodarone N-deethylation: an approach to predict the contribution with relative activity factor. Drug Metab Dispos. 2000 Nov;28(11):1303-10. (PMID: 11038157)
Fabre G, Julian B, Saint-Aubert B, Joyeux H, Berger Y: Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions. Drug Metab Dispos. 1993 Nov-Dec;21(6):978-85. (PMID: 7905403)

>  <Comments>  (76) 


$$$$
CC01887
     RDKit          3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0810    1.5320   -0.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0940   -0.3990 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3410    2.2850    0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1220    2.1320   -0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7000   -0.4150   -1.4990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7770   -0.7760    0.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5360    2.0220   -0.5450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3650    3.2740    1.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4640    3.5550    0.2110 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5310    0.4770   -2.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6080   -1.7700   -1.8220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8610   -2.1290    0.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7370    0.9930   -1.6110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6880    2.7600   -0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5130    4.0030    1.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1970    4.1140   -0.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1690   -2.6260   -1.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6820    3.7450    0.7460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5560    5.5090   -0.7940 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1630    5.9650   -2.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5830    5.5890    0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  7 13  1  0
  7 14  1  0
  8 15  2  0
  9 16  1  0
 10 13  1  0
 11 17  2  0
 12 17  1  0
 14 18  2  0
 15 18  1  0
 16 19  1  0
 19 20  1  0
 19 21  1  0
M  END
>  <Name>  (77) 
Amitriptyline

>  <InChIKey>  (77) 
KRMDCWKBEZIMAB-UHFFFAOYSA-N

>  <PubChem_CID>  (77) 
2160

>  <CYP1A2>  (77) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2A6>  (77) 


>  <CYP2B6>  (77) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<14,H;Hydroxylation;R3>
<13,H;Hydroxylation;R4>

>  <CYP2C8>  (77) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2C9>  (77) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2C19>  (77) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2D6>  (77) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<14,H;Hydroxylation;R3>
<13,H;Hydroxylation;R4>

>  <CYP2E1>  (77) 


>  <CYP3A4>  (77) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<18,20;Cleavage;R2>
<20,H;Oxidation;R2>
<14,H;Hydroxylation;R3>
<13,H;Hydroxylation;R4>

>  <References>  (77) 
Breyer-Pfaff U: The metabolic fate of amitriptyline, nortriptyline and amitriptylinoxide in man. Drug Metab Rev. 2004 Oct;36(3-4):723-46. doi: 10.1081/DMR-200033482. (PMID: 15554244)
Venkatakrishnan K, von Moltke LL, Greenblatt DJ: Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrate. J Pharmacol Exp Ther. 2001 Apr;297(1):326-37. (PMID: 11259560)
Ekins S, Bravi G, Ring BJ, Gillespie TA, Gillespie JS, Vandenbranden M, Wrighton SA, Wikel JH: Three-dimensional quantitative structure activity relationship analyses of substrates for CYP2B6. J Pharmacol Exp Ther. 1999 Jan;288(1):21-9. (PMID: 9862748)

>  <Comments>  (77) 
10 and 13 Hydroxyaltion for CYP2B6 are recorded in the seceond reference whose PMID is 11259560.

$$$$
CC01888
     RDKit          3D

 14 15  0  0  0  0  0  0  0  0999 V2000
   -0.5220    2.9500    0.2050 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2640    0.5920   -0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2370   -0.4150   -0.1310 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4770    0.1550    0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1390    0.4060    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9410    1.8060    0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3900    1.4870    0.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9690   -1.7690   -0.5580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7370   -0.6370    0.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9960    1.4380   -0.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7270   -0.7690    0.5150 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3860    1.2840   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1170   -0.9260    0.5490 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9470    0.0990    0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  6  2  0
  2  3  1  0
  2  5  1  0
  2  6  1  0
  3  4  1  0
  3  8  1  0
  4  7  2  0
  4  9  1  0
  5 10  2  0
  5 11  1  0
  6  7  1  0
 10 12  1  0
 11 13  2  0
 12 14  2  0
 13 14  1  0
M  END
>  <Name>  (78) 
Antipyrine

>  <InChIKey>  (78) 
VEQOALNAAJBPNY-UHFFFAOYSA-N

>  <PubChem_CID>  (78) 
2206

>  <CYP1A2>  (78) 
<2,H;Hydroxylation;R1>
<13,H;Hydroxylation;R2>
<12,13;Cleavage;R3>
<13,H;Oxidation;R3>

>  <CYP2A6>  (78) 
<2,H;Hydroxylation;R1>
<13,H;Hydroxylation;R2>
<12,13;Cleavage;R3>
<13,H;Oxidation;R3>

>  <CYP2B6>  (78) 
<2,H;Hydroxylation;R1>

>  <CYP2C8>  (78) 
<2,H;Hydroxylation;R1>
<13,H;Hydroxylation;R2>
<12,13;Cleavage;R3>
<13,H;Oxidation;R3>

>  <CYP2C9>  (78) 
<2,H;Hydroxylation;R1>
<13,H;Hydroxylation;R2>
<12,13;Cleavage;R3>
<13,H;Oxidation;R3>

>  <CYP2C19>  (78) 


>  <CYP2D6>  (78) 
<2,H;Hydroxylation;R1>
<12,13;Cleavage;R2>
<13,H;Oxidation;R2>

>  <CYP2E1>  (78) 
<2,H;Hydroxylation;R1>
<13,H;Hydroxylation;R2>
<12,13;Cleavage;R3>
<13,H;Oxidation;R3>

>  <CYP3A4>  (78) 
<2,H;Hydroxylation;R1>
<12,13;Cleavage;R2>
<13,H;Oxidation;R2>

>  <References>  (78) 
Engel G, Hofmann U, Heidemann H, Cosme J, Eichelbaum M: Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation. Clin Pharmacol Ther. 1996 Jun;59(6):613-23. doi: 10.1016/S0009-9236(96)90001-6. (PMID: 8681486)
Sharer JE, Wrighton SA: Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine. Drug Metab Dispos. 1996 Apr;24(4):487-94. (PMID: 8801065)

>  <Comments>  (78) 


$$$$
CC01889
     RDKit          3D

 37 40  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3690    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7850   -2.3030   -0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6510   -4.5920   -0.0920 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.2570    1.8110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2320   -0.4050   -0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4690   -5.7820   -4.9850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6800   -9.6640   -4.7410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9900   -3.1080   -0.2390 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.0600    0.7260   -0.0140 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4060   -6.5560   -4.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1010   -8.4140   -4.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6010   -4.9320   -1.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0080   -6.8330   -2.3360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2110   -0.8980    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8750   -7.7040   -4.8070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5440   -7.9770   -2.8980 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9670   -6.1230   -3.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2270   -4.8600    1.2440 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4910   -6.3560   -0.9900 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.5040   -2.8460   -1.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6170    2.9740    0.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -6.2670   -4.6270 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.2850   -5.9330   -6.3630 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770   -4.4280   -4.6480 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7940   -9.3300   -5.5200 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.2840  -10.2810   -5.5460 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0690  -10.5420   -3.7240 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8630   -2.7400   -1.8580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6140   -2.7060   -2.6810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3290   -2.6170    1.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4460   -2.3640   -4.1860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0310   -4.1130    1.4650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0840   -2.4650   -3.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3360   -2.4990   -3.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9060   -2.1280   -5.4340 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.5060   -6.7830    0.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0
  1  5  1  0
  2  9  1  0
  2 15  1  0
  2 31  1  0
  3  6  2  0
  3 15  1  0
  4  9  1  0
  4 13  1  6
  4 19  1  0
  5 10  1  0
  5 22  2  0
  6 10  1  0
  7 11  1  0
  7 23  1  0
  7 24  1  0
  7 25  1  0
  8 12  1  0
  8 26  1  0
  8 27  1  0
  8 28  1  0
  9 21  1  6
 11 16  2  0
 11 18  1  0
 12 16  1  0
 12 17  2  0
 13 20  1  0
 14 17  1  0
 14 18  2  0
 14 20  1  0
 19 33  1  0
 20 37  1  1
 21 29  2  0
 21 30  1  0
 29 35  1  0
 30 34  2  0
 31 33  1  0
 32 34  1  0
 32 35  2  0
 32 36  1  0
M  END
>  <Name>  (79) 
Aprepitant

>  <InChIKey>  (79) 
ATALOFNDEOCMKK-OITMNORJSA-N

>  <PubChem_CID>  (79) 
135413536

>  <CYP1A2>  (79) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<4,5;Cleavage;R1>
<5,H;Oxidation;R1>
<6,7;Cleavage;R1>
<6,H;Oxidation;R1>
<2,3;Oxidation;R1>

>  <CYP2A6>  (79) 


>  <CYP2B6>  (79) 


>  <CYP2C8>  (79) 


>  <CYP2C9>  (79) 


>  <CYP2C19>  (79) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<4,5;Cleavage;R1>
<5,H;Oxidation;R1>
<6,7;Cleavage;R1>
<6,H;Oxidation;R1>
<2,3;Oxidation;R1>

>  <CYP2D6>  (79) 


>  <CYP2E1>  (79) 


>  <CYP3A4>  (79) 
<7,8;Cleavage;R1>
<8,H;Oxidation;R1>
<1,2;Cleavage;R2>
<1,H;Oxidation;R2>
<4,5;Cleavage;R2>
<5,H;Oxidation;R2>
<6,7;Cleavage;R2>
<6,H;Oxidation;R2>
<2,3;Oxidation;R2>

>  <References>  (79) 
Sanchez RI, Wang RW, Newton DJ, Bakhtiar R, Lu P, Chiu SH, Evans DC, Huskey SE: Cytochrome P450 3A4 is the major enzyme involved in the metabolism of the substance P receptor antagonist aprepitant. Drug Metab Dispos. 2004 Nov;32(11):1287-92. doi: 10.1124/dmd.104.000216. Epub 2004 Aug 10. (PMID: 15304427)

>  <Comments>  (79) 
Metabolic pathway is not identified. Too many possible combinations because of the two adjacent oxygen atoms.

$$$$
CC01890
     RDKit          3D

 22 21  0  0  0  0  0  0  0  0999 V2000
   10.1270    3.3080   -2.6290 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8510    4.8200   -0.9420 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8710    1.5580    1.4530 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7460    0.7020    1.9870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6580    0.8720    0.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0100    1.4510    3.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8160    0.4310   -0.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1120    0.5960    3.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4170    1.7080   -0.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4690    0.6900    0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7050   -0.8280   -1.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4010   -1.9960   -0.6140 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6380    2.7370   -0.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2360   -0.3180    1.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4470   -2.3160   -0.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2990   -2.6660   -1.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2270   -1.6330    1.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4220   -2.2230   -0.3400 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6240   -2.7690   -1.4670 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5070   -3.3210    0.5000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1780   -3.2830    0.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5920    3.7460   -1.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 22  1  0
  2 22  2  0
  3  4  1  0
  3  5  1  0
  4  6  1  0
  5  7  1  0
  6  8  1  0
  7 11  2  0
  9 10  1  0
  9 13  1  0
 10 14  1  0
 11 12  1  0
 12 16  1  0
 13 22  1  0
 14 17  2  0
 15 17  1  0
 15 20  1  0
 16 19  2  0
 18 19  1  0
 18 21  1  0
 20 21  2  0
M  END
>  <Name>  (80) 
Arachidonic acid

>  <InChIKey>  (80) 
YZXBAPSDXZZRGB-DOFZRALJSA-N

>  <PubChem_CID>  (80) 
444899

>  <CYP1A2>  (80) 
<5,6;EpOxidation;R1>
<8,9;EpOxidation;R2>
<11,12;EpOxidation;R3>
<2,H;Hydroxylation;R4>
<1,H;Hydroxylation;R5>
<0,H;Hydroxylation;R6>
<7,H;Hydroxylation;R7>
<13,H;Hydroxylation;R8>
<10,H;Hydroxylation;R9>

>  <CYP2A6>  (80) 
<1,H;Hydroxylation;R1>

>  <CYP2B6>  (80) 
<1,H;Hydroxylation;R1>
<5,6;EpOxidation;R2>

>  <CYP2C8>  (80) 
<0,H;Hydroxylation;R1>
<1,H;Hydroxylation;R2>
<5,6;EpOxidation;R3>
<8,9;EpOxidation;R4>
<7,H;Hydroxylation;R5>
<13,H;Hydroxylation;R6>
<10,H;Hydroxylation;R7>

>  <CYP2C9>  (80) 
<0,H;Hydroxylation;R1>
<1,H;Hydroxylation;R2>
<5,6;EpOxidation;R3>
<8,9;EpOxidation;R4>
<7,H;Hydroxylation;R5>
<13,H;Hydroxylation;R6>
<10,H;Hydroxylation;R7>

>  <CYP2C19>  (80) 
<5,6;EpOxidation;R1>
<8,9;EpOxidation;R2>
<1,H;Hydroxylation;R3>

>  <CYP2D6>  (80) 
<1,H;Hydroxylation;R1>

>  <CYP2E1>  (80) 
<1,H;Hydroxylation;R1>

>  <CYP3A4>  (80) 
<1,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>
<7,H;Hydroxylation;R3>
<13,H;Hydroxylation;R4>
<10,H;Hydroxylation;R5>

>  <References>  (80) 
Rifkind AB, Lee C, Chang TK, Waxman DJ: Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch Biochem Biophys. 1995 Jul 10;320(2):380-9. doi: 10.1016/0003-9861(95)90023-3. (PMID: 7625847)
Bylund J, Kunz T, Valmsen K, Oliw EH: Cytochromes P450 with bisallylic hydroxylation activity on arachidonic and linoleic acids studied with human recombinant enzymes and with human and rat liver microsomes. J Pharmacol Exp Ther. 1998 Jan;284(1):51-60. (PMID: 9435160)

>  <Comments>  (80) 


$$$$
CC01892
     RDKit          3D

 14 14  0  0  0  0  0  0  0  0999 V2000
   -0.2530   -1.3280    0.0220 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8930   -0.6570    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8830    0.6740    0.0820 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2670    1.3280    0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4100    0.6630    0.0280 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4060   -0.6680    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5990   -1.3610   -0.0330 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8700   -0.6330   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0290   -1.6300   -0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0930   -1.3390    0.0770 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3560   -0.5980    0.1190 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4110   -1.4290    0.8510 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8290   -0.3160   -1.3090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2760    3.0640    0.0950 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  2 10  1  0
  3  4  2  0
  4  5  1  0
  4 14  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
M  END
>  <Name>  (81) 
Atrazine

>  <InChIKey>  (81) 
MXWJVTOOROXGIU-UHFFFAOYSA-N

>  <PubChem_CID>  (81) 
2256

>  <CYP1A2>  (81) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<9,10;Cleavage;R2>
<10,H;Oxidation;R2>

>  <CYP2A6>  (81) 


>  <CYP2B6>  (81) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<9,10;Cleavage;R2>
<10,H;Oxidation;R2>

>  <CYP2C8>  (81) 


>  <CYP2C9>  (81) 


>  <CYP2C19>  (81) 


>  <CYP2D6>  (81) 


>  <CYP2E1>  (81) 


>  <CYP3A4>  (81) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<9,10;Cleavage;R2>
<10,H;Oxidation;R2>

>  <References>  (81) 
Lang DH, Rettie AE, Bocker RH: Identification of enzymes involved in the metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in human liver microsomes. Chem Res Toxicol. 1997 Sep;10(9):1037-44. doi: 10.1021/tx970081l. (PMID: 9305587)

>  <Comments>  (81) 


$$$$
CC01893
     RDKit          3D

 27 30  0  0  0  0  0  0  0  0999 V2000
   -3.4850    0.0180    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9280    1.3150   -0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7720    2.4230   -0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8700   -0.1420    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1270    2.2430   -0.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6780    0.9710   -0.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4710    1.4520   -0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5700   -1.1260    0.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7190    0.3960    0.0380 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2410   -0.8960    0.1230 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0030   -2.2620    0.1920 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8430    2.8200   -0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6580    2.6860   -0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3650    2.5430   -1.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3270    2.7120    1.1150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7420    2.4210   -1.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4110    2.4410   -0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7030    2.5890    1.1460 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1400    2.2880    0.0060 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.3200   -2.0310    0.2200 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.5740   -2.0620   -0.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0190   -3.4710   -1.4210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4270   -4.3400   -0.2980 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2100   -3.5610    0.6300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2660   -3.1270    1.7570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5620   -1.8800    1.4930 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3260   -5.3590   -0.8580 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  2  0
  1  8  1  0
  2  3  2  0
  2  7  1  0
  3  5  1  0
  4  6  1  0
  5  6  2  0
  7  9  2  0
  7 12  1  0
  8 10  1  0
  8 11  2  0
  9 10  1  0
 20 10  1  6
 12 13  1  0
 13 14  2  0
 13 15  1  0
 14 16  1  0
 15 18  2  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 20 21  1  0
 20 26  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23 27  1  0
 24 25  1  0
 25 26  1  0
M  END
>  <Name>  (82) 
Azelastine

>  <InChIKey>  (82) 
MBUVEWMHONZEQD-GOSISDBHSA-N

>  <PubChem_CID>  (82) 
12831280

>  <CYP1A2>  (82) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (82) 


>  <CYP2B6>  (82) 


>  <CYP2C8>  (82) 


>  <CYP2C9>  (82) 


>  <CYP2C19>  (82) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2D6>  (82) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (82) 


>  <CYP3A4>  (82) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (82) 
Imai T, Taketani M, Suzu T, Kusube K, Otagiri M: In vitro identification of the human cytochrome P-450 enzymes involved in the N-demethylation of azelastine. Drug Metab Dispos. 1999 Aug;27(8):942-6. (PMID: 10421623)
Nakajima M, Nakamura S, Tokudome S, Shimada N, Yamazaki H, Yokoi T: Azelastine N-demethylation by cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in human liver microsomes: evaluation of approach to predict the contribution of multiple CYPs. Drug Metab Dispos. 1999 Dec;27(12):1381-91. (PMID: 10570018)

>  <Comments>  (82) 


$$$$
CC01894
     RDKit          3D

 20 24  0  0  0  0  0  0  0  0999 V2000
    3.8520   -0.2940   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8800   -1.7060   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6180    0.3960   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0690    0.4180   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6180    1.8130   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6750   -2.4370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1150   -2.3900   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8500    2.5080   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0550    1.8100   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4360   -0.3640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2820   -0.2710   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4600   -1.7590    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3050   -1.6650   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7130   -3.8310    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1310   -3.7840   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4360    2.5710   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8740    3.9020   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9350   -4.5020    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4670    3.9640   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6870    4.6290   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  6  1  0
  2  7  1  0
  3  5  1  0
  3 10  2  0
  4  9  2  0
  4 11  1  0
  5  8  2  0
  5 16  1  0
  6 12  2  0
  6 14  1  0
  7 13  1  0
  7 15  2  0
  8  9  1  0
  8 17  1  0
 10 12  1  0
 11 13  2  0
 14 18  2  0
 15 18  1  0
 16 19  2  0
 17 20  2  0
 19 20  1  0
M  END
>  <Name>  (83) 
Benzo[a]pyrene

>  <InChIKey>  (83) 
FMMWHPNWAFZXNH-UHFFFAOYSA-N

>  <PubChem_CID>  (83) 
2336

>  <CYP1A2>  (83) 
<8,9;EpOxidation;R1>
<1,2;EpOxidation;R2>
<0,5;EpOxidation;R3>
<11,H;Hydroxylation;R4>
<1,H;Hydroxylation;R5>

>  <CYP2A6>  (83) 


>  <CYP2B6>  (83) 


>  <CYP2C8>  (83) 
<8,9;EpOxidation;R1>
<0,5;EpOxidation;R2>
<11,H;Hydroxylation;R3>

>  <CYP2C9>  (83) 
<11,H;Hydroxylation;R1>
<0,5;EpOxidation;R2>

>  <CYP2C19>  (83) 


>  <CYP2D6>  (83) 


>  <CYP2E1>  (83) 
<11,H;Hydroxylation;R1>
<0,5;EpOxidation;R2>

>  <CYP3A4>  (83) 
<8,9;EpOxidation;R1>
<1,2;EpOxidation;R2>
<0,5;EpOxidation;R3>
<11,H;Hydroxylation;R4>
<1,H;Hydroxylation;R5>

>  <References>  (83) 
Bauer E, Guo Z, Ueng YF, Bell LC, Zeldin D, Guengerich FP: Oxidation of benzo[a]pyrene by recombinant human cytochrome P450 enzymes. Chem Res Toxicol. 1995 Jan-Feb;8(1):136-42. (PMID: 7703357)

>  <Comments>  (83) 
Xenosite reports 9,12,14 are SoMs for CYP1A2. However, they cannot be identified in the reference.

$$$$
CC01895
     RDKit          3D

 22 26  0  0  0  0  0  0  0  0999 V2000
   -1.4160    0.2380   -0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3820   -1.1790   -0.0520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1460   -1.8370   -0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0520   -1.1300   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2700   -1.8090   -0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4740   -1.1060   -0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4750    0.2880    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6750    0.9980    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6670    2.3920    0.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4590    3.0880    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2480    2.3970    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0370    3.0820    0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1660    2.3770    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2040    0.9720   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0270    0.2780   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2500    0.9880    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5890   -1.8940   -0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8090   -1.2300   -0.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8600    0.1540   -0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6700    0.8750   -0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5760   -3.2610   -0.0930 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9810   -1.9270   -0.0900 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1 14  2  0
  1 20  1  0
  2  3  2  0
  2 17  1  0
  3  4  1  0
  4  5  2  0
  4 15  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7 16  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 16  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 17 18  2  0
 17 21  1  0
 18 19  1  0
 18 22  1  0
 19 20  2  0
M  END
>  <Name>  (84) 
Benzo[a]pyrene-7,8-diol

>  <InChIKey>  (84) 
FWKXMJCJEOUXDE-UHFFFAOYSA-N

>  <PubChem_CID>  (84) 
42267

>  <CYP1A2>  (84) 
<2,3;Epoxidation;R1>

>  <CYP2A6>  (84) 


>  <CYP2B6>  (84) 


>  <CYP2C8>  (84) 


>  <CYP2C9>  (84) 


>  <CYP2C19>  (84) 


>  <CYP2D6>  (84) 


>  <CYP2E1>  (84) 


>  <CYP3A4>  (84) 


>  <References>  (84) 
Kim JH, Stansbury KH, Walker NJ, Trush MA, Strickland PT, Sutter TR: Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis. 1998 Oct;19(10):1847-53. doi: 10.1093/carcin/19.10.1847. (PMID: 9806168)

>  <Comments>  (84) 


$$$$
CC01896
     RDKit          3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.0020    1.3150    0.3560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0980    0.0190   -0.1530 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1970    1.9620    0.5200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1400    2.0230    0.7300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1480   -0.6850   -0.5260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3650   -0.5580   -0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3360    1.3020    0.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3850    1.4260    0.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4240    0.0640   -0.3650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5120    0.1390    0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1160   -1.8370   -0.9380 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5430   -1.8180   -0.7760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5010    2.1150    0.9530 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7500   -0.4680   -0.7270 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9220    0.1370   -0.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1810   -0.3610   -0.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2920   -1.4810   -1.4090 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1380   -2.0960   -1.8870 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8830   -1.5910   -1.5470 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5630   -1.9000   -1.6870 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5560   -3.0500   -2.5240 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  1  0
  5 11  2  0
  6 10  2  0
  6 12  1  0
  7  9  2  0
  8 10  1  0
  8 13  1  0
  9 14  1  0
 14 15  2  0
 14 19  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 20  1  0
 18 19  2  0
 20 21  1  0
M  END
>  <Name>  (85) 
Biochanin A

>  <InChIKey>  (85) 
WUADCCWRTIWANL-UHFFFAOYSA-N

>  <PubChem_CID>  (85) 
5280373

>  <CYP1A2>  (85) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<3,H;Hydroxylation;R2>
<20,H;Hydroxylation;R3>

>  <CYP2A6>  (85) 


>  <CYP2B6>  (85) 


>  <CYP2C8>  (85) 


>  <CYP2C9>  (85) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (85) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2D6>  (85) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (85) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP3A4>  (85) 


>  <References>  (85) 
Tolleson WH, Doerge DR, Churchwell MI, Marques MM, Roberts DW: Metabolism of biochanin A and formononetin by human liver microsomes in vitro. J Agric Food Chem. 2002 Aug 14;50(17):4783-90. (PMID: 12166960)
Wang B, Zhou SF: Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr Med Chem. 2009;16(31):4066-218. (PMID: 19754423)

>  <Comments>  (85) 


$$$$
CC01897
     RDKit          3D

 28 29  0  0  0  0  0  0  0  0999 V2000
   -0.0160    1.3440    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9150   -3.0770   -0.4900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2420    2.0930    0.0010 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.0050   -2.2120    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6250   -4.5300   -0.5000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5100    2.6820    1.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2930   -0.7750    0.0100 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.4670   -4.9820   -0.0270 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9740   -2.6660   -0.9220 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0600   -0.5960   -0.0110 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1490    3.2360   -1.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0880   -0.4230    1.2690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3030   -6.7220   -1.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5780    3.5820    2.0150 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6830    2.3160    2.1430 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5670   -5.4280   -1.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4340   -1.0990    1.2180 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4630    4.0190   -1.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2120   -6.2750   -0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1490   -7.1650   -0.5430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5930   -2.3640    1.7510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5110   -0.4500    0.6430 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5900    3.1180   -1.5290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3270    5.2340   -1.9390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7460   -1.0700    0.5960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8280   -2.9840    1.7040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9040   -2.3380    1.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  8  1  0
  2 11  2  0
  3  5  1  0
  3  6  1  0
  3 10  2  0
  4  7  1  0
  4 12  1  6
  5  8  1  0
  6  9  2  0
  6 17  1  0
  7 15  1  0
  7 16  1  0
  8 13  1  1
  9 20  1  0
 12 19  1  0
 13 18  1  0
 14 17  2  0
 14 21  1  0
 18 22  2  0
 18 23  1  0
 19 24  1  0
 19 25  1  0
 20 21  2  0
 22 27  1  0
 23 26  2  0
 26 28  1  0
 27 28  2  0
M  END
>  <Name>  (86) 
Bortezomib

>  <InChIKey>  (86) 
BMIMGBIOLNWHGX-HOTGVXAUSA-N

>  <PubChem_CID>  (86) 
59803646

>  <CYP1A2>  (86) 
<7,4;Cleavage;R1>

>  <CYP2A6>  (86) 


>  <CYP2B6>  (86) 


>  <CYP2C8>  (86) 


>  <CYP2C9>  (86) 
<4,25;Cleavage;R1>

>  <CYP2C19>  (86) 
<4,25;Cleavage;R1>

>  <CYP2D6>  (86) 
<4,25;Cleavage;R1>

>  <CYP2E1>  (86) 


>  <CYP3A4>  (86) 
<4,25;Cleavage;R1>

>  <References>  (86) 
Pekol T, Daniels JS, Labutti J, Parsons I, Nix D, Baronas E, Hsieh F, Gan LS, Miwa G: Human metabolism of the proteasome inhibitor bortezomib: identification of circulating metabolites. Drug Metab Dispos. 2005 Jun;33(6):771-7. doi: 10.1124/dmd.104.002956. Epub 2005 Mar 11. (PMID: 15764713)
Labutti J, Parsons I, Huang R, Miwa G, Gan LS, Daniels JS: Oxidative deboronation of the peptide boronic acid proteasome inhibitor bortezomib: contributions from reactive oxygen species in this novel cytochrome P450 reaction. Chem Res Toxicol. 2006 Apr;19(4):539-46. doi: 10.1021/tx050313d. (PMID: 16608165)

>  <Comments>  (86) 
The mechanism is completely identified.

$$$$
CC01898
     RDKit          3D

 25 27  0  0  0  0  0  0  0  0999 V2000
   -8.0490   -0.3380   -0.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1490   -1.3680    0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7990   -1.3240   -0.2860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3480   -0.1890   -0.9670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2240    0.8470   -1.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5690    0.7870   -0.9080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0180   -0.1880   -1.2970 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6600    1.0070   -1.9820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3290   -0.7270    0.3140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1580   -1.9850    0.8600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8540   -2.3470    0.7180 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.6130   -0.0400    0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.6530    1.4360    0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.6790   -0.6470    0.2820 O   0  0  0  0  0  0  0  0  0  0  0  0
  -11.6570    2.0770   -0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.7380    3.4700   -0.4460 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.7760    4.2280    0.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7920    3.5750    1.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7420    2.1800    1.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.7540    3.9760   -1.2130 O   0  0  0  0  0  0  0  0  0  0  0  0
  -13.3550    5.0970   -0.5750 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.8540    5.5970    0.1810 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6060    6.1070   -0.2780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9180    4.3430    1.7370 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9950    3.5490    2.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  1  9  1  0
  2  3  2  0
  2 11  1  0
  3  4  1  0
  4  5  2  0
  4  7  1  0
  5  6  1  0
  7  8  1  0
  9 10  2  0
  9 12  1  0
 10 11  1  0
 12 13  1  0
 12 14  2  0
 13 15  2  0
 13 19  1  0
 15 16  1  0
 16 17  2  0
 16 20  1  0
 17 18  1  0
 17 22  1  0
 18 19  2  0
 18 24  1  0
 20 21  1  0
 22 23  1  0
 24 25  1  0
M  END
>  <Name>  (87) 
BPR0L075

>  <InChIKey>  (87) 
UZJVBXKFBQNDTQ-UHFFFAOYSA-N

>  <PubChem_CID>  (87) 
10359957

>  <CYP1A2>  (87) 
<3,H;Hydroxylation;R1>
<24,H;Hydroxylation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>

>  <CYP2A6>  (87) 


>  <CYP2B6>  (87) 


>  <CYP2C8>  (87) 


>  <CYP2C9>  (87) 
<3,H;Hydroxylation;R1>
<24,H;Hydroxylation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>
<12,13;Cleavage;R4>
<12,H;Oxidation;R4>
<15,16;Cleavage;R5>
<16,H;Oxidation;R5>
<18,19;Cleavage;R6>
<19,H;Oxidation;R6>

>  <CYP2C19>  (87) 
<3,H;Hydroxylation;R1>
<24,H;Hydroxylation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>
<12,13;Cleavage;R4>
<12,H;Oxidation;R4>
<15,16;Cleavage;R5>
<16,H;Oxidation;R5>
<18,19;Cleavage;R6>
<19,H;Oxidation;R6>

>  <CYP2D6>  (87) 
<3,H;Hydroxylation;R1>
<24,H;Hydroxylation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>
<15,16;Cleavage;R4>
<16,H;Oxidation;R4>

>  <CYP2E1>  (87) 
<3,H;Hydroxylation;R1>
<24,H;Hydroxylation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>
<12,13;Cleavage;R4>
<12,H;Oxidation;R4>
<15,16;Cleavage;R5>
<16,H;Oxidation;R5>
<18,19;Cleavage;R6>
<19,H;Oxidation;R6>

>  <CYP3A4>  (87) 
<5,H;Hydroxylation;R1>
<3,H;Hydroxylation;R2>
<8,7;Cleavage;R3>
<8,H;Oxidation;R3>
<12,13;Cleavage;R4>
<12,H;Oxidation;R4>
<15,16;Cleavage;R5>
<16,H;Oxidation;R5>
<18,19;Cleavage;R6>
<19,H;Oxidation;R6>

>  <References>  (87) 
Yao HT, Wu YS, Chang YW, Hsieh HP, Chen WC, Lan SJ, Chen CT, Chao YS, Chang L, Sun HY, Yeh TK: Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes. Drug Metab Dispos. 2007 Jul;35(7):1042-9. doi: 10.1124/dmd.106.014597. Epub 2007  Apr 2. (PMID: 17403915)

>  <Comments>  (87) 


$$$$
CC01899
     RDKit          2D

  4  3  0  0  0  0  0  0  0  0999 V2000
    0.0000   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140   -0.6190    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.7140   -0.6190    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.6190    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
M  END
>  <Name>  (88) 
Bromodichloromethane

>  <InChIKey>  (88) 
FMWLUWPQPKEARP-UHFFFAOYSA-N

>  <PubChem_CID>  (88) 
6359

>  <CYP1A2>  (88) 
<1,3;Cleavage;R1>

>  <CYP2A6>  (88) 
<1,3;Cleavage;R1>

>  <CYP2B6>  (88) 


>  <CYP2C8>  (88) 


>  <CYP2C9>  (88) 


>  <CYP2C19>  (88) 


>  <CYP2D6>  (88) 


>  <CYP2E1>  (88) 
<1,3;Cleavage;R1>

>  <CYP3A4>  (88) 
<1,3;Cleavage;R1>

>  <References>  (88) 
Allis JW, Zhao G: Quantitative evaluation of bromodichloromethane metabolism by recombinant rat and human cytochrome P450s. Chem Biol Interact. 2002 May 20;140(2):137-53. (PMID: 12076521)
Lilly PD, Andersen ME, Ross TM, Pegram RA: Physiologically based estimation of in vivo rates of bromodichloromethane metabolism. Toxicology. 1997 Dec 26;124(2):141-52. (PMID: 9458004)

>  <Comments>  (88) 


$$$$
CC01901
     RDKit          3D

 14 15  0  0  0  0  0  0  0  0999 V2000
    3.5950    2.6770   -0.0050 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3470   -1.3750    0.0040 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6480   -1.4160    0.0060 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1170    1.0210    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4630    0.6490   -0.0010 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0820   -1.1970    0.0060 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8040    0.6730    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8150   -0.6930    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6100    1.4500   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4170   -0.7600    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8580   -0.1290    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6730   -2.8560    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6620    2.3560   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1980    1.3350   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  2  0
  2 10  2  0
  3  8  1  0
  3 10  1  0
  3 12  1  0
  4  7  1  0
  4 11  1  0
  4 13  1  0
  5  9  1  0
  5 10  1  0
  5 14  1  0
  6  8  1  0
  6 11  2  0
  7  8  2  0
  7  9  1  0
M  END
>  <Name>  (89) 
Caffeine

>  <InChIKey>  (89) 
RYYVLZVUVIJVGH-UHFFFAOYSA-N

>  <PubChem_CID>  (89) 
2519

>  <CYP1A2>  (89) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<11,10;Cleavage;R2>
<11,H;Oxidation;R2>
<8,9;Cleavage;R3>
<9,H;Oxidation;R3>
<7,H;Hydroxylation;R4>

>  <CYP2A6>  (89) 


>  <CYP2B6>  (89) 


>  <CYP2C8>  (89) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<7,H;Hydroxylation;R2>

>  <CYP2C9>  (89) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<7,H;Hydroxylation;R2>

>  <CYP2C19>  (89) 


>  <CYP2D6>  (89) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<11,10;Cleavage;R2>
<11,H;Oxidation;R2>
<8,9;Cleavage;R3>
<9,H;Oxidation;R3>
<7,H;Hydroxylation;R4>

>  <CYP2E1>  (89) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<11,10;Cleavage;R2>
<11,H;Oxidation;R2>

>  <CYP3A4>  (89) 
<7,H;Hydroxylation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <References>  (89) 
Lang DH, Rettie AE: In vitro evaluation of potential in vivo probes for human flavin-containing monooxygenase (FMO): metabolism of benzydamine and caffeine by FMO and P450 isoforms. Br J Clin Pharmacol. 2000 Oct;50(4):311-4. doi: 10.1046/j.1365-2125.2000.00265.x. (PMID: 11012553)
Ha HR, Chen J, Krahenbuhl S, Follath F: Biotransformation of caffeine by cDNA-expressed human cytochromes P-450. Eur J Clin Pharmacol. 1996;49(4):309-15. (PMID: 8857078)

>  <Comments>  (89) 
Xenosite records site 6 as SoM but it cannot be identified. More CYPs are updated.

$$$$
CC01902
     RDKit          3D

 22 22  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3780    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1690    2.0890    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3330    2.1120    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2110   -0.6800   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3790    1.4200   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7530    2.3420    1.4040 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4050    0.0350   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2320   -2.0400   -0.0200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9090    2.9870    1.6600 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5940   -0.6250   -0.0360 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1300   -2.4740   -0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3410    3.2240    3.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6020    3.3760    0.7430 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6770    3.9690    3.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1160    4.2090    4.5400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4520    4.9540    4.5500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8840    5.1910    5.9740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1560    6.4060    6.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5880    6.6430    7.8070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5940    7.5840    8.4920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9810    7.2760    7.8190 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  3  6  2  0
  4  7  1  0
  5  8  2  0
  5  9  1  0
  6  8  1  0
  7 10  1  0
  8 11  1  0
  9 12  1  0
 10 13  1  0
 10 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
M  END
>  <Name>  (90) 
Capsaicin

>  <InChIKey>  (90) 
YKPUWZUDDOIDPM-SOFGYWHQSA-N

>  <PubChem_CID>  (90) 
1548943

>  <CYP1A2>  (90) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (90) 


>  <CYP2B6>  (90) 
<5,6;Dehydrogenation;R1>

>  <CYP2C8>  (90) 
<15,H;Hydroxylation;R1>
<15,17;Dehydrogenation;R2>
<15,16;Dehydrogenation;R3>

>  <CYP2C9>  (90) 
<15,17;Dehydrogenation;R1>
<15,16;Dehydrogenation;R2>
<16,H;Hydroxylation;R3>
<17,H;Hydroxylation;R4>

>  <CYP2C19>  (90) 
<15,17;Dehydrogenation;R1>
<15,16;Dehydrogenation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>

>  <CYP2D6>  (90) 


>  <CYP2E1>  (90) 
<15,17;Dehydrogenation;R1>
<15,16;Dehydrogenation;R2>
<16,H;Hydroxylation;R3>
<17,H;Hydroxylation;R4>

>  <CYP3A4>  (90) 
<15,H;Hydroxylation;R1>
<5,6;Dehydrogenation;R2>

>  <References>  (90) 
Reilly CA, Ehlhardt WJ, Jackson DA, Kulanthaivel P, Mutlib AE, Espina RJ, Moody DE, Crouch DJ, Yost GS: Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells. Chem Res Toxicol. 2003 Mar;16(3):336-49. doi: 10.1021/tx025599q. (PMID: 12641434)

>  <Comments>  (90) 
M8 is the metabolite of M9. The location of the hydroxylation cannot be identified, so we didn't record it.

$$$$
CC01903
     RDKit          3D

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.0060    1.3790    0.2470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0010   -0.0010   -0.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2280    2.0940    0.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1750    2.0600    0.5850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1620   -0.7040    0.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1680   -0.6260   -0.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4090    1.4140   -0.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2360    3.4700    0.4750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1300    3.3930    0.8570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1420   -2.0460   -0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3660    0.0810   -0.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0730    4.0950    0.8050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2980   -2.7320   -0.1950 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0810   -2.6390   -0.1140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2760   -4.1920   -0.3140 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  6 11  2  0
  7 11  1  0
  8 12  2  0
  9 12  1  0
 10 13  1  0
 10 14  2  0
 13 15  1  0
M  END
>  <Name>  (91) 
Carbaryl

>  <InChIKey>  (91) 
CVXBEEMKQHEXEN-UHFFFAOYSA-N

>  <PubChem_CID>  (91) 
6129

>  <CYP1A2>  (91) 
<10,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>
<8,H;Hydroxylation;R3>

>  <CYP2A6>  (91) 


>  <CYP2B6>  (91) 
<10,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>
<8,H;Hydroxylation;R3>

>  <CYP2C8>  (91) 


>  <CYP2C9>  (91) 


>  <CYP2C19>  (91) 
<10,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>
<8,H;Hydroxylation;R3>

>  <CYP2D6>  (91) 


>  <CYP2E1>  (91) 


>  <CYP3A4>  (91) 
<10,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>
<8,H;Hydroxylation;R3>

>  <References>  (91) 
Tang J, Cao Y, Rose RL, Hodgson E: In vitro metabolism of carbaryl by human cytochrome P450 and its inhibition by chlorpyrifos. Chem Biol Interact. 2002 Oct 20;141(3):229-41. (PMID: 12385721)

>  <Comments>  (91) 


$$$$
CC01904
     RDKit          3D

 16 17  0  0  0  0  0  0  0  0999 V2000
   -0.0300    1.3910   -0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0200    0.0040   -0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1890    2.0740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3020    1.8760   -0.0260 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4660   -0.4510   -0.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1690   -0.6940   -0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2050    3.4340    0.0040 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3800    1.3700    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1990    0.8470   -0.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3730   -0.0130    0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0140    4.1060    1.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5510    0.9540    0.2280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3780    0.9160   -1.9980 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9200    5.4510    1.1420 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9260    3.5010    2.2050 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7120    6.1820    2.3940 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5  9  1  0
  6 10  1  0
  7 11  1  0
  8 10  2  0
  9 12  1  0
  9 13  1  0
 11 14  1  0
 11 15  2  0
 14 16  1  0
M  END
>  <Name>  (92) 
Carbofuran

>  <InChIKey>  (92) 
DUEPRVBVGDRKAG-UHFFFAOYSA-N

>  <PubChem_CID>  (92) 
2566

>  <CYP1A2>  (92) 
<15,H;Hydroxylation;R1>

>  <CYP2A6>  (92) 


>  <CYP2B6>  (92) 


>  <CYP2C8>  (92) 
<15,H;Hydroxylation;R1>

>  <CYP2C9>  (92) 


>  <CYP2C19>  (92) 
<15,H;Hydroxylation;R1>

>  <CYP2D6>  (92) 


>  <CYP2E1>  (92) 


>  <CYP3A4>  (92) 
<15,H;Hydroxylation;R1>

>  <References>  (92) 
Usmani KA, Hodgson E, Rose RL: In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol. Chem Biol Interact. 2004 Dec 7;150(3):221-32. doi: 10.1016/j.cbi.2004.09.015. (PMID: 15560889)

>  <Comments>  (92) 


$$$$
CC01905
     RDKit          3D

 30 33  0  0  0  0  0  0  0  0999 V2000
   -3.7140   -1.3820    0.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0840   -1.3100    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3650   -2.7190    0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6960   -0.4240    0.5060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5460   -2.6120   -0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0030   -0.2410    0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4900   -3.4630   -0.1440 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0480   -3.1650    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3810   -0.8760    0.6080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9430    0.8830    0.7060 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8950   -2.9010   -0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3500   -0.5160   -0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0440   -2.2250    0.4360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8560    1.8220    0.8530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7990   -1.8350   -0.3100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3800    2.3260   -0.5270 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.0850    3.1520   -0.3880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4170    3.1290   -1.0990 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9390    2.2590    0.1690 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2850    2.8460    0.1110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2650    1.6950    0.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6160    2.0490    0.1430 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7310    1.2810    0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8870   -0.1450   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8810    2.0790    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1770   -0.6550   -0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8930   -1.0840   -0.0710 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1620    1.5450   -0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3170    0.1590   -0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0060   -2.5390   -0.1740 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5  7  1  0
  5 11  2  0
  6 12  1  0
  8 13  2  0
  9 13  1  0
 10 14  1  0
 11 15  1  0
 12 15  2  0
 14 16  1  0
 16 17  1  0
 16 18  1  1
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 24 26  1  0
 24 27  1  0
 25 28  2  0
 26 29  2  0
 27 30  1  0
 28 29  1  0
M  END
>  <Name>  (93) 
Carvedilol

>  <InChIKey>  (93) 
OGHNVEJMJSYVRP-KRWDZBQOSA-N

>  <PubChem_CID>  (93) 
185395

>  <CYP1A2>  (93) 
<24,H;Hydroxylation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2A6>  (93) 


>  <CYP2B6>  (93) 


>  <CYP2C8>  (93) 


>  <CYP2C9>  (93) 
<4,H;Hydroxylation;R1>
<5,H;Hydroxylation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>

>  <CYP2C19>  (93) 


>  <CYP2D6>  (93) 
<4,H;Hydroxylation;R1>
<5,H;Hydroxylation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>

>  <CYP2E1>  (93) 
<4,H;Hydroxylation;R1>
<5,H;Hydroxylation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>

>  <CYP3A4>  (93) 
<4,H;Hydroxylation;R1>
<24,H;Hydroxylation;R2>

>  <References>  (93) 
Oldham HG, Clarke SE: In vitro identification of the human cytochrome P450 enzymes involved in the metabolism of R(+)- and S(-)-carvedilol. Drug Metab Dispos. 1997 Aug;25(8):970-7. (PMID: 9280405)
Zhou SF: Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin Pharmacokinet. 2009;48(12):761-804. doi: 10.2165/11318070-000000000-00000. (PMID: 19902987)

>  <Comments>  (93) 


$$$$
CC01906
     RDKit          3D

 26 28  0  0  0  0  0  0  0  0999 V2000
    3.4160   -4.6090   -0.2690 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.1990    4.5310   -1.0150 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.4970    5.6480    0.3330 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.0260    4.2600    1.1450 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1500   -4.9250   -0.9000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6670   -5.0860   -0.8240 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7440    1.3390   -0.0330 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5730    2.0390   -0.0210 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3400   -5.0130    1.3880 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8440    2.1920    0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6920   -0.0790   -0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2510    1.8260   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3240    3.4690    0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9250    3.3300    0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8520   -0.8530   -0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4450   -0.7080   -0.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5230   -2.8520   -0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9970    1.8230    1.1710 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8820    1.5320   -1.2210 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7730   -2.2440   -0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3550   -2.0980   -0.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9800    1.2200   -0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3560    1.5180    1.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2420    1.2260   -1.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9180    4.4330    0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4340    0.9020   -0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  2  0
  1  6  2  0
  1  9  1  0
  1 17  1  0
  2 25  1  0
  3 25  1  0
  4 25  1  0
  7  8  1  0
  7 10  1  0
  7 11  1  0
  8 14  2  0
 10 12  1  0
 10 13  2  0
 11 15  2  0
 11 16  1  0
 12 18  2  0
 12 19  1  0
 13 14  1  0
 14 25  1  0
 15 20  1  0
 16 21  2  0
 17 20  2  0
 17 21  1  0
 18 23  1  0
 19 24  2  0
 22 23  2  0
 22 24  1  0
 22 26  1  0
M  END
>  <Name>  (94) 
Celecoxib

>  <InChIKey>  (94) 
RZEKVGVHFLEQIL-UHFFFAOYSA-N

>  <PubChem_CID>  (94) 
2662

>  <CYP1A2>  (94) 
<0,H;Hydroxylation;R1>

>  <CYP2A6>  (94) 


>  <CYP2B6>  (94) 


>  <CYP2C8>  (94) 


>  <CYP2C9>  (94) 
<0,H;Hydroxylation;R1>

>  <CYP2C19>  (94) 
<0,H;Hydroxylation;R1>

>  <CYP2D6>  (94) 
<0,H;Hydroxylation;R1>

>  <CYP2E1>  (94) 
<0,H;Hydroxylation;R1>

>  <CYP3A4>  (94) 
<0,H;Hydroxylation;R1>

>  <References>  (94) 
Tang C, Shou M, Mei Q, Rushmore TH, Rodrigues AD: Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor. J Pharmacol Exp Ther. 2000 May;293(2):453-9. (PMID: 10773015)

>  <Comments>  (94) 


$$$$
CC01907
     RDKit          3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    9.2890    0.0450    0.1860 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.7020   -4.2120    0.6280 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.3510   -1.2390   -0.3250 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3570    3.3000    1.1460 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1790    0.1510   -0.7280 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8570    1.0080    0.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6660    2.4360    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6520   -1.6350    0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1970   -2.0440   -0.3360 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9350   -2.9400    0.4710 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2290   -3.3890    0.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7240   -0.7300   -0.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9620   -1.5230   -0.7590 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2430   -3.3030    0.8170 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0610   -4.1620    0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2770    4.6550    0.6310 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0350    2.9650    1.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0190   -1.1010    0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8020   -2.2930   -0.7830 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2870   -2.3890    0.7330 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8520   -3.6200   -0.3810 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 18  1  0
  2 10  1  0
  2 11  1  0
  3  5  1  0
  3  8  1  0
  3  9  1  0
  4  7  1  0
  4 16  1  0
  4 17  1  0
  5  6  1  0
  6  7  1  0
  8 10  2  0
  8 12  1  0
  9 11  2  0
  9 13  1  0
 10 14  1  0
 11 15  1  0
 12 18  2  0
 13 19  2  0
 14 20  2  0
 15 21  2  0
 18 20  1  0
 19 21  1  0
M  END
>  <Name>  (95) 
Chlorpromazine

>  <InChIKey>  (95) 
ZPEIMTDSQAKGNT-UHFFFAOYSA-N

>  <PubChem_CID>  (95) 
2726

>  <CYP1A2>  (95) 
<10,H;Hydroxylation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>
<1,2;Cleavage;R3>
<2,H;Oxidation;R3>
<13,S;S-Oxidation;R4>

>  <CYP2A6>  (95) 


>  <CYP2B6>  (95) 
<13,S;S-Oxidation;R1>

>  <CYP2C8>  (95) 


>  <CYP2C9>  (95) 
<13,S;S-Oxidation;R1>

>  <CYP2C19>  (95) 


>  <CYP2D6>  (95) 
<10,H;Hydroxylation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>
<1,2;Cleavage;R3>
<2,H;Oxidation;R3>

>  <CYP2E1>  (95) 


>  <CYP3A4>  (95) 
<13,S;S-Oxidation;R1>

>  <References>  (95) 
Yoshii K, Kobayashi K, Tsumuji M, Tani M, Shimada N, Chiba K: Identification of human cytochrome P450 isoforms involved in the 7-hydroxylation of chlorpromazine by human liver microsomes. Life Sci. 2000;67(2):175-84. doi: 10.1016/s0024-3205(00)00613-5. (PMID: 10901285)
Cashman JR, Yang Z, Yang L, Wrighton SA: Stereo- and regioselective N- and S-oxidation of tertiary amines and sulfides in the presence of adult human liver microsomes. Drug Metab Dispos. 1993 May-Jun;21(3):492-501. (PMID: 8100507)
Zanger UM, Schwab M: Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013 Apr;138(1):103-41. doi: 10.1016/j.pharmthera.2012.12.007. Epub 2013 Jan 16. (PMID: 23333322)

>  <Comments>  (95) 
N-Oxide might be considered as metabolites for N.3 atom as well.

$$$$
CC01908
     RDKit          3D

 17 17  0  0  0  0  0  0  0  0999 V2000
   -0.0220    1.7580    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.1660    2.4650    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2280    2.4320    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0240   -0.5080    1.5800 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2600   -0.4040   -0.5140 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2650   -0.3700   -0.5380 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1480    3.8470    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2480    3.8140    0.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0300   -0.2570    2.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0590    4.5230    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0120   -0.6670    3.6650 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9970    0.3390    1.9470 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0830    6.2580    0.0350 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.1580   -0.3940    4.5370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8830   -0.9610    5.9320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0800   -0.6760    6.8420 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  2  7  2  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  8 11  2  0
  9 11  1  0
 10 12  1  0
 10 13  2  0
 11 14  1  0
 12 15  1  0
 15 16  1  0
 16 17  1  0
M  END
>  <Name>  (96) 
Chlorpropamide

>  <InChIKey>  (96) 
RKWGIWYCVPQPMF-UHFFFAOYSA-N

>  <PubChem_CID>  (96) 
2727

>  <CYP1A2>  (96) 
<16,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <CYP2A6>  (96) 
<16,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <CYP2B6>  (96) 


>  <CYP2C8>  (96) 
<16,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <CYP2C9>  (96) 
<16,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <CYP2C19>  (96) 
<16,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <CYP2D6>  (96) 
<16,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <CYP2E1>  (96) 
<16,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <CYP3A4>  (96) 
<16,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <References>  (96) 
Shon JH, Yoon YR, Kim MJ, Kim KA, Lim YC, Liu KH, Shin DH, Lee CH, Cha IJ, Shin JG: Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism. Br J Clin Pharmacol. 2005 May;59(5):552-63. doi: 10.1111/j.1365-2125.2005.02364.x. (PMID: 15842554)

>  <Comments>  (96) 
Concentration of metabolites in CYP2A6 and 2E1 is very low.

$$$$
CC01910
     RDKit          3D

 11 12  0  0  0  0  0  0  0  0999 V2000
    1.3330    0.6250    0.2650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2120    1.4210    0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0080    0.7740   -0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5940   -1.3800   -0.3940 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.0710   -0.6280   -0.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0710   -1.4210   -0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2530   -0.7460    0.1730 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5300   -1.2400    0.3190 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3560   -0.1320    0.4980 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5690   -0.1620    0.6630 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6250    1.0690    0.4690 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  7  1  0
  1 11  1  0
  2  3  1  0
  3  5  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
M  END
>  <Name>  (97) 
Chlorzoxazone

>  <InChIKey>  (97) 
TZFWDZFKRBELIQ-UHFFFAOYSA-N

>  <PubChem_CID>  (97) 
2733

>  <CYP1A2>  (97) 
<7,H;Hydroxylation;R1>

>  <CYP2A6>  (97) 
<7,H;Hydroxylation;R1>

>  <CYP2B6>  (97) 
<7,H;Hydroxylation;R1>

>  <CYP2C8>  (97) 


>  <CYP2C9>  (97) 
<7,H;Hydroxylation;R1>

>  <CYP2C19>  (97) 
<7,H;Hydroxylation;R1>

>  <CYP2D6>  (97) 
<7,H;Hydroxylation;R1>

>  <CYP2E1>  (97) 
<7,H;Hydroxylation;R1>

>  <CYP3A4>  (97) 
<7,H;Hydroxylation;R1>

>  <References>  (97) 
Shimada T, Tsumura F, Yamazaki H: Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes. Drug Metab Dispos. 1999 Nov;27(11):1274-80. (PMID: 10534312)
Draper AJ, Madan A, Latham J, Parkinson A: Development of a non-high pressure liquid chromatography assay to determine [14C]chlorzoxazone 6-hydroxylase (CYP2E1) activity in human liver microsomes. Drug Metab Dispos. 1998 Apr;26(4):305-12. (PMID: 9531516)

>  <Comments>  (97) 
More CYPs are added. The BoMs match Xenosite now.

$$$$
CC01911
     RDKit          3D

 27 30  0  0  0  0  0  0  0  0999 V2000
   -0.0150    1.2860    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2260   -0.4020   -0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0090    0.6210   -0.0140 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2650    1.7000   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4660    8.4510   -8.1650 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3480    8.0580   -6.8260 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2150    9.5180   -8.4990 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6640    8.9520   -5.8120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2060    2.1400    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5480    8.5680   -4.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2940    9.8550   -9.6620 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9160    6.7770   -6.5110 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1310   10.3430   -6.1570 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9530   10.3010   -7.4460 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1160    7.2880   -4.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8010    6.3930   -5.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7500    3.1270    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0020    6.9090   -2.8760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0470    1.8580   -1.2270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0340    1.8450    1.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5430    5.5560   -2.8790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9000    3.6170   -1.4400 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3920    5.0660   -1.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2770    2.7370    1.2830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2900    2.7500   -1.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1180    2.4550    0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0
  1  5  1  0
  1 10  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5 18  1  0
  6  7  1  0
  6  8  1  0
  7  9  2  0
  7 13  1  0
  8 12  2  0
  8 15  1  0
  9 11  1  0
  9 14  1  0
 10 20  1  0
 10 21  1  0
 11 16  2  0
 13 17  2  0
 14 15  1  0
 16 17  1  0
 16 19  1  0
 18 23  1  0
 19 22  1  0
 20 26  1  0
 21 25  1  0
 22 24  1  0
 23 24  1  0
 25 27  1  0
 26 27  1  0
M  END
>  <Name>  (98) 
Cilostazol

>  <InChIKey>  (98) 
RRGUKTPIGVIEKM-UHFFFAOYSA-N

>  <PubChem_CID>  (98) 
2754

>  <CYP1A2>  (98) 
<3,H;Hydroxylation;R1>

>  <CYP2A6>  (98) 


>  <CYP2B6>  (98) 


>  <CYP2C8>  (98) 


>  <CYP2C9>  (98) 


>  <CYP2C19>  (98) 
<20,H;Hydroxylation;R1>

>  <CYP2D6>  (98) 
<3,H;Hydroxylation;R1>

>  <CYP2E1>  (98) 


>  <CYP3A4>  (98) 
<20,H;Hydroxylation;R1>
<3,H;Hydroxylation;R2>

>  <References>  (98) 
Suri A, Forbes WP, Bramer SL: Effects of CYP3A inhibition on the metabolism of cilostazol. Clin Pharmacokinet. 1999;37 Suppl 2:61-8. doi: 10.2165/00003088-199937002-00007. (PMID: 10702888)
Abbas R, Chow CP, Browder NJ, Thacker D, Bramer SL, Fu CJ, Forbes W, Odomi M, Flockhart DA: In vitro metabolism and interaction of cilostazol with human hepatic cytochrome P450 isoforms. Hum Exp Toxicol. 2000 Mar;19(3):178-84. doi: 10.1191/096032700678827717. (PMID: 10889516)

>  <Comments>  (98) 
CYP3A is used instead of CYP3A4.

$$$$
CC01913
     RDKit          3D

 21 23  0  0  0  0  0  0  0  0999 V2000
   -0.3440    1.2520    0.4940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5340    2.3210    0.5630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6610    1.4170    0.9300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9330   -0.6520   -0.8140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1460   -0.6410    0.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8610    2.2590    0.1480 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0890    3.5420    1.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0900    2.6280    1.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7930   -1.5980   -0.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0070   -0.3460   -2.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2360   -0.0070    1.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3140   -1.7530   -0.2150 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6940    1.2440    0.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3860    3.4120   -0.5880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2100    3.6940    1.5070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7300    2.8140    1.9690 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.7150   -2.2350   -1.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9310   -0.9870   -2.9680 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8430    1.3260   -0.0180 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7820   -1.9320   -2.4260 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  1  0
  5 10  2  0
  5 11  1  0
  6 12  1  0
  6 13  2  0
  7 14  1  0
  7 15  1  0
  8 16  1  0
  9 16  2  0
  9 17  1  0
 10 18  1  0
 11 19  2  0
 12 14  1  0
 14 20  2  0
 18 21  2  0
 19 21  1  0
M  END
>  <Name>  (99) 
Clobazam

>  <InChIKey>  (99) 
CXOXHMZGEKVPMT-UHFFFAOYSA-N

>  <PubChem_CID>  (99) 
2789

>  <CYP1A2>  (99) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (99) 


>  <CYP2B6>  (99) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C8>  (99) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C9>  (99) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<11,H;Oxidation;R2>

>  <CYP2C19>  (99) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<11,H;Oxidation;R2>

>  <CYP2D6>  (99) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (99) 


>  <CYP3A4>  (99) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (99) 
Giraud C, Tran A, Rey E, Vincent J, Treluyer JM, Pons G: In vitro characterization of clobazam metabolism by recombinant cytochrome P450 enzymes: importance of CYP2C19. Drug Metab Dispos. 2004 Nov;32(11):1279-86. (PMID: 15483195)

>  <Comments>  (99) 
Metabolites under 0.01 are considered as not detectable.

$$$$
CC01914
     RDKit          3D

 22 24  0  0  0  0  0  0  0  0999 V2000
    1.5210    3.6320   -0.4120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6940    4.2260    0.8260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3060    3.5670    1.9790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7500    2.3030    1.9000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5880    1.7120    0.6540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9500    2.3720   -0.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7130    1.7340   -1.8280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7550    1.6480   -2.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5520    0.7240   -1.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8330    0.4300   -1.7610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6750   -0.4200   -1.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2560   -1.0080    0.0990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0010   -0.7200    0.5870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1500    0.1580   -0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0760    0.4260    0.5240 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8520   -0.6910    1.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7030   -1.3090   -0.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5480   -2.4470    0.5350 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3640   -3.0410   -0.5320 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3240   -2.0110   -0.9510 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1460   -4.1200    0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3020   -2.0960    0.9570 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5 15  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 14  2  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 22  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
M  END
>  <Name>  (100) 
Clomipramine

>  <InChIKey>  (100) 
GDLIGKIOYRNHDA-UHFFFAOYSA-N

>  <PubChem_CID>  (100) 
2801

>  <CYP1A2>  (100) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<9,H;Hydroxylation;R3>

>  <CYP2A6>  (100) 


>  <CYP2B6>  (100) 


>  <CYP2C8>  (100) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2C9>  (100) 
<9,H;Hydroxylation;R1>

>  <CYP2C19>  (100) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2D6>  (100) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<9,H;Hydroxylation;R3>
<17,H;Hydroxylation;R4>

>  <CYP2E1>  (100) 


>  <CYP3A4>  (100) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <References>  (100) 
Nielsen KK, Flinois JP, Beaune P, Brosen K: The biotransformation of clomipramine in vitro, identification of the cytochrome P450s responsible for the separate metabolic pathways. J Pharmacol Exp Ther. 1996 Jun;277(3):1659-64. (PMID: 8667235)

>  <Comments>  (100) 


$$$$
CC01915
     RDKit          3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    1.0800    0.5470    1.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5140    0.7390    2.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1410   -0.4490    3.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4570   -1.7960    2.1930 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.1000   -0.7920    0.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6670   -1.3110   -0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8940   -0.1450   -1.2510 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5030    1.0160   -0.5910 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8700    2.0010   -1.6110 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.9520    2.9550   -1.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5730    1.6000    0.3910 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2270    2.8690   -1.7820 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6060    1.6760   -2.9660 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.2350    3.7580   -1.4110 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9790    4.7450   -0.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7170    4.8440    0.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7120    3.9550   -0.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7010    2.6380   -2.3350 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8490    3.3520   -1.8210 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7480    2.2880   -3.6510 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6710    2.8660   -4.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  2  0
  1 11  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  9  8  1  1
  8 11  1  0
  9 10  1  0
  9 18  1  0
 10 12  2  0
 10 17  1  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
M  END
>  <Name>  (101) 
Clopidogrel

>  <InChIKey>  (101) 
GKTWGGQPFAXNFI-OAHLLOKOSA-N

>  <PubChem_CID>  (101) 
667556

>  <CYP1A2>  (101) 
<17,H;Oxidation;R1>
<17,18;Reduction;R1>
<18,19;Oxidation;R1>
<15,19;Reduction;R1>

>  <CYP2A6>  (101) 


>  <CYP2B6>  (101) 
<17,H;Oxidation;R1>
<17,18;Reduction;R1>
<18,19;Oxidation;R1>
<15,19;Reduction;R1>

>  <CYP2C8>  (101) 
<17,H;Oxidation;R1>
<17,18;Reduction;R1>
<18,19;Oxidation;R1>
<15,19;Reduction;R1>

>  <CYP2C9>  (101) 
<17,H;Oxidation;R1>
<17,18;Reduction;R1>
<18,19;Oxidation;R1>
<15,19;Reduction;R1>

>  <CYP2C19>  (101) 
<17,H;Oxidation;R1>
<17,18;Reduction;R1>
<18,19;Oxidation;R1>
<15,19;Reduction;R1>

>  <CYP2D6>  (101) 
<17,H;Oxidation;R1>
<17,18;Reduction;R1>
<18,19;Oxidation;R1>
<15,19;Reduction;R1>

>  <CYP2E1>  (101) 


>  <CYP3A4>  (101) 


>  <References>  (101) 
Kazui M, Nishiya Y, Ishizuka T, Hagihara K, Farid NA, Okazaki O, Ikeda T, Kurihara A: Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite. Drug Metab Dispos. 2010 Jan;38(1):92-9. doi: 10.1124/dmd.109.029132. (PMID: 19812348)
Dansette PM, Libraire J, Bertho G, Mansuy D: Metabolic oxidative cleavage of thioesters: evidence for the formation of sulfenic acid intermediates in the bioactivation of the antithrombotic prodrugs ticlopidine and clopidogrel. Chem Res Toxicol. 2009 Feb;22(2):369-73. doi: 10.1021/tx8004828. (PMID: 19170597)

>  <Comments>  (101) 
Site 3 was reported as the SoM in Xenosite, but in the paper, CYP3A4 didn't generate 2-oxo metabolite from clopidogrel.

$$$$
CC01916
     RDKit          3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.2680    0.9740    1.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6310    1.9650    2.8520 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.0120    1.4890    0.2230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0050    2.9330   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3550    0.6300   -0.8240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3970   -0.7450   -0.6100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1040   -1.2620    0.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2240   -0.4040    1.6970 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2750    3.6420    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4150    4.9500    0.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4530    5.9010    0.8000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7120    7.0260    1.6700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8390    5.8120    0.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7740    6.5090    0.6910 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0120    4.8820   -0.8820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0980    3.4920   -0.4500 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5600    3.0550   -0.1740 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6080    3.8920    0.1080 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0590    3.6220    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5510    3.8140   -1.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0540    5.3920    0.6900 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  8  1  0
  3  4  1  0
  3  5  1  0
  4  9  1  0
  4 16  2  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  9 10  2  0
  9 17  1  0
 10 11  1  0
 10 21  1  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 17 18  2  0
 18 19  1  0
 18 21  1  0
 19 20  1  0
M  END
>  <Name>  (102) 
Clotiazepam

>  <InChIKey>  (102) 
CHBRHODLKOZEPZ-UHFFFAOYSA-N

>  <PubChem_CID>  (102) 
2811

>  <CYP1A2>  (102) 
<1,H;Hydroxylation;R1>
<7,8;Cleavage;R2>
<8,H;Oxidation;R2>

>  <CYP2A6>  (102) 


>  <CYP2B6>  (102) 
<1,H;Hydroxylation;R1>
<7,8;Cleavage;R2>
<8,H;Oxidation;R2>

>  <CYP2C8>  (102) 


>  <CYP2C9>  (102) 


>  <CYP2C19>  (102) 
<1,H;Hydroxylation;R1>
<7,8;Cleavage;R2>
<8,H;Oxidation;R2>

>  <CYP2D6>  (102) 
<1,H;Hydroxylation;R1>
<7,8;Cleavage;R2>
<8,H;Oxidation;R2>

>  <CYP2E1>  (102) 


>  <CYP3A4>  (102) 
<1,H;Hydroxylation;R1>
<7,8;Cleavage;R2>
<8,H;Oxidation;R2>

>  <References>  (102) 
Niwa T, Shiraga T, Ishii I, Kagayama A, Takagi A: Contribution of human hepatic cytochrome p450 isoforms to the metabolism of psychotropic drugs. Biol Pharm Bull. 2005 Sep;28(9):1711-6. (PMID: 16141545)
Mandrioli R, Mercolini L, Raggi MA: Benzodiazepine metabolism: an analytical perspective. Curr Drug Metab. 2008 Oct;9(8):827-44. (PMID: 18855614)

>  <Comments>  (102) 
Followed Xenosite.

$$$$
CC01917
     RDKit          3D

 23 26  0  0  0  0  0  0  0  0999 V2000
   -1.5480   -0.4800   -0.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5680   -1.2720    0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8910   -0.9720    0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2150    0.1130   -0.7310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2140    0.9140   -1.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8860    0.6330   -0.9870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8880    1.4970   -1.4680 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0640    2.1480   -0.5470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0210    3.5320   -0.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7710    4.1750    0.4250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5200    3.4400    1.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4970    2.0600    1.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7150    1.3990    0.3440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7480   -0.0690    0.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2520   -0.8370    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9650   -0.6770    0.4640 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0760   -2.1420    0.5490 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2120   -2.5950   -0.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4510   -1.8980   -0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2630   -0.4760   -0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1970    0.1160    0.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4970   -2.3930   -0.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1510   -1.9620    0.7300 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1 15  1  0
  2  3  1  0
  3  4  2  0
  3 23  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 13  2  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 16 21  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 22  1  0
 20 21  1  0
M  END
>  <Name>  (103) 
Clozapine

>  <InChIKey>  (103) 
QZUDBNBUXVUHMW-UHFFFAOYSA-N

>  <PubChem_CID>  (103) 
135398737

>  <CYP1A2>  (103) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,N;N-Oxidation;R2>

>  <CYP2A6>  (103) 


>  <CYP2B6>  (103) 


>  <CYP2C8>  (103) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,N;N-Oxidation;R2>

>  <CYP2C9>  (103) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (103) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,N;N-Oxidation;R2>

>  <CYP2D6>  (103) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,N;N-Oxidation;R2>

>  <CYP2E1>  (103) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP3A4>  (103) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,N;N-Oxidation;R2>

>  <References>  (103) 
Tugnait M, Hawes EM, McKay G, Eichelbaum M, Midha KK: Characterization of the human hepatic cytochromes P450 involved in the in vitro oxidation of clozapine. Chem Biol Interact. 1999 Apr 1;118(2):171-89. (PMID: 10359460)
Fang J, Coutts RT, McKenna KF, Baker GB: Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine. Naunyn Schmiedebergs Arch Pharmacol. 1998 Nov;358(5):592-9. (PMID: 9840430)

>  <Comments>  (103) 


$$$$
CC01919
     RDKit          3D

 27 28  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3910    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5980    2.8730   -0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8260    1.9950   -0.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8340    1.4890   -0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8480    2.8860   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6540    2.1560   -0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8590    1.5020   -0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0460    2.2040   -0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4950    2.4520   -0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3580    1.4630   -0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1680    2.0980    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2950    3.3270   -0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2370    2.4090   -0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3890    1.4110   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2620    3.6440   -0.0590 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.0350    3.4190   -0.0380 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.8110    0.5910   -0.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2120   -0.6860   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5080    1.0350   -0.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4000    0.0100   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2040    2.0550    0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.6280    3.7610   -0.1290 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1660   -0.6970    0.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.1420    1.0580   -0.1420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8970    3.4500    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0470    5.0670   -0.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  7  2  0
  1 12  1  0
  1 22  1  0
  2  8  2  0
  2 13  1  0
  2 23  1  0
  3  5  2  0
  3 10  1  0
  4  6  2  0
  4  9  1  0
  5 14  1  0
  6 15  1  0
  7 19  1  0
  7 24  1  0
  8 18  1  0
  8 25  1  0
  9 11  1  0
  9 17  2  0
 10 11  1  0
 10 16  2  0
 12 15  2  0
 13 14  2  0
 14 20  1  0
 15 21  1  0
 18 20  2  0
 19 21  2  0
 22 26  1  0
 23 27  1  0
M  END
>  <Name>  (104) 
Curcumin

>  <InChIKey>  (104) 
VFLDPWHFBUODDF-FCXRPNKRSA-N

>  <PubChem_CID>  (104) 
969516

>  <CYP1A2>  (104) 
<20,21;Cleavage;R1>
<21,H;Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2A6>  (104) 


>  <CYP2B6>  (104) 


>  <CYP2C8>  (104) 


>  <CYP2C9>  (104) 


>  <CYP2C19>  (104) 


>  <CYP2D6>  (104) 
<20,21;Cleavage;R1>
<21,H;Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2E1>  (104) 


>  <CYP3A4>  (104) 


>  <References>  (104) 
Sakano K, Kawanishi S: Metal-mediated DNA damage induced by curcumin in the presence of human cytochrome P450 isozymes. Arch Biochem Biophys. 2002 Sep 15;405(2):223-30. doi: 10.1016/s0003-9861(02)00302-8. (PMID: 12220536)

>  <Comments>  (104) 


$$$$
CC01920
     RDKit          3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -3.3570    0.0250   10.4930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8590   -0.1810   10.5240 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.1610    0.6370    9.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3990    0.1090    8.1170 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3150    0.8260    7.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8930    2.0180    7.7900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7980    2.7530    7.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1480    2.3060    5.7620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5880    1.1320    5.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6770    0.3920    6.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0430   -1.0890    5.2830 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8840   -1.6690    6.5010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6870   -1.0450    7.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2630   -1.6140    8.6090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9850   -2.7550    8.2680 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7760   -3.3610    7.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1560   -2.8170    6.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9330   -3.2960    9.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7020   -3.7330    9.9360 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2780    0.1980   11.8710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8250   -0.5700   12.9760 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4030   -1.9540   12.8410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2150   -0.0600   14.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  2 20  1  0
  3  4  1  0
  4  5  1  0
  4 13  1  0
  5  6  1  0
  5 10  2  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 17  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 18  1  0
 16 17  2  0
 18 19  3  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
M  END
>  <Name>  (105) 
Cyamemazine

>  <InChIKey>  (105) 
SLFGIOIONGJGRT-CQSZACIVSA-N

>  <PubChem_CID>  (105) 
14050068

>  <CYP1A2>  (105) 
<14,S;S-Oxidation;R1>
<3,4;Cleavage;R2>
<4,H;Oxidation;R2>
<3,5;Cleavage;R3>
<5,H;Oxidation;R3>

>  <CYP2A6>  (105) 


>  <CYP2B6>  (105) 
<3,4;Cleavage;R1>
<4,H;Oxidation;R1>
<3,5;Cleavage;R2>
<5,H;Oxidation;R2>

>  <CYP2C8>  (105) 
<14,S;S-Oxidation;R1>
<3,4;Cleavage;R2>
<4,H;Oxidation;R2>
<3,5;Cleavage;R3>
<5,H;Oxidation;R3>

>  <CYP2C9>  (105) 
<14,S;S-Oxidation;R1>
<9,H;Hydroxylation;R2>
<10,H;Hydroxylation;R3>
<11,H;Hydroxylation;R4>
<12,H;Hydroxylation;R5>

>  <CYP2C19>  (105) 
<14,S;S-Oxidation;R1>
<3,4;Cleavage;R2>
<4,H;Oxidation;R2>
<3,5;Cleavage;R3>
<5,H;Oxidation;R3>

>  <CYP2D6>  (105) 
<14,S;S-Oxidation;R1>
<9,H;Hydroxylation;R2>
<10,H;Hydroxylation;R3>
<11,H;Hydroxylation;R4>
<12,H;Hydroxylation;R5>

>  <CYP2E1>  (105) 


>  <CYP3A4>  (105) 
<3,4;Cleavage;R1>
<4,H;Oxidation;R1>
<3,5;Cleavage;R2>
<5,H;Oxidation;R2>
<14,S;S-Oxidation;R3>
<9,H;Hydroxylation;R4>
<10,H;Hydroxylation;R5>
<11,H;Hydroxylation;R6>
<12,H;Hydroxylation;R7>

>  <References>  (105) 
Arbus C, Benyamina A, Llorca PM, Bayle F, Bromet N, Massiere F, Garay RP, Hameg A: Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine. Eur J Pharm Sci. 2007 Dec;32(4-5):357-66. doi: 10.1016/j.ejps.2007.09.003. Epub 2007 Sep 14. (PMID: 17951033)

>  <Comments>  (105) 


$$$$
CC01921
     RDKit          3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    3.1200   -2.6170   -1.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2260   -2.0650   -0.5680 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8600   -2.1010   -0.9610 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0830   -1.0150    0.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6980   -1.0290   -0.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8120   -0.4930    0.5840 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3590   -0.4270    0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1800    1.0080   -0.2200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6630    0.5680    1.5740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8710    1.6170    1.5150 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9580    1.9800    0.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7530    1.3910   -1.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8230    3.3230    0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6660   -1.1610    0.5650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8880    2.7230   -1.5160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0940    3.6820   -0.9070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0200   -0.5280    0.7560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0480   -1.2490   -0.1190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3680   -0.6320    0.0680 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3030   -1.3670   -0.7950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7700   -0.9050    1.4540 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  2  4  1  0
  3  5  2  0
  4  6  2  0
  5  6  1  0
  5  7  1  0
  6  9  1  0
  7  8  1  0
  7 14  2  0
  8 11  2  0
  8 12  1  0
  9 10  2  0
 10 11  1  0
 11 13  1  0
 12 15  2  0
 13 16  2  0
 14 17  1  0
 15 16  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
M  END
>  <Name>  (106) 
Cyclobenzaprine

>  <InChIKey>  (106) 
JURKNVYFZMSNLP-UHFFFAOYSA-N

>  <PubChem_CID>  (106) 
2895

>  <CYP1A2>  (106) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2A6>  (106) 


>  <CYP2B6>  (106) 


>  <CYP2C8>  (106) 


>  <CYP2C9>  (106) 


>  <CYP2C19>  (106) 


>  <CYP2D6>  (106) 


>  <CYP2E1>  (106) 


>  <CYP3A4>  (106) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <References>  (106) 
Wang RW, Liu L, Cheng H: Identification of human liver cytochrome P450 isoforms involved in the in vitro metabolism of cyclobenzaprine. Drug Metab Dispos. 1996 Jul;24(7):786-91. (PMID: 8818577)

>  <Comments>  (106) 


$$$$
CC01922
     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    1.1660    1.4920    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6510    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1660    0.1580    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3820    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0470    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0470    1.2380    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3820    1.2380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7620    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330    2.4750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0470   -1.2380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0470   -2.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7620   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4760   -2.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4760   -1.2380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7620   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4760    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7620    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  9  1  0
  2  3  2  0
  2 19  1  0
  3  4  1  0
  4  5  1  0
  4  9  2  0
  5  6  1  0
  5 12  1  0
  6  7  1  0
  6 10  2  0
  7  8  1  0
  7 20  1  0
  8  9  1  0
  8 11  2  0
 12 13  1  0
 13 14  1  0
 13 18  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
M  END
>  <Name>  (107) 
Cyclohexylline

>  <InChIKey>  (107) 
GZDFOOAFMQSYOV-UHFFFAOYSA-N

>  <PubChem_CID>  (107) 
3076831

>  <CYP1A2>  (107) 
<0,H;Hydroxylation;R1>

>  <CYP2A6>  (107) 


>  <CYP2B6>  (107) 


>  <CYP2C8>  (107) 


>  <CYP2C9>  (107) 


>  <CYP2C19>  (107) 


>  <CYP2D6>  (107) 


>  <CYP2E1>  (107) 


>  <CYP3A4>  (107) 


>  <References>  (107) 
Racha JK, Rettie AE, Kunze KL: Mechanism-based inactivation of human cytochrome P450 1A2 by furafylline: detection of a 1:1 adduct to protein and evidence for the formation of a novel imidazomethide intermediate. Biochemistry. 1998 May 19;37(20):7407-19. doi: 10.1021/bi973011m. (PMID: 9585555)

>  <Comments>  (107) 


$$$$
CC01923
     RDKit          3D

 14 14  0  0  0  0  0  0  0  0999 V2000
   -0.7780    0.0140   -0.1410 P   0  0  2  0  0  0  0  0  0  0  0  0
   -1.5870   -1.4430   -0.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8170   -0.0400    0.3800 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5790    1.0700    0.7120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7800    0.4520   -1.6500 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4060    1.2460   -0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5660   -1.1520   -0.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6400    2.7520   -0.2330 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.4840   -1.8010    2.2750 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.9730   -1.2560   -0.4750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6630   -0.1860    0.3980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9450    1.1760    0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6810   -2.3340    0.7690 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8940    1.2600    0.3570 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  1
  1  4  1  0
  1  5  2  0
  2 10  1  0
  3  6  1  0
  3  7  1  0
  4 12  1  0
  6 14  1  0
  7 13  1  0
  8 14  1  0
  9 13  1  0
 10 11  1  0
 11 12  1  0
M  END
>  <Name>  (108) 
Cyclophosphamide

>  <InChIKey>  (108) 
CMSMOCZEIVJLDB-CQSZACIVSA-N

>  <PubChem_CID>  (108) 
9554282

>  <CYP1A2>  (108) 
<10,H;Hydroxylation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>
<2,6;Cleavage;R3>
<6,H;Oxidation;R3>

>  <CYP2A6>  (108) 
<10,H;Hydroxylation;R1>

>  <CYP2B6>  (108) 
<10,H;Hydroxylation;R1>

>  <CYP2C8>  (108) 
<10,H;Hydroxylation;R1>

>  <CYP2C9>  (108) 
<10,H;Hydroxylation;R1>

>  <CYP2C19>  (108) 
<10,H;Hydroxylation;R1>

>  <CYP2D6>  (108) 


>  <CYP2E1>  (108) 


>  <CYP3A4>  (108) 
<10,H;Hydroxylation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>
<2,6;Cleavage;R3>
<6,H;Oxidation;R3>

>  <References>  (108) 
Roy P, Yu LJ, Crespi CL, Waxman DJ: Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles. Drug Metab Dispos. 1999 Jun;27(6):655-66. (PMID: 10348794)
Bohnenstengel F, Hofmann U, Eichelbaum M, Kroemer HK: Characterization of the cytochrome P450 involved in side-chain oxidation of cyclophosphamide in humans. Eur J Clin Pharmacol. 1996;51(3-4):297-301. (PMID: 9010702)

>  <Comments>  (108) 


$$$$
CC01924
     RDKit          2D

 13 13  0  0  0  0  0  0  0  0999 V2000
    1.4610   -1.3590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8740   -0.6440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3220   -0.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5680   -0.3670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6540   -1.1870    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4930    0.7760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9100    1.3590    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2900    0.9890    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1470    0.0460    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8610   -0.3670    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5760    0.0460    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5760    0.8710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2900   -0.3670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  2  0
  2  3  2  0
  3  4  1  0
  3  6  1  0
  4  5  1  0
  4  9  2  0
  6  7  2  0
  6  8  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
M  END
>  <Name>  (109) 
Dacarbazine

>  <InChIKey>  (109) 
OMJKFYKNWZZKTK-POHAHGRESA-N

>  <PubChem_CID>  (109) 


>  <CYP1A2>  (109) 
<10,11;Cleavage;R1>
<11,H;Oxidation;R1>
<10,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP2A6>  (109) 


>  <CYP2B6>  (109) 


>  <CYP2C8>  (109) 


>  <CYP2C9>  (109) 


>  <CYP2C19>  (109) 


>  <CYP2D6>  (109) 


>  <CYP2E1>  (109) 
<10,11;Cleavage;R1>
<11,H;Oxidation;R1>
<10,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP3A4>  (109) 


>  <References>  (109) 
Reid JM, Kuffel MJ, Miller JK, Rios R, Ames MM: Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1. Clin Cancer Res. 1999 Aug;5(8):2192-7. (PMID: 10473105)

>  <Comments>  (109) 


$$$$
CC01925
     RDKit          3D

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.7390   -0.0180   -0.3640 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4610    0.8220   -1.2130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8510    0.7830   -1.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5250   -0.0920   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8210   -0.9290    0.4860 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4250   -0.8980    0.4980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7390    0.0180   -0.3640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4610   -0.8220   -1.2130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8510   -0.7830   -1.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5250    0.0920   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8210    0.9290    0.4860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4250    0.8980    0.4980 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0510    1.7520   -2.1240 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2070    2.5700   -2.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3140    1.6900   -2.1190 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0510   -1.7520   -2.1240 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2070   -2.5710   -2.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3150   -1.6900   -2.1190 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8850   -0.1230   -0.3620 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2770   -1.1040    0.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8850    0.1230   -0.3620 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2770    1.1040    0.6000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6730   -1.7830    1.4030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6730    1.7840    1.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5420   -1.7580    1.4070 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5420    1.7580    1.4070 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3330    2.6230    2.2250 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5920    3.4970    3.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3330   -2.6230    2.2260 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5920   -3.4970    3.1180 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  2 13  1  0
  3  4  2  0
  3 15  1  0
  4  5  1  0
  4 19  1  0
  5  6  2  0
  6 23  1  0
  7  8  2  0
  7 12  1  0
  8  9  1  0
  8 16  1  0
  9 10  2  0
  9 18  1  0
 10 11  1  0
 10 21  1  0
 11 12  2  0
 12 24  1  0
 13 14  1  0
 14 15  1  0
 16 17  1  0
 17 18  1  0
 19 20  1  0
 21 22  1  0
 23 25  2  0
 23 29  1  0
 24 26  2  0
 24 27  1  0
 27 28  1  0
 29 30  1  0
M  END
>  <Name>  (110) 
DDB

>  <InChIKey>  (110) 
JMZOMFYRADAWOG-UHFFFAOYSA-N

>  <PubChem_CID>  (110) 
108213

>  <CYP1A2>  (110) 
<20,21;Cleavage;R1>
<21,H;Oxidation;R1>
<7,8;Cleavage;R2>
<8,H;Oxidation;R2>

>  <CYP2A6>  (110) 


>  <CYP2B6>  (110) 


>  <CYP2C8>  (110) 


>  <CYP2C9>  (110) 
<25,26;Cleavage;R1>
<24,25;Cleavage;R1>
<25,H;Oxidation;R1>
<28,29;Cleavage;R2>
<27,28;Cleavage;R2>
<28,H;Oxidation;R2>

>  <CYP2C19>  (110) 


>  <CYP2D6>  (110) 


>  <CYP2E1>  (110) 


>  <CYP3A4>  (110) 
<25,26;Cleavage;R1>
<24,25;Cleavage;R1>
<25,H;Oxidation;R1>
<28,29;Cleavage;R2>
<27,28;Cleavage;R2>
<28,H;Oxidation;R2>

>  <References>  (110) 
Baek MS, Kim JY, Myung SW, Yim YH, Jeong JH, Kim DH: Metabolism of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) by human liver microsomes: characterization of metabolic pathways and of cytochrome P450 isoforms involved. Drug Metab Dispos. 2001 Apr;29(4 Pt 1):381-8. (PMID: 11259320)

>  <Comments>  (110) 


$$$$
CC01926
     RDKit          3D

 33 35  0  0  0  0  0  0  0  0999 V2000
    0.1370    1.6790    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5850    0.3310    0.4090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0420    2.7590   -0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2130    1.9540   -0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2500   -0.2090    1.6580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3700   -0.4350   -0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5860    4.0180   -0.4470 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4630    2.5980    0.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5940    3.2480   -0.6240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2480    0.9180   -0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6800   -1.4810    2.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8050   -1.7040   -0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140    4.2720   -0.7220 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5100    5.1860   -0.5590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5710    2.2420    1.5530 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3660    2.7790   -0.5460 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0140    3.5880   -0.9420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9810   -0.0160   -1.1590 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2030    0.9600    0.5420 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4600   -2.2190    1.1570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3420   -1.9970    3.3060 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9170    1.9240    1.8930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9700   -1.0400   -1.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4170   -1.3280    4.2430 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7290   -3.2390    3.7650 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8670    0.8710    2.9370 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4560   -0.3150    2.7880 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4030   -1.3700    3.7870 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0330   -2.5790    3.4920 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7430   -1.2260    5.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0050   -3.6310    4.4050 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7130   -2.2750    5.9240 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3450   -3.4780    5.6220 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  4 10  1  0
  5 11  1  0
  6 12  2  0
  7 13  1  0
  7 14  1  0
  8 15  1  0
  8 16  2  0
  9 13  2  0
  9 17  1  0
 10 18  1  0
 10 19  2  0
 11 20  2  0
 11 21  1  0
 12 20  1  0
 15 22  1  0
 18 23  1  0
 21 24  1  0
 21 25  2  0
 22 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 29 31  1  0
 30 32  2  0
 31 33  2  0
 32 33  1  0
M  CHG  2  21   1  24  -1
M  END
>  <Name>  (111) 
Dehydropranidipine

>  <InChIKey>  (111) 
UZYMZRZCYLNXQU-DHZHZOJOSA-N

>  <PubChem_CID>  (111) 
10003684

>  <CYP1A2>  (111) 
<13,14;Cleavage;R1>

>  <CYP2A6>  (111) 


>  <CYP2B6>  (111) 


>  <CYP2C8>  (111) 


>  <CYP2C9>  (111) 


>  <CYP2C19>  (111) 


>  <CYP2D6>  (111) 
<13,14;Cleavage;R1>

>  <CYP2E1>  (111) 


>  <CYP3A4>  (111) 
<13,14;Cleavage;R1>

>  <References>  (111) 
Kudo S, Okumura H, Miyamoto G, Ishizaki T: Cytochrome P-450 isoforms involved in carboxylic acid ester cleavage of Hantzsch pyridine ester of pranidipine. Drug Metab Dispos. 1999 Feb;27(2):303-8. (PMID: 9929520)

>  <Comments>  (111) 
Used the supposed metabolic pathway in the reference.

$$$$
CC01928
     RDKit          3D

 16 16  0  0  0  0  0  0  0  0999 V2000
    8.5610    0.1550    0.5960 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1050    0.6400   -0.5540 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.6020   -0.0310    1.4540 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.8290    1.1770    1.1220 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.6220   -2.1950    0.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1320   -2.1730   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4500   -1.0520    0.7240 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.4890   -1.3250    2.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0710   -0.9750    0.2640 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4360    0.1920    0.8530 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0100    0.2500    0.3640 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2820   -3.4120   -0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3700   -1.0380    0.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6720   -3.4750   -0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7630   -1.0900    0.3690 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4080   -2.3160    0.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1 15  1  0
  5  6  1  0
  5 12  2  0
  5 13  1  0
  6  7  1  0
  7  8  1  1
  7  9  1  0
  9 10  1  0
 10 11  1  0
 12 14  1  0
 13 15  2  0
 14 16  2  0
 15 16  1  0
M  END
>  <Name>  (112) 
Dexfenfluramine

>  <InChIKey>  (112) 
DBGIVFWFUFKIQN-VIFPVBQESA-N

>  <PubChem_CID>  (112) 
66265

>  <CYP1A2>  (112) 
<1,2;Cleavage;R1>
<11,H;Oxidation;R1>

>  <CYP2A6>  (112) 


>  <CYP2B6>  (112) 


>  <CYP2C8>  (112) 


>  <CYP2C9>  (112) 


>  <CYP2C19>  (112) 


>  <CYP2D6>  (112) 
<1,2;Cleavage;R1>
<11,H;Oxidation;R1>

>  <CYP2E1>  (112) 


>  <CYP3A4>  (112) 


>  <References>  (112) 
Haritos VS, Ching MS, Ghabrial H, Gross AS, Taavitsainen P, Pelkonen O, Battaglia SE, Smallwood RA, Ahokas JT: Metabolism of dexfenfluramine in human liver microsomes and by recombinant enzymes: role of CYP2D6 and 1A2. Pharmacogenetics. 1998 Oct;8(5):423-32. (PMID: 9825834)

>  <Comments>  (112) 


$$$$
CC01929
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.7080    0.5750   -0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6790   -0.8170   -0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4810    1.3260   -0.1220 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9040    1.2870   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6080   -1.5040   -0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8920   -1.5020    0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7190    0.6970   -0.1670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1080    0.5910    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7180   -0.7650   -0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0990   -0.8040    0.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7680    1.3290   -0.2230 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5920   -2.9990   -0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8740   -3.6780   -0.0350 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2410    1.3550    0.0910 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4100    0.5470    0.1520 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6240   -5.0540   -0.4220 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3500   -3.7160    1.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  2  0
  5 12  1  0
  6 10  2  0
  7  9  1  0
  7 11  2  0
  8 10  1  0
  8 14  1  0
 12 13  1  0
 13 16  1  0
 13 17  1  0
 14 15  1  0
M  END
>  <Name>  (113) 
DiMMAMC

>  <InChIKey>  (113) 
LXMHUJTYIQLCAN-UHFFFAOYSA-N

>  <PubChem_CID>  (113) 
8931830

>  <CYP1A2>  (113) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<8,9;Cleavage;R2>
<9,H;Oxidation;R2>
<8,10;Cleavage;R3>
<10,H;Oxidation;R3>

>  <CYP2A6>  (113) 


>  <CYP2B6>  (113) 


>  <CYP2C8>  (113) 


>  <CYP2C9>  (113) 


>  <CYP2C19>  (113) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2D6>  (113) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (113) 


>  <CYP3A4>  (113) 


>  <References>  (113) 
Venhorst J, Onderwater RC, Meerman JH, Commandeur JN, Vermeulen NP: Influence of N-substitution of 7-methoxy-4-(aminomethyl)-coumarin on cytochrome P450 metabolism and selectivity. Drug Metab Dispos. 2000 Dec;28(12):1524-32. (PMID: 11095593)

>  <Comments>  (113) 


$$$$
CC01930
     RDKit          3D

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.1120    1.8800    0.2270 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6470    0.6190    0.8930 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4640    1.2210   -0.3820 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7740    2.1030   -1.1160 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3540    3.4620    1.3280 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1590   -0.0970    1.9520 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3080    0.0920   -1.2270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2940    3.0640   -2.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9650   -1.0970    2.3550 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0590    0.1820    2.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6810   -0.3870   -1.6240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2370    3.0950   -3.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5240   -1.8370    3.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3790   -2.9580    3.8840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7070   -2.4430    4.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5890   -3.9920    2.8050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4160   -0.6350    3.5800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7160   -0.4040    4.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6460   -1.6480    4.0270 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  2  0
  2  6  1  0
  3  7  1  0
  4  8  1  0
  6  9  2  0
  6 10  1  0
  7 11  1  0
  8 12  1  0
  9 13  1  0
 10 17  2  0
 13 14  1  0
 13 19  2  0
 14 15  1  0
 14 16  1  0
 17 18  1  0
 17 19  1  0
M  END
>  <Name>  (114) 
Diazinon

>  <InChIKey>  (114) 
FHIVAFMUCKRCQO-UHFFFAOYSA-N

>  <PubChem_CID>  (114) 
3017

>  <CYP1A2>  (114) 
<3,4;Desulphuration;R1>
<3,8;Cleavage;R2>

>  <CYP2A6>  (114) 


>  <CYP2B6>  (114) 
<3,4;Desulphuration;R1>
<3,8;Cleavage;R2>

>  <CYP2C8>  (114) 
<3,4;Desulphuration;R1>
<3,8;Cleavage;R2>

>  <CYP2C9>  (114) 


>  <CYP2C19>  (114) 
<3,4;Desulphuration;R1>
<3,8;Cleavage;R2>

>  <CYP2D6>  (114) 
<3,4;Desulphuration;R1>
<3,8;Cleavage;R2>

>  <CYP2E1>  (114) 


>  <CYP3A4>  (114) 
<3,4;Desulphuration;R1>
<3,8;Cleavage;R2>

>  <References>  (114) 
Mutch E, Williams FM: Diazinon, chlorpyrifos and parathion are metabolised by multiple cytochromes P450 in human liver. Toxicology. 2006 Jul 5;224(1-2):22-32. doi: 10.1016/j.tox.2006.04.024. Epub 2006  Apr 26. (PMID: 16757081)

>  <Comments>  (114) 


$$$$
CC01931
     RDKit          3D

 22 26  0  0  0  0  0  0  0  0999 V2000
    2.4280    1.4740    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6500    0.7620    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6510   -0.6300    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4520   -1.3350    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2360   -0.6560    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0470   -1.3850    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2070   -0.7540    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4280   -1.4730    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6500   -0.7610   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6510    0.6310   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4520    1.3350   -0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2370    0.6570   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0470    1.3850   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2070    0.7550    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8650    1.4450    0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8930    2.8370    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7020    3.5540    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4850    2.8770    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8650   -1.4450   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8930   -2.8370   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7020   -3.5540    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4850   -2.8770    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1 14  2  0
  1 18  1  0
  2  3  2  0
  2 15  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5 14  1  0
  6  7  2  0
  7  8  1  0
  7 12  1  0
  8  9  2  0
  8 22  1  0
  9 10  1  0
  9 19  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
M  END
>  <Name>  (115) 
Dibenz[a,h]anthracene

>  <InChIKey>  (115) 
LHRCREOYAASXPZ-UHFFFAOYSA-N

>  <PubChem_CID>  (115) 
5889

>  <CYP1A2>  (115) 
<17,18;Epoxidation;R1>
<1,2;Epoxidation;R2>
<15,16;Epoxidation;R3>
<5,0;Epoxidation;R4>

>  <CYP2A6>  (115) 


>  <CYP2B6>  (115) 
<17,18;Epoxidation;R1>
<1,2;Epoxidation;R2>
<15,16;Epoxidation;R3>
<5,0;Epoxidation;R4>
<12,13;Epoxidation;R5>
<6,7;Epoxidation;R6>

>  <CYP2C8>  (115) 
<17,18;Epoxidation;R1>
<1,2;Epoxidation;R2>
<15,16;Epoxidation;R3>
<5,0;Epoxidation;R4>
<12,13;Epoxidation;R5>
<6,7;Epoxidation;R6>

>  <CYP2C9>  (115) 
<17,18;Epoxidation;R1>
<1,2;Epoxidation;R2>
<15,16;Epoxidation;R3>
<5,0;Epoxidation;R4>
<12,13;Epoxidation;R5>
<6,7;Epoxidation;R6>

>  <CYP2C19>  (115) 


>  <CYP2D6>  (115) 


>  <CYP2E1>  (115) 
<17,18;Epoxidation;R1>
<1,2;Epoxidation;R2>
<15,16;Epoxidation;R3>
<5,0;Epoxidation;R4>
<12,13;Epoxidation;R5>
<6,7;Epoxidation;R6>

>  <CYP3A4>  (115) 
<17,18;Epoxidation;R1>
<1,2;Epoxidation;R2>
<15,16;Epoxidation;R3>
<5,0;Epoxidation;R4>
<12,13;Epoxidation;R5>
<6,7;Epoxidation;R6>

>  <References>  (115) 
Shou M, Krausz KW, Gonzalez FJ, Gelboin HV: Metabolic activation of the potent carcinogen dibenzo[a,h]anthracene by cDNA-expressed human cytochromes P450. Arch Biochem Biophys. 1996 Apr 1;328(1):201-7. doi: 10.1006/abbi.1996.0161. (PMID: 8638931)

>  <Comments>  (115) 


$$$$
CC01932
     RDKit          3D

 24 29  0  0  0  0  0  0  0  0999 V2000
   -1.8990   -1.1580    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8310   -2.5710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6090   -3.2180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5680   -2.4910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7680   -3.1940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9800   -2.5170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9990   -1.1290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2260   -0.4740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2750    0.9130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0900    1.6400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8300    1.0130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6280    1.7450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6200    1.0720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6880   -0.3670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5450   -1.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860   -0.3940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9830   -3.3580    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2430   -2.7730    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3520   -1.3910    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1960   -0.6100    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7710    1.8830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7320    3.2750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5070    3.9150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6540    3.1520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1 14  2  0
  1 20  1  0
  2  3  2  0
  2 17  1  0
  3  4  1  0
  4  5  2  0
  4 15  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7 16  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 16  1  0
 12 13  2  0
 12 24  1  0
 13 14  1  0
 13 21  1  0
 14 15  1  0
 15 16  2  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
M  END
>  <Name>  (116) 
Dibenzo[a,l]pyrene

>  <InChIKey>  (116) 
JNTHRSHGARDABO-UHFFFAOYSA-N

>  <PubChem_CID>  (116) 
9119

>  <CYP1A2>  (116) 
<8,9;EpOxidation;R1>
<11,H;Hydroxylation;R2>
<0,5;EpOxidation;R3>
<1,2;EpOxidation;R4>

>  <CYP2A6>  (116) 
<11,H;Hydroxylation;R1>
<0,5;EpOxidation;R2>

>  <CYP2B6>  (116) 
<8,9;EpOxidation;R1>
<11,H;Hydroxylation;R2>
<0,5;EpOxidation;R3>
<1,2;EpOxidation;R4>

>  <CYP2C8>  (116) 
<8,9;EpOxidation;R1>
<11,H;Hydroxylation;R2>
<0,5;EpOxidation;R3>

>  <CYP2C9>  (116) 
<8,9;EpOxidation;R1>
<11,H;Hydroxylation;R2>
<0,5;EpOxidation;R3>
<1,2;EpOxidation;R4>

>  <CYP2C19>  (116) 


>  <CYP2D6>  (116) 
<8,9;EpOxidation;R1>
<11,H;Hydroxylation;R2>
<0,5;EpOxidation;R3>

>  <CYP2E1>  (116) 
<8,9;EpOxidation;R1>
<11,H;Hydroxylation;R2>
<0,5;EpOxidation;R3>

>  <CYP3A4>  (116) 
<8,9;EpOxidation;R1>
<11,H;Hydroxylation;R2>
<0,5;EpOxidation;R3>
<1,2;EpOxidation;R4>

>  <References>  (116) 
Shou M, Krausz KW, Gonzalez FJ, Gelboin HV: Metabolic activation of the potent carcinogen dibenzo[a,l]pyrene by human recombinant cytochromes P450, lung and liver microsomes. Carcinogenesis. 1996 Nov;17(11):2429-33. doi: 10.1093/carcin/17.11.2429. (PMID: 8968059)

>  <Comments>  (116) 
Updated BoMs. Followed Xenosite.

$$$$
CC01933
     RDKit          3D

 19 20  0  0  0  0  0  0  0  0999 V2000
    1.3570    0.6030   -0.4090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6490    0.9250    0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6430    1.6800   -0.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2240   -0.2260    0.8720 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4890    0.0400    2.2460 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2200    0.2240    3.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5810   -1.0160    3.4760 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1160   -1.7400    2.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4010   -0.6540    4.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2150    1.3290   -0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0060    1.0520   -0.6730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0940    0.0480   -1.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0400   -0.6810   -1.9830 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2610   -0.4050   -1.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3960    1.0590   -1.5540 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3110    1.7920   -2.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4780    3.1530   -2.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7310    3.7800   -1.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8160    3.0450   -0.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1 10  2  0
  1 14  1  0
  2  3  1  0
  2  4  1  0
  3 15  2  0
  3 19  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
M  END
>  <Name>  (117) 
Diphenhydramine

>  <InChIKey>  (117) 
ZZVUWRFHKOJYTH-UHFFFAOYSA-N

>  <PubChem_CID>  (117) 
3100

>  <CYP1A2>  (117) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2A6>  (117) 


>  <CYP2B6>  (117) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2C8>  (117) 


>  <CYP2C9>  (117) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2C19>  (117) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2D6>  (117) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2E1>  (117) 


>  <CYP3A4>  (117) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <References>  (117) 
Akutsu T, Kobayashi K, Sakurada K, Ikegaya H, Furihata T, Chiba K: Identification of human cytochrome p450 isozymes involved in diphenhydramine N-demethylation. Drug Metab Dispos. 2007 Jan;35(1):72-8. doi: 10.1124/dmd.106.012088. Epub 2006 Oct 4. (PMID: 17020955)

>  <Comments>  (117) 


$$$$
CC01934
     RDKit          3D

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.8090   -2.6710   -0.0070 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.4870   -4.5490    0.0090 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.1380    1.7270    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6970    3.5060   -0.0110 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8440    1.3530   -0.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7950   -0.0450   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9820    2.1470   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5340   -0.6380   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9330   -0.8470    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3570    4.0370   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7780    4.4530   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4070   -2.0260   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8110   -2.2340    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5500   -2.8280    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  1  0
  2 14  1  0
  3  7  2  0
  4  7  1  0
  4 10  1  0
  4 11  1  0
  5  6  1  0
  5  7  1  0
  6  8  2  0
  6  9  1  0
  8 12  1  0
  9 13  2  0
 12 14  2  0
 13 14  1  0
M  END
>  <Name>  (118) 
Diuron

>  <InChIKey>  (118) 
XMTQQYYKAHVGBJ-UHFFFAOYSA-N

>  <PubChem_CID>  (118) 
3120

>  <CYP1A2>  (118) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2A6>  (118) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2B6>  (118) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2C8>  (118) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2C9>  (118) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2C19>  (118) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2D6>  (118) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2E1>  (118) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP3A4>  (118) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <References>  (118) 
Abass K, Reponen P, Turpeinen M, Jalonen J, Pelkonen O: Characterization of diuron N-demethylation by mammalian hepatic microsomes and cDNA-expressed human cytochrome P450 enzymes. Drug Metab Dispos. 2007 Sep;35(9):1634-41. doi: 10.1124/dmd.107.016295. Epub 2007 Jun 18. (PMID: 17576805)

>  <Comments>  (118) 


$$$$
CC01935
     RDKit          3D

 30 34  0  0  0  0  0  0  0  0999 V2000
   -0.1950    1.4340   -0.2610 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0700    0.0850    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8550    2.3930   -0.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4820    1.6600   -0.8050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2660   -0.5470   -0.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9910   -0.5980    0.6250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3220    3.0320   -1.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4990    3.4390    0.9760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1530    0.3960   -0.7970 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9400    2.7190   -1.2070 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4720   -1.8920   -0.0520 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8090   -1.9660    0.8430 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4280    4.0300   -1.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6400    4.4190    1.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4050   -2.5960    0.5080 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0530    5.0410   -0.0920 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5730   -4.2810    0.7980 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.2350    5.8540    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9740    7.0210    1.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2710    7.7710    1.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1230    8.8710    2.1850 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7490    8.9400    3.4270 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3340   10.0270    1.9950 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3610   10.1310    4.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6050    8.0520    4.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4900   10.8220    3.1750 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6590   10.3080    1.0160 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8050   10.5040    5.2810 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0690    8.4110    5.3100 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6750    9.6180    5.9200 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  4 10  2  0
  5  9  1  0
  5 11  1  0
  6 12  2  0
  7 13  1  0
  8 14  1  0
 11 15  2  0
 12 15  1  0
 13 16  1  0
 14 16  1  0
 15 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 22 24  2  0
 22 25  1  0
 23 26  1  0
 23 27  2  0
 24 26  1  0
 24 28  1  0
 25 29  2  0
 28 30  2  0
 29 30  1  0
M  END
>  <Name>  (119) 
Domperidone

>  <InChIKey>  (119) 
FGXWKSZFVQUSTL-UHFFFAOYSA-N

>  <PubChem_CID>  (119) 
3151

>  <CYP1A2>  (119) 
<5,H;Hydroxylation;R1>

>  <CYP2A6>  (119) 


>  <CYP2B6>  (119) 
<5,H;Hydroxylation;R1>

>  <CYP2C8>  (119) 
<5,H;Hydroxylation;R1>

>  <CYP2C9>  (119) 


>  <CYP2C19>  (119) 


>  <CYP2D6>  (119) 
<5,H;Hydroxylation;R1>

>  <CYP2E1>  (119) 


>  <CYP3A4>  (119) 
<5,H;Hydroxylation;R1>
<12,13;Cleavage;R2>
<12,H;Oxidation;R2>

>  <References>  (119) 
Ward BA, Morocho A, Kandil A, Galinsky RE, Flockhart DA, Desta Z: Characterization of human cytochrome P450 enzymes catalyzing domperidone N-dealkylation and hydroxylation in vitro. Br J Clin Pharmacol. 2004 Sep;58(3):277-87. doi: 10.1111/j.1365-2125.2004.02156.x. (PMID: 15327587)

>  <Comments>  (119) 


$$$$
CC01937
     RDKit          3D

 35 39  0  0  0  0  0  0  0  0999 V2000
   -0.0480    1.4150    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0290    0.0230    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1760   -0.6480    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3820    0.0600    0.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3810    1.4360    0.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1630    2.1310    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0550    2.3480   -0.0010 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8280    3.5070    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4690    3.6190   -0.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4920    2.0630   -0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0090    1.9840    1.3920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5350    1.1880    2.3610 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2180    1.3880    3.4550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1580    2.3270    3.2120 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0250    2.7050    1.9040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8090    4.6510    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1600    5.0180   -1.4340 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1160    6.1330   -1.4360 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3630    5.6210   -0.8560 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7870    4.3480   -1.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0680    4.6590   -2.9960 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8210    5.1710   -3.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3970    6.4440   -2.8430 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3360    3.4440   -3.6300 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5660    3.2330   -4.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8300    2.0270   -4.8610 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8700    1.0300   -4.8760 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6450    1.2380   -4.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3750    2.4400   -3.6470 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3670    1.7630   -5.6240 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    7.6110    4.3190   -4.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5620   -0.6150    0.1010 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1920   -2.0080    0.0900 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1720   -2.4360    0.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6000    0.3680    0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  3 33  1  0
  4  5  1  0
  4 32  1  0
  5  6  2  0
  6  8  1  0
  7  9  1  0
  7 10  1  0
  8  9  2  0
  8 16  1  0
 10 11  1  0
 11 12  1  0
 11 15  2  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 23  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 24  1  0
 22 23  1  0
 24 25  2  0
 24 29  1  0
 25 26  1  0
 25 31  1  0
 26 27  2  0
 26 30  1  0
 27 28  1  0
 28 29  2  0
 32 35  1  0
 33 34  1  0
M  END
>  <Name>  (120) 
DY-9760E

>  <InChIKey>  (120) 
KSWPGVNFLOBEBO-UHFFFAOYSA-N

>  <PubChem_CID>  (120) 
9870401

>  <CYP1A2>  (120) 
<23,24;Cleavage;R1>
<24,H;Oxidation;R1>
<15,H;Hydroxylation;R2>
<28,H;Oxidation;R3>
<28,29;Reduction;R3>

>  <CYP2A6>  (120) 


>  <CYP2B6>  (120) 


>  <CYP2C8>  (120) 
<23,24;Cleavage;R1>
<24,H;Oxidation;R1>
<15,H;Hydroxylation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>
<28,H;Oxidation;R4>
<28,29;Reduction;R4>

>  <CYP2C9>  (120) 
<23,24;Cleavage;R1>
<24,H;Oxidation;R1>
<15,H;Hydroxylation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>
<28,H;Oxidation;R4>
<28,29;Reduction;R4>

>  <CYP2C19>  (120) 
<23,24;Cleavage;R1>
<24,H;Oxidation;R1>
<15,H;Hydroxylation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>
<33,34;Cleavage;R4>
<34,H;Oxidation;R4>
<28,H;Oxidation;R5>
<28,29;Reduction;R5>

>  <CYP2D6>  (120) 
<23,24;Cleavage;R1>
<24,H;Oxidation;R1>
<15,H;Hydroxylation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>
<33,34;Cleavage;R4>
<34,H;Oxidation;R4>
<28,H;Oxidation;R5>
<28,29;Reduction;R5>

>  <CYP2E1>  (120) 


>  <CYP3A4>  (120) 
<23,24;Cleavage;R1>
<24,H;Oxidation;R1>
<33,34;Cleavage;R2>
<34,H;Oxidation;R2>
<28,H;Oxidation;R3>
<28,29;Reduction;R3>
<0,1;Cleavage;R4>
<0,H;Oxidation;R4>
<15,H;Hydroxylation;R5>
<26,H;Hydroxylation;R6>

>  <References>  (120) 
Tachibana S, Fujimaki Y, Yokoyama H, Okazaki O, Sudo K: In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidaz olylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions. Drug Metab Dispos. 2005 Nov;33(11):1628-36. doi: 10.1124/dmd.105.004903. Epub 2005 Jul 27. (PMID: 16049129)

>  <Comments>  (120) 


$$$$
CC01938
     RDKit          3D

 21 23  0  0  1  0  0  0  0  0999 V2000
   -1.8520   -4.1700   -0.4700 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.6250   -0.2560   -2.3270 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8430    1.3560   -2.2090 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.2810    1.7930   -1.9570 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0150    1.9860    0.3760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3180    3.6190    1.2220 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2210    1.5290    1.0160 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7500   -0.7470    1.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0240   -0.3270    0.6270 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5280   -1.7350    0.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1840    0.6660   -0.2070 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.5030   -0.2520    0.7670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9490   -0.2940    0.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4630    0.1600    0.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1190    0.1810    0.6660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3160    0.8970   -1.7190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8810   -1.6530   -0.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2030   -0.6710    0.9060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1970    2.4430    0.8810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9570   -2.5080   -0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1180   -2.0170    0.5590 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 20  1  0
  2 16  1  0
  3 16  1  0
  4 16  1  0
  5 11  1  0
  5 19  1  0
  6 19  2  0
  7 15  1  0
  7 19  1  0
  8  9  1  0
  8 10  1  0
  8 12  1  0
  9 10  1  0
 11 13  1  0
 11 14  1  1
 11 16  1  0
 12 14  3  0
 13 15  2  0
 13 17  1  0
 15 18  1  0
 17 20  2  0
 18 21  2  0
 20 21  1  0
M  END
>  <Name>  (121) 
Efavirenz

>  <InChIKey>  (121) 
XPOQHMRABVBWPR-ZDUSSCGKSA-N

>  <PubChem_CID>  (121) 
64139

>  <CYP1A2>  (121) 
<4,H;Hydroxylation;R1>

>  <CYP2A6>  (121) 
<4,H;Hydroxylation;R1>

>  <CYP2B6>  (121) 
<4,H;Hydroxylation;R1>

>  <CYP2C8>  (121) 


>  <CYP2C9>  (121) 
<4,H;Hydroxylation;R1>

>  <CYP2C19>  (121) 


>  <CYP2D6>  (121) 


>  <CYP2E1>  (121) 


>  <CYP3A4>  (121) 
<4,H;Hydroxylation;R1>

>  <References>  (121) 
Ward BA, Gorski JC, Jones DR, Hall SD, Flockhart DA, Desta Z: The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity. J Pharmacol Exp Ther. 2003 Jul;306(1):287-300. doi: 10.1124/jpet.103.049601. Epub 2003 Apr 3. (PMID: 12676886)

>  <Comments>  (121) 


$$$$
CC01939
     RDKit          3D

 27 30  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.5080    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.2890    1.9660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0740    2.4000    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6690   -0.5540    1.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4950   -0.3700   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2040    0.9130   -0.0140 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5250    3.3430    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8320    3.7610    0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7480   -2.0790    1.1740 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.4690    4.2290    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9840    4.7320    0.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6620   -2.4850    0.0850 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3820   -2.6620    2.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3550    5.0540    1.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4030   -3.6840    0.5170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8170   -2.8950   -1.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9390   -4.0170    1.9500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7410    6.2230    1.5290 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0250    6.4730    3.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3460    7.5130    1.0840 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9490    5.6120    1.0960 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3650    7.4860    3.9190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9120    5.6590    3.9290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5870    7.6820    5.2690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1350    5.8550    5.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4700    6.8650    5.9500 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  1
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  1  0
 10  5  1  1
  6  7  1  0
  8 11  1  0
  9 11  2  0
  9 12  1  0
 10 13  1  0
 10 14  1  0
 12 15  1  0
 13 16  1  0
 13 17  1  0
 14 18  1  0
 15 19  1  0
 16 18  1  0
 19 20  1  0
 19 21  2  0
 19 22  2  0
 20 23  2  0
 20 24  1  0
 23 25  1  0
 24 26  2  0
 25 27  2  0
 26 27  1  0
M  END
>  <Name>  (122) 
Eletriptan

>  <InChIKey>  (122) 
BBMOMQCRLMEOQE-RTBURBONSA-N

>  <PubChem_CID>  (122) 


>  <CYP1A2>  (122) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (122) 


>  <CYP2B6>  (122) 


>  <CYP2C8>  (122) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C9>  (122) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (122) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2D6>  (122) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (122) 


>  <CYP3A4>  (122) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (122) 
Evans DC, O'Connor D, Lake BG, Evers R, Allen C, Hargreaves R: Eletriptan metabolism by human hepatic CYP450 enzymes and transport by human P-glycoprotein. Drug Metab Dispos. 2003 Jul;31(7):861-9. doi: 10.1124/dmd.31.7.861. (PMID: 12814962)

>  <Comments>  (122) 


$$$$
CC01940
     RDKit          3D

 19 22  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4090    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3940    1.8430   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2130    2.1020    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1840   -0.7140    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3240   -0.4180   -0.0130 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1720    0.6770   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0090    3.0920   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4210    1.3930    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2180    3.6080    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4020   -0.0290    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1630   -2.2200    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5590    0.7840   -0.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3850    3.1780   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6640    2.0490    0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6370   -0.7080    0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1560    2.0260   -0.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7730    1.3480    0.0340 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7850    0.0210    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  4 10  1  0
  5 11  1  0
  5 12  1  0
  6  7  1  0
  7 13  1  0
  8 14  2  0
  9 11  2  0
  9 15  1  0
 11 16  1  0
 13 17  2  0
 14 17  1  0
 15 18  2  0
 16 19  2  0
 18 19  1  0
M  END
>  <Name>  (123) 
Ellipticine

>  <InChIKey>  (123) 
CTSPAMFJBXKSOY-UHFFFAOYSA-N

>  <PubChem_CID>  (123) 
3213

>  <CYP1A2>  (123) 
<14,H;Hydroxylation;R1>
<16,H;Hydroxylation;R2>
<0,H;Hydroxylation;R3>

>  <CYP2A6>  (123) 


>  <CYP2B6>  (123) 


>  <CYP2C8>  (123) 


>  <CYP2C9>  (123) 
<9,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>

>  <CYP2C19>  (123) 


>  <CYP2D6>  (123) 
<14,H;Hydroxylation;R1>
<16,H;Hydroxylation;R2>
<0,H;Hydroxylation;R3>
<5,N;N-Oxidation;R4>

>  <CYP2E1>  (123) 


>  <CYP3A4>  (123) 
<14,H;Hydroxylation;R1>
<16,H;Hydroxylation;R2>
<0,H;Hydroxylation;R3>
<5,N;N-Oxidation;R4>

>  <References>  (123) 
Stiborova M, Sejbal J, Borek-Dohalska L, Aimova D, Poljakova J, Forsterova K, Rupertova M, Wiesner J, Hudecek J, Wiessler M, Frei E: The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N2-oxide. Cancer Res. 2004 Nov 15;64(22):8374-80. doi: 10.1158/0008-5472.CAN-04-2202. (PMID: 15548707)

>  <Comments>  (123) 


$$$$
CC01941
     RDKit          3D

 20 23  0  0  1  0  0  0  0  0999 V2000
   10.3770    3.0490   -0.3030 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2000   -2.8320    0.5680 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5030    1.5170    0.0820 C   0  0  1  0  0  0  0  0  0  0  0  0
    8.4850    0.0120    0.1280 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.2390   -0.7070    0.4930 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.0790   -0.1380   -0.3080 C   0  0  2  0  0  0  0  0  0  0  0  0
    9.8620    1.7620   -0.5710 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.3360    2.0280   -0.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8500   -0.5390   -0.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0140    1.3800   -0.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7010    0.6920    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3070   -2.2050    0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4110    2.0860    1.4870 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7840   -0.8400   -0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0450   -2.8500    0.8600 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7810   -2.1450    0.4750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5660   -0.2330   -0.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5710   -2.8090    0.6860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3590   -0.8960   -0.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770   -2.1780    0.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
  7  1  1  1
  2 20  1  0
  3  4  1  0
  3  7  1  0
  3  8  1  0
  3 13  1  1
  4  5  1  0
  4  9  1  1
  5  6  1  0
  5 12  1  6
  6 10  1  1
  6 14  1  0
  7 11  1  0
  8 10  1  0
  9 11  1  0
 12 15  1  0
 14 16  2  0
 14 17  1  0
 15 16  1  0
 16 18  1  0
 17 19  2  0
 18 20  2  0
 19 20  1  0
M  END
>  <Name>  (124) 
Estradiol

>  <InChIKey>  (124) 
VOXZDWNPVJITMN-NZKIEYOBSA-N

>  <PubChem_CID>  (124) 
14880

>  <CYP1A2>  (124) 
<7,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>
<10,H;Hydroxylation;R4>

>  <CYP2A6>  (124) 
<17,H;Hydroxylation;R1>

>  <CYP2B6>  (124) 
<7,H;Hydroxylation;R1>

>  <CYP2C8>  (124) 
<7,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>

>  <CYP2C9>  (124) 
<7,H;Hydroxylation;R1>
<10,H;Hydroxylation;R2>

>  <CYP2C19>  (124) 
<7,H;Hydroxylation;R1>

>  <CYP2D6>  (124) 
<7,H;Hydroxylation;R1>

>  <CYP2E1>  (124) 


>  <CYP3A4>  (124) 
<2,H;Hydroxylation;R1>
<7,H;Hydroxylation;R2>
<17,H;Hydroxylation;R3>
<16,H;Hydroxylation;R4>
<12,H;Hydroxylation;R5>
<10,H;Hydroxylation;R6>

>  <References>  (124) 
Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT: Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology. 2003 Aug;144(8):3382-98. doi: 10.1210/en.2003-0192. (PMID: 12865317)
Corrigan BW, Nicholls B, Thakrar B, Lam R, Grosse C, Alianti J, Palmer JL: Heterogeneity in systemic availability of ondansetron and granisetron following oral administration. Drug Metab Dispos. 1999 Jan;27(1):110-2. (PMID: 9884318)

>  <Comments>  (124) 


$$$$
CC01942
     RDKit          3D

 20 23  0  0  1  0  0  0  0  0999 V2000
   10.3430    2.8640   -0.8390 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2420   -2.8500    0.2900 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4470    1.6130    0.0460 C   0  0  1  0  0  0  0  0  0  0  0  0
    8.4750    0.1110    0.1180 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2310   -0.5980    0.5090 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.1380   -0.1490   -0.4530 C   0  0  2  0  0  0  0  0  0  0  0  0
    9.9000    1.8650   -0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4060    2.0270   -0.9620 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8390   -0.4260   -0.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0590    1.3520   -0.7050 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7380    0.7270    0.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3360   -2.1040    0.4940 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1540    2.2190    1.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8350   -0.8490   -0.2330 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0420   -2.7180    0.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8060   -2.0900    0.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6420   -0.3100   -0.7260 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5930   -2.7560    0.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4320   -0.9770   -0.5520 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4230   -2.1930    0.1150 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  7  2  0
  2 20  1  0
  3  4  1  0
  3  7  1  0
  3  8  1  0
  3 13  1  1
  4  5  1  0
  4  9  1  0
  5  6  1  0
  5 12  1  6
  6 10  1  1
  6 14  1  0
  7 11  1  0
  8 10  1  0
  9 11  1  0
 12 15  1  0
 14 16  2  0
 14 17  1  0
 15 16  1  0
 16 18  1  0
 17 19  2  0
 18 20  2  0
 19 20  1  0
M  END
>  <Name>  (125) 
Estrone

>  <InChIKey>  (125) 
DNXHEGUUPJUMQT-QYFVKBAZSA-N

>  <PubChem_CID>  (125) 
133184

>  <CYP1A2>  (125) 
<7,H;Hydroxylation;R1>
<10,H;Hydroxylation;R2>

>  <CYP2A6>  (125) 


>  <CYP2B6>  (125) 
<7,H;Hydroxylation;R1>

>  <CYP2C8>  (125) 
<7,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>

>  <CYP2C9>  (125) 
<7,H;Hydroxylation;R1>
<10,H;Hydroxylation;R2>

>  <CYP2C19>  (125) 
<7,H;Hydroxylation;R1>

>  <CYP2D6>  (125) 
<7,H;Hydroxylation;R1>

>  <CYP2E1>  (125) 


>  <CYP3A4>  (125) 
<7,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>
<10,H;Hydroxylation;R4>

>  <References>  (125) 
Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT: Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology. 2003 Aug;144(8):3382-98. doi: 10.1210/en.2003-0192. (PMID: 12865317)
Ohe T, Hirobe M, Mashino T: Novel metabolic pathway of estrone and 17beta-estradiol catalyzed by cytochrome P-450. Drug Metab Dispos. 2000 Feb;28(2):110-2. (PMID: 10640505)

>  <Comments>  (125) 


$$$$
CC01943
     RDKit          3D

  3  2  0  0  0  0  0  0  0  0999 V2000
    2.7320    0.2590   -0.2280 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2400    0.2630   -0.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6970   -0.0840    1.0520 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
M  END
>  <Name>  (126) 
Ethanol

>  <InChIKey>  (126) 
LFQSCWFLJHTTHZ-UHFFFAOYSA-N

>  <PubChem_CID>  (126) 
702

>  <CYP1A2>  (126) 
<1,2;Oxidation;R1>

>  <CYP2A6>  (126) 


>  <CYP2B6>  (126) 
<1,2;Oxidation;R1>

>  <CYP2C8>  (126) 
<1,2;Oxidation;R1>

>  <CYP2C9>  (126) 
<1,2;Oxidation;R1>

>  <CYP2C19>  (126) 


>  <CYP2D6>  (126) 
<1,2;Oxidation;R1>

>  <CYP2E1>  (126) 
<1,2;Oxidation;R1>

>  <CYP3A4>  (126) 
<1,2;Oxidation;R1>

>  <References>  (126) 
Hamitouche S, Poupon J, Dreano Y, Amet Y, Lucas D: Ethanol oxidation into acetaldehyde by 16 recombinant human cytochrome P450 isoforms: role of CYP2C isoforms in human liver microsomes. Toxicol Lett. 2006 Dec 15;167(3):221-30. doi: 10.1016/j.toxlet.2006.09.011. Epub  2006 Oct 12. (PMID: 17084997)
Salmela KS, Kessova IG, Tsyrlov IB, Lieber CS: Respective roles of human cytochrome P-4502E1, 1A2, and 3A4 in the hepatic microsomal ethanol oxidizing system. Alcohol Clin Exp Res. 1998 Dec;22(9):2125-32. (PMID: 9884161)

>  <Comments>  (126) 


$$$$
CC01944
     RDKit          3D

 22 25  0  0  1  0  0  0  0  0999 V2000
   12.3930    0.2340   -2.5470 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1210    0.2370   -2.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8840   -0.2530   -0.7800 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5840   -0.2510   -0.2730 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3650   -0.8060    1.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0140   -0.4570    1.6950 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9250   -0.6780    0.6700 C   0  0  1  0  0  0  0  0  0  0  0  0
    5.5490   -0.4310    1.2170 C   0  0  2  0  0  0  0  0  0  0  0  0
    5.0680   -1.1790    2.4350 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6920   -0.5240    2.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1690   -0.7030    1.0450 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.4450   -1.9240    0.9950 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2760    0.4100    0.7100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5400    1.3190    0.4380 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4660   -0.7650    0.1890 C   0  0  1  0  0  0  0  0  0  0  0  0
    4.6130    0.2270   -0.9530 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0180    0.2330   -1.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1320    0.2650   -0.5080 C   0  0  2  0  0  0  0  0  0  0  0  0
    8.5230    0.2320   -1.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7940    0.7290   -2.3390 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0910    0.7310   -2.8440 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6750   -2.1660   -0.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2 21  1  0
  3  4  1  0
  4  5  1  0
  4 19  2  0
  5  6  1  0
  7  6  1  1
  7  8  1  0
  7 18  1  0
  8  9  1  1
  8 15  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  1
 11 13  1  0
 11 15  1  0
 13 14  3  0
 15 16  1  0
 15 22  1  6
 16 17  1  0
 18 17  1  6
 18 19  1  0
 19 20  1  0
 20 21  2  0
M  END
>  <Name>  (127) 
Ethinylestradiol

>  <InChIKey>  (127) 
BFPYWIDHMRZLRN-SLHNCBLASA-N

>  <PubChem_CID>  (127) 
5991

>  <CYP1A2>  (127) 
<14,H;Hydroxylation;R1>

>  <CYP2A6>  (127) 


>  <CYP2B6>  (127) 


>  <CYP2C8>  (127) 
<14,H;Hydroxylation;R1>

>  <CYP2C9>  (127) 
<14,H;Hydroxylation;R1>

>  <CYP2C19>  (127) 
<14,H;Hydroxylation;R1>

>  <CYP2D6>  (127) 


>  <CYP2E1>  (127) 


>  <CYP3A4>  (127) 
<14,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <References>  (127) 
Wang B, Sanchez RI, Franklin RB, Evans DC, Huskey SE: The involvement of CYP3A4 and CYP2C9 in the metabolism of 17 alpha-ethinylestradiol. Drug Metab Dispos. 2004 Nov;32(11):1209-12. doi: 10.1124/dmd.104.000182. Epub 2004 Aug 10. (PMID: 15304426)

>  <Comments>  (127) 


$$$$
CC01946
     RDKit          3D

 12 12  0  0  0  0  0  0  0  0999 V2000
   -0.0380    1.3680    0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0150   -0.0260    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1600    2.0820    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2040    2.0810    0.1110 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2410   -0.6930   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3900    1.4320    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1560    3.4460    0.0850 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3410    1.2250    0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4280    0.0410   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2830   -2.1840   -0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2260   -2.7420   -1.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1880   -3.5230   -1.9120 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  3  6  2  0
  3  7  1  0
  4  8  1  0
  5  9  2  0
  5 10  1  0
  6  9  1  0
 10 11  1  0
 11 12  2  0
M  END
>  <Name>  (128) 
Eugenol

>  <InChIKey>  (128) 
RRAFCDWBNXTKKO-UHFFFAOYSA-N

>  <PubChem_CID>  (128) 
3314

>  <CYP1A2>  (128) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <CYP2A6>  (128) 


>  <CYP2B6>  (128) 


>  <CYP2C8>  (128) 


>  <CYP2C9>  (128) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <CYP2C19>  (128) 


>  <CYP2D6>  (128) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <CYP2E1>  (128) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <CYP3A4>  (128) 


>  <References>  (128) 
Sakano K, Inagaki Y, Oikawa S, Hiraku Y, Kawanishi S: Copper-mediated oxidative DNA damage induced by eugenol: possible involvement of O-demethylation. Mutat Res. 2004 Dec 31;565(1):35-44. doi: 10.1016/j.mrgentox.2004.08.009. (PMID: 15576237)

>  <Comments>  (128) 


$$$$
CC01947
     RDKit          3D

 25 27  0  0  0  0  0  0  0  0999 V2000
    1.2530    0.5380    0.2300 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0800    1.3020    0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3240    2.6110    0.6240 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8240    3.4440    0.5940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1530    0.6790    0.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3110    1.4060    0.1580 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4640    0.6130   -0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1700   -0.6850   -0.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0070   -1.4270   -0.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2430   -0.8260   -0.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5000   -1.5870   -0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4920   -2.8910   -0.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7610   -3.6290   -0.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7640   -4.8230   -0.7810 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9880   -2.8610   -0.2390 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8560   -1.5040    0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6480   -0.8560    0.1060 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2640   -3.4330   -0.2660 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4300   -4.7610   -0.5460 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4050   -2.6590   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6140   -3.3020   -0.0350 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.5670   -2.5390   -0.7670 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2430   -1.3100    0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3050   -0.5160    0.6240 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9800   -0.7290    0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1 10  1  0
  2  3  1  0
  2  5  1  0
  3  4  1  0
  5  6  1  0
  5  8  2  0
  6  7  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 17  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 15 18  1  0
 16 17  1  0
 16 25  1  0
 18 19  1  0
 18 20  2  0
 20 21  1  0
 20 23  1  0
 21 22  1  0
 23 24  1  0
 23 25  2  0
M  END
>  <Name>  (129) 
Eupatilin

>  <InChIKey>  (129) 
DRRWBCNQOKKKOL-UHFFFAOYSA-N

>  <PubChem_CID>  (129) 
5273755

>  <CYP1A2>  (129) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (129) 


>  <CYP2B6>  (129) 


>  <CYP2C8>  (129) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C9>  (129) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (129) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2D6>  (129) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (129) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP3A4>  (129) 


>  <References>  (129) 
Lee HS, Ji HY, Park EJ, Kim SY: In vitro metabolism of eupatilin by multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes. Xenobiotica. 2007 Aug;37(8):803-17. doi: 10.1080/00498250701534877. (PMID: 17701830)

>  <Comments>  (129) 


$$$$
CC01948
     RDKit          3D

 14 14  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1690    2.2100    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2250    2.1780    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0230   -0.5220    1.4420 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.1500    3.5920    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2440    3.5600    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2310   -0.1540    2.1120 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1690   -2.0450    1.4340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0560    4.2670    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9420   -0.1080    3.5520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2130    0.2720    4.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9230    0.3170    5.7580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7000    0.3530    6.8710 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  3  6  1  0
  4  7  2  0
  5  8  1  0
  5  9  1  6
  6 10  2  0
  7 10  1  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  3  0
M  END
>  <Name>  (130) 
Fenproporex

>  <InChIKey>  (130) 
IQUFSXIQAFPIMR-NSHDSACASA-N

>  <PubChem_CID>  (130) 
37888393

>  <CYP1A2>  (130) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <CYP2A6>  (130) 


>  <CYP2B6>  (130) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <CYP2C8>  (130) 


>  <CYP2C9>  (130) 


>  <CYP2C19>  (130) 


>  <CYP2D6>  (130) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <CYP2E1>  (130) 


>  <CYP3A4>  (130) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <References>  (130) 
Kraemer T, Pflugmann T, Bossmann M, Kneller NM, Peters FT, Paul LD, Springer D, Staack RF, Maurer HH: Fenproporex N-dealkylation to amphetamine--enantioselective in vitro studies in human liver microsomes as well as enantioselective in vivo studies in Wistar and Dark Agouti rats. Biochem Pharmacol. 2004 Sep 1;68(5):947-57. doi: 10.1016/j.bcp.2004.05.009. (PMID: 15294457)

>  <Comments>  (130) 


$$$$
CC01949
     RDKit          3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -1.6350   -1.0740    0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2340   -1.6420   -1.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7690   -2.8630   -1.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7050   -3.5150   -0.8010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1100   -2.9490    0.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5760   -1.7290    0.8090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0760    0.2440    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9190    1.1410    0.7990 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3590    2.4140    1.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9290    3.1980    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2820    2.7990   -0.5340 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3990    0.4450    0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9920    1.6160   -0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3810    1.6130   -0.4220 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1790    0.5170   -0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5750   -0.6080    0.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1990   -0.6590    0.6330 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3850   -1.7650    0.7750 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9600   -1.2200    1.9890 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5750    4.1670   -0.3870 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8720    3.6890   -1.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6090   -1.6800    0.6050 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7990   -2.7650    1.2110 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6 19  1  0
  7  8  2  0
  7 12  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 20  2  0
 11 13  1  0
 11 21  1  0
 12 13  2  0
 12 17  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 22  2  0
 18 23  1  0
M  CHG  2  18   1  23  -1
M  END
>  <Name>  (131) 
Flunitrazepam

>  <InChIKey>  (131) 
PPTYJKAXVCCBDU-UHFFFAOYSA-N

>  <PubChem_CID>  (131) 
3380

>  <CYP1A2>  (131) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (131) 
<4,H;Hydroxylation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2B6>  (131) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C8>  (131) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C9>  (131) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (131) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2D6>  (131) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (131) 


>  <CYP3A4>  (131) 
<9,H;Hydroxylation;R1>
<21,11;Cleavage;R2>
<21,H;Oxidation;R2>

>  <References>  (131) 
Hesse LM, Venkatakrishnan K, von Moltke LL, Shader RI, Greenblatt DJ: CYP3A4 is the major CYP isoform mediating the in vitro hydroxylation and demethylation of flunitrazepam. Drug Metab Dispos. 2001 Feb;29(2):133-40. (PMID: 11159802)
Gafni I, Busto UE, Tyndale RF, Kaplan HL, Sellers EM: The role of cytochrome P450 2C19 activity in flunitrazepam metabolism in vivo. J Clin Psychopharmacol. 2003 Apr;23(2):169-75. (PMID: 12640218)

>  <Comments>  (131) 


$$$$
CC01950
     RDKit          3D

 22 23  0  0  0  0  0  0  0  0999 V2000
   -0.2060    1.3430    0.2870 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.2290   -0.0220   -0.3290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1420    1.8010    0.3590 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0990    2.3110   -0.4660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4810   -1.1230    0.4920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0090   -0.2240   -1.6910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4980    2.1370    1.6380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3470    3.3170   -1.3030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5000   -2.4100   -0.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0100   -1.5100   -2.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6480    2.0430    2.7390 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8010    2.6010    1.8090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3240    4.1690   -1.9560 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2650   -2.6020   -1.4010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1000    2.4070    4.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2510    2.9650    3.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5900    5.0980   -2.7960 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4080    2.8630    4.1840 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8860    3.2740    5.5400 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2270    3.1010    5.7110 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.6440    4.5890    5.8010 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.2960    2.5780    6.5510 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  6
  2  5  2  0
  2  6  1  0
  3  7  1  0
  4  8  1  0
  5  9  1  0
  6 10  2  0
  7 11  2  0
  7 12  1  0
  8 13  1  0
  9 14  2  0
 10 14  1  0
 11 15  1  0
 12 16  2  0
 13 17  1  0
 15 18  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
M  END
>  <Name>  (132) 
Fluoxetine

>  <InChIKey>  (132) 
RTHCYVBBDHJXIQ-INIZCTEOSA-N

>  <PubChem_CID>  (132) 
1548968

>  <CYP1A2>  (132) 


>  <CYP2A6>  (132) 


>  <CYP2B6>  (132) 


>  <CYP2C8>  (132) 


>  <CYP2C9>  (132) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (132) 
<4,5;Cleavage;R1>
<4,H;Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2D6>  (132) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (132) 


>  <CYP3A4>  (132) 
<4,5;Cleavage;R1>
<4,H;Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <References>  (132) 
Brown CM, Reisfeld B, Mayeno AN: Cytochromes P450: a structure-based summary of biotransformations using representative substrates. Drug Metab Rev. 2008;40(1):1-100. doi: 10.1080/03602530802309742. (PMID: 18259985)
Ring BJ, Eckstein JA, Gillespie JS, Binkley SN, VandenBranden M, Wrighton SA: Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine. J Pharmacol Exp Ther. 2001 Jun;297(3):1044-50. (PMID: 11356927)
Margolis JM, O'Donnell JP, Mankowski DC, Ekins S, Obach RS: (R)-, (S)-, and racemic fluoxetine N-demethylation by human cytochrome P450 enzymes. Drug Metab Dispos. 2000 Oct;28(10):1187-91. (PMID: 10997938)

>  <Comments>  (132) 


$$$$
CC01951
     RDKit          3D

 19 19  0  0  0  0  0  0  0  0999 V2000
   -4.6060    1.0480    0.8830 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4390    2.8400    0.5470 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3030    1.7930   -1.1450 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.3990    1.9390   -0.2850 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5350   -1.0480   -1.0260 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7630   -2.3590    0.5660 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1780    1.4490   -0.1840 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6730   -1.4010   -0.2120 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8270   -0.3800   -0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.6950   -0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5060    1.0910   -0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4420    0.7620   -0.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1990    1.4070   -0.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1990   -0.6820   -0.6550 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7900   -0.7710    1.3600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4430   -0.6350   -0.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0380   -0.6920   -0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2570   -1.3650   -0.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6830    1.5960    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 19  1  0
  2 19  1  0
  3 19  1  0
  4 11  2  0
  5  8  1  0
  6  8  2  0
  7 10  1  0
  7 11  1  0
  8 16  1  0
  9 11  1  0
  9 14  1  0
  9 15  1  0
 10 13  2  0
 10 17  1  0
 12 13  1  0
 12 16  2  0
 12 19  1  0
 16 18  1  0
 17 18  2  0
M  CHG  2   5  -1   8   1
M  END
>  <Name>  (133) 
Flutamide

>  <InChIKey>  (133) 
MKXKFYHWDHIYRV-UHFFFAOYSA-N

>  <PubChem_CID>  (133) 
3397

>  <CYP1A2>  (133) 
<1,H;Hydroxylation;R1>

>  <CYP2A6>  (133) 


>  <CYP2B6>  (133) 


>  <CYP2C8>  (133) 


>  <CYP2C9>  (133) 
<1,H;Hydroxylation;R1>

>  <CYP2C19>  (133) 
<1,H;Hydroxylation;R1>

>  <CYP2D6>  (133) 


>  <CYP2E1>  (133) 


>  <CYP3A4>  (133) 


>  <References>  (133) 
Goda R, Nagai D, Akiyama Y, Nishikawa K, Ikemoto I, Aizawa Y, Nagata K, Yamazoe Y: Detection of a new N-oxidized metabolite of flutamide, N-[4-nitro-3-(trifluoromethyl)phenyl]hydroxylamine, in human liver microsomes and urine of prostate cancer patients. Drug Metab Dispos. 2006 May;34(5):828-35. doi: 10.1124/dmd.105.008623. Epub 2006  Feb 28. (PMID: 16507648)
Shet MS, McPhaul M, Fisher CW, Stallings NR, Estabrook RW: Metabolism of the antiandrogenic drug (Flutamide) by human CYP1A2. Drug Metab Dispos. 1997 Nov;25(11):1298-303. (PMID: 9351907)
Maw HH, Zeng X, Campbell S, Taub ME, Teitelbaum AM: N-Methylation of BI 187004 by Thiol S-Methyltransferase. Drug Metab Dispos. 2018 Jun;46(6):770-778. doi: 10.1124/dmd.117.079764. Epub 2018 Mar 7. (PMID: 29514826)

>  <Comments>  (133) 


$$$$
CC01952
     RDKit          3D

 22 22  0  0  0  0  0  0  0  0999 V2000
    5.1090   -5.1020    2.7520 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4400   -5.2850    1.3820 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3610   -4.8200    0.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2530   -3.3090    0.4950 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4560   -2.5040    0.9280 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7050   -2.8610    0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0430   -1.7440   -0.8060 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6350   -0.6480   -0.4340 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9180   -0.6740    0.9360 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5830    0.5450    1.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7270    0.6870    2.7380 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7400   -0.2220    3.2470 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6680   -1.9360   -2.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9090   -0.9160   -3.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5610   -1.0880   -4.4820 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9670   -2.2770   -4.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7370   -3.2970   -3.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0840   -3.1290   -2.6460 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6120   -2.4550   -6.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7090   -2.6380   -7.1450 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.8050   -3.5270   -6.5900 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.9550   -1.3800   -6.8770 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7 13  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 13 14  2  0
 13 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 19  1  0
 17 18  2  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
M  END
>  <Name>  (134) 
Fluvoxamine

>  <InChIKey>  (134) 
CJOFXWAVKWHTFT-XSFVSMFZSA-N

>  <PubChem_CID>  (134) 
5324346

>  <CYP1A2>  (134) 
<8,9;Cleavage;R1>
<9,H;Oxidation;R1>
<10,11;Cleavage;R2>
<10,H;Oxidation;R2>

>  <CYP2A6>  (134) 


>  <CYP2B6>  (134) 


>  <CYP2C8>  (134) 


>  <CYP2C9>  (134) 


>  <CYP2C19>  (134) 


>  <CYP2D6>  (134) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<2,H;Oxidation;R1>

>  <CYP2E1>  (134) 


>  <CYP3A4>  (134) 


>  <References>  (134) 
Spigset O, Axelsson S, Norstrom A, Hagg S, Dahlqvist R: The major fluvoxamine metabolite in urine is formed by CYP2D6. Eur J Clin Pharmacol. 2001 Nov;57(9):653-8. (PMID: 11791895)
Wang B, Zhou SF: Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr Med Chem. 2009;16(31):4066-218. (PMID: 19754423)

>  <Comments>  (134) 
In Zhou's paper, it should be 2D6 rather than 2B6. They made a mistake.

$$$$
CC01953
     RDKit          3D

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0180    1.2780    0.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0750    0.0550   -0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2170    1.8840    0.7740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1360    1.9340    0.9320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1540   -0.6250   -0.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3200   -0.5270   -0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3560    1.2390    0.3560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3710    1.3470    0.6850 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4410    0.0630   -0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4780    0.1250    0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0810   -1.7050   -1.1470 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5050    1.9850    1.0920 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7690   -0.4620   -0.6510 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9390    0.2020   -0.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2000   -0.2870   -0.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3150   -1.4580   -1.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1630   -2.1330   -1.7420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9070   -1.6360   -1.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5870   -1.8650   -1.6370 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5840   -3.0690   -2.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  1  0
  5 11  2  0
  6 10  2  0
  7  9  2  0
  8 10  1  0
  8 12  1  0
  9 13  1  0
 13 14  2  0
 13 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 19  1  0
 17 18  2  0
 19 20  1  0
M  END
>  <Name>  (135) 
Formononetin

>  <InChIKey>  (135) 
HKQYGTCOTHHOMP-UHFFFAOYSA-N

>  <PubChem_CID>  (135) 
5280378

>  <CYP1A2>  (135) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<10,H;Hydroxylation;R2>
<13,H;Hydroxylation;R3>
<3,H;Hydroxylation;R4>
<19,H;Hydroxylation;R5>

>  <CYP2A6>  (135) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2B6>  (135) 


>  <CYP2C8>  (135) 


>  <CYP2C9>  (135) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<10,H;Hydroxylation;R2>
<13,H;Hydroxylation;R3>
<3,H;Hydroxylation;R4>
<19,H;Hydroxylation;R5>

>  <CYP2C19>  (135) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<10,H;Hydroxylation;R2>
<13,H;Hydroxylation;R3>
<3,H;Hydroxylation;R4>
<19,H;Hydroxylation;R5>

>  <CYP2D6>  (135) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<10,H;Hydroxylation;R2>
<13,H;Hydroxylation;R3>
<3,H;Hydroxylation;R4>
<19,H;Hydroxylation;R5>

>  <CYP2E1>  (135) 


>  <CYP3A4>  (135) 


>  <References>  (135) 
Tolleson WH, Doerge DR, Churchwell MI, Marques MM, Roberts DW: Metabolism of biochanin A and formononetin by human liver microsomes in vitro. J Agric Food Chem. 2002 Aug 14;50(17):4783-90. (PMID: 12166960)

>  <Comments>  (135) 


$$$$
CC01955
     RDKit          2D

 19 21  0  0  0  0  0  0  0  0999 V2000
    1.1050    1.3700    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5900    0.7020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1050    0.0350    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3200    0.2900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3940   -0.1230    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1090    0.2900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1090    1.1150    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3940    1.5270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3200    1.1150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8230   -0.1230    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3940    2.3520    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4150    0.7020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8230    1.5270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3940   -0.9480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8630   -1.0250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1090   -1.3600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1950   -2.1810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0020   -2.3520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4150   -1.6380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  9  1  0
  2  3  2  0
  2 12  1  0
  3  4  1  0
  4  5  1  0
  4  9  2  0
  5  6  1  0
  5 14  1  0
  6  7  1  0
  6 10  2  0
  7  8  1  0
  7 13  1  0
  8  9  1  0
  8 11  2  0
 14 16  1  0
 15 16  1  0
 15 19  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
M  END
>  <Name>  (136) 
Furafylline

>  <InChIKey>  (136) 
KGQZGCIVHYLPBH-UHFFFAOYSA-N

>  <PubChem_CID>  (136) 
3433

>  <CYP1A2>  (136) 
<0,H;Hydroxylation;R1>

>  <CYP2A6>  (136) 


>  <CYP2B6>  (136) 


>  <CYP2C8>  (136) 


>  <CYP2C9>  (136) 


>  <CYP2C19>  (136) 


>  <CYP2D6>  (136) 


>  <CYP2E1>  (136) 


>  <CYP3A4>  (136) 


>  <References>  (136) 
Racha JK, Rettie AE, Kunze KL: Mechanism-based inactivation of human cytochrome P450 1A2 by furafylline: detection of a 1:1 adduct to protein and evidence for the formation of a novel imidazomethide intermediate. Biochemistry. 1998 May 19;37(20):7407-19. doi: 10.1021/bi973011m. (PMID: 9585555)

>  <Comments>  (136) 


$$$$
CC01956
     RDKit          3D

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.6810   -0.4110   -0.9340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2190    0.6460   -0.7010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4870    1.8350   -0.9600 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7530    1.4620   -1.3430 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8660    0.1520   -1.3080 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1020   -0.6560   -1.5570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5880    0.6320   -0.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4090    1.4080   -0.8310 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9190   -0.1880    0.7290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0730   -0.6380    1.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9020   -1.2260    2.5050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9590   -1.7470    3.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2720   -1.6660    2.7860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4430   -1.1140    1.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3940   -0.6300    0.7320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4360   -2.1060   -0.8130 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -6.7450   -0.9260    0.7830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9900   -0.2140   -0.5990 C   0  0  1  0  0  0  0  0  0  0  0  0
   -7.4920    0.3150    1.2980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6380   -2.1800    0.8580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2690   -0.8360   -1.8130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3400   -0.7260   -0.5810 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0420    3.2640   -0.8390 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  5  1  0
  1 16  1  0
  2  3  1  0
  2  7  1  0
  3  4  2  0
  3 23  1  0
  4  5  1  0
  5  6  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 10 15  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 17  1  0
 15 18  1  0
 17 19  1  0
 17 20  1  0
 17 22  1  0
 18 21  1  6
 18 22  1  0
M  END
>  <Name>  (137) 
Furametpyr

>  <InChIKey>  (137) 
NRTLIYOWLVMQBO-SNVBAGLBSA-N

>  <PubChem_CID>  (137) 
86290041

>  <CYP1A2>  (137) 
<3,4;Cleavage;R1>
<4,H;Oxidation;R1>

>  <CYP2A6>  (137) 


>  <CYP2B6>  (137) 


>  <CYP2C8>  (137) 


>  <CYP2C9>  (137) 


>  <CYP2C19>  (137) 
<3,4;Cleavage;R1>
<4,H;Oxidation;R1>

>  <CYP2D6>  (137) 


>  <CYP2E1>  (137) 


>  <CYP3A4>  (137) 
<3,4;Cleavage;R1>
<4,H;Oxidation;R1>

>  <References>  (137) 
Nagahori H, Yoshino H, Tomigahara Y, Isobe N, Kaneko H, Nakatsuka I: Metabolism of furametpyr. 1. Identification of metabolites and in vitro biotransformation in rats and humans. J Agric Food Chem. 2000 Nov;48(11):5754-9. (PMID: 11087550)

>  <Comments>  (137) 


$$$$
CC01957
     RDKit          3D

 20 22  0  0  0  0  0  0  0  0999 V2000
   -0.0370    1.4010    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0570    0.0250    0.2230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2060    2.1470   -0.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2940    2.0100    0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2430   -0.6590    0.1950 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0860   -0.7350    0.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4610    1.3680   -0.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2060    3.3570   -0.4370 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4420    1.2620    0.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4580    3.3500   -0.1240 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4170    0.0450   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3230   -0.1060    0.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6190    2.0610   -0.5180 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6110   -0.8160   -0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4400   -0.8460    0.7540 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8340   -0.3860    0.4950 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5260   -2.1220   -0.5250 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9450   -1.2270    0.5110 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6330   -2.9690   -0.5110 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8440   -2.5190    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  2  0
  4 10  1  0
  5 11  1  0
  6 12  2  0
  7 11  2  0
  7 13  1  0
  9 12  1  0
 11 14  1  0
 12 15  1  0
 14 16  2  0
 14 17  1  0
 16 18  1  0
 17 19  2  0
 18 20  2  0
 19 20  1  0
M  END
>  <Name>  (138) 
Galangin

>  <InChIKey>  (138) 
VCCRNZQBSJXYJD-UHFFFAOYSA-N

>  <PubChem_CID>  (138) 
5281616

>  <CYP1A2>  (138) 
<8,H;Hydroxylation;R1>

>  <CYP2A6>  (138) 


>  <CYP2B6>  (138) 


>  <CYP2C8>  (138) 


>  <CYP2C9>  (138) 
<8,H;Hydroxylation;R1>

>  <CYP2C19>  (138) 


>  <CYP2D6>  (138) 


>  <CYP2E1>  (138) 


>  <CYP3A4>  (138) 


>  <References>  (138) 
Otake Y, Hsieh F, Walle T: Glucuronidation versus oxidation of the flavonoid galangin by human liver microsomes and hepatocytes. Drug Metab Dispos. 2002 May;30(5):576-81. doi: 10.1124/dmd.30.5.576. (PMID: 11950790)

>  <Comments>  (138) 


$$$$
CC01958
     RDKit          2D

 14 14  0  0  0  0  0  0  0  0999 V2000
    1.0720   -0.4120    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010   -0.4120    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860    0.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860    1.2380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5010    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7860   -1.2380    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    1.2380    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  5  1  0
  2  3  1  0
  2  4  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7 12  1  0
  8  9  1  0
  8 14  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
M  END
>  <Name>  (139) 
Guanabenz

>  <InChIKey>  (139) 
WDZVGELJXXEGPV-YIXHJXPBSA-N

>  <PubChem_CID>  (139) 
5702063

>  <CYP1A2>  (139) 
<0,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>

>  <CYP2A6>  (139) 


>  <CYP2B6>  (139) 


>  <CYP2C8>  (139) 


>  <CYP2C9>  (139) 


>  <CYP2C19>  (139) 


>  <CYP2D6>  (139) 


>  <CYP2E1>  (139) 


>  <CYP3A4>  (139) 


>  <References>  (139) 
Clement B, Demesmaeker M: Formation of guanoxabenz from guanabenz in human liver. A new metabolic marker for CYP1A2. Drug Metab Dispos. 1997 Nov;25(11):1266-71. (PMID: 9351903)

>  <Comments>  (139) 


$$$$
CC01959
     RDKit          3D

 24 27  0  0  0  0  0  0  0  0999 V2000
    5.2040   -1.8460    0.5340 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4720   -1.3300    0.6920 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7270    0.0070    0.4110 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7170    0.8340   -0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4260    0.3250   -0.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1750   -1.0290    0.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9750    0.4990    0.5710 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.8330   -1.2300   -0.1760 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3220   -0.0420   -0.5970 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2500    0.8690   -0.6000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6420    0.2270   -1.0570 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0520    0.7050    0.5490 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2540   -1.1060   -1.3630 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5230    0.9910    0.3960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4370   -0.0290    0.5620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7940    0.2470    0.4170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1740    1.5510    0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1990    2.5160   -0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9220    2.2160    0.1100 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7240   -0.7300    0.5720 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0000   -0.1230    0.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0980   -1.1760    0.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5470   -0.7210    0.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8700   -1.5890   -0.7330 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  3  7  1  0
  4  5  1  0
  5  6  2  0
  5 10  1  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  1
 11 13  2  0
 12 14  1  0
 14 15  2  0
 14 19  1  0
 15 16  1  0
 16 17  2  0
 16 20  1  0
 17 18  1  0
 18 19  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 23 24  1  0
M  END
>  <Name>  (140) 
H259-31

>  <InChIKey>  (140) 
DIUOJMLXZJHNDR-DEOSSOPVSA-N

>  <PubChem_CID>  (140) 
70693563

>  <CYP1A2>  (140) 
<1,S;S-Oxidation;R1>
<20,H;Hydroxylation;R2>
<0,1;Reduction;R3>
<6,7;Cleavage;R4>
<7,H;Oxidation;R4>

>  <CYP2A6>  (140) 


>  <CYP2B6>  (140) 


>  <CYP2C8>  (140) 


>  <CYP2C9>  (140) 
<1,S;S-Oxidation;R1>
<20,H;Hydroxylation;R2>
<0,1;Reduction;R3>
<6,7;Cleavage;R4>
<7,H;Oxidation;R4>

>  <CYP2C19>  (140) 
<20,H;Hydroxylation;R1>
<0,1;Reduction;R2>
<6,7;Cleavage;R3>
<7,H;Oxidation;R3>

>  <CYP2D6>  (140) 


>  <CYP2E1>  (140) 


>  <CYP3A4>  (140) 
<1,S;S-Oxidation;R1>
<20,H;Hydroxylation;R2>
<0,1;Reduction;R3>
<6,7;Cleavage;R4>
<7,H;Oxidation;R4>

>  <References>  (140) 
Abelo A, Andersson TB, Bredberg U, Skanberg I, Weidolf L: Stereoselective metabolism by human liver CYP enzymes of a substituted benzimidazole. Drug Metab Dispos. 2000 Jan;28(1):58-64. (PMID: 10611141)

>  <Comments>  (140) 


$$$$
CC01960
     RDKit          3D

  7  6  0  0  0  0  0  0  0  0999 V2000
    0.1040   -0.1670    0.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4570   -0.1470    0.4390 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330    0.7030    1.3300 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3010   -1.4020    0.7590 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3980    0.2250   -0.9860 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.1750    0.2560   -1.0660 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.2770   -1.0090   -2.3420 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  5  6  1  1
  5  7  1  0
M  END
>  <Name>  (141) 
Halothane

>  <InChIKey>  (141) 
BCQZXOMGPXTTIC-SFOWXEAESA-N

>  <PubChem_CID>  (141) 
445258

>  <CYP1A2>  (141) 
<4,H;Oxidation;R1>
<4,6;Cleavage;R1>

>  <CYP2A6>  (141) 
<4,H;Oxidation;R1>
<4,6;Cleavage;R1>

>  <CYP2B6>  (141) 
<4,H;Oxidation;R1>
<4,6;Cleavage;R1>

>  <CYP2C8>  (141) 


>  <CYP2C9>  (141) 


>  <CYP2C19>  (141) 


>  <CYP2D6>  (141) 
<4,H;Oxidation;R1>
<4,6;Cleavage;R1>

>  <CYP2E1>  (141) 
<4,H;Oxidation;R1>
<4,6;Cleavage;R1>

>  <CYP3A4>  (141) 


>  <References>  (141) 
Spracklin DK, Hankins DC, Fisher JM, Thummel KE, Kharasch ED: Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro. J Pharmacol Exp Ther. 1997 Apr;281(1):400-11. (PMID: 9103523)

>  <Comments>  (141) 


$$$$
CC01961
     RDKit          3D

 16 18  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3870    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2880    1.8240    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1580    2.3720    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3700   -0.3970   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0230   -0.9650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1300    0.7400   -0.0040 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5850    3.2630    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6940    3.6360    0.7560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7260   -1.7430   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6450   -2.2810   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6280    4.0750    0.3400 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9490    3.7790   -0.3780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6910   -2.6690   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9920   -3.9940   -0.0220 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4120   -4.0940   -0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5  7  1  0
  5 10  1  0
  6 11  2  0
  8 12  2  0
  8 13  1  0
  9 12  1  0
 10 14  2  0
 11 14  1  0
 14 15  1  0
 15 16  1  0
M  END
>  <Name>  (142) 
Harmaline

>  <InChIKey>  (142) 
RERZNCLIYCABFS-UHFFFAOYSA-N

>  <PubChem_CID>  (142) 
3564

>  <CYP1A2>  (142) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (142) 


>  <CYP2B6>  (142) 


>  <CYP2C8>  (142) 


>  <CYP2C9>  (142) 


>  <CYP2C19>  (142) 


>  <CYP2D6>  (142) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (142) 


>  <CYP3A4>  (142) 


>  <References>  (142) 
Yu AM, Idle JR, Krausz KW, Kupfer A, Gonzalez FJ: Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine. J Pharmacol Exp Ther. 2003 Apr;305(1):315-22. doi: 10.1124/jpet.102.047050. (PMID: 12649384)

>  <Comments>  (142) 


$$$$
CC01962
     RDKit          3D

 16 18  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4670    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3240    1.8860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0230    2.4330    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3540   -0.3830   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9950   -0.9780    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1300    0.7630   -0.0140 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5920    3.2490    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6630    3.7640    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6850   -1.7340   -0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6530   -2.3110   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6080    4.1250    0.0190 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0200    3.7300   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6860   -2.6900   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0140   -4.0090   -0.0300 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2130   -4.7400   -0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  1  0
  5  7  1  0
  5 10  1  0
  6 11  2  0
  8 12  1  0
  8 13  1  0
  9 12  2  0
 10 14  2  0
 11 14  1  0
 14 15  1  0
 15 16  1  0
M  END
>  <Name>  (143) 
Harmine

>  <InChIKey>  (143) 
BXNJHAXVSOCGBA-UHFFFAOYSA-N

>  <PubChem_CID>  (143) 
5280953

>  <CYP1A2>  (143) 
<3,H;Hydroxylation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2A6>  (143) 


>  <CYP2B6>  (143) 


>  <CYP2C8>  (143) 


>  <CYP2C9>  (143) 
<3,H;Hydroxylation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2C19>  (143) 
<3,H;Hydroxylation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2D6>  (143) 
<3,H;Hydroxylation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2E1>  (143) 


>  <CYP3A4>  (143) 


>  <References>  (143) 
Yu AM, Idle JR, Krausz KW, Kupfer A, Gonzalez FJ: Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine. J Pharmacol Exp Ther. 2003 Apr;305(1):315-22. doi: 10.1124/jpet.102.047050. (PMID: 12649384)

>  <Comments>  (143) 


$$$$
CC01964
     RDKit          3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.9390    0.1750   -1.2270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9290    0.2890   -0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4210    0.0410   -0.6980 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3550    0.3590   -0.6170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9520   -1.2380   -0.5540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1160    1.1950   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3050    0.4690    0.4980 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2240   -1.6720    0.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1940   -2.0490   -1.6550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8440    1.3520    0.7980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0480    2.2400   -1.2890 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2320   -0.7960    1.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6470    0.5320   -0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9920   -0.7660    1.8870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7260   -2.9480    0.9160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7030   -3.3190   -1.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9750    0.3680    1.9340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5390    2.5500    0.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7230    3.4200   -1.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9640   -3.7660   -0.1740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4810    3.5700    0.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  3  5  1  0
  3  6  1  0
  4  7  1  0
  5  8  2  0
  5  9  1  0
  6 10  2  0
  6 11  1  0
  7 12  1  0
  7 13  1  0
  8 14  1  0
  8 15  1  0
  9 16  2  0
 10 17  1  0
 10 18  1  0
 11 19  2  0
 14 17  1  0
 15 20  2  0
 16 20  1  0
 18 21  2  0
 19 21  1  0
M  END
>  <Name>  (144) 
Imipramine

>  <InChIKey>  (144) 
BCGWQEUPMDMJNV-UHFFFAOYSA-N

>  <PubChem_CID>  (144) 
3696

>  <CYP1A2>  (144) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<10,H;Hydroxylation;R3>
<17,H;Hydroxylation;R4>

>  <CYP2A6>  (144) 


>  <CYP2B6>  (144) 


>  <CYP2C8>  (144) 


>  <CYP2C9>  (144) 


>  <CYP2C19>  (144) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<10,H;Hydroxylation;R3>
<17,H;Hydroxylation;R4>

>  <CYP2D6>  (144) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<10,H;Hydroxylation;R3>
<17,H;Hydroxylation;R4>

>  <CYP2E1>  (144) 


>  <CYP3A4>  (144) 


>  <References>  (144) 
Koyama E, Chiba K, Tani M, Ishizaki T: Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs. J Pharmacol Exp Ther. 1997 Jun;281(3):1199-210. (PMID: 9190854)

>  <Comments>  (144) 


$$$$
CC01965
     RDKit          3D

 21 23  0  0  0  0  0  0  0  0999 V2000
   -3.1970    1.7830    5.6100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6970    1.8870    5.8750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0110    0.5220    5.8350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0410    2.8860    5.0720 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0120    2.6520    3.7260 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0920    2.0140    3.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1520    1.8350    1.7800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8720    2.3140    0.9680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9610    2.9890    1.5300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0210    3.1700    2.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7850    2.1150   -0.4900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6710    2.5240   -1.2300 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4250    1.4050   -0.9940 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3200    1.0000   -0.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2500    1.1830    1.2810 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6320    1.1220   -2.4260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8370    1.4610   -3.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0290    1.1850   -4.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0190    0.5700   -5.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1840    0.2340   -4.5380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3770    0.5090   -3.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5 10  1  0
  6  7  1  0
  7  8  2  0
  7 15  1  0
  8  9  1  0
  8 11  1  0
  9 10  2  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 13 16  1  0
 14 15  1  0
 16 17  2  0
 16 21  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
M  END
>  <Name>  (145) 
Ipriflavone

>  <InChIKey>  (145) 
SFBODOKJTYAUCM-UHFFFAOYSA-N

>  <PubChem_CID>  (145) 
3747

>  <CYP1A2>  (145) 
<1,3;Cleavage;R1>
<1,H;Oxidation;R1>
<14,H;Hydroxylation;R2>
<0,H;Hydroxylation;R3>
<2,H;Hydroxylation;R4>

>  <CYP2A6>  (145) 


>  <CYP2B6>  (145) 


>  <CYP2C8>  (145) 


>  <CYP2C9>  (145) 
<1,3;Cleavage;R1>
<1,H;Oxidation;R1>
<14,H;Hydroxylation;R2>
<0,H;Hydroxylation;R3>
<2,H;Hydroxylation;R4>

>  <CYP2C19>  (145) 
<1,3;Cleavage;R1>
<1,H;Oxidation;R1>
<14,H;Hydroxylation;R2>
<0,H;Hydroxylation;R3>
<2,H;Hydroxylation;R4>

>  <CYP2D6>  (145) 


>  <CYP2E1>  (145) 


>  <CYP3A4>  (145) 
<1,3;Cleavage;R1>
<1,H;Oxidation;R1>

>  <References>  (145) 
Moon Y, Kim SY, Ji HY, Kim YK, Chae HJ, Chae SW, Lee HS: Characterization of cytochrome P450s mediating ipriflavone metabolism in human liver microsomes. Xenobiotica. 2007 Mar;37(3):246-59. doi: 10.1080/00498250601146962. (PMID: 17624023)

>  <Comments>  (145) 


$$$$
CC01966
     RDKit          3D

 27 27  0  0  0  0  0  0  0  0999 V2000
    3.5420   -0.7580   -0.3840 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.2330    3.3690   -0.6060 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2930    7.9160    0.2330 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4440   12.3950   -1.9040 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8340    8.7060   -0.8220 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4120   10.4290   -2.2790 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0460   11.1310   -3.8460 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9620    9.6800   -0.6050 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7940    5.6330   -0.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7280    4.5770   -0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2840    6.9300    0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4270   13.3660   -2.3690 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3120    2.3570   -0.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7270   14.6880   -2.5730 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4830   13.5200   -1.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6660    1.1080   -1.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0420    2.5190    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1410    1.4570    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7620    0.0460   -1.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4970    0.2150   -0.4710 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3410   11.3590   -2.6770 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7450    9.6570   -1.2730 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2110    0.8170   -1.7720 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.8930   -2.0310   -0.9100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8460   -2.8690   -0.7460 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.1660   -1.9530   -2.2290 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.9530   -2.5510   -0.2550 F   0  0  0  0  0  0  0  0  0  0  0  0
  1 20  1  0
  1 24  1  0
  2 10  1  0
  2 13  1  0
  3  5  1  0
  3 11  1  0
  4 12  1  0
  4 21  2  0
  5 22  1  0
  6 21  1  0
  6 22  2  0
  7 21  1  0
  8 22  1  0
  9 10  1  0
  9 11  1  0
 12 14  1  0
 12 15  1  0
 13 16  2  0
 13 17  1  0
 16 19  1  0
 16 23  1  0
 17 18  2  0
 18 20  1  0
 19 20  2  0
 24 25  1  0
 24 26  1  0
 24 27  1  0
M  END
>  <Name>  (146) 
JPC-2056

>  <InChIKey>  (146) 
NDJYKXNKFMMXEW-UHFFFAOYSA-N

>  <PubChem_CID>  (146) 
10097835

>  <CYP1A2>  (146) 
<1,H;Hydroxylation;R1>

>  <CYP2A6>  (146) 


>  <CYP2B6>  (146) 


>  <CYP2C8>  (146) 


>  <CYP2C9>  (146) 


>  <CYP2C19>  (146) 
<1,6;Cyclization;R1>

>  <CYP2D6>  (146) 
<1,6;Cyclization;R1>

>  <CYP2E1>  (146) 


>  <CYP3A4>  (146) 
<1,6;Cyclization;R1>

>  <References>  (146) 
Diaz DS, Kozar MP, Smith KS, Asher CO, Sousa JC, Schiehser GA, Jacobus DP, Milhous WK, Skillman DR, Shearer TW: Role of specific cytochrome P450 isoforms in the conversion of phenoxypropoxybiguanide analogs in human liver microsomes to potent antimalarial dihydrotriazines. Drug Metab Dispos. 2008 Feb;36(2):380-5. doi: 10.1124/dmd.106.013920. Epub 2007 Nov 15. (PMID: 18006651)
Arfeen M, Patel DS, Abbat S, Taxak N, Bharatam PV: Importance of cytochromes in cyclization reactions: quantum chemical study on a model reaction of proguanil to cycloguanil. J Comput Chem. 2014 Oct 30;35(28):2047-55. doi: 10.1002/jcc.23719. Epub 2014 Sep  5. (PMID: 25196060)

>  <Comments>  (146) 
This is an oxidative cyclization reaction.

$$$$
CC01967
     RDKit          3D

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.1190   -0.0630    0.0850 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0570    1.1610    0.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2660    2.0010    0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2430    1.8630    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1000    3.3850    0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5600    1.4730    0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3720    1.0780    0.0920 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2680    3.2050    0.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1270    3.9950    0.0460 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2070    4.2330    0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7950    0.1300    0.0770 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6730    2.3080    0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5110    3.9970    0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4820    3.6830    0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5490    5.2360    0.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6570    3.5760   -0.6480 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5650    4.5080    0.0440 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7010    6.0220    0.6690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8120    4.3570   -0.6650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8380    5.5830   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9210    6.4180    0.0360 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0240    5.8690   -0.6760 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  2  4  1  0
  3  5  2  0
  3  6  1  0
  4  7  1  0
  4  8  2  0
  5  9  1  0
  5 10  1  0
  6 11  1  0
  6 12  2  0
  8  9  1  0
  8 13  1  0
 10 14  2  0
 12 14  1  0
 13 15  2  0
 13 16  1  0
 14 17  1  0
 15 18  1  0
 16 19  2  0
 18 20  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
M  END
>  <Name>  (147) 
Kaempferide

>  <InChIKey>  (147) 
SQFSKOYWJBQGKQ-UHFFFAOYSA-N

>  <PubChem_CID>  (147) 
5281666

>  <CYP1A2>  (147) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (147) 


>  <CYP2B6>  (147) 


>  <CYP2C8>  (147) 


>  <CYP2C9>  (147) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (147) 


>  <CYP2D6>  (147) 


>  <CYP2E1>  (147) 


>  <CYP3A4>  (147) 


>  <References>  (147) 
Otake Y, Hsieh F, Walle T: Glucuronidation versus oxidation of the flavonoid galangin by human liver microsomes and hepatocytes. Drug Metab Dispos. 2002 May;30(5):576-81. doi: 10.1124/dmd.30.5.576. (PMID: 11950790)

>  <Comments>  (147) 


$$$$
CC01968
     RDKit          3D

 31 34  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4190    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1960    2.0720    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0840    2.3010    0.0190 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2440   -0.6760   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1900   -0.7400    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3860    1.3400   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9380    3.5620    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4330    1.9270    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5960    3.6830    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2590   -2.0860   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3870    0.0210   -0.0210 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1480   -2.1020    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5980    2.0170   -0.0220 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1080    1.7470   -1.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0950    1.7300    1.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0690   -2.7780   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4410   -2.7580   -0.0360 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8560    1.2680   -0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4390    1.3780   -1.1700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3890    1.9550   -2.4840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4260    1.3620    1.2330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1240   -4.1510   -0.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0330    2.2460   -0.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1010    1.1880    0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3660   -4.4530   -1.1770 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.3060   -4.8980   -0.0570 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.3890   -4.4660    1.1070 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.0470    2.9820    1.1800 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4120    0.8250    0.0390 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8030    0.7080    1.4080 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  4 10  1  0
  5 11  2  0
  5 12  1  0
  6 13  1  0
  7 12  2  0
  7 14  1  0
  8 10  1  0
  9 15  2  0
  9 16  1  0
 11 17  1  0
 11 18  1  0
 13 17  2  0
 14 19  1  0
 15 20  1  0
 15 21  1  0
 16 22  2  0
 18 23  1  0
 19 24  1  0
 20 25  2  0
 22 25  1  0
 23 26  1  0
 23 27  1  0
 23 28  1  0
 24 29  1  0
 25 30  1  0
 30 31  1  0
M  END
>  <Name>  (148) 
KR-60436

>  <InChIKey>  (148) 
ZFDXQUVDLKGYIL-UHFFFAOYSA-N

>  <PubChem_CID>  (148) 
10113707

>  <CYP1A2>  (148) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP2A6>  (148) 


>  <CYP2B6>  (148) 


>  <CYP2C8>  (148) 


>  <CYP2C9>  (148) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>
<7,8;Dehydrogenation;R3>

>  <CYP2C19>  (148) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP2D6>  (148) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>
<7,8;Dehydrogenation;R3>

>  <CYP2E1>  (148) 


>  <CYP3A4>  (148) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>
<7,8;Dehydrogenation;R3>

>  <References>  (148) 
Ji HY, Lee HW, Kim HH, Choi JK, Lee HS: Characterization of human liver cytochrome P450 enzymes involved in the metabolism of a new H+/K+-ATPase inhibitor KR-60436. Toxicol Lett. 2005 Jan 15;155(1):103-14. doi: 10.1016/j.toxlet.2004.09.001. (PMID: 15585365)

>  <Comments>  (148) 


$$$$
CC01969
     RDKit          3D

 17 17  0  0  0  0  0  0  0  0999 V2000
    2.4900    1.1150    0.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7430    1.2950   -0.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3920    0.2360   -0.6960 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7890   -1.0080   -0.7520 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5360   -1.1950   -0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8840   -0.1340    0.4130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6170   -0.3220    0.9770 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4860   -0.1880    0.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8520   -0.2730    0.8450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8780   -0.0120   -0.1730 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1560   -0.4690    0.3880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9750    1.4480   -0.3100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3790    0.0020   -0.9790 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7830    2.2700    1.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8800   -2.5500   -0.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2120   -1.9980    0.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0320    1.7920   -1.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1 14  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5 15  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 13  2  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 11 16  1  0
 12 17  1  0
M  END
>  <Name>  (149) 
Lidocaine

>  <InChIKey>  (149) 
NNJVILVZKWQKPM-UHFFFAOYSA-N

>  <PubChem_CID>  (149) 
3676

>  <CYP1A2>  (149) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>
<14,H;Hydroxylation;R3>
<12,H;Hydroxylation;R4>

>  <CYP2A6>  (149) 


>  <CYP2B6>  (149) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2C8>  (149) 


>  <CYP2C9>  (149) 


>  <CYP2C19>  (149) 


>  <CYP2D6>  (149) 
<12,H;Hydroxylation;R1>
<14,H;Hydroxylation;R2>

>  <CYP2E1>  (149) 


>  <CYP3A4>  (149) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>
<14,H;Hydroxylation;R3>
<12,H;Hydroxylation;R4>

>  <References>  (149) 
Imaoka S, Yamada T, Hiroi T, Hayashi K, Sakaki T, Yabusaki Y, Funae Y: Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Systematic characterization and comparison with those of the rat. Biochem Pharmacol. 1996 Apr 26;51(8):1041-50. doi: 10.1016/0006-2952(96)00052-4. (PMID: 8866826)
Wang JS, Backman JT, Taavitsainen P, Neuvonen PJ, Kivisto KT: Involvement of CYP1A2 and CYP3A4 in lidocaine N-deethylation and 3-hydroxylation in humans. Drug Metab Dispos. 2000 Aug;28(8):959-65. (PMID: 10901707)
Imaoka S, Enomoto K, Oda Y, Asada A, Fujimori M, Shimada T, Fujita S, Guengerich FP, Funae Y: Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: comparison of those with rat hepatic cytochrome P-450s. J Pharmacol Exp Ther. 1990 Dec;255(3):1385-91. (PMID: 2262908)

>  <Comments>  (149) 


$$$$
CC01970
     RDKit          3D

 20 19  0  0  0  0  0  0  0  0999 V2000
   -0.0190    1.5260    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4170    2.0550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4120   -0.5260    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3960    3.5850    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8100   -1.3580   -0.9170 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8310    4.1150   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2240   -1.8800   -0.9070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8110    5.6450    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8760   -1.5900   -2.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2460    6.1740   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4080   -2.5650   -2.9290 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2260    7.6810    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0600   -2.2760   -4.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1710    8.2710    0.0160 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3790    8.3680   -0.0040 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4290   -3.1560   -5.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0910   -2.8620   -6.6840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4600   -3.7420   -7.7650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1220   -3.4490   -9.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  3  5  1  0
  4  6  2  0
  5  7  1  0
  6  8  1  0
  7  9  1  0
  8 10  1  0
  9 11  1  0
 10 12  2  0
 11 13  1  0
 12 14  1  0
 13 15  2  0
 13 16  1  0
 14 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
M  END
>  <Name>  (150) 
Linoleic acid

>  <InChIKey>  (150) 
OYHQOLUKZRVURQ-AVQMFFATSA-N

>  <PubChem_CID>  (150) 
5282457

>  <CYP1A2>  (150) 
<9,H;Hydroxylation;R1>
<8,9;Reduction;R1>
<7,8;Dehydrogenation;R1>
<5,H;Hydroxylation;R2>
<5,6;Reduction;R2>
<6,7;Dehydrogenation;R2>
<7,H;Hydroxylation;R3>
<1,H;Hydroxylation;R4>
<0,H;Hydroxylation;R5>

>  <CYP2A6>  (150) 


>  <CYP2B6>  (150) 


>  <CYP2C8>  (150) 
<7,H;Hydroxylation;R1>

>  <CYP2C9>  (150) 
<9,H;Hydroxylation;R1>
<8,9;Reduction;R1>
<7,8;Dehydrogenation;R1>
<5,H;Hydroxylation;R2>
<5,6;Reduction;R2>
<6,7;Dehydrogenation;R2>
<7,H;Hydroxylation;R3>
<1,H;Hydroxylation;R4>
<0,H;Hydroxylation;R5>
<5,6;EpOxidation;R6>
<8,9;EpOxidation;R7>

>  <CYP2C19>  (150) 
<9,H;Hydroxylation;R1>
<8,9;Reduction;R1>
<7,8;Dehydrogenation;R1>
<5,H;Hydroxylation;R2>
<5,6;Reduction;R2>
<6,7;Dehydrogenation;R2>
<7,H;Hydroxylation;R3>
<1,H;Hydroxylation;R4>
<0,H;Hydroxylation;R5>
<5,6;EpOxidation;R6>
<8,9;EpOxidation;R7>

>  <CYP2D6>  (150) 


>  <CYP2E1>  (150) 


>  <CYP3A4>  (150) 
<9,H;Hydroxylation;R1>
<8,9;Reduction;R1>
<7,8;Dehydrogenation;R1>
<5,H;Hydroxylation;R2>
<5,6;Reduction;R2>
<6,7;Dehydrogenation;R2>
<7,H;Hydroxylation;R3>
<1,H;Hydroxylation;R4>
<0,H;Hydroxylation;R5>

>  <References>  (150) 
Adas F, Salaun JP, Berthou F, Picart D, Simon B, Amet Y: Requirement for omega and (omega;-1)-hydroxylations of fatty acids by human cytochromes P450 2E1 and 4A11. J Lipid Res. 1999 Nov;40(11):1990-7. (PMID: 10553002)
Bylund J, Kunz T, Valmsen K, Oliw EH: Cytochromes P450 with bisallylic hydroxylation activity on arachidonic and linoleic acids studied with human recombinant enzymes and with human and rat liver microsomes. J Pharmacol Exp Ther. 1998 Jan;284(1):51-60. (PMID: 9435160)
Wang B, Zhou SF: Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr Med Chem. 2009;16(31):4066-218. (PMID: 19754423)

>  <Comments>  (150) 


$$$$
CC01971
     RDKit          3D

 20 21  0  0  0  0  0  0  0  0999 V2000
    3.4700    0.4900   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5560   -0.8940    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1770    1.0770    0.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7360    0.9680   -0.1800 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4690   -1.6380    0.1810 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8560   -1.2610   -0.1520 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1270    0.2770    0.3240 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9900    2.3110    0.1000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5700   -0.1040   -0.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2080    2.3590   -0.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2830   -1.0580    0.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5660   -3.1020    0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1630    0.9740    0.5170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3380   -1.8410    0.6160 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2880    0.5400   -0.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5380    1.3040    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7960    0.5300   -0.3990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0270    1.3560   -0.0030 C   0  0  1  0  0  0  0  0  0  0  0  0
   -6.2630    0.4680   -0.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9390    1.7590    1.3680 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  1  0
  4 10  1  0
  5 11  1  0
  5 12  1  0
  6  9  2  0
  7 11  1  0
  7 13  1  0
 11 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  1
 18 20  1  0
M  END
>  <Name>  (151) 
Lisofylline

>  <InChIKey>  (151) 
NSMXQKNUPPXBRG-SECBINFHSA-N

>  <PubChem_CID>  (151) 
501254

>  <CYP1A2>  (151) 
<1,2;Oxidation;R1>

>  <CYP2A6>  (151) 
<3,H;Hydroxylation;R1>

>  <CYP2B6>  (151) 


>  <CYP2C8>  (151) 


>  <CYP2C9>  (151) 


>  <CYP2C19>  (151) 


>  <CYP2D6>  (151) 


>  <CYP2E1>  (151) 


>  <CYP3A4>  (151) 
<3,H;Hydroxylation;R1>

>  <References>  (151) 
Lee SH, Slattery JT: Cytochrome P450 isozymes involved in lisofylline metabolism to pentoxifylline in human liver microsomes. Drug Metab Dispos. 1997 Dec;25(12):1354-8. (PMID: 9394024)
Shin HS, Slattery JT: CYP3A4-mediated oxidation of lisofylline to lisofylline 4,5-diol in human liver microsomes. J Pharm Sci. 1998 Mar;87(3):390-3. doi: 10.1021/js970382f. (PMID: 9523995)

>  <Comments>  (151) 


$$$$
CC01974
     RDKit          3D

  8  8  0  0  0  0  0  0  0  0999 V2000
    1.9430    5.2230    0.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5810    5.2320    0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1010    4.0550    0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5840    2.8770    0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1590    1.5910    0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9410    2.8730    0.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6290    4.0500    0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1310    4.0590    0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
M  END
>  <Name>  (152) 
m-Xylene

>  <InChIKey>  (152) 
IVSZLXZYQVIEFR-UHFFFAOYSA-N

>  <PubChem_CID>  (152) 
7929

>  <CYP1A2>  (152) 
<2,H;Hydroxylation;R1>
<4,H;Hydroxylation;R2>

>  <CYP2A6>  (152) 


>  <CYP2B6>  (152) 


>  <CYP2C8>  (152) 


>  <CYP2C9>  (152) 


>  <CYP2C19>  (152) 


>  <CYP2D6>  (152) 


>  <CYP2E1>  (152) 
<2,H;Hydroxylation;R1>
<3,H;Hydroxylation;R2>
<4,H;Hydroxylation;R3>
<0,H;Hydroxylation;R4>
<6,H;Hydroxylation;R5>
<7,H;Hydroxylation;R6>

>  <CYP3A4>  (152) 


>  <References>  (152) 
Tassaneeyakul W, Birkett DJ, Edwards JW, Veronese ME, Tassaneeyakul W, Tukey RH, Miners JO: Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene. J Pharmacol Exp Ther. 1996 Jan;276(1):101-8. doi: 10.1163/2211730x96x00063. (PMID: 8558417)

>  <Comments>  (152) 
Ring hydroxylated metabolites are 5%.

$$$$
CC01975
     RDKit          3D

 19 18  0  0  0  0  0  0  0  0999 V2000
   -0.0220    1.8100    0.0120 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.4130    2.3390    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7510    2.3090   -1.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0710   -0.4020    0.2020 P   0  0  0  0  0  0  0  0  0  0  0  0
    2.1040    1.9430    1.2800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0570    2.6100   -1.1340 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1600    2.4380   -2.2550 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6100    0.2380    1.5770 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8640    0.2490   -1.0390 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3510   -2.2440    0.2210 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.3800    2.3010    1.4920 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5100    1.3030    2.1150 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7600    3.0910   -2.3110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1460   -0.6050    2.6340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1230   -0.0750   -2.2180 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0460    1.9190    2.7250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2240    3.3580   -1.9570 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4820    2.4490    2.7140 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  6
  1  4  1  0
  2  5  1  0
  3  6  1  0
  4  7  1  0
  4  8  2  0
  5  9  1  0
  5 10  1  0
  5 11  2  0
  6 12  1  0
  6 13  2  0
  7 14  1  0
  9 15  1  0
 10 16  1  0
 12 17  1  0
 14 18  1  0
 17 19  1  0
M  END
>  <Name>  (153) 
Malathion

>  <InChIKey>  (153) 
JXSJBGJIGXNWCI-QMMMGPOBSA-N

>  <PubChem_CID>  (153) 
10892866

>  <CYP1A2>  (153) 
<8,9;Desulfuration;R1>

>  <CYP2A6>  (153) 


>  <CYP2B6>  (153) 
<8,9;Desulfuration;R1>

>  <CYP2C8>  (153) 


>  <CYP2C9>  (153) 


>  <CYP2C19>  (153) 
<8,9;Desulfuration;R1>

>  <CYP2D6>  (153) 


>  <CYP2E1>  (153) 


>  <CYP3A4>  (153) 
<8,9;Desulfuration;R1>

>  <References>  (153) 
Buratti FM, D'Aniello A, Volpe MT, Meneguz A, Testai E: Malathion bioactivation in the human liver: the contribution of different cytochrome p450 isoforms. Drug Metab Dispos. 2005 Mar;33(3):295-302. doi: 10.1124/dmd.104.001693. Epub 2004 Nov 22. (PMID: 15557345)

>  <Comments>  (153) 
The paper also mentioned that DMDTP can be formed by CYP450 but no detailed information can be found.

$$$$
CC01976
     RDKit          3D

 21 24  0  0  0  0  0  0  0  0999 V2000
   -0.0120    1.5160    0.0150 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.2120    0.0180   -0.1520 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4910    1.7050    0.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3770    2.1330   -1.3530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8010    2.1000    1.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5370   -0.5510   -1.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0430   -0.7490    0.6130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2400    1.1360   -0.8730 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1020    2.3670    1.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4440    1.5090   -2.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6650    3.6240    1.1870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4130    0.4340   -1.9380 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.4570   -1.8890   -1.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1300   -2.1100    0.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6030    1.2280   -0.8780 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4880    2.4640    1.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3420    4.1980    2.4330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3860   -2.6750   -0.6710 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2310    1.9000    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2110    5.6610    2.4320 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8790    6.1450    3.6470 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  1
  2  6  2  0
  2  7  1  0
  3  8  2  0
  3  9  1  0
  4 10  1  0
  5 11  1  0
  6 12  1  0
  6 13  1  0
  7 14  2  0
  8 12  1  0
  8 15  1  0
  9 16  2  0
 12 10  1  1
 11 17  1  0
 13 18  2  0
 14 18  1  0
 15 19  2  0
 16 19  1  0
 17 20  1  0
 20 21  1  0
M  END
>  <Name>  (154) 
Maprotiline

>  <InChIKey>  (154) 
QSLMDECMDJKHMQ-GSXCWMCISA-N

>  <PubChem_CID>  (154) 


>  <CYP1A2>  (154) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (154) 


>  <CYP2B6>  (154) 


>  <CYP2C8>  (154) 


>  <CYP2C9>  (154) 


>  <CYP2C19>  (154) 


>  <CYP2D6>  (154) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (154) 


>  <CYP3A4>  (154) 


>  <References>  (154) 
Brachtendorf L, Jetter A, Beckurts KT, Holscher AH, Fuhr U: Cytochrome P450 enzymes contributing to demethylation of maprotiline in man. Pharmacol Toxicol. 2002 Mar;90(3):144-9. (PMID: 12071336)

>  <Comments>  (154) 


$$$$
CC01977
     RDKit          3D

 15 16  0  0  0  0  0  0  0  0999 V2000
    0.1140    1.1540    0.2770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0540    0.2290   -0.7250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3460    1.7130    0.5510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0450    1.4320    0.9270 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9970   -0.1900   -1.5130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3410   -0.1920   -0.8310 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4360    1.3050   -0.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9590    0.5630    0.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2530    0.3620   -1.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8080    1.8600   -0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1060    2.3590    1.3840 C   0  0  1  0  0  0  0  0  0  0  0  0
    4.3720    1.2300    2.2660 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3190    3.2620    1.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4710    1.7100    3.6340 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7430    0.5280    4.5300 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  4  8  1  0
  5  9  1  0
  6  8  1  0
  7  9  2  0
  7 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  6
 12 14  1  0
 14 15  1  0
M  END
>  <Name>  (155) 
MDE

>  <InChIKey>  (155) 
PVXVWWANJIWJOO-VIFPVBQESA-N

>  <PubChem_CID>  (155) 
13909090

>  <CYP1A2>  (155) 
<13,14;Cleavage;R1>
<12,13;Cleavage;R1>
<13,H;Oxidation;R1>
<1,2;Cleavage;R2>
<11,H;Oxidation;R2>

>  <CYP2A6>  (155) 


>  <CYP2B6>  (155) 
<13,14;Cleavage;R1>
<12,13;Cleavage;R1>
<13,H;Oxidation;R1>
<1,2;Cleavage;R2>
<11,H;Oxidation;R2>

>  <CYP2C8>  (155) 
<13,14;Cleavage;R1>
<12,13;Cleavage;R1>
<13,H;Oxidation;R1>

>  <CYP2C9>  (155) 
<13,14;Cleavage;R1>
<12,13;Cleavage;R1>
<13,H;Oxidation;R1>

>  <CYP2C19>  (155) 


>  <CYP2D6>  (155) 
<13,14;Cleavage;R1>
<12,13;Cleavage;R1>
<13,H;Oxidation;R1>

>  <CYP2E1>  (155) 
<13,14;Cleavage;R1>
<12,13;Cleavage;R1>
<13,H;Oxidation;R1>

>  <CYP3A4>  (155) 
<13,14;Cleavage;R1>
<12,13;Cleavage;R1>
<13,H;Oxidation;R1>
<1,2;Cleavage;R2>
<11,H;Oxidation;R2>

>  <References>  (155) 
Kreth K, Kovar K, Schwab M, Zanger UM: Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs. Biochem Pharmacol. 2000 Jun 15;59(12):1563-71. doi: 10.1016/s0006-2952(00)00284-7. (PMID: 10799653)

>  <Comments>  (155) 


$$$$
CC01978
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4020    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3850    1.8270   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2360    2.0840    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3250   -0.3920   -0.0130 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1990   -0.7060    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1330    0.7120   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8920    3.2460    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4170    1.3690    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3950   -0.0240    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9580    3.7610    1.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6070    2.0270    0.0620 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4510    5.1410    1.4430 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6300    1.0300    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5920    5.8030    2.6080 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0990    7.2220    2.6110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3120    5.2570    3.6540 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  5  7  1  0
  6 10  2  0
  8 11  1  0
  9 10  1  0
  9 12  1  0
 11 13  1  0
 12 14  1  0
 13 15  1  0
 15 16  1  0
 15 17  2  0
M  END
>  <Name>  (156) 
Melatonin

>  <InChIKey>  (156) 
DRLFMBDRBRZALE-UHFFFAOYSA-N

>  <PubChem_CID>  (156) 
896

>  <CYP1A2>  (156) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<3,H;Hydroxylation;R2>

>  <CYP2A6>  (156) 


>  <CYP2B6>  (156) 


>  <CYP2C8>  (156) 


>  <CYP2C9>  (156) 


>  <CYP2C19>  (156) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<3,H;Hydroxylation;R2>

>  <CYP2D6>  (156) 


>  <CYP2E1>  (156) 


>  <CYP3A4>  (156) 


>  <References>  (156) 
Ma X, Idle JR, Krausz KW, Gonzalez FJ: Metabolism of melatonin by human cytochromes p450. Drug Metab Dispos. 2005 Apr;33(4):489-94. doi: 10.1124/dmd.104.002410. Epub 2004  Dec 22. (PMID: 15616152)

>  <Comments>  (156) 


$$$$
CC01979
     RDKit          3D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -0.1070    0.0550    0.1150 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2390    1.4800    0.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6290   -0.6280   -0.8600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1520   -0.6270    0.7520 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3240   -1.9440   -1.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4620   -1.9430    0.4160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7230   -2.6010   -0.5620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0520    2.1670   -0.5850 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2110    3.6580   -0.3630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0420    4.3700   -0.1790 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8040    4.3170   -1.4170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8220    3.7580    0.8840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0540    2.2690    0.7060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0260    1.4670    1.8220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5370    1.6810    2.9250 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3350    1.1480    1.6040 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0860    1.0670    2.8130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0450   -0.3560    3.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  8  1  0
  2 13  1  0
  2 14  1  0
  3  5  1  0
  4  6  2  0
  5  7  2  0
  6  7  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
M  END
>  <Name>  (157) 
Meperidine

>  <InChIKey>  (157) 
XADCESSVHJOZHK-UHFFFAOYSA-N

>  <PubChem_CID>  (157) 
4058

>  <CYP1A2>  (157) 
<14,15;Cleavage;R1>
<15,H;Oxidation;R1>

>  <CYP2A6>  (157) 


>  <CYP2B6>  (157) 
<14,15;Cleavage;R1>
<15,H;Oxidation;R1>

>  <CYP2C8>  (157) 
<14,15;Cleavage;R1>
<15,H;Oxidation;R1>

>  <CYP2C9>  (157) 


>  <CYP2C19>  (157) 
<14,15;Cleavage;R1>
<15,H;Oxidation;R1>

>  <CYP2D6>  (157) 
<14,15;Cleavage;R1>
<15,H;Oxidation;R1>

>  <CYP2E1>  (157) 


>  <CYP3A4>  (157) 
<14,15;Cleavage;R1>
<15,H;Oxidation;R1>

>  <References>  (157) 
Ramirez J, Innocenti F, Schuetz EG, Flockhart DA, Relling MV, Santucci R, Ratain MJ: CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes. Drug Metab Dispos. 2004 Sep;32(9):930-6. (PMID: 15319333)

>  <Comments>  (157) 


$$$$
CC01980
     RDKit          3D

 16 17  0  0  0  0  0  0  0  0999 V2000
    1.2500    0.9420   -0.2060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4250    1.8040    0.2060 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.1390    2.5910    1.4810 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2920    3.4310    1.9820 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1030    0.8450    0.5880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9730    0.0470    0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9150   -0.6720   -0.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2180   -0.5920   -1.7900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2900    0.2090   -1.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6290    1.0060    0.3460 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6220    1.4140   -0.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1290    2.4580   -1.2770 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8670    3.1440   -2.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8500    2.7660   -0.9100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1550    3.6540   -1.3840 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7350    0.9180   -0.6460 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  2  0
  1  9  1  0
  2  3  1  1
  2 10  1  0
  2 14  1  0
  3  4  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
 10 11  1  0
 11 12  1  0
 11 16  2  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
M  END
>  <Name>  (158) 
Mephenytoin

>  <InChIKey>  (158) 
GMHKMTDVRCWUDX-GFCCVEGCSA-N

>  <PubChem_CID>  (158) 
119127

>  <CYP1A2>  (158) 


>  <CYP2A6>  (158) 


>  <CYP2B6>  (158) 
<13,12;Cleavage;R1>
<13,H;Oxidation;R1>

>  <CYP2C8>  (158) 


>  <CYP2C9>  (158) 
<13,12;Cleavage;R1>
<13,H;Oxidation;R1>

>  <CYP2C19>  (158) 
<7,H;Hydroxylation;R1>

>  <CYP2D6>  (158) 


>  <CYP2E1>  (158) 


>  <CYP3A4>  (158) 


>  <References>  (158) 
Goldstein JA, Faletto MB, Romkes-Sparks M, Sullivan T, Kitareewan S, Raucy JL, Lasker JM, Ghanayem BI: Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans. Biochemistry. 1994 Feb 22;33(7):1743-52. doi: 10.1021/bi00173a017. (PMID: 8110777)
Walsky RL, Obach RS: Validated assays for human cytochrome P450 activities. Drug Metab Dispos. 2004 Jun;32(6):647-60. doi: 10.1124/dmd.32.6.647. (PMID: 15155557)
Coller JK, Somogyi AA, Bochner F: Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms. Br J Clin Pharmacol. 1999 Aug;48(2):158-67. doi: 10.1046/j.1365-2125.1999.00005.x. (PMID: 10417492)
Ko JW, Desta Z, Flockhart DA: Human N-demethylation of (S)-mephenytoin by cytochrome P450s 2C9 and 2B6. Drug Metab Dispos. 1998 Aug;26(8):775-8. (PMID: 9698292)

>  <Comments>  (158) 


$$$$
CC01982
     RDKit          3D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -0.0250    1.3690    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0200   -0.0110   -0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1730    2.0590    0.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2040    2.0460    0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1770   -0.6990   -0.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3710    1.3730    0.0990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0270    1.9390    1.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770   -0.0090   -0.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1820   -2.1980   -0.3190 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6710    2.1230    0.2300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2460    2.5130    1.0470 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6710    1.3240    2.0650 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9050   -0.8860   -0.0730 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1420    2.3960    2.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2500   -0.8580   -1.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  3  6  2  0
  4  7  1  0
  5  8  2  0
  5  9  1  0
  6  8  1  0
  6 10  1  0
  7 11  1  0
  7 12  2  0
  8 13  1  0
 11 14  1  0
 13 15  1  0
M  END
>  <Name>  (159) 
Methiocarb

>  <InChIKey>  (159) 
YFBPRJGDJKVWAH-UHFFFAOYSA-N

>  <PubChem_CID>  (159) 
16248

>  <CYP1A2>  (159) 
<10,S;S-oxidation;R1>

>  <CYP2A6>  (159) 


>  <CYP2B6>  (159) 
<10,S;S-oxidation;R1>

>  <CYP2C8>  (159) 


>  <CYP2C9>  (159) 
<10,S;S-oxidation;R1>

>  <CYP2C19>  (159) 
<10,S;S-oxidation;R1>

>  <CYP2D6>  (159) 
<10,S;S-oxidation;R1>

>  <CYP2E1>  (159) 


>  <CYP3A4>  (159) 
<10,S;S-oxidation;R1>

>  <References>  (159) 
Usmani KA, Karoly ED, Hodgson E, Rose RL: In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily. Drug Metab Dispos. 2004 Mar;32(3):333-9. doi: 10.1124/dmd.32.3.333. (PMID: 14977868)

>  <Comments>  (159) 


$$$$
CC01983
     RDKit          3D

 21 22  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1680    0.0620   -0.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3090    2.0860    0.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5780    2.2920   -1.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1900   -0.2880   -1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6790   -0.9090    0.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9300    3.0220   -0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9020    1.6890    1.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2540    1.7310   -1.5320 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.6070    4.0480   -0.7670 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.4660    2.0270   -2.6200 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.3630   -1.6090   -1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5100   -2.2300   -0.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1480    3.5580   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1180    2.2230    1.9830 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5100   -2.5840   -1.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7460    3.1570    1.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6780   -3.8830   -1.4830 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9440    3.6830    1.5420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3400   -4.6320   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2930    3.0800    2.7900 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  4 10  1  0
  4 11  1  0
  5 12  1  0
  6 13  2  0
  7 14  1  0
  8 15  2  0
 12 16  2  0
 13 16  1  0
 14 17  2  0
 15 17  1  0
 16 18  1  0
 17 19  1  0
 18 20  1  0
 19 21  1  0
M  END
>  <Name>  (160) 
Methoxychlor

>  <InChIKey>  (160) 
IAKOZHOLGAGEJT-UHFFFAOYSA-N

>  <PubChem_CID>  (160) 
4115

>  <CYP1A2>  (160) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP2A6>  (160) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP2B6>  (160) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP2C8>  (160) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP2C9>  (160) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP2C19>  (160) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP2D6>  (160) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP2E1>  (160) 


>  <CYP3A4>  (160) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <References>  (160) 
Hu Y, Kupfer D: Metabolism of the endocrine disruptor pesticide-methoxychlor by human P450s: pathways involving a novel catechol metabolite. Drug Metab Dispos. 2002 Sep;30(9):1035-42. doi: 10.1124/dmd.30.9.1035. (PMID: 12167570)
Stresser DM, Kupfer D: Catalytic characteristics of CYP3A4: requirement for a phenolic function in ortho hydroxylation of estradiol and mono-O-demethylated methoxychlor. Biochemistry. 1997 Feb 25;36(8):2203-10. doi: 10.1021/bi962129k. (PMID: 9047321)

>  <Comments>  (160) 


$$$$
CC01984
     RDKit          3D

 21 22  0  0  0  0  0  0  0  0999 V2000
    0.1720    1.5500   -0.2310 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.2500    0.1020   -0.6100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4640    2.1140    0.2830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7950    2.4720   -0.9970 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7510   -0.3120   -1.8450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1840   -0.8590    0.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4770    2.5410   -0.5820 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6600    2.2010    1.6640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4210    1.7110   -1.1330 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.0340    4.0160   -0.1010 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.2130    2.8600   -2.6450 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.8120   -1.6660   -2.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1240   -2.2140   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6700    3.0560   -0.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8510    2.7150    2.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0180    2.7920    3.5120 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3720   -2.6210   -1.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8480    3.1400    1.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4670   -3.9250   -1.6510 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0180    3.6460    1.7770 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0230   -4.8100   -0.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  6
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  4 10  1  0
  4 11  1  0
  5 12  1  0
  6 13  2  0
  7 14  1  0
  8 15  2  0
 12 17  2  0
 13 17  1  0
 14 18  2  0
 15 16  1  0
 15 18  1  0
 17 19  1  0
 18 20  1  0
 19 21  1  0
M  END
>  <Name>  (161) 
Methoxychlor-catechol

>  <InChIKey>  (161) 
CFAVOGVJXCIQLR-AWEZNQCLSA-N

>  <PubChem_CID>  (161) 
101363929

>  <CYP1A2>  (161) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (161) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2B6>  (161) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C8>  (161) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C9>  (161) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (161) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2D6>  (161) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (161) 


>  <CYP3A4>  (161) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (161) 
Hu Y, Kupfer D: Metabolism of the endocrine disruptor pesticide-methoxychlor by human P450s: pathways involving a novel catechol metabolite. Drug Metab Dispos. 2002 Sep;30(9):1035-42. doi: 10.1124/dmd.30.9.1035. (PMID: 12167570)

>  <Comments>  (161) 


$$$$
CC01985
     RDKit          3D

 20 21  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.1680    0.0620   -0.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3090    2.0860    0.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5780    2.2920   -1.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1900   -0.2880   -1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6790   -0.9090    0.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9300    3.0220   -0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9020    1.6890    1.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2540    1.7310   -1.5320 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.6070    4.0480   -0.7670 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.4660    2.0270   -2.6200 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.3630   -1.6090   -1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5100   -2.2300   -0.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1480    3.5580   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1180    2.2230    1.9830 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5100   -2.5840   -1.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7460    3.1570    1.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6780   -3.8830   -1.4830 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9440    3.6830    1.5420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3400   -4.6320   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  6
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  4 10  1  0
  4 11  1  0
  5 12  1  0
  6 13  2  0
  7 14  1  0
  8 15  2  0
 12 16  2  0
 13 16  1  0
 14 17  2  0
 15 17  1  0
 16 18  1  0
 17 19  1  0
 18 20  1  0
M  END
>  <Name>  (162) 
Methoxychlor-mono-OH

>  <InChIKey>  (162) 
BUZUQNXGKRJIJT-CQSZACIVSA-N

>  <PubChem_CID>  (162) 
13590211

>  <CYP1A2>  (162) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<9,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>

>  <CYP2A6>  (162) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<9,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>

>  <CYP2B6>  (162) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<9,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>

>  <CYP2C8>  (162) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<9,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>

>  <CYP2C9>  (162) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (162) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<9,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>

>  <CYP2D6>  (162) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<9,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>

>  <CYP2E1>  (162) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<9,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>

>  <CYP3A4>  (162) 
<9,H;Hydroxylation;R1>
<12,H;Hydroxylation;R2>

>  <References>  (162) 
Hu Y, Kupfer D: Metabolism of the endocrine disruptor pesticide-methoxychlor by human P450s: pathways involving a novel catechol metabolite. Drug Metab Dispos. 2002 Sep;30(9):1035-42. doi: 10.1124/dmd.30.9.1035. (PMID: 12167570)
Stresser DM, Kupfer D: Catalytic characteristics of CYP3A4: requirement for a phenolic function in ortho hydroxylation of estradiol and mono-O-demethylated methoxychlor. Biochemistry. 1997 Feb 25;36(8):2203-10. doi: 10.1021/bi962129k. (PMID: 9047321)

>  <Comments>  (162) 


$$$$
CC01986
     RDKit          3D

 13 13  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3880    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1750    2.0940    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2030    2.0530    0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2130   -0.6770   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1650   -0.7020    0.0100 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3800    1.4150   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1460    3.4810    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3990    0.0340   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0690   -2.1270    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6760    2.1850   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1210    2.4340    1.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3150    2.0570    1.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  4  8  1  0
  5  9  2  0
  6 10  1  0
  7  9  1  0
  7 11  1  0
 11 12  1  0
 12 13  2  0
M  END
>  <Name>  (163) 
Methyleugenol

>  <InChIKey>  (163) 
ZYEMGPIYFIJGTP-UHFFFAOYSA-N

>  <PubChem_CID>  (163) 
7127

>  <CYP1A2>  (163) 
<2,H;Hydroxylation;R1>

>  <CYP2A6>  (163) 


>  <CYP2B6>  (163) 


>  <CYP2C8>  (163) 


>  <CYP2C9>  (163) 
<2,H;Hydroxylation;R1>

>  <CYP2C19>  (163) 
<2,H;Hydroxylation;R1>

>  <CYP2D6>  (163) 
<2,H;Hydroxylation;R1>

>  <CYP2E1>  (163) 


>  <CYP3A4>  (163) 


>  <References>  (163) 
Jeurissen SM, Bogaards JJ, Boersma MG, ter Horst JP, Awad HM, Fiamegos YC, van Beek TA, Alink GM, Sudholter EJ, Cnubben NH, Rietjens IM: Human cytochrome p450 enzymes of importance for the bioactivation of methyleugenol to the proximate carcinogen 1'-hydroxymethyleugenol. Chem Res Toxicol. 2006 Jan;19(1):111-6. doi: 10.1021/tx050267h. (PMID: 16411663)
Gardner I, Wakazono H, Bergin P, de Waziers I, Beaune P, Kenna JG, Caldwell J: Cytochrome P450 mediated bioactivation of methyleugenol to 1'-hydroxymethyleugenol in Fischer 344 rat and human liver microsomes. Carcinogenesis. 1997 Sep;18(9):1775-83. doi: 10.1093/carcin/18.9.1775. (PMID: 9328175)

>  <Comments>  (163) 


$$$$
CC01987
     RDKit          3D

 20 20  0  0  0  0  0  0  0  0999 V2000
   -1.0070    0.8290   -0.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0640   -0.4240   -0.8980 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2200    1.3260    0.1730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2110    1.6620   -0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1170   -1.1590   -1.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2670   -0.8680   -1.3720 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3870    0.5830    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9750    3.0160   -0.1520 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3030    1.1640    0.1850 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3460   -0.6730   -0.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1730   -2.1630   -1.9530 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8550    1.2690    0.6020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -3.0550    3.9480    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4970   -1.4630   -0.7670 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5460    5.3640   -0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6090    6.3450    0.0380 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0120    6.3480    1.4380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0750    7.6600   -0.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1990    7.2570    1.6610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7480    7.7650   -1.7600 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  4  8  1  0
  4  9  2  0
  5 10  2  0
  6 11  1  0
  7 10  1  0
  7 12  1  0
  8 13  1  0
 10 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 17 19  1  0
 18 20  1  0
M  END
>  <Name>  (164) 
Metoclopramide

>  <InChIKey>  (164) 
TTWJBBZEZQICBI-UHFFFAOYSA-N

>  <PubChem_CID>  (164) 
4168

>  <CYP1A2>  (164) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2A6>  (164) 


>  <CYP2B6>  (164) 


>  <CYP2C8>  (164) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2C9>  (164) 


>  <CYP2C19>  (164) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2D6>  (164) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2E1>  (164) 


>  <CYP3A4>  (164) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <References>  (164) 
Desta Z, Wu GM, Morocho AM, Flockhart DA: The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6. Drug Metab Dispos. 2002 Mar;30(3):336-43. doi: 10.1124/dmd.30.3.336. (PMID: 11854155)

>  <Comments>  (164) 


$$$$
CC01988
     RDKit          3D

 20 23  0  0  1  0  0  0  0  0999 V2000
    3.3030   -1.0630    0.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2800   -0.2430   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9240    0.9530   -0.6490 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9620   -0.7050    0.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6010    0.4860   -0.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5980    1.3170   -0.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9670   -1.6660    0.9980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3420   -2.0690    0.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2630   -1.0720    0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4910   -1.3960   -0.4400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6330   -3.3840    0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8610   -3.7090   -0.4650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7890   -2.7180   -0.7220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2900    0.9410   -0.3140 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8740    0.3610    0.3550 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.4070    2.3720    0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8950    3.1080   -0.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9510    2.5710    0.5740 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1500    1.1830    0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1830    3.2980    0.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  4  1  0
  2  3  1  0
  3  6  2  0
  4  5  2  0
  4  7  1  0
  5  6  1  0
  5 14  1  0
  7  8  1  0
  8  9  2  0
  8 11  1  0
  9 10  1  0
  9 15  1  0
 10 13  2  0
 11 12  2  0
 12 13  1  0
 14 15  1  0
 14 16  1  0
 15 19  1  6
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
M  END
>  <Name>  (165) 
Mianserin

>  <InChIKey>  (165) 
UEQUQVLFIPOEMF-SFHVURJKSA-N

>  <PubChem_CID>  (165) 
154412

>  <CYP1A2>  (165) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<7,H;Hydroxylation;R2>
<1,N;Oxidation;R3>

>  <CYP2A6>  (165) 


>  <CYP2B6>  (165) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<7,H;Hydroxylation;R2>

>  <CYP2C8>  (165) 


>  <CYP2C9>  (165) 


>  <CYP2C19>  (165) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2D6>  (165) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<7,H;Hydroxylation;R2>

>  <CYP2E1>  (165) 


>  <CYP3A4>  (165) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<7,H;Hydroxylation;R2>
<1,N;Oxidation;R3>

>  <References>  (165) 
Koyama E, Chiba K, Tani M, Ishizaki T: Identification of human cytochrome P450 isoforms involved in the stereoselective metabolism of mianserin enantiomers. J Pharmacol Exp Ther. 1996 Jul;278(1):21-30. (PMID: 8764331)

>  <Comments>  (165) 


$$$$
CC01989
     RDKit          3D

 20 23  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.4290    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.2670    1.9380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5320   -0.6890    1.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0700    1.9100    1.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2050   -0.1140    2.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6130    1.9220   -1.2430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5300    1.3450    2.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9050   -0.1170   -1.5580 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3920   -0.5880   -0.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7290    2.4660   -1.1340 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0130    1.3440   -1.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2860   -2.0670    1.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3600    2.4060    1.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2750   -0.6330   -1.6810 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6390   -0.9090    3.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9490    2.9560   -1.2230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8050    2.9420   -0.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7080   -2.8460    2.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3960   -2.2620    3.3650 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  7  1  0
  2  4  1  0
  2 10  1  1
  3  5  2  0
  3 11  1  0
  4  6  2  0
  4 13  1  0
  5  8  1  0
  5 14  1  0
  6  8  1  0
  6 16  1  0
  7 12  1  0
  9 10  1  0
  9 12  1  0
  9 15  1  0
 11 17  2  0
 13 19  2  0
 14 18  2  0
 16 20  2  0
 17 18  1  0
 19 20  1  0
M  END
>  <Name>  (166) 
Mirtazapine

>  <InChIKey>  (166) 
RONZAEMNMFQXRA-MRXNPFEDSA-N

>  <PubChem_CID>  (166) 
3085218

>  <CYP1A2>  (166) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<8,H;Hydroxylation;R2>
<1,N;Oxidation;R3>

>  <CYP2A6>  (166) 


>  <CYP2B6>  (166) 


>  <CYP2C8>  (166) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C9>  (166) 
<8,H;Hydroxylation;R2>

>  <CYP2C19>  (166) 


>  <CYP2D6>  (166) 
<8,H;Hydroxylation;R2>
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (166) 


>  <CYP3A4>  (166) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<8,H;Hydroxylation;R2>
<1,N;Oxidation;R3>

>  <References>  (166) 
Stormer E, von Moltke LL, Shader RI, Greenblatt DJ: Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4. Drug Metab Dispos. 2000 Oct;28(10):1168-75. (PMID: 10997935)

>  <Comments>  (166) 


$$$$
CC01991
     RDKit          3D

 30 33  0  0  0  0  0  0  0  0999 V2000
    4.9430    5.6450    1.7340 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.8740    6.6900    2.2720 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.8480    2.1460   -1.1400 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.2370   -1.7400   -0.4780 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1970    4.3340    0.9800 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4500    3.0270    1.3640 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2600   -1.9570    0.8250 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2730   -3.1930   -0.4520 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.8870   -3.7410   -0.3210 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5400    2.2700    0.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4620    0.8290    0.9310 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6540    3.0600    0.7220 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3290   -1.1760    0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9620   -3.7030   -1.7000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4020    0.2170    0.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0100    2.8090    0.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9930   -3.7710   -1.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4750   -4.2250    0.9220 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4120    0.0370    1.5630 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8940    4.2610    1.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2670   -1.3360    1.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3150    1.6630   -0.4970 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0320    3.7320    0.4970 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7080   -4.2810   -1.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1900   -4.7360    1.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3070   -4.7640    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6070    1.4330   -0.9650 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3280    3.5140    0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6040    2.3620   -0.6930 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0030    4.9040    3.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1 20  1  0
  1 30  1  1
  3 29  1  0
  4  8  1  0
  4 13  1  0
  5 12  1  0
  5 20  1  0
  6 10  1  0
  6 20  2  0
  7 13  2  0
  7 21  1  0
  8  9  1  0
  8 14  1  6
  9 17  2  0
  9 18  1  0
 10 11  1  0
 10 12  2  0
 11 15  2  0
 11 19  1  0
 12 16  1  0
 13 15  1  0
 16 22  2  0
 16 23  1  0
 17 24  1  0
 18 25  2  0
 19 21  2  0
 22 27  1  0
 23 28  2  0
 24 26  2  0
 25 26  1  0
 27 29  2  0
 28 29  1  0
M  END
>  <Name>  (167) 
ML-3603

>  <InChIKey>  (167) 
LDYVDKCSGKMMHS-DHMKHTPVSA-N

>  <PubChem_CID>  (167) 
53239057

>  <CYP1A2>  (167) 
<9,S;Oxidation;R1>

>  <CYP2A6>  (167) 


>  <CYP2B6>  (167) 


>  <CYP2C8>  (167) 


>  <CYP2C9>  (167) 


>  <CYP2C19>  (167) 
<9,S;Oxidation;R1>

>  <CYP2D6>  (167) 
<9,S;Oxidation;R1>

>  <CYP2E1>  (167) 


>  <CYP3A4>  (167) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<9,S;Oxidation;R2>
<23,N;Oxidation;R3>

>  <References>  (167) 
Kammerer B, Scheible H, Albrecht W, Gleiter CH, Laufer S: Pharmacokinetics of ML3403 ({4-[5-(4-fluorophenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-pheny lethyl)-amine), a 4-Pyridinylimidazole-type p38 mitogen-activated protein kinase inhibitor. Drug Metab Dispos. 2007 Jun;35(6):875-83. doi: 10.1124/dmd.106.013409. Epub 2007  Mar 7. (PMID: 17344341)

>  <Comments>  (167) 


$$$$
CC01992
     RDKit          3D

 41 45  0  0  0  0  0  0  0  0999 V2000
    1.3780    2.7390    0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2700    1.4960    0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9000    2.8890    0.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6330    3.0390   -1.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6360    3.1100    1.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2280    4.6290   -1.0920 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4010    2.0600    1.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0000    4.7240   -2.7310 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.2090    2.2020    2.7120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5050    1.0900    0.9370 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0100    3.6150   -2.8750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7000    6.0750   -2.8870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8640    2.6770   -3.8760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0790    3.5360   -2.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6580    7.1950   -2.8650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8010    1.6490   -4.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0110    2.5210   -2.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3360    8.5170   -3.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6520    0.6430   -5.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8810    1.5800   -3.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0140    9.1550   -2.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2740    9.0930   -4.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5550   -0.3440   -5.1980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6360   10.3680   -2.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0770    8.5300   -0.7310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8950   10.3040   -4.6130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4060   -1.3480   -6.2640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5780   10.9410   -3.5930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2660    9.3760    0.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5340    8.4640   -0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5340    7.2100   -0.7850 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3770   -1.2660   -7.0910 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3570   -2.3790   -6.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2040   -2.1570   -8.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2290   -3.3140   -7.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1320   -3.2150   -8.2390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1080   -2.0640   -8.9470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9430   -4.1460   -9.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9550   -2.9850   -9.9390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8710   -4.0240  -10.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4000   -2.8630  -11.0170 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  2  3  1  0
  4  6  1  0
  5  7  1  0
  6  8  1  0
  7  9  1  0
  7 10  2  0
  8 11  1  0
  8 12  1  1
 11 13  2  0
 11 14  1  0
 12 15  1  0
 13 16  1  0
 14 17  2  0
 15 18  1  0
 16 19  1  0
 16 20  2  0
 17 20  1  0
 18 21  2  0
 18 22  1  0
 19 23  2  0
 21 24  1  0
 21 25  1  0
 22 26  2  0
 23 27  1  0
 24 28  2  0
 25 29  1  0
 25 30  1  0
 25 31  1  0
 26 28  1  0
 27 32  2  0
 27 33  1  0
 32 34  1  0
 33 35  2  0
 34 36  2  0
 34 37  1  0
 35 36  1  0
 36 38  1  0
 37 39  2  0
 38 40  2  0
 39 40  1  0
 39 41  1  0
M  END
>  <Name>  (168) 
Montelukast

>  <InChIKey>  (168) 
UCHDWCPVSPXUMX-TZIWLTJVSA-N

>  <PubChem_CID>  (168) 
5281040

>  <CYP1A2>  (168) 


>  <CYP2A6>  (168) 
<13,S;S-Oxidation;R1>

>  <CYP2B6>  (168) 


>  <CYP2C8>  (168) 


>  <CYP2C9>  (168) 
<0,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>

>  <CYP2C19>  (168) 


>  <CYP2D6>  (168) 


>  <CYP2E1>  (168) 


>  <CYP3A4>  (168) 
<13,S;S-Oxidation;R1>
<10,H;Hydroxylation;R2>

>  <References>  (168) 
Chiba M, Xu X, Nishime JA, Balani SK, Lin JH: Hepatic microsomal metabolism of montelukast, a potent leukotriene D4 receptor antagonist, in humans. Drug Metab Dispos. 1997 Sep;25(9):1022-31. (PMID: 9311616)

>  <Comments>  (168) 


$$$$
CC01993
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.1850    1.3840   -0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1530   -0.0250   -0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9950    2.0910   -0.3640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3950    2.0560    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3330   -0.7320    0.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0580   -0.6960   -0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2070    1.4170   -0.5230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5680    1.3390    0.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5420   -0.0540    0.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2300    0.0220   -0.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4360    2.2240   -0.7820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6420   -0.8360    0.5450 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7370    1.5970   -0.3320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8170   -0.0470    0.6950 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8810    1.5910    1.1650 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5260    2.8500    1.8970 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3360    0.6150    1.7580 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  4  8  2  0
  5  9  2  0
  6 10  1  0
  7 10  2  0
  7 11  1  0
  8  9  1  0
  9 12  1  0
 11 13  1  0
 12 14  1  0
 13 15  1  0
 15 16  1  0
 15 17  2  0
M  END
>  <Name>  (169) 
Nabumetone

>  <InChIKey>  (169) 
BLXXJMDCKKHMKV-UHFFFAOYSA-N

>  <PubChem_CID>  (169) 
4409

>  <CYP1A2>  (169) 
<10,11;Cleavage;R1>
<11,H;Oxidation;R1>

>  <CYP2A6>  (169) 


>  <CYP2B6>  (169) 
<10,11;Cleavage;R1>
<11,H;Oxidation;R1>

>  <CYP2C8>  (169) 


>  <CYP2C9>  (169) 


>  <CYP2C19>  (169) 
<10,11;Cleavage;R1>
<11,H;Oxidation;R1>

>  <CYP2D6>  (169) 
<10,11;Cleavage;R1>
<11,H;Oxidation;R1>

>  <CYP2E1>  (169) 
<10,11;Cleavage;R1>
<11,H;Oxidation;R1>

>  <CYP3A4>  (169) 


>  <References>  (169) 
Turpeinen M, Hofmann U, Klein K, Murdter T, Schwab M, Zanger UM: A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes. Drug Metab Dispos. 2009 May;37(5):1017-24. doi: 10.1124/dmd.108.025700. Epub 2009 Feb 9. (PMID: 19204080)

>  <Comments>  (169) 


$$$$
CC01994
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0340    1.3810    0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0060    0.0250   -0.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2640    2.0330    0.1470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1550    2.0580    0.3080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2350   -0.6250   -0.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1830   -0.6510   -0.6140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4550    1.3550   -0.1260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3780    1.3980    0.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4220    0.0570   -0.1890 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4050    0.0110   -0.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7460    2.0970    0.0030 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.5740   -0.6670   -0.3280 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4440    1.8830    1.3140 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7080    1.8100   -1.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7230    0.1210   -0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8150    3.0820    1.8310 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6840    0.8070    1.8430 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  4  8  2  0
  5  9  2  0
  6 10  1  0
  7 10  2  0
  7 11  1  0
  8  9  1  0
  9 12  1  0
 11 13  1  0
 11 14  1  6
 12 15  1  0
 13 16  1  0
 13 17  2  0
M  END
>  <Name>  (170) 
Naproxen

>  <InChIKey>  (170) 
CMWTZPSULFXXJA-VIFPVBQESA-N

>  <PubChem_CID>  (170) 
156391

>  <CYP1A2>  (170) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (170) 


>  <CYP2B6>  (170) 


>  <CYP2C8>  (170) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C9>  (170) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (170) 


>  <CYP2D6>  (170) 


>  <CYP2E1>  (170) 


>  <CYP3A4>  (170) 


>  <References>  (170) 
Tracy TS, Marra C, Wrighton SA, Gonzalez FJ, Korzekwa KR: Involvement of multiple cytochrome P450 isoforms in naproxen O-demethylation. Eur J Clin Pharmacol. 1997;52(4):293-8. (PMID: 9248768)

>  <Comments>  (170) 


$$$$
CC01995
     RDKit          3D

 26 27  0  0  0  0  0  0  0  0999 V2000
    0.6600    1.6260   -1.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5880    0.3370   -1.7750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8100    2.0140   -0.5420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6680   -0.5360   -1.6140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8880    1.1430   -0.3790 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2460    3.1960    1.7790 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4160    2.4590   -1.4100 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8090   -0.1370   -0.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0070    2.8400    1.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1310    1.5320    0.3490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5560   -0.0100   -2.4460 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1880    3.7330   -0.8190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990    5.9700   -0.4780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4070    4.5950   -1.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0780    4.5160    2.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4800    2.2380    2.8500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4880   -1.3400   -2.9450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3860    6.8320   -0.6290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1620    6.4220    0.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9290    5.5790    1.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8150    2.4810    3.5160 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7520    6.9270    1.9610 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0200    1.4720    4.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3390    8.1270   -0.1150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1110    7.7150    0.7100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2010    8.5680    0.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  7  1  0
  2  4  1  0
  2 11  1  0
  3  5  2  0
  4  8  2  0
  5  8  1  0
  5 10  1  0
  6  9  1  0
  6 15  1  0
  6 16  1  0
  7 12  1  0
  9 10  1  0
 11 17  1  0
 12 14  1  0
 13 14  1  0
 13 18  2  0
 13 19  1  0
 15 20  1  0
 16 21  1  0
 18 24  1  0
 19 25  2  0
 20 22  1  0
 21 23  1  0
 24 26  2  0
 25 26  1  0
M  END
>  <Name>  (171) 
NE-100

>  <InChIKey>  (171) 
YBLIQJGXRLZBCZ-UHFFFAOYSA-N

>  <PubChem_CID>  (171) 
9841596

>  <CYP1A2>  (171) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>
<3,4;Cleavage;R2>
<4,H;Oxidation;R2>

>  <CYP2A6>  (171) 


>  <CYP2B6>  (171) 


>  <CYP2C8>  (171) 


>  <CYP2C9>  (171) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>
<3,4;Cleavage;R2>
<4,H;Oxidation;R2>
<13,14;Cleavage;R3>
<14,H;Oxidation;R3>

>  <CYP2C19>  (171) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>
<3,4;Cleavage;R2>
<4,H;Oxidation;R2>
<13,14;Cleavage;R3>
<14,H;Oxidation;R3>

>  <CYP2D6>  (171) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>
<3,4;Cleavage;R2>
<4,H;Oxidation;R2>
<13,14;Cleavage;R3>
<14,H;Oxidation;R3>
<21,H;Hydroxylation;R4>
<22,H;Hydroxylation;R5>
<23,H;Hydroxylation;R6>

>  <CYP2E1>  (171) 


>  <CYP3A4>  (171) 
<15,6;Cleavage;R1>
<15,H;Oxidation;R1>
<16,6;Cleavage;R2>
<16,H;Oxidation;R2>
<21,H;Hydroxylation;R3>
<22,H;Hydroxylation;R4>
<23,H;Hydroxylation;R5>

>  <References>  (171) 
Yamamoto T, Hagima N, Fukasawa M, Yamaguchi J, Nakamura M, Kohno Y, Nagata K, Yamazoe Y: Metabolism of N,N-dipropyl-2-[4-methoxy-3-(2-phenyl-ethoxy)-phenyl]-ethyl-amine-monohydrochlori de (NE-100), a novel sigma ligand: contribution of cytochrome P450 forms involved in the formation of individual metabolites in human liver and small intestine. Drug Metab Pharmacokinet. 2003;18(3):173-85. (PMID: 15618733)

>  <Comments>  (171) 


$$$$
CC01996
     RDKit          3D

 35 37  0  0  0  0  0  0  0  0999 V2000
    0.4840    1.2560   -0.4290 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.0690   -0.1930   -0.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9780    1.4680   -0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0750    1.9000   -1.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7920   -0.5650    0.7200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5350   -1.1680   -1.2070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7140    1.9570   -1.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5500    1.1140    1.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7500    2.3970   -2.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5410    1.9810   -1.7520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1640   -1.9000    0.8490 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1510   -2.5010   -1.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1310    2.3860   -2.4610 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2000    2.1000   -1.2360 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5450    1.9680    1.4020 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1310    0.2070    1.7610 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2840    3.0490   -3.8820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9880    1.7490   -3.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2430    2.1700   -0.7680 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7020   -2.8750   -0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0500   -2.2870    1.9280 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1550    1.6340    2.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4110    1.7770   -3.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6020   -1.3850    2.5740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2120   -3.4990    2.1310 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1330    0.4760    2.4940 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2770    0.7730    1.6420 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0530    1.8480    2.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1050   -0.4220    1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9580    2.5380    1.2810 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4510    3.5100    0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3160    2.2210    1.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2960    4.1560   -0.4810 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1610    2.8670    0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6500    3.8340   -0.5180 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  6
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5 11  1  0
  6 12  2  0
  7 13  1  0
  7 14  1  0
  8 15  1  0
  8 16  2  0
  9 13  1  0
  9 17  1  0
 10 18  1  0
 10 19  2  0
 11 20  2  0
 11 21  1  0
 12 20  1  0
 15 22  1  0
 18 23  1  0
 21 24  1  0
 21 25  2  0
 22 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  1  0
 28 30  1  0
 30 31  2  0
 30 32  1  0
 31 33  1  0
 32 34  2  0
 33 35  2  0
 34 35  1  0
M  CHG  2  21   1  24  -1
M  END
>  <Name>  (172) 
Nicardipine

>  <InChIKey>  (172) 
ZBBHBTPTTSWHBA-XMMPIXPASA-N

>  <PubChem_CID>  (172) 
6603948

>  <CYP1A2>  (172) 


>  <CYP2A6>  (172) 


>  <CYP2B6>  (172) 


>  <CYP2C8>  (172) 
<16,18;Cleavage;R1>
<18,H;Oxidation;R1>
<7,H;Oxidation;R2>
<25,H;Oxidation;R2>

>  <CYP2C9>  (172) 


>  <CYP2C19>  (172) 


>  <CYP2D6>  (172) 
<16,18;Cleavage;R1>
<18,H;Oxidation;R1>

>  <CYP2E1>  (172) 


>  <CYP3A4>  (172) 
<16,18;Cleavage;R1>
<18,H;Oxidation;R1>
<7,H;Oxidation;R2>
<25,H;Oxidation;R2>

>  <References>  (172) 
Nakamura K, Ariyoshi N, Iwatsubo T, Fukunaga Y, Higuchi S, Itoh K, Shimada N, Nagashima K, Yokoi T, Yamamoto K, Horiuchi R, Kamataki T: Inhibitory effects of nicardipine to cytochrome P450 (CYP) in human liver microsomes. Biol Pharm Bull. 2005 May;28(5):882-5. (PMID: 15863898)

>  <Comments>  (172) 


$$$$
CC01997
     RDKit          3D

 12 13  0  0  0  0  0  0  0  0999 V2000
    1.1240    0.6150   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1580    1.2470    0.6500 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0140    0.5900    0.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5920   -1.2980    0.4680 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.2680   -0.6650    0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2420   -1.2800   -0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9790   -0.6390   -0.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7190   -0.9130   -0.3960 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2950   -0.5140   -1.7290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5110   -2.1420   -0.5880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1360   -2.9830    0.6130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6360   -2.8070    0.5560 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  7  1  0
  2  3  1  0
  3  5  2  0
  4  5  1  6
  4  8  1  0
  4 12  1  0
  5  6  1  0
  6  7  2  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
M  END
>  <Name>  (173) 
Nicotine

>  <InChIKey>  (173) 
SNICXCGAKADSCV-JTQLQIEISA-N

>  <PubChem_CID>  (173) 
89594

>  <CYP1A2>  (173) 
<2,H;Oxidation;R1>

>  <CYP2A6>  (173) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<2,H;Oxidation;R2>
<5,H;Hydroxylation;R3>

>  <CYP2B6>  (173) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<2,H;Oxidation;R2>

>  <CYP2C8>  (173) 
<2,H;Oxidation;R1>

>  <CYP2C9>  (173) 
<2,H;Oxidation;R1>

>  <CYP2C19>  (173) 
<2,H;Oxidation;R1>

>  <CYP2D6>  (173) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<2,H;Oxidation;R2>

>  <CYP2E1>  (173) 
<2,H;Oxidation;R2>

>  <CYP3A4>  (173) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<2,H;Oxidation;R2>

>  <References>  (173) 
Yamanaka H, Nakajima M, Fukami T, Sakai H, Nakamura A, Katoh M, Takamiya M, Aoki Y, Yokoi T: CYP2A6 AND CYP2B6 are involved in nornicotine formation from nicotine in humans: interindividual differences in these contributions. Drug Metab Dispos. 2005 Dec;33(12):1811-8. doi: 10.1124/dmd.105.006254. Epub 2005 Aug 31. (PMID: 16135656)
Yamazaki H, Inoue K, Hashimoto M, Shimada T: Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes. Arch Toxicol. 1999 Mar;73(2):65-70. (PMID: 10350185)
Hukkanen J, Jacob P 3rd, Benowitz NL: Metabolism and disposition kinetics of nicotine. Pharmacol Rev. 2005 Mar;57(1):79-115. doi: 10.1124/pr.57.1.3. (PMID: 15734728)

>  <Comments>  (173) 
Followed Xenosite. Metabolites for 2A6 and 2B6 are confirmed. The others are not.

$$$$
CC01998
     RDKit          3D

 14 14  0  0  0  0  0  0  0  0999 V2000
    8.6810    0.1720    0.3930 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1710    0.4720   -0.8420 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.7650    0.0810    1.2130 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.0030    1.2800    0.8040 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.6680   -2.1340    0.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1830   -2.0830    0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5230   -0.8080    0.5480 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.4930   -0.7530    2.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1470   -0.8120    0.0830 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2820   -3.3820    0.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4560   -0.9820    0.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6650   -3.4780    0.4540 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8420   -1.0660    0.3880 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4420   -2.3230    0.4840 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1 13  1  0
  5  6  1  0
  5 10  2  0
  5 11  1  0
  6  7  1  0
  7  8  1  1
  7  9  1  0
 10 12  1  0
 11 13  2  0
 12 14  2  0
 13 14  1  0
M  END
>  <Name>  (174) 
Nordexfenfluramine

>  <InChIKey>  (174) 
MLBHFBKZUPLWBD-ZETCQYMHSA-N

>  <PubChem_CID>  (174) 
9815618

>  <CYP1A2>  (174) 
<2,H;Hydroxylation;R1>

>  <CYP2A6>  (174) 


>  <CYP2B6>  (174) 


>  <CYP2C8>  (174) 


>  <CYP2C9>  (174) 


>  <CYP2C19>  (174) 


>  <CYP2D6>  (174) 


>  <CYP2E1>  (174) 


>  <CYP3A4>  (174) 


>  <References>  (174) 
Haritos VS, Ching MS, Ghabrial H, Gross AS, Taavitsainen P, Pelkonen O, Battaglia SE, Smallwood RA, Ahokas JT: Metabolism of dexfenfluramine in human liver microsomes and by recombinant enzymes: role of CYP2D6 and 1A2. Pharmacogenetics. 1998 Oct;8(5):423-32. (PMID: 9825834)

>  <Comments>  (174) 


$$$$
CC02000
     RDKit          3D

 20 22  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4760    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2340    2.2630    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1940    2.1160    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5720   -0.6200   -1.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5370   -0.7430    1.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3250    1.9670   -0.7900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2750    3.3660    0.8710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4790    1.3290    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1600    0.1960   -2.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6060   -2.0040   -1.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4980   -2.1240    0.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4520    0.8690   -1.8150 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4650    2.7680   -0.6710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4000    4.1510    0.9620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3400    1.7630    1.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0700   -2.7480   -0.1110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5050    3.8420    0.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5930    0.9960    1.2110 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3690    1.4580    2.3700 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  7 13  1  0
  7 14  1  0
  8 15  2  0
  9 16  1  0
 10 13  1  0
 11 17  2  0
 12 17  1  0
 14 18  2  0
 15 18  1  0
 16 19  1  0
 19 20  1  0
M  END
>  <Name>  (175) 
Nortriptyline

>  <InChIKey>  (175) 
PHVGLTMQBUFIQQ-UHFFFAOYSA-N

>  <PubChem_CID>  (175) 
4543

>  <CYP1A2>  (175) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (175) 


>  <CYP2B6>  (175) 


>  <CYP2C8>  (175) 


>  <CYP2C9>  (175) 


>  <CYP2C19>  (175) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2D6>  (175) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<13,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>

>  <CYP2E1>  (175) 


>  <CYP3A4>  (175) 
<13,H;Hydroxylation;R1>
<12,H;Hydroxylation;R2>

>  <References>  (175) 
Breyer-Pfaff U: The metabolic fate of amitriptyline, nortriptyline and amitriptylinoxide in man. Drug Metab Rev. 2004 Oct;36(3-4):723-46. doi: 10.1081/DMR-200033482. (PMID: 15554244)
Finch CK, Chrisman CR, Baciewicz AM, Self TH: Rifampin and rifabutin drug interactions: an update. Arch Intern Med. 2002 May 13;162(9):985-92. (PMID: 11996607)

>  <Comments>  (175) 


$$$$
CC02001
     RDKit          2D

 17 18  0  0  0  0  0  0  0  0999 V2000
    2.1430    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8580    1.4440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -0.2060    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140    0.2060    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4290   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4290   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1430   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1430    0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8580   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  2 17  1  0
  3  4  2  0
  4  5  1  0
  4  8  1  0
  5  6  2  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 15  1  0
 11 12  1  0
 11 16  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
M  END
>  <Name>  (176) 
o-Aminoazotoluene

>  <InChIKey>  (176) 
PFRYFZZSECNQOL-WUKNDPDISA-N

>  <PubChem_CID>  (176) 


>  <CYP1A2>  (176) 
<16,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>

>  <CYP2A6>  (176) 


>  <CYP2B6>  (176) 


>  <CYP2C8>  (176) 


>  <CYP2C9>  (176) 


>  <CYP2C19>  (176) 


>  <CYP2D6>  (176) 


>  <CYP2E1>  (176) 


>  <CYP3A4>  (176) 


>  <References>  (176) 
Degawa M, Kanazawa C, Hashimoto Y: In vitro metabolism of o-aminoazotoluene and mutagenesis of Salmonella by the metabolites. Carcinogenesis. 1982;3(10):1113-7. doi: 10.1093/carcin/3.10.1113. (PMID: 6756667)

>  <Comments>  (176) 


$$$$
CC02002
     RDKit          3D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -0.9830    2.1830    0.7750 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7520   -0.1310    0.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7250   -0.1760    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5380    0.9910    0.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4560   -1.2880   -0.2870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5010    0.9030    0.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4190   -1.3300   -0.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9330    0.9640    0.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8480   -1.3320   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8950    0.8450    0.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8120   -1.4060   -0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5890   -0.2000   -0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5500   -0.3140    0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  4  1  0
  2  3  1  0
  2  4  2  0
  2  5  1  0
  3  6  2  0
  3  7  1  0
  4  8  1  0
  5  9  2  0
  6 10  1  0
  7 11  2  0
  8 12  2  0
  9 12  1  0
 10 13  2  0
 11 13  1  0
M  END
>  <Name>  (177) 
o-Phenylphenol

>  <InChIKey>  (177) 
LLEMOWNGBBNAJR-UHFFFAOYSA-N

>  <PubChem_CID>  (177) 
7017

>  <CYP1A2>  (177) 
<4,H;Hydroxylation;R1>

>  <CYP2A6>  (177) 


>  <CYP2B6>  (177) 


>  <CYP2C8>  (177) 


>  <CYP2C9>  (177) 


>  <CYP2C19>  (177) 


>  <CYP2D6>  (177) 


>  <CYP2E1>  (177) 


>  <CYP3A4>  (177) 


>  <References>  (177) 
Ozawa S, Ohta K, Miyajima A, Kurebayashi H, Sunouchi M, Shimizu M, Murayama N, Matsumoto Y, Fukuoka M, Ohno Y: Metabolic activation of o-phenylphenol to a major cytotoxic metabolite, phenylhydroquinone: role of human CYP1A2 and rat CYP2C11/CYP2E1. Xenobiotica. 2000 Oct;30(10):1005-17. doi: 10.1080/00498250050200159. (PMID: 11315102)

>  <Comments>  (177) 


$$$$
CC02003
     RDKit          3D

 28 30  0  0  0  0  0  0  0  0999 V2000
   -0.0870    0.1040   -0.1560 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0160    1.8180   -0.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2440    2.4810   -0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1710    2.5380    0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2780    3.8840    0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5290    1.7240   -0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1580    3.9310    0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0720    4.6010    0.1470 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5900    4.5710    0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4920    2.5920   -0.8970 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.4590    4.6420    0.1980 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0980    5.9640    0.2140 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7060    5.7220    0.5480 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6790    3.8340   -0.2080 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8320    1.9070   -0.9950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5680    3.8410    0.0220 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5360    5.8510    0.3930 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8960    4.4140    0.0530 C   0  0  1  0  0  0  0  0  0  0  0  0
   -5.9160    3.4280   -0.4860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2750    4.6660    1.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8810    3.2250   -1.9650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1380    3.8890    2.4240 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8540    5.8890    1.5980 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3310    2.0090   -2.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4340    4.2150   -2.8430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3260    1.7800   -3.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4290    3.9880   -4.2170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8740    2.7700   -4.7220 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  3  5  1  0
  3  6  1  0
  4  7  2  0
  5  8  2  0
  5  9  1  0
  6 10  1  0
  7  8  1  0
  7 11  1  0
  8 12  1  0
  9 13  2  0
  9 14  1  0
 10 14  1  0
 10 15  1  1
 11 16  1  0
 11 17  2  0
 16 18  1  0
 18 19  1  1
 18 20  1  0
 19 21  1  0
 20 22  2  0
 20 23  1  0
 21 24  2  0
 21 25  1  0
 24 26  1  0
 25 27  2  0
 26 28  2  0
 27 28  1  0
M  END
>  <Name>  (178) 
Ochratoxin A

>  <InChIKey>  (178) 
RWQKHEORZBHNRI-BONVTDFDSA-N

>  <PubChem_CID>  (178) 
12313657

>  <CYP1A2>  (178) 
<2,H;Hydroxylation;R1>

>  <CYP2A6>  (178) 


>  <CYP2B6>  (178) 


>  <CYP2C8>  (178) 


>  <CYP2C9>  (178) 
<2,H;Hydroxylation;R1>

>  <CYP2C19>  (178) 


>  <CYP2D6>  (178) 


>  <CYP2E1>  (178) 


>  <CYP3A4>  (178) 
<2,H;Hydroxylation;R1>

>  <References>  (178) 
Zepnik H, Pahler A, Schauer U, Dekant W: Ochratoxin A-induced tumor formation: is there a role of reactive ochratoxin A metabolites? Toxicol Sci. 2001 Jan;59(1):59-67. doi: 10.1093/toxsci/59.1.59. (PMID: 11134544)

>  <Comments>  (178) 


$$$$
CC02004
     RDKit          3D

 22 25  0  0  0  0  0  0  0  0999 V2000
    1.4120    0.8030    0.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1880    1.4060    0.3560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9400    0.5870    0.5690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8780   -0.8000    0.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3350   -1.4030    0.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4540   -0.6030    0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6520    1.3960   -0.1370 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0310    2.6370   -0.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3810    2.8820   -0.4080 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1620    3.8090   -0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8070    3.7960    0.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0590    2.7800    0.4410 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5790    5.1710   -0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6160    6.1180   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7310    7.5870   -0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1410    5.3910    0.3640 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.2810    1.7630   -0.6780 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4080    1.7440    0.3510 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1570    3.0020    0.3900 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0580    2.9340    1.5250 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2210    4.0980    0.6390 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0890    4.1500   -0.3840 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  1  7  1  0
  2  3  2  0
  2 12  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
  9 17  1  0
  9 22  1  0
 10 11  2  0
 10 13  1  0
 11 12  1  0
 11 16  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
M  END
>  <Name>  (179) 
Olanzapine

>  <InChIKey>  (179) 
KVWDHTXUZHCGIO-UHFFFAOYSA-N

>  <PubChem_CID>  (179) 
135398745

>  <CYP1A2>  (179) 
<0,H;Hydroxylation;R1>
<18,N;N-Oxidation;R2>
<18,19;Cleavage;R3>
<19,H;Oxidation;R3>
<10,H;Hydroxylation;R4>

>  <CYP2A6>  (179) 


>  <CYP2B6>  (179) 


>  <CYP2C8>  (179) 


>  <CYP2C9>  (179) 


>  <CYP2C19>  (179) 


>  <CYP2D6>  (179) 
<0,H;Hydroxylation;R1>
<18,N;N-Oxidation;R2>
<18,19;Cleavage;R3>
<19,H;Oxidation;R3>
<10,H;Hydroxylation;R4>

>  <CYP2E1>  (179) 


>  <CYP3A4>  (179) 
<0,H;Hydroxylation;R1>
<18,N;N-Oxidation;R2>
<18,19;Cleavage;R3>
<19,H;Oxidation;R3>

>  <References>  (179) 
Ring BJ, Catlow J, Lindsay TJ, Gillespie T, Roskos LK, Cerimele BJ, Swanson SP, Hamman MA, Wrighton SA: Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine. J Pharmacol Exp Ther. 1996 Feb;276(2):658-66. (PMID: 8632334)

>  <Comments>  (179) 


$$$$
CC02005
     RDKit          3D

 22 25  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4490    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3110    1.8620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0960    2.3670    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3720   -0.3680   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0040   -0.9690    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1140    0.7850   -0.0070 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6940    3.3220   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7660    3.8430    0.0730 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.2480    1.9830   -0.0130 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7500   -1.7080   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6020   -2.2940   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5780    0.8350   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5480    4.1110   -0.6570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8870    4.6380   -0.5980 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7360   -2.6500   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1220    4.4890    0.1750 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4890    5.2200    1.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1240    3.5850   -0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6500    4.7970    1.6680 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6890    6.3400    1.8640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0640    3.7920    0.8820 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  4 10  2  0
  5  7  1  0
  5 11  1  0
  6 12  2  0
  7 13  1  0
  8 14  1  0
  9 14  1  0
  9 15  1  6
 11 16  2  0
 12 16  1  0
 15 17  1  0
 17 18  1  0
 17 19  1  0
 18 20  2  0
 18 21  1  0
 19 22  2  0
 20 22  1  0
M  END
>  <Name>  (180) 
Ondansetron

>  <InChIKey>  (180) 
FELGMEQIXOGIFQ-ZDUSSCGKSA-N

>  <PubChem_CID>  (180) 
698135

>  <CYP1A2>  (180) 
<16,H;Hydroxylation;R1>
<15,H;Hydroxylation;R2>

>  <CYP2A6>  (180) 


>  <CYP2B6>  (180) 


>  <CYP2C8>  (180) 


>  <CYP2C9>  (180) 


>  <CYP2C19>  (180) 


>  <CYP2D6>  (180) 
<16,H;Hydroxylation;R1>
<15,H;Hydroxylation;R2>

>  <CYP2E1>  (180) 


>  <CYP3A4>  (180) 


>  <References>  (180) 
Dixon CM, Colthup PV, Serabjit-Singh CJ, Kerr BM, Boehlert CC, Park GR, Tarbit MH: Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans. Drug Metab Dispos. 1995 Nov;23(11):1225-30. (PMID: 8591723)
Fischer V, Vickers AE, Heitz F, Mahadevan S, Baldeck JP, Minery P, Tynes R: The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron. Drug Metab Dispos. 1994 Mar-Apr;22(2):269-74. (PMID: 8013282)

>  <Comments>  (180) 


$$$$
CC02006
     RDKit          3D

  8  8  0  0  0  0  0  0  0  0999 V2000
   -0.0130    1.0760    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1750    1.7830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1580    3.1650    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0480    3.8410    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2380    3.1330    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2190    1.7500    0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0710    5.5770    0.0320 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.7540    3.9810    0.0490 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  7  1  0
  5  6  2  0
  5  8  1  0
M  END
>  <Name>  (181) 
o-Dichlorobenzene

>  <InChIKey>  (181) 
RFFLAFLAYFXFSW-UHFFFAOYSA-N

>  <PubChem_CID>  (181) 
7239

>  <CYP1A2>  (181) 
<2,H;Hydroxylation;R1>
<3,H;Hydroxylation;R2>
<4,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>

>  <CYP2A6>  (181) 


>  <CYP2B6>  (181) 


>  <CYP2C8>  (181) 


>  <CYP2C9>  (181) 


>  <CYP2C19>  (181) 


>  <CYP2D6>  (181) 


>  <CYP2E1>  (181) 
<2,H;Hydroxylation;R1>
<3,H;Hydroxylation;R2>
<4,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>

>  <CYP3A4>  (181) 
<2,H;Hydroxylation;R1>
<3,H;Hydroxylation;R2>
<4,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>

>  <References>  (181) 
Bogaards JJ, van Ommen B, Wolf CR, van Bladeren PJ: Human cytochrome P450 enzyme selectivities in the oxidation of chlorinated benzenes. Toxicol Appl Pharmacol. 1995 May;132(1):44-52. (PMID: 7747284)

>  <Comments>  (181) 


$$$$
CC02007
     RDKit          3D

 19 20  0  0  0  0  0  0  0  0999 V2000
   -0.6950    2.5740   -1.2090 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4320    0.8420   -1.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0170   -4.3590   -2.9970 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4600   -0.0220   -1.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2640   -1.4010   -1.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3170    3.2360   -0.4080 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8700    2.8800   -2.6140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3780   -2.3210   -1.7570 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.9200   -3.4650   -2.6460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2470    2.8120   -0.3880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5680   -4.9350   -1.7790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4560   -5.4230   -3.8130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7890    0.3650   -0.6360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0360   -1.8870   -0.9090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1200   -3.8790   -0.8450 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9850   -1.0090   -0.5440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1050   -2.8070   -0.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5370   -6.3500   -4.3210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9160   -7.4380   -5.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  1  7  2  0
  1 10  1  0
  2  4  2  0
  2 13  1  0
  3  9  1  0
  3 11  1  0
  3 12  1  0
  4  5  1  0
  8  5  1  1
  5 14  2  0
  8  9  1  0
  8 17  1  0
 11 15  1  0
 12 18  1  0
 13 16  2  0
 14 16  1  0
 15 17  1  0
 18 19  1  0
M  END
>  <Name>  (182) 
OSU-6162

>  <InChIKey>  (182) 
GZVBVBMMNFIXGE-CQSZACIVSA-N

>  <PubChem_CID>  (182) 
9795741

>  <CYP1A2>  (182) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>

>  <CYP2A6>  (182) 


>  <CYP2B6>  (182) 


>  <CYP2C8>  (182) 


>  <CYP2C9>  (182) 


>  <CYP2C19>  (182) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>

>  <CYP2D6>  (182) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>

>  <CYP2E1>  (182) 


>  <CYP3A4>  (182) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>

>  <References>  (182) 
Wienkers LC, Wynalda MA: Multiple cytochrome P450 enzymes responsible for the oxidative metabolism of the substituted (S)-3-phenylpiperidine, (S,S)-3-[3-(methylsulfonyl)phenyl]-1-propylpiperidine hydrochloride, in human liver microsomes. Drug Metab Dispos. 2002 Dec;30(12):1372-7. doi: 10.1124/dmd.30.12.1372. (PMID: 12433806)

>  <Comments>  (182) 


$$$$
CC02009
     RDKit          3D

 14 14  0  0  0  0  0  0  0  0999 V2000
    2.3050    1.2650    0.0280 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2470    1.5220   -0.0140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0120   -0.4690    0.0070 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6780   -0.0070    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6640   -0.9720    0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3170    1.3380    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0500    0.7410    0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6890   -0.6010    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0350    1.7030    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1660    0.2980    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4060   -0.5600    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5040    0.4870   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7470   -0.3230    1.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6950   -0.2920   -1.3050 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  7  1  0
  1 12  1  0
  2 10  2  0
  3  4  1  0
  3 10  1  0
  4  5  2  0
  4  6  1  0
  5  8  1  0
  6  9  2  0
  7  8  2  0
  7  9  1  0
 10 11  1  0
 12 13  1  0
 12 14  1  0
M  END
>  <Name>  (183) 
p-Isopropyloxyacetanilide

>  <InChIKey>  (183) 
QCSNJTIWCIMFFY-UHFFFAOYSA-N

>  <PubChem_CID>  (183) 
95213

>  <CYP1A2>  (183) 
<8,9;Cleavage;R1>
<9,H;Oxidation;R1>
<0,H;Hydroxylation;R2>

>  <CYP2A6>  (183) 


>  <CYP2B6>  (183) 


>  <CYP2C8>  (183) 


>  <CYP2C9>  (183) 


>  <CYP2C19>  (183) 


>  <CYP2D6>  (183) 


>  <CYP2E1>  (183) 


>  <CYP3A4>  (183) 


>  <References>  (183) 
Guengerich FP, Parikh A, Yun CH, Kim D, Nakamura K, Notley LM, Gillam EM: What makes P450s work? Searches for answers with known and new P450s. Drug Metab Rev. 2000 Aug-Nov;32(3-4):267-81. doi: 10.1081/DMR-100102334. (PMID: 11139129)

>  <Comments>  (183) 


$$$$
CC02010
     RDKit          3D

 12 12  0  0  0  0  0  0  0  0999 V2000
    3.3330   -0.5080   -0.0170 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4560   -0.7060    0.1150 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2420   -0.9630    0.0550 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8540   -0.7230    0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0330   -1.8580   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2400    0.5260    0.1140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9660   -0.4890    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3600   -1.7410   -0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1600    0.6440    0.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3480   -0.1680    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2530    1.3160   -0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9940    0.7490    0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  7  1  0
  1 12  1  0
  2 10  2  0
  3  4  1  0
  3 10  1  0
  4  5  2  0
  4  6  1  0
  5  8  1  0
  6  9  2  0
  7  8  2  0
  7  9  1  0
 10 11  1  0
M  END
>  <Name>  (184) 
p-Methoxyacetanilide

>  <InChIKey>  (184) 
XVAIDCNLVLTVFM-UHFFFAOYSA-N

>  <PubChem_CID>  (184) 
5827

>  <CYP1A2>  (184) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<8,H;Hydroxylation;R2>

>  <CYP2A6>  (184) 


>  <CYP2B6>  (184) 


>  <CYP2C8>  (184) 


>  <CYP2C9>  (184) 


>  <CYP2C19>  (184) 


>  <CYP2D6>  (184) 


>  <CYP2E1>  (184) 


>  <CYP3A4>  (184) 


>  <References>  (184) 
Guengerich FP, Parikh A, Yun CH, Kim D, Nakamura K, Notley LM, Gillam EM: What makes P450s work? Searches for answers with known and new P450s. Drug Metab Rev. 2000 Aug-Nov;32(3-4):267-81. doi: 10.1081/DMR-100102334. (PMID: 11139129)

>  <Comments>  (184) 


$$$$
CC02011
     RDKit          3D

  8  8  0  0  0  0  0  0  0  0999 V2000
    0.0670    0.0110   -0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9460   -0.7310    0.7620 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3200   -0.6150    0.5720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7980    0.2450   -0.4090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9350    0.9910   -1.2020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5620    0.8710   -1.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4020   -0.1140    0.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1430    0.3600   -0.5970 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  8  1  0
  5  6  2  0
M  END
>  <Name>  (185) 
p-Cresol

>  <InChIKey>  (185) 
IWDCLRJOBJJRNH-UHFFFAOYSA-N

>  <PubChem_CID>  (185) 
2879

>  <CYP1A2>  (185) 
<5,H;Dehydrogenation;R1>

>  <CYP2A6>  (185) 


>  <CYP2B6>  (185) 


>  <CYP2C8>  (185) 


>  <CYP2C9>  (185) 


>  <CYP2C19>  (185) 
<5,H;Dehydrogenation;R1>

>  <CYP2D6>  (185) 
<5,H;Dehydrogenation;R1>

>  <CYP2E1>  (185) 
<3,H;Hydroxylation;R1>
<6,H;Hydroxylation;R2>
<5,H;Dehydrogenation;R3>

>  <CYP3A4>  (185) 


>  <References>  (185) 
Yan Z, Zhong HM, Maher N, Torres R, Leo GC, Caldwell GW, Huebert N: Bioactivation of 4-methylphenol (p-cresol) via cytochrome P450-mediated aromatic oxidation in human liver microsomes. Drug Metab Dispos. 2005 Dec;33(12):1867-76. doi: 10.1124/dmd.105.006387. Epub 2005 Sep 20. (PMID: 16174805)
Sugumaran M: Reactivities of Quinone Methides versus o-Quinones in Catecholamine Metabolism and Eumelanin Biosynthesis. Int J Mol Sci. 2016 Sep 20;17(9). pii: ijms17091576. doi: 10.3390/ijms17091576. (PMID: 27657049)

>  <Comments>  (185) 


$$$$
CC02012
     RDKit          3D

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.0810    1.9290    0.1620 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6050    0.5790    0.7440 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5230    1.4100   -0.3740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7350    2.1230   -1.2310 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1080    3.4820    1.3270 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1520   -0.1220    1.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5210    0.2970   -1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2870    3.1600   -2.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9370   -1.1930    2.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0330    0.1850    2.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9540   -0.0440   -1.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1540    3.1510   -3.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5440   -1.9580    3.3530 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4360   -0.5730    3.5940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6400   -1.6380    4.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0550   -2.4310    5.1580 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3190   -3.3640    5.5080 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1190   -2.1260    5.7130 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  2  0
  2  6  1  0
  3  7  1  0
  4  8  1  0
  6  9  2  0
  6 10  1  0
  7 11  1  0
  8 12  1  0
  9 13  1  0
 10 14  2  0
 13 15  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
M  CHG  2  16   1  17  -1
M  END
>  <Name>  (186) 
Parathion

>  <InChIKey>  (186) 
LCCNCVORNKJIRZ-UHFFFAOYSA-N

>  <PubChem_CID>  (186) 
991

>  <CYP1A2>  (186) 
<3,4;Desulfation;R1>
<3,8;Cleavage;R2>

>  <CYP2A6>  (186) 


>  <CYP2B6>  (186) 
<3,4;Desulfation;R1>
<3,8;Cleavage;R2>

>  <CYP2C8>  (186) 
<3,4;Desulfation;R1>
<3,8;Cleavage;R2>

>  <CYP2C9>  (186) 
<3,4;Desulfation;R1>
<3,8;Cleavage;R2>

>  <CYP2C19>  (186) 
<3,4;Desulfation;R1>
<3,8;Cleavage;R2>

>  <CYP2D6>  (186) 
<3,4;Desulfation;R1>
<3,8;Cleavage;R2>

>  <CYP2E1>  (186) 


>  <CYP3A4>  (186) 
<3,4;Desulfation;R1>
<3,8;Cleavage;R2>

>  <References>  (186) 
Foxenberg RJ, McGarrigle BP, Knaak JB, Kostyniak PJ, Olson JR: Human hepatic cytochrome p450-specific metabolism of parathion and chlorpyrifos. Drug Metab Dispos. 2007 Feb;35(2):189-93. doi: 10.1124/dmd.106.012427. Epub 2006  Nov 1. (PMID: 17079358)
Mutch E, Williams FM: Diazinon, chlorpyrifos and parathion are metabolised by multiple cytochromes P450 in human liver. Toxicology. 2006 Jul 5;224(1-2):22-32. doi: 10.1016/j.tox.2006.04.024. Epub 2006  Apr 26. (PMID: 16757081)

>  <Comments>  (186) 
2E1 is also reported in Xenosite but it is removed in our dataset based on the two papers in the reference.

$$$$
CC02013
     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
    8.6650    1.2910    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.1350    2.2670    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5370    0.7670    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4030    2.2670    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6650   -0.7570    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.3930   -1.7640    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1350   -0.7330    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6610   -1.7570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5330   -0.2600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5250   -2.2600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3970   -0.7640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8010   -0.2540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0010   -0.2330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8950   -0.7680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2570   -2.2670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8010    0.7880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0010    0.7670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8950    1.3020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1350   -1.7330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1350    1.2670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2690   -0.2330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2690    0.7670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2690   -2.2330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4030    1.2670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 16  1  0
  2 20  2  0
  3 24  1  0
  4 24  2  0
  5  8  1  0
  5  9  1  0
  5 12  1  0
  6 10  1  0
  6 11  1  0
  6 15  1  0
  7 13  1  0
  7 19  1  0
  7 21  1  0
  8 10  1  0
  9 11  1  0
 12 14  1  0
 12 16  2  0
 13 14  2  0
 13 17  1  0
 16 18  1  0
 17 18  2  0
 17 20  1  0
 19 23  1  0
 20 22  1  0
 21 22  2  0
 22 24  1  0
M  END
>  <Name>  (187) 
Pefloxacin

>  <InChIKey>  (187) 
FHFYDNQZQSQIAI-UHFFFAOYSA-N

>  <PubChem_CID>  (187) 
51081

>  <CYP1A2>  (187) 
<18,19;Cleavage;R1>
<19,H;Oxidation;R1>

>  <CYP2A6>  (187) 


>  <CYP2B6>  (187) 


>  <CYP2C8>  (187) 


>  <CYP2C9>  (187) 


>  <CYP2C19>  (187) 


>  <CYP2D6>  (187) 


>  <CYP2E1>  (187) 


>  <CYP3A4>  (187) 


>  <References>  (187) 
Kinzig-Schippers M, Fuhr U, Zaigler M, Dammeyer J, Rusing G, Labedzki A, Bulitta J, Sorgel F: Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2. Clin Pharmacol Ther. 1999 Mar;65(3):262-74. doi: 10.1016/S0009-9236(99)70105-0. (PMID: 10096258)

>  <Comments>  (187) 


$$$$
CC02014
     RDKit          3D

 24 27  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3900    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1420    2.1590    0.1180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0040    0.0000   -0.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3130    2.0730    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3540    1.7290   -0.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0680    3.3850    0.7710 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0890   -0.6710   -0.6520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0960   -0.7200    0.3520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8160    2.1910    1.4600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5050    0.1890   -1.2380 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.4820    2.5340   -0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1940    4.1760    0.8990 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0610   -2.0600   -0.7420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1140   -2.0990    0.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1700    2.9040    1.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4010    3.7500    0.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0350   -2.7680   -0.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6530    3.0180    2.8520 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8170    3.9120    2.8200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1460    1.6890    3.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4500    3.9810    4.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7790    1.7590    4.6280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9440    2.6530    4.5960 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4270    2.7670    5.9780 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  2  0
  6 12  1  0
  7 10  1  0
  7 13  1  0
  8 14  2  0
  9 15  1  0
 11 16  1  0
 12 16  2  0
 13 17  2  0
 14 17  1  0
 15 18  1  0
 18 19  1  0
 18 20  1  0
 19 21  1  0
 20 22  1  0
 21 23  1  0
 22 23  1  0
 23 24  1  0
M  END
>  <Name>  (188) 
Perazine

>  <InChIKey>  (188) 
WEYVCQFUGFRXOM-UHFFFAOYSA-N

>  <PubChem_CID>  (188) 
4744

>  <CYP1A2>  (188) 
<15,S;S-Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2A6>  (188) 
<15,S;S-Oxidation;R1>

>  <CYP2B6>  (188) 
<15,S;S-Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2C8>  (188) 


>  <CYP2C9>  (188) 
<15,S;S-Oxidation;R1>

>  <CYP2C19>  (188) 
<15,S;S-Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2D6>  (188) 
<15,S;S-Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2E1>  (188) 
<15,S;S-Oxidation;R1>

>  <CYP3A4>  (188) 
<15,S;S-Oxidation;R1>

>  <References>  (188) 
Wojcikowski J, Pichard-Garcia L, Maurel P, Daniel WA: The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes. Eur Neuropsychopharmacol. 2004 May;14(3):199-208. doi: 10.1016/S0924-977X(03)00105-6. (PMID: 15056479)

>  <Comments>  (188) 


$$$$
CC02015
     RDKit          3D

 27 30  0  0  0  0  0  0  0  0999 V2000
   -0.1710    2.2120   -0.4920 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9550    3.0250   -0.3690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0940    0.8390   -0.7270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4950    2.8260   -0.3640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1590    2.7010   -0.9820 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8580    4.1860    0.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9930    0.2710   -1.3810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1360    0.0290   -0.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9340    2.7900    1.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3390    1.2460   -1.9510 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.2550    3.5450   -0.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9520    5.0180    0.5370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0230   -1.1040   -1.5920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0960   -1.3360   -0.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3160    3.4310    1.2360 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1500    4.6970   -0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8210    6.4650    1.4870 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.0170   -1.9020   -1.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7370    3.3960    2.6430 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9410    4.2310    2.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6860    4.0700    3.4150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3680    4.3420    4.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1130    4.1810    4.8790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3160    5.0160    4.9800 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7380    4.9810    6.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6380    5.5850    7.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4580    6.9610    6.9200 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  2  0
  6 12  1  0
  7 10  1  0
  7 13  1  0
  8 14  2  0
  9 15  1  0
 11 16  1  0
 12 16  2  0
 12 17  1  0
 13 18  2  0
 14 18  1  0
 15 19  1  0
 19 20  1  0
 19 21  1  0
 20 22  1  0
 21 23  1  0
 22 24  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
M  END
>  <Name>  (189) 
Perphenazine

>  <InChIKey>  (189) 
RGCVKNLCSQQDEP-UHFFFAOYSA-N

>  <PubChem_CID>  (189) 
4748

>  <CYP1A2>  (189) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>

>  <CYP2A6>  (189) 


>  <CYP2B6>  (189) 


>  <CYP2C8>  (189) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>

>  <CYP2C9>  (189) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>

>  <CYP2C19>  (189) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>

>  <CYP2D6>  (189) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>
<17,S;S-Oxidation;R2>
<14,H;Hydroxylation;R3>

>  <CYP2E1>  (189) 


>  <CYP3A4>  (189) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>

>  <References>  (189) 
Olesen OV, Linnet K: Identification of the human cytochrome P450 isoforms mediating in vitro N-dealkylation of perphenazine. Br J Clin Pharmacol. 2000 Dec;50(6):563-71. doi: 10.1046/j.1365-2125.2000.00298.x. (PMID: 11136295)
Zhou SF: Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin Pharmacokinet. 2009;48(12):761-804. doi: 10.2165/11318070-000000000-00000. (PMID: 19902987)

>  <Comments>  (189) 


$$$$
CC02016
     RDKit          2D

 13 13  0  0  0  0  0  0  0  0999 V2000
    2.8660   -2.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5980    2.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    2.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660   -1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -3.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    3.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  1 10  1  0
  2 12  2  0
  3  4  1  0
  3 12  1  0
  4  6  2  0
  4  7  1  0
  5  8  2  0
  5  9  1  0
  6  8  1  0
  7  9  2  0
 10 11  1  0
 12 13  1  0
M  END
>  <Name>  (190) 
Phenacetin

>  <InChIKey>  (190) 
CPJSUEIXXCENMM-UHFFFAOYSA-N

>  <PubChem_CID>  (190) 
4754

>  <CYP1A2>  (190) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<9,H;Hydroxylation;R2>

>  <CYP2A6>  (190) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2B6>  (190) 


>  <CYP2C8>  (190) 


>  <CYP2C9>  (190) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2C19>  (190) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2D6>  (190) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2E1>  (190) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP3A4>  (190) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <References>  (190) 
Nakajima M, Kobayashi K, Oshima K, Shimada N, Tokudome S, Chiba K, Yokoi T: Activation of phenacetin O-deethylase activity by alpha-naphthoflavone in human liver microsomes. Xenobiotica. 1999 Sep;29(9):885-98. doi: 10.1080/004982599238137. (PMID: 10548449)
Guengerich FP, Parikh A, Yun CH, Kim D, Nakamura K, Notley LM, Gillam EM: What makes P450s work? Searches for answers with known and new P450s. Drug Metab Rev. 2000 Aug-Nov;32(3-4):267-81. doi: 10.1081/DMR-100102334. (PMID: 11139129)
Kobayashi K, Nakajima M, Oshima K, Shimada N, Yokoi T, Chiba K: Involvement of CYP2E1 as A low-affinity enzyme in phenacetin O-deethylation in human liver microsomes. Drug Metab Dispos. 1999 Aug;27(8):860-5. (PMID: 10421611)

>  <Comments>  (190) 


$$$$
CC02018
     RDKit          3D

 19 21  0  0  0  0  0  0  0  0999 V2000
   -0.0570    1.5580    0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2250    0.2250    0.2410 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4370    1.7730   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9440   -0.4240    0.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9900    0.4090    0.0580 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9220    2.4070    0.1260 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0490   -1.6320    0.2820 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7660    2.4210   -1.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9550    2.6060    1.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7410    1.8750   -2.1360 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0900    3.5590   -1.7210 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0640    2.1880    1.8550 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3250    3.7900    1.4760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3920    4.1530   -2.9320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5380    2.9510    2.9050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8000    4.5530    2.5260 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0430    2.4700   -3.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3710    3.6110   -3.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9050    4.1330    3.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  6  2  0
  2  4  1  0
  3  5  1  0
  3  8  1  0
  3  9  1  0
  4  5  1  0
  4  7  2  0
  8 10  2  0
  8 11  1  0
  9 12  2  0
  9 13  1  0
 10 17  1  0
 11 14  2  0
 12 15  1  0
 13 16  2  0
 14 18  1  0
 15 19  2  0
 16 19  1  0
 17 18  2  0
M  END
>  <Name>  (191) 
Phenytoin

>  <InChIKey>  (191) 
CXOFVDLJLONNDW-UHFFFAOYSA-N

>  <PubChem_CID>  (191) 
1775

>  <CYP1A2>  (191) 
<14,H;Hydroxylation;R1>
<16,H;Hydroxylation;R2>
<14,15;EpOxidation;R3>
<15,16;EpOxidation;R4>
<8,H;Hydroxylation;R5>
<10,H;Hydroxylation;R6>
<8,9;EpOxidation;R7>
<9,10;EpOxidation;R8>
<15,H;Hydroxylation;R9>
<9,H;Hydroxylation;R10>

>  <CYP2A6>  (191) 
<14,H;Hydroxylation;R1>
<16,H;Hydroxylation;R2>
<14,15;EpOxidation;R3>
<15,16;EpOxidation;R4>
<8,H;Hydroxylation;R5>
<10,H;Hydroxylation;R6>
<8,9;EpOxidation;R7>
<9,10;EpOxidation;R8>

>  <CYP2B6>  (191) 
<15,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>

>  <CYP2C8>  (191) 
<14,15;EpOxidation;R1>
<15,16;EpOxidation;R2>
<8,9;EpOxidation;R3>
<9,10;EpOxidation;R4>

>  <CYP2C9>  (191) 
<14,H;Hydroxylation;R1>
<16,H;Hydroxylation;R2>
<14,15;EpOxidation;R3>
<15,16;EpOxidation;R4>
<8,H;Hydroxylation;R5>
<10,H;Hydroxylation;R6>
<8,9;EpOxidation;R7>
<9,10;EpOxidation;R8>
<15,H;Hydroxylation;R9>
<9,H;Hydroxylation;R10>

>  <CYP2C19>  (191) 
<14,H;Hydroxylation;R1>
<16,H;Hydroxylation;R2>
<14,15;EpOxidation;R3>
<15,16;EpOxidation;R4>
<8,H;Hydroxylation;R5>
<10,H;Hydroxylation;R6>
<8,9;EpOxidation;R7>
<9,10;EpOxidation;R8>
<15,H;Hydroxylation;R9>
<9,H;Hydroxylation;R10>

>  <CYP2D6>  (191) 
<14,15;EpOxidation;R1>
<15,16;EpOxidation;R2>
<8,9;EpOxidation;R3>
<9,10;EpOxidation;R4>
<15,H;Hydroxylation;R5>
<9,H;Hydroxylation;R6>

>  <CYP2E1>  (191) 
<14,15;EpOxidation;R1>
<15,16;EpOxidation;R2>
<8,9;EpOxidation;R3>
<9,10;EpOxidation;R4>

>  <CYP3A4>  (191) 
<14,15;EpOxidation;R1>
<15,16;EpOxidation;R2>
<8,9;EpOxidation;R3>
<9,10;EpOxidation;R4>

>  <References>  (191) 
Komatsu T, Yamazaki H, Asahi S, Gillam EM, Guengerich FP, Nakajima M, Yokoi T: Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9, 2C19, and 3A4. Drug Metab Dispos. 2000 Nov;28(11):1361-8. (PMID: 11038165)
Ono S, Hatanaka T, Hotta H, Satoh T, Gonzalez FJ, Tsutsui M: Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica. 1996 Jul;26(7):681-93. doi: 10.3109/00498259609046742. (PMID: 8819299)

>  <Comments>  (191) 


$$$$
CC02019
     RDKit          3D

 13 12  0  0  0  0  0  0  0  0999 V2000
    0.0600    1.8750   -0.0690 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2770   -0.1900   -0.4090 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.6440    2.1570   -0.0060 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5900    2.7300   -1.2680 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7240    2.3750    1.5460 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.4140   -0.3510   -2.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1000    1.6730    1.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0060    2.6970   -1.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2260   -0.3430   -1.9850 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.6060    1.9120    1.3840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6950    3.3750   -2.2650 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5160   -2.0150   -1.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0200   -2.2440   -1.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  2  0
  2  6  1  0
  3  7  1  0
  4  8  1  0
  6  9  1  0
  7 10  1  0
  8 11  1  0
  9 12  1  0
 12 13  1  0
M  END
>  <Name>  (192) 
Phorate

>  <InChIKey>  (192) 
BULVZWIRKLYCBC-UHFFFAOYSA-N

>  <PubChem_CID>  (192) 
4790

>  <CYP1A2>  (192) 
<10,S;S-Oxidation;R1>

>  <CYP2A6>  (192) 
<10,S;S-Oxidation;R1>

>  <CYP2B6>  (192) 
<10,S;S-Oxidation;R1>

>  <CYP2C8>  (192) 
<10,S;S-Oxidation;R1>

>  <CYP2C9>  (192) 
<10,S;S-Oxidation;R1>

>  <CYP2C19>  (192) 
<10,S;S-Oxidation;R1>

>  <CYP2D6>  (192) 
<10,S;S-Oxidation;R1>

>  <CYP2E1>  (192) 


>  <CYP3A4>  (192) 
<10,S;S-Oxidation;R1>

>  <References>  (192) 
Usmani KA, Karoly ED, Hodgson E, Rose RL: In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily. Drug Metab Dispos. 2004 Mar;32(3):333-9. doi: 10.1124/dmd.32.3.333. (PMID: 14977868)

>  <Comments>  (192) 
Other metabolites are also possible but cannot find articles as proof.

$$$$
CC02020
     RDKit          3D

 25 28  0  0  0  0  0  0  0  0999 V2000
   -5.2650   -1.6470    0.4540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9210   -1.3460    0.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5090   -0.0550    0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4610    0.9260   -0.2170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8030    0.6170   -0.1650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2090   -0.6700    0.1650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5320   -0.9720    0.2090 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2400    0.2210   -0.1310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0690    0.2730    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5520    1.5000   -0.3040 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0950   -0.5670    0.2670 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1760    1.3930   -0.2430 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0980    0.0630    0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4230   -0.3520    0.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4530    0.5560    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1610    1.8770   -0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8660    2.2870   -0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8560    0.1280    0.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7100    0.9330    0.7420 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0560    0.5840    0.8850 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5690   -0.4570    0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7170   -0.8020    0.3870 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7080   -1.1910   -0.7970 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2680   -1.2410   -0.2740 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.3340   -1.6920   -1.3990 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  3  9  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  9 10  1  0
  9 11  2  0
 10 12  1  0
 11 13  1  0
 12 13  2  0
 12 17  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 18  1  0
 16 17  2  0
 18 19  2  0
 18 24  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  6
M  END
>  <Name>  (193) 
Pimobendan

>  <InChIKey>  (193) 
GLBJJMFZWDBELO-NSHDSACASA-N

>  <PubChem_CID>  (193) 
6918916

>  <CYP1A2>  (193) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (193) 


>  <CYP2B6>  (193) 


>  <CYP2C8>  (193) 


>  <CYP2C9>  (193) 


>  <CYP2C19>  (193) 


>  <CYP2D6>  (193) 


>  <CYP2E1>  (193) 


>  <CYP3A4>  (193) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (193) 
Kuriya Si, Ohmori S, Hino M, Ishii I, Nakamura H, Senda C, Igarashi T, Kiuchi M, Kitada M: Identification of cytochrome P-450 isoform(s) responsible for the metabolism of pimobendan in human liver microsomes. Drug Metab Dispos. 2000 Jan;28(1):73-8. (PMID: 10611143)

>  <Comments>  (193) 


$$$$
CC02021
     RDKit          3D

 34 38  0  0  0  0  0  0  0  0999 V2000
    5.0500   -0.4370   -0.1960 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1440   -0.0100    0.5530 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2080    0.1430   -0.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4440    0.5650    0.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6160    0.8310    1.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5610    0.6790    2.3570 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3270    0.2590    1.9010 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7280   -0.1950   -1.6000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4330   -0.5440   -1.4830 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7170   -0.8990   -2.4000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7130   -0.7270    0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3520   -2.1870    0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9130   -2.4490    0.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9950   -1.5870   -0.2730 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2820   -0.2010    0.1140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6880    0.1870   -0.3510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3590   -1.8870    0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3730   -1.0170   -0.5350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7830   -1.3310   -0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7970   -0.4610   -0.7760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1850   -0.7690   -0.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4870    0.9940   -0.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3480    1.8600   -1.6000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0640    3.1940   -1.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9200    3.6630   -0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0600    2.7950    0.9870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3480    1.4620    0.7620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6420    4.9670    0.1370 F   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1870   -1.0820   -1.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4610   -1.3650   -0.7250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7340   -1.3370    0.6330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7300   -1.0230    1.5330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4550   -0.7450    1.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9790   -1.6130    1.0780 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  9  1  0
  1 11  1  0
  2  3  1  0
  2  7  2  0
  3  4  2  0
  3  8  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  8  9  1  0
  9 10  2  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 17  1  0
 15 16  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 21 29  2  0
 21 33  1  0
 22 23  2  0
 22 27  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 25 28  1  0
 26 27  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 31 34  1  0
 32 33  2  0
M  END
>  <Name>  (194) 
Pimozide

>  <InChIKey>  (194) 
YVUQSNJEYSNKRX-UHFFFAOYSA-N

>  <PubChem_CID>  (194) 
16362

>  <CYP1A2>  (194) 
<13,14;Cleavage;R1>
<14,H;Oxidation;R1>

>  <CYP2A6>  (194) 


>  <CYP2B6>  (194) 


>  <CYP2C8>  (194) 


>  <CYP2C9>  (194) 


>  <CYP2C19>  (194) 


>  <CYP2D6>  (194) 


>  <CYP2E1>  (194) 


>  <CYP3A4>  (194) 
<13,14;Cleavage;R1>
<14,H;Oxidation;R1>

>  <References>  (194) 
Desta Z, Kerbusch T, Soukhova N, Richard E, Ko JW, Flockhart DA: Identification and characterization of human cytochrome P450 isoforms interacting with pimozide. J Pharmacol Exp Ther. 1998 May;285(2):428-37. (PMID: 9580580)

>  <Comments>  (194) 


$$$$
CC02022
     RDKit          3D

 23 26  0  0  0  0  0  0  0  0999 V2000
   -4.1190   -0.9300    0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8210   -0.8520    0.3280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8730    0.2870   -0.2860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2900    1.5940    0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9070    0.2500   -0.9180 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8180    1.6240   -0.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0530    0.4340    0.3550 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.0940   -2.1420    0.6620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6850    0.7350    1.8090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7430    0.2750   -0.4260 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.0320   -0.9350    0.1160 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.8030   -2.2060   -0.1570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0730    1.5580   -0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4530    1.4210   -0.9630 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1510    0.2480   -0.3020 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.3440   -1.0170   -0.6420 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.3080   -2.1190   -0.1870 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5540   -0.0800   -0.8020 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.6870   -1.6000   -0.6790 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1750    0.4470    1.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5880    0.5950    0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0240    2.0040   -0.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0660    0.0060    1.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  2  7  1  0
  2  8  1  0
  3  4  1  0
  3  5  2  0
  4  6  1  0
  6  7  1  0
  7  9  1  1
  7 10  1  0
  8 12  1  0
 10 11  1  0
 10 13  1  1
 11 12  1  6
 11 16  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 18  1  0
 15 20  1  1
 16 17  1  1
 17 19  1  0
 18 19  1  0
 18 21  1  1
 21 22  1  0
 21 23  2  0
M  END
>  <Name>  (195) 
Progesterone

>  <InChIKey>  (195) 
RJKFOVLPORLFTN-LEKSSAKUSA-N

>  <PubChem_CID>  (195) 
5994

>  <CYP1A2>  (195) 
<9,H;Hydroxylation;R1>

>  <CYP2A6>  (195) 
<9,H;Hydroxylation;R1>

>  <CYP2B6>  (195) 


>  <CYP2C8>  (195) 


>  <CYP2C9>  (195) 
<9,H;Hydroxylation;R1>
<4,H;Hydroxylation;R2>
<0,H;Hydroxylation;R3>

>  <CYP2C19>  (195) 
<9,H;Hydroxylation;R1>
<4,H;Hydroxylation;R2>
<0,H;Hydroxylation;R3>
<3,H;Hydroxylation;R4>
<14,H;Hydroxylation;R5>

>  <CYP2D6>  (195) 
<9,H;Hydroxylation;R1>
<4,H;Hydroxylation;R2>

>  <CYP2E1>  (195) 


>  <CYP3A4>  (195) 
<9,H;Hydroxylation;R1>
<4,H;Hydroxylation;R2>
<0,H;Hydroxylation;R3>
<14,H;Hydroxylation;R4>

>  <References>  (195) 
Niwa T, Yabusaki Y, Honma K, Matsuo N, Tatsuta K, Ishibashi F, Katagiri M: Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones. Xenobiotica. 1998 Jun;28(6):539-47. doi: 10.1080/004982598239290. (PMID: 9667077)
Yamazaki H, Shimada T: Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Arch Biochem Biophys. 1997 Oct 1;346(1):161-9. doi: 10.1006/abbi.1997.0302. (PMID: 9328296)

>  <Comments>  (195) 


$$$$
CC02023
     RDKit          3D

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0430    1.5840    0.0510 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1520    2.4400    0.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0690    0.1900   -0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2720    2.2060    0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4690    1.9520    0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9770    3.8260    0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2760   -0.5260   -0.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1230   -0.5360   -0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7560    2.2410    1.5560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8770    0.2290   -0.0190 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.5500    2.8320    0.2860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0540    4.7000    0.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2660   -1.9130   -0.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1310   -1.9160   -0.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1070    2.9140    1.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3470    4.2000    0.4310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0700   -2.6070   -0.5380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6150    2.9690    2.9600 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7940    3.8840    3.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9430    3.5530    2.8930 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  7 10  1  0
  7 13  1  0
  8 14  2  0
  9 15  1  0
 11 16  2  0
 12 16  1  0
 13 17  2  0
 14 17  1  0
 15 18  1  0
 18 19  1  0
 18 20  1  0
M  END
>  <Name>  (196) 
Promazine

>  <InChIKey>  (196) 
ZGUGWUXLJSTTMA-UHFFFAOYSA-N

>  <PubChem_CID>  (196) 
4926

>  <CYP1A2>  (196) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<13,S;S-Oxidation;R3>

>  <CYP2A6>  (196) 
<13,S;S-Oxidation;R1>

>  <CYP2B6>  (196) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<13,S;S-Oxidation;R3>

>  <CYP2C8>  (196) 


>  <CYP2C9>  (196) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<13,S;S-Oxidation;R3>

>  <CYP2C19>  (196) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<13,S;S-Oxidation;R3>

>  <CYP2D6>  (196) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<13,S;S-Oxidation;R3>

>  <CYP2E1>  (196) 
<13,S;S-Oxidation;R1>

>  <CYP3A4>  (196) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<13,S;S-Oxidation;R3>

>  <References>  (196) 
Wojcikowski J, Pichard-Garcia L, Maurel P, Daniel WA: Contribution of human cytochrome p-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine. Br J Pharmacol. 2003 Apr;138(8):1465-74. doi: 10.1038/sj.bjp.0705195. (PMID: 12721102)

>  <Comments>  (196) 


$$$$
CC02024
     RDKit          3D

 25 26  0  0  0  0  0  0  0  0999 V2000
    5.1520   -1.2950   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6450   -1.2510   -0.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8360   -1.3430    1.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2180   -1.3830    1.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9150   -1.3750   -0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2300   -1.3280   -1.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8490   -1.2940   -1.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1780    0.2050   -0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6710    0.2490   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9750    1.5410   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7050    2.7350    0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0440    3.9430    0.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3410    3.9840    0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0750    2.8150    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4290    1.5880   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1490    0.4390   -0.0560 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0340   -0.7830   -0.0610 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5280    0.8160   -0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3990   -0.4410   -0.0990 C   0  0  2  0  0  0  0  0  0  0  0  0
   -4.8750   -0.0380   -0.1030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7120   -1.2450   -0.1420 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1280   -1.2450    1.0500 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1090   -0.7900   -0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0410   -2.0030   -0.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.4950   -1.5290   -0.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  7  1  0
  2  8  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  8  9  1  0
  9 10  1  0
  9 17  2  0
 10 11  2  0
 10 15  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 19 22  1  1
 20 21  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
M  END
>  <Name>  (197) 
Propafenone

>  <InChIKey>  (197) 
JWHAUXFOSRPERK-SFHVURJKSA-N

>  <PubChem_CID>  (197) 
184820

>  <CYP1A2>  (197) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>

>  <CYP2A6>  (197) 


>  <CYP2B6>  (197) 


>  <CYP2C8>  (197) 


>  <CYP2C9>  (197) 


>  <CYP2C19>  (197) 


>  <CYP2D6>  (197) 
<11,H;Hydroxylation;R1>

>  <CYP2E1>  (197) 


>  <CYP3A4>  (197) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>

>  <References>  (197) 
Botsch S, Gautier JC, Beaune P, Eichelbaum M, Kroemer HK: Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites. Mol Pharmacol. 1993 Jan;43(1):120-6. (PMID: 8423765)
Kroemer HK, Fischer C, Meese CO, Eichelbaum M: Enantiomer/enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanism. Mol Pharmacol. 1991 Jul;40(1):135-42. (PMID: 1857335)

>  <Comments>  (197) 


$$$$
CC02025
     RDKit          3D

 13 13  0  0  0  0  0  0  0  0999 V2000
    1.2200    0.7140    0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5030    1.4740    0.2460 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1970    1.1810    1.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4290    1.1690   -0.9080 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0040    1.3940    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020    2.7620    0.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2100    0.7100   -0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4950    1.4650   -0.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1880    1.1570   -1.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4210    1.1700    0.9310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1930   -0.6880   -0.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0070   -1.3830    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2060   -0.6840    0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  2  0
  1 13  1  0
  2  3  1  0
  2  4  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  7 11  2  0
  8  9  1  0
  8 10  1  0
 11 12  1  0
 12 13  2  0
M  END
>  <Name>  (198) 
Propofol

>  <InChIKey>  (198) 
OLBCVFGFOZPWHH-UHFFFAOYSA-N

>  <PubChem_CID>  (198) 
4943

>  <CYP1A2>  (198) 
<5,H;Hydroxylation;R1>

>  <CYP2A6>  (198) 
<5,H;Hydroxylation;R1>

>  <CYP2B6>  (198) 
<5,H;Hydroxylation;R1>

>  <CYP2C8>  (198) 
<5,H;Hydroxylation;R1>

>  <CYP2C9>  (198) 
<5,H;Hydroxylation;R1>

>  <CYP2C19>  (198) 
<5,H;Hydroxylation;R1>

>  <CYP2D6>  (198) 
<5,H;Hydroxylation;R1>

>  <CYP2E1>  (198) 
<5,H;Hydroxylation;R1>

>  <CYP3A4>  (198) 
<5,H;Hydroxylation;R1>

>  <References>  (198) 
Guitton J, Buronfosse T, Desage M, Flinois JP, Perdrix JP, Brazier JL, Beaune P: Possible involvement of multiple human cytochrome P450 isoforms in the liver metabolism of propofol. Br J Anaesth. 1998 Jun;80(6):788-95. doi: 10.1093/bja/80.6.788. (PMID: 9771309)
Court MH, Duan SX, Hesse LM, Venkatakrishnan K, Greenblatt DJ: Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes. Anesthesiology. 2001 Jan;94(1):110-9. doi: 10.1097/00000542-200101000-00021. (PMID: 11135730)

>  <Comments>  (198) 


$$$$
CC02027
     RDKit          3D

 25 26  0  0  1  0  0  0  0  0999 V2000
    5.0520    0.6840   -0.4800 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7430    1.3840   -0.4900 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9400   -1.7380    0.2410 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4330   -3.9810   -4.7540 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3740   -5.1030   -3.0890 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9610   -1.4620   -0.2230 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.6060   -0.7110   -0.3310 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.8540   -0.4000    0.4440 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.9330    0.6020    0.4090 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.9410    0.2260    1.4710 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4800   -1.9450   -1.5700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4770   -1.4640    0.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8250   -2.6170   -1.5780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3580   -1.8080   -0.3630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7760   -2.5650    0.2690 C   0  0  2  0  0  0  0  0  0  0  0  0
    6.0830   -3.9180   -1.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1160   -3.8630   -0.4770 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0210   -4.9420   -1.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1220   -4.9950   -0.2020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4130   -6.2670   -1.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9700   -6.0740   -2.1330 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5340   -7.4230   -0.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7110   -5.5960   -3.5650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2090   -8.6550   -1.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3870   -4.8840   -3.7400 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  8  1  1  6
  9  2  1  6
 15  3  1  6
  4 25  1  0
  5 25  2  0
  6  7  1  0
  6  8  1  0
  6 11  1  6
  7  9  1  0
  7 12  1  1
  8 10  1  0
  9 10  1  0
 11 13  1  0
 12 14  2  0
 13 16  2  0
 14 15  1  0
 15 17  1  0
 16 18  1  0
 17 19  1  0
 18 21  1  0
 19 20  1  0
 20 22  1  0
 21 23  1  0
 22 24  1  0
 23 25  1  0
M  END
>  <Name>  (199) 
Prostaglandin H2

>  <InChIKey>  (199) 
YIBNHAJFJUQSRA-YNNPMVKQSA-N

>  <PubChem_CID>  (199) 
445049

>  <CYP1A2>  (199) 
<10,20;Cleavage;R1>
<9,22;Cleavage;R1>
<9,10;Redunction;R1>
<20,24;Oxidation;R1>
<22,23;Oxidation;R1>
<23,24;Cleavage;R1>

>  <CYP2A6>  (199) 


>  <CYP2B6>  (199) 


>  <CYP2C8>  (199) 


>  <CYP2C9>  (199) 


>  <CYP2C19>  (199) 


>  <CYP2D6>  (199) 


>  <CYP2E1>  (199) 
<10,20;Cleavage;R1>
<9,22;Cleavage;R1>
<9,10;Redunction;R1>
<20,24;Oxidation;R1>
<22,23;Oxidation;R1>
<23,24;Cleavage;R1>

>  <CYP3A4>  (199) 
<10,20;Cleavage;R1>
<9,22;Cleavage;R1>
<9,10;Redunction;R1>
<20,24;Oxidation;R1>
<22,23;Oxidation;R1>
<23,24;Cleavage;R1>

>  <References>  (199) 
Plastaras JP, Guengerich FP, Nebert DW, Marnett LJ: Xenobiotic-metabolizing cytochromes P450 convert prostaglandin endoperoxide to hydroxyheptadecatrienoic acid and the mutagen, malondialdehyde. J Biol Chem. 2000 Apr 21;275(16):11784-90. doi: 10.1074/jbc.275.16.11784. (PMID: 10766802)

>  <Comments>  (199) 
This reaction is very special.

$$$$
CC02028
     RDKit          3D

 24 24  0  0  0  0  0  0  0  0999 V2000
    0.4860   -3.9100    0.1690 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.9940   -6.7500   -0.4960 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.1900   -8.4310   -0.5410 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.1460   -2.5830    0.1800 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4070    1.5590    0.5800 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5340    5.9670   -0.7380 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6930    2.0890    0.4990 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9110    4.0740    0.4200 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3000    6.1360    1.5240 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5150    4.1210    0.5780 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2520   -0.4980    0.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4340   -1.9790    0.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6030    0.1670    0.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5540    7.4250   -0.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2160   -3.9390    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1560    7.9190   -1.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4800    7.8890   -1.8330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0220   -4.6680   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4250   -4.6220   -0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4510   -6.0060   -0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0440   -6.0510   -0.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2550   -6.7230   -0.3350 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9030    5.4480    0.3910 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7440    3.4810    0.4920 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 18  1  0
  2 20  1  0
  3 22  1  0
  4 12  1  0
  4 15  1  0
  5  7  1  0
  5 13  1  0
  6 14  1  0
  6 23  2  0
  7 24  1  0
  8 23  1  0
  8 24  2  0
  9 23  1  0
 10 24  1  0
 11 12  1  0
 11 13  1  0
 14 16  1  0
 14 17  1  0
 15 18  2  0
 15 19  1  0
 18 21  1  0
 19 20  2  0
 20 22  1  0
 21 22  2  0
M  END
>  <Name>  (200) 
PS-15

>  <InChIKey>  (200) 
LXMYLZNSNKNNEJ-UHFFFAOYSA-N

>  <PubChem_CID>  (200) 
72970

>  <CYP1A2>  (200) 
<1,6;Cyclization;R1>

>  <CYP2A6>  (200) 


>  <CYP2B6>  (200) 


>  <CYP2C8>  (200) 


>  <CYP2C9>  (200) 


>  <CYP2C19>  (200) 
<1,6;Cyclization;R1>

>  <CYP2D6>  (200) 
<1,6;Cyclization;R1>

>  <CYP2E1>  (200) 


>  <CYP3A4>  (200) 
<1,6;Cyclization;R1>

>  <References>  (200) 
Diaz DS, Kozar MP, Smith KS, Asher CO, Sousa JC, Schiehser GA, Jacobus DP, Milhous WK, Skillman DR, Shearer TW: Role of specific cytochrome P450 isoforms in the conversion of phenoxypropoxybiguanide analogs in human liver microsomes to potent antimalarial dihydrotriazines. Drug Metab Dispos. 2008 Feb;36(2):380-5. doi: 10.1124/dmd.106.013920. Epub 2007 Nov 15. (PMID: 18006651)

>  <Comments>  (200) 
Oxidative cyclization is replaced with its intermediate hydroxylation metabolite.

$$$$
CC02029
     RDKit          3D

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.3400    0.3540    0.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5590    1.4200    0.1670 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0640   -1.0030    0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5760    0.8790    0.5820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9390    1.0970   -0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0520    2.5920    0.3670 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1660   -1.8320    0.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2660   -1.3360   -0.1650 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3430    2.2300    0.6050 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6910    0.0570    0.7570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2600   -0.2920   -0.3110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9160    2.0740   -0.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4450   -1.3230    0.6190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0370   -3.2650    0.2090 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3270    3.2590    0.8600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5710   -0.6520   -0.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2220    1.6910   -0.6040 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0660   -3.8010    0.7580 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9230   -3.8620   -0.4180 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0720    3.5820   -0.4130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5420    0.3380   -0.7630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1250    2.7110   -0.7320 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1140    4.6360   -0.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4260    2.2210   -1.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8520    4.9550   -1.3370 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7290    6.0670   -1.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7100    3.8320   -1.6780 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  4 10  2  0
  5 11  2  0
  5 12  1  0
  6  9  1  0
  7 13  2  0
  7 14  1  0
  8 11  1  0
  9 15  1  0
 10 13  1  0
 11 16  1  0
 12 17  2  0
 14 18  1  0
 14 19  2  0
 15 20  1  0
 16 21  2  0
 17 21  1  0
 17 22  1  0
 20 23  1  0
 22 24  1  0
 23 25  1  0
 25 26  1  0
 25 27  1  0
M  CHG  2  14   1  18  -1
M  END
>  <Name>  (201) 
Pyrazoloacridine

>  <InChIKey>  (201) 
HZCWPKGYTCJSEB-UHFFFAOYSA-N

>  <PubChem_CID>  (201) 
339455

>  <CYP1A2>  (201) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (201) 


>  <CYP2B6>  (201) 


>  <CYP2C8>  (201) 


>  <CYP2C9>  (201) 


>  <CYP2C19>  (201) 


>  <CYP2D6>  (201) 


>  <CYP2E1>  (201) 


>  <CYP3A4>  (201) 
<14,15;Cleavage;R1>
<15,H;Oxidation;R1>
<14,16;Cleavage;R2>
<16,H;Oxidation;R2>

>  <References>  (201) 
Reid JM, Walker DL, Miller JK, Benson LM, Tomlinson AJ, Naylor S, Blajeski AL, LoRusso PM, Ames MM: The metabolism of pyrazoloacridine (NSC 366140) by cytochromes p450 and flavin monooxygenase in human liver microsomes. Clin Cancer Res. 2004 Feb 15;10(4):1471-80. (PMID: 14977851)

>  <Comments>  (201) 


$$$$
CC02030
     RDKit          3D

 10 11  0  0  0  0  0  0  0  0999 V2000
    0.0210    0.6400   -0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0400   -0.7540   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1670    1.3900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1470    1.3740    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1440   -1.4600   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2090   -1.4360   -0.0240 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3660    0.6780   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3440    0.6720   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3440   -0.7300    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3580   -0.7260    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  4  8  2  0
  5  9  2  0
  6 10  1  0
  7 10  2  0
  8  9  1  0
M  END
>  <Name>  (202) 
Quinoline

>  <InChIKey>  (202) 
SMWDFEZZVXVKRB-UHFFFAOYSA-N

>  <PubChem_CID>  (202) 
7047

>  <CYP1A2>  (202) 
<0,9;EpOxidation;R1>
<6,H;Hydroxylation;R2>
<4,N;N-Oxidation;R3>

>  <CYP2A6>  (202) 
<0,9;EpOxidation;R1>
<6,H;Hydroxylation;R2>
<4,N;N-Oxidation;R3>

>  <CYP2B6>  (202) 
<0,9;EpOxidation;R1>

>  <CYP2C8>  (202) 


>  <CYP2C9>  (202) 


>  <CYP2C19>  (202) 


>  <CYP2D6>  (202) 
<0,9;EpOxidation;R1>

>  <CYP2E1>  (202) 
<0,9;EpOxidation;R1>
<6,H;Hydroxylation;R2>
<4,N;N-Oxidation;R3>

>  <CYP3A4>  (202) 
<0,9;EpOxidation;R1>
<6,H;Hydroxylation;R2>
<4,N;N-Oxidation;R3>
<2,H;Hydroxylation;R4>

>  <References>  (202) 
Reigh G, McMahon H, Ishizaki M, Ohara T, Shimane K, Esumi Y, Green C, Tyson C, Ninomiya S: Cytochrome P450 species involved in the metabolism of quinoline. Carcinogenesis. 1996 Sep;17(9):1989-96. doi: 10.1093/carcin/17.9.1989. (PMID: 8824525)
Dowers TS, Rock DA, Rock DA, Perkins BN, Jones JP: An analysis of the regioselectivity of aromatic hydroxylation and N-oxygenation by cytochrome P450 enzymes. Drug Metab Dispos. 2004 Mar;32(3):328-32. doi: 10.1124/dmd.32.3.328. (PMID: 14977867)

>  <Comments>  (202) 
Some metablites are generated by rat CYP450 enzymes.

$$$$
CC02031
     RDKit          3D

 24 26  0  0  0  0  0  0  0  0999 V2000
   -0.0830    1.2680    0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1220   -0.0140   -0.1760 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1930    1.7400    0.1980 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4260    2.3220    0.3360 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1100    1.6960    0.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7460    1.0830    0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7120    1.9050   -1.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2000   -0.3900   -0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0430    0.6940   -0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7080    2.0160    1.3870 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9840    2.4790   -1.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9380    2.5700    1.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6120    2.8200    0.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5470    2.6750   -2.2920 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3580    3.4700   -3.6020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0170    1.5260   -2.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7590   -1.6470   -0.5450 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.1890    4.2790   -4.8740 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4350    0.6110   -0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8340    3.2750   -2.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7230    4.1080   -3.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.4720    4.8780   -4.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9680   -0.6510   -0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1520   -1.7570   -0.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  8  1  0
  3  9  1  0
  4  6  1  0
  5  6  1  0
  5  7  2  0
  5 10  1  0
  7 11  1  0
  7 16  1  0
  8  9  2  0
  8 17  1  0
  9 19  1  0
 10 12  2  0
 11 13  2  0
 11 14  1  0
 12 13  1  0
 14 20  1  0
 15 20  1  0
 15 21  1  0
 17 24  2  0
 18 21  1  0
 18 22  1  0
 19 23  2  0
 23 24  1  0
M  END
>  <Name>  (203) 
Rabeprazole-thioether

>  <InChIKey>  (203) 
BSXAHDOWMOSVAP-UHFFFAOYSA-N

>  <PubChem_CID>  (203) 
9949996

>  <CYP1A2>  (203) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<12,S;S-Oxidation;R2>

>  <CYP2A6>  (203) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<12,S;S-Oxidation;R2>

>  <CYP2B6>  (203) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C8>  (203) 


>  <CYP2C9>  (203) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<12,S;S-Oxidation;R2>

>  <CYP2C19>  (203) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<12,S;S-Oxidation;R2>

>  <CYP2D6>  (203) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<12,S;S-Oxidation;R2>

>  <CYP2E1>  (203) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<12,S;S-Oxidation;R2>

>  <CYP3A4>  (203) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<12,S;S-Oxidation;R2>

>  <References>  (203) 
Miura M, Satoh S, Tada H, Habuchi T, Suzuki T: Stereoselective metabolism of rabeprazole-thioether to rabeprazole by human liver microsomes. Eur J Clin Pharmacol. 2006 Feb;62(2):113-7. doi: 10.1007/s00228-005-0077-8. Epub  2005 Dec 31. (PMID: 16389533)

>  <Comments>  (203) 


$$$$
CC02032
     RDKit          3D

 21 21  0  0  0  0  0  0  0  0999 V2000
   -0.6480    0.0600    0.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0270   -1.0010    0.8980 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0480    0.4530   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8630    0.5610    0.9820 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0710   -1.2840    0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1540   -0.4210   -0.9270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0490    0.5580    0.1350 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9010   -2.4150    0.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1950    0.6540    1.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0440    1.7750   -0.6600 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3810   -1.8510    1.4710 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.1430   -3.4690    1.7410 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2890   -4.2830    2.6840 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8590   -5.6120    2.7930 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2810   -6.5830    3.6220 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9530   -7.7540    3.5840 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1600   -6.2280    4.3640 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4950   -8.9010    4.3090 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4840   -7.0120    5.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3360   -9.2940    4.1290 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3390   -9.4570    5.0210 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  3  6  1  0
  4  7  1  0
  5  6  2  0
  5  8  1  0
  7  9  1  0
  7 10  1  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 16 18  1  0
 17 19  1  0
 18 20  1  0
 18 21  2  0
M  CHG  2  18   1  20  -1
M  END
>  <Name>  (204) 
Ranitidine

>  <InChIKey>  (204) 
VMXUWOKSQNHOCA-UKTHLTGXSA-N

>  <PubChem_CID>  (204) 
3001055

>  <CYP1A2>  (204) 
<17,19;Cleavage;R1>
<19,H;Oxidation;R1>
<17,18;Cleavage;R2>
<18,H;Oxidation;R2>

>  <CYP2A6>  (204) 


>  <CYP2B6>  (204) 


>  <CYP2C8>  (204) 


>  <CYP2C9>  (204) 


>  <CYP2C19>  (204) 
<17,19;Cleavage;R1>
<19,H;Oxidation;R1>
<17,18;Cleavage;R2>
<18,H;Oxidation;R2>

>  <CYP2D6>  (204) 
<17,19;Cleavage;R1>
<19,H;Oxidation;R1>
<17,18;Cleavage;R2>
<18,H;Oxidation;R2>

>  <CYP2E1>  (204) 


>  <CYP3A4>  (204) 


>  <References>  (204) 
Chung WG, Park CS, Roh HK, Lee WK, Cha YN: Oxidation of ranitidine by isozymes of flavin-containing monooxygenase and cytochrome P450. Jpn J Pharmacol. 2000 Oct;84(2):213-20. (PMID: 11128045)

>  <Comments>  (204) 


$$$$
CC02033
     RDKit          3D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -1.4130   -0.1220    0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4410   -1.0750   -0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7470   -0.8260    0.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0560    0.3690    1.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0520    1.3040    1.2190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7440    1.0640    0.7860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1600   -2.5950   -0.8330 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.5810    2.2420    1.2830 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.1210   -0.4460   -0.3720 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8310    0.3560   -1.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1560   -0.0970   -1.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0970    0.6590   -1.8640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7340    1.8640   -2.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4240    2.3160   -2.3550 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4830    1.5620   -1.6580 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6050   -1.3940   -0.5620 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7720   -1.2620    0.9340 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2020   -2.5130    1.4450 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  9  1  0
  2  3  1  0
  2  7  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  8  1  0
  9 10  1  0
 10 11  2  0
 10 15  1  0
 11 12  1  0
 11 16  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 16 17  1  0
 17 18  1  0
M  END
>  <Name>  (205) 
Reduced diclofenac

>  <InChIKey>  (205) 
NFWJEEBVQAMWHK-UHFFFAOYSA-N

>  <PubChem_CID>  (205) 
22294737

>  <CYP1A2>  (205) 
<5,H;Hydroxylation;R1>

>  <CYP2A6>  (205) 


>  <CYP2B6>  (205) 


>  <CYP2C8>  (205) 
<5,H;Hydroxylation;R1>

>  <CYP2C9>  (205) 
<5,H;Hydroxylation;R1>

>  <CYP2C19>  (205) 
<5,H;Hydroxylation;R1>

>  <CYP2D6>  (205) 
<5,H;Hydroxylation;R1>

>  <CYP2E1>  (205) 


>  <CYP3A4>  (205) 
<5,H;Hydroxylation;R1>

>  <References>  (205) 
Mancy A, Antignac M, Minoletti C, Dijols S, Mouries V, Duong NT, Battioni P, Dansette PM, Mansuy D: Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: particular efficiency and regioselectivity of P450 2Cs. Biochemistry. 1999 Oct 26;38(43):14264-70. doi: 10.1021/bi991195u. (PMID: 10572000)

>  <Comments>  (205) 
Rates of metabolites for CYP1A2, CYP2D6, and CYP3A4 are low.

$$$$
CC02034
     RDKit          3D

 15 16  0  0  0  0  0  0  0  0999 V2000
   -1.1610   -3.1780   -3.6390 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5410    1.4470   -0.8960 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0690    1.9040    1.1890 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2970    0.1550    0.7300 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0630    0.1220    0.2400 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1120   -2.3900   -4.5690 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0160   -3.9860   -5.8940 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2880   -2.0110   -2.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9090   -1.7110   -3.3760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6360   -1.4060   -1.4990 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2500   -0.4800   -0.9420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860   -0.7720   -2.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4460   -0.1660   -1.5790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0920   -3.1830   -4.8030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2530    0.8980    0.3030 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  8  1  0
  1 14  1  0
  2 15  1  0
  3 15  1  0
  4 15  1  0
  5 11  1  0
  5 15  1  0
  6  9  1  0
  6 14  2  0
  7 14  1  0
  8  9  2  0
  8 10  1  0
  9 12  1  0
 10 11  2  0
 11 13  1  0
 12 13  2  0
M  END
>  <Name>  (206) 
Riluzole

>  <InChIKey>  (206) 
FTALBRSUTCGOEG-UHFFFAOYSA-N

>  <PubChem_CID>  (206) 
5070

>  <CYP1A2>  (206) 
<0,H;Hydroxylation;R1>

>  <CYP2A6>  (206) 


>  <CYP2B6>  (206) 


>  <CYP2C8>  (206) 


>  <CYP2C9>  (206) 


>  <CYP2C19>  (206) 


>  <CYP2D6>  (206) 


>  <CYP2E1>  (206) 


>  <CYP3A4>  (206) 


>  <References>  (206) 
Sanderink GJ, Bournique B, Stevens J, Petry M, Martinet M: Involvement of human CYP1A isoenzymes in the metabolism and drug interactions of riluzole in vitro. J Pharmacol Exp Ther. 1997 Sep;282(3):1465-72. (PMID: 9316860)

>  <Comments>  (206) 


$$$$
CC02036
     RDKit          3D

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.9280   -0.5320    0.8250 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2230   -0.2590    0.3700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9870    0.7210    0.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2640    0.9880    0.5390 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7830    0.2810   -0.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0250   -0.6950   -1.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7490   -0.9710   -0.7000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4220    1.4920    2.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9260   -2.0400   -1.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1230   -0.3870   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5170   -0.6870    0.4830 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.0530   -0.0150   -1.1470 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4800    0.1390   -0.2530 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8270   -2.1680    0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2310   -2.4750    0.7880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7980   -0.0850    0.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2340   -1.5320    0.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1260    1.5400    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8200    2.4450   -1.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4510    3.9040   -0.7270 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1 10  1  0
  2  3  2  0
  2  7  1  0
  3  4  1  0
  3  8  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  9  1  0
 11 10  1  6
 10 12  2  0
 11 13  1  0
 11 14  1  0
 13 16  1  0
 13 18  1  0
 14 15  1  0
 15 17  1  0
 16 17  1  0
 18 19  1  0
 19 20  1  0
M  END
>  <Name>  (207) 
Ropivacaine

>  <InChIKey>  (207) 
ZKMNUMMKYBVTFN-HNNXBMFYSA-N

>  <PubChem_CID>  (207) 
175805

>  <CYP1A2>  (207) 
<15,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>

>  <CYP2A6>  (207) 


>  <CYP2B6>  (207) 
<16,H;Hydroxylation;R1>

>  <CYP2C8>  (207) 


>  <CYP2C9>  (207) 


>  <CYP2C19>  (207) 


>  <CYP2D6>  (207) 
<16,H;Hydroxylation;R1>

>  <CYP2E1>  (207) 


>  <CYP3A4>  (207) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>
<16,H;Hydroxylation;R2>
<14,H;Hydroxylation;R3>
<19,H;Hydroxylation;R4>

>  <References>  (207) 
Ekstrom G, Gunnarsson UB: Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes. Drug Metab Dispos. 1996 Sep;24(9):955-61. (PMID: 8886604)
Oda Y, Furuichi K, Tanaka K, Hiroi T, Imaoka S, Asada A, Fujimori M, Funae Y: Metabolism of a new local anesthetic, ropivacaine, by human hepatic cytochrome P450. Anesthesiology. 1995 Jan;82(1):214-20. doi: 10.1097/00000542-199501000-00026. (PMID: 7832304)

>  <Comments>  (207) 


$$$$
CC02037
     RDKit          3D

 25 27  0  0  0  0  0  0  0  0999 V2000
   -0.0160    1.3420    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0790    2.0830    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7420   -0.4080   -0.0170 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.3900    1.3110   -0.0140 C   0  0  1  0  0  0  0  0  0  0  0  0
    9.3200   -4.4040    0.5580 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5780   -4.5610    1.8480 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9450   -0.7670    0.0070 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7360   -3.2470   -0.0910 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0400    3.2950    0.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1930    1.6050   -1.2820 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5320    0.9190   -1.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9900   -0.3420   -1.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6790   -0.3680   -1.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6130    1.5790   -0.6460 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8420    0.9520   -0.5690 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9050   -1.0000   -1.6080 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1980   -0.9610   -0.9740 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0300   -2.2620   -1.5410 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3600   -3.0160   -1.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6430   -5.3890   -0.1540 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2020   -5.6440    2.5010 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5490   -2.2590    0.6220 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2360   -6.5350    0.5050 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5210   -6.6590    1.8580 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  2  8  2  0
  3  5  1  0
  3 10  2  0
  4  5  1  0
  5 11  1  6
  6  7  2  0
  6  9  1  0
  6 21  1  0
  7 22  1  0
  9 20  1  0
  9 23  1  0
 11 12  1  0
 12 14  2  0
 12 15  1  0
 13 16  1  0
 13 17  2  0
 13 18  1  0
 14 17  1  0
 15 16  2  0
 18 19  1  0
 19 20  1  0
 21 24  2  0
 22 25  2  0
 24 25  1  0
M  END
>  <Name>  (208) 
Rosiglitazone

>  <InChIKey>  (208) 
YASAKCUCGLMORW-HNNXBMFYSA-N

>  <PubChem_CID>  (208) 
445655

>  <CYP1A2>  (208) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<22,H;Hydroxylation;R2>
<20,H;Hydroxylation;R3>

>  <CYP2A6>  (208) 


>  <CYP2B6>  (208) 


>  <CYP2C8>  (208) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<22,H;Hydroxylation;R2>

>  <CYP2C9>  (208) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<22,H;Hydroxylation;R2>

>  <CYP2C19>  (208) 


>  <CYP2D6>  (208) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<22,H;Hydroxylation;R2>

>  <CYP2E1>  (208) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<22,H;Hydroxylation;R2>

>  <CYP3A4>  (208) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (208) 
Baldwin SJ, Clarke SE, Chenery RJ: Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone. Br J Clin Pharmacol. 1999 Sep;48(3):424-32. doi: 10.1046/j.1365-2125.1999.00030.x. (PMID: 10510156)

>  <Comments>  (208) 


$$$$
CC02038
     RDKit          3D

 22 26  0  0  1  0  0  0  0  0999 V2000
   -0.0180    1.4700    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1640    2.1770    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0700    2.3480    0.0190 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1880   -0.6140    0.3600 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0680   -0.6770   -0.3360 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8490    3.5310    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4890    1.4510   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5710    3.6220    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3010   -1.9600    0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3200    0.1830    0.8440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0760   -2.0230   -0.3910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6410    4.6910    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2070    4.8610    0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1090   -2.7310   -0.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3560   -2.5150    0.5450 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2270   -2.7330   -0.7450 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9850    5.8950    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3980    5.9840    0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1260   -4.1230   -0.1540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1890   -4.1080   -0.8000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0200   -4.8000   -0.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6 12  1  0
  7  9  2  0
  7 13  1  0
  8 11  1  0
  9 14  1  0
 10 15  1  0
 10 16  2  0
 12 15  2  0
 12 17  1  0
 13 18  2  0
 14 19  2  0
 15 20  1  0
 17 21  2  0
 18 19  1  0
 20 22  2  0
 21 22  1  0
M  END
>  <Name>  (209) 
Rutaecarpine

>  <InChIKey>  (209) 
ACVGWSKVRYFWRP-UHFFFAOYSA-N

>  <PubChem_CID>  (209) 
65752

>  <CYP1A2>  (209) 
<4,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>
<20,H;Hydroxylation;R3>
<18,H;Hydroxylation;R4>

>  <CYP2A6>  (209) 


>  <CYP2B6>  (209) 


>  <CYP2C8>  (209) 


>  <CYP2C9>  (209) 
<4,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>
<20,H;Hydroxylation;R3>
<18,H;Hydroxylation;R4>
<19,H;Hydroxylation;R5>

>  <CYP2C19>  (209) 


>  <CYP2D6>  (209) 
<4,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>
<20,H;Hydroxylation;R3>
<18,H;Hydroxylation;R4>

>  <CYP2E1>  (209) 


>  <CYP3A4>  (209) 
<4,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>
<20,H;Hydroxylation;R3>
<18,H;Hydroxylation;R4>
<19,H;Hydroxylation;R5>

>  <References>  (209) 
Lee SK, Lee JH, Yoo HH, Kim DH, Jahng Y, Jeong TC: Characterization of human liver cytochrome P450 enzymes involved in the metabolism of rutaecarpine. J Pharm Biomed Anal. 2006 Apr 11;41(1):304-9. doi: 10.1016/j.jpba.2005.10.039. Epub 2005 Nov 28. (PMID: 16318905)
Ueng YF, Don MJ, Jan WC, Wang SY, Ho LK, Chen CF: Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450. Drug Metab Dispos. 2006 May;34(5):821-7. doi: 10.1124/dmd.105.007849. Epub 2006 Feb 24. (PMID: 16501007)

>  <Comments>  (209) 


$$$$
CC02039
     RDKit          3D

 14 14  0  0  0  0  0  0  0  0999 V2000
    3.7100    1.4800    0.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9440    0.2810   -0.6040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9200   -0.6550   -0.7320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6560   -0.4050   -0.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4320    0.8000    0.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4530    1.7400    0.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6060   -1.4520   -0.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7660   -1.2830    0.2630 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.5700   -0.1870   -0.2590 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6710   -1.2840    1.7740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7140   -0.3550   -1.6990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6520    0.9880    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2720    2.0080    0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9040   -0.2580    0.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  7  1  0
  5  6  2  0
  7  8  1  0
  8  9  1  0
  8 10  1  1
  9 11  1  0
  9 14  1  0
 12 13  3  0
 12 14  1  0
M  END
>  <Name>  (210) 
Selegiline

>  <InChIKey>  (210) 
MEZLKOACVSPNER-GFCCVEGCSA-N

>  <PubChem_CID>  (210) 
26757

>  <CYP1A2>  (210) 
<3,4;Cleavage;R1>
<4,H;Oxidation;R1>
<2,3;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2A6>  (210) 
<3,4;Cleavage;R1>
<4,H;Oxidation;R1>
<2,3;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2B6>  (210) 
<3,4;Cleavage;R1>
<4,H;Oxidation;R1>
<2,3;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2C8>  (210) 


>  <CYP2C9>  (210) 
<3,4;Cleavage;R1>
<4,H;Oxidation;R1>

>  <CYP2C19>  (210) 
<3,4;Cleavage;R1>
<4,H;Oxidation;R1>
<2,3;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2D6>  (210) 
<3,4;Cleavage;R1>
<4,H;Oxidation;R1>
<2,3;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2E1>  (210) 
<3,4;Cleavage;R1>
<4,H;Oxidation;R1>

>  <CYP3A4>  (210) 
<3,4;Cleavage;R1>
<4,H;Oxidation;R1>
<2,3;Cleavage;R2>
<2,H;Oxidation;R2>

>  <References>  (210) 
Benetton SA, Fang C, Yang YO, Alok R, Year M, Lin CC, Yeh LT: P450 phenotyping of the metabolism of selegiline to desmethylselegiline and methamphetamine. Drug Metab Pharmacokinet. 2007 Apr;22(2):78-87. (PMID: 17495414)

>  <Comments>  (210) 


$$$$
CC02040
     RDKit          3D

 20 22  0  0  0  0  0  0  0  0999 V2000
   -2.6400    8.7890    2.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3890    7.7420    1.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3700    8.5450    3.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8700    6.4500    1.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6020    6.1870    2.5170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8450    7.2490    3.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0550    4.7890    2.4670 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.5370    7.0210    3.5880 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.2020    5.9260    2.7660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4210    4.6270    2.8020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8650    3.7630    3.1980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5970    2.8260    2.4680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3650    1.8690    3.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9120    3.7320    4.5950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6790    2.7760    5.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4080    1.8420    4.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5260    6.6110    4.9900 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3830    0.6260    5.2570 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.6750    2.8170    6.9810 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.2510    7.7690    5.8230 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  2  4  1  0
  3  6  2  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  6  8  1  0
  7 10  1  0
  7 11  1  1
  8  9  1  0
  8 17  1  1
  9 10  1  0
 11 12  2  0
 11 14  1  0
 12 13  1  0
 13 16  2  0
 14 15  2  0
 15 16  1  0
 15 19  1  0
 16 18  1  0
 17 20  1  0
M  END
>  <Name>  (211) 
Sertraline

>  <InChIKey>  (211) 
VGKDLMBJGBXTGI-SJCJKPOMSA-N

>  <PubChem_CID>  (211) 
68617

>  <CYP1A2>  (211) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (211) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2B6>  (211) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C8>  (211) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C9>  (211) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (211) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2D6>  (211) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (211) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP3A4>  (211) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <References>  (211) 
Obach RS, Cox LM, Tremaine LM: Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study. Drug Metab Dispos. 2005 Feb;33(2):262-70. doi: 10.1124/dmd.104.002428. Epub 2004  Nov 16. (PMID: 15547048)
Kobayashi K, Ishizuka T, Shimada N, Yoshimura Y, Kamijima K, Chiba K: Sertraline N-demethylation is catalyzed by multiple isoforms of human cytochrome P-450 in vitro. Drug Metab Dispos. 1999 Jul;27(7):763-6. (PMID: 10383917)

>  <Comments>  (211) 


$$$$
CC02041
     RDKit          3D

  8  8  0  0  0  0  0  0  0  0999 V2000
    1.1560    0.6760   -0.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0180    1.4440   -0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0500    2.8720   -0.3600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9550    3.5830   -0.8700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1130    0.8270    0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1080   -0.5390    0.7190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0300   -1.2970    0.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1630   -0.6900   -0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  8  1  0
  2  3  1  0
  2  5  1  0
  3  4  2  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
M  END
>  <Name>  (212) 
Styrene

>  <InChIKey>  (212) 
PPBRXRYQALVLMV-UHFFFAOYSA-N

>  <PubChem_CID>  (212) 
7501

>  <CYP1A2>  (212) 
<0,1;EpOxidation;R1>

>  <CYP2A6>  (212) 
<0,1;EpOxidation;R1>

>  <CYP2B6>  (212) 
<0,1;EpOxidation;R1>

>  <CYP2C8>  (212) 
<0,1;EpOxidation;R1>

>  <CYP2C9>  (212) 
<0,1;EpOxidation;R1>

>  <CYP2C19>  (212) 


>  <CYP2D6>  (212) 
<0,1;EpOxidation;R1>

>  <CYP2E1>  (212) 
<0,1;EpOxidation;R1>

>  <CYP3A4>  (212) 
<0,1;EpOxidation;R1>

>  <References>  (212) 
Nakajima T, Elovaara E, Gonzalez FJ, Gelboin HV, Raunio H, Pelkonen O, Vainio H, Aoyama T: Styrene metabolism by cDNA-expressed human hepatic and pulmonary cytochromes P450. Chem Res Toxicol. 1994 Nov-Dec;7(6):891-6. (PMID: 7696548)

>  <Comments>  (212) 


$$$$
CC02042
     RDKit          2D

 15 17  0  0  0  0  0  0  0  0999 V2000
    4.6660   -1.6380    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6660    1.3620    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3320   -0.1170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4260    0.3970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3320   -1.1580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5320   -0.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4260   -1.6720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5320   -1.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6660    0.3620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8000   -0.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8000   -1.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9060    0.3970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9060   -1.6720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -0.1170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -1.1580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  8  2  0
  1 11  1  0
  2  9  1  0
  3  4  1  0
  3  5  1  0
  4  6  1  0
  5  7  1  0
  6  8  1  0
  6  9  2  0
  7  8  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 11 13  1  0
 12 14  2  0
 13 15  2  0
 14 15  1  0
M  END
>  <Name>  (213) 
Tacrine

>  <InChIKey>  (213) 
YLJREFDVOIBQDA-UHFFFAOYSA-N

>  <PubChem_CID>  (213) 
1935

>  <CYP1A2>  (213) 
<14,H;Hydroxylation;R1>
<8,H;Hydroxylation;R2>
<11,H;Hydroxylation;R3>
<13,H;Hydroxylation;R4>

>  <CYP2A6>  (213) 


>  <CYP2B6>  (213) 


>  <CYP2C8>  (213) 


>  <CYP2C9>  (213) 


>  <CYP2C19>  (213) 


>  <CYP2D6>  (213) 


>  <CYP2E1>  (213) 


>  <CYP3A4>  (213) 


>  <References>  (213) 
Spaldin V, Madden S, Adams DA, Edwards RJ, Davies DS, Park BK: Determination of human hepatic cytochrome P4501A2 activity in vitro use of tacrine as an isoenzyme-specific probe. Drug Metab Dispos. 1995 Sep;23(9):929-34. (PMID: 8565783)

>  <Comments>  (213) 


$$$$
CC02043
     RDKit          3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4020    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0030   -0.0520 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2660    2.1210    0.0530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2370    2.0900    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1820   -0.6580   -0.0630 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1960   -0.6990   -0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4520    1.3420    0.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3080    3.3400    0.1040 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4210    1.3780   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2570    3.4460    0.0800 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3610   -0.0160   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3990   -0.0110   -0.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6700    1.9480    0.0790 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6040   -0.8100   -0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5680   -0.7000   -0.1310 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7410   -1.9130    0.8140 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6440   -0.4670   -0.9020 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9070   -2.6530    0.7960 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8050   -1.2110   -0.9140 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9430   -2.3010   -0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0440   -3.7260    1.6210 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0890   -3.0310   -0.0830 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9470   -2.4310   -1.0560 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  2  0
  4 10  1  0
  5 11  1  0
  6 12  2  0
  7 11  2  0
  7 13  1  0
  9 12  1  0
 11 14  1  0
 12 15  1  0
 14 16  2  0
 14 17  1  0
 16 18  1  0
 17 19  2  0
 18 20  2  0
 18 21  1  0
 19 20  1  0
 20 22  1  0
 22 23  1  0
M  END
>  <Name>  (214) 
Tamarixetin

>  <InChIKey>  (214) 
FPLMIPQZHHQWHN-UHFFFAOYSA-N

>  <PubChem_CID>  (214) 
5281699

>  <CYP1A2>  (214) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (214) 


>  <CYP2B6>  (214) 


>  <CYP2C8>  (214) 


>  <CYP2C9>  (214) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (214) 


>  <CYP2D6>  (214) 


>  <CYP2E1>  (214) 


>  <CYP3A4>  (214) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (214) 
Breinholt VM, Offord EA, Brouwer C, Nielsen SE, Brosen K, Friedberg T: In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids. Food Chem Toxicol. 2002 May;40(5):609-16. (PMID: 11955666)

>  <Comments>  (214) 


$$$$
CC02045
     RDKit          3D

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.3760    1.2710   -0.4950 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3530   -0.0540    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6380    1.7860   -0.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2730    2.2950   -1.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2580    1.8910    0.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5400    2.8780   -1.3870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5900    2.1770   -2.6620 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5900    1.4070    2.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5560    2.4200    1.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1810    2.9480   -0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1420    3.4090   -2.6270 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1860    2.6280   -3.8240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5180    2.4360    3.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1740    2.4520    2.2330 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4420    3.4720   -0.0360 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2160    3.9980   -2.6630 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3830    3.2180   -3.8690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3980    2.4190   -5.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3310    1.6240    2.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2910    4.7890    0.4870 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1470    1.7940   -4.9790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8640    2.8270   -6.3010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6160    1.5820   -6.1260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1050    2.6170   -7.4520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1390    1.9940   -7.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9530    1.7440   -8.4360 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3670    2.2060   -9.6480 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  3  4  2  0
  3  5  1  0
  4  6  1  0
  4  7  1  0
  5  8  1  0
  5  9  2  0
  6 10  2  0
  6 11  1  0
  7 12  1  0
  8 13  1  0
  9 10  1  0
  9 14  1  0
 10 15  1  0
 11 16  2  0
 11 17  1  0
 12 17  2  0
 12 18  1  0
 14 19  1  0
 15 20  1  0
 18 21  2  0
 18 22  1  0
 21 23  1  0
 22 24  2  0
 23 25  2  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
M  END
>  <Name>  (215) 
Tangeretin

>  <InChIKey>  (215) 
ULSUXBXHSYSGDT-UHFFFAOYSA-N

>  <PubChem_CID>  (215) 
68077

>  <CYP1A2>  (215) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (215) 


>  <CYP2B6>  (215) 


>  <CYP2C8>  (215) 


>  <CYP2C9>  (215) 


>  <CYP2C19>  (215) 


>  <CYP2D6>  (215) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (215) 


>  <CYP3A4>  (215) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<12,13;Cleavage;R2>
<13,H;Oxidation;R2>
<15,16;Cleavage;R2>
<16,H;Oxidation;R2>

>  <References>  (215) 
Breinholt VM, Rasmussen SE, Brosen K, Friedberg TH: In vitro metabolism of genistein and tangeretin by human and murine cytochrome P450s. Pharmacol Toxicol. 2003 Jul;93(1):14-22. (PMID: 12828569)

>  <Comments>  (215) 


$$$$
CC02046
     RDKit          3D

 26 28  0  0  0  0  0  0  0  0999 V2000
    0.3860    1.2550   -0.4890 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3440   -0.0420    0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6460    1.7780   -0.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2750    2.2840   -1.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2720    1.8960    0.9200 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5410    2.8720   -1.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5880    2.1600   -2.6660 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6110    1.4230    2.0250 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5680    2.4290    0.9950 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1870    2.9510   -0.1570 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1370    3.3990   -2.6440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1760    2.6150   -3.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5300    2.4680    2.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1900    2.4720    2.2190 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4470    3.4800   -0.0610 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2110    3.9880   -2.6870 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3710    3.2080   -3.8810 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3840    2.4100   -5.0530 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3500    1.6470    2.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2940    4.7990    0.4550 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1310    1.7890   -4.9850 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8530    2.8230   -6.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6350    1.5840   -6.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0970    2.6240   -7.4600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1400    2.0050   -7.3560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8840    1.8070   -8.4800 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  3  4  2  0
  3  5  1  0
  4  6  1  0
  4  7  1  0
  5  8  1  0
  5  9  2  0
  6 10  2  0
  6 11  1  0
  7 12  1  0
  8 13  1  0
  9 10  1  0
  9 14  1  0
 10 15  1  0
 11 16  2  0
 11 17  1  0
 12 17  2  0
 12 18  1  0
 14 19  1  0
 15 20  1  0
 18 21  2  0
 18 22  1  0
 21 23  1  0
 22 24  2  0
 23 25  2  0
 24 25  1  0
 25 26  1  0
M  END
>  <Name>  (216) 
Tangeretin-T27

>  <InChIKey>  (216) 
IECRXMSGDFIOEY-UHFFFAOYSA-N

>  <PubChem_CID>  (216) 
3010100

>  <CYP1A2>  (216) 
<16,H;Hydroxylation;R1>
<19,H;Hydroxylation;R2>

>  <CYP2A6>  (216) 


>  <CYP2B6>  (216) 


>  <CYP2C8>  (216) 


>  <CYP2C9>  (216) 


>  <CYP2C19>  (216) 


>  <CYP2D6>  (216) 


>  <CYP2E1>  (216) 


>  <CYP3A4>  (216) 
<16,H;Hydroxylation;R1>
<19,H;Hydroxylation;R2>

>  <References>  (216) 
Breinholt VM, Rasmussen SE, Brosen K, Friedberg TH: In vitro metabolism of genistein and tangeretin by human and murine cytochrome P450s. Pharmacol Toxicol. 2003 Jul;93(1):14-22. (PMID: 12828569)

>  <Comments>  (216) 


$$$$
CC02047
     RDKit          3D

 17 16  0  0  0  0  0  0  0  0999 V2000
   -0.0660    1.3460   -0.0440 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0360   -0.0460   -0.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1320    2.1590   -0.0810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1470    1.8930    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1620   -0.7360   -0.0280 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1240   -0.6260   -0.0910 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9830    1.8750   -1.2990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2720    3.1240    0.0040 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1680   -2.1740   -0.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4050    2.9320   -1.2570 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.5850   -2.6780   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5420   -4.4520   -0.0260 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1920   -4.8070    0.0770 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0620   -4.8660   -1.3280 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8990   -4.8900    1.1940 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0150   -4.4450   -1.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8590   -4.4640    1.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  4  8  2  0
  5  9  1  0
  7 10  1  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 12 15  2  0
 13 16  1  0
 13 17  1  0
M  END
>  <Name>  (217) 
Tauromustine

>  <InChIKey>  (217) 
RCLLNBVPCJDIPX-UHFFFAOYSA-N

>  <PubChem_CID>  (217) 
55456

>  <CYP1A2>  (217) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<11,15;Denitrosation;R3>
<15,N;N-Oxidation;R3>

>  <CYP2A6>  (217) 


>  <CYP2B6>  (217) 


>  <CYP2C8>  (217) 


>  <CYP2C9>  (217) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<11,15;Denitrosation;R3>
<15,N;N-Oxidation;R3>

>  <CYP2C19>  (217) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<11,15;Denitrosation;R3>
<15,N;N-Oxidation;R3>

>  <CYP2D6>  (217) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<11,15;Denitrosation;R3>
<15,N;N-Oxidation;R3>

>  <CYP2E1>  (217) 


>  <CYP3A4>  (217) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<11,15;Denitrosation;R3>
<15,N;N-Oxidation;R3>

>  <References>  (217) 
Tuvesson H, Gunnarsson PO, Seidegard J: Metabolism of tauromustine in liver and lung microsomes from various species. Xenobiotica. 1999 Aug;29(8):783-92. doi: 10.1080/004982599238236. (PMID: 10553719)

>  <Comments>  (217) 


$$$$
CC02048
     RDKit          3D

 14 15  0  0  1  0  0  0  0  0999 V2000
    6.6960   -0.3830    0.8750 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1880   -0.4070    2.4460 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1800   -4.3660    1.8820 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4870   -2.9820    0.9680 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5860   -2.0840    1.5970 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3240   -3.6770    1.4260 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2240   -1.6940    1.8100 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.4360   -1.5700    0.5190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4310   -0.5020    0.8700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2530    0.4220    1.7400 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9590   -3.4380    1.6540 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5070   -1.0880    1.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7950   -1.3500    1.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3030   -2.7300    1.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 13  1  0
  2  7  1  0
  2 10  1  0
  3 11  2  0
  4 14  2  0
  7  5  1  6
  5 11  1  0
  5 12  1  0
  6 11  1  0
  6 14  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 12 13  2  0
 13 14  1  0
M  END
>  <Name>  (218) 
Tegafur

>  <InChIKey>  (218) 
WFWLQNSHRPWKFK-LURJTMIESA-N

>  <PubChem_CID>  (218) 
148755

>  <CYP1A2>  (218) 
<5,6;Cleavage;R1>
<6,H;Oxidation;R1>

>  <CYP2A6>  (218) 
<5,6;Cleavage;R1>
<6,H;Oxidation;R1>

>  <CYP2B6>  (218) 
<5,6;Cleavage;R1>
<6,H;Oxidation;R1>

>  <CYP2C8>  (218) 
<5,6;Cleavage;R1>
<6,H;Oxidation;R1>

>  <CYP2C9>  (218) 
<5,6;Cleavage;R1>
<6,H;Oxidation;R1>

>  <CYP2C19>  (218) 
<5,6;Cleavage;R1>
<6,H;Oxidation;R1>

>  <CYP2D6>  (218) 
<5,6;Cleavage;R1>
<6,H;Oxidation;R1>

>  <CYP2E1>  (218) 
<5,6;Cleavage;R1>
<6,H;Oxidation;R1>

>  <CYP3A4>  (218) 
<5,6;Cleavage;R1>
<6,H;Oxidation;R1>

>  <References>  (218) 
Komatsu T, Yamazaki H, Shimada N, Nakajima M, Yokoi T: Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes. Drug Metab Dispos. 2000 Dec;28(12):1457-63. (PMID: 11095583)

>  <Comments>  (218) 


$$$$
CC02049
     RDKit          3D

 22 23  0  0  0  0  0  0  0  0999 V2000
   -0.0530    1.3970    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1910    0.0220    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2170    2.0560   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3900    1.8390    0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5500   -0.1390   -0.0200 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8280   -0.9340    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1800    1.0690   -0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5340    3.4620   -0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4280    0.9040    0.0520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1420   -0.4590    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5770    4.3280   -0.0050 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6940    1.4250    0.0750 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0880    5.5870   -0.0150 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6770    0.3970    0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2860    6.7210   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0310    7.8870   -0.0150 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0180    6.7110    0.0210 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3490    9.1630   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3810   10.2630   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6920   11.6040   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7240   12.7040   -0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0340   14.0450   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  5  7  1  0
  6 10  2  0
  8 11  2  0
  9 10  1  0
  9 12  1  0
 11 13  1  0
 12 14  1  0
 13 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
M  END
>  <Name>  (219) 
Tegaserod

>  <InChIKey>  (219) 
IKBKZGMPCYNSLU-RGVLZGJSSA-N

>  <PubChem_CID>  (219) 
135409453

>  <CYP1A2>  (219) 
<18,19;Cleavage;R1>
<19,H;Oxidation;R1>

>  <CYP2A6>  (219) 


>  <CYP2B6>  (219) 


>  <CYP2C8>  (219) 


>  <CYP2C9>  (219) 


>  <CYP2C19>  (219) 


>  <CYP2D6>  (219) 
<18,19;Cleavage;R1>
<19,H;Oxidation;R1>

>  <CYP2E1>  (219) 


>  <CYP3A4>  (219) 


>  <References>  (219) 
Vickers AE, Zollinger M, Dannecker R, Tynes R, Heitz F, Fischer V: In vitro metabolism of tegaserod in human liver and intestine: assessment of drug interactions. Drug Metab Dispos. 2001 Oct;29(10):1269-76. (PMID: 11560869)

>  <Comments>  (219) 


$$$$
CC02050
     RDKit          3D

 22 23  0  0  0  0  0  0  0  0999 V2000
   -6.4320    0.3690    0.7050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6890    1.4420    0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3470    1.2600   -0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7860   -0.0420   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5840   -1.1250    0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8790   -0.9090    0.7450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5480    2.3420   -0.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2520    2.1280   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7010    0.8480   -0.7810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4430   -0.2240   -0.3930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8280   -1.6000   -0.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3890   -1.4990   -0.6380 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0720   -2.8540   -0.9700 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2590   -1.1310    0.6280 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7460   -1.0100    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3600    0.1440    0.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7730    0.2590    0.4460 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9310    0.3530    0.2800 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3840    0.4700    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8350    1.8920    0.4130 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1110   -0.5270    0.9750 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7150    0.1680   -1.3920 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  3  7  1  0
  4  5  1  0
  4 10  1  0
  5  6  2  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  3  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
M  END
>  <Name>  (220) 
Terbinafine

>  <InChIKey>  (220) 
DOMXUEMWDBAQBQ-WEVVVXLNSA-N

>  <PubChem_CID>  (220) 
1549008

>  <CYP1A2>  (220) 
<17,18;EpOxidation;R1>
<14,15;EpOxidation;R2>
<8,H;Hydroxylation;R3>
<9,H;Hydroxylation;R4>
<10,H;Hydroxylation;R5>
<0,1;Cleavage;R6>
<0,H;Oxidation;R6>
<1,11;Cleavage;R7>
<11,H;Oxidation;R7>

>  <CYP2A6>  (220) 


>  <CYP2B6>  (220) 
<8,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>
<10,H;Hydroxylation;R3>
<0,1;Cleavage;R4>
<0,H;Oxidation;R4>

>  <CYP2C8>  (220) 
<8,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>
<10,H;Hydroxylation;R3>
<0,1;Cleavage;R4>
<0,H;Oxidation;R4>
<1,11;Cleavage;R5>
<11,H;Oxidation;R5>

>  <CYP2C9>  (220) 
<17,18;EpOxidation;R1>
<14,15;EpOxidation;R2>
<8,H;Hydroxylation;R3>
<9,H;Hydroxylation;R4>
<10,H;Hydroxylation;R5>
<0,1;Cleavage;R6>
<0,H;Oxidation;R6>
<1,11;Cleavage;R7>
<11,H;Oxidation;R7>

>  <CYP2C19>  (220) 
<8,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>
<10,H;Hydroxylation;R3>
<0,1;Cleavage;R4>
<0,H;Oxidation;R4>
<1,11;Cleavage;R5>
<11,H;Oxidation;R5>

>  <CYP2D6>  (220) 


>  <CYP2E1>  (220) 


>  <CYP3A4>  (220) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,11;Cleavage;R2>
<11,H;Oxidation;R2>

>  <References>  (220) 
Vickers AE, Sinclair JR, Zollinger M, Heitz F, Glanzel U, Johanson L, Fischer V: Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions. Drug Metab Dispos. 1999 Sep;27(9):1029-38. (PMID: 10460803)

>  <Comments>  (220) 


$$$$
CC02051
     RDKit          3D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -0.4880   -1.3640    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6790   -0.7290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7110    0.6020    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4170    1.2920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5810    0.6630    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6200   -0.6670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8340   -1.3230    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0820   -0.5550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2720   -1.5150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8570   -1.4480    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1430   -0.7470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2460    0.1310    1.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2810   -1.7700    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3710    3.0280    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.2460    0.1300   -1.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  2 10  1  0
  3  4  2  0
  4  5  1  0
  4 14  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 11 15  1  0
M  END
>  <Name>  (221) 
Terbuthylazine

>  <InChIKey>  (221) 
FZXISNSWEXTPMF-UHFFFAOYSA-N

>  <PubChem_CID>  (221) 
22206

>  <CYP1A2>  (221) 
<1,H;Hydroxylation;R1>
<1,2;Cleavage;R1>
<12,H;Hydroxylation;R2>
<11,H;Hydroxylation;R3>
<13,H;Hydroxylation;R4>

>  <CYP2A6>  (221) 


>  <CYP2B6>  (221) 


>  <CYP2C8>  (221) 


>  <CYP2C9>  (221) 


>  <CYP2C19>  (221) 


>  <CYP2D6>  (221) 


>  <CYP2E1>  (221) 


>  <CYP3A4>  (221) 
<1,H;Hydroxylation;R1>
<1,2;Cleavage;R1>

>  <References>  (221) 
Lang DH, Rettie AE, Bocker RH: Identification of enzymes involved in the metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in human liver microsomes. Chem Res Toxicol. 1997 Sep;10(9):1037-44. doi: 10.1021/tx970081l. (PMID: 9305587)

>  <Comments>  (221) 


$$$$
CC02052
     RDKit          3D

 16 16  0  0  0  0  0  0  0  0999 V2000
   -0.1960   -1.5640    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9010   -0.8130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8000    0.5120    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3990    1.0880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4970    0.3370    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3950   -0.9880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5340   -1.7680    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8550   -1.1340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9390   -2.2140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1450   -1.4110    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3550   -0.5840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3690    0.3000    1.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5900   -1.4870    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5330    2.8450    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.3690    0.2990   -1.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3340    3.0220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  2 10  1  0
  3  4  2  0
  4  5  1  0
  4 14  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 11 15  1  0
 14 16  1  0
M  END
>  <Name>  (222) 
Terbutryne

>  <InChIKey>  (222) 
IROINLKCQGIITA-UHFFFAOYSA-N

>  <PubChem_CID>  (222) 
13450

>  <CYP1A2>  (222) 
<1,H;Hydroxylation;R1>
<13,S;S-Oxidation;R2>
<8,H;Hydroxylation;R3>
<9,H;Hydroxylation;R4>
<10,H;Hydroxylation;R5>

>  <CYP2A6>  (222) 


>  <CYP2B6>  (222) 
<1,H;Hydroxylation;R1>
<13,S;S-Oxidation;R2>

>  <CYP2C8>  (222) 


>  <CYP2C9>  (222) 


>  <CYP2C19>  (222) 


>  <CYP2D6>  (222) 


>  <CYP2E1>  (222) 


>  <CYP3A4>  (222) 
<1,H;Hydroxylation;R1>
<13,S;S-Oxidation;R2>

>  <References>  (222) 
Lang DH, Rettie AE, Bocker RH: Identification of enzymes involved in the metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in human liver microsomes. Chem Res Toxicol. 1997 Sep;10(9):1037-44. doi: 10.1021/tx970081l. (PMID: 9305587)

>  <Comments>  (222) 


$$$$
CC02054
     RDKit          3D

 13 14  0  0  0  0  0  0  0  0999 V2000
    1.2130    0.5920    0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0370    1.3820    0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0200    2.5990    0.2840 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0930    0.6030   -0.1330 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3450    1.3030   -0.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1340   -0.7960   -0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1870   -1.3920   -0.5480 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0870   -1.4650   -0.1920 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1180   -2.8950   -0.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2350   -0.7620    0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4890   -1.2730    0.2160 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2420   -0.2170    0.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5020    0.9400    0.4830 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1 10  2  0
  1 13  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
M  END
>  <Name>  (223) 
Theophylline

>  <InChIKey>  (223) 
ZFXYFBGIUFBOJW-UHFFFAOYSA-N

>  <PubChem_CID>  (223) 
2153

>  <CYP1A2>  (223) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>
<6,H;Hydroxylation;R3>

>  <CYP2A6>  (223) 


>  <CYP2B6>  (223) 


>  <CYP2C8>  (223) 


>  <CYP2C9>  (223) 


>  <CYP2C19>  (223) 


>  <CYP2D6>  (223) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>
<6,H;Hydroxylation;R3>

>  <CYP2E1>  (223) 
<6,H;Hydroxylation;R1>

>  <CYP3A4>  (223) 


>  <References>  (223) 
Zhang ZY, Kaminsky LS: Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation. Biochem Pharmacol. 1995 Jul 17;50(2):205-11. doi: 10.1016/0006-2952(95)00120-o. (PMID: 7632164)
Ha HR, Chen J, Freiburghaus AU, Follath F: Metabolism of theophylline by cDNA-expressed human cytochromes P-450. Br J Clin Pharmacol. 1995 Mar;39(3):321-6. doi: 10.1111/j.1365-2125.1995.tb04455.x. (PMID: 7619675)

>  <Comments>  (223) 


$$$$
CC02055
     RDKit          3D

 14 16  0  0  0  0  0  0  0  0999 V2000
   -4.8270    0.6410    0.0130 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1260    1.0400   -0.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2280   -1.1760    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0930   -1.2700   -0.0180 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1780    0.6140   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0850   -0.7740    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9380   -0.0660    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3880   -0.0790    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3940    1.3000   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2610   -1.5410    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5560    0.5190   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4940   -0.8770    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1610    1.0650    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3820   -1.0150   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 13  1  0
  1 14  1  0
  2  5  1  0
  2  7  1  0
  3  6  1  0
  3  7  2  0
  4  8  1  0
  4 14  2  0
  5  6  2  0
  5  9  1  0
  6 10  1  0
  7  8  1  0
  8 13  2  0
  9 11  2  0
 10 12  2  0
 11 12  1  0
M  END
>  <Name>  (224) 
Thiabendazole

>  <InChIKey>  (224) 
WJCNZQLZVWNLKY-UHFFFAOYSA-N

>  <PubChem_CID>  (224) 
5430

>  <CYP1A2>  (224) 
<0,H;Hydroxylation;R1>

>  <CYP2A6>  (224) 


>  <CYP2B6>  (224) 


>  <CYP2C8>  (224) 


>  <CYP2C9>  (224) 


>  <CYP2C19>  (224) 


>  <CYP2D6>  (224) 


>  <CYP2E1>  (224) 


>  <CYP3A4>  (224) 


>  <References>  (224) 
Coulet M, Dacasto M, Eeckhoutte C, Larrieu G, Sutra JF, Alvinerie M, Mace K, Pfeifer AM, Galtier P: Identification of human and rabbit cytochromes P450 1A2 as major isoforms involved in thiabendazole 5-hydroxylation. Fundam Clin Pharmacol. 1998;12(2):225-35. (PMID: 9565779)

>  <Comments>  (224) 


$$$$
CC02056
     RDKit          3D

 25 28  0  0  0  0  0  0  0  0999 V2000
   -0.9640    0.8750    0.5140 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1490   -0.4900    0.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9660   -0.9560    1.9930 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.2420    1.4560    0.8990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3440   -1.4430    0.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2170    0.7390    1.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1130    1.7600    0.3090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4150    3.5460   -2.7700 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1700   -0.9020   -0.5420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1330    2.2420   -1.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3120    3.1940   -1.3480 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.5680   -2.7940    0.6940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3880   -2.2540   -0.7700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6850   -2.7690   -1.8460 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5840   -3.2010   -0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4880    2.3410   -3.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5630    4.4280   -3.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4720    2.7920    0.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4030    1.3590    1.9550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0930    4.4630   -0.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5550   -4.5780   -1.8060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3800    5.7340   -2.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6560    3.4020    0.9560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6200    2.6890    1.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2650    5.4220   -0.7460 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  1  7  1  0
  2  5  2  0
  2  9  1  0
  3  5  1  0
  3  6  1  0
  4  6  2  0
  4 18  1  0
  5 12  1  0
  6 19  1  0
  7 10  1  0
  8 11  1  0
  8 16  1  0
  8 17  1  0
  9 13  2  0
 11 10  1  6
 11 20  1  0
 12 15  2  0
 13 14  1  0
 13 15  1  0
 14 21  1  0
 17 22  1  0
 18 23  2  0
 19 24  2  0
 20 25  1  0
 22 25  1  0
 23 24  1  0
M  END
>  <Name>  (225) 
Thioridazine

>  <InChIKey>  (225) 
KLBQZWRITKRQQV-MRXNPFEDSA-N

>  <PubChem_CID>  (225) 
6604030

>  <CYP1A2>  (225) 
<1,S;S-Oxidation;R1>
<24,S;S-Oxidation;R2>
<16,17;Cleavage;R3>
<17,H;Oxidation;R3>

>  <CYP2A6>  (225) 
<24,S;S-Oxidation;R1>

>  <CYP2B6>  (225) 
<1,S;S-Oxidation;R1>
<24,S;S-Oxidation;R2>

>  <CYP2C8>  (225) 


>  <CYP2C9>  (225) 
<1,S;S-Oxidation;R1>
<24,S;S-Oxidation;R2>

>  <CYP2C19>  (225) 
<1,S;S-Oxidation;R1>
<24,S;S-Oxidation;R2>
<16,17;Cleavage;R3>
<17,H;Oxidation;R3>

>  <CYP2D6>  (225) 
<1,S;S-Oxidation;R1>
<24,S;S-Oxidation;R2>
<16,17;Cleavage;R3>
<17,H;Oxidation;R3>

>  <CYP2E1>  (225) 
<1,S;S-Oxidation;R1>

>  <CYP3A4>  (225) 
<1,S;S-Oxidation;R1>
<24,S;S-Oxidation;R2>
<16,17;Cleavage;R3>
<17,H;Oxidation;R3>

>  <References>  (225) 
Wojcikowski J, Maurel P, Daniel WA: Characterization of human cytochrome p450 enzymes involved in the metabolism of the piperidine-type phenothiazine neuroleptic thioridazine. Drug Metab Dispos. 2006 Mar;34(3):471-6. doi: 10.1124/dmd.105.006445. Epub 2005 Nov 4. (PMID: 16272405)

>  <Comments>  (225) 


$$$$
CC02057
     RDKit          3D

 17 19  0  0  0  0  0  0  0  0999 V2000
    1.1180    0.5290    0.5950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1340    1.0490    1.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1330    0.1180    0.8720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5840   -1.3720    0.2610 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.9940   -0.7750    0.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1610   -1.5240   -0.3400 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0090   -0.5230   -1.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3140    0.7710   -0.5030 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2430    1.7610   -1.5690 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0900    2.9680   -1.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4450    1.1930    0.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4280    3.0340   -1.7200 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1970    1.7290   -2.5410 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.1840    4.1790   -1.4710 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6070    5.2690   -0.8250 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2740    5.2150   -0.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5200    4.0700   -0.6790 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  2  0
  1 11  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 11  1  0
  9 10  1  0
 10 12  2  0
 10 17  1  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
M  END
>  <Name>  (226) 
Ticlopidine

>  <InChIKey>  (226) 
PHWBOXQYWZNQIN-UHFFFAOYSA-N

>  <PubChem_CID>  (226) 
5472

>  <CYP1A2>  (226) 
<13,H;Oxidation;R1>
<13,14;Reduction;R1>
<14,15;Oxidation;R1>
<11,15;Reduction;R1>

>  <CYP2A6>  (226) 


>  <CYP2B6>  (226) 


>  <CYP2C8>  (226) 
<13,H;Oxidation;R1>
<13,14;Reduction;R1>
<14,15;Oxidation;R1>
<11,15;Reduction;R1>

>  <CYP2C9>  (226) 
<13,H;Oxidation;R1>
<13,14;Reduction;R1>
<14,15;Oxidation;R1>
<11,15;Reduction;R1>

>  <CYP2C19>  (226) 
<13,H;Oxidation;R1>
<13,14;Reduction;R1>
<14,15;Oxidation;R1>
<11,15;Reduction;R1>

>  <CYP2D6>  (226) 
<13,H;Oxidation;R1>
<13,14;Reduction;R1>
<14,15;Oxidation;R1>
<11,15;Reduction;R1>

>  <CYP2E1>  (226) 


>  <CYP3A4>  (226) 
<13,H;Oxidation;R1>
<13,14;Reduction;R1>
<14,15;Oxidation;R1>
<11,15;Reduction;R1>

>  <References>  (226) 
Dansette PM, Libraire J, Bertho G, Mansuy D: Metabolic oxidative cleavage of thioesters: evidence for the formation of sulfenic acid intermediates in the bioactivation of the antithrombotic prodrugs ticlopidine and clopidogrel. Chem Res Toxicol. 2009 Feb;22(2):369-73. doi: 10.1021/tx8004828. (PMID: 19170597)

>  <Comments>  (226) 


$$$$
CC02058
     RDKit          3D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -0.0460    1.4750    0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0040    0.0040   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1400    2.2130   -0.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2730    2.1410    0.0910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2850   -0.7880    0.0410 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.0620   -0.5710   -0.0870 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0930    3.5910   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3040    3.5190    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0680   -2.1560   -0.6090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7040   -0.9770    1.5000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1260    4.2430    0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3300   -2.9080   -0.6010 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1690    5.7490    0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0760   -4.1650   -1.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2850   -2.1370   -1.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3540   -5.0050   -1.3520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6300   -2.8640   -1.4480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4400   -4.2340   -2.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  4  8  2  0
  5  9  1  0
  5 10  1  1
  7 11  2  0
  8 11  1  0
  9 12  1  0
 11 13  1  0
 12 14  1  0
 12 15  1  0
 14 16  1  0
 15 17  1  0
 16 18  1  0
 17 18  1  0
M  END
>  <Name>  (227) 
Tolperisone

>  <InChIKey>  (227) 
FSKFPVLPFLJRQB-CQSZACIVSA-N

>  <PubChem_CID>  (227) 
688590

>  <CYP1A2>  (227) 
<0,H;Hydroxylation;R1>

>  <CYP2A6>  (227) 


>  <CYP2B6>  (227) 


>  <CYP2C8>  (227) 


>  <CYP2C9>  (227) 


>  <CYP2C19>  (227) 
<0,H;Hydroxylation;R1>

>  <CYP2D6>  (227) 
<0,H;Hydroxylation;R1>

>  <CYP2E1>  (227) 


>  <CYP3A4>  (227) 


>  <References>  (227) 
Dalmadi B, Leibinger J, Szeberenyi S, Borbas T, Farkas S, Szombathelyi Z, Tihanyi K: Identification of metabolic pathways involved in the biotransformation of tolperisone by human microsomal enzymes. Drug Metab Dispos. 2003 May;31(5):631-6. doi: 10.1124/dmd.31.5.631. (PMID: 12695352)

>  <Comments>  (227) 


$$$$
CC02059
     RDKit          3D

  7  7  0  0  0  0  0  0  0  0999 V2000
    1.2070    0.7020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.3980   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    2.8860   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2060    0.7020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2060   -0.6910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.3880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2060   -0.6910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  7  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
M  END
>  <Name>  (228) 
Toluene

>  <InChIKey>  (228) 
YXFVVABEGXRONW-UHFFFAOYSA-N

>  <PubChem_CID>  (228) 
1140

>  <CYP1A2>  (228) 
<0,H;Hydroxylation;R1>
<4,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<2,H;Hydroxylation;R4>

>  <CYP2A6>  (228) 


>  <CYP2B6>  (228) 
<0,H;Hydroxylation;R1>
<4,H;Hydroxylation;R2>

>  <CYP2C8>  (228) 
<0,H;Hydroxylation;R1>

>  <CYP2C9>  (228) 


>  <CYP2C19>  (228) 


>  <CYP2D6>  (228) 


>  <CYP2E1>  (228) 
<0,H;Hydroxylation;R1>
<4,H;Hydroxylation;R2>

>  <CYP3A4>  (228) 


>  <References>  (228) 
Nakajima T, Wang RS, Elovaara E, Gonzalez FJ, Gelboin HV, Raunio H, Pelkonen O, Vainio H, Aoyama T: Toluene metabolism by cDNA-expressed human hepatic cytochrome P450. Biochem Pharmacol. 1997 Feb 7;53(3):271-7. doi: 10.1016/s0006-2952(96)00652-1. (PMID: 9065730)

>  <Comments>  (228) 


$$$$
CC02060
     RDKit          3D

 29 31  0  0  0  0  0  0  0  0999 V2000
   -4.0680    0.1800   -1.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6290    0.9280    0.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1260    0.9030    0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4720   -0.2820    0.3390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2340   -1.5510    0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0090   -2.4920   -0.6800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7230   -3.6720   -0.6880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6600   -3.9240    0.2990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8880   -2.9940    1.2980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1760   -1.8130    1.3210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0040   -0.3070    0.4390 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6210   -0.8920    1.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9970   -0.9140    1.6350 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7680   -0.3540    0.6250 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1240   -0.3770    0.7160 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6280    0.2650   -0.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1570    0.2730   -0.4170 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6540   -1.1100   -0.4220 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5190   -1.6020   -1.8000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0940   -1.0420   -0.1380 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1580    0.2290   -0.4780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7840    0.2490   -0.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3680    2.1630    0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4530    3.0470   -0.8060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7400    4.2260   -0.7850 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0590    4.5370    0.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1480    3.6690    1.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5640    2.4880    1.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8670    0.2100   -1.2220 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1 29  1  0
  2  3  1  0
  3  4  2  0
  3 23  1  0
  4  5  1  0
  4 11  1  0
  5  6  2  0
  5 10  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 11 12  2  0
 11 22  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 21  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 21 22  2  0
 23 24  2  0
 23 28  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
M  END
>  <Name>  (229) 
Toremifene

>  <InChIKey>  (229) 
XFCLJVABOIYOMF-QPLCGJKRSA-N

>  <PubChem_CID>  (229) 
3005573

>  <CYP1A2>  (229) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<1,3;Cleavage;R3>
<3,H;Oxidation;R3>

>  <CYP2A6>  (229) 


>  <CYP2B6>  (229) 


>  <CYP2C8>  (229) 


>  <CYP2C9>  (229) 


>  <CYP2C19>  (229) 


>  <CYP2D6>  (229) 


>  <CYP2E1>  (229) 


>  <CYP3A4>  (229) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<1,3;Cleavage;R3>
<3,H;Oxidation;R3>

>  <References>  (229) 
Berthou F, Dreano Y, Belloc C, Kangas L, Gautier JC, Beaune P: Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes. Biochem Pharmacol. 1994 May 18;47(10):1883-95. doi: 10.1016/0006-2952(94)90319-0. (PMID: 8204106)

>  <Comments>  (229) 
The deamino metabolite might be a product from demethyl metabolite. Xenosite didn't record <17,18;Cleavage> for CYP3A4.

$$$$
CC02061
     RDKit          3D

 22 22  0  0  0  0  0  0  0  0999 V2000
   -0.4780    1.9650   -0.4930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5100    0.5660   -0.7200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1430    2.7470   -1.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3040    2.4730    0.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7010   -0.0880   -0.7660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3530   -6.2680   -1.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4030   -7.6710   -1.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9560   -3.5470   -0.9310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1930   -5.6010   -0.9550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7300   -1.4880   -0.8940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1430   -4.2050   -1.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9250   -2.1440   -0.9390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4110   -8.2870   -0.7420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5520   -8.3320   -1.3430 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1870    4.2430   -1.2070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5770    3.9710    0.5260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9000    2.1010   -2.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4950    2.2360    1.9660 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6340    1.7220    0.7710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7420    4.6740    0.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9640   -6.3630   -0.5300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4400   -2.2640   -0.9800 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  3 15  1  0
  3 17  1  0
  4 16  1  0
  4 18  1  0
  4 19  1  0
  5 10  1  0
  6  7  1  0
  6  9  2  0
  7 13  2  0
  7 14  1  0
  8 11  2  0
  8 12  1  0
  9 11  1  0
  9 21  1  0
 10 12  2  0
 10 22  1  0
 15 20  1  0
 16 20  1  0
M  END
>  <Name>  (230) 
trans-Retinoic acid

>  <InChIKey>  (230) 
SHGAZHPCJJPHSC-YCNIQYBTSA-N

>  <PubChem_CID>  (230) 
444795

>  <CYP1A2>  (230) 
<21,H;Hydroxylation;R1>

>  <CYP2A6>  (230) 


>  <CYP2B6>  (230) 


>  <CYP2C8>  (230) 
<21,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>
<1,2;Epoxidation;R3>

>  <CYP2C9>  (230) 
<21,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>
<1,2;Epoxidation;R3>

>  <CYP2C19>  (230) 


>  <CYP2D6>  (230) 


>  <CYP2E1>  (230) 


>  <CYP3A4>  (230) 
<0,H;Hydroxylation;R1>
<21,H;Hydroxylation;R2>

>  <References>  (230) 
Marill J, Idres N, Capron CC, Nguyen E, Chabot GG: Retinoic acid metabolism and mechanism of action: a review. Curr Drug Metab. 2003 Feb;4(1):1-10. (PMID: 12570742)

>  <Comments>  (230) 


$$$$
CC02063
     RDKit          3D

 31 34  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3770    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0970    2.1490    0.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2460    2.0410    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2950   -0.7840    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1860   -0.7170   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1960    1.4460    0.5620 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.4270    1.3320    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2800    3.5470    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4540    0.1810   -0.2680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4020   -0.0550   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1550   -2.2240   -0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4400    2.3370    0.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8750    1.0570    2.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7440    2.0630    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5650   -0.7590   -0.0130 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2380    3.4620    1.3920 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3690    4.2130    1.3280 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4680    5.3850    2.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4280    3.8060    0.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6180    6.1460    1.9980 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5770    4.5710    0.4680 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6710    5.7420    1.1980 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9250    6.5740    1.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9050    6.1150    2.2080 C   0  0  1  0  0  0  0  0  0  0  0  0
   10.2350    6.8460    2.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3740    6.6800    3.8740 S   0  0  0  0  0  0  0  0  0  0  0  0
   10.5620    7.5900    3.1390 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.9460    6.7510    1.1190 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7890    7.7100    4.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0040    8.3660    5.2350 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  4  9  1  0
  5 10  1  0
  6 11  2  0
  6 12  1  0
  7 10  1  0
  7 13  1  0
  7 14  1  1
  8 11  1  0
  8 15  1  0
 11 16  1  0
 13 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 19 21  1  0
 20 22  2  0
 21 23  2  0
 22 23  1  0
 23 24  1  0
 25 24  1  6
 25 26  1  0
 25 27  1  0
 26 28  1  0
 26 29  2  0
 27 30  1  0
 28 30  1  0
 30 31  2  0
M  END
>  <Name>  (231) 
Troglitazone

>  <InChIKey>  (231) 
GXPHKUHSUJUWKP-CYFREDJKSA-N

>  <PubChem_CID>  (231) 
6518172

>  <CYP1A2>  (231) 
<8,9;Oxidation;R1>
<4,30;Cleavage;R1>

>  <CYP2A6>  (231) 
<8,9;Oxidation;R1>
<4,30;Cleavage;R1>

>  <CYP2B6>  (231) 
<8,9;Oxidation;R1>
<4,30;Cleavage;R1>

>  <CYP2C8>  (231) 
<8,9;Oxidation;R1>
<4,30;Cleavage;R1>

>  <CYP2C9>  (231) 
<8,9;Oxidation;R1>
<4,30;Cleavage;R1>

>  <CYP2C19>  (231) 
<8,9;Oxidation;R1>
<4,30;Cleavage;R1>

>  <CYP2D6>  (231) 
<8,9;Oxidation;R1>
<4,30;Cleavage;R1>

>  <CYP2E1>  (231) 
<8,9;Oxidation;R1>
<4,30;Cleavage;R1>

>  <CYP3A4>  (231) 
<8,9;Oxidation;R1>
<4,30;Cleavage;R1>

>  <References>  (231) 
Tang W: Drug metabolite profiling and elucidation of drug-induced hepatotoxicity. Expert Opin Drug Metab Toxicol. 2007 Jun;3(3):407-20. doi: 10.1517/17425255.3.3.407. (PMID: 17539747)
Okada R, Maeda K, Nishiyama T, Aoyama S, Tozuka Z, Hiratsuka A, Ikeda T, Kusuhara H, Sugiyama Y: Involvement of different human glutathione transferase isoforms in the glutathione conjugation of reactive metabolites of troglitazone. Drug Metab Dispos. 2011 Dec;39(12):2290-7. doi: 10.1124/dmd.111.040469. Epub 2011 Sep 13. (PMID: 21914835)
Yokoi T: Troglitazone. Handb Exp Pharmacol. 2010;(196):419-35. doi: 10.1007/978-3-642-00663-0_14. (PMID: 20020270)

>  <Comments>  (231) 
Phase II metabolites are involved. Better double check.

$$$$
CC02064
     RDKit          2D

 60 64  0  0  0  0  0  0  0  0999 V2000
   13.6810   -0.5980    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5900   -4.6900    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.3220    6.1980    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5720    2.0080    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.0040    0.9970    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2380   -4.1590    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7510    5.4690    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2410    0.4100    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.5010    4.4120    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0080   -5.6980    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4170    5.0440    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3540   -2.8180    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.5500    3.0340    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4030   -4.6710    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8120    6.0710    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4880   -1.3180    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6260    0.6830    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1240   -0.6870    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0910    2.0520    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6210    0.6830    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.1940    1.4850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9260   -1.2880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2890    2.6870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0540   -0.0860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2270   -0.0520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3230   -1.3210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9260    2.7200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0540    1.4510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8940    2.4190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9280   -1.0200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3210    2.4190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3550   -1.0200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1630    1.2170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6250   -2.2550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5900    3.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0860    0.1820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1630    0.2160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6240   -2.2550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5920    3.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0860    1.1840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9590    1.8230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2180   -3.0610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9980    4.4600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2200   -0.3180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9620   -0.3860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9530   -2.9970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1670    4.4720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2900    1.7890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8320    2.8150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8170   -3.9770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0040    4.3490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2200   -1.3180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8820    0.0040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2600   -3.9490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7470    5.3800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3680    1.4020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6280    3.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4100   -4.7820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4110    5.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3540   -1.8180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 53  1  0
  2 54  1  0
  3 55  1  0
  4 56  1  0
  5 53  2  0
  6 54  2  0
  7 55  2  0
  8 56  2  0
  9 57  1  0
 10 58  1  0
 11 59  1  0
 12 60  1  0
 13 57  2  0
 14 58  2  0
 15 59  2  0
 16 60  2  0
 17 21  1  0
 17 25  1  0
 18 22  1  0
 18 26  1  0
 19 23  1  0
 19 27  1  0
 20 24  1  0
 20 28  1  0
 21 29  1  0
 21 33  2  0
 22 30  1  0
 22 34  2  0
 23 31  1  0
 23 35  2  0
 24 32  1  0
 24 36  2  0
 25 30  1  0
 25 37  2  0
 26 32  1  0
 26 38  2  0
 27 29  1  0
 27 39  2  0
 28 31  1  0
 28 40  2  0
 33 37  1  0
 33 41  1  0
 34 38  1  0
 34 42  1  0
 35 39  1  0
 35 43  1  0
 36 40  1  0
 36 44  1  0
 37 45  1  0
 38 46  1  0
 39 47  1  0
 40 48  1  0
 41 49  1  0
 42 50  1  0
 43 51  1  0
 44 52  1  0
 45 53  1  0
 46 54  1  0
 47 55  1  0
 48 56  1  0
 49 57  1  0
 50 58  1  0
 51 59  1  0
 52 60  1  0
M  END
>  <Name>  (232) 
Urporphyrinogen

>  <InChIKey>  (232) 
QTTNOSKSLATGQB-UHFFFAOYSA-N

>  <PubChem_CID>  (232) 
440775

>  <CYP1A2>  (232) 
<14,H;Hydroxylation;R1>
<29,H;Hydroxylation;R2>
<44,H;Hydroxylation;R3>
<59,H;Hydroxylation;R4>

>  <CYP2A6>  (232) 


>  <CYP2B6>  (232) 


>  <CYP2C8>  (232) 


>  <CYP2C9>  (232) 


>  <CYP2C19>  (232) 


>  <CYP2D6>  (232) 


>  <CYP2E1>  (232) 
<14,H;Hydroxylation;R1>
<29,H;Hydroxylation;R2>
<44,H;Hydroxylation;R3>
<59,H;Hydroxylation;R4>

>  <CYP3A4>  (232) 
<14,H;Hydroxylation;R1>
<29,H;Hydroxylation;R2>
<44,H;Hydroxylation;R3>
<59,H;Hydroxylation;R4>

>  <References>  (232) 
Sinclair PR, Gorman N, Tsyrlov IB, Fuhr U, Walton HS, Sinclair JF: Uroporphyrinogen oxidation catalyzed by human cytochromes P450. Drug Metab Dispos. 1998 Oct;26(10):1019-25. (PMID: 9763408)

>  <Comments>  (232) 
Different tissue's cells give different results.

$$$$
CC02065
     RDKit          3D

 33 34  0  0  0  0  0  0  0  0999 V2000
   -6.8870    1.3830    1.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5490    1.1060   -0.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0780    0.1010   -1.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9480   -0.6180   -0.6610 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9600    2.9830    0.5170 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7220    1.9370   -1.3240 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7250   -0.1740   -2.1780 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6590    1.8150   -0.5170 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3080   -1.1800    1.8820 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4200   -2.5320   -0.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6420   -3.5010    0.7320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8340   -2.5570   -1.5730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5010   -1.0980    2.1820 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7680    1.7300    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6580    1.2010   -0.9040 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4580   -0.0770   -1.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3760   -0.8230   -0.9740 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4920   -0.2980   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6890    0.9740    0.4540 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3140   -1.1160    0.4120 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.0180   -0.4660   -0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8190   -1.2140    0.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4700   -0.4690    0.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6210   -1.1880    0.7210 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8190   -0.4240    0.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0620   -1.1210    0.9050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2910   -0.3370    0.5230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7560    0.6650    1.3530 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8990    3.2320    1.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4370    1.1310   -2.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0080   -1.2390   -2.8070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8860    2.7590    0.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3030   -1.2290    3.0170 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1 28  1  0
  2  3  1  0
  2  8  1  0
  3  4  2  0
  3  7  1  0
  4 27  1  0
  5 14  1  0
  5 29  1  0
  6 15  1  0
  6 30  1  0
  7 31  1  0
  8 32  1  0
 20  9  1  1
  9 33  3  0
 10 11  1  0
 10 12  1  0
 10 20  1  0
 13 24  1  0
 14 15  2  0
 14 19  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
M  END
>  <Name>  (233) 
Verapamil

>  <InChIKey>  (233) 
SGTNSNPWRIOYBX-HHHXNRCGSA-N

>  <PubChem_CID>  (233) 
65808

>  <CYP1A2>  (233) 
<7,8;Cleavage;R1>
<7,H;Oxidation;R1>
<8,9;Cleavage;R2>
<9,H;Oxidation;R2>

>  <CYP2A6>  (233) 


>  <CYP2B6>  (233) 


>  <CYP2C8>  (233) 
<25,24;Cleavage;R1>
<25,H;Oxidation;R1>
<13,24;Cleavage;R2>
<13,H;Oxidation;R2>
<31,32;Cleavage;R3>
<32,H;Oxidation;R3>
<0,1;Cleavage;R4>
<0,H;Oxidation;R4>

>  <CYP2C9>  (233) 
<7,8;Cleavage;R1>
<7,H;Oxidation;R1>
<8,9;Cleavage;R2>
<9,H;Oxidation;R2>

>  <CYP2C19>  (233) 


>  <CYP2D6>  (233) 


>  <CYP2E1>  (233) 
<7,8;Cleavage;R1>
<7,H;Oxidation;R1>
<8,9;Cleavage;R2>
<9,H;Oxidation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>

>  <CYP3A4>  (233) 
<7,8;Cleavage;R1>
<7,H;Oxidation;R1>
<8,9;Cleavage;R2>
<9,H;Oxidation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>

>  <References>  (233) 
Busse D, Cosme J, Beaune P, Kroemer HK, Eichelbaum M: Cytochromes of the P450 2C subfamily are the major enzymes involved in the O-demethylation of verapamil in humans. Naunyn Schmiedebergs Arch Pharmacol. 1995 Dec;353(1):116-21. (PMID: 8750925)
Kroemer HK, Gautier JC, Beaune P, Henderson C, Wolf CR, Eichelbaum M: Identification of P450 enzymes involved in metabolism of verapamil in humans. Naunyn Schmiedebergs Arch Pharmacol. 1993 Sep;348(3):332-7. (PMID: 8232610)
Tracy TS, Korzekwa KR, Gonzalez FJ, Wainer IW: Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil. Br J Clin Pharmacol. 1999 May;47(5):545-52. doi: 10.1046/j.1365-2125.1999.00923.x. (PMID: 10336579)

>  <Comments>  (233) 


$$$$
CC02066
     RDKit          3D

 28 31  0  0  1  0  0  0  0  0999 V2000
   -4.3720    0.7010   -0.1190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4050   -0.6870   -0.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2200   -1.4060   -0.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0100   -0.7370   -0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0080    0.6400   -0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1740    1.3290   -0.0560 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6160    1.4160   -0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7800    0.6630   -0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9240   -0.6540   -0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6800   -1.4280   -0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6760   -2.6410   -0.4900 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7480    2.7890    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9180    3.3650    0.3730 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8100    4.7350    0.4460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5540    5.2280    0.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4680    3.9650   -0.0600 S   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2990   -1.1710   -0.1670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3300   -2.5190   -0.2500 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3030   -0.4770   -0.0880 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6190    3.1040   -0.3560 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.3420    1.9490    0.3450 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.5020    0.7880   -0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8410    1.3340   -0.0970 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8090    2.7760    0.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9800    4.4200    0.1480 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1180    4.8960   -0.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6820    1.8050   -0.1020 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5290    2.3970    0.8730 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  1  7  1  0
  2  3  2  0
  2 10  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5 23  1  0
  7  8  1  0
  7 12  1  0
  8  9  2  0
  9 10  1  0
  9 17  1  0
 10 11  2  0
 12 13  2  0
 12 16  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 17 18  1  0
 17 19  2  0
 20 21  1  0
 20 24  1  0
 20 25  1  1
 21 22  1  0
 21 27  1  6
 22 23  1  0
 23 24  1  0
 25 26  1  0
 27 28  1  0
M  END
>  <Name>  (234) 
Voreloxin

>  <InChIKey>  (234) 
XZAFZXJXZHRNAQ-CHWSQXEVSA-N

>  <PubChem_CID>  (234) 
9865776

>  <CYP1A2>  (234) 
<11,15;Reduction;R1>
<26,27;Cleavage;R2>
<27,H;Oxidation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>

>  <CYP2A6>  (234) 


>  <CYP2B6>  (234) 


>  <CYP2C8>  (234) 


>  <CYP2C9>  (234) 


>  <CYP2C19>  (234) 


>  <CYP2D6>  (234) 
<11,15;Reduction;R1>

>  <CYP2E1>  (234) 


>  <CYP3A4>  (234) 
<11,15;Reduction;R1>
<26,27;Cleavage;R2>
<27,H;Oxidation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>

>  <References>  (234) 
Evanchik MJ, Allen D, Yoburn JC, Silverman JA, Hoch U: Metabolism of (+)-1,4-dihydro-7-(trans-3-methoxy-4-methylamino-1-pyrrolidinyl)-4-oxo-1-(2-thiaz olyl)-1,8-naphthyridine-3-carboxylic acid (voreloxin; formerly SNS-595), a novel replication-dependent DNA-damaging agent. Drug Metab Dispos. 2009 Mar;37(3):594-601. doi: 10.1124/dmd.108.023432. Epub 2008 Dec 12. (PMID: 19074528)

>  <Comments>  (234) 


$$$$
CC02067
     RDKit          3D

 23 25  0  0  1  0  0  0  0  0999 V2000
    2.0440    0.2690    8.9340 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6550    0.0320    6.6760 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0530    4.3120    8.5670 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5430    4.0440    4.0570 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7210    2.9250    6.2650 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.4060    2.2080    7.5430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9540    2.4100    5.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1840    3.1390    6.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0710    3.0920    8.6790 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3610    0.8770    7.7290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7550    2.4430    9.9510 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6550    3.5230    4.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7610    4.3560    6.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9880    2.1500    5.4530 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7580    1.0570   10.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4540    3.2070   11.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1200    4.5830    6.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3470    2.3760    5.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7660    3.9650    3.2020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4580    0.4180   11.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9120    3.5930    5.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1540    2.5670   12.2770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1570    1.1740   12.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  1  0
  1 15  1  0
  2 10  1  0
  3  9  2  0
  4 12  2  0
  5  6  1  0
  5  7  1  6
  5  8  1  0
  6  9  1  0
  6 10  2  0
  7 12  1  0
  8 13  2  0
  8 14  1  0
  9 11  1  0
 11 15  2  0
 11 16  1  0
 12 19  1  0
 13 17  1  0
 14 18  2  0
 15 20  1  0
 16 22  2  0
 17 21  2  0
 18 21  1  0
 20 23  2  0
 22 23  1  0
M  END
>  <Name>  (235) 
(R)-Warfarin

>  <InChIKey>  (235) 
QTXVAVXCBMYBJW-OAHLLOKOSA-N

>  <PubChem_CID>  (235) 


>  <CYP1A2>  (235) 
<16,H;Hydroxylation;R1>
<18,H;Hydroxylation;R2>

>  <CYP2A6>  (235) 


>  <CYP2B6>  (235) 


>  <CYP2C8>  (235) 
<8,H;Hydroxylation;R1>
<18,H;Hydroxylation;R2>

>  <CYP2C9>  (235) 
<8,H;Hydroxylation;R1>
<18,H;Hydroxylation;R2>
<17,H;Hydroxylation;R3>

>  <CYP2C19>  (235) 
<8,H;Hydroxylation;R1>
<18,H;Hydroxylation;R2>
<17,H;Hydroxylation;R3>
<16,H;Hydroxylation;R4>

>  <CYP2D6>  (235) 


>  <CYP2E1>  (235) 


>  <CYP3A4>  (235) 
<17,H;Hydroxylation;R1>
<3,H;Hydroxylation;R2>

>  <References>  (235) 
Rendic S: Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448. doi: 10.1081/DMR-120001392. (PMID: 11996015)
Kaminsky LS, de Morais SM, Faletto MB, Dunbar DA, Goldstein JA: Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe. Mol Pharmacol. 1993 Feb;43(2):234-9. (PMID: 8429826)
Zhang Z, Fasco MJ, Huang Z, Guengerich FP, Kaminsky LS: Human cytochromes P4501A1 and P4501A2: R-warfarin metabolism as a probe. Drug Metab Dispos. 1995 Dec;23(12):1339-46. (PMID: 8689941)

>  <Comments>  (235) 


$$$$
CC02068
     RDKit          3D

 16 17  0  0  0  0  0  0  0  0999 V2000
   -0.0240    1.6300    0.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0220    0.1680    0.1310 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.0030    2.4640    0.7140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4580    2.6620    0.7340 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0280   -0.5500    0.8580 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2000    0.0110   -1.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7330    3.8520    1.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6370    4.1860    1.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3200   -0.2120    0.6820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6850   -1.6000    1.7440 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6530    4.8930    1.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0670    5.4580    1.4380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2740   -0.7700    1.4550 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6270    0.5960   -0.1730 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2160    6.1430    1.6350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1380    6.4450    1.6990 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  1  6
  3  7  1  0
  4  8  1  0
  5  9  1  0
  5 10  1  0
  7  8  2  0
  7 11  1  0
  8 12  1  0
  9 13  1  0
  9 14  2  0
 11 15  2  0
 12 16  2  0
 15 16  1  0
M  END
>  <Name>  (236) 
Zileuton

>  <InChIKey>  (236) 
MWLSOWXNZPKENC-ZETCQYMHSA-N

>  <PubChem_CID>  (236) 
10220327

>  <CYP1A2>  (236) 
<5,H;Hydroxylation;R1>
<8,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<7,H;Hydroxylation;R4>

>  <CYP2A6>  (236) 


>  <CYP2B6>  (236) 


>  <CYP2C8>  (236) 


>  <CYP2C9>  (236) 
<5,H;Hydroxylation;R1>
<8,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<7,H;Hydroxylation;R4>

>  <CYP2C19>  (236) 


>  <CYP2D6>  (236) 


>  <CYP2E1>  (236) 
<5,H;Hydroxylation;R1>
<8,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<7,H;Hydroxylation;R4>

>  <CYP3A4>  (236) 
<10,S;S-Oxidation;R1>

>  <References>  (236) 
Machinist JM, Mayer MD, Shet MS, Ferrero JL, Rodrigues AD: Identification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193. Drug Metab Dispos. 1995 Oct;23(10):1163-74. (PMID: 8654206)

>  <Comments>  (236) 


$$$$
CC02069
     RDKit          3D

 21 23  0  0  1  0  0  0  0  0999 V2000
    5.7540   -1.3780   -0.1190 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1120   -3.0900    1.3610 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1940   -2.9790    0.0480 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7920   -6.2690   -2.7130 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4090   -6.3590    3.1080 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7550   -2.1720   -1.0460 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.2680   -1.8800   -1.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4570   -3.0230   -1.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2480   -5.0840   -1.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3510   -6.2290   -0.5380 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6210   -0.9380   -0.8880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0440   -5.1330   -2.4990 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0130   -4.0080   -0.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3060   -6.6010    0.8910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1500   -3.0970   -2.8890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4800   -6.0090    1.6940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9830   -6.9370   -1.5330 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3930   -4.1550   -3.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4130   -2.5430    0.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5130   -5.7440    3.8470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1250   -5.9470    3.6760 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 11  1  0
  1 19  1  0
  2 19  2  0
  3  6  1  0
  3 19  1  0
  4 12  1  0
  4 17  1  0
  5 16  1  0
  5 20  1  0
  5 21  1  0
  6  7  1  1
  6 11  1  0
  7  8  1  0
  8 13  2  0
  8 15  1  0
  9 10  1  0
  9 12  2  0
  9 13  1  0
 10 14  1  0
 10 17  2  0
 12 18  1  0
 14 16  1  0
 15 18  2  0
M  END
>  <Name>  (237) 
Zolmitriptan

>  <InChIKey>  (237) 
ULSDMUVEXKOYBU-ZDUSSCGKSA-N

>  <PubChem_CID>  (237) 
60857

>  <CYP1A2>  (237) 
<1,2;Cleavage;R1>
<2,H;Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>
<1,N;N-Oxidation;R3>

>  <CYP2A6>  (237) 


>  <CYP2B6>  (237) 


>  <CYP2C8>  (237) 


>  <CYP2C9>  (237) 


>  <CYP2C19>  (237) 


>  <CYP2D6>  (237) 


>  <CYP2E1>  (237) 


>  <CYP3A4>  (237) 


>  <References>  (237) 
Wild MJ, McKillop D, Butters CJ: Determination of the human cytochrome P450 isoforms involved in the metabolism of zolmitriptan. Xenobiotica. 1999 Aug;29(8):847-57. doi: 10.1080/004982599238290. (PMID: 10553725)

>  <Comments>  (237) 


$$$$
CC02070
     RDKit          3D

 23 25  0  0  1  0  0  0  0  0999 V2000
   -0.0010    1.3780   -0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0130    0.0160    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3090    1.7680   -0.0360 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2050    2.2820   -0.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2230   -0.8430    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2580   -0.4150    0.0460 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0710    0.6300    0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9020    2.9970   -0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4920    2.6320   -1.5530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2910   -0.5520   -0.8370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2920   -1.9460    0.8570 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4770    0.7350    0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2470    3.1120   -0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5300    3.4360   -1.8560 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7880    2.1910   -2.4370 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4140   -1.3540   -0.8270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4200   -2.7420    0.8580 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0550    1.9650    0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8830    4.4780   -0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8090    3.7770   -3.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3800    3.9680   -0.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4800   -2.4460    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7090   -3.3180    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5 10  2  0
  5 11  1  0
  6  7  2  0
  7 12  1  0
  8 13  2  0
  9 14  1  0
  9 15  2  0
 10 16  1  0
 11 17  2  0
 12 18  2  0
 13 18  1  0
 13 19  1  0
 14 20  1  0
 14 21  1  0
 16 22  2  0
 17 22  1  0
 22 23  1  0
M  END
>  <Name>  (238) 
Zolpidem

>  <InChIKey>  (238) 
ZAFYATHCZYHLPB-UHFFFAOYSA-N

>  <PubChem_CID>  (238) 
5732

>  <CYP1A2>  (238) 
<9,H;Hydroxylation;R1>
<0,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <CYP2A6>  (238) 


>  <CYP2B6>  (238) 


>  <CYP2C8>  (238) 


>  <CYP2C9>  (238) 
<9,H;Hydroxylation;R1>
<0,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <CYP2C19>  (238) 
<9,H;Hydroxylation;R1>
<0,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <CYP2D6>  (238) 
<9,H;Hydroxylation;R1>
<0,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>

>  <CYP2E1>  (238) 


>  <CYP3A4>  (238) 
<9,H;Hydroxylation;R1>
<0,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>
<19,H;Hydroxylation;R3>
<20,H;Hydroxylation;R4>

>  <References>  (238) 
Von Moltke LL, Greenblatt DJ, Granda BW, Duan SX, Grassi JM, Venkatakrishnan K, Harmatz JS, Shader RI: Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations. Br J Clin Pharmacol. 1999 Jul;48(1):89-97. doi: 10.1046/j.1365-2125.1999.00953.x. (PMID: 10383565)
Wang B, Zhou SF: Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr Med Chem. 2009;16(31):4066-218. (PMID: 19754423)

>  <Comments>  (238) 


$$$$
CC02072
     RDKit          3D

  4  3  0  0  0  0  0  0  0  0999 V2000
   -0.4080   -0.0260    0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0860   -0.1780    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8800   -0.3030    1.8020 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -1.2020   -1.8040    0.3000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  1  0
M  END
>  <Name>  (239) 
1,2-Dibromoethane

>  <InChIKey>  (239) 
PAAZPARNPHGIKF-UHFFFAOYSA-N

>  <PubChem_CID>  (239) 
7839

>  <CYP1A2>  (239) 


>  <CYP2A6>  (239) 
<0,1;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2B6>  (239) 
<0,1;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2C8>  (239) 


>  <CYP2C9>  (239) 


>  <CYP2C19>  (239) 


>  <CYP2D6>  (239) 


>  <CYP2E1>  (239) 
<0,1;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP3A4>  (239) 


>  <References>  (239) 
Wormhoudt LW, Ploemen JH, de Waziers I, Commandeur JN, Beaune PH, van Bladeren PJ, Vermeulen NP: Inter-individual variability in the oxidation of 1,2-dibromoethane: use of heterologously expressed human cytochrome P450 and human liver microsomes. Chem Biol Interact. 1996 Sep 6;101(3):175-92. (PMID: 8870687)

>  <Comments>  (239) 


$$$$
CC02073
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    1.2380    0.6400    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4750    1.4960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0230    1.2590    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2460    0.5850    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6790    1.5360    0.0040 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.2490   -0.7980    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6850   -1.7430    0.0020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.0340   -1.4680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1880   -0.7740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5590   -1.8280   -0.0020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.7350    0.8760   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9470    1.5630   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4210    0.6900   -0.0020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.9600    2.9430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7440    3.6100    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5240    2.9120    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1490    3.9640    0.0020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  9  1  0
  2 11  2  0
  2 16  1  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
M  END
>  <Name>  (240) 
2,2',4,5,5'-Pentachlorobiphenyl

>  <InChIKey>  (240) 
LAHWLEDBADHJGA-UHFFFAOYSA-N

>  <PubChem_CID>  (240) 
37807

>  <CYP1A2>  (240) 


>  <CYP2A6>  (240) 
<2,H;Hydroxylation;R1>

>  <CYP2B6>  (240) 


>  <CYP2C8>  (240) 


>  <CYP2C9>  (240) 


>  <CYP2C19>  (240) 


>  <CYP2D6>  (240) 


>  <CYP2E1>  (240) 


>  <CYP3A4>  (240) 
<2,H;Hydroxylation;R1>

>  <References>  (240) 
McGraw JE Sr, Waller DP: Specific human CYP 450 isoform metabolism of a pentachlorobiphenyl (PCB-IUPAC# 101). Biochem Biophys Res Commun. 2006 May 26;344(1):129-33. doi: 10.1016/j.bbrc.2006.03.122. Epub 2006 Mar 29. (PMID: 16616008)

>  <Comments>  (240) 


$$$$
CC02074
     RDKit          3D

 11 11  0  0  0  0  0  0  0  0999 V2000
    2.5210    0.6930    2.8910 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5390    0.8310    1.7900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5860    1.4520    1.9460 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2190    0.2300    0.4820 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9780    0.4980   -0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6680   -0.0530   -1.3520 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5890   -0.8720   -2.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8270   -1.1400   -1.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1500   -0.5740   -0.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3360   -0.9040    0.4200 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4280   -0.2400   -0.2170 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  4  9  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
M  END
>  <Name>  (241) 
2-Methoxyacetophenone

>  <InChIKey>  (241) 
DWPLEOPKBWNPQV-UHFFFAOYSA-N

>  <PubChem_CID>  (241) 
68481

>  <CYP1A2>  (241) 


>  <CYP2A6>  (241) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2B6>  (241) 


>  <CYP2C8>  (241) 


>  <CYP2C9>  (241) 


>  <CYP2C19>  (241) 


>  <CYP2D6>  (241) 


>  <CYP2E1>  (241) 


>  <CYP3A4>  (241) 


>  <References>  (241) 
Su T, Bao Z, Zhang QY, Smith TJ, Hong JY, Ding X: Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 2000 Sep 15;60(18):5074-9. (PMID: 11016631)

>  <Comments>  (241) 


$$$$
CC02075
     RDKit          3D

 10 10  0  0  0  0  0  0  0  0999 V2000
    1.1610    2.4190    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6980    3.2160    0.0130 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.0460    3.1340    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2530    2.4190    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7900    3.2150    0.0130 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.2510    1.0200    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0460    0.3220    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1600    1.0200    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0460    4.5690    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0460    5.7290    0.0140 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  8  1  0
  3  4  1  0
  3  9  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  2  0
  9 10  3  0
M  END
>  <Name>  (242) 
2,6-Dichlorobenzonitrilie

>  <InChIKey>  (242) 
YOYAIZYFCNQIRF-UHFFFAOYSA-N

>  <PubChem_CID>  (242) 
3031

>  <CYP1A2>  (242) 


>  <CYP2A6>  (242) 
<6,H;Hydroxylation;R1>
<7,H;Hydroxylation;R2>
<5,H;Hydroxylation;R3>

>  <CYP2B6>  (242) 


>  <CYP2C8>  (242) 


>  <CYP2C9>  (242) 


>  <CYP2C19>  (242) 


>  <CYP2D6>  (242) 


>  <CYP2E1>  (242) 


>  <CYP3A4>  (242) 


>  <References>  (242) 
Ding X, Spink DC, Bhama JK, Sheng JJ, Vaz AD, Coon MJ: Metabolic activation of 2,6-dichlorobenzonitrile, an olfactory-specific toxicant, by rat, rabbit, and human cytochromes P450. Mol Pharmacol. 1996 Jun;49(6):1113-21. (PMID: 8649351)

>  <Comments>  (242) 


$$$$
CC02076
     RDKit          3D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4130    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2400   -0.6710   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3940    0.0490   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3730    1.4430   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1940    2.1230    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2570    2.0780    0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1480   -0.6850    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3940    1.3220    0.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3050   -0.0680    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5720   -0.8850    0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5640   -1.8500   -1.1530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8500   -2.6800   -1.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  1  7  1  0
  2  3  2  0
  2  8  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  7  9  2  0
  8 10  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
M  END
>  <Name>  (243) 
2n-Propylquinoline

>  <InChIKey>  (243) 
IZXJPGLOYYDHRM-UHFFFAOYSA-N

>  <PubChem_CID>  (243) 
74166

>  <CYP1A2>  (243) 


>  <CYP2A6>  (243) 
<0,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>

>  <CYP2B6>  (243) 


>  <CYP2C8>  (243) 


>  <CYP2C9>  (243) 
<9,10;EpOxidation;R1>
<7,8;EpOxidation;R2>
<0,H;Hydroxylation;R3>
<2,H;Hydroxylation;R4>

>  <CYP2C19>  (243) 
<0,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>

>  <CYP2D6>  (243) 


>  <CYP2E1>  (243) 
<9,10;EpOxidation;R1>
<7,8;EpOxidation;R2>
<0,H;Hydroxylation;R3>

>  <CYP3A4>  (243) 
<9,10;EpOxidation;R1>
<7,8;EpOxidation;R2>
<0,H;Hydroxylation;R3>
<2,H;Hydroxylation;R4>
<5,H;Hydroxylation;R5>
<4,H;Hydroxylation;R6>
<7,H;Hydroxylation;R7>
<8,H;Hydroxylation;R8>

>  <References>  (243) 
Belliard AM, Baune B, Fakhfakh M, Hocquemiller R, Farinotti R: Determination of the human cytochrome P450s involved in the metabolism of 2n-propylquinoline. Xenobiotica. 2003 Apr;33(4):341-55. doi: 10.1080/0049825031000065188. (PMID: 12745870)

>  <Comments>  (243) 


$$$$
CC02077
     RDKit          3D

 16 18  0  0  0  0  0  0  0  0999 V2000
    1.2620    0.6470   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0850    1.3940   -0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0860    0.6390   -0.1110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1380   -0.7510   -0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0770   -1.4710    0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2850   -0.7470    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5770   -1.4100    0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7050   -0.7040    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7070    0.7580    0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7580    1.3890    0.1030 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4690    1.3850    0.0180 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3400    1.1610   -0.2050 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2110    0.1160   -0.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5210   -1.0720   -0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1750   -2.8520    0.0680 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9170   -3.4230    0.7770 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1 11  1  0
  2  3  1  0
  3  4  2  0
  3 12  1  0
  4  5  1  0
  4 14  1  0
  5  6  2  0
  5 15  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 12 13  1  0
 13 14  2  0
 15 16  1  0
M  END
>  <Name>  (244) 
5-MOP

>  <InChIKey>  (244) 
BGEBZHIAGXMEMV-UHFFFAOYSA-N

>  <PubChem_CID>  (244) 
2355

>  <CYP1A2>  (244) 


>  <CYP2A6>  (244) 
<4,5;EpOxidation;R1>

>  <CYP2B6>  (244) 


>  <CYP2C8>  (244) 


>  <CYP2C9>  (244) 


>  <CYP2C19>  (244) 


>  <CYP2D6>  (244) 


>  <CYP2E1>  (244) 


>  <CYP3A4>  (244) 


>  <References>  (244) 
Koenigs LL, Trager WF: Mechanism-based inactivation of P450 2A6 by furanocoumarins. Biochemistry. 1998 Jul 14;37(28):10047-61. doi: 10.1021/bi980003c. (PMID: 9665710)

>  <Comments>  (244) 


$$$$
CC02078
     RDKit          3D

 16 18  0  0  0  0  0  0  0  0999 V2000
    1.2410    0.6770    0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0420    1.4120    0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1510    2.7840    0.2330 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1150    3.4260    0.2330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1240    0.6400   -0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1280   -0.7490   -0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0950   -1.4410   -0.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2780   -0.7100   -0.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5530   -1.3970   -0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6830   -0.7040    0.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6940    0.7540    0.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7490    1.3690    0.3200 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4600    1.3930    0.2160 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4110    1.0990   -0.0380 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2320    0.0220   -0.1730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4880   -1.1340   -0.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  8  1  0
  1 13  1  0
  2  3  1  0
  2  5  1  0
  3  4  1  0
  5  6  2  0
  5 14  1  0
  6  7  1  0
  6 16  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 14 15  1  0
 15 16  2  0
M  END
>  <Name>  (245) 
8-MOP

>  <InChIKey>  (245) 
QXKHYNVANLEOEG-UHFFFAOYSA-N

>  <PubChem_CID>  (245) 
4114

>  <CYP1A2>  (245) 


>  <CYP2A6>  (245) 
<5,6;EpOxidation;R1>

>  <CYP2B6>  (245) 


>  <CYP2C8>  (245) 


>  <CYP2C9>  (245) 


>  <CYP2C19>  (245) 


>  <CYP2D6>  (245) 


>  <CYP2E1>  (245) 


>  <CYP3A4>  (245) 


>  <References>  (245) 
Koenigs LL, Trager WF: Mechanism-based inactivation of P450 2A6 by furanocoumarins. Biochemistry. 1998 Jul 14;37(28):10047-61. doi: 10.1021/bi980003c. (PMID: 9665710)

>  <Comments>  (245) 


$$$$
CC02079
     RDKit          3D

 22 24  0  0  1  0  0  0  0  0999 V2000
   -1.8520   -4.1700   -0.4700 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.6250   -0.2560   -2.3270 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8430    1.3560   -2.2090 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.2810    1.7930   -1.9570 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0150    1.9860    0.3760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3180    3.6190    1.2220 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2210    1.5290    1.0160 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7500   -0.7470    1.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0240   -0.3270    0.6270 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5280   -1.7350    0.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1840    0.6660   -0.2070 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.5030   -0.2520    0.7670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9490   -0.2940    0.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4630    0.1600    0.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1190    0.1810    0.6660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3160    0.8970   -1.7190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8810   -1.6530   -0.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2030   -0.6710    0.9060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3500   -0.1790    1.4860 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1970    2.4430    0.8810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9570   -2.5080   -0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1180   -2.0170    0.5590 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 21  1  0
  2 16  1  0
  3 16  1  0
  4 16  1  0
  5 11  1  0
  5 20  1  0
  6 20  2  0
  7 15  1  0
  7 20  1  0
  8  9  1  0
  8 10  1  0
  8 12  1  0
  9 10  1  0
 11 13  1  0
 11 14  1  1
 11 16  1  0
 12 14  3  0
 13 15  2  0
 13 17  1  0
 15 18  1  0
 17 21  2  0
 18 19  1  0
 18 22  2  0
 21 22  1  0
M  END
>  <Name>  (246) 
8-OH-Efavirenz

>  <InChIKey>  (246) 
OOVOMPCQLMFEDT-ZDUSSCGKSA-N

>  <PubChem_CID>  (246) 
487643

>  <CYP1A2>  (246) 


>  <CYP2A6>  (246) 
<14,H;Hydroxylation;R1>

>  <CYP2B6>  (246) 
<14,H;Hydroxylation;R1>

>  <CYP2C8>  (246) 


>  <CYP2C9>  (246) 
<14,H;Hydroxylation;R1>

>  <CYP2C19>  (246) 
<14,H;Hydroxylation;R1>

>  <CYP2D6>  (246) 
<14,H;Hydroxylation;R1>

>  <CYP2E1>  (246) 


>  <CYP3A4>  (246) 


>  <References>  (246) 
Ward BA, Gorski JC, Jones DR, Hall SD, Flockhart DA, Desta Z: The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity. J Pharmacol Exp Ther. 2003 Jul;306(1):287-300. doi: 10.1124/jpet.103.049601. Epub 2003 Apr 3. (PMID: 12676886)

>  <Comments>  (246) 


$$$$
CC02081
     RDKit          3D

 22 22  0  0  0  0  0  0  0  0999 V2000
   -0.2530    1.5870    0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2450    0.1890    0.2190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8320    2.3700   -0.4360 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3920    2.0930    1.7160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4160   -0.4760    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3600   -2.4500   -0.7610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5600   -1.7300   -0.9340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8010   -1.8330   -0.3280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1720   -1.7850   -0.6820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4150   -1.8740   -0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9780   -2.5010   -0.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5910   -2.5420   -0.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5350   -0.5150   -1.0130 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7370   -2.3880   -1.0120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9040    3.8640   -0.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6640    3.5940    1.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4540    1.7260   -1.6480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5400    1.8360    2.9020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7120    1.3540    1.9430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6190    4.2870    1.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1410   -0.2820   -0.7790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1150   -2.6360   -0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  3 15  1  0
  3 17  1  0
  4 16  1  0
  4 18  1  0
  4 19  1  0
  5 10  1  0
  6  7  1  0
  6  9  2  0
  7 13  2  0
  7 14  1  0
  8 11  2  0
  8 12  1  0
  9 11  1  0
  9 21  1  0
 10 12  2  0
 10 22  1  0
 15 20  1  0
 16 20  1  0
M  END
>  <Name>  (247) 
9-cis-Retinoic acid

>  <InChIKey>  (247) 
SHGAZHPCJJPHSC-ZVCIMWCZSA-N

>  <PubChem_CID>  (247) 
449171

>  <CYP1A2>  (247) 


>  <CYP2A6>  (247) 
<21,H;Hydroxylation;R1>

>  <CYP2B6>  (247) 
<21,H;Hydroxylation;R1>

>  <CYP2C8>  (247) 
<21,H;Hydroxylation;R1>

>  <CYP2C9>  (247) 
<21,H;Hydroxylation;R1>

>  <CYP2C19>  (247) 


>  <CYP2D6>  (247) 


>  <CYP2E1>  (247) 


>  <CYP3A4>  (247) 
<21,H;Hydroxylation;R1>

>  <References>  (247) 
Marill J, Capron CC, Idres N, Chabot GG: Human cytochrome P450s involved in the metabolism of 9-cis- and 13-cis-retinoic acids. Biochem Pharmacol. 2002 Mar 1;63(5):933-43. doi: 10.1016/s0006-2952(01)00925-x. (PMID: 11911845)

>  <Comments>  (247) 


$$$$
CC02082
     RDKit          3D

  9  8  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4610    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2410    2.2100    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0360    1.8580   -1.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0230   -0.5220    1.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1940    2.1190    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2390    1.4960    0.0210 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2180    3.8800    0.0290 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0040    4.1710    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  6  1  0
  2  5  1  0
  3  4  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
M  END
>  <Name>  (248) 
DETC-Me

>  <InChIKey>  (248) 
AQTFQQHFHGBCPG-UHFFFAOYSA-N

>  <PubChem_CID>  (248) 
119467

>  <CYP1A2>  (248) 
<7,S;S-Oxidation;R1>

>  <CYP2A6>  (248) 
<7,S;S-Oxidation;R1>

>  <CYP2B6>  (248) 
<7,S;S-Oxidation;R1>

>  <CYP2C8>  (248) 


>  <CYP2C9>  (248) 
<7,S;S-Oxidation;R1>

>  <CYP2C19>  (248) 


>  <CYP2D6>  (248) 
<7,S;S-Oxidation;R1>

>  <CYP2E1>  (248) 
<7,S;S-Oxidation;R1>

>  <CYP3A4>  (248) 
<7,S;S-Oxidation;R1>

>  <References>  (248) 
Madan A, Parkinson A, Faiman MD: Identification of the human and rat P450 enzymes responsible for the sulfoxidation of S-methyl N,N-diethylthiolcarbamate (DETC-ME). The terminal step in the bioactivation of disulfiram. Drug Metab Dispos. 1995 Oct;23(10):1153-62. (PMID: 8654205)

>  <Comments>  (248) 


$$$$
CC02083
     RDKit          3D

  7  6  0  0  0  0  0  0  0  0999 V2000
    0.2390    3.0960    1.8750 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7560    2.3780    0.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2360    3.1010   -0.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2800    2.3860    0.6240 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2710    1.0400    0.6210 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0890    1.0380    0.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5990   -0.3640    0.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
M  END
>  <Name>  (249) 
ETBE

>  <InChIKey>  (249) 
NUMQCACRALPSHD-UHFFFAOYSA-N

>  <PubChem_CID>  (249) 
12512

>  <CYP1A2>  (249) 


>  <CYP2A6>  (249) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2B6>  (249) 


>  <CYP2C8>  (249) 


>  <CYP2C9>  (249) 


>  <CYP2C19>  (249) 


>  <CYP2D6>  (249) 


>  <CYP2E1>  (249) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP3A4>  (249) 


>  <References>  (249) 
Hong JY, Yang CS, Lee M, Wang YY, Huang WQ, Tan Y, Patten CJ, Bondoc FY: Role of cytochromes P450 in the metabolism of methyl tert-butyl ether in human livers. Arch Toxicol. 1997;71(4):266-9. (PMID: 9101044)

>  <Comments>  (249) 
(Need to confirm).

$$$$
CC02084
     RDKit          3D

  9  8  0  0  0  0  0  0  0  0999 V2000
   -2.2510    2.0570    2.6930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8990    1.4630    1.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4850    2.2410    0.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0350    3.7020    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5150    3.9140   -0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1350    3.1510   -1.1600 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2920    3.6370   -2.4760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4480    3.1160   -1.0660 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8060    2.3720   -0.1460 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
M  END
>  <Name>  (250) 
MNAN

>  <InChIKey>  (250) 
KSFCDINBDBFFSI-UHFFFAOYSA-N

>  <PubChem_CID>  (250) 
25805

>  <CYP1A2>  (250) 


>  <CYP2A6>  (250) 
<4,5;Cleavage;R1>
<4,H;Oxidation;R1>

>  <CYP2B6>  (250) 


>  <CYP2C8>  (250) 


>  <CYP2C9>  (250) 


>  <CYP2C19>  (250) 


>  <CYP2D6>  (250) 


>  <CYP2E1>  (250) 
<4,5;Cleavage;R1>
<4,H;Oxidation;R1>
<5,6;Cleavage;R2>
<6,H;Oxidation;R2>

>  <CYP3A4>  (250) 


>  <References>  (250) 
Chen SC, Wang X, Xu G, Zhou L, Vennerstrom JL, Gonzalez F, Gelboin HV, Mirvish SS: Depentylation of [3H-pentyl]methyl-n-amylnitrosamine by rat esophageal and liver microsomes and by rat and human cytochrome P450 isoforms. Cancer Res. 1999 Jan 1;59(1):91-8. (PMID: 9892192)

>  <Comments>  (250) 
<5,6;Cleavage> for CYP2E1 is tested using rat. The reaction is depentylation.

$$$$
CC02085
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    1.4910    0.2650    0.9740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8090    0.9260    1.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9910    0.0920    0.8360 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8210    0.4520   -0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4120   -0.1620   -0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1800    0.1170   -1.9760 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.9900   -0.9690    0.5270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2320   -1.6070    0.3430 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3130   -1.1490    1.7360 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9190   -0.5360    1.9600 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4920    0.1250   -0.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5960   -0.6540   -0.8070 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2140   -1.4740    0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3260   -2.2440   -0.2490 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7070   -1.5010    1.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4100   -2.4800    2.6760 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.6020   -0.7220    1.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  2  0
  1 10  1  0
  2  3  1  0
  3 11  2  0
  3 17  1  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 15 17  2  0
M  END
>  <Name>  (251) 
MOCA

>  <InChIKey>  (251) 
IBOFVQJTBBUKMU-UHFFFAOYSA-N

>  <PubChem_CID>  (251) 
7543

>  <CYP1A2>  (251) 


>  <CYP2A6>  (251) 
<0,H;Oxidation;R1>
<10,H;Oxidation;R2>

>  <CYP2B6>  (251) 


>  <CYP2C8>  (251) 


>  <CYP2C9>  (251) 


>  <CYP2C19>  (251) 


>  <CYP2D6>  (251) 


>  <CYP2E1>  (251) 


>  <CYP3A4>  (251) 
<0,H;Oxidation;R1>
<10,H;Oxidation;R2>

>  <References>  (251) 
Yun CH, Shimada T, Guengerich FP: Contributions of human liver cytochrome P450 enzymes to the N-oxidation of 4,4'-methylene-bis(2-chloroaniline). Carcinogenesis. 1992 Feb;13(2):217-22. doi: 10.1093/carcin/13.2.217. (PMID: 1740010)

>  <Comments>  (251) 
(Need to confirm oxidation).

$$$$
CC02086
     RDKit          3D

  6  5  0  0  0  0  0  0  0  0999 V2000
    0.2390    3.0960    1.8750 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7560    2.3780    0.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2360    3.1010   -0.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2800    2.3860    0.6240 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2710    1.0400    0.6210 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1540    1.0380    0.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
M  END
>  <Name>  (252) 
MTBE

>  <InChIKey>  (252) 
BZLVMXJERCGZMT-UHFFFAOYSA-N

>  <PubChem_CID>  (252) 
15413

>  <CYP1A2>  (252) 


>  <CYP2A6>  (252) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2B6>  (252) 


>  <CYP2C8>  (252) 


>  <CYP2C9>  (252) 


>  <CYP2C19>  (252) 


>  <CYP2D6>  (252) 


>  <CYP2E1>  (252) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP3A4>  (252) 


>  <References>  (252) 
Hong JY, Yang CS, Lee M, Wang YY, Huang WQ, Tan Y, Patten CJ, Bondoc FY: Role of cytochromes P450 in the metabolism of methyl tert-butyl ether in human livers. Arch Toxicol. 1997;71(4):266-9. (PMID: 9101044)

>  <Comments>  (252) 


$$$$
CC02087
     RDKit          3D

 11 10  0  0  0  0  0  0  0  0999 V2000
   -1.4550    2.1300    0.4990 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4460    1.7980    1.1600 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3400    3.4350    0.4460 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0320    3.8240    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2240    4.0590   -0.5340 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4580    3.6160   -1.2990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6340    4.2180   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7490    4.0150   -1.4520 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1690    3.8390   -2.9200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4100    4.8020   -0.9630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8540    4.9110   -0.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  3  4  1  0
  3  5  1  0
  4  6  1  0
  5  7  1  0
  6  8  1  0
  7 10  1  0
  8  9  1  0
 10 11  1  0
M  END
>  <Name>  (253) 
NDBA

>  <InChIKey>  (253) 
YGJHZCLPZAZIHH-UHFFFAOYSA-N

>  <PubChem_CID>  (253) 
13542

>  <CYP1A2>  (253) 


>  <CYP2A6>  (253) 
<4,5;Cleavage;R1>
<5,H;Oxidation;R1>
<3,4;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2B6>  (253) 


>  <CYP2C8>  (253) 


>  <CYP2C9>  (253) 


>  <CYP2C19>  (253) 


>  <CYP2D6>  (253) 


>  <CYP2E1>  (253) 
<4,5;Cleavage;R1>
<5,H;Oxidation;R1>
<3,4;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP3A4>  (253) 


>  <References>  (253) 
Kushida H, Fujita K, Suzuki A, Yamada M, Endo T, Nohmi T, Kamataki T: Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase. Carcinogenesis. 2000 Jun;21(6):1227-32. (PMID: 10837014)
Shu L, Hollenberg PF: Identification of the cytochrome P450 isozymes involved in the metabolism of N-nitrosodipropyl-,N-nitrosodibutyl- and N-nitroso-n-butyl-n-propylamine. Carcinogenesis. 1996 Apr;17(4):839-48. doi: 10.1093/carcin/17.4.839. (PMID: 8625499)

>  <Comments>  (253) 


$$$$
CC02088
     RDKit          3D

  9  8  0  0  0  0  0  0  0  0999 V2000
   -1.4550    2.1300    0.4990 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4460    1.7980    1.1600 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3400    3.4350    0.4460 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0320    3.8240    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2240    4.0590   -0.5340 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4580    3.6160   -1.2990 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8900    4.0580   -1.4690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6340    4.2180   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4940    4.8650   -1.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  3  4  1  0
  3  5  1  0
  4  6  1  0
  5  8  1  0
  6  7  1  0
  8  9  1  0
M  END
>  <Name>  (254) 
NDPA

>  <InChIKey>  (254) 
YLKFDHTUAUWZPQ-UHFFFAOYSA-N

>  <PubChem_CID>  (254) 
12130

>  <CYP1A2>  (254) 


>  <CYP2A6>  (254) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>
<3,4;Cleavage;R2>
<4,H;Oxidation;R2>

>  <CYP2B6>  (254) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>
<3,4;Cleavage;R2>
<4,H;Oxidation;R2>

>  <CYP2C8>  (254) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>
<3,4;Cleavage;R2>
<4,H;Oxidation;R2>

>  <CYP2C9>  (254) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>
<3,4;Cleavage;R2>
<4,H;Oxidation;R2>

>  <CYP2C19>  (254) 


>  <CYP2D6>  (254) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>
<3,4;Cleavage;R2>
<4,H;Oxidation;R2>

>  <CYP2E1>  (254) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>
<3,4;Cleavage;R2>
<4,H;Oxidation;R2>
<2,H;Oxidation;R3>
<1,H;Hydroxylation;R4>
<5,H;Hydroxylation;R5>
<0,H;Hydroxylation;R6>
<6,H;Hydroxyaltion;R7>

>  <CYP3A4>  (254) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>
<3,4;Cleavage;R2>
<4,H;Oxidation;R2>
<2,H;Oxidation;R3>

>  <References>  (254) 
Teiber JF, Hollenberg PF: Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine. Carcinogenesis. 2000 Aug;21(8):1559-66. (PMID: 10910959)
Shu L, Hollenberg PF: Identification of the cytochrome P450 isozymes involved in the metabolism of N-nitrosodipropyl-,N-nitrosodibutyl- and N-nitroso-n-butyl-n-propylamine. Carcinogenesis. 1996 Apr;17(4):839-48. doi: 10.1093/carcin/17.4.839. (PMID: 8625499)

>  <Comments>  (254) 
Denitrosation is determined by checking nitrite.

$$$$
CC02090
     RDKit          3D

 10 10  0  0  0  0  0  0  0  0999 V2000
   -1.5100    2.0420    0.9170 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4110    1.5050    0.2630 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4190    3.3710    0.7070 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4530    4.1740    1.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2810    4.1230   -0.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4610    3.6120    2.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4190    4.3880    2.9140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4820    5.7550    2.6720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5890    6.3410    1.7820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3640    5.5550    1.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  3  4  1  0
  3  5  1  0
  4  6  2  0
  4 10  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
M  END
>  <Name>  (255) 
NMPhA

>  <InChIKey>  (255) 
MAXCWSIJKVASQC-UHFFFAOYSA-N

>  <PubChem_CID>  (255) 
11957

>  <CYP1A2>  (255) 


>  <CYP2A6>  (255) 
<0,1;Cleavage;R1>
<0,H;Hydroxylation;R1>

>  <CYP2B6>  (255) 


>  <CYP2C8>  (255) 


>  <CYP2C9>  (255) 


>  <CYP2C19>  (255) 


>  <CYP2D6>  (255) 


>  <CYP2E1>  (255) 


>  <CYP3A4>  (255) 


>  <References>  (255) 
Kushida H, Fujita K, Suzuki A, Yamada M, Endo T, Nohmi T, Kamataki T: Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase. Carcinogenesis. 2000 Jun;21(6):1227-32. (PMID: 10837014)

>  <Comments>  (255) 


$$$$
CC02091
     RDKit          3D

  7  7  0  0  0  0  0  0  0  0999 V2000
   -1.5910    2.3840    0.9940 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2740    1.6010    0.3230 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2000    3.4020    0.2730 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2920    4.2830    1.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0360    5.6000    1.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6920    5.6230   -0.2270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3200    4.2480   -0.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  3  4  1  0
  3  7  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
M  END
>  <Name>  (256) 
NPYR

>  <InChIKey>  (256) 
WNYADZVDBIBLJJ-UHFFFAOYSA-N

>  <PubChem_CID>  (256) 
13591

>  <CYP1A2>  (256) 


>  <CYP2A6>  (256) 
<2,3;Cleavage;R1>
<3,H;Hydroxylation;R1>
<2,6;Cleavage;R2>
<6,H;Hydroxylation;R2>

>  <CYP2B6>  (256) 


>  <CYP2C8>  (256) 


>  <CYP2C9>  (256) 


>  <CYP2C19>  (256) 


>  <CYP2D6>  (256) 


>  <CYP2E1>  (256) 
<2,3;Cleavage;R1>
<3,H;Hydroxylation;R1>
<2,6;Cleavage;R2>
<6,H;Hydroxylation;R2>

>  <CYP3A4>  (256) 


>  <References>  (256) 
Kushida H, Fujita K, Suzuki A, Yamada M, Endo T, Nohmi T, Kamataki T: Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase. Carcinogenesis. 2000 Jun;21(6):1227-32. (PMID: 10837014)

>  <Comments>  (256) 
The reference was wrong. The first activation metabolite is a hydroxyl metabolite. The final stable one should be an N-dealkylation metabolite by referencing NNN.

$$$$
CC02092
     RDKit          3D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4260    2.0470   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6580    1.9870    1.2420 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2070   -0.7020   -1.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2350   -0.7070    1.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3420    3.2740    0.9460 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3230    2.7810    2.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1790   -2.0880   -1.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2560   -2.0260    1.1690 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0550   -2.7230    0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8770    1.7570    1.5970 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3030    2.2110    2.6440 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  1
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  4  8  1  0
  4 12  1  0
  5  9  1  0
  6 10  2  0
  7  8  1  0
  9 11  2  0
 10 11  1  0
 12 13  2  0
M  END
>  <Name>  (257) 
N-Nitrosonornicotine

>  <InChIKey>  (257) 
XKABJYQDMJTNGQ-VIFPVBQESA-N

>  <PubChem_CID>  (257) 
12613538

>  <CYP1A2>  (257) 


>  <CYP2A6>  (257) 
<2,3;Cleavage;R1>
<3,H;Hydroxylation;R1>

>  <CYP2B6>  (257) 


>  <CYP2C8>  (257) 


>  <CYP2C9>  (257) 


>  <CYP2C19>  (257) 


>  <CYP2D6>  (257) 
<2,3;Cleavage;R1>
<3,H;Hydroxylation;R1>

>  <CYP2E1>  (257) 
<2,3;Cleavage;R1>
<3,H;Hydroxylation;R1>

>  <CYP3A4>  (257) 
<2,3;Cleavage;R1>
<3,H;Hydroxylation;R1>

>  <References>  (257) 
Patten CJ, Smith TJ, Friesen MJ, Tynes RE, Yang CS, Murphy SE: Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes. Carcinogenesis. 1997 Aug;18(8):1623-30. doi: 10.1093/carcin/18.8.1623. (PMID: 9276639)

>  <Comments>  (257) 


$$$$
CC02093
     RDKit          3D

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.6160    1.0720    1.8610 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9590    1.4140    1.3680 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0300    1.6010   -0.1460 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6000    0.3340   -0.8840 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5880   -0.4860   -0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2270    0.4000    0.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0660    2.2380    2.4490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2920    1.8790    3.2650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4790    2.6090    3.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5900    2.2970    3.9120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5200    1.2570    4.8390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3450    0.5160    4.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4060   -0.4720    5.9330 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3460   -1.4270    5.9890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2180   -0.9830    6.9220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6830   -0.5450    8.3110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3380   -1.6290    9.0330 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2340    0.8400    4.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  7  8  1  0
  8  9  2  0
  8 18  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 18  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
M  END
>  <Name>  (258) 
ROX-M-4

>  <InChIKey>  (258) 
VQSXCZMVUMSITD-UHFFFAOYSA-N

>  <PubChem_CID>  (258) 
10220561

>  <CYP1A2>  (258) 


>  <CYP2A6>  (258) 
<0,1;Cleavage;R1>
<1,H;Oxidation;R2>

>  <CYP2B6>  (258) 


>  <CYP2C8>  (258) 


>  <CYP2C9>  (258) 


>  <CYP2C19>  (258) 


>  <CYP2D6>  (258) 


>  <CYP2E1>  (258) 


>  <CYP3A4>  (258) 


>  <References>  (258) 
Sasaki M, Nakayama M, Numazawa S, Oguro T, Honma S, Iwamura S, Tsukamoto K, Yoshida T: Cytochrome P450 enzymes involved in the metabolic pathway of the histamine 2 (H2)-receptor antagonist roxatidine acetate by human liver microsomes. Arzneimittelforschung. 2001;51(8):651-8. doi: 10.1055/s-0031-1300096. (PMID: 11556126)

>  <Comments>  (258) 
<16,17; Cleavage> need to confirm. This might involve two-step reaction.

$$$$
CC02094
     RDKit          3D

 14 15  0  0  0  0  0  0  0  0999 V2000
    1.6960   -2.8490    1.5500 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7930   -1.9350    0.7400 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.5880   -0.8650    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5930   -1.1120   -0.6480 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0270    0.3960    0.1560 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1860    0.5130    0.9440 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.3760   -1.0630    1.8140 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4160    0.8450    0.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3860    1.6960    0.6640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5270    2.0480    0.0280 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7250    1.5170   -1.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8370    0.6520   -1.8130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6700    0.3120   -1.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6210    1.5800   -0.4380 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  2  7  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  5 14  1  0
  6  7  1  0
  6  8  1  6
  8  9  2  0
  8 13  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
M  END
>  <Name>  (259) 
SM-12502

>  <InChIKey>  (259) 
FZXAQGVGSAANBR-GMSGAONNSA-N

>  <PubChem_CID>  (259) 
14649075

>  <CYP1A2>  (259) 


>  <CYP2A6>  (259) 
<2,S;S-Oxidation;R1>

>  <CYP2B6>  (259) 


>  <CYP2C8>  (259) 


>  <CYP2C9>  (259) 


>  <CYP2C19>  (259) 


>  <CYP2D6>  (259) 


>  <CYP2E1>  (259) 


>  <CYP3A4>  (259) 


>  <References>  (259) 
Nunoya K, Yokoi Y, Kimura K, Kodama T, Funayama M, Inoue K, Nagashima K, Funae Y, Shimada N, Green C, Kamataki T: (+)-cis-3,5-dimethyl-2-(3-pyridyl) thiazolidin-4-one hydrochloride (SM-12502) as a novel substrate for cytochrome P450 2A6 in human liver microsomes. J Pharmacol Exp Ther. 1996 May;277(2):768-74. (PMID: 8627557)

>  <Comments>  (259) 


$$$$
CC02095
     RDKit          3D

  7  6  0  0  0  0  0  0  0  0999 V2000
    0.6920    1.8740    2.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2090    1.1560    1.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6890    1.8790   -0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2020    3.3260   -0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2000    1.1630   -1.3210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7350    1.8810   -0.0760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2100    2.5440    1.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  3  6  1  0
  6  7  1  0
M  END
>  <Name>  (260) 
TAME

>  <InChIKey>  (260) 
HVZJRWJGKQPSFL-UHFFFAOYSA-N

>  <PubChem_CID>  (260) 
61247

>  <CYP1A2>  (260) 


>  <CYP2A6>  (260) 
<5,6;Cleavage;R1>
<6,H;Oxidation;R1>

>  <CYP2B6>  (260) 


>  <CYP2C8>  (260) 


>  <CYP2C9>  (260) 


>  <CYP2C19>  (260) 


>  <CYP2D6>  (260) 


>  <CYP2E1>  (260) 
<5,6;Cleavage;R1>
<6,H;Oxidation;R1>

>  <CYP3A4>  (260) 


>  <References>  (260) 
Hong JY, Yang CS, Lee M, Wang YY, Huang WQ, Tan Y, Patten CJ, Bondoc FY: Role of cytochromes P450 in the metabolism of methyl tert-butyl ether in human livers. Arch Toxicol. 1997;71(4):266-9. (PMID: 9101044)

>  <Comments>  (260) 
6 (O for O-Dealkylation).

$$$$
CC02096
     RDKit          3D

 36 39  0  0  0  0  0  0  0  0999 V2000
   -3.1920    0.8540   -0.5490 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.9050    1.5800   -0.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2630   -0.5230    0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4370    1.6730   -0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6750    0.9230   -0.6740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9350    2.7700    0.4210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3650   -1.6340   -0.7680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2390   -0.7090    1.4600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3560    2.8570    0.3600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6840    1.1110   -0.8100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3400    1.1050    0.2030 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6260    0.2510   -1.6940 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1330    3.3970    0.7430 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7180    3.5590    0.7750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4400   -2.9080   -0.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3120   -1.9900    2.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5310    3.7280    0.6520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7210    1.3140    0.0340 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7240    0.4840   -1.8590 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5430    0.4770   -0.2170 C   0  0  2  0  0  0  0  0  0  0  0  0
   -3.4140   -3.0990    1.1710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5550   -4.0610   -1.0810 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9200    0.7250   -0.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4610    0.1850    0.9590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3690    1.4200   -1.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6600   -3.8540   -2.2980 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5460   -5.1820   -0.5540 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7850    0.6410    0.5090 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6950    0.7030   -0.9560 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7730   -0.3460    0.9100 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1810    0.1340    0.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7350    0.9570    1.7660 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9530   -0.2480   -0.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0500    1.3980    1.6480 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2690    0.1940   -0.4310 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8170    1.0170    0.5490 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  1
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5 11  1  0
  5 12  2  0
  6 13  1  0
  6 14  1  0
  7 15  1  0
  8 16  2  0
  9 13  1  0
  9 17  1  0
 10 18  1  0
 10 19  2  0
 20 11  1  1
 15 21  2  0
 15 22  1  0
 16 21  1  0
 18 23  1  0
 20 24  1  0
 20 25  1  0
 22 26  1  0
 22 27  2  0
 24 28  1  0
 25 29  1  0
 28 29  1  0
 28 30  1  0
 30 31  1  0
 31 32  2  0
 31 33  1  0
 32 34  1  0
 33 35  2  0
 34 36  2  0
 35 36  1  0
M  CHG  2  22   1  26  -1
M  END
>  <Name>  (261) 
Barnidipine

>  <InChIKey>  (261) 
VXMOONUMYLCFJD-DHLKQENFSA-N

>  <PubChem_CID>  (261) 
443869

>  <CYP1A2>  (261) 


>  <CYP2A6>  (261) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>
<7,H;Oxidation;R3>
<26,H;Oxidation;R3>

>  <CYP2B6>  (261) 


>  <CYP2C8>  (261) 


>  <CYP2C9>  (261) 


>  <CYP2C19>  (261) 


>  <CYP2D6>  (261) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>
<7,H;Oxidation;R3>
<26,H;Oxidation;R3>

>  <CYP2E1>  (261) 


>  <CYP3A4>  (261) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>
<7,H;Oxidation;R3>
<26,H;Oxidation;R3>

>  <References>  (261) 
Teramura T, Fukunaga Y, Van Hoogdalem EJ, Watanabe T, Higuchi S: Examination of metabolic pathways and identification of human liver cytochrome P450 isozymes responsible for the metabolism of barnidipine, a calcium channel blocker. Xenobiotica. 1997 Sep;27(9):885-900. doi: 10.1080/004982597240064. (PMID: 9381730)

>  <Comments>  (261) 
A ring reaarangment happened, starting at site 13 and ends at site 1. Metabolites for CYP2C8 cannot be confirmed. It may not be a substrate for CYP2C8. <20,11;Cleavage;R2> should be <5,11;Hydrolysis> and requires hydrolase, hence it's removed.

$$$$
CC02097
     RDKit          3D

  4  3  0  0  0  0  0  0  0  0999 V2000
   -1.0560    0.5700   -0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2970    0.0810   -0.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1170   -0.2560   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3470    0.2670    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  3  4  2  0
M  END
>  <Name>  (262) 
Butadiene

>  <InChIKey>  (262) 
KAKZBPTYRLMSJV-UHFFFAOYSA-N

>  <PubChem_CID>  (262) 
7845

>  <CYP1A2>  (262) 


>  <CYP2A6>  (262) 
<0,1;Epoxidation;R1>
<2,3;Epoxidation;R2>

>  <CYP2B6>  (262) 


>  <CYP2C8>  (262) 


>  <CYP2C9>  (262) 
<0,1;Epoxidation;R1>
<2,3;Epoxidation;R2>

>  <CYP2C19>  (262) 


>  <CYP2D6>  (262) 


>  <CYP2E1>  (262) 
<0,1;Epoxidation;R1>
<2,3;Epoxidation;R2>

>  <CYP3A4>  (262) 


>  <References>  (262) 
Duescher RJ, Elfarra AA: Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1. Arch Biochem Biophys. 1994 Jun;311(2):342-9. doi: 10.1006/abbi.1994.1246. (PMID: 8203896)
Rendic S, Guengerich FP: Contributions of human enzymes in carcinogen metabolism. Chem Res Toxicol. 2012 Jul 16;25(7):1316-83. doi: 10.1021/tx300132k. Epub 2012 May 10. (PMID: 22531028)

>  <Comments>  (262) 
The rate of metabolites of CYP2C9 and 2E1 may be low.

$$$$
CC02099
     RDKit          3D

 20 23  0  0  0  0  0  0  0  0999 V2000
    0.1420    0.8450   -0.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2310   -0.6240    0.0650 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.2100    1.4970   -0.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3690    1.6740    0.1110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3480   -0.0400   -1.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0760   -1.3960    0.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8760    1.5740    1.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7710    2.0610   -1.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2640    2.9050    0.7830 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6540    1.2180   -0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6240   -1.8880    1.2060 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7980   -1.6840   -0.9830 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1140    2.2140    1.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0060    2.7050   -1.2200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4050    3.6570    1.0990 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8000    1.9630    0.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9660   -2.4040    0.8920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8740   -2.6260   -0.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6860    2.7760    0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6780    3.1870    0.7580 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  2  5  1  0
  2  6  1  6
  3  7  2  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  6 11  1  0
  6 12  2  0
  7 13  1  0
  8 14  2  0
  9 15  1  0
 10 16  2  0
 11 17  1  0
 12 18  1  0
 13 19  2  0
 14 19  1  0
 15 20  2  0
 16 20  1  0
 17 18  1  0
M  END
>  <Name>  (263) 
Cibenzoline

>  <InChIKey>  (263) 
IPOBOOXFSRWSHL-MRXNPFEDSA-N

>  <PubChem_CID>  (263) 
76969192

>  <CYP1A2>  (263) 


>  <CYP2A6>  (263) 
<15,16;Dehydrogenation;R1>

>  <CYP2B6>  (263) 


>  <CYP2C8>  (263) 


>  <CYP2C9>  (263) 


>  <CYP2C19>  (263) 


>  <CYP2D6>  (263) 
<15,16;Dehydrogenation;R1>
<0,H;Hydroxylation;R2>
<8,H;Hydroxylation;R3>

>  <CYP2E1>  (263) 


>  <CYP3A4>  (263) 
<15,16;Dehydrogenation;R1>

>  <References>  (263) 
Niwa T, Shiraga T, Mitani Y, Terakawa M, Tokuma Y, Kagayama A: Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A. Drug Metab Dispos. 2000 Sep;28(9):1128-34. (PMID: 10950860)

>  <Comments>  (263) 
<19,H;Hydroxylation> and <20,H;Hydroxylation> for CYP3A4 and 2D6 are reported in Yannick's sheet but not in the paper from Xenosite. <19,H;Hydroxylation> and <20,H;Hydroxylation> are reported as BoMs in Xenosite's dataset but can't be indentified in its reference.

$$$$
CC02100
     RDKit          3D

 32 34  0  0  0  0  0  0  0  0999 V2000
    6.4190   -0.0900   -0.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5750   -0.1140   -1.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6100   -0.9640   -0.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4940   -1.7920    0.3870 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3410   -1.7680    1.1520 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3040   -0.9190    0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5060   -2.6230    0.7170 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.4020    0.7500   -0.6200 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3680    0.5450    0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1870    1.4650    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0800    1.2450    1.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0020    2.2180    0.8400 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0620    1.8950    1.7970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    2.8670    1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7950    2.7230    0.2040 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.6650    2.9380   -0.8070 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.4740    1.9620   -0.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1550    2.7050   -2.1290 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3970    3.5420   -3.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3590    1.3820    0.0350 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6540    1.1530    0.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3540    2.0600    0.7390 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2200   -0.1950    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5700   -0.4350    0.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0930   -1.7060    0.3010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2820   -2.7350   -0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9420   -2.4920   -0.4590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4170   -1.2410   -0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9370   -3.7860   -1.0340 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -5.8080   -4.0130   -0.3230 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3570    0.5740    0.9140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6570    0.0190    1.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  8  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  7  1  0
  5  6  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 17  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 20  1  1
 16 17  1  0
 16 18  1  6
 18 19  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  2  0
 23 28  1  0
 24 25  1  0
 24 31  1  0
 25 26  2  0
 26 27  1  0
 26 30  1  0
 27 28  2  0
 27 29  1  0
 31 32  1  0
M  END
>  <Name>  (264) 
Cisapride

>  <InChIKey>  (264) 
DCSUBABJRXZOMT-RBBKRZOGSA-N

>  <PubChem_CID>  (264) 
5311047

>  <CYP1A2>  (264) 


>  <CYP2A6>  (264) 
<22,H;Hydroxylation;R1>
<27,H;Hydroxylation;R2>

>  <CYP2B6>  (264) 
<16,17;Cleavage;R1>
<17,H;Oxidation;R1>

>  <CYP2C8>  (264) 
<16,17;Cleavage;R1>
<17,H;Oxidation;R1>
<22,H;Hydroxylation;R2>
<27,H;Hydroxylation;R3>
<23,H;UnspOxidation;R4>
<24,25;UnspReduction;R4>
<24,25;UnspReduction;R5>
<26,H;UnspOxidation;R5>

>  <CYP2C9>  (264) 


>  <CYP2C19>  (264) 


>  <CYP2D6>  (264) 


>  <CYP2E1>  (264) 


>  <CYP3A4>  (264) 
<16,17;Cleavage;R1>
<17,H;Oxidation;R1>
<22,H;Hydroxylation;R2>
<27,H;Hydroxylation;R3>
<23,H;UnspOxidation;R4>
<24,25;UnspReduction;R4>
<24,25;UnspReduction;R5>
<26,H;UnspOxidation;R5>

>  <References>  (264) 
Desta Z, Soukhova N, Mahal SK, Flockhart DA: Interaction of cisapride with the human cytochrome P450 system: metabolism and inhibition studies. Drug Metab Dispos. 2000 Jul;28(7):789-800. (PMID: 10859153)
Desta Z, Soukhova N, Morocho AM, Flockhart DA: Stereoselective metabolism of cisapride and enantiomer-enantiomer interaction in human cytochrome P450 enzymes: major role of CYP3A. J Pharmacol Exp Ther. 2001 Aug;298(2):508-20. (PMID: 11454912)

>  <Comments>  (264) 
12 (N for 11 N-Dealkylation). 4 (Reaction type unknown).

$$$$
CC02101
     RDKit          3D

  9  9  0  0  0  0  0  0  0  0999 V2000
    0.3370   -0.1770    1.4270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9220   -0.5900    0.7540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8560    0.2380    0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1510   -0.7090   -0.4680 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3650   -2.1220    0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2210   -1.9430    0.7080 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8660    1.7320    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9290    2.2400   -1.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5370    1.8690   -2.7180 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  6  1  0
  3  4  1  0
  3  7  1  0
  4  5  1  0
  5  6  2  0
  7  8  1  0
  8  9  1  0
M  END
>  <Name>  (265) 
Clomethiazole

>  <InChIKey>  (265) 
PCLITLDOTJTVDJ-UHFFFAOYSA-N

>  <PubChem_CID>  (265) 
10783

>  <CYP1A2>  (265) 


>  <CYP2A6>  (265) 
<6,H;Hydroxylation;R1>

>  <CYP2B6>  (265) 


>  <CYP2C8>  (265) 


>  <CYP2C9>  (265) 


>  <CYP2C19>  (265) 


>  <CYP2D6>  (265) 


>  <CYP2E1>  (265) 


>  <CYP3A4>  (265) 


>  <References>  (265) 
Centerholt C, Ekblom M, Odergren T, Borga O, Popescu G, Molz KH, Couturier A, Weil A: Pharmacokinetics and sedative effects in healthy subjects and subjects with impaired liver function after continuous infusion of clomethiazole. Eur J Clin Pharmacol. 2003 Jun;59(2):117-22. doi: 10.1007/s00228-003-0598-y. Epub 2003 May 7. (PMID: 12734608)

>  <Comments>  (265) 


$$$$
CC02102
     RDKit          3D

 13 14  0  0  0  0  0  0  0  0999 V2000
    1.1010    0.4970   -0.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2600    1.1810    0.5650 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9410    0.6130    0.8020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6970   -1.1270    0.6070 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.3420   -0.6050    0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4430   -1.2750   -0.5510 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8030   -0.7240   -0.8210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6530   -1.0620   -0.4790 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6860   -0.0250   -1.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5660   -2.1110   -0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5010   -2.3440   -1.1590 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2110   -2.8750    0.8410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7080   -2.6260    0.8400 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  7  1  0
  2  3  1  0
  3  5  2  0
  4  5  1  6
  4  8  1  0
  4 13  1  0
  5  6  1  0
  6  7  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
M  END
>  <Name>  (266) 
Cotinine

>  <InChIKey>  (266) 
UIKROCXWUNQSPJ-VIFPVBQESA-N

>  <PubChem_CID>  (266) 
854019

>  <CYP1A2>  (266) 


>  <CYP2A6>  (266) 
<6,H;Hydroxylation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidaiton;R2>
<4,H;Hydroxylation;R3>

>  <CYP2B6>  (266) 


>  <CYP2C8>  (266) 


>  <CYP2C9>  (266) 


>  <CYP2C19>  (266) 


>  <CYP2D6>  (266) 


>  <CYP2E1>  (266) 


>  <CYP3A4>  (266) 


>  <References>  (266) 
Murphy SE, Johnson LM, Pullo DA: Characterization of multiple products of cytochrome P450 2A6-catalyzed cotinine metabolism. Chem Res Toxicol. 1999 Jul;12(7):639-45. doi: 10.1021/tx990015e. (PMID: 10409404)

>  <Comments>  (266) 
8 (N for N-Dealkylation).

$$$$
CC02103
     RDKit          3D

 24 26  0  0  0  0  0  0  0  0999 V2000
    1.2070    0.2150   -1.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2480    1.0880   -0.8530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0210    0.6030   -0.3550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2150   -0.7630   -0.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1940   -1.6760   -0.5080 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0280   -1.2310   -1.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9290   -2.0080   -1.2940 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0530    1.4800   -0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2700    0.9820    0.4270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4460   -0.3950    0.6000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4160   -1.2770    0.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3650    1.9430    0.7320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6900    1.2180    0.6760 C   0  0  2  0  0  0  0  0  0  0  0  0
   -6.7290    2.0860    1.1250 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6370   -0.0710    1.4860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9480   -0.8150    1.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4570    0.1930    2.9700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6050   -0.9650    1.0500 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2470    2.8220    0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3330    3.7080    0.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8260    3.8090    1.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4350    3.0860    3.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9210    4.5630   -0.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8620    2.7720   -1.0510 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  3  8  1  0
  4  5  1  0
  4 11  1  0
  5  6  1  0
  6  7  2  0
  8  9  2  0
  9 10  1  0
  9 12  1  0
 10 11  2  0
 10 18  1  0
 12 13  1  0
 13 14  1  1
 13 15  1  0
 14 19  1  0
 15 16  1  0
 15 17  1  0
 15 18  1  0
 19 20  1  0
 19 24  2  0
 20 21  2  0
 20 23  1  0
 21 22  1  0
M  END
>  <Name>  (267) 
Decursinol angelate

>  <InChIKey>  (267) 
AGABNGOXUSXQDD-XKGFZTIGSA-N

>  <PubChem_CID>  (267) 
776123

>  <CYP1A2>  (267) 


>  <CYP2A6>  (267) 
<1,2;Epoxidation;R1>

>  <CYP2B6>  (267) 


>  <CYP2C8>  (267) 


>  <CYP2C9>  (267) 


>  <CYP2C19>  (267) 


>  <CYP2D6>  (267) 


>  <CYP2E1>  (267) 


>  <CYP3A4>  (267) 


>  <References>  (267) 
Yoo HH, Lee MW, Kim YC, Yun CH, Kim DH: Mechanism-based inactivation of cytochrome P450 2A6 by decursinol angelate isolated from Angelica Gigas. Drug Metab Dispos. 2007 Oct;35(10):1759-65. doi: 10.1124/dmd.107.016584. Epub 2007 Jul 9. (PMID: 17620343)

>  <Comments>  (267) 


$$$$
CC02104
     RDKit          3D

  8  7  0  0  0  0  0  0  0  0999 V2000
   -0.1370   -0.0860   -0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3690   -0.1380    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0900   -0.6460   -1.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7430   -0.6450   -0.4320 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4600   -1.3840   -2.1560 S   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1170   -1.3400   -1.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8520   -1.8640   -2.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0750   -1.8380   -2.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
M  END
>  <Name>  (268) 
Diallyl disulfide

>  <InChIKey>  (268) 
PFRGXCVKLLPLIP-UHFFFAOYSA-N

>  <PubChem_CID>  (268) 
16590

>  <CYP1A2>  (268) 


>  <CYP2A6>  (268) 
<3,S;S-Oxidation;R1>
<4,S;S-Oxidation;R2>

>  <CYP2B6>  (268) 


>  <CYP2C8>  (268) 
<3,S;S-Oxidation;R1>
<4,S;S-Oxidation;R2>

>  <CYP2C9>  (268) 
<3,S;S-Oxidation;R1>
<4,S;S-Oxidation;R2>

>  <CYP2C19>  (268) 
<3,S;S-Oxidation;R1>
<4,S;S-Oxidation;R2>

>  <CYP2D6>  (268) 
<3,S;S-Oxidation;R1>
<4,S;S-Oxidation;R2>

>  <CYP2E1>  (268) 
<3,S;S-Oxidation;R1>
<4,S;S-Oxidation;R2>

>  <CYP3A4>  (268) 


>  <References>  (268) 
Teyssier C, Guenot L, Suschetet M, Siess MH: Metabolism of diallyl disulfide by human liver microsomal cytochromes P-450 and flavin-containing monooxygenases. Drug Metab Dispos. 1999 Jul;27(7):835-41. (PMID: 10383929)

>  <Comments>  (268) 


$$$$
CC02106
     RDKit          3D

 11 10  0  0  0  0  0  0  0  0999 V2000
   -3.1740    1.8990    1.5740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4010    2.4640    0.4730 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1350    3.5580   -0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7460    2.4890    0.6270 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2700    1.8540    1.9130 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2160    1.6680   -0.7130 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5300    2.1130   -2.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0920    1.0260   -0.6690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2650    4.0880    0.5260 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5890    4.8980    1.7100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1340    4.3620    0.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  4  9  1  0
  6  7  1  0
  6  8  1  0
  9 10  1  0
  9 11  1  0
M  END
>  <Name>  (269) 
Hexamethylphosphoramide

>  <InChIKey>  (269) 
GNOIPBMMFNIUFM-UHFFFAOYSA-N

>  <PubChem_CID>  (269) 
12679

>  <CYP1A2>  (269) 


>  <CYP2A6>  (269) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<5,6;Cleavage;R3>
<6,H;Oxidation;R3>
<5,7;Cleavage;R4>
<7,H;Oxidation;R4>
<8,9;Cleavage;R5>
<9,H;Oxidation;R5>
<8,10;Cleavage;R6>
<10,H;Oxidation;R6>

>  <CYP2B6>  (269) 


>  <CYP2C8>  (269) 


>  <CYP2C9>  (269) 


>  <CYP2C19>  (269) 


>  <CYP2D6>  (269) 


>  <CYP2E1>  (269) 


>  <CYP3A4>  (269) 


>  <References>  (269) 
Su T, Bao Z, Zhang QY, Smith TJ, Hong JY, Ding X: Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 2000 Sep 15;60(18):5074-9. (PMID: 11016631)

>  <Comments>  (269) 
2 (N for N-Demethylation). 6 (N for N-Demethylation). 9 (N for N-Demethylation).

$$$$
CC02108
     RDKit          3D

  9 10  0  0  0  0  0  0  0  0999 V2000
    1.4350    4.1220   -4.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5180    3.9210   -3.2280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    2.8300   -3.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2760    1.9510   -4.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6330    2.1270   -5.3760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5040    3.2340   -5.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4320    1.0560   -6.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5770    0.2630   -5.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9970    0.8120   -4.6100 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  9  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
M  END
>  <Name>  (270) 
Indole

>  <InChIKey>  (270) 
SIKJAQJRHWYJAI-UHFFFAOYSA-N

>  <PubChem_CID>  (270) 
798

>  <CYP1A2>  (270) 


>  <CYP2A6>  (270) 
<1,H;Hydroxylation;R1>
<6,H;Hydroxylation;R2>
<5,H;Oxidation;R3>
<5,6;Reduction;R3>

>  <CYP2B6>  (270) 


>  <CYP2C8>  (270) 


>  <CYP2C9>  (270) 


>  <CYP2C19>  (270) 
<1,H;Hydroxylation;R1>
<6,H;Hydroxylation;R2>
<5,H;Oxidation;R3>
<5,6;Reduction;R3>

>  <CYP2D6>  (270) 


>  <CYP2E1>  (270) 
<1,H;Hydroxylation;R1>
<6,H;Hydroxylation;R2>
<5,H;Oxidation;R3>
<5,6;Reduction;R3>

>  <CYP3A4>  (270) 


>  <References>  (270) 
Gillam EM, Notley LM, Cai H, De Voss JJ, Guengerich FP: Oxidation of indole by cytochrome P450 enzymes. Biochemistry. 2000 Nov 14;39(45):13817-24. doi: 10.1021/bi001229u. (PMID: 11076521)

>  <Comments>  (270) 


$$$$
CC02109
     RDKit          3D

 24 26  0  0  0  0  0  0  0  0999 V2000
   -2.5590    0.5800    0.3960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0690    0.3920    0.5150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3760   -0.5230    0.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7530   -0.3370    0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2480    0.9650    0.1840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3640    2.0150    0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0670    1.7980    0.4310 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7880   -1.9100    0.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5890   -1.3960    0.0120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7280    1.2220    0.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9630   -1.8010    1.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3220    0.4180   -1.1380 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.3720    0.1840   -0.7120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2140    1.1400   -0.4520 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4310    0.6110   -0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3040   -0.7840   -0.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4000   -1.6000   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6120   -1.0380    0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7450    0.3440    0.4240 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6660    1.1690    0.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9870   -1.0240   -0.6020 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9470    0.8860    0.7590 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5840   -0.8140   -1.7960 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.8530   -0.2040    0.9450 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  7  1  0
 12  2  1  1
  3  4  1  0
  3  8  1  0
  4  5  2  0
  4  9  1  0
  5  6  1  0
  5 10  1  0
  6  7  2  0
  9 11  1  0
 12 13  1  0
 12 23  2  0
 13 14  2  0
 13 21  1  0
 14 15  1  0
 15 16  2  0
 15 20  1  0
 16 17  1  0
 16 21  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 19 22  1  0
 22 24  1  0
M  END
>  <Name>  (271) 
Omeprazole

>  <InChIKey>  (271) 
SUBDBMMJDZJVOS-DEOSSOPVSA-N

>  <PubChem_CID>  (271) 
9568614

>  <CYP1A2>  (271) 


>  <CYP2A6>  (271) 
<15,H;Hydroxylation;R1>

>  <CYP2B6>  (271) 


>  <CYP2C8>  (271) 
<15,H;Hydroxylation;R1>

>  <CYP2C9>  (271) 
<15,H;Hydroxylation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2C19>  (271) 
<15,H;Hydroxylation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2D6>  (271) 


>  <CYP2E1>  (271) 


>  <CYP3A4>  (271) 
<8,S;S-Oxidation;R1>
<8,9;Reduction;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>

>  <References>  (271) 
Abelo A, Andersson TB, Antonsson M, Naudot AK, Skanberg I, Weidolf L: Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes. Drug Metab Dispos. 2000 Aug;28(8):966-72. (PMID: 10901708)
Karam WG, Goldstein JA, Lasker JM, Ghanayem BI: Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes. Drug Metab Dispos. 1996 Oct;24(10):1081-7. (PMID: 8894508)

>  <Comments>  (271) 
The stereoscopy information of bonds was not recorded. Thus, we considered both R and S isomers.

$$$$
CC02110
     RDKit          3D

 15 16  0  0  1  0  0  0  0  0999 V2000
   -4.3820    1.7090    4.2210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0910    1.1650    3.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6300    1.9490    2.3860 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.2920    1.5110    1.7830 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.7130    0.3990    0.8440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9900    0.8050    0.3480 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5510    1.7020    1.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6520    2.2050    1.0530 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1930    1.1080    2.7690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1170    0.8870    2.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9810    1.7850    1.4890 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0800    1.1530    0.9710 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9060   -0.1170    1.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7410   -0.3290    1.9350 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2780   -1.6130    2.4010 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  1
  3  4  1  0
  3  7  1  0
  4  5  1  0
  4  9  1  1
  5  6  1  0
  6  7  1  0
  7  8  2  0
  9 10  1  0
 10 11  2  0
 10 14  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
M  END
>  <Name>  (272) 
Pilocarpine

>  <InChIKey>  (272) 
QCHFTSOMWOSFHM-WPRPVWTQSA-N

>  <PubChem_CID>  (272) 
5910

>  <CYP1A2>  (272) 


>  <CYP2A6>  (272) 
<2,H;Hydroxylation;R1>

>  <CYP2B6>  (272) 


>  <CYP2C8>  (272) 


>  <CYP2C9>  (272) 


>  <CYP2C19>  (272) 


>  <CYP2D6>  (272) 


>  <CYP2E1>  (272) 


>  <CYP3A4>  (272) 


>  <References>  (272) 
Endo T, Ban M, Hirata K, Yamamoto A, Hara Y, Momose Y: Involvement of CYP2A6 in the formation of a novel metabolite, 3-hydroxypilocarpine, from pilocarpine in human liver microsomes. Drug Metab Dispos. 2007 Mar;35(3):476-83. doi: 10.1124/dmd.106.013425. Epub 2006  Dec 18. (PMID: 17178767)

>  <Comments>  (272) 


$$$$
CC02111
     RDKit          3D

 14 16  0  0  0  0  0  0  0  0999 V2000
    1.2550    0.6610    0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0700    1.4030    0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0910    0.6410   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1180   -0.7440   -0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0960   -1.4510   -0.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2850   -0.7260   -0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5620   -1.4120   -0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6890   -0.7130    0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6970    0.7460    0.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7500    1.3640    0.3180 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4620    1.3880    0.2150 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3590    1.1380   -0.0280 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2050    0.0780   -0.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4870   -1.0960   -0.2360 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1 11  1  0
  2  3  1  0
  3  4  2  0
  3 12  1  0
  4  5  1  0
  4 14  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 12 13  1  0
 13 14  2  0
M  END
>  <Name>  (273) 
Psoralen

>  <InChIKey>  (273) 
ZCCUUQDIBDJBTK-UHFFFAOYSA-N

>  <PubChem_CID>  (273) 
6199

>  <CYP1A2>  (273) 


>  <CYP2A6>  (273) 
<7,8;EpOxidation;R1>

>  <CYP2B6>  (273) 


>  <CYP2C8>  (273) 


>  <CYP2C9>  (273) 


>  <CYP2C19>  (273) 


>  <CYP2D6>  (273) 


>  <CYP2E1>  (273) 


>  <CYP3A4>  (273) 


>  <References>  (273) 
Koenigs LL, Trager WF: Mechanism-based inactivation of P450 2A6 by furanocoumarins. Biochemistry. 1998 Jul 14;37(28):10047-61. doi: 10.1021/bi980003c. (PMID: 9665710)

>  <Comments>  (273) 
The reaction in CYP2A6 should be two steps. The first step is <13,14;EpOxidation>. Need to confirm.

$$$$
CC02112
     RDKit          3D

 12 13  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3950    2.0240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6310   -0.6730    0.9340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0310    2.2700   -1.2030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0520    2.2620    1.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3310    2.7490   -1.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3490    2.7410    1.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9940    2.9830   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1690    3.0660   -2.2450 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2480    3.4470   -0.2900 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2030    3.8820   -1.6620 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  4  2  0
  3  5  2  0
  3  6  1  0
  5  7  1  0
  6  8  2  0
  7  9  2  0
  7 10  1  0
  8  9  1  0
  9 11  1  0
 10 12  1  0
 11 12  1  0
M  END
>  <Name>  (274) 
Safrole

>  <InChIKey>  (274) 
ZMQAAUBTXCXRIC-UHFFFAOYSA-N

>  <PubChem_CID>  (274) 
5144

>  <CYP1A2>  (274) 
<10,11;Cleavage;R1>
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>
<2,H;Hydroxylation;R2>

>  <CYP2A6>  (274) 
<10,11;Cleavage;R1>
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>
<2,H;Hydroxylation;R2>

>  <CYP2B6>  (274) 


>  <CYP2C8>  (274) 


>  <CYP2C9>  (274) 
<2,H;Hydroxylation;R1>

>  <CYP2C19>  (274) 
<10,11;Cleavage;R1>
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <CYP2D6>  (274) 
<10,11;Cleavage;R1>
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>
<2,H;Hydroxylation;R2>

>  <CYP2E1>  (274) 
<10,11;Cleavage;R1>
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>
<2,H;Hydroxylation;R2>

>  <CYP3A4>  (274) 
<2,H;Hydroxylation;R1>

>  <References>  (274) 
Ueng YF, Hsieh CH, Don MJ, Chi CW, Ho LK: Identification of the main human cytochrome P450 enzymes involved in safrole 1'-hydroxylation. Chem Res Toxicol. 2004 Aug;17(8):1151-6. doi: 10.1021/tx030055p. (PMID: 15310247)
Wang B, Zhou SF: Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr Med Chem. 2009;16(31):4066-218. (PMID: 19754423)

>  <Comments>  (274) 


$$$$
CC02113
     RDKit          3D

 10  9  0  0  0  0  0  0  0  0999 V2000
   -0.5060   -0.6040   -0.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8340   -0.0150   -0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2450   -0.3530    1.3440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0680   -1.8050    1.7180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7920   -2.8300    0.8760 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1440   -2.4530    0.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0930   -1.8780    1.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2720   -2.0240    3.1840 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1410   -2.5360    3.7290 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2910   -1.7850    3.8120 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  8  1  0
  5  6  1  0
  6  7  1  0
  8  9  1  0
  8 10  2  0
M  END
>  <Name>  (275) 
Valproic acid

>  <InChIKey>  (275) 
NIJJYAXOARWZEE-UHFFFAOYSA-N

>  <PubChem_CID>  (275) 
3121

>  <CYP1A2>  (275) 
<0,H;Hydroxylation;R1>
<1,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>

>  <CYP2A6>  (275) 
<0,H;Hydroxylation;R1>
<1,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>
<2,H;Hydroxylation;R5>
<4,H;Hydroxylation;R6>
<0,1;Dehydrogenation;R7>
<5,6;Dehydrogenation;R8>

>  <CYP2B6>  (275) 
<0,H;Hydroxylation;R1>
<1,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>
<2,H;Hydroxylation;R5>
<4,H;Hydroxylation;R6>
<0,1;Dehydrogenation;R7>
<5,6;Dehydrogenation;R8>

>  <CYP2C8>  (275) 
<0,H;Hydroxylation;R1>
<1,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>

>  <CYP2C9>  (275) 
<0,H;Hydroxylation;R1>
<1,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>
<0,1;Dehydrogenation;R5>
<5,6;Dehydrogenation;R6>

>  <CYP2C19>  (275) 
<0,H;Hydroxylation;R1>
<1,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>

>  <CYP2D6>  (275) 
<0,H;Hydroxylation;R1>
<1,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>

>  <CYP2E1>  (275) 
<0,H;Hydroxylation;R1>
<1,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>

>  <CYP3A4>  (275) 


>  <References>  (275) 
Kiang TK, Ho PC, Anari MR, Tong V, Abbott FS, Chang TK: Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1/*1 genotype. Toxicol Sci. 2006 Dec;94(2):261-71. doi: 10.1093/toxsci/kfl096. Epub 2006 Aug 31. (PMID: 16945988)

>  <Comments>  (275) 
Need to double check. Metabolite rate for CYP1A2, 2E1, 2D6 is low.

$$$$
CC02114
     RDKit          3D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -1.4270   -0.6110   -1.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6270   -0.3470    0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2440   -0.3330    1.3920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6140   -0.5800    1.5250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3910   -0.8450    0.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7980   -0.8600   -0.8700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6990   -1.1790   -2.3100 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -5.0760   -1.1440    0.6300 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.3440   -0.0100    2.8340 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.8120   -0.0990   -0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2580    1.2150   -0.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6180    1.4960   -0.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5550    0.4610   -0.4050 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1310   -0.8490   -0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7720   -1.1270   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3190   -2.7740    0.2730 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.2490    0.7350   -0.6060 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.0710    3.1400   -0.7440 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  2 10  1  0
  3  4  2  0
  3  9  1  0
  4  5  1  0
  5  6  2  0
  5  8  1  0
  6  7  1  0
 10 11  2  0
 10 15  1  0
 11 12  1  0
 12 13  2  0
 12 18  1  0
 13 14  1  0
 13 17  1  0
 14 15  2  0
 15 16  1  0
M  END
>  <Name>  (276) 
2,2,4,4,5,5-Hexachlorobiphenyl

>  <InChIKey>  (276) 
MVWHGTYKUMDIHL-UHFFFAOYSA-N

>  <PubChem_CID>  (276) 
37034

>  <CYP1A2>  (276) 


>  <CYP2A6>  (276) 


>  <CYP2B6>  (276) 
<2,H;Hydroxylation;R1>
<12,H;Hydroxylation;R2>

>  <CYP2C8>  (276) 


>  <CYP2C9>  (276) 


>  <CYP2C19>  (276) 


>  <CYP2D6>  (276) 


>  <CYP2E1>  (276) 


>  <CYP3A4>  (276) 


>  <References>  (276) 
Ariyoshi N, Oguri K, Koga N, Yoshimura H, Funae Y: Metabolism of highly persistent PCB congener, 2,4,5,2',4',5'-hexachlorobiphenyl, by human CYP2B6. Biochem Biophys Res Commun. 1995 Jul 17;212(2):455-60. doi: 10.1006/bbrc.1995.1991. (PMID: 7626059)

>  <Comments>  (276) 


$$$$
CC02115
     RDKit          3D

 22 24  0  0  1  0  0  0  0  0999 V2000
    2.3410    0.8880   -2.5910 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -5.0480   -0.1610   -0.2760 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.6660   -2.1660    1.2920 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8490   -2.7790   -0.9110 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5530   -0.5770    0.0300 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2650   -1.7260   -0.5420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1350    0.6520   -0.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8620   -0.6400   -0.3760 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.7230   -1.7600   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6250    0.6790   -0.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3490   -0.4230   -0.2650 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7050    0.5370    0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3790    1.9510   -0.7200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5150   -1.9750   -0.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8270    1.5470   -0.5990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7510    2.4310   -0.7350 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4170    1.2760   -0.9150 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8000    0.9140    1.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2020    2.3620   -0.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5840    1.9980    1.7680 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2860    2.7220    0.8100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2970   -3.4120    1.5790 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 17  1  0
  2 11  1  0
  2 15  1  0
  3 14  1  0
  3 22  1  0
  4 14  2  0
  5  6  1  0
  5  7  1  0
  8  5  1  1
  6  9  1  0
  7 10  1  0
  8 12  1  0
  8 14  1  0
  9 11  1  0
 10 11  2  0
 10 13  1  0
 12 17  2  0
 12 18  1  0
 13 15  1  0
 15 16  2  0
 17 19  1  0
 18 20  2  0
 19 21  2  0
 20 21  1  0
M  END
>  <Name>  (277) 
2-Oxo-clopidogrel

>  <InChIKey>  (277) 
AZRUDPJZBRJPHU-HNNXBMFYSA-N

>  <PubChem_CID>  (277) 
71082648

>  <CYP1A2>  (277) 


>  <CYP2A6>  (277) 


>  <CYP2B6>  (277) 
<18,20;Cleavage;R1>

>  <CYP2C8>  (277) 


>  <CYP2C9>  (277) 
<18,20;Cleavage;R1>

>  <CYP2C19>  (277) 
<18,20;Cleavage;R1>

>  <CYP2D6>  (277) 


>  <CYP2E1>  (277) 


>  <CYP3A4>  (277) 
<18,20;Cleavage;R1>

>  <References>  (277) 
Kazui M, Nishiya Y, Ishizuka T, Hagihara K, Farid NA, Okazaki O, Ikeda T, Kurihara A: Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite. Drug Metab Dispos. 2010 Jan;38(1):92-9. doi: 10.1124/dmd.109.029132. (PMID: 19812348)

>  <Comments>  (277) 


$$$$
CC02117
     RDKit          3D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -0.0190    1.5260    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3950    2.0470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3760   -0.5120    0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2370    2.2590   -1.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1200    2.4120    1.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4630    2.7530   -0.7010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0480    2.0730   -2.5520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3590    2.8340    0.6720 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4800    3.0530   -1.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0700    2.3760   -3.4290 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2830    2.8650   -2.9500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8910    2.1970   -4.7650 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  3  5  1  0
  3  6  2  0
  5  7  2  0
  5  8  1  0
  6  9  1  0
  7  9  1  0
  7 10  1  0
  8 11  2  0
 10 12  2  0
 11 12  1  0
 11 13  1  0
M  END
>  <Name>  (278) 
5-Hydroxytryptamine

>  <InChIKey>  (278) 
QZAYGJVTTNCVMB-UHFFFAOYSA-N

>  <PubChem_CID>  (278) 
5202

>  <CYP1A2>  (278) 


>  <CYP2A6>  (278) 


>  <CYP2B6>  (278) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C8>  (278) 


>  <CYP2C9>  (278) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (278) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2D6>  (278) 


>  <CYP2E1>  (278) 


>  <CYP3A4>  (278) 


>  <References>  (278) 
Fradette C, Yamaguchi N, Du Souich P: 5-Hydroxytryptamine is biotransformed by CYP2C9, 2C19 and 2B6 to hydroxylamine, which is converted into nitric oxide. Br J Pharmacol. 2004 Feb;141(3):407-14. doi: 10.1038/sj.bjp.0705632. Epub 2004 Jan 12. (PMID: 14718257)

>  <Comments>  (278) 


$$$$
CC02118
     RDKit          3D

 30 33  0  0  1  0  0  0  0  0999 V2000
   24.0536   -0.5351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8838   -1.2102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0536    0.8151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3932   -0.5351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7197   -0.5351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8779   -2.5605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2351    1.4903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8838    1.4903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0493    2.0248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3932    0.8151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5383   -1.2102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7197    0.8151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7197   -3.2355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2351    3.4005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5383   -2.5605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3743   -0.5351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5266    0.1400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4282    4.0873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0361    4.0930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3743   -3.2355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2046   -1.2102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6213    3.3947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2046   -2.5605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8144    4.0873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0231   -3.2355    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.0133    3.3947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2063    4.0816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0075    2.0153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0839   -3.2566    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.8728    2.8827    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  3  9  1  0
  4 10  1  0
  5 11  1  0
  5 12  1  0
  6 13  1  0
  7 14  1  0
 11 15  1  0
 11 16  1  0
 11 17  1  0
 14 18  1  0
 14 19  1  0
 15 20  1  0
 16 21  1  0
 18 22  1  0
 20 23  1  0
 22 24  1  0
 23 25  1  0
 24 26  1  0
 26 27  1  0
 26 28  1  0
  7 10  1  0
  8 12  1  0
 13 15  1  0
 21 23  1  0
  1  2  1  0
  6 29  1  0
  1  3  1  0
  8 30  1  0
M  END
>  <Name>  (279) 
5beta-Cholestane-3,7,12-trihydroxy

>  <InChIKey>  (279) 
RIVQQZVHIVNQFH-ZVLSSJCSSA-N

>  <PubChem_CID>  (279) 


>  <CYP1A2>  (279) 


>  <CYP2A6>  (279) 


>  <CYP2B6>  (279) 
<1,H;Hydroxylation;R1>

>  <CYP2C8>  (279) 


>  <CYP2C9>  (279) 


>  <CYP2C19>  (279) 
<1,H;Hydroxylation;R1>

>  <CYP2D6>  (279) 


>  <CYP2E1>  (279) 


>  <CYP3A4>  (279) 
<1,H;Hydroxylation;R1>

>  <References>  (279) 
Furster C, Wikvall K: Identification of CYP3A4 as the major enzyme responsible for 25-hydroxylation of 5beta-cholestane-3alpha,7alpha,12alpha-triol in human liver microsomes. Biochim Biophys Acta. 1999 Jan 29;1437(1):46-52. doi: 10.1016/s0005-2760(98)00175-1. (PMID: 9931427)

>  <Comments>  (279) 


$$$$
CC02119
     RDKit          3D

 25 27  0  0  0  0  0  0  0  0999 V2000
    1.0190    0.5080   -0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2500    0.4240    0.6610 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1150    1.2270    0.3790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3470    2.0740    1.8530 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.2310    1.1940   -0.4530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3130    0.5170   -1.6160 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2240   -0.1940   -1.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9370   -0.2360   -1.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2380   -1.1990   -1.8020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.8400    1.1050    1.6940 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1440    0.5270    2.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4520    2.1170    2.2560 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8610    1.1480    3.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0920    0.6380    3.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8320    1.2150    4.5470 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2120    2.3630    5.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6090   -0.5120    2.9310 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8200   -0.9800    3.3720 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2270   -2.1460    2.6660 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8840   -1.1300    1.9080 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6580   -0.6160    1.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9850    3.6500    4.8830 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1020    4.5080    5.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2970    3.6900    7.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9730    2.2700    6.5790 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  8  1  0
  2 10  1  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
 10 11  1  0
 10 12  2  0
 11 13  2  0
 11 21  1  0
 13 14  1  0
 14 15  1  0
 14 17  2  0
 15 16  1  0
 16 22  1  0
 16 25  1  0
 17 18  1  0
 17 20  1  0
 18 19  1  0
 20 21  2  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
M  END
>  <Name>  (280) 
RP73401

>  <InChIKey>  (280) 
RRRUXBQSQLKHEL-UHFFFAOYSA-N

>  <PubChem_CID>  (280) 
154575

>  <CYP1A2>  (280) 


>  <CYP2A6>  (280) 


>  <CYP2B6>  (280) 
<23,H;Hydroxylation;R1>
<22,H;Hydroxylation;R2>

>  <CYP2C8>  (280) 


>  <CYP2C9>  (280) 


>  <CYP2C19>  (280) 


>  <CYP2D6>  (280) 


>  <CYP2E1>  (280) 


>  <CYP3A4>  (280) 


>  <References>  (280) 
Stevens JC, White RB, Hsu SH, Martinet M: Human liver CYP2B6-catalyzed hydroxylation of RP 73401. J Pharmacol Exp Ther. 1997 Sep;282(3):1389-95. (PMID: 9316851)

>  <Comments>  (280) 


$$$$
CC02120
     RDKit          3D

 23 26  0  0  0  0  0  0  0  0999 V2000
   -0.5810    3.2360    0.9080 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7980    3.2870    1.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5910    4.0970    0.4310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5960    3.6360   -1.0130 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.1290    3.5480   -1.4620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6070    2.6380   -0.4480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3950    2.4310    1.8330 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.5420    1.4680    2.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4110    1.6110    4.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3920    0.7270    4.7580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0600   -0.3070    4.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9260   -0.4550    2.7030 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1260    0.4320    1.9690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3810    1.6470    1.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9990    0.9700    0.0820 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8380    1.6720    1.3790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8040    1.1210    0.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5160    0.3070    1.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0550    2.5940    4.6520 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.3280    5.2900    0.7560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5310    4.9620   -1.7970 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.9290    5.9190   -0.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6080    6.9700   -0.3690 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  7  1  1  6
  2  3  1  0
  3  4  1  0
  3 20  2  0
  4  5  1  6
  4 21  1  0
  5  6  1  0
  7  8  1  0
  7 14  1  0
  8  9  2  0
  8 13  1  0
  9 10  1  0
  9 19  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 16 18  1  0
 17 18  1  0
 20 22  1  0
 21 22  1  0
 22 23  2  0
M  END
>  <Name>  (281) 
R-95913

>  <InChIKey>  (281) 
MJAMUSZUMAHFLH-NVXWUHKLSA-N

>  <PubChem_CID>  (281) 
86318464

>  <CYP1A2>  (281) 


>  <CYP2A6>  (281) 


>  <CYP2B6>  (281) 
<1,22;Cleavage;R1>

>  <CYP2C8>  (281) 


>  <CYP2C9>  (281) 
<1,22;Cleavage;R1>

>  <CYP2C19>  (281) 
<1,22;Cleavage;R1>

>  <CYP2D6>  (281) 
<1,22;Cleavage;R1>

>  <CYP2E1>  (281) 


>  <CYP3A4>  (281) 
<1,22;Cleavage;R1>

>  <References>  (281) 
Rehmel JL, Eckstein JA, Farid NA, Heim JB, Kasper SC, Kurihara A, Wrighton SA, Ring BJ: Interactions of two major metabolites of prasugrel, a thienopyridine antiplatelet agent, with the cytochromes P450. Drug Metab Dispos. 2006 Apr;34(4):600-7. doi: 10.1124/dmd.105.007989. Epub 2006 Jan 13. (PMID: 16415119)

>  <Comments>  (281) 


$$$$
CC02121
     RDKit          3D

 18 18  0  0  0  0  0  0  0  0999 V2000
   -1.8590   -0.4410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6210    0.2760    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8590   -1.8720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1000    0.2760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6210    1.7070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6210   -0.4410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1000   -2.5900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6210   -2.5900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3410   -0.4410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1000    1.7070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6170    2.4240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8620    2.4240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8620    0.2760    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3410   -1.8720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0020   -2.9480   -1.2430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8590    1.7070    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.1030   -0.4410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3410    0.2760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5 11  1  0
  5 12  2  0
  6 13  1  0
  7 14  2  0
  8 15  1  0
  9 14  1  0
 11 16  1  0
 13 17  1  0
 17 18  1  0
M  END
>  <Name>  (282) 
Acetochlor

>  <InChIKey>  (282) 
VTNQPKFIQCLBDU-UHFFFAOYSA-N

>  <PubChem_CID>  (282) 
1988

>  <CYP1A2>  (282) 


>  <CYP2A6>  (282) 


>  <CYP2B6>  (282) 
<3,4;Cleavage;R1>

>  <CYP2C8>  (282) 


>  <CYP2C9>  (282) 


>  <CYP2C19>  (282) 


>  <CYP2D6>  (282) 


>  <CYP2E1>  (282) 


>  <CYP3A4>  (282) 
<3,4;Cleavage;R1>

>  <References>  (282) 
Coleman S, Liu S, Linderman R, Hodgson E, Rose RL: In vitro metabolism of alachlor by human liver microsomes and human cytochrome P450 isoforms. Chem Biol Interact. 1999 Aug 30;122(1):27-39. (PMID: 10475613)
Coleman S, Linderman R, Hodgson E, Rose RL: Comparative metabolism of chloroacetamide herbicides and selected metabolites in human and rat liver microsomes. Environ Health Perspect. 2000 Dec;108(12):1151-7. doi: 10.1289/ehp.001081151. (PMID: 11133395)

>  <Comments>  (282) 


$$$$
CC02122
     RDKit          3D

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.1780    1.7180    0.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6790    0.4240    0.6430 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0430    2.7620    0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1840    1.9600    0.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9680   -0.0190    1.8830 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8890   -0.4490   -0.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5460    4.0380   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5210    2.5040    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6750    3.2380    0.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1260    0.8280    0.8980 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3800   -1.4530    2.0930 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8950    0.7370    2.8290 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3720   -0.9230   -0.9890 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8110    4.2770    0.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8710    2.2820   -1.4460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1830    0.6260    2.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5550   -1.7750    3.8590 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.8850    0.0780   -1.8700 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5 11  1  0
  5 12  2  0
  6 13  1  0
  7 14  2  0
  8 15  1  0
  9 14  1  0
 10 16  1  0
 11 17  1  0
 13 18  1  0
M  END
>  <Name>  (283) 
Alachlor

>  <InChIKey>  (283) 
XCSGPAVHZFQHGE-UHFFFAOYSA-N

>  <PubChem_CID>  (283) 
2078

>  <CYP1A2>  (283) 


>  <CYP2A6>  (283) 


>  <CYP2B6>  (283) 
<10,11;Cleavage;R1>

>  <CYP2C8>  (283) 


>  <CYP2C9>  (283) 


>  <CYP2C19>  (283) 


>  <CYP2D6>  (283) 


>  <CYP2E1>  (283) 


>  <CYP3A4>  (283) 
<10,11;Cleavage;R1>

>  <References>  (283) 
Coleman S, Liu S, Linderman R, Hodgson E, Rose RL: In vitro metabolism of alachlor by human liver microsomes and human cytochrome P450 isoforms. Chem Biol Interact. 1999 Aug 30;122(1):27-39. (PMID: 10475613)
Coleman S, Linderman R, Hodgson E, Rose RL: Comparative metabolism of chloroacetamide herbicides and selected metabolites in human and rat liver microsomes. Environ Health Perspect. 2000 Dec;108(12):1151-7. doi: 10.1289/ehp.001081151. (PMID: 11133395)

>  <Comments>  (283) 


$$$$
CC02123
     RDKit          3D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -0.1940    0.2330    1.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0510    1.1920   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0510    2.6340    0.3870 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6910    3.5690   -0.5530 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.1310    3.4320   -0.4010 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6770    4.1680    0.7210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8640    3.6940   -1.6280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8060    5.0730   -2.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1820    4.9780   -0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0640    0.7800   -1.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0470   -0.5750   -1.6530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0900   -1.5270   -0.6470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2120   -1.1230    0.6800 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9230    5.3530   -3.2460 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8720    6.6300   -3.7980 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7080    7.6320   -3.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5970    7.3560   -2.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6470    6.0780   -1.7240 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1 13  1  0
  2  3  1  0
  2 10  1  0
  3  4  1  0
  4  5  1  0
  4  9  1  1
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8 14  2  0
  8 18  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
M  END
>  <Name>  (284) 
Benzphetamine

>  <InChIKey>  (284) 
YXKTVDFXDRQTKV-OAHLLOKOSA-N

>  <PubChem_CID>  (284) 
29010891

>  <CYP1A2>  (284) 


>  <CYP2A6>  (284) 


>  <CYP2B6>  (284) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <CYP2C8>  (284) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <CYP2C9>  (284) 


>  <CYP2C19>  (284) 


>  <CYP2D6>  (284) 


>  <CYP2E1>  (284) 


>  <CYP3A4>  (284) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <References>  (284) 
Ekins S, Wrighton SA: The role of CYP2B6 in human xenobiotic metabolism. Drug Metab Rev. 1999 Aug;31(3):719-54. doi: 10.1081/DMR-100101942. (PMID: 10461547)
Maenpaa J, Pelkonen O, Cresteil T, Rane A: The role of cytochrome P450 3A (CYP3A) isoform(s) in oxidative metabolism of testosterone and benzphetamine in human adult and fetal liver. J Steroid Biochem Mol Biol. 1993 Jan;44(1):61-7. (PMID: 8424894)

>  <Comments>  (284) 


$$$$
CC02124
     RDKit          3D

 23 26  0  0  0  0  0  0  0  0999 V2000
    5.3750   -0.6010   -0.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1230    0.0890   -1.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3790    0.6510    0.0360 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2290    1.2780   -0.5340 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.4530    0.2970   -1.2410 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3860    1.9130    0.5890 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.0570    1.8910    0.1540 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.5520    1.1080    1.8790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6950   -0.3980   -0.2570 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.5500    0.4270    0.0800 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.0740    2.6700    0.9560 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1830   -1.6490   -0.6550 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6650    0.4830   -0.9430 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.9080   -0.0450    1.3610 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3950    2.6400    0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8140    1.2190   -0.1740 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.0310   -1.4620    1.3990 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0700    1.2500   -1.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2460   -0.8390   -1.4290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4280   -2.3130    0.4300 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.7570   -2.8890   -0.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6910   -1.7840   -0.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4860   -3.3680    1.0560 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  4  3  1  1
  4  5  1  0
  4  6  1  0
  9  5  1  6
  6  7  1  0
  6  8  1  1
  7 10  1  0
  7 11  1  1
  9 10  1  0
  9 12  1  0
 10 13  1  0
 10 14  1  1
 11 15  1  0
 12 20  1  0
 13 16  1  0
 13 19  1  1
 14 17  1  0
 15 16  1  0
 16 18  1  6
 17 20  1  0
 19 22  1  0
 20 21  1  0
 20 23  1  1
 21 22  1  0
M  END
>  <Name>  (285) 
beta-Arteether

>  <InChIKey>  (285) 
AGXLQRPCBKYRSR-JWETUGRJSA-N

>  <PubChem_CID>  (285) 
3647519

>  <CYP1A2>  (285) 


>  <CYP2A6>  (285) 


>  <CYP2B6>  (285) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2C8>  (285) 


>  <CYP2C9>  (285) 


>  <CYP2C19>  (285) 


>  <CYP2D6>  (285) 


>  <CYP2E1>  (285) 


>  <CYP3A4>  (285) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <References>  (285) 
Grace JM, Aguilar AJ, Trotman KM, Peggins JO, Brewer TG: Metabolism of beta-arteether to dihydroqinghaosu by human liver microsomes and recombinant cytochrome P450. Drug Metab Dispos. 1998 Apr;26(4):313-7. (PMID: 9531517)

>  <Comments>  (285) 


$$$$
CC02126
     RDKit          3D

 21 21  0  0  0  0  0  0  0  0999 V2000
    0.0540    2.1270    1.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3910    0.7400    0.9720 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9890    3.1010    0.5990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2240    2.5560    1.4400 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0880   -0.1550    1.9980 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0790    0.2830   -0.2180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6520    4.4610    0.6390 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3940    2.7580    0.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5330    3.9240    1.4480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3230    1.5880    1.7600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4100   -1.5990    1.6920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3670    0.1500    3.1010 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2000   -0.5570   -0.9550 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6030    4.8750    1.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7310    3.2720   -1.1710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2090    2.0420    2.8980 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0470   -1.9380    2.3040 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.6660   -0.6180   -2.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3380    0.6050   -3.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6150    1.5840   -2.4860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8380    2.7540   -3.4090 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5 11  1  0
  5 12  2  0
  6 13  1  0
  7 14  2  0
  8 15  1  0
  9 14  1  0
 10 16  1  0
 11 17  1  0
 13 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
M  END
>  <Name>  (286) 
Butachlor

>  <InChIKey>  (286) 
HKPHPIREJKHECO-UHFFFAOYSA-N

>  <PubChem_CID>  (286) 
31677

>  <CYP1A2>  (286) 


>  <CYP2A6>  (286) 


>  <CYP2B6>  (286) 
<5,6;Cleavage;R1>

>  <CYP2C8>  (286) 


>  <CYP2C9>  (286) 


>  <CYP2C19>  (286) 


>  <CYP2D6>  (286) 


>  <CYP2E1>  (286) 


>  <CYP3A4>  (286) 
<5,6;Cleavage;R1>

>  <References>  (286) 
Coleman S, Liu S, Linderman R, Hodgson E, Rose RL: In vitro metabolism of alachlor by human liver microsomes and human cytochrome P450 isoforms. Chem Biol Interact. 1999 Aug 30;122(1):27-39. (PMID: 10475613)
Coleman S, Linderman R, Hodgson E, Rose RL: Comparative metabolism of chloroacetamide herbicides and selected metabolites in human and rat liver microsomes. Environ Health Perspect. 2000 Dec;108(12):1151-7. doi: 10.1289/ehp.001081151. (PMID: 11133395)

>  <Comments>  (286) 


$$$$
CC02127
     RDKit          3D

 18 19  0  0  0  0  0  0  0  0999 V2000
    6.0940   -4.4930    0.6920 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.4300    3.2550    0.8760 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0310    1.5120    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2930    2.1040   -1.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1710    2.4240    0.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6520    1.8470    0.5830 C   0  0  2  0  0  0  0  0  0  0  0  0
    6.5970    2.7250   -0.9040 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3110   -0.0510    0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5460    1.1440   -0.1870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2240    1.0050    0.5350 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6480   -0.6060    1.4240 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2300   -0.9500   -0.9020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0900    4.0000   -0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2940    0.1600   -0.3010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5490    2.3210    0.8310 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8910   -1.9690    1.5930 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4690   -2.3150   -0.7540 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7990   -2.8160    0.4970 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 18  1  0
  2  6  1  0
  2 13  1  0
  3  4  1  0
  3  5  1  0
  3  6  1  0
  3  8  1  0
  4  7  1  0
  5  7  1  0
  6  9  1  6
  8 11  2  0
  8 12  1  0
  9 10  1  0
 10 14  1  0
 10 15  1  0
 11 16  1  0
 12 17  2  0
 16 18  2  0
 17 18  1  0
M  END
>  <Name>  (287) 
Demethylsibutramine

>  <InChIKey>  (287) 
PLXKZKLXYHLWHR-HNNXBMFYSA-N

>  <PubChem_CID>  (287) 
9838199

>  <CYP1A2>  (287) 


>  <CYP2A6>  (287) 


>  <CYP2B6>  (287) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C8>  (287) 


>  <CYP2C9>  (287) 


>  <CYP2C19>  (287) 


>  <CYP2D6>  (287) 


>  <CYP2E1>  (287) 


>  <CYP3A4>  (287) 


>  <References>  (287) 
Bae SK, Cao S, Seo KA, Kim H, Kim MJ, Shon JH, Liu KH, Zhou HH, Shin JG: Cytochrome P450 2B6 catalyzes the formation of pharmacologically active sibutramine (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine) metabolites in human liver microsomes. Drug Metab Dispos. 2008 Aug;36(8):1679-88. doi: 10.1124/dmd.108.020727. Epub 2008 May 12. (PMID: 18474675)

>  <Comments>  (287) 


$$$$
CC02128
     RDKit          3D

 30 30  0  0  0  0  0  0  0  0999 V2000
    0.0170    0.4640    1.5970 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.0340   -0.7080    0.6510 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3410    1.0870    1.5300 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2470   -0.0210    3.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2070   -1.0800    0.1010 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9800   -1.3180    0.3840 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4920    2.3850    1.8610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3440    1.1840    3.9620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4290   -0.3310    0.4070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2610   -2.2320   -0.8020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8280    3.0140    1.7930 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5300    3.0380    2.2140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6040    0.7070    5.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8160    0.5280   -0.7990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5310   -3.5020    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9870    4.3580    2.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9360    2.2640    1.3940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7270    1.5960    6.3660 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7030   -0.4750    5.5950 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1740    1.1850   -0.5420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5870   -4.7060   -0.9360 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2380    4.9400    2.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1800    2.8560    1.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5600    2.0440   -1.7470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8390   -5.8920   -0.1810 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3320    4.1910    1.6680 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4380    6.6110    2.4940 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -5.9180    2.7010   -1.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8800   -6.9740   -1.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9020    4.9290    1.5890 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  1
  2  5  1  0
  2  6  2  0
  3  7  1  0
  4  8  1  0
  5  9  1  0
  5 10  1  0
  7 11  1  0
  7 12  2  0
  8 13  1  0
  9 14  1  0
 10 15  1  0
 11 16  2  0
 11 17  1  0
 13 18  1  0
 13 19  2  0
 14 20  1  0
 15 21  1  0
 16 22  1  0
 17 23  2  0
 20 24  1  0
 21 25  1  0
 22 26  2  0
 22 27  1  0
 23 26  1  0
 24 28  1  0
 25 29  1  0
 26 30  1  0
M  END
>  <Name>  (288) 
Dexloxiglumide

>  <InChIKey>  (288) 
QNQZBKQEIFTHFZ-GOSISDBHSA-N

>  <PubChem_CID>  (288) 
65937

>  <CYP1A2>  (288) 


>  <CYP2A6>  (288) 


>  <CYP2B6>  (288) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <CYP2C8>  (288) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <CYP2C9>  (288) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <CYP2C19>  (288) 


>  <CYP2D6>  (288) 


>  <CYP2E1>  (288) 


>  <CYP3A4>  (288) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <References>  (288) 
Hall M, Persiani S, Cheung YL, Matthews A, Cybulski ZR, Holding JD, Kapil R, D'Amato M, Makovec F, Rovati LC: Interaction of dexloxiglumide, a cholecystokinin type-1 receptor antagonist, with human cytochromes P450. Biopharm Drug Dispos. 2004 May;25(4):163-76. doi: 10.1002/bdd.397. (PMID: 15108219)

>  <Comments>  (288) 


$$$$
CC02129
     RDKit          3D

 20 23  0  0  0  0  0  0  0  0999 V2000
   -2.7290   -0.1730    0.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5950    0.4630    0.6590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6040   -1.1610   -0.7860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3580   -1.4930   -1.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2190   -0.8530   -0.7940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3420    0.1150    0.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8640    0.8030    0.7650 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.5260    2.2330    1.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1110    3.0230   -0.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2540    3.0160   -1.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5800    1.5740   -1.4980 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0060    0.7900   -0.2560 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.2810   -0.6660   -0.6260 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.1060   -1.2490   -1.3870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6460   -1.4610    0.5360 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3180   -0.0050    1.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5560   -1.4440    1.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7770   -2.8490    0.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9550    0.1640    0.6610 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9040   -0.6620   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1 19  1  0
  2  6  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5 14  1  0
  6  7  1  0
  7  8  1  1
  7 12  1  0
  7 16  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 12 11  1  6
 12 13  1  0
 13 14  1  1
 13 15  1  0
 15 17  1  0
 15 18  1  0
 16 17  1  0
 19 20  1  0
M  END
>  <Name>  (289) 
Dextromethorphan

>  <InChIKey>  (289) 
MKXZASYAUGDDCJ-NJAFHUGGSA-N

>  <PubChem_CID>  (289) 
5360696

>  <CYP1A2>  (289) 


>  <CYP2A6>  (289) 


>  <CYP2B6>  (289) 
<16,17;Cleavage;R1>
<17,H;Oxidation;R1>

>  <CYP2C8>  (289) 


>  <CYP2C9>  (289) 
<16,17;Cleavage;R1>
<17,H;Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2C19>  (289) 
<16,17;Cleavage;R1>
<17,H;Oxidation;R1>

>  <CYP2D6>  (289) 
<16,17;Cleavage;R1>
<17,H;Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2E1>  (289) 


>  <CYP3A4>  (289) 
<16,17;Cleavage;R1>
<17,H;Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <References>  (289) 
Wang Y, Unadkat JD: Enzymes in addition to CYP3A4 and 3A5 mediate N-demethylation of dextromethorphan in human liver microsomes. Biopharm Drug Dispos. 1999 Oct;20(7):341-6. (PMID: 10760842)
Flanagan JU, McLaughlin LA, Paine MJ, Sutcliffe MJ, Roberts GC, Wolf CR: Role of conserved Asp293 of cytochrome P450 2C9 in substrate recognition and catalytic activity. Biochem J. 2003 Mar 15;370(Pt 3):921-6. doi: 10.1042/BJ20021841. (PMID: 12482324)
von Moltke LL, Greenblatt DJ, Grassi JM, Granda BW, Venkatakrishnan K, Schmider J, Harmatz JS, Shader RI: Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro: role of CYP2C9, CYP2C19, CYP2D6, and CYP3A. J Pharm Pharmacol. 1998 Sep;50(9):997-1004. doi: 10.1111/j.2042-7158.1998.tb06914.x. (PMID: 9811160)
Bapiro TE, Hasler JA, Ridderstrom M, Masimirembwa CM: The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant. Potential implications for CYP2D6 phenotyping studies and the clinical use of CYP2D6 substrate drugs in some African populations. Biochem Pharmacol. 2002 Nov 1;64(9):1387-98. doi: 10.1016/s0006-2952(02)01351-5. (PMID: 12392820)

>  <Comments>  (289) 


$$$$
CC02130
     RDKit          3D

 20 22  0  0  0  0  0  0  0  0999 V2000
    1.6960   -2.6210    0.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3480   -1.4280    0.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6990   -0.2110    0.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3780   -0.2110   -0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2740   -1.4340   -0.4220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3840   -2.6240   -0.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4340   -4.1300   -0.4890 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.3810    1.0230   -0.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4190    0.9480    0.4870 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2840    0.9660    1.6700 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1000    2.9820    0.0240 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3870    2.0450   -0.2660 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4880    2.1530   -1.4670 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0960    2.0770   -1.0260 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8020    1.0530   -0.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2530    0.2050    0.9660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6940    1.9320   -0.6600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5780    0.2380    1.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0160    1.9560   -0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4580    1.1090    0.7340 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  3  9  1  0
  4  5  1  0
  4  8  1  0
  5  6  2  0
  6  7  1  0
  8 14  2  0
  8 15  1  0
  9 10  1  0
  9 12  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 15 16  2  0
 15 17  1  0
 16 18  1  0
 17 19  2  0
 18 20  2  0
 19 20  1  0
M  END
>  <Name>  (290) 
Diazepam

>  <InChIKey>  (290) 
AAOVKJBEBIDNHE-UHFFFAOYSA-N

>  <PubChem_CID>  (290) 
3016

>  <CYP1A2>  (290) 


>  <CYP2A6>  (290) 


>  <CYP2B6>  (290) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C8>  (290) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C9>  (290) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (290) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<4,H;Hydroxylation;R2>

>  <CYP2D6>  (290) 


>  <CYP2E1>  (290) 


>  <CYP3A4>  (290) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<4,H;Hydroxylation;R2>

>  <References>  (290) 
Yang TJ, Krausz KW, Sai Y, Gonzalez FJ, Gelboin HV: Eight inhibitory monoclonal antibodies define the role of individual P-450s in human liver microsomal diazepam, 7-ethoxycoumarin, and imipramine metabolism. Drug Metab Dispos. 1999 Jan;27(1):102-9. (PMID: 9884317)

>  <Comments>  (290) 


$$$$
CC02131
     RDKit          3D

 19 20  0  0  0  0  0  0  0  0999 V2000
   -1.4770   -0.0940    0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4570   -1.0990    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7890   -0.8860    0.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1740    0.3290    0.9370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2210    1.3180    1.1380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8860    1.1130    0.7720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0780   -2.6480   -0.6420 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.7990    2.3680    1.2470 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.1550   -0.3900   -0.2330 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8020    0.4120   -0.8930 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1410   -0.0110   -0.9360 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0970    0.7440   -1.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7320    1.9150   -2.2780 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4060    2.3330   -2.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4520    1.5810   -1.5760 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5830   -1.2680   -0.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8370   -1.1040    1.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2060   -0.0880    1.7840 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6490   -2.2960    1.8370 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  9  1  0
  2  3  1  0
  2  7  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  8  1  0
  9 10  1  0
 10 11  2  0
 10 15  1  0
 11 12  1  0
 11 16  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
M  END
>  <Name>  (291) 
Diclofenac

>  <InChIKey>  (291) 
DCOPUUMXTXDBNB-UHFFFAOYSA-N

>  <PubChem_CID>  (291) 
3033

>  <CYP1A2>  (291) 


>  <CYP2A6>  (291) 


>  <CYP2B6>  (291) 
<6,H;Hydroxylation;R1>

>  <CYP2C8>  (291) 
<6,H;Hydroxylation;R1>
<15,H;Hydroxylation;R2>

>  <CYP2C9>  (291) 
<14,H;Hydroxylation;R1>
<16,H;Hydroxylation;R2>
<15,H;Hydroxylation;R3>

>  <CYP2C19>  (291) 
<6,H;Hydroxylation;R1>
<15,H;Hydroxylation;R2>

>  <CYP2D6>  (291) 


>  <CYP2E1>  (291) 


>  <CYP3A4>  (291) 
<6,H;Hydroxylation;R1>

>  <References>  (291) 
Mancy A, Antignac M, Minoletti C, Dijols S, Mouries V, Duong NT, Battioni P, Dansette PM, Mansuy D: Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: particular efficiency and regioselectivity of P450 2Cs. Biochemistry. 1999 Oct 26;38(43):14264-70. doi: 10.1021/bi991195u. (PMID: 10572000)
Tang W, Stearns RA, Wang RW, Chiu SH, Baillie TA: Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac. Chem Res Toxicol. 1999 Feb;12(2):192-9. doi: 10.1021/tx9802217. (PMID: 10027798)
Bort R, Mace K, Boobis A, Gomez-Lechon MJ, Pfeifer A, Castell J: Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways. Biochem Pharmacol. 1999 Sep 1;58(5):787-96. doi: 10.1016/s0006-2952(99)00167-7. (PMID: 10449188)

>  <Comments>  (291) 
Xenosite reported that 5 is a SoM for CYP2C9. But I can't confirm it in the reference.

$$$$
CC02132
     RDKit          3D

 19 21  0  0  0  0  0  0  0  0999 V2000
   -0.0190    1.5460    0.0100 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.5220    1.8780   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3130    1.8440    1.4950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0460    2.3560   -1.2310 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.3100   -0.3830    0.6740 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.2520   -0.6290   -1.3680 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8290    0.9580    1.2470 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.8550    3.6200    0.3240 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.3400    1.3000   -1.5020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.7470    1.4790    2.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7720    2.5350    2.1320 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.0160   -1.4270    1.7670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1810   -2.0660   -1.0800 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5230    0.9590    1.8650 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.8890    1.5740    3.9230 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.5100   -2.5340    1.0840 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7510   -2.4020    0.2690 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1720   -3.7490    0.1110 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  6
  2  6  1  0
  2  7  1  6
  3  8  1  0
  3  9  1  0
  3 10  1  0
  4 11  2  0
  4 12  1  0
  6  8  1  0
  6 13  1  1
  7 14  1  0
  8 11  1  0
  8 15  1  1
 11 16  1  0
 13 17  1  0
 18 14  1  6
 17 18  1  0
 18 19  2  0
M  END
>  <Name>  (292) 
Endosulfan

>  <InChIKey>  (292) 
RDYMFSUJUZBWLH-KUGKFLLMSA-N

>  <PubChem_CID>  (292) 


>  <CYP1A2>  (292) 


>  <CYP2A6>  (292) 


>  <CYP2B6>  (292) 
<1,S;S-Oxidation;R1>

>  <CYP2C8>  (292) 


>  <CYP2C9>  (292) 


>  <CYP2C19>  (292) 


>  <CYP2D6>  (292) 


>  <CYP2E1>  (292) 


>  <CYP3A4>  (292) 
<1,S;S-Oxidation;R1>

>  <References>  (292) 
Casabar RC, Wallace AD, Hodgson E, Rose RL: Metabolism of endosulfan-alpha by human liver microsomes and its utility as a simultaneous in vitro probe for CYP2B6 and CYP3A4. Drug Metab Dispos. 2006 Oct;34(10):1779-85. doi: 10.1124/dmd.106.010199. Epub 2006 Jul 19. (PMID: 16855053)

>  <Comments>  (292) 


$$$$
CC02133
     RDKit          3D

 23 26  0  0  1  0  0  0  0  0999 V2000
    0.3060    1.0150    1.5280 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6630    1.9960    2.8980 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0080    1.5430    0.2690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0030    2.9930   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3250    0.6940   -0.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3400   -0.6840   -0.5940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0310   -1.2140    0.6560 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2870   -0.3660    1.7150 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2770    3.7010    0.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4720    4.9980    0.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4770    5.9250    0.8360 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8120    5.8700    0.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1890    4.9250   -0.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1340    3.5340   -0.3090 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5510    3.0990   -0.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6200    3.9210    0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0640    3.6300   -0.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5080    3.8150   -1.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1070    5.4300    0.6650 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.4790    7.0590    1.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6290    7.5520    2.4130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7230    7.5960    1.6480 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5350    6.8500    0.8380 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  8  1  0
  3  4  1  0
  3  5  1  0
  4  9  1  0
  4 14  2  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  9 10  2  0
  9 15  1  0
 10 11  1  0
 10 19  1  0
 11 12  1  0
 11 20  1  0
 12 13  1  0
 12 23  2  0
 13 14  1  0
 15 16  2  0
 16 17  1  0
 16 19  1  0
 17 18  1  0
 20 21  1  0
 20 22  2  0
 22 23  1  0
M  END
>  <Name>  (293) 
Etizolam

>  <InChIKey>  (293) 
VMZUTJCNQWMAGF-UHFFFAOYSA-N

>  <PubChem_CID>  (293) 
3307

>  <CYP1A2>  (293) 


>  <CYP2A6>  (293) 


>  <CYP2B6>  (293) 
<13,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>

>  <CYP2C8>  (293) 


>  <CYP2C9>  (293) 


>  <CYP2C19>  (293) 
<13,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>

>  <CYP2D6>  (293) 


>  <CYP2E1>  (293) 


>  <CYP3A4>  (293) 
<13,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>

>  <References>  (293) 
Niwa T, Shiraga T, Ishii I, Kagayama A, Takagi A: Contribution of human hepatic cytochrome p450 isoforms to the metabolism of psychotropic drugs. Biol Pharm Bull. 2005 Sep;28(9):1711-6. (PMID: 16141545)
Mandrioli R, Mercolini L, Raggi MA: Benzodiazepine metabolism: an analytical perspective. Curr Drug Metab. 2008 Oct;9(8):827-44. (PMID: 18855614)

>  <Comments>  (293) 
The metabolites and SoM need to be confirmed. One of the metabolites should be alpha-Hydroxyetizolam, which indicates <17,H> should be the BoM rather than <21,H>.

$$$$
CC02135
     RDKit          3D

 16 17  0  0  0  0  0  0  0  0999 V2000
   -1.4180   -0.8350   -0.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7860   -1.0370   -0.2640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6430    0.0070    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1330    1.2540    0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7650    1.4560    0.3600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9080    0.4130    0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3410   -2.1480   -0.6050 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.5830    0.6340    0.0900 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.2130   -0.2510    1.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7220   -0.3410    1.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2390   -0.6730   -0.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7030    0.3570   -1.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1780    0.2670   -1.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5280   -0.8690    1.9220 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8690    2.0430    0.3890 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3950    2.8240   -0.7620 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  8  1  0
  8  9  1  0
  8 13  1  0
  8 15  1  1
  9 10  1  0
  9 14  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 15 16  1  0
M  END
>  <Name>  (294) 
Ketamine

>  <InChIKey>  (294) 
YQEZLKZALYSWHR-CYBMUJFWSA-N

>  <PubChem_CID>  (294) 
644025

>  <CYP1A2>  (294) 


>  <CYP2A6>  (294) 


>  <CYP2B6>  (294) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C8>  (294) 


>  <CYP2C9>  (294) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (294) 


>  <CYP2D6>  (294) 


>  <CYP2E1>  (294) 


>  <CYP3A4>  (294) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (294) 
Hijazi Y, Boulieu R: Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes. Drug Metab Dispos. 2002 Jul;30(7):853-8. doi: 10.1124/dmd.30.7.853. (PMID: 12065445)

>  <Comments>  (294) 


$$$$
CC02136
     RDKit          3D

 26 27  0  0  0  0  0  0  0  0999 V2000
    0.2730   -0.4230    0.3840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4890   -1.1960    1.4620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3280    0.9770    0.2400 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.7230   -0.3090    0.7780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1650   -1.1540   -0.9290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9260   -1.4390    0.9960 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.4110    1.7190   -0.7660 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2420    1.7100    1.5800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1370   -0.7450    2.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6400    0.2260   -0.1080 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7630   -2.3910   -1.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5370   -0.5900   -1.9790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6430   -0.1580    0.9330 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6330   -2.3700    1.9840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2090    2.6600   -1.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4670   -0.6400    2.3840 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9700    0.3300    0.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6640   -3.0610   -2.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6360   -1.2610   -3.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9020   -0.4140    0.2200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0040    0.1930    2.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3830   -0.0990    1.5010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0320   -2.4950   -3.3390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3820    2.8890   -1.3160 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9650    3.0540    1.4730 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5580    3.4300   -2.5400 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  1
  4  9  2  0
  4 10  1  0
  5 11  2  0
  5 12  1  0
  6 13  1  0
  6 14  1  1
  7 15  1  0
  8 25  1  0
  9 16  1  0
 10 17  2  0
 11 18  1  0
 12 19  2  0
 13 20  1  0
 13 21  1  0
 15 24  2  0
 15 26  1  0
 16 22  2  0
 17 22  1  0
 18 23  2  0
 19 23  1  0
M  END
>  <Name>  (295) 
LAAM

>  <InChIKey>  (295) 
XBMIVRRWGCYBTQ-XMSQKQJNSA-N

>  <PubChem_CID>  (295) 
22308

>  <CYP1A2>  (295) 


>  <CYP2A6>  (295) 


>  <CYP2B6>  (295) 
<11,13;Cleavage;R1>
<13,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP2C8>  (295) 
<11,13;Cleavage;R1>
<13,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP2C9>  (295) 


>  <CYP2C19>  (295) 
<11,13;Cleavage;R1>
<13,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP2D6>  (295) 


>  <CYP2E1>  (295) 


>  <CYP3A4>  (295) 
<11,13;Cleavage;R1>
<13,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <References>  (295) 
Neff JA, Moody DE: Differential N-demethylation of l-alpha-acetylmethadol (LAAM) and norLAAM by cytochrome P450s 2B6, 2C18, and 3A4. Biochem Biophys Res Commun. 2001 Jun 15;284(3):751-6. doi: 10.1006/bbrc.2001.5054. (PMID: 11396966)
Moody DE, Alburges ME, Parker RJ, Collins JM, Strong JM: The involvement of cytochrome P450 3A4 in the N-demethylation of L-alpha-acetylmethadol (LAAM), norLAAM, and methadone. Drug Metab Dispos. 1997 Dec;25(12):1347-53. (PMID: 9394023)

>  <Comments>  (295) 


$$$$
CC02137
     RDKit          3D

 14 13  0  0  0  0  0  0  0  0999 V2000
    0.5190    0.5000   -0.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3010    0.4360    0.6650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7550   -0.6000    1.6220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4910   -1.9620    1.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6330   -2.5340    0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9880   -2.4820    0.8770 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0170   -2.9950    2.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3490   -4.3360    2.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7500   -5.4150    1.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2410   -5.5800    1.3290 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0230   -5.6260    2.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0490   -7.0270    3.1460 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8910   -7.8640    2.8570 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0110   -7.2380    3.9890 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
M  END
>  <Name>  (296) 
Lauric acid

>  <InChIKey>  (296) 
POULHZVOKOAJMA-UHFFFAOYSA-N

>  <PubChem_CID>  (296) 
3893

>  <CYP1A2>  (296) 


>  <CYP2A6>  (296) 


>  <CYP2B6>  (296) 
<1,H;Hydroxylation;R1>

>  <CYP2C8>  (296) 
<1,H;Hydroxylation;R1>

>  <CYP2C9>  (296) 
<1,H;Hydroxylation;R1>

>  <CYP2C19>  (296) 


>  <CYP2D6>  (296) 


>  <CYP2E1>  (296) 
<1,H;Hydroxylation;R1>

>  <CYP3A4>  (296) 


>  <References>  (296) 
Imaoka S, Yamada T, Hiroi T, Hayashi K, Sakaki T, Yabusaki Y, Funae Y: Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Systematic characterization and comparison with those of the rat. Biochem Pharmacol. 1996 Apr 26;51(8):1041-50. doi: 10.1016/0006-2952(96)00052-4. (PMID: 8866826)

>  <Comments>  (296) 


$$$$
CC02138
     RDKit          3D

 34 37  0  0  0  0  0  0  0  0999 V2000
   -0.0870    1.6130    0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1180    0.0720    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3480    2.1340   -0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9600    2.0840   -1.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6500    2.2080    1.4710 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7990   -0.6310   -0.7230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1030   -0.6720    0.7340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2820    1.9940    0.9870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7680    2.7360   -1.2430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4320    1.7470   -0.9100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9230    3.5670    1.5170 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8160    1.5110    2.4770 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7560   -2.0200   -0.8270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1540   -2.0610    0.6360 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5900    2.4480    0.8400 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0760    3.1910   -1.3940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1820    2.2240   -2.0570 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4770    4.1110    2.7290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6820    4.5140    0.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2210   -2.7350   -0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9860    3.0470   -0.3520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5420    1.7210   -1.9190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1570    3.6820   -2.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4440    2.2390   -3.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0320    4.2350   -3.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4690    3.7590   -3.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3700    4.3060   -4.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9520    4.2080   -1.7840 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1190    5.5560   -4.7040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5060    3.5990   -4.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9670    6.0800   -5.6770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3600    4.1150   -5.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0830    5.3530   -6.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1310    5.9940   -7.2730 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  2  6  2  0
  2  7  1  0
  3  8  2  0
  3  9  1  0
  4 10  1  0
  5 11  1  0
  5 12  2  0
  6 13  1  0
  7 14  2  0
  8 15  1  0
  9 16  2  0
 10 17  1  0
 11 18  1  0
 11 19  1  0
 13 20  2  0
 14 20  1  0
 15 21  2  0
 16 21  1  0
 17 22  1  0
 17 23  1  0
 22 24  1  0
 23 25  1  0
 24 26  1  0
 25 26  1  0
 26 27  1  0
 26 28  1  0
 27 29  2  0
 27 30  1  0
 29 31  1  0
 30 32  2  0
 31 33  2  0
 32 33  1  0
 33 34  1  0
M  END
>  <Name>  (297) 
Loperamide

>  <InChIKey>  (297) 
RDOIQAHITMMDAJ-UHFFFAOYSA-N

>  <PubChem_CID>  (297) 
3955

>  <CYP1A2>  (297) 


>  <CYP2A6>  (297) 


>  <CYP2B6>  (297) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2C8>  (297) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2C9>  (297) 


>  <CYP2C19>  (297) 


>  <CYP2D6>  (297) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2E1>  (297) 


>  <CYP3A4>  (297) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <References>  (297) 
Kim KA, Chung J, Jung DH, Park JY: Identification of cytochrome P450 isoforms involved in the metabolism of loperamide in human liver microsomes. Eur J Clin Pharmacol. 2004 Oct;60(8):575-81. doi: 10.1007/s00228-004-0815-3. Epub 2004 Sep 8. (PMID: 15365656)

>  <Comments>  (297) 


$$$$
CC02139
     RDKit          3D

 18 19  0  0  1  0  0  0  0  0999 V2000
    0.7000    0.5720    2.8890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6330    0.4000    1.6920 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0490    0.7950    0.2930 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.1950    0.5160   -0.6800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4970   -0.6130   -1.0680 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9560    1.5830   -1.0650 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7770    2.9010   -0.7560 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6020    3.7260   -1.1460 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6370    3.2110   -0.0370 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6910    2.2880    0.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3820    2.6550    0.8900 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3730    4.6110    0.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1660   -0.0330   -0.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0070    0.4630   -1.1970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0860   -0.2840   -1.6760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3390   -1.5520   -1.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5070   -2.0750   -0.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4280   -1.3280    0.3030 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  1
  3  4  1  0
  3 10  1  0
  3 13  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
  9 12  1  0
 10 11  2  0
 13 14  2  0
 13 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
M  END
>  <Name>  (298) 
Mephobarbital

>  <InChIKey>  (298) 
ALARQZQTBTVLJV-ZDUSSCGKSA-N

>  <PubChem_CID>  (298) 
6451435

>  <CYP1A2>  (298) 


>  <CYP2A6>  (298) 


>  <CYP2B6>  (298) 
<14,15;Cleavage;R1>
<15,H;Oxidation;R1>

>  <CYP2C8>  (298) 


>  <CYP2C9>  (298) 


>  <CYP2C19>  (298) 
<6,H;Hydroxylation;R1>

>  <CYP2D6>  (298) 


>  <CYP2E1>  (298) 


>  <CYP3A4>  (298) 


>  <References>  (298) 
Kobayashi K, Abe S, Nakajima M, Shimada N, Tani M, Chiba K, Yamamoto T: Role of human CYP2B6 in S-mephobarbital N-demethylation. Drug Metab Dispos. 1999 Dec;27(12):1429-33. (PMID: 10570024)
Kobayashi K, Kogo M, Tani M, Shimada N, Ishizaki T, Numazawa S, Yoshida T, Yamamoto T, Kuroiwa Y, Chiba K: Role of CYP2C19 in stereoselective hydroxylation of mephobarbital by human liver microsomes. Drug Metab Dispos. 2001 Jan;29(1):36-40. (PMID: 11124227)

>  <Comments>  (298) 


$$$$
CC02140
     RDKit          3D

 23 24  0  0  0  0  0  0  0  0999 V2000
   -0.2800   -0.2040    0.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3400   -0.6930   -1.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2220   -1.3680    1.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4430    1.0870    0.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7690    0.1030   -0.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6390   -1.4750   -1.2290 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.5960   -2.7370    0.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0300   -1.2160    2.2900 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4940    2.1600   -0.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0610    1.2580    1.6970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5680    0.5580    0.8770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3660   -0.0610   -1.4380 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7430   -0.7930   -0.5850 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9540   -1.9960   -2.6160 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3660   -3.7730    1.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1400    3.3520   -0.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7100    2.4470    2.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9180    0.8410    0.6870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7170    0.2210   -1.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7990   -1.7510   -0.3090 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3060    0.2320   -1.4470 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7490    3.4940    1.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4920    0.6720   -0.5690 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  2  0
  4 10  1  0
  5 11  2  0
  5 12  1  0
  6 13  1  0
  6 14  1  6
  7 15  1  0
  9 16  1  0
 10 17  2  0
 11 18  1  0
 12 19  2  0
 13 20  1  0
 13 21  1  0
 16 22  2  0
 17 22  1  0
 18 23  2  0
 19 23  1  0
M  END
>  <Name>  (299) 
Methadone

>  <InChIKey>  (299) 
USSIQXCVUWKGNF-QGZVFWFLSA-N

>  <PubChem_CID>  (299) 
22267

>  <CYP1A2>  (299) 


>  <CYP2A6>  (299) 


>  <CYP2B6>  (299) 
<8,9;Cleavage;R1>
<9,H;Oxidation;R1>
<8,10;Cleavage;R2>
<10,H;Oxidation;R2>

>  <CYP2C8>  (299) 
<8,9;Cleavage;R1>
<9,H;Oxidation;R1>
<8,10;Cleavage;R2>
<10,H;Oxidation;R2>

>  <CYP2C9>  (299) 


>  <CYP2C19>  (299) 
<8,9;Cleavage;R1>
<9,H;Oxidation;R1>
<8,10;Cleavage;R2>
<10,H;Oxidation;R2>

>  <CYP2D6>  (299) 
<8,9;Cleavage;R1>
<9,H;Oxidation;R1>
<8,10;Cleavage;R2>
<10,H;Oxidation;R2>

>  <CYP2E1>  (299) 


>  <CYP3A4>  (299) 
<8,9;Cleavage;R1>
<9,H;Oxidation;R1>
<8,10;Cleavage;R2>
<10,H;Oxidation;R2>

>  <References>  (299) 
Iribarne C, Berthou F, Baird S, Dreano Y, Picart D, Bail JP, Beaune P, Menez JF: Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Chem Res Toxicol. 1996 Mar;9(2):365-73. doi: 10.1021/tx950116m. (PMID: 8839037)
Gerber JG, Rhodes RJ, Gal J: Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19. Chirality. 2004 Jan;16(1):36-44. doi: 10.1002/chir.10303. (PMID: 14628297)

>  <Comments>  (299) 


$$$$
CC02141
     RDKit          3D

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.1490    1.5290   -0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2220    0.0790   -0.5800 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4370    2.0770    0.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7910    2.4610   -0.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7420   -0.3360   -1.8090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2300   -0.8800    0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4670    2.5040   -0.5060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6130    2.1460    1.7240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4240    1.7180   -1.1510 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.0290    4.0110   -0.0990 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.1760    2.8390   -2.6240 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.8050   -1.6900   -2.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1710   -2.2350    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6550    3.0010    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7980    2.6410    2.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3460   -2.6230   -1.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8050    3.0640    1.4030 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4060   -3.9490   -1.5180 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9660    3.5490    1.9260 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  4 10  1  0
  4 11  1  0
  5 12  1  0
  6 13  2  0
  7 14  1  0
  8 15  2  0
 12 16  2  0
 13 16  1  0
 14 17  2  0
 15 17  1  0
 16 18  1  0
 17 19  1  0
M  END
>  <Name>  (300) 
Methoxychlor-bis-OH

>  <InChIKey>  (300) 
IUGDILGOLSSKNE-UHFFFAOYSA-N

>  <PubChem_CID>  (300) 
76302

>  <CYP1A2>  (300) 


>  <CYP2A6>  (300) 


>  <CYP2B6>  (300) 
<2,H;Hydroxylation;R1>
<18,H;Hydroxylation;R2>
<11,H;Hydroxylation;R3>
<8,H;Hydroxylation;R4>

>  <CYP2C8>  (300) 


>  <CYP2C9>  (300) 


>  <CYP2C19>  (300) 
<2,H;Hydroxylation;R1>
<18,H;Hydroxylation;R2>
<11,H;Hydroxylation;R3>
<8,H;Hydroxylation;R4>

>  <CYP2D6>  (300) 


>  <CYP2E1>  (300) 


>  <CYP3A4>  (300) 
<2,H;Hydroxylation;R1>
<18,H;Hydroxylation;R2>
<11,H;Hydroxylation;R3>
<8,H;Hydroxylation;R4>

>  <References>  (300) 
Hu Y, Kupfer D: Metabolism of the endocrine disruptor pesticide-methoxychlor by human P450s: pathways involving a novel catechol metabolite. Drug Metab Dispos. 2002 Sep;30(9):1035-42. doi: 10.1124/dmd.30.9.1035. (PMID: 12167570)

>  <Comments>  (300) 


$$$$
CC02142
     RDKit          3D

 19 19  0  0  0  0  0  0  0  0999 V2000
   -1.5760   -0.2870    0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3410    0.3830   -0.2220 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8770   -1.5360   -0.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4970    0.2580    0.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3080    1.7560   -0.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8520   -0.4640   -0.1750 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.6620   -0.4220   -1.4530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0840   -2.1800   -0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0100   -2.1690   -1.5560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6870   -0.4120    1.2890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2450    1.5110    1.7650 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0770    2.3540   -0.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3030    2.4640   -0.6680 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6580   -0.2440    1.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9870   -1.6270    0.6910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6520   -3.5950   -1.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2880    3.0580   -2.2250 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.8250    0.5260    0.8570 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5060    0.6370    2.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  8  1  0
  3  9  1  0
  4 10  2  0
  4 11  1  0
  5 12  1  0
  5 13  2  0
  6  7  1  6
  6 14  1  0
  8 15  2  0
  9 16  1  0
 10 15  1  0
 12 17  1  0
 14 18  1  0
 18 19  1  0
M  END
>  <Name>  (301) 
Metolachlor

>  <InChIKey>  (301) 
WVQBLGZPHOPPFO-LBPRGKRZSA-N

>  <PubChem_CID>  (301) 
11140605

>  <CYP1A2>  (301) 


>  <CYP2A6>  (301) 


>  <CYP2B6>  (301) 
<9,14;Cleavage;R1>

>  <CYP2C8>  (301) 


>  <CYP2C9>  (301) 


>  <CYP2C19>  (301) 


>  <CYP2D6>  (301) 


>  <CYP2E1>  (301) 


>  <CYP3A4>  (301) 
<9,14;Cleavage;R1>

>  <References>  (301) 
Coleman S, Liu S, Linderman R, Hodgson E, Rose RL: In vitro metabolism of alachlor by human liver microsomes and human cytochrome P450 isoforms. Chem Biol Interact. 1999 Aug 30;122(1):27-39. (PMID: 10475613)
Coleman S, Linderman R, Hodgson E, Rose RL: Comparative metabolism of chloroacetamide herbicides and selected metabolites in human and rat liver microsomes. Environ Health Perspect. 2000 Dec;108(12):1151-7. doi: 10.1289/ehp.001081151. (PMID: 11133395)

>  <Comments>  (301) 


$$$$
CC02144
     RDKit          3D

 20 23  0  0  0  0  0  0  0  0999 V2000
    1.2930    0.0880    0.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3760    0.9760   -0.2790 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1310   -1.2910    0.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0110   -2.1770    0.6770 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0260   -1.6530    1.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1440   -0.2810    1.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2950    0.5370    0.9970 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0880   -1.8050   -0.8480 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8120    2.0200   -1.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1440   -1.3290   -0.9540 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6970   -0.2800   -0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9680    0.8660    0.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5420    1.8740    0.7210 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7950    1.8180    1.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5650    0.6950    0.9040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0140   -0.3760    0.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3790   -2.7510   -1.5530 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8430    3.0310   -0.7040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8270   -1.6160   -0.0560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2550    1.9580   -1.7150 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  7  2  0
  2  9  1  0
  2 12  1  0
  3  4  2  0
  3  8  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  8 10  1  0
  8 17  2  0
  9 18  1  0
  9 20  1  0
 10 11  1  0
 11 12  2  0
 11 16  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 19  1  0
 18 20  1  0
M  END
>  <Name>  (302) 
Nevirapine

>  <InChIKey>  (302) 
NQDJXKOVJZTUJA-UHFFFAOYSA-N

>  <PubChem_CID>  (302) 
4463

>  <CYP1A2>  (302) 


>  <CYP2A6>  (302) 


>  <CYP2B6>  (302) 
<12,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>

>  <CYP2C8>  (302) 


>  <CYP2C9>  (302) 
<0,H;Hydroxylation;R1>

>  <CYP2C19>  (302) 


>  <CYP2D6>  (302) 
<12,H;Hydroxylation;R1>
<0,H;Hdroxylation;R2>

>  <CYP2E1>  (302) 


>  <CYP3A4>  (302) 
<12,H;Hydroxylation;R1>
<13,H;Hydroxylation;R2>
<0,H;Hydroxylaton;R3>

>  <References>  (302) 
Erickson DA, Mather G, Trager WF, Levy RH, Keirns JJ: Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450. Drug Metab Dispos. 1999 Dec;27(12):1488-95. (PMID: 10570031)

>  <Comments>  (302) 


$$$$
CC02145
     RDKit          3D

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.3130   -0.3560    0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5060   -1.1500    1.3680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2100    1.1070    0.2640 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.7790   -0.3270    0.7930 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1700   -1.1270   -0.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9610   -1.4530    1.0650 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.4570    1.9220   -0.7010 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2430    1.7780    1.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1500   -0.7530    2.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7890    0.1420   -0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7350   -2.4050   -1.1250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5580   -0.6180   -2.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8140   -0.2880    0.9250 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4980   -2.4320    2.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3990    2.6260   -1.4870 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4790   -0.7170    2.4900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1200    0.1800    0.3490 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5950   -3.1360   -2.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7030   -1.3430   -3.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1020    0.3230    2.2130 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4640   -0.2500    1.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1240   -2.6030   -3.3660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6190    2.6180   -1.4160 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3710    3.2800    1.5970 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3800    3.4310   -2.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  1
  4  9  2  0
  4 10  1  0
  5 11  2  0
  5 12  1  0
  6 13  1  0
  6 14  1  1
  7 15  1  0
  8 24  1  0
  9 16  1  0
 10 17  2  0
 11 18  1  0
 12 19  2  0
 13 20  1  0
 15 23  2  0
 15 25  1  0
 16 21  2  0
 17 21  1  0
 18 22  2  0
 19 22  1  0
M  END
>  <Name>  (303) 
nor-LAAM

>  <InChIKey>  (303) 
VWCUGCYZZGRKEE-DYESRHJHSA-N

>  <PubChem_CID>  (303) 
6101785

>  <CYP1A2>  (303) 


>  <CYP2A6>  (303) 


>  <CYP2B6>  (303) 
<11,12;Cleavage;R1>
<12,H;Oxidation;R1>

>  <CYP2C8>  (303) 


>  <CYP2C9>  (303) 


>  <CYP2C19>  (303) 


>  <CYP2D6>  (303) 


>  <CYP2E1>  (303) 


>  <CYP3A4>  (303) 
<11,12;Cleavage;R1>
<12,H;Oxidation;R1>

>  <References>  (303) 
Neff JA, Moody DE: Differential N-demethylation of l-alpha-acetylmethadol (LAAM) and norLAAM by cytochrome P450s 2B6, 2C18, and 3A4. Biochem Biophys Res Commun. 2001 Jun 15;284(3):751-6. doi: 10.1006/bbrc.2001.5054. (PMID: 11396966)

>  <Comments>  (303) 


$$$$
CC02146
     RDKit          3D

 20 22  0  0  0  0  0  0  0  0999 V2000
    8.1390   -1.6600    0.6620 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6470   -0.4700   -0.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3410   -1.1850    0.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6300    1.0160    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8020   -1.1750    0.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1370   -0.5670   -0.5880 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4310   -2.6690   -0.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8840    1.8230   -0.9710 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2340    1.3220    1.4830 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1920   -0.7830   -0.0090 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.8420   -1.2710   -0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1630   -3.4200    0.1250 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8570    3.3010   -0.6780 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2120    2.7960    1.8000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8980   -2.7740   -0.3800 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5510    3.6600    0.7550 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5110    0.6790    0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9290    1.0350   -0.1700 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4850   -1.4000    0.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9180    0.0350    0.3800 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  1  0
  1 19  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  3  6  1  0
  3  7  1  0
  4  8  1  0
  4  9  1  0
 10  5  1  1
  6 11  1  0
  7 12  1  0
  8 13  1  0
  9 14  1  0
 10 17  1  0
 11 15  1  0
 12 15  1  0
 13 16  1  0
 14 16  1  0
 17 18  1  0
 18 20  1  0
 19 20  1  0
M  END
>  <Name>  (304) 
Perhexiline

>  <InChIKey>  (304) 
CYXKNKQEMFBLER-GOSISDBHSA-N

>  <PubChem_CID>  (304) 
38988177

>  <CYP1A2>  (304) 


>  <CYP2A6>  (304) 


>  <CYP2B6>  (304) 
<15,H;Hydroxylation;R1>
<0,H;hydroxylation;R2>

>  <CYP2C8>  (304) 


>  <CYP2C9>  (304) 


>  <CYP2C19>  (304) 


>  <CYP2D6>  (304) 
<15,H;Hydroxylation;R1>
<0,H;hydroxylation;R2>

>  <CYP2E1>  (304) 


>  <CYP3A4>  (304) 
<15,H;Hydroxylation;R1>
<0,H;hydroxylation;R2>

>  <References>  (304) 
Davies BJ, Coller JK, Somogyi AA, Milne RW, Sallustio BC: CYP2B6, CYP2D6, and CYP3A4 catalyze the primary oxidative metabolism of perhexiline enantiomers by human liver microsomes. Drug Metab Dispos. 2007 Jan;35(1):128-38. doi: 10.1124/dmd.106.012252. Epub 2006  Oct 18. (PMID: 17050648)

>  <Comments>  (304) 
This molecule has the cis-trans problem. Need to confirm.

$$$$
CC02147
     RDKit          3D

 26 27  0  0  0  0  0  0  0  0999 V2000
   -0.5280   -0.2200   -0.7970 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.3570   -1.6160   -0.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0140   -1.8050    1.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1710   -3.0850    1.5600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0420   -4.1770    0.7390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4140   -3.9880   -0.5790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5770   -2.7080   -1.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9030    0.2890   -0.4480 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5280    0.6990   -0.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7990    0.5180   -1.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2640    0.5310    0.9640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1460    1.0180   -1.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4540    0.3190    1.8430 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6120    1.0300    1.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9580    1.2250   -1.9540 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5060    1.2650    0.3360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8800    1.7750    0.6850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9800    1.2770    2.7460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4320    0.2660   -2.8570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9240    0.1820   -0.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9800    1.1010    0.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3760    0.5840   -0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4320    1.5030    0.3420 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8070    0.9940   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8960    1.6470    0.4290 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9290   -0.0030   -0.6800 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  8  1  0
  1  9  1  1
  2  3  2  0
  2  7  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  8 10  2  0
  8 11  1  0
  9 20  1  0
 10 12  1  0
 10 19  1  0
 11 13  2  0
 11 14  1  0
 12 15  2  0
 12 16  1  0
 14 16  2  0
 14 18  1  0
 16 17  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  2  0
M  END
>  <Name>  (305) 
Seratrodast

>  <InChIKey>  (305) 
ZBVKEHDGYSLCCC-SFHVURJKSA-N

>  <PubChem_CID>  (305) 
73346713

>  <CYP1A2>  (305) 


>  <CYP2A6>  (305) 


>  <CYP2B6>  (305) 
<0,H;Hyrxoylation;R1>

>  <CYP2C8>  (305) 
<19,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>

>  <CYP2C9>  (305) 
<19,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>

>  <CYP2C19>  (305) 
<19,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>

>  <CYP2D6>  (305) 


>  <CYP2E1>  (305) 


>  <CYP3A4>  (305) 
<0,H;Hyroxylation;R1>

>  <References>  (305) 
Kumar GN, Dubberke E, Rodrigues AD, Roberts E, Dennisen JF: Identification of cytochromes P450 involved in the human liver microsomal metabolism of the thromboxane A2 inhibitor seratrodast (ABT-001). Drug Metab Dispos. 1997 Jan;25(1):110-5. (PMID: 9010637)

>  <Comments>  (305) 


$$$$
CC02148
     RDKit          3D

 19 20  0  0  0  0  0  0  0  0999 V2000
    5.9900   -4.5060    0.7070 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.5330    3.3040    0.8270 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0530    1.5120   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3050    2.0940   -1.4470 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2200    2.4020    0.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6790    1.8860    0.5440 C   0  0  2  0  0  0  0  0  0  0  0  0
    6.6230    2.7000   -0.9690 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3030   -0.0540    0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5760    1.1530   -0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2240    1.0640    0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5990   -0.6080    1.4090 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2330   -0.9560   -0.9250 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9520    4.0300   -0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6980    3.4890    1.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4550   -0.0700   -0.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4110    2.3220    0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8120   -1.9740    1.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4430   -2.3250   -0.7650 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7320   -2.8240    0.4970 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 19  1  0
  2  6  1  0
  2 13  1  0
  2 14  1  0
  3  4  1  0
  3  5  1  0
  3  6  1  0
  3  8  1  0
  4  7  1  0
  5  7  1  0
  6  9  1  6
  8 11  2  0
  8 12  1  0
  9 10  1  0
 10 15  1  0
 10 16  1  0
 11 17  1  0
 12 18  2  0
 17 19  2  0
 18 19  1  0
M  END
>  <Name>  (306) 
Sibutramine

>  <InChIKey>  (306) 
UNAANXDKBXWMLN-INIZCTEOSA-N

>  <PubChem_CID>  (306) 
937011

>  <CYP1A2>  (306) 


>  <CYP2A6>  (306) 


>  <CYP2B6>  (306) 
<5,6;Cleavage;R1>
<6,H;Oxidation;R1>
<5,7;Cleavage;R2>
<7,H;Oxidation;R2>

>  <CYP2C8>  (306) 


>  <CYP2C9>  (306) 


>  <CYP2C19>  (306) 
<5,6;Cleavage;R1>
<6,H;Oxidation;R1>
<5,7;Cleavage;R2>
<7,H;Oxidation;R2>

>  <CYP2D6>  (306) 


>  <CYP2E1>  (306) 


>  <CYP3A4>  (306) 
<5,6;Cleavage;R1>
<6,H;Oxidation;R1>
<5,7;Cleavage;R2>
<7,H;Oxidation;R2>

>  <References>  (306) 
Bae SK, Cao S, Seo KA, Kim H, Kim MJ, Shon JH, Liu KH, Zhou HH, Shin JG: Cytochrome P450 2B6 catalyzes the formation of pharmacologically active sibutramine (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine) metabolites in human liver microsomes. Drug Metab Dispos. 2008 Aug;36(8):1679-88. doi: 10.1124/dmd.108.020727. Epub 2008 May 12. (PMID: 18474675)

>  <Comments>  (306) 


$$$$
CC02149
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.0220    1.7580    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.1670    2.4640    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    2.4310    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0240   -0.5080    1.5800 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2600   -0.4040   -0.5140 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2650   -0.3700   -0.5380 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1520    3.8450    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2520    3.8120    0.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0580   -0.2500    2.4030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0590    4.5240    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1660   -0.9020    3.5510 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9590    0.6460    2.0270 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0780    5.9210    0.0360 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1880   -0.6800    4.3620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0040    0.9160    2.7900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1520    0.2480    3.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  2  7  2  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  8 11  2  0
  9 11  1  0
 10 12  2  0
 10 13  1  0
 11 14  1  0
 12 15  1  0
 13 16  2  0
 15 17  2  0
 16 17  1  0
M  END
>  <Name>  (307) 
Sulfadiazine

>  <InChIKey>  (307) 
SEEPANYCNGTZFQ-UHFFFAOYSA-N

>  <PubChem_CID>  (307) 
5215

>  <CYP1A2>  (307) 


>  <CYP2A6>  (307) 


>  <CYP2B6>  (307) 
<0,H;Hydroxylation;R1>

>  <CYP2C8>  (307) 
<0,H;Hydroxylation;R1>

>  <CYP2C9>  (307) 
<0,H;Hydroxylation;R1>

>  <CYP2C19>  (307) 
<0,H;Hydroxylation;R1>

>  <CYP2D6>  (307) 


>  <CYP2E1>  (307) 


>  <CYP3A4>  (307) 


>  <References>  (307) 
Winter HR, Unadkat JD: Identification of cytochrome P450 and arylamine N-acetyltransferase isoforms involved in sulfadiazine metabolism. Drug Metab Dispos. 2005 Jul;33(7):969-76. doi: 10.1124/dmd.104.002998. Epub 2005  Apr 20. (PMID: 15843491)

>  <Comments>  (307) 


$$$$
CC02150
     RDKit          3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    1.6630   -2.6700    0.2830 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3140   -1.4670    0.5410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7300   -0.2280    0.2300 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4280   -0.2230   -0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2190   -1.4360   -0.5710 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4020   -2.6470   -0.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4120   -4.1160   -0.6280 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.3740    1.0220   -0.4940 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5000    0.9360    0.4770 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5320    0.8610    1.4870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9860    3.1640    0.1430 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3710    2.1510   -0.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4820    2.0860   -1.4310 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.8650    3.0470   -2.3900 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0920    2.1140   -1.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8020    1.0430   -0.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2560    0.2150    0.9680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6800    1.9440   -0.6640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5870    0.2750    1.3760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0110    2.0020   -0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4630    1.1660    0.7620 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  3  9  1  0
  4  5  1  0
  4  8  1  0
  5  6  2  0
  6  7  1  0
  8 15  2  0
  8 16  1  0
  9 10  1  0
  9 12  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  6
 13 15  1  0
 16 17  2  0
 16 18  1  0
 17 19  1  0
 18 20  2  0
 19 21  2  0
 20 21  1  0
M  END
>  <Name>  (308) 
Temazepam

>  <InChIKey>  (308) 
SEQDDYPDSLOBDC-HNNXBMFYSA-N

>  <PubChem_CID>  (308) 
12325869

>  <CYP1A2>  (308) 


>  <CYP2A6>  (308) 


>  <CYP2B6>  (308) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C8>  (308) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C9>  (308) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (308) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2D6>  (308) 


>  <CYP2E1>  (308) 


>  <CYP3A4>  (308) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (308) 
Yang TJ, Shou M, Korzekwa KR, Gonzalez FJ, Gelboin HV, Yang SK: Role of cDNA-expressed human cytochromes P450 in the metabolism of diazepam. Biochem Pharmacol. 1998 Mar 15;55(6):889-96. doi: 10.1016/s0006-2952(97)00558-3. (PMID: 9586962)
Ono S, Hatanaka T, Miyazawa S, Tsutsui M, Aoyama T, Gonzalez FJ, Satoh T: Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19 and the 3A subfamily. Xenobiotica. 1996 Nov;26(11):1155-66. doi: 10.3109/00498259609050260. (PMID: 8948091)

>  <Comments>  (308) 


$$$$
CC02151
     RDKit          3D

 21 24  0  0  0  0  0  0  0  0999 V2000
   -3.5280    1.3340   -0.9110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3400    0.1210   -0.5010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5710   -1.0820   -0.1520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3200   -0.9440    0.2820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6470    0.3790    0.4750 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.4960    1.5930    0.1860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5130   -2.1920    0.6000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1990   -2.1070   -0.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5230   -0.8000    0.1460 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.3310    0.3990   -0.3040 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.8450   -0.7340   -0.5950 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.5640    0.5620   -0.1340 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.7910    1.7330   -0.7110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3880    1.7220   -0.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660   -1.8200   -0.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2170   -1.1780   -0.6520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9910    0.3710   -0.6380 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.2740    0.4660    1.9560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5600    0.6420    1.3940 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9180    1.0060    0.2450 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5530    0.1410   -0.4630 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  2 21  2  0
  3  4  2  0
  4  5  1  0
  4  7  1  0
  5  6  1  0
  5 10  1  0
  5 18  1  1
  7  8  1  0
  9  8  1  6
  9 10  1  0
  9 11  1  0
 10 14  1  1
 11 12  1  0
 11 15  1  1
 12 13  1  0
 12 17  1  0
 12 19  1  1
 13 14  1  0
 15 16  1  0
 16 17  1  0
 17 20  1  1
M  END
>  <Name>  (309) 
Testosterone

>  <InChIKey>  (309) 
MUMGGOZAMZWBJJ-DYKIIFRCSA-N

>  <PubChem_CID>  (309) 
6013

>  <CYP1A2>  (309) 


>  <CYP2A6>  (309) 


>  <CYP2B6>  (309) 
<18,H;Hydroxylation;R1>

>  <CYP2C8>  (309) 


>  <CYP2C9>  (309) 
<12,H;Hydroxylation;R1>
<7,H;Hydroxylation;R2>
<17,H;Hydroxylation;R3>
<18,H;Hydroxylation;R4>
<19,20;Oxidation;R5>

>  <CYP2C19>  (309) 
<12,H;Hydroxylation;R1>
<7,H;Hydroxylation;R2>
<17,H;Hydroxylation;R3>
<18,H;Hydroxylation;R4>
<19,20;Oxidation;R5>

>  <CYP2D6>  (309) 


>  <CYP2E1>  (309) 


>  <CYP3A4>  (309) 
<12,H;Hydroxylation;R1>
<7,H;Hydroxylation;R2>
<17,H;Hydroxylation;R3>
<18,H;Hydroxylation;R4>
<19,20;Oxidation;R5>

>  <References>  (309) 
Imaoka S, Yamada T, Hiroi T, Hayashi K, Sakaki T, Yabusaki Y, Funae Y: Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Systematic characterization and comparison with those of the rat. Biochem Pharmacol. 1996 Apr 26;51(8):1041-50. doi: 10.1016/0006-2952(96)00052-4. (PMID: 8866826)
Yamazaki H, Shimada T: Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Arch Biochem Biophys. 1997 Oct 1;346(1):161-9. doi: 10.1006/abbi.1997.0302. (PMID: 9328296)

>  <Comments>  (309) 


$$$$
CC02153
     RDKit          3D

 19 20  0  0  0  0  0  0  0  0999 V2000
   -1.9880   -1.1680    1.5490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1420   -0.8650    0.8520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1050    0.0640   -0.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9090    0.6850   -0.5060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7580    0.3790    0.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7990   -0.5430    1.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2380    0.3630   -0.8660 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2850   -0.4290   -0.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5420    1.0540   -0.1620 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.6910    2.3380    0.6580 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0100    3.0230    0.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1750    2.0820    0.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0260    0.7980   -0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7070    0.1130    0.1490 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.5460    1.3750   -1.5540 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5580   -1.1710   -0.6710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6770   -2.0750   -0.3730 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5270   -2.4830    1.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4750   -3.2800   -1.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  3  7  1  0
  4  5  1  0
  5  6  2  0
  5  9  1  0
  7  8  1  0
  9 10  1  0
  9 14  1  0
  9 15  1  6
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 16  1  6
 16 17  1  0
 17 18  1  0
 17 19  1  0
M  END
>  <Name>  (310) 
Tramadol

>  <InChIKey>  (310) 
TVYLLZQTGLZFBW-ZBFHGGJFSA-N

>  <PubChem_CID>  (310) 
33741

>  <CYP1A2>  (310) 
<15,17;Cleavage;R1>
<17,H;Oxidation;R1>
<15,16;Cleavage;R2>
<16,H;Oxidation;R2>

>  <CYP2A6>  (310) 


>  <CYP2B6>  (310) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<15,17;Cleavage;R2>
<17,H;Oxidation;R2>
<15,16;Cleavage;R3>
<16,H;Oxidation;R3>

>  <CYP2C8>  (310) 


>  <CYP2C9>  (310) 
<15,17;Cleavage;R1>
<17,H;Oxidation;R1>
<15,16;Cleavage;R2>
<16,H;Oxidation;R2>

>  <CYP2C19>  (310) 
<15,17;Cleavage;R1>
<17,H;Oxidation;R1>
<15,16;Cleavage;R2>
<16,H;Oxidation;R2>

>  <CYP2D6>  (310) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<15,17;Cleavage;R2>
<17,H;Oxidation;R2>
<15,16;Cleavage;R3>
<16,H;Oxidation;R3>

>  <CYP2E1>  (310) 


>  <CYP3A4>  (310) 
<15,17;Cleavage;R1>
<17,H;Oxidation;R1>
<15,16;Cleavage;R2>
<16,H;Oxidation;R2>

>  <References>  (310) 
Zhou SF: Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin Pharmacokinet. 2009;48(12):761-804. doi: 10.2165/11318070-000000000-00000. (PMID: 19902987)
Subrahmanyam V, Renwick AB, Walters DG, Young PJ, Price RJ, Tonelli AP, Lake BG: Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes. Drug Metab Dispos. 2001 Aug;29(8):1146-55. (PMID: 11454734)

>  <Comments>  (310) 


$$$$
CC02154
     RDKit          3D

 17 17  0  0  0  0  0  0  0  0999 V2000
   -0.0370    1.4630    0.0150 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0500   -0.0020    0.1260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3740    1.8750    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6370    1.8390   -1.5110 P   0  0  1  0  0  0  0  0  0  0  0  0
   -0.4990   -0.4030    1.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7870    2.2380    1.4550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0510    1.4100   -1.6060 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5360    3.5010   -1.7630 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2320    1.0780   -2.6340 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5160   -2.2010    1.6670 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.4700    2.8860    1.4470 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.5230    4.1240   -0.8710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9960    3.7420   -3.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3030    1.4600   -3.9010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9810    5.4630   -0.3660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1200    2.9620   -4.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1920    6.2270    0.7280 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  4  1  1  1
  2  5  1  0
  3  6  1  0
  4  7  2  0
  4  8  1  0
  4  9  1  0
  5 10  1  0
  6 11  1  0
  8 12  1  0
  8 13  1  0
  9 14  1  0
 12 15  1  0
 13 16  1  0
 14 16  1  0
 15 17  1  0
M  END
>  <Name>  (311) 
Trofosfamide

>  <InChIKey>  (311) 
UMKFEPPTGMDVMI-QGZVFWFLSA-N

>  <PubChem_CID>  (311) 
9576167

>  <CYP1A2>  (311) 


>  <CYP2A6>  (311) 
<12,H;Hydroxylation;R1>

>  <CYP2B6>  (311) 
<13,14;Cleavage;R1>
<14,H;Oxidation;R1>
<12,H;Hydroxylation;R2>

>  <CYP2C8>  (311) 


>  <CYP2C9>  (311) 
<12,H;Hydroxylation;R1>

>  <CYP2C19>  (311) 


>  <CYP2D6>  (311) 


>  <CYP2E1>  (311) 


>  <CYP3A4>  (311) 
<2,3;Cleavage;R1>
<3,H;Oxidation;R1>
<2,6;Cleavage;R2>
<6,H;Oxidation;R2>
<13,14;Cleavage;R3>
<14,H;Oxidation;R3>
<12,H;Hydroxylation;R4>

>  <References>  (311) 
May-Manke A, Kroemer H, Hempel G, Bohnenstengel F, Hohenlochter B, Blaschke G, Boos J: Investigation of the major human hepatic cytochrome P450 involved in 4-hydroxylation and N-dechloroethylation of trofosfamide. Cancer Chemother Pharmacol. 1999;44(4):327-34. doi: 10.1007/s002800050985. (PMID: 10447581)
Zhang J, Tian Q, Yung Chan S, Chuen Li S, Zhou S, Duan W, Zhu YZ: Metabolism and transport of oxazaphosphorines and the clinical implications. Drug Metab Rev. 2005;37(4):611-703. doi: 10.1080/03602530500364023. (PMID: 16393888)

>  <Comments>  (311) 


$$$$
CC02155
     RDKit          3D

 24 26  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.5000    0.0100 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4360    2.0000   -0.0010 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.6910    2.0490    1.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1470   -0.7030   -0.3350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1600   -0.6860    0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1680    1.2140   -1.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4110    3.4960   -0.3080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4710    3.5360    1.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3290   -0.1290   -0.6560 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1050   -2.1010   -0.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1880   -2.0710    0.3360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2770    0.0100    0.6800 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3510    1.2430   -2.3800 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5410    1.8420   -1.3350 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4540    4.1740    0.6360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3330    4.3220    2.2130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0500   -2.7740   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0720   -4.2810   -0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3300   -4.8110    1.3520 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3080   -6.3400    1.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7100   -6.8700    2.7150 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6880   -8.4000    2.7000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1950    3.7720    2.8670 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  1
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  6
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  6 13  1  0
  7 10  1  0
  7 14  1  0
  7 15  1  0
  8 16  1  0
  9 16  2  0
  9 17  1  0
 11 18  2  0
 12 18  1  0
 17 24  2  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
M  END
>  <Name>  (312) 
11-Oxo-delta8-tetrahydrocannabinol

>  <InChIKey>  (312) 
BGIBNWZALWRTHR-IRXDYDNUSA-N

>  <PubChem_CID>  (312) 


>  <CYP1A2>  (312) 


>  <CYP2A6>  (312) 


>  <CYP2B6>  (312) 


>  <CYP2C8>  (312) 
<20,H;Hydroxylation;R1>

>  <CYP2C9>  (312) 
<20,H;Hydroxylation;R1>

>  <CYP2C19>  (312) 
<20,H;Hydroxylation;R1>

>  <CYP2D6>  (312) 


>  <CYP2E1>  (312) 


>  <CYP3A4>  (312) 
<20,H;Hydroxylation;R1>

>  <References>  (312) 
Watanabe K, Matsunaga T, Kimura T, Funahashi T, Funae Y, Ohshima T, Yamamoto I: Major cytochrome P450 enzymes responsible for microsomal aldehyde oxygenation of 11-oxo-Delta8-tetrahydrocannabinol and 9-anthraldehyde in human liver. Drug Metab Pharmacokinet. 2002;17(6):516-21. (PMID: 15618706)

>  <Comments>  (312) 


$$$$
CC02156
     RDKit          3D

 27 31  0  0  0  0  0  0  0  0999 V2000
   -3.2880    0.9370    1.7660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4880    0.4640    1.2300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5180   -0.2420    0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3420   -0.5010   -0.6760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1180   -0.0350   -0.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1220    0.6690    1.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8230    0.9990    1.3160 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0170    0.5440    0.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7640   -0.1130   -0.5980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2540   -0.7860   -1.8170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8650   -1.7540   -1.4810 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1510   -1.2020   -1.0920 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2180    0.2610   -0.9150 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.5050    0.7680    0.3710 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.7100    0.5990   -0.7700 C   0  0  1  0  0  0  0  0  0  0  0  0
    4.3150   -0.1660    0.4050 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2160   -0.9390    1.1360 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.1230    0.0390    1.5700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6020   -1.9010    0.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4950    0.4220   -2.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9450    0.7980   -1.8670 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6060    0.6120   -3.1060 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9640    0.9680   -2.9070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7450    2.2730    0.5210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0400    2.8240    1.5760 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5480    2.9220   -0.6620 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7330    4.3280   -0.5260 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  9  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 14  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 13 12  1  1
 12 19  1  0
 13 14  1  0
 13 15  1  0
 14 18  1  0
 14 24  1  1
 15 16  1  0
 15 20  1  6
 17 16  1  6
 17 18  1  0
 17 19  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
M  END
>  <Name>  (313) 
18-Methoxycoronaridine

>  <InChIKey>  (313) 
DTJQBBHYRQYDEG-RLHIPHHXSA-N

>  <PubChem_CID>  (313) 
76957258

>  <CYP1A2>  (313) 


>  <CYP2A6>  (313) 


>  <CYP2B6>  (313) 


>  <CYP2C8>  (313) 


>  <CYP2C9>  (313) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (313) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2D6>  (313) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (313) 


>  <CYP3A4>  (313) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (313) 
Zhang W, Ramamoorthy Y, Tyndale RF, Glick SD, Maisonneuve IM, Kuehne ME, Sellers EM: Metabolism of 18-methoxycoronaridine, an ibogaine analog, to 18-hydroxycoronaridine by genetically variable CYP2C19. Drug Metab Dispos. 2002 Jun;30(6):663-9. doi: 10.1124/dmd.30.6.663. (PMID: 12019193)

>  <Comments>  (313) 


$$$$
CC02157
     RDKit          3D

 34 37  0  0  0  0  0  0  0  0999 V2000
    0.3180    1.2770    0.7540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0850   -0.0920    0.6030 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6670    1.5200    0.4870 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7280    2.1520    1.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3080   -0.6960    0.2180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2120   -0.6000    0.8230 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2560    0.3050    0.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3290    2.7740    0.5330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0030    1.6260    1.2950 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5230   -2.1410   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2490    0.2650    1.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6910    0.1810   -0.2030 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7910    4.0030    1.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4480    2.8530    0.0360 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3300   -2.5070   -1.4980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4720   -0.3190    1.3660 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7750    5.1760    0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3840    4.0010    2.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4670   -2.0390   -2.2340 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4570    0.6510    1.7030 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3140    6.3550    0.9650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9230    5.1820    3.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8870    6.3500    2.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3180    7.8040    3.0020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.2320   -3.4820   -1.8710 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2100   -4.0020   -3.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2770   -5.0570   -3.4240 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.9450   -6.2280   -2.6900 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4320   -5.4180   -4.8660 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7180   -5.4960   -5.4030 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9030   -5.8370   -6.7410 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8020   -6.1050   -7.5500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5160   -6.0320   -7.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3320   -5.6910   -5.6840 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5  7  2  0
  5 10  1  0
  6 11  1  0
  7 12  1  0
  8 13  1  0
  8 14  2  0
  9 11  2  0
 10 15  1  0
 11 16  1  0
 13 17  2  0
 13 18  1  0
 15 19  2  0
 15 25  1  0
 16 20  1  0
 17 21  1  0
 18 22  2  0
 21 23  2  0
 22 23  1  0
 23 24  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  1
 27 29  1  0
 29 30  2  0
 29 34  1  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
M  END
>  <Name>  (314) 
2'-Hydroxy-indomethacin-phenethylamide

>  <InChIKey>  (314) 
AOIQKSHKQIJFMK-RUZDIDTESA-N

>  <PubChem_CID>  (314) 
44274898

>  <CYP1A2>  (314) 


>  <CYP2A6>  (314) 


>  <CYP2B6>  (314) 


>  <CYP2C8>  (314) 


>  <CYP2C9>  (314) 


>  <CYP2C19>  (314) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2D6>  (314) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (314) 


>  <CYP3A4>  (314) 
<14,15;Oxidation;R1>

>  <References>  (314) 
Remmel RP, Crews BC, Kozak KR, Kalgutkar AS, Marnett LJ: Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites. Drug Metab Dispos. 2004 Jan;32(1):113-22. doi: 10.1124/dmd.32.1.113. (PMID: 14709628)

>  <Comments>  (314) 


$$$$
CC02158
     RDKit          3D

 14 15  0  0  0  0  0  0  0  0999 V2000
    3.6460    1.5170   -0.2780 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3900   -0.5550    0.7080 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1710   -0.8120    0.6290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9040    0.1500   -0.4250 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.8060   -0.3220   -1.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6610    1.5440    0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5700   -0.4110   -0.7820 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4230    0.6940   -0.8410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8240    2.0580    0.9260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0110   -1.6200   -0.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6900    0.5540   -0.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1130   -0.6270    0.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2980   -1.7380    0.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7170    0.8090    0.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 11  1  0
  1 14  1  0
  2 12  1  0
  2 14  1  0
  4  3  1  1
  4  5  1  0
  4  6  1  0
  5  7  1  0
  6  9  1  0
  7  8  1  0
  7 10  2  0
  8 11  2  0
 10 13  1  0
 11 12  1  0
 12 13  2  0
M  END
>  <Name>  (315) 
BDB

>  <InChIKey>  (315) 
VHMRXGAIDDCGDU-VIFPVBQESA-N

>  <PubChem_CID>  (315) 
54579998

>  <CYP1A2>  (315) 


>  <CYP2A6>  (315) 


>  <CYP2B6>  (315) 


>  <CYP2C8>  (315) 


>  <CYP2C9>  (315) 


>  <CYP2C19>  (315) 
<12,13;Cleavage;R1>
<11,12;Cleavage;R1>
<12,H;Oxidation;R1>

>  <CYP2D6>  (315) 
<12,13;Cleavage;R1>
<11,12;Cleavage;R1>
<12,H;Oxidation;R1>

>  <CYP2E1>  (315) 


>  <CYP3A4>  (315) 
<12,13;Cleavage;R1>
<11,12;Cleavage;R1>
<12,H;Oxidation;R1>

>  <References>  (315) 
Meyer MR, Peters FT, Maurer HH: Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers. Toxicol Lett. 2009 Oct 8;190(1):54-60. doi: 10.1016/j.toxlet.2009.06.866. Epub 2009 Jul 2. (PMID: 19576971)
Maurer HH, Bickeboeller-Friedrich J, Kraemer T, Peters FT: Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy'). Toxicol Lett. 2000 Mar 15;112-113:133-42. (PMID: 10720722)

>  <Comments>  (315) 


$$$$
CC02159
     RDKit          3D

 29 31  0  0  0  0  0  0  0  0999 V2000
   -0.0780    1.4600   -0.6460 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0730    0.0930   -0.4080 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2420   -0.5430   -0.7670 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2700    0.1750   -1.3650 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1240    1.5350   -1.6030 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9570    2.1780   -1.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4210   -0.4550   -1.7170 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4370    0.3430   -2.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3330    2.1450   -0.2680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4740    3.4710    0.0280 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8240    3.6990    0.3250 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4710    2.5660    0.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5680    1.5700   -0.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9470    2.3710    0.4490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5490    3.6100    0.6940 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5260    1.7860   -0.6820 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1370    1.5340    1.5540 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4530    4.4300    0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7660    4.1440    0.6330 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7730    5.0900    0.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5670    6.3200    0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3540    6.6080   -0.5620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6570    5.6660   -0.5650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1340    7.9500   -1.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1870    8.0060   -1.7530 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8540    7.5240    0.0370 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.2650    8.7410    0.4730 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9660    6.9220    0.6860 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3050    7.7600   -1.5390 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  9  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  7  1  0
  5  6  2  0
  7  8  1  0
  9 10  1  0
  9 13  2  0
 10 11  1  0
 10 18  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 14 16  1  0
 14 17  1  0
 18 19  2  0
 18 23  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 26  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 26 27  2  0
 26 28  2  0
 26 29  1  0
M  END
>  <Name>  (316) 
DRF-4367

>  <InChIKey>  (316) 
MVZNVBXATDCMMJ-UHFFFAOYSA-N

>  <PubChem_CID>  (316) 
9802596

>  <CYP1A2>  (316) 


>  <CYP2A6>  (316) 


>  <CYP2B6>  (316) 


>  <CYP2C8>  (316) 


>  <CYP2C9>  (316) 


>  <CYP2C19>  (316) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2D6>  (316) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (316) 


>  <CYP3A4>  (316) 


>  <References>  (316) 
Muzeeb S, Basha SJ, Shashikumar D, Mullangi R, Srinivas NR: Glucuronidation of DRF-6574, hydroxy metabolite of DRF-4367 (a novel COX-2 inhibitor) by pooled human liver, intestinal microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT1A1, 1A3 and 1A8. Eur J Drug Metab Pharmacokinet. 2006 Oct-Dec;31(4):299-309. doi: 10.1007/BF03190471. (PMID: 17315542)

>  <Comments>  (316) 


$$$$
CC02160
     RDKit          3D

 18 20  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3960    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2040   -0.6760   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4000    0.0300   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3890    1.4270   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1890    2.1080    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2970    2.1150    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3110    3.3280    0.0260 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5940    1.3460    0.0220 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.8980    0.8630    1.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6810    2.2180   -0.4420 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9710    1.4960   -0.4540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7830    2.0400   -1.6440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8620    3.0840   -2.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4500    2.6580   -1.8420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6800    1.8720   -0.0220 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6960   -0.3940   -0.0340 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4700    0.7470   -0.4490 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4 17  1  0
  5  6  2  0
  5 16  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  1
  9 11  1  0
 11 12  1  0
 11 15  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 16 18  1  0
 17 18  1  0
M  END
>  <Name>  (317) 
MDPPP

>  <InChIKey>  (317) 
NIYQOTCYXGXMPI-SNVBAGLBSA-N

>  <PubChem_CID>  (317) 
92973653

>  <CYP1A2>  (317) 


>  <CYP2A6>  (317) 


>  <CYP2B6>  (317) 


>  <CYP2C8>  (317) 


>  <CYP2C9>  (317) 


>  <CYP2C19>  (317) 
<10,11;Cleavage;R1>
<11,12;Cleavage;R1>
<11,H;Oxidation;R1>

>  <CYP2D6>  (317) 
<10,11;Cleavage;R1>
<11,12;Cleavage;R1>
<11,H;Oxidation;R1>

>  <CYP2E1>  (317) 


>  <CYP3A4>  (317) 


>  <References>  (317) 
Springer D, Staack RF, Paul LD, Kraemer T, Maurer HH: Identification of cytochrome P450 enzymes involved in the metabolism of 3',4'-methylenedioxy-alpha-pyrrolidinopropiophenone (MDPPP), a designer drug, in human liver microsomes. Xenobiotica. 2005 Mar;35(3):227-37. doi: 10.1080/00498250400028239. (PMID: 16019948)

>  <Comments>  (317) 


$$$$
CC02162
     RDKit          3D

 24 25  0  0  0  0  0  0  0  0999 V2000
   -0.1940    1.6540    0.1420 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.3410    0.1490    0.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9370    2.1420    1.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5070    2.3630    0.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7030   -0.5270    1.3490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1100   -0.5820   -0.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6910    2.9770    2.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2770    1.6930    0.6300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6510    3.1750    1.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6130    2.1490   -0.5470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8260   -1.9150    1.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2370   -1.9710   -1.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5870    3.4620    2.3120 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7420    3.5180    2.9670 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0790    1.4610    1.6910 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5950    1.4850   -0.5310 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9230    3.8790    1.8010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1030    1.9980   -1.7940 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7960    2.1220   -0.2460 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5970   -2.6460    0.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1990   -2.6130    2.5410 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1330    1.7920   -2.7560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3610   -1.9350    3.5650 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3300   -3.8430    2.4800 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  1
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5 11  1  0
  6 12  2  0
  7 13  1  0
  7 14  1  0
  8 15  1  0
  8 16  2  0
  9 13  1  0
  9 17  1  0
 10 18  1  0
 10 19  2  0
 11 20  2  0
 11 21  1  0
 12 20  1  0
 18 22  1  0
 21 23  1  0
 21 24  2  0
M  CHG  2  21   1  23  -1
M  END
>  <Name>  (318) 
MOP-13031

>  <InChIKey>  (318) 
JPXPPUOCSLMCHK-CQSZACIVSA-N

>  <PubChem_CID>  (318) 
748472

>  <CYP1A2>  (318) 


>  <CYP2A6>  (318) 


>  <CYP2B6>  (318) 


>  <CYP2C8>  (318) 


>  <CYP2C9>  (318) 


>  <CYP2C19>  (318) 
<7,H;Oxidation;R1>
<14,H;Reduction;R1>

>  <CYP2D6>  (318) 
<7,H;Oxidation;R1>
<14,H;Reduction;R1>

>  <CYP2E1>  (318) 
<7,H;Oxidation;R1>
<14,H;Reduction;R1>

>  <CYP3A4>  (318) 
<7,H;Oxidation;R1>
<14,H;Reduction;R1>

>  <References>  (318) 
Kudo S, Okumura H, Miyamoto G, Ishizaki T: Cytochrome P-450 isoforms involved in carboxylic acid ester cleavage of Hantzsch pyridine ester of pranidipine. Drug Metab Dispos. 1999 Feb;27(2):303-8. (PMID: 9929520)

>  <Comments>  (318) 
The reaction type is not identified. Is another path (13-7-3-1) possible?

$$$$
CC02163
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0760    1.1000    0.3110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3420    1.6140    1.5770 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3490    2.9660    1.4690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7190    3.7460    2.5590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7240    5.1140    2.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3540    5.7240    1.2510 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0170    4.9340    0.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0180    3.5670    0.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3580    7.1880    1.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6800    7.8710    2.0840 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0400    7.8420   -0.1630 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.5590    7.7640   -0.3290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3790    9.2500   -0.1500 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8580    9.2530   -0.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2950   10.3730   -1.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9780   10.9750   -1.6750 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0440    9.8330   -1.4490 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  8  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  6  9  1  0
  7  8  2  0
  9 10  2  0
  9 11  1  0
 11 12  1  1
 11 13  1  0
 13 14  1  0
 13 17  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
M  END
>  <Name>  (319) 
MOPPP

>  <InChIKey>  (319) 
QJWOQBGBEFNYKB-NSHDSACASA-N

>  <PubChem_CID>  (319) 
66833826

>  <CYP1A2>  (319) 


>  <CYP2A6>  (319) 


>  <CYP2B6>  (319) 


>  <CYP2C8>  (319) 


>  <CYP2C9>  (319) 


>  <CYP2C19>  (319) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2D6>  (319) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (319) 


>  <CYP3A4>  (319) 


>  <References>  (319) 
Springer D, Staack RF, Paul LD, Kraemer T, Maurer HH: Identification of cytochrome P450 enzymes involved in the metabolism of 4'-methoxy-alpha-pyrrolidinopropiophenone (MOPPP), a designer drug, in human liver microsomes. Xenobiotica. 2003 Oct;33(10):989-98. doi: 10.1080/00498250310001602775. (PMID: 14555336)

>  <Comments>  (319) 


$$$$
CC02164
     RDKit          3D

 16 17  0  0  0  0  0  0  0  0999 V2000
   -0.0130    1.0860    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7180    1.5720    1.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0050    1.8050    2.4050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6320    2.2540    3.5420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0130    2.4760    3.5240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7370    2.2380    2.3510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0850    1.7880    1.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7010    2.9550    4.7330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0710    3.1600    5.7490 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1890    3.1920    4.7100 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.9210    1.8580    4.8690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5600    4.0880    5.8130 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0240    4.2790    5.7320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3030    5.7670    6.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9110    6.4050    6.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9620    5.4130    5.5060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  7  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  8  1  0
  6  7  2  0
  8  9  2  0
  8 10  1  0
 10 11  1  1
 10 12  1  0
 12 13  1  0
 12 16  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
M  END
>  <Name>  (320) 
MPPP

>  <InChIKey>  (320) 
APSJUNFBAXIXLK-GFCCVEGCSA-N

>  <PubChem_CID>  (320) 
92973650

>  <CYP1A2>  (320) 


>  <CYP2A6>  (320) 


>  <CYP2B6>  (320) 


>  <CYP2C8>  (320) 


>  <CYP2C9>  (320) 


>  <CYP2C19>  (320) 
<0,H;Hydroxylation;R1>

>  <CYP2D6>  (320) 
<0,H;Hydroxylation;R1>

>  <CYP2E1>  (320) 


>  <CYP3A4>  (320) 


>  <References>  (320) 
Springer D, Paul LD, Staack RF, Kraemer T, Maurer HH: Identification of cytochrome p450 enzymes involved in the metabolism of 4'-methyl-alpha-pyrrolidinopropiophenone, a novel scheduled designer drug, in human liver microsomes. Drug Metab Dispos. 2003 Aug;31(8):979-82. doi: 10.1124/dmd.31.8.979. (PMID: 12867484)

>  <Comments>  (320) 


$$$$
CC02165
     RDKit          3D

 30 33  0  0  0  0  0  0  0  0999 V2000
   -1.0360    1.9600   -0.6460 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2250    0.6530   -0.8320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2020   -0.1780   -1.1030 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0440    0.2400   -1.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2870    1.6240   -1.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1810    2.4580   -0.7190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3860    2.3640   -1.0580 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6820    3.6920   -0.5520 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2090    2.7940   -0.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4060    2.8400    1.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7640    3.8070    1.9380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9650    3.8480    3.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8050    2.9040    3.9140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4530    1.9430    3.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2510    1.8920    1.7710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0090    2.9080    5.2320 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3250    4.7830    4.0160 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8930    1.8690    5.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4500    5.5290    3.1890 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6460    6.2300    3.9940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8990    7.5670    3.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0540    7.6210    2.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1840    6.6390    2.4260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9960    3.6070   -0.7530 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9530    4.7970   -0.6720 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3720    4.2940   -0.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9820    5.5370   -2.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0250   -0.6140   -1.5260 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7260   -2.0320   -1.7310 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0280   -2.7720   -2.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  1  9  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4 28  1  0
  5  6  1  0
  5  7  1  0
  6  8  2  0
  7 24  2  0
  8 24  1  0
  9 10  1  0
 10 11  2  0
 10 15  1  0
 11 12  1  0
 12 13  2  0
 12 17  1  0
 13 14  1  0
 13 16  1  0
 14 15  2  0
 16 18  1  0
 17 19  1  0
 19 20  1  0
 19 23  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 24 25  1  0
 25 26  1  0
 25 27  1  0
 28 29  1  0
 29 30  1  0
M  END
>  <Name>  (321) 
V11294

>  <InChIKey>  (321) 
CGFRGBQJWVFTRF-UHFFFAOYSA-N

>  <PubChem_CID>  (321) 


>  <CYP1A2>  (321) 


>  <CYP2A6>  (321) 


>  <CYP2B6>  (321) 


>  <CYP2C8>  (321) 


>  <CYP2C9>  (321) 
<18,H;Hydroxylation;R1>
<19,H;Hydroxylation;R2>
<25,H;Hydroxylation;R3>
<1,2;Cleavage;R4>
<1,H;Oxidation;R4>

>  <CYP2C19>  (321) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2D6>  (321) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2E1>  (321) 


>  <CYP3A4>  (321) 
<18,H;Hydroxylation;R1>
<19,H;Hydroxylation;R2>
<25,H;Hydroxylation;R3>
<1,2;Cleavage;R4>
<1,H;Oxidation;R4>

>  <References>  (321) 
Subrahmanyam V, Renwick AB, Walters DG, Price RJ, Tonelli AP, Lake BG: Metabolism of a novel phosphodiesterase-IV inhibitor (V11294) by human hepatic cytochrome P450 forms. Xenobiotica. 2002 Jun;32(6):521-34. doi: 10.1080/00498250210128684. (PMID: 12160484)

>  <Comments>  (321) 


$$$$
CC02166
     RDKit          3D

 25 28  0  0  1  0  0  0  0  0999 V2000
    0.6380   -2.6450   -0.4110 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3490   -1.4670   -0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6960   -0.2410   -0.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6920   -0.1980   -0.5250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3980   -1.4050   -0.6430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7350   -2.6110   -0.5920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6240   -4.0940   -0.7470 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.4580    1.0530   -0.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4640    0.9230   -0.3200 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5840    1.1510    0.4160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0020    2.3510    0.1110 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2210    0.2000    1.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2090    2.8870   -0.7510 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2420    2.0600   -1.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0590    2.3010   -1.9310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1580    2.1570   -1.1230 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7330    1.0420    0.2180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9130    0.1510    1.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7550    1.9270   -0.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1030    0.1460    1.9750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9400    1.9130    0.5850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1150    1.0230    1.6300 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2840    0.2570    0.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7860   -1.5350    1.7050 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2050   -0.6370    0.6980 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  3  9  1  0
  4  5  1  0
  4  8  1  0
  5  6  2  0
  6  7  1  0
  8 16  2  0
  8 17  1  0
  9 10  1  0
  9 14  1  0
 10 11  2  0
 10 12  1  0
 11 13  1  0
 12 25  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 17 18  2  0
 17 19  1  0
 18 20  1  0
 19 21  2  0
 20 22  2  0
 21 22  1  0
 23 25  1  0
 24 25  1  0
M  END
>  <Name>  (322) 
Adinazolam

>  <InChIKey>  (322) 
GJSLOMWRLALDCT-UHFFFAOYSA-N

>  <PubChem_CID>  (322) 
37632

>  <CYP1A2>  (322) 


>  <CYP2A6>  (322) 


>  <CYP2B6>  (322) 


>  <CYP2C8>  (322) 


>  <CYP2C9>  (322) 


>  <CYP2C19>  (322) 
<1,2;Cleavage;R1>
<2,H;Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2D6>  (322) 


>  <CYP2E1>  (322) 


>  <CYP3A4>  (322) 
<1,2;Cleavage;R1>
<2,H;Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <References>  (322) 
Venkatakrishnan K, von Moltke LL, Duan SX, Fleishaker JC, Shader RI, Greenblatt DJ: Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man. J Pharm Pharmacol. 1998 Mar;50(3):265-74. doi: 10.1111/j.2042-7158.1998.tb06859.x. (PMID: 9600717)

>  <Comments>  (322) 


$$$$
CC02167
     RDKit          3D

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.9080    1.0280   -0.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2290    1.6490   -0.8980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4320    0.9590   -0.8900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5330   -0.3170   -0.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0440   -1.1280   -0.3600 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.4250   -0.9370    0.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7890   -0.2620    0.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1320    1.7300   -0.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2830    1.1220    0.2100 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6050    1.5960    0.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1640    3.0030   -0.9070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9980    3.5250   -1.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1850    2.8760   -1.4340 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5500    0.7540    0.9200 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8840    1.1400    1.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8530    0.2030    1.7080 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2070   -0.9300    0.8580 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7380   -1.9960    1.6940 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6810   -2.5420    2.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2290   -0.5350   -0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5170   -0.0350    0.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2700    2.3970    0.6110 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5600    2.8160    0.7440 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3540    3.2550    0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0290    2.8480   -0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  7  2  0
  1  8  1  0
  2  3  2  0
  2 13  1  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  8  9  1  0
  8 11  2  0
  9 10  1  0
 10 14  2  0
 10 25  1  0
 11 12  1  0
 12 13  2  0
 14 15  1  0
 15 16  1  0
 15 22  2  0
 16 17  1  0
 17 18  1  0
 17 20  1  0
 18 19  1  0
 20 21  1  0
 22 23  1  0
 22 24  1  0
 24 25  2  0
M  END
>  <Name>  (323) 
Amodiaquine

>  <InChIKey>  (323) 
OVCDSSHSILBFBN-UHFFFAOYSA-N

>  <PubChem_CID>  (323) 
2165

>  <CYP1A2>  (323) 


>  <CYP2A6>  (323) 


>  <CYP2B6>  (323) 


>  <CYP2C8>  (323) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2C9>  (323) 


>  <CYP2C19>  (323) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2D6>  (323) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2E1>  (323) 


>  <CYP3A4>  (323) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <References>  (323) 
Li XQ, Bjorkman A, Andersson TB, Ridderstrom M, Masimirembwa CM: Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate. J Pharmacol Exp Ther. 2002 Feb;300(2):399-407. doi: 10.1124/jpet.300.2.399. (PMID: 11805197)

>  <Comments>  (323) 


$$$$
CC02168
     RDKit          3D

 21 22  0  0  0  0  0  0  0  0999 V2000
    3.9520   -4.1310   -0.8600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9780   -3.2610   -0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1090   -1.8040   -0.5130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1360   -0.9340    0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2610    0.4640   -0.1490 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4990    0.9800    0.4470 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6960    2.4430    0.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5240    3.2730    0.5750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2130    2.6710    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1460    1.1960    0.4610 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.1580    0.6070   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2200    0.0600   -1.0930 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2560    0.6880    0.7650 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4670    0.1410    0.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0850   -0.8610    1.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4540   -1.3610    2.3350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2800   -1.3990    0.6250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8600   -0.9410   -0.5440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2470    0.0570   -1.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0550    0.6040   -0.8440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3900    1.6960   -1.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  6
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 14 20  1  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
M  END
>  <Name>  (324) 
Bupivacaine

>  <InChIKey>  (324) 
LEBVLXFERQHONN-INIZCTEOSA-N

>  <PubChem_CID>  (324) 
92253

>  <CYP1A2>  (324) 


>  <CYP2A6>  (324) 


>  <CYP2B6>  (324) 


>  <CYP2C8>  (324) 


>  <CYP2C9>  (324) 


>  <CYP2C19>  (324) 
<3,4;Cleavage;R1>
<3,H;Oxidation;R1>

>  <CYP2D6>  (324) 
<3,4;Cleavage;R1>
<3,H;Oxidation;R1>

>  <CYP2E1>  (324) 


>  <CYP3A4>  (324) 
<3,4;Cleavage;R1>
<3,H;Oxidation;R1>

>  <References>  (324) 
Gantenbein M, Attolini L, Bruguerolle B, Villard PH, Puyoou F, Durand A, Lacarelle B, Hardwigsen J, Le-Treut YP: Oxidative metabolism of bupivacaine into pipecolylxylidine in humans is mainly catalyzed by CYP3A. Drug Metab Dispos. 2000 Apr;28(4):383-5. (PMID: 10725304)

>  <Comments>  (324) 


$$$$
CC02169
     RDKit          3D

 18 18  0  0  0  0  0  0  0  0999 V2000
   -4.4200    0.8810   -1.7060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8610   -0.3490   -1.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3920   -1.6680   -1.5500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4010   -0.3280   -0.9140 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5940   -0.3780   -1.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9160   -0.4580   -3.2280 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2380   -0.3420   -1.6870 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2800   -0.4140   -0.4930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4210   -0.5670    0.6570 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6440   -0.4040   -0.3920 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4970   -0.1620    0.6960 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1520    0.6690    1.7700 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0250    0.8540    2.8500 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2590    0.2000    2.8710 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6140   -0.6320    1.8100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7400   -0.8100    0.7340 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3830    0.3780    4.1710 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.5170    1.9080    4.1240 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 11 16  1  0
 12 13  1  0
 13 14  2  0
 13 18  1  0
 14 15  1  0
 14 17  1  0
 15 16  2  0
M  END
>  <Name>  (325) 
Chlorproguanil

>  <InChIKey>  (325) 
ISZNZKHCRKXXAU-UHFFFAOYSA-N

>  <PubChem_CID>  (325) 
22323

>  <CYP1A2>  (325) 


>  <CYP2A6>  (325) 


>  <CYP2B6>  (325) 


>  <CYP2C8>  (325) 


>  <CYP2C9>  (325) 


>  <CYP2C19>  (325) 
<1,9;Cyclization;R1>

>  <CYP2D6>  (325) 


>  <CYP2E1>  (325) 


>  <CYP3A4>  (325) 


>  <References>  (325) 
Wright JD, Helsby NA, Ward SA: The role of S-mephenytoin hydroxylase (CYP2C19) in the metabolism of the antimalarial biguanides. Br J Clin Pharmacol. 1995 Apr;39(4):441-4. doi: 10.1111/j.1365-2125.1995.tb04474.x. (PMID: 7640152)
Arfeen M, Patel DS, Abbat S, Taxak N, Bharatam PV: Importance of cytochromes in cyclization reactions: quantum chemical study on a model reaction of proguanil to cycloguanil. J Comput Chem. 2014 Oct 30;35(28):2047-55. doi: 10.1002/jcc.23719. Epub 2014 Sep  5. (PMID: 25196060)

>  <Comments>  (325) 
The reaction type is oxidative cyclization.

$$$$
CC02171
     RDKit          3D

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.6700    1.4030   -0.6410 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4490    0.0870   -0.3760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9200    2.0340   -0.7090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5750    2.0140   -0.8400 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4210   -0.8770   -0.1230 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8980   -0.1150   -0.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1330    3.0610   -1.6190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9460    1.6360    0.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5080    1.1070   -0.7020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9800   -2.4570    0.1060 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.3660    3.6800   -1.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1770    2.2590    0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2660   -3.0280   -1.4010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1950   -3.1790    0.2550 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0810   -2.4290    1.0500 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3880    3.2780   -0.8430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0790   -3.4850   -2.4210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1070   -3.0230   -1.5600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5180   -3.9330   -3.6030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6670   -3.4710   -2.7420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8540   -3.9240   -3.7640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4650   -4.4120   -5.0520 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  6  9  1  0
  7 11  1  0
  8 12  2  0
 10 13  1  0
 10 14  2  0
 10 15  2  0
 11 16  2  0
 12 16  1  0
 13 17  2  0
 13 18  1  0
 17 19  1  0
 18 20  2  0
 19 21  2  0
 20 21  1  0
 21 22  1  0
M  END
>  <Name>  (326) 
Compound 4

>  <InChIKey>  (326) 
VVUQNTKYPPFMID-UHFFFAOYSA-N

>  <PubChem_CID>  (326) 
10245060

>  <CYP1A2>  (326) 


>  <CYP2A6>  (326) 


>  <CYP2B6>  (326) 


>  <CYP2C8>  (326) 
<17,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>

>  <CYP2C9>  (326) 
<0,H;Hydroxylation;R1>

>  <CYP2C19>  (326) 
<17,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>

>  <CYP2D6>  (326) 


>  <CYP2E1>  (326) 


>  <CYP3A4>  (326) 


>  <References>  (326) 
Marques-Soares C, Dijols S, Macherey AC, Wester MR, Johnson EF, Dansette PM, Mansuy D: Sulfaphenazole derivatives as tools for comparing cytochrome P450 2C5 and human cytochromes P450 2Cs: identification of a new high affinity substrate common to those enzymes. Biochemistry. 2003 Jun 3;42(21):6363-9. doi: 10.1021/bi027391+. (PMID: 12767217)

>  <Comments>  (326) 


$$$$
CC02172
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0120   -0.2040   -0.1440 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4160   -0.1580   -0.0980 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1570   -0.1410   -1.2830 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5480   -0.0970   -1.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1860   -0.0760   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4670   -0.0810    1.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0770   -0.1250    1.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9410    0.0090    0.0500 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.5200   -1.6510    0.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3880    0.6040   -1.1950 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3060    0.6170    1.3160 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7210   -2.2800    1.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2010   -3.5860    1.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4830   -4.2510    0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9660   -5.5710    0.1470 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2840   -3.5980   -1.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8040   -2.2910   -1.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  7  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  8  1  0
  6  7  2  0
  8  9  1  0
  8 10  2  0
  8 11  2  0
  9 12  2  0
  9 17  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
M  END
>  <Name>  (327) 
Dapsone

>  <InChIKey>  (327) 
MQJKPEGWNLWLTK-UHFFFAOYSA-N

>  <PubChem_CID>  (327) 
2955

>  <CYP1A2>  (327) 


>  <CYP2A6>  (327) 


>  <CYP2B6>  (327) 


>  <CYP2C8>  (327) 
<0,H;Hydroxylation;R1>
<12,H;Hydroxylation;R2>

>  <CYP2C9>  (327) 
<0,H;Hydroxylation;R1>
<12,H;Hydroxylation;R2>

>  <CYP2C19>  (327) 
<0,H;Hydroxylation;R1>
<12,H;Hydroxylation;R2>

>  <CYP2D6>  (327) 


>  <CYP2E1>  (327) 
<0,H;Hydroxylation;R1>
<12,H;Hydroxylation;R2>

>  <CYP3A4>  (327) 
<0,H;Hydroxylation;R1>
<12,H;Hydroxylation;R2>

>  <References>  (327) 
Mitra AK, Thummel KE, Kalhorn TF, Kharasch ED, Unadkat JD, Slattery JT: Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo. Clin Pharmacol Ther. 1995 Nov;58(5):556-66. doi: 10.1016/0009-9236(95)90176-0. (PMID: 7586950)
Winter HR, Wang Y, Unadkat JD: CYP2C8/9 mediate dapsone N-hydroxylation at clinical concentrations of dapsone. Drug Metab Dispos. 2000 Aug;28(8):865-8. (PMID: 10901692)

>  <Comments>  (327) 


$$$$
CC02173
     RDKit          3D

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0070    1.5010    0.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0170    0.0500    0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2320    2.1500   -0.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1580    2.2780    0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2530   -0.5800    0.4840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1190   -0.7720    0.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4910    1.3220   -0.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2650    3.5350   -0.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1210    3.6560   -0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4490    0.0940    0.4960 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3390   -1.9480    0.7610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0370   -2.1410    0.5540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3740   -0.2780    0.0660 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8060    0.9900   -1.6960 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6700    2.0930    0.3140 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0940    4.2860   -0.3790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3810    4.4460   -0.1190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1950   -2.7400    0.7950 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3510   -4.1940    1.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9470   -4.9680    1.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6660   -6.4190    1.4080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9610   -7.1910    1.4270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6800   -8.6420    1.7300 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  6 13  1  0
  7 10  1  0
  7 14  1  0
  7 15  1  0
  8 16  1  0
  9 16  2  0
  9 17  1  0
 11 18  2  0
 12 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
M  END
>  <Name>  (328) 
delta9-Tetrahydrocannabinol

>  <InChIKey>  (328) 
VBGLYOIFKLUMQG-UHFFFAOYSA-N

>  <PubChem_CID>  (328) 
2543

>  <CYP1A2>  (328) 


>  <CYP2A6>  (328) 


>  <CYP2B6>  (328) 


>  <CYP2C8>  (328) 


>  <CYP2C9>  (328) 
<20,H;Hydroxylation;R1>

>  <CYP2C19>  (328) 
<20,H;Hydroxylation;R1>

>  <CYP2D6>  (328) 


>  <CYP2E1>  (328) 


>  <CYP3A4>  (328) 
<19,21;EpOxidation;R1>
<17,H;Hydroxylation;R2>
<18,H;Hydroxylation;R3>
<20,H;Hydroxylation;R4>

>  <References>  (328) 
Bland TM, Haining RL, Tracy TS, Callery PS: CYP2C-catalyzed delta9-tetrahydrocannabinol metabolism: kinetics, pharmacogenetics and interaction with phenytoin. Biochem Pharmacol. 2005 Oct 1;70(7):1096-103. doi: 10.1016/j.bcp.2005.07.007. (PMID: 16112652)
Maurer HH, Sauer C, Theobald DS: Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine. Ther Drug Monit. 2006 Jun;28(3):447-53. doi: 10.1097/01.ftd.0000211812.27558.6e. (PMID: 16778732)
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (328) 
<17,H;Hydroxylation> needs to be confirmed for CYP2C19 and 3A4.

$$$$
CC02174
     RDKit          3D

 29 33  0  0  1  0  0  0  0  0999 V2000
   -1.1430   -4.0100   -0.6950 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0130   -3.0800    1.2170 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9910    2.2260    1.6390 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3870    1.2430   -0.0650 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1380    0.9400    1.6640 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8110    2.2560   -2.2800 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9940    2.4000   -0.7100 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1990   -2.4500    0.4150 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.6110   -2.5410   -1.0400 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.2920   -1.0110    0.9280 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.1000   -2.2810   -1.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6950   -0.4660    0.6170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1050   -3.9130   -1.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5210   -1.0460   -0.3980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1240   -3.1620    0.3880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8300   -0.0820    0.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1550    0.6530    1.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7900   -0.5000   -0.6620 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4030    1.1560    1.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1960    0.5960    0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7600    0.6590   -0.7330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9810    0.0380    1.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0370    0.8540    0.8520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8050    1.5030   -1.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9410    1.6090   -0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2470    2.2740    0.9340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1210   -0.0060    1.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6680    2.1800   -3.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8730    3.6960   -0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 13  1  0
  1 15  1  0
  2 15  2  0
  3 19  1  0
  3 26  1  0
  4 20  1  0
  4 26  1  0
  5 23  1  0
  5 27  1  0
  6 24  1  0
  6 28  1  0
  7 25  1  0
  7 29  1  0
  8  9  1  0
  8 10  1  0
  8 15  1  6
  9 11  1  1
  9 13  1  0
 10 12  1  0
 10 16  1  6
 11 14  1  0
 12 14  2  0
 12 17  1  0
 14 18  1  0
 16 21  2  0
 16 22  1  0
 17 19  2  0
 18 20  2  0
 19 20  1  0
 21 24  1  0
 22 23  2  0
 23 25  1  0
 24 25  2  0
M  END
>  <Name>  (329) 
Deoxypodophyllotoxin

>  <InChIKey>  (329) 
ZGLXUQQMLLIKAN-SVIJTADQSA-N

>  <PubChem_CID>  (329) 
345501

>  <CYP1A2>  (329) 


>  <CYP2A6>  (329) 


>  <CYP2B6>  (329) 


>  <CYP2C8>  (329) 


>  <CYP2C9>  (329) 


>  <CYP2C19>  (329) 
<12,H;Hydroxylation;R1>
<19,20;Cleavage;R2>
<20,21;Cleavage;R2>
<20,H;Oxidation;R2>

>  <CYP2D6>  (329) 


>  <CYP2E1>  (329) 


>  <CYP3A4>  (329) 
<12,H;Hydroxylation;R1>
<19,20;Cleavage;R2>
<20,21;Cleavage;R2>
<20,H;Oxidation;R2>
<24,25;Cleavage;R3>
<25,H;Oxidation;R3>
<27,28;Cleavage;R4>
<28,H;Oxidation;R4>
<0,1;Cleavage;R5>
<0,H;Oxidation;R5>

>  <References>  (329) 
Sang S, Lee MJ, Yang I, Buckley B, Yang CS: Human urinary metabolite profile of tea polyphenols analyzed by liquid chromatography/electrospray ionization tandem mass spectrometry with data-dependent acquisition. Rapid Commun Mass Spectrom. 2008 May;22(10):1567-78. doi: 10.1002/rcm.3546. (PMID: 18433082)

>  <Comments>  (329) 


$$$$
CC02175
     RDKit          3D

 23 26  0  0  0  0  0  0  0  0999 V2000
   -0.2180    1.6240   -0.2270 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.4550    0.0890   -0.2230 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.2700    1.7500   -0.5460 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.1620    2.2310   -1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5030    2.1980    1.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7960   -0.1650    0.4360 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.7650   -0.4140    0.5590 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9220    0.4600    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4720    1.8420   -2.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8190    2.8990    0.1040 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5710    1.8540   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4050    3.7240    1.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8820    0.4180   -0.4850 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.0500   -1.6610    0.6170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6340    1.9150   -3.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5040    2.7700   -0.7290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2330    0.3120    0.2260 C   0  0  2  0  0  0  0  0  0  0  0  0
   -3.3790   -1.8580    1.3560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4730   -1.1230    0.6000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3320    0.8900   -0.6480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5630   -1.7730    0.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6990    0.3550   -0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7120   -1.1620   -0.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  1
  2  6  1  0
  2  7  1  1
  3  8  1  0
  3  9  1  0
  3 10  1  1
  4 11  1  0
  5 12  1  0
  6 13  1  0
  6 14  1  6
  7  8  1  0
  9 15  3  0
 13 11  1  1
 11 16  2  0
 13 17  1  0
 14 18  1  0
 17 19  1  0
 17 20  1  6
 18 19  1  0
 19 21  2  0
 20 22  1  0
 21 23  1  0
 22 23  1  0
M  END
>  <Name>  (330) 
Desogestrel

>  <InChIKey>  (330) 
RPLCPCMSCLEKRS-BPIQYHPVSA-N

>  <PubChem_CID>  (330) 
40973

>  <CYP1A2>  (330) 


>  <CYP2A6>  (330) 


>  <CYP2B6>  (330) 


>  <CYP2C8>  (330) 


>  <CYP2C9>  (330) 
<12,H;Hydroxylation;R1>

>  <CYP2C19>  (330) 
<12,H;Hydroxylation;R1>

>  <CYP2D6>  (330) 


>  <CYP2E1>  (330) 


>  <CYP3A4>  (330) 


>  <References>  (330) 
Gentile DM, Verhoeven CH, Shimada T, Back DJ: The role of CYP2C in the in vitro bioactivation of the contraceptive steroid desogestrel. J Pharmacol Exp Ther. 1998 Dec;287(3):975-82. (PMID: 9864282)

>  <Comments>  (330) 


$$$$
CC02176
     RDKit          3D

 39 44  0  0  0  0  0  0  0  0999 V2000
    1.8040    1.1710   -0.4550 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7010    2.1230   -0.4970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4130    1.9020   -1.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5510    0.6510   -1.9710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5650    0.4200   -2.6210 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5640   -0.3160   -1.9410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6680   -0.0680   -1.2280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6930   -1.0030   -1.2370 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8270   -0.7470   -0.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9810    0.4070    0.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9180    1.4320    0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0420    2.7120    1.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8440   -1.6970   -0.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0320   -1.5010    0.1140 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0930   -2.3630    0.0840 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8780   -3.4050   -0.8630 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1860   -4.0400   -1.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1910   -0.3610    0.8970 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1720    0.5860    0.9610 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9530   -3.5490   -2.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1760   -4.1400   -2.5570 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6320   -5.2240   -1.8100 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8670   -5.7160   -0.7550 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6450   -5.1250   -0.4470 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4800    3.9150    0.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5170    5.0900    1.1860 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1410    5.0720    2.5260 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7210    3.8840    3.1150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6690    2.7130    2.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8890    4.0440   -0.9710 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5000    4.9350   -1.7090 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7760    3.0720   -1.2770 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1990    3.1650   -2.6340 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6870    1.8230   -3.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8370    0.9690   -3.7670 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2840   -0.2880   -4.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5820   -0.6930   -3.8650 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4330    0.1580   -3.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9860    1.4150   -2.7640 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  7  1  0
  1 11  2  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 13  1  0
 10 11  1  0
 10 19  1  0
 11 12  1  0
 12 25  1  0
 12 29  2  0
 13 14  2  0
 14 15  1  0
 14 18  1  0
 15 16  1  0
 16 17  1  0
 17 20  2  0
 17 24  1  0
 18 19  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 25 26  2  0
 25 30  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 30 31  2  0
 30 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  2  0
 34 39  1  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
M  END
>  <Name>  (331) 
Dibenzylfluorescein

>  <InChIKey>  (331) 
YZJGKSLPSGPFEV-UHFFFAOYSA-N

>  <PubChem_CID>  (331) 
371436

>  <CYP1A2>  (331) 


>  <CYP2A6>  (331) 


>  <CYP2B6>  (331) 


>  <CYP2C8>  (331) 
<28,29;Cleavage;R1>
<29,H;Oxidation;R1>

>  <CYP2C9>  (331) 
<28,29;Cleavage;R1>
<29,H;Oxidation;R1>

>  <CYP2C19>  (331) 
<28,29;Cleavage;R1>
<29,H;Oxidation;R1>

>  <CYP2D6>  (331) 


>  <CYP2E1>  (331) 


>  <CYP3A4>  (331) 
<28,29;Cleavage;R1>
<29,H;Oxidation;R1>

>  <References>  (331) 
Donato MT, Jimenez N, Castell JV, Gomez-Lechon MJ: Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes. Drug Metab Dispos. 2004 Jul;32(7):699-706. doi: 10.1124/dmd.32.7.699. (PMID: 15205384)
Stresser DM, Turner SD, Blanchard AP, Miller VP, Crespi CL: Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4. Drug Metab Dispos. 2002 Jul;30(7):845-52. doi: 10.1124/dmd.30.7.845. (PMID: 12065444)

>  <Comments>  (331) 
The hydrolysis reaction breaking <32,30> for CYP3A4, 2C19, 2C9, and 2C8 should not be included because it usually requires hydrolase.

$$$$
CC02177
     RDKit          3D

 26 27  0  0  0  0  0  0  0  0999 V2000
   -0.0200    1.3800    0.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9620    1.6600   -0.8570 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1670    0.9830   -0.8200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3940    0.0270    0.1530 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4180   -0.2550    1.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2120    0.4190    1.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6770    2.8600   -2.0800 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.0120    0.0640    2.2400 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.2400    2.0680    0.0530 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5100    1.4880   -0.0560 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4090    2.4540   -0.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7300    3.6840    0.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3990    3.4200    0.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3790    4.3600    0.2470 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8280    2.2820   -0.1380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9540    2.1470   -0.2110 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4740    5.2800    0.1270 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7080    5.4550    1.9170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3750    6.0800   -0.2870 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4670    5.3830    2.5590 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3040    6.6900    2.1920 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5340    4.4250    2.3820 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.7080   -0.7090    0.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6120   -0.0090    0.9980 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.5100   -1.9900    0.7160 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.2230   -0.8110   -1.1060 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  9  1  0
  2  3  1  0
  2  7  1  0
  3  4  2  0
  4  5  1  0
  4 23  1  0
  5  6  2  0
  6  8  1  0
  9 10  1  0
  9 13  1  0
 10 11  2  0
 11 12  1  0
 11 15  1  0
 12 13  2  0
 12 17  1  0
 13 14  1  0
 15 16  3  0
 17 18  1  1
 17 19  2  0
 18 20  1  0
 18 21  1  0
 18 22  1  0
 23 24  1  0
 23 25  1  0
 23 26  1  0
M  END
>  <Name>  (332) 
Fipronil

>  <InChIKey>  (332) 
ZOCSXAVNDGMNBV-SANMLTNESA-N

>  <PubChem_CID>  (332) 
15278225

>  <CYP1A2>  (332) 


>  <CYP2A6>  (332) 


>  <CYP2B6>  (332) 


>  <CYP2C8>  (332) 


>  <CYP2C9>  (332) 


>  <CYP2C19>  (332) 
<20,S;S-Oxidation;R1>

>  <CYP2D6>  (332) 


>  <CYP2E1>  (332) 


>  <CYP3A4>  (332) 
<20,S;S-Oxidation;R1>

>  <References>  (332) 
Tang J, Amin Usmani K, Hodgson E, Rose RL: In vitro metabolism of fipronil by human and rat cytochrome P450 and its interactions with testosterone and diazepam. Chem Biol Interact. 2004 Apr 15;147(3):319-29. doi: 10.1016/j.cbi.2004.03.002. (PMID: 15135087)

>  <Comments>  (332) 
Xenosite reports 19 as SoM. Need to confirm.

$$$$
CC02178
     RDKit          3D

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.8570    1.5700    0.5800 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.7760    0.0580    0.4800 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.3530    1.9590    0.4410 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.2240    2.3500   -0.5780 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5300   -0.5240    1.6860 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.6860   -0.3890    0.5240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3030    3.4650    0.2000 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.0540    1.5010    1.7060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9610    1.2590   -0.7760 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9510    3.7200   -0.5130 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.5180   -2.0530    1.5910 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.9740   -0.0340    1.7390 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.8860   -0.1310    2.8640 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7640   -1.9120    0.3810 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.4470    3.8900   -0.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3500    4.1670    1.4430 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1160    4.7200    0.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1020   -2.5330    1.4600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2550   -2.6580    2.7370 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2650   -2.4460    0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6860   -0.5620    0.6180 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0890   -2.3340    0.5370 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.9770    4.2330    0.0040 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.2840    3.9900   -1.8820 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4220   -3.4610    2.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7500   -3.5810    3.5390 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9020    4.6720   -1.4890 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3740   -4.0630    3.3290 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5210    5.9490   -1.9150 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0920   -4.9400    4.0320 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  6
  2  5  1  0
  2  6  1  1
  3  7  1  0
  3  8  1  0
  3  9  1  6
  4 10  1  0
  5 11  1  0
  5 12  1  0
  5 13  1  1
  6 14  1  0
  7 10  1  0
  7 15  1  0
  7 16  1  1
  8 12  1  0
 10 17  1  1
 11 18  1  0
 11 19  1  0
 11 20  1  6
 12 21  1  6
 14 18  1  0
 14 22  1  1
 15 23  1  0
 15 24  2  0
 18 25  2  0
 19 26  2  0
 23 27  1  0
 25 28  1  0
 26 28  1  0
 27 29  1  0
 28 30  2  0
M  END
>  <Name>  (333) 
Fluticasone

>  <InChIKey>  (333) 
MGNNYOODZCAHBA-GQKYHHCASA-N

>  <PubChem_CID>  (333) 
5311101

>  <CYP1A2>  (333) 


>  <CYP2A6>  (333) 


>  <CYP2B6>  (333) 


>  <CYP2C8>  (333) 


>  <CYP2C9>  (333) 


>  <CYP2C19>  (333) 
<25,27;Cleavage;R1>

>  <CYP2D6>  (333) 


>  <CYP2E1>  (333) 


>  <CYP3A4>  (333) 
<25,27;Cleavage;R1>

>  <References>  (333) 
Pearce RE, Leeder JS, Kearns GL: Biotransformation of fluticasone: in vitro characterization. Drug Metab Dispos. 2006 Jun;34(6):1035-40. doi: 10.1124/dmd.105.009043. Epub 2006 Mar 24. (PMID: 16565171)

>  <Comments>  (333) 


$$$$
CC02180
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -2.0060    1.3020    1.3230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2140    0.5880    0.2040 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.2830    1.6500   -0.3640 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4340    2.3690    0.3320 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2300    1.7520   -1.7270 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9670    1.0650   -2.6520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7410    1.2400   -3.8480 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9490    0.2270   -2.1530 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2150    0.0200   -0.8010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2000   -0.6250   -0.4260 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8020   -0.4730   -3.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3920   -0.6160    0.7220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7630   -1.0240    0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6010   -2.1720    0.6400 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2030   -2.6670    2.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3100   -2.7470    2.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9530   -1.3790    1.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  2  9  1  0
  2 12  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  8 11  1  0
  9 10  2  0
 12 13  2  0
 12 17  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
M  END
>  <Name>  (334) 
Hexobarbital

>  <InChIKey>  (334) 
UYXAWHWODHRRMR-LBPRGKRZSA-N

>  <PubChem_CID>  (334) 
7036944

>  <CYP1A2>  (334) 


>  <CYP2A6>  (334) 


>  <CYP2B6>  (334) 


>  <CYP2C8>  (334) 


>  <CYP2C9>  (334) 
<11,H;Hydroxylation;R1>

>  <CYP2C19>  (334) 
<11,H;Hydroxylation;R1>

>  <CYP2D6>  (334) 


>  <CYP2E1>  (334) 


>  <CYP3A4>  (334) 


>  <References>  (334) 
Saito K, Dan H, Masuda K, Katsu T, Hanioka N, Yamamoto S, Miyano K, Yamano S, Narimatsu S: Stereoselective hexobarbital 3'-hydroxylation by CYP2C19 expressed in yeast cells and the roles of amino acid residues at positions 300 and 476. Chirality. 2007 Jul;19(7):550-8. doi: 10.1002/chir.20412. (PMID: 17487889)
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (334) 


$$$$
CC02181
     RDKit          3D

 23 27  0  0  0  0  0  0  0  0999 V2000
   -3.0600    2.0040    0.7860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3090    1.4680    0.4390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3930    0.2380   -0.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2460   -0.4810   -0.5830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0110    0.0680   -0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9170    1.2770    0.4460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6110    1.5690    0.7010 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1400    0.5670    0.1700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7020   -0.3760   -0.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5840   -0.2890   -0.5600 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6200   -1.5600   -1.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2630   -1.6020   -1.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9440   -2.3000   -0.5410 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2700   -1.6760   -0.7340 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2180   -0.1980   -0.9310 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.6430    0.5230    0.2770 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.5580    0.5550   -0.7990 C   0  0  1  0  0  0  0  0  0  0  0  0
    4.4300   -0.2850    0.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5090   -0.8770    1.2120 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.1100   -0.2680    1.5180 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1280   -2.0990    0.3810 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3030    0.6970   -2.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6280    1.4410   -1.9140 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  3  4  1  0
  3 10  1  0
  4  5  2  0
  5  6  1  0
  5  9  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
 16  8  1  6
  9 12  1  0
 10 11  1  0
 12 13  1  0
 13 14  1  0
 15 14  1  1
 14 21  1  0
 15 16  1  0
 15 17  1  0
 16 20  1  0
 17 18  1  0
 17 22  1  6
 19 18  1  6
 19 20  1  0
 19 21  1  0
 22 23  1  0
M  END
>  <Name>  (335) 
Ibogaine

>  <InChIKey>  (335) 
HSIBGVUMFOSJPD-NPPSGXECSA-N

>  <PubChem_CID>  (335) 
92223505

>  <CYP1A2>  (335) 


>  <CYP2A6>  (335) 


>  <CYP2B6>  (335) 


>  <CYP2C8>  (335) 


>  <CYP2C9>  (335) 


>  <CYP2C19>  (335) 
<13,14;Cleavage;R1>
<14,H;Oxidation;R1>

>  <CYP2D6>  (335) 
<13,14;Cleavage;R1>
<14,H;Oxidation;R1>

>  <CYP2E1>  (335) 


>  <CYP3A4>  (335) 
<13,14;Cleavage;R1>
<14,H;Oxidation;R1>

>  <References>  (335) 
Obach RS, Pablo J, Mash DC: Cytochrome P4502D6 catalyzes the O-demethylation of the psychoactive alkaloid ibogaine to 12-hydroxyibogamine. Drug Metab Dispos. 1998 Aug;26(8):764-8. (PMID: 9698290)

>  <Comments>  (335) 


$$$$
CC02182
     RDKit          3D

 25 27  0  0  0  0  0  0  0  0999 V2000
   -0.0230    1.3610    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0150   -0.0130   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2480   -0.4620   -0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2780    1.8340    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1260    0.7140   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1290    2.1310    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6850   -1.9040   -0.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8280    3.1100    0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7950    2.4490    1.2980 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8310   -2.3560   -1.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5110    0.8860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5780    2.5630   -1.0240 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6040   -1.5860   -2.3910 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0040    3.1480    1.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2210    2.0460    2.5060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2440   -0.8850   -0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0390    2.1620    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1970    3.2700    0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0440    3.0460    3.6970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2130   -3.6130   -1.7590 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6210    3.4420    2.5020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8480    2.3460    3.6970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8270    3.4200    5.2010 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.3880    2.3370    0.0310 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6220    3.7460    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  1  6  1  0
  2  3  2  0
  2 16  1  0
  3  5  1  0
  3  7  1  0
  4  5  2  0
  4  8  1  0
  5 11  1  0
  6  9  1  0
  6 12  2  0
  7 10  1  0
  8 18  2  0
  9 14  2  0
  9 15  1  0
 10 13  2  0
 10 20  1  0
 11 17  2  0
 14 21  1  0
 15 22  2  0
 17 18  1  0
 17 24  1  0
 19 21  2  0
 19 22  1  0
 19 23  1  0
 24 25  1  0
M  END
>  <Name>  (336) 
Indomethacin

>  <InChIKey>  (336) 
CGIGDMFJXJATDK-UHFFFAOYSA-N

>  <PubChem_CID>  (336) 
3715

>  <CYP1A2>  (336) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2A6>  (336) 


>  <CYP2B6>  (336) 


>  <CYP2C8>  (336) 


>  <CYP2C9>  (336) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (336) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2D6>  (336) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (336) 


>  <CYP3A4>  (336) 


>  <References>  (336) 
Nakajima M, Inoue T, Shimada N, Tokudome S, Yamamoto T, Kuroiwa Y: Cytochrome P450 2C9 catalyzes indomethacin O-demethylation in human liver microsomes. Drug Metab Dispos. 1998 Mar;26(3):261-6. (PMID: 9492390)
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (336) 


$$$$
CC02183
     RDKit          3D

 33 36  0  0  0  0  0  0  0  0999 V2000
   -0.0210    1.4050    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0060    0.0000   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2970    1.8270   -0.0010 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2370    2.0780    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4080   -0.3920   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2070   -0.7110    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1320    0.7360   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7010    3.1130    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4170    1.3670    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9450   -1.8000   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4060   -0.0250    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6370    0.7980   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8260    3.8440    1.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9620    3.6700   -1.0450 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1170   -2.2650   -1.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5790   -0.7120    0.0140 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1400    5.2050    1.2800 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6260    3.1780    2.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8310   -1.5250   -2.3600 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6270    0.2600    0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2550    5.8820    2.4750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7450    3.8670    3.6800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0620    5.2150    3.6740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2100    6.0750    5.1750 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.5880   -3.5020   -1.6950 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7550   -3.9530   -3.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3010   -5.3820   -3.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4730   -5.8470   -4.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6700   -5.6330   -5.1670 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8300   -6.0630   -6.4710 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7920   -6.7090   -7.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5950   -6.9240   -6.4600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4350   -6.4910   -5.1570 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5  7  2  0
  5 10  1  0
  6 11  1  0
  7 12  1  0
  8 13  1  0
  8 14  2  0
  9 11  2  0
 10 15  1  0
 11 16  1  0
 13 17  2  0
 13 18  1  0
 15 19  2  0
 15 25  1  0
 16 20  1  0
 17 21  1  0
 18 22  2  0
 21 23  2  0
 22 23  1  0
 23 24  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 28 33  1  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
M  END
>  <Name>  (337) 
Indomethacin-phenethylamide

>  <InChIKey>  (337) 
VYDBTNADENXYSN-UHFFFAOYSA-N

>  <PubChem_CID>  (337) 
4292

>  <CYP1A2>  (337) 


>  <CYP2A6>  (337) 


>  <CYP2B6>  (337) 


>  <CYP2C8>  (337) 


>  <CYP2C9>  (337) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (337) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<14,H;Hydroxylation;R2>

>  <CYP2D6>  (337) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (337) 


>  <CYP3A4>  (337) 
<13,H;Hydroxylation;R1>
<14,H;Hydroxylation;R2>

>  <References>  (337) 
Remmel RP, Crews BC, Kozak KR, Kalgutkar AS, Marnett LJ: Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites. Drug Metab Dispos. 2004 Jan;32(1):113-22. doi: 10.1124/dmd.32.1.113. (PMID: 14709628)
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (337) 
<27,H;Oxidation> is also reported in the reference.

$$$$
CC02184
     RDKit          3D

 25 27  0  0  0  0  0  0  0  0999 V2000
   -5.0690   -1.1470    0.0980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7360   -1.1890    0.4530 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3890    0.2140   -0.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6870    0.5800   -0.4120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6320   -0.3840   -0.6240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3170   -1.7280   -0.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0420   -2.1120   -0.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2590    0.9160    0.2260 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2930    0.0950    0.5190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6510    0.5770    0.9360 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8860    1.9120    1.3630 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8990    0.5950   -0.7150 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5500    0.9920   -0.6030 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5110    0.0180   -0.4250 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8480    0.3970   -0.3230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1590    1.7520   -0.4050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1390    2.6640   -0.5840 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8850    2.2660   -0.6820 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1210   -1.4350   -0.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8230   -0.5310   -0.1470 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0620    0.1780   -0.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2080   -0.8150    0.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2400   -1.7120   -0.9580 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.4210   -0.1210    0.1790 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.0120   -1.5210    1.3070 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  7  1  0
  2  9  1  0
  3  4  1  0
  3  8  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  6
 12 13  1  0
 13 14  2  0
 13 18  1  0
 14 15  1  0
 14 19  1  0
 15 16  2  0
 15 20  1  0
 16 17  1  0
 17 18  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 22 25  1  0
M  END
>  <Name>  (338) 
Lansoprazole

>  <InChIKey>  (338) 
MJIHNNLFOKEZEW-RUZDIDTESA-N

>  <PubChem_CID>  (338) 
9578005

>  <CYP1A2>  (338) 


>  <CYP2A6>  (338) 


>  <CYP2B6>  (338) 


>  <CYP2C8>  (338) 


>  <CYP2C9>  (338) 
<20,H;Hydroxylation;R1>
<21,H;Hydroxylation;R2>

>  <CYP2C19>  (338) 
<20,H;Hydroxylation;R1>
<21,H;Hydroxylation;R2>

>  <CYP2D6>  (338) 


>  <CYP2E1>  (338) 


>  <CYP3A4>  (338) 
<20,H;Hydroxylation;R1>
<21,H;Hydroxylation;R2>
<14,S;S-Oxidation;R3>

>  <References>  (338) 
Kim KA, Kim MJ, Park JY, Shon JH, Yoon YR, Lee SS, Liu KH, Chun JH, Hyun MH, Shin JG: Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes. Drug Metab Dispos. 2003 Oct;31(10):1227-34. doi: 10.1124/dmd.31.10.1227. (PMID: 12975331)
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (338) 
Need to confirm <6,H> and <10,11>.

$$$$
CC02185
     RDKit          3D

 27 30  0  0  1  0  0  0  0  0999 V2000
    0.1340    1.1630    0.4310 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.8710    3.9190    1.0460 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1090    3.4740    1.0750 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0840    0.5110   -0.4240 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.2400   -0.1540    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4540    0.9700   -0.6560 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3700   -1.4140   -0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0110   -0.8190   -0.1460 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8710    1.1020   -0.4120 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6920   -1.1480    0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4320    0.1470    1.5130 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5850   -0.3370   -0.6140 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9590    0.0870   -0.1190 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6950    2.5530   -0.6670 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2520   -2.5010    0.3360 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5400    0.3560    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0690   -3.3910    1.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9970   -2.9360   -0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0030    3.3430    0.5710 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8410    0.9990   -1.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8610   -0.0330    1.1670 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6400   -4.6890    1.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5640   -4.2330    0.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4780    1.2510   -0.8870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4970    0.2150    1.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3860   -5.1100    0.8740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8140    0.8560    0.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 27  1  0
  2 19  1  0
  3 19  2  0
  4  6  1  0
  4  8  1  0
  4  9  1  0
  5  6  1  0
  5  7  1  0
  5 11  1  0
  5 12  1  0
  7  8  1  0
  8 10  2  0
  9 13  2  0
  9 14  1  0
 10 13  1  0
 10 15  1  0
 13 16  1  0
 14 19  1  0
 15 17  2  0
 15 18  1  0
 16 20  2  0
 16 21  1  0
 17 22  1  0
 18 23  2  0
 20 24  1  0
 21 25  2  0
 22 26  2  0
 23 26  1  0
 24 27  2  0
 25 27  1  0
M  END
>  <Name>  (339) 
Licofelone

>  <InChIKey>  (339) 
UAWXGRJVZSAUSZ-UHFFFAOYSA-N

>  <PubChem_CID>  (339) 
133021

>  <CYP1A2>  (339) 


>  <CYP2A6>  (339) 


>  <CYP2B6>  (339) 


>  <CYP2C8>  (339) 
<0,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>
<18,H;Hydroxylation;R3>
<15,H;Hydroxylation;R4>
<9,H;Hydroxylation;R5>

>  <CYP2C9>  (339) 
<0,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>
<18,H;Hydroxylation;R3>
<15,H;Hydroxylation;R4>
<9,H;Hydroxylation;R5>

>  <CYP2C19>  (339) 
<9,H;Hydroxylation;R1>

>  <CYP2D6>  (339) 
<9,H;Hydroxylation;R1>

>  <CYP2E1>  (339) 


>  <CYP3A4>  (339) 
<9,H;Hydroxylation;R1>

>  <References>  (339) 
Albrecht W, Unger A, Nussler AK, Laufer S: In vitro metabolism of 2-[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl] acetic acid (licofelone, ML3000), an inhibitor of cyclooxygenase-1 and -2 and 5-lipoxygenase. Drug Metab Dispos. 2008 May;36(5):894-903. doi: 10.1124/dmd.108.020347. Epub 2008 Feb 11. (PMID: 18268076)
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (339) 
<24,H;Hydroxylation> is reported in the new reference.

$$$$
CC02186
     RDKit          3D

 10 10  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4190    2.0380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7350    2.0140   -1.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6540   -0.7420   -1.1380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5470   -0.6720    0.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3720    3.5560    0.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5340    3.4950   -1.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3850    4.1650   -0.7650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4690    5.6480   -1.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  6
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  4  8  1  0
  7  9  1  0
  8  9  2  0
  9 10  1  0
M  END
>  <Name>  (340) 
Limonene

>  <InChIKey>  (340) 
XMGQYMWWDOXHJM-SNVBAGLBSA-N

>  <PubChem_CID>  (340) 
439250

>  <CYP1A2>  (340) 


>  <CYP2A6>  (340) 


>  <CYP2B6>  (340) 


>  <CYP2C8>  (340) 
<7,H;Hydroxylation;R1>
<8,H;Hydroxylation;R2>

>  <CYP2C9>  (340) 
<7,H;Hydroxylation;R1>
<8,H;Hydroxylation;R2>

>  <CYP2C19>  (340) 
<7,H;Hydroxylation;R1>
<8,H;Hydroxylation;R2>

>  <CYP2D6>  (340) 


>  <CYP2E1>  (340) 


>  <CYP3A4>  (340) 
<7,H;Hydroxylation;R1>
<8,H;Hydroxylation;R2>

>  <References>  (340) 
Miyazawa M, Shindo M, Shimada T: Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. Drug Metab Dispos. 2002 May;30(5):602-7. doi: 10.1124/dmd.30.5.602. (PMID: 11950794)

>  <Comments>  (340) 


$$$$
CC02187
     RDKit          3D

 38 41  0  0  0  0  0  0  0  0999 V2000
    6.7350   -2.9240   -1.4010 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6690   -5.2980   -1.3540 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5470    4.4200    0.5830 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4410    3.7020   -0.0860 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4000    0.9070    2.6980 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.1580    1.8000    0.6140 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5330    7.9980   -3.6300 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5450    2.6380    1.6290 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7720   -6.0130   -1.7570 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6530   -4.1690   -3.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4770    1.6930    1.8520 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5400    0.4930    0.9660 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5760   -4.7960   -2.3680 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0550   -2.8040   -2.6460 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6400   -1.7700   -0.6720 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2920   -4.3650   -2.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9010    0.4950   -0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2250   -0.6480    1.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9520   -0.6320   -1.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2760   -1.7750    0.5680 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7290    2.5290    2.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6200   -6.2690   -1.1670 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2320   -7.4120   -0.3640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5070   -3.1840   -2.5060 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4280    3.5930    0.6360 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1510   -8.4380   -0.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9530   -7.5140    0.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8130    1.7190    1.7830 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5060    5.3300   -0.4730 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7990   -9.5460    0.6390 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5970   -8.6200    0.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5210   -9.6360    1.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9120    4.9220   -1.7410 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1200    6.6420   -0.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9050    5.8480   -2.7790 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1170    7.5590   -1.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5060    7.1650   -2.5450 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1100    9.3120   -3.2890 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 14  1  0
  1 15  1  0
  2 16  1  0
  2 22  1  0
  3 25  1  0
  3 29  1  0
  4 25  2  0
  5 28  1  0
  6 28  2  0
  7 37  1  0
  7 38  1  0
  8 11  1  0
  8 21  1  0
  8 25  1  0
  9 13  1  0
  9 22  2  0
 10 13  1  0
 10 14  1  0
 11 12  1  0
 12 17  2  0
 12 18  1  0
 13 16  2  0
 15 19  2  0
 15 20  1  0
 16 24  1  0
 17 19  1  0
 18 20  2  0
 21 28  1  0
 22 23  1  0
 23 26  2  0
 23 27  1  0
 26 30  1  0
 27 31  2  0
 29 33  2  0
 29 34  1  0
 30 32  2  0
 31 32  1  0
 33 35  1  0
 34 36  2  0
 35 37  2  0
 36 37  1  0
M  END
>  <Name>  (341) 
Muraglitazar

>  <InChIKey>  (341) 
IRLWJILLXJGJTD-UHFFFAOYSA-N

>  <PubChem_CID>  (341) 
206044

>  <CYP1A2>  (341) 


>  <CYP2A6>  (341) 


>  <CYP2B6>  (341) 


>  <CYP2C8>  (341) 
<19,20;Cleavage;R1>
<20,H;Oxidation;R1>
<33,H;Hydroxylation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>
<23,24;Reduction;R4>

>  <CYP2C9>  (341) 
<33,H;Hydroxylation;R1>
<23,24;Reduction;R2>

>  <CYP2C19>  (341) 
<33,H;Hydroxylation;R1>
<28,H;Hydroxylation;R2>

>  <CYP2D6>  (341) 
<19,20;Cleavage;R1>
<20,H;Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>
<23,24;Reduction;R3>

>  <CYP2E1>  (341) 


>  <CYP3A4>  (341) 
<21,H;Hydroxylation;R1>
<19,20;Cleavage;R2>
<20,H;Oxidation;R2>
<33,H;Hydroxylation;R3>
<22,32;Cleavage;R4>

>  <References>  (341) 
Zhang D, Wang L, Chandrasena G, Ma L, Zhu M, Zhang H, Davis CD, Humphreys WG: Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar. Drug Metab Dispos. 2007 Jan;35(1):139-49. doi: 10.1124/dmd.106.011932. Epub 2006  Oct 24. (PMID: 17062778)

>  <Comments>  (341) 
The metabolites and metabolic pathway are not identified.

$$$$
CC02189
     RDKit          3D

 26 28  0  0  0  0  0  0  0  0999 V2000
   -3.7200    4.7770   -1.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7620    3.9340   -1.7270 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8070    2.6750   -1.1890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1720    2.3490    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3260    1.0480    0.4950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9870    0.0740   -0.1970 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5520    0.4280   -1.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4870    1.7000   -1.9100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6940    0.6200    1.7940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0160    0.0770    1.5520 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.7240    0.0490    2.8730 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2200   -1.5640    1.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6490   -2.5140    1.3190 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1120   -3.6480    0.7630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1020   -3.3740    0.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2770   -2.0260    0.3250 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8800   -4.3450   -0.4950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3850   -5.6570   -0.4780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1500   -5.9520    0.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6100   -4.9580    0.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0190   -6.7320   -1.0430 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4320   -6.6330   -1.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7680   -5.8740   -2.1890 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9130   -7.8780   -1.3580 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4500    3.2350    0.7620 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4070    3.8780    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  8  1  0
  4  5  1  0
  4 25  1  0
  5  6  2  0
  5  9  1  0
  6  7  1  0
  7  8  2  0
 10  9  1  1
 10 11  2  0
 10 12  1  0
 12 13  2  0
 12 16  1  0
 13 14  1  0
 14 15  2  0
 14 20  1  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 18 21  1  0
 19 20  2  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 25 26  1  0
M  END
>  <Name>  (342) 
Pantoprazole

>  <InChIKey>  (342) 
IQPSEEYGBUAQFF-AREMUKBSSA-N

>  <PubChem_CID>  (342) 
11181988

>  <CYP1A2>  (342) 


>  <CYP2A6>  (342) 


>  <CYP2B6>  (342) 


>  <CYP2C8>  (342) 


>  <CYP2C9>  (342) 


>  <CYP2C19>  (342) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<8,S;S-Oxidation;R2>

>  <CYP2D6>  (342) 


>  <CYP2E1>  (342) 


>  <CYP3A4>  (342) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (342) 
Meyer UA: Interaction of proton pump inhibitors with cytochromes P450: consequences for drug interactions. Yale J Biol Med. 1996 May-Jun;69(3):203-9. (PMID: 9165689)

>  <Comments>  (342) 


$$$$
CC02190
     RDKit          3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.8800    0.4100    1.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.5450   -0.5350    1.8860 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0220    1.7680    1.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8550   -0.5950   -1.0910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0100   -1.0470    0.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3890   -0.0790    3.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4300   -1.8500    1.5930 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7950    2.1750    2.4990 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4280    2.6010    0.8180 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6960    0.2180   -1.8280 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8000   -1.9520   -1.3530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0310   -0.3810    1.4050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4760    1.2970    3.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0960   -0.9890    3.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4780   -0.3250   -2.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5820   -2.4940   -2.3550 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2700    1.7400    4.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8770   -0.5280    4.8260 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4190   -1.6800   -3.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9630    0.8310    5.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  1  1
  3  7  1  0
  3  8  1  0
  4  9  1  0
  4 10  2  0
  5 11  2  0
  5 12  1  0
  6 13  1  0
  7 14  2  0
  7 15  1  0
  9 14  1  0
 11 16  1  0
 12 17  2  0
 14 18  1  0
 15 19  2  0
 16 20  2  0
 17 20  1  0
 18 21  2  0
 19 21  1  0
M  END
>  <Name>  (343) 
Phenprocoumon

>  <InChIKey>  (343) 
DQDAYGNAKTZFIW-CYBMUJFWSA-N

>  <PubChem_CID>  (343) 
54681545

>  <CYP1A2>  (343) 


>  <CYP2A6>  (343) 


>  <CYP2B6>  (343) 


>  <CYP2C8>  (343) 
<6,H;Hydroxylation;R1>

>  <CYP2C9>  (343) 
<14,H;Hydroxylation;R1>
<15,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>

>  <CYP2C19>  (343) 
<14,H;Hydroxylation;R1>
<15,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>

>  <CYP2D6>  (343) 


>  <CYP2E1>  (343) 


>  <CYP3A4>  (343) 
<14,H;Hydroxylation;R1>
<15,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>

>  <References>  (343) 
Ufer M, Kammerer B, Kahlich R, Kirchheiner J, Yasar U, Brockmoller J, Rane A: Genetic polymorphisms of cytochrome P450 2C9 causing reduced phenprocoumon (S)-7-hydroxylation in vitro and in vivo. Xenobiotica. 2004 Sep;34(9):847-59. doi: 10.1080/00498250400009197. (PMID: 15742978)
Ufer M, Svensson JO, Krausz KW, Gelboin HV, Rane A, Tybring G: Identification of cytochromes P450 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitro. Eur J Clin Pharmacol. 2004 May;60(3):173-82. doi: 10.1007/s00228-004-0740-5. Epub 2004 Mar 31. (PMID: 15054565)

>  <Comments>  (343) 
Regardless of the R/S format.

$$$$
CC02191
     RDKit          3D

 25 27  0  0  0  0  0  0  0  0999 V2000
    1.7970   -1.3600   -6.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3020   -2.1390   -5.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8890   -1.2950   -4.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4200   -1.9100   -2.9470 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0170   -1.2500   -1.8390 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0900    0.1010   -1.8690 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5390    0.8100   -2.9750 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9430    0.0940   -4.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3740    0.8100   -0.6390 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4510    2.0230   -0.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7690    1.6370    0.1240 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8880    1.4750    1.4770 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1240    1.0220    1.9340 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3290    0.8100    3.2950 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3050    1.0450    4.2130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0770    1.5120    3.7500 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8660    1.7260    2.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5890    0.7870    5.6560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4980    0.2600    6.5600 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.7730   -0.9460    6.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3360   -1.9390    5.5860 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5880   -0.8020    6.1700 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.3650    6.6950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2410    0.6450    6.9110 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2490    1.4600    7.0550 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  8  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  6  9  1  0
  7  8  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 17  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 18  1  0
 16 17  2  0
 19 18  1  6
 19 20  1  0
 19 25  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
M  END
>  <Name>  (344) 
Pioglitazone

>  <InChIKey>  (344) 
HYAFETHFCAUJAY-QGZVFWFLSA-N

>  <PubChem_CID>  (344) 
29010894

>  <CYP1A2>  (344) 


>  <CYP2A6>  (344) 


>  <CYP2B6>  (344) 


>  <CYP2C8>  (344) 
<0,1;Cleavage;R1>
<1,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<0,H;Oxidation;R4>

>  <CYP2C9>  (344) 


>  <CYP2C19>  (344) 
<1,H;Hydroxylation;R1>

>  <CYP2D6>  (344) 


>  <CYP2E1>  (344) 


>  <CYP3A4>  (344) 
<0,1;Cleavage;R1>
<1,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<0,H;Oxidation;R4>

>  <References>  (344) 
Jaakkola T, Laitila J, Neuvonen PJ, Backman JT: Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: potential for interactions with CYP2C8 inhibitors. Basic Clin Pharmacol Toxicol. 2006 Jul;99(1):44-51. doi: 10.1111/j.1742-7843.2006.pto_437.x. (PMID: 16867170)
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (344) 
The M-VI metabolite needs to be identified. The methyl group is cleaved and it's a strange reaction in Phase I.

$$$$
CC02192
     RDKit          3D

 23 26  0  0  1  0  0  0  0  0999 V2000
   -5.5060    1.1360    0.7110 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7120    0.1430    0.7080 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2960    0.2410    0.0740 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.4640   -0.9860   -0.3620 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.0220   -0.9690    0.1610 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.6920    0.3170   -0.3390 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.1850    0.4070    0.1800 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.6130    1.4810   -0.5240 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6600   -0.1370   -0.5560 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.1470    1.5960   -0.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3530   -2.1700   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7710   -1.6660   -0.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7420   -2.2150   -0.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8860   -0.9540    0.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4300    0.3920    1.6100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9410    1.4760   -0.6780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2240   -2.1010   -0.1540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2250    0.8330    1.6700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3950   -0.9830    0.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2470    0.9940   -1.3190 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8720    0.6410   -0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1180    0.2360   -0.3300 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.9990    2.0790   -0.4730 C   0  0  0  0  0  0  0  0  0  0  0  0
 22  1  1  1
  2 21  2  0
  3  4  1  0
  3  8  1  0
  3  9  1  0
  3 15  1  1
  4  5  1  0
  4 11  1  1
  5  6  1  0
  5 13  1  6
  6  7  1  0
  6 10  1  1
  7 14  1  0
  7 16  1  0
  7 18  1  1
  8 10  1  0
  9 12  1  0
  9 21  1  1
 11 12  1  0
 13 17  1  0
 14 17  2  0
 14 19  1  0
 16 20  1  0
 19 22  1  0
 20 22  1  0
 21 23  1  0
M  END
>  <Name>  (345) 
Pregnenolone

>  <InChIKey>  (345) 
ORNBQBCIOKFOEO-QGVNFLHTSA-N

>  <PubChem_CID>  (345) 
8955

>  <CYP1A2>  (345) 


>  <CYP2A6>  (345) 


>  <CYP2B6>  (345) 


>  <CYP2C8>  (345) 


>  <CYP2C9>  (345) 


>  <CYP2C19>  (345) 
<4,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>

>  <CYP2D6>  (345) 
<0,H;Hydroxylation;R1>

>  <CYP2E1>  (345) 


>  <CYP3A4>  (345) 
<4,H;Hydroxylation;R2>

>  <References>  (345) 
Niwa T, Yabusaki Y, Honma K, Matsuo N, Tatsuta K, Ishibashi F, Katagiri M: Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones. Xenobiotica. 1998 Jun;28(6):539-47. doi: 10.1080/004982598239290. (PMID: 9667077)

>  <Comments>  (345) 


$$$$
CC02193
     RDKit          3D

 17 17  0  0  0  0  0  0  0  0999 V2000
    1.7820   -5.6370   -0.3810 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.8680    2.9100    0.1870 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6580    0.2300   -0.1500 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7610    2.1060    0.5610 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2960    4.1470    1.4590 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9450    0.5460   -0.7000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0330    3.7630    0.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2780    2.9110   -0.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8890    4.8200   -0.9100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4740   -1.1640   -0.1670 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6550    3.1180    0.7650 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4620   -2.0660    0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2700   -1.6830   -0.6660 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8390    0.9210   -0.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2500   -3.4470    0.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0540   -3.0620   -0.7330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0460   -3.9390   -0.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 17  1  0
  2  7  1  0
  2 11  1  0
  3 10  1  0
  3 14  1  0
  4 11  1  0
  4 14  1  0
  5 11  2  0
  6 14  2  0
  7  8  1  0
  7  9  1  0
 10 12  2  0
 10 13  1  0
 12 15  1  0
 13 16  2  0
 15 17  2  0
 16 17  1  0
M  END
>  <Name>  (346) 
Proguanil

>  <InChIKey>  (346) 
SSOLNOMRVKKSON-UHFFFAOYSA-N

>  <PubChem_CID>  (346) 
4923

>  <CYP1A2>  (346) 


>  <CYP2A6>  (346) 


>  <CYP2B6>  (346) 


>  <CYP2C8>  (346) 


>  <CYP2C9>  (346) 
<1,H;Hydroxylation;R1>

>  <CYP2C19>  (346) 
<1,3;Cleavage;R1>
<1,H;Oxidation;R1>
<1,H;Hydroxylation;R2>

>  <CYP2D6>  (346) 
<1,H;Hydroxylation;R1>

>  <CYP2E1>  (346) 


>  <CYP3A4>  (346) 
<1,H;Hydroxylation;R1>

>  <References>  (346) 
Diaz DS, Kozar MP, Smith KS, Asher CO, Sousa JC, Schiehser GA, Jacobus DP, Milhous WK, Skillman DR, Shearer TW: Role of specific cytochrome P450 isoforms in the conversion of phenoxypropoxybiguanide analogs in human liver microsomes to potent antimalarial dihydrotriazines. Drug Metab Dispos. 2008 Feb;36(2):380-5. doi: 10.1124/dmd.106.013920. Epub 2007 Nov 15. (PMID: 18006651)
Arfeen M, Patel DS, Abbat S, Taxak N, Bharatam PV: Importance of cytochromes in cyclization reactions: quantum chemical study on a model reaction of proguanil to cycloguanil. J Comput Chem. 2014 Oct 30;35(28):2047-55. doi: 10.1002/jcc.23719. Epub 2014 Sep  5. (PMID: 25196060)

>  <Comments>  (346) 
<7,H;Hydroxylation;R1> indicates the oxidative cyclization reaction.

$$$$
CC02194
     RDKit          3D

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.1740    1.3450   -0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1780   -0.0570   -0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3100    2.1770   -0.0380 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0240    1.9730   -0.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4180   -0.8570    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0040   -0.7810   -0.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3370    1.8480    0.8420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3440    3.4450   -0.7730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1960    1.2520   -0.8630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6280   -2.0820   -0.7770 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3460   -0.5570    0.8850 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1810   -0.1250   -0.7050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1130    0.6270    1.6960 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7160    2.7590    1.1360 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.9500    3.3710   -2.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3450   -2.1250   -2.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1690   -3.2060   -0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6160   -1.0290   -0.9550 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.2040    2.5940   -2.9830 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.9930    4.6060   -2.7170 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.2050    2.8810   -2.1630 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.5750   -3.2850   -2.8770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8660   -1.0480   -2.7800 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.4000   -4.3690   -0.8830 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1010   -4.4090   -2.2430 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  5 11  2  0
  6 12  2  0
  7 13  1  0
  7 14  2  0
  8 15  1  0
  9 12  1  0
 10 16  2  0
 10 17  1  0
 11 13  1  0
 12 18  1  0
 15 19  1  0
 15 20  1  0
 15 21  1  0
 16 22  1  0
 16 23  1  0
 17 24  2  0
 22 25  2  0
 24 25  1  0
M  END
>  <Name>  (347) 
Quazepam

>  <InChIKey>  (347) 
IKMPWMZBZSAONZ-UHFFFAOYSA-N

>  <PubChem_CID>  (347) 
4999

>  <CYP1A2>  (347) 


>  <CYP2A6>  (347) 


>  <CYP2B6>  (347) 


>  <CYP2C8>  (347) 


>  <CYP2C9>  (347) 
<10,11;Desulfuration;R1>

>  <CYP2C19>  (347) 
<10,11;Desulfuration;R1>

>  <CYP2D6>  (347) 


>  <CYP2E1>  (347) 


>  <CYP3A4>  (347) 
<10,11;Desulfuration;R1>

>  <References>  (347) 
Miura M, Ohkubo T: In vitro metabolism of quazepam in human liver and intestine and assessment of drug interactions. Xenobiotica. 2004 Nov-Dec;34(11-12):1001-11. doi: 10.1080/02772240400015214. (PMID: 15801544)

>  <Comments>  (347) 


$$$$
CC02195
     RDKit          3D

 24 27  0  0  0  0  0  0  0  0999 V2000
    0.5740   -2.5230   -0.1080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7220   -2.1110   -0.4710 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0580   -3.7680   -0.5830 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3880   -1.7300    0.7160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2800   -0.7960    0.0100 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.4610   -2.9360   -1.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3520   -4.1820   -0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2830   -4.5280   -1.3620 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6400   -2.1640    1.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8830   -0.9760    1.4040 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.2940   -0.3500   -0.8940 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9240   -4.1480   -1.7020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1200   -3.3900    0.5720 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4290   -1.3970    1.8430 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2290    0.3310    1.9470 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1130   -1.8780    1.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6600   -2.1030    2.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7860    0.1760    3.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1980    0.9840    1.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3370   -1.1040    1.8160 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.0550   -0.6750    3.2630 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.4840    0.1660    0.9660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8590   -1.8960    4.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6440   -2.1060    5.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  0
  2  6  2  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  6
  6 12  1  0
  7 13  1  0
  8 12  2  0
  9 13  2  0
  9 14  1  0
 10 15  1  0
 10 16  1  6
 14 17  1  0
 15 18  1  0
 15 19  1  0
 20 16  1  6
 18 21  1  0
 19 22  1  0
 20 21  1  0
 20 22  1  0
 21 23  1  1
 23 24  2  0
M  END
>  <Name>  (348) 
Quinine

>  <InChIKey>  (348) 
LOUPRKONTZGTKE-WZBLMQSHSA-N

>  <PubChem_CID>  (348) 
3034034

>  <CYP1A2>  (348) 
<17,14;Cleavage;R1>
<21,H;Hydroxylation;R2>

>  <CYP2A6>  (348) 


>  <CYP2B6>  (348) 


>  <CYP2C8>  (348) 


>  <CYP2C9>  (348) 
<17,14;Cleavage;R1>
<21,H;Hydroxylation;R2>

>  <CYP2C19>  (348) 
<17,14;Cleavage;R1>
<21,H;Hydroxylation;R2>

>  <CYP2D6>  (348) 
<17,14;Cleavage;R1>
<21,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>

>  <CYP2E1>  (348) 


>  <CYP3A4>  (348) 
<17,14;Cleavage;R1>
<21,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>

>  <References>  (348) 
Zhao XJ, Yokoyama H, Chiba K, Wanwimolruk S, Ishizaki T: Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450. J Pharmacol Exp Ther. 1996 Dec;279(3):1327-34. (PMID: 8968357)
Mirghani RA, Yasar U, Zheng T, Cook JM, Gustafsson LL, Tybring G, Ericsson O: Enzyme kinetics for the formation of 3-hydroxyquinine and three new metabolites of quinine in vitro; 3-hydroxylation by CYP3A4 is indeed the major metabolic pathway. Drug Metab Dispos. 2002 Dec;30(12):1368-71. doi: 10.1124/dmd.30.12.1368. (PMID: 12433805)
Marcsisin SR, Jin X, Bettger T, McCulley N, Sousa JC, Shanks GD, Tekwani BL, Sahu R, Reichard GA, Sciotti RJ, Melendez V, Pybus BS: CYP450 phenotyping and metabolite identification of quinine by accurate mass UPLC-MS analysis: a possible metabolic link to blackwater fever. Malar J. 2013 Jun 21;12:214. doi: 10.1186/1475-2875-12-214. (PMID: 23800033)

>  <Comments>  (348) 


$$$$
CC02196
     RDKit          3D

 33 36  0  0  0  0  0  0  0  0999 V2000
    5.4550   -0.4980    0.5450 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5700    0.5190   -0.0450 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0290   -0.7270    1.9990 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0500    0.5490    2.7230 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9920    1.3930    2.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3500    1.7620    0.7110 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6570    0.2540    4.1080 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5330    1.5650   -2.0120 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8430    0.2720   -1.5120 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.6390   -0.6980   -2.1790 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1650    0.2590   -1.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2930   -0.5090   -1.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0630   -0.3580   -0.7640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1400   -1.7570   -0.7250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0030   -2.5140   -0.9320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2130   -1.8910   -1.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3870   -4.5260   -0.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0810   -3.7750   -0.5080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3280   -2.3670   -0.4850 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4150   -0.1450   -0.3160 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2740    0.4580   -0.5450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5460    0.5590   -0.1110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5010    1.9590   -0.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2620    2.5950   -0.3910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1710    1.8220   -0.5880 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7710    2.4040    0.0930 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5950    1.2850    0.2710 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8820    0.1970    0.1520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3060   -1.6650    1.7340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4020   -1.2120    0.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8340   -3.0950    1.8590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1810    3.8100   -0.4280 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1970    3.8050    0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  6  1  0
  2  9  1  0
  3  4  1  0
  4  5  1  0
  4  7  1  0
  5  6  1  0
  8  9  2  0
  9 10  2  0
  9 12  1  0
 11 12  2  0
 11 13  1  0
 12 16  1  0
 13 14  2  0
 13 21  1  0
 14 15  1  0
 14 19  1  0
 15 16  2  0
 17 18  1  0
 18 19  1  0
 20 21  2  0
 20 22  1  0
 21 25  1  0
 22 23  2  0
 22 28  1  0
 23 24  1  0
 23 26  1  0
 24 25  1  0
 24 32  2  0
 26 27  1  0
 26 33  1  0
 27 28  2  0
 28 30  1  0
 29 30  1  0
 29 31  1  0
M  END
>  <Name>  (349) 
Sildenafil

>  <InChIKey>  (349) 
BNRNXUUZRGQAQC-UHFFFAOYSA-N

>  <PubChem_CID>  (349) 
135398744

>  <CYP1A2>  (349) 


>  <CYP2A6>  (349) 


>  <CYP2B6>  (349) 


>  <CYP2C8>  (349) 


>  <CYP2C9>  (349) 
<21,22;Cleavage;R1>
<22,H;Oxidation;R1>

>  <CYP2C19>  (349) 
<21,22;Cleavage;R1>
<22,H;Oxidation;R1>

>  <CYP2D6>  (349) 
<21,22;Cleavage;R1>
<22,H;Oxidation;R1>

>  <CYP2E1>  (349) 


>  <CYP3A4>  (349) 
<21,22;Cleavage;R1>
<22,H;Oxidation;R1>

>  <References>  (349) 
Warrington JS, Shader RI, von Moltke LL, Greenblatt DJ: In vitro biotransformation of sildenafil (Viagra): identification of human cytochromes and potential drug interactions. Drug Metab Dispos. 2000 Apr;28(4):392-7. (PMID: 10725306)
Hyland R, Roe EG, Jones BC, Smith DA: Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil. Br J Clin Pharmacol. 2001 Mar;51(3):239-48. doi: 10.1046/j.1365-2125.2001.00318.x. (PMID: 11298070)

>  <Comments>  (349) 


$$$$
CC02198
     RDKit          3D

 18 18  0  0  0  0  0  0  0  0999 V2000
   -0.0200    1.6520    0.0110 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3420    2.0560    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9980    2.0300   -0.9480 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6590    2.1610    1.5720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1540   -0.6940    0.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2000    2.3740    2.6340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0180    2.3540    1.7340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1360   -2.0420    0.0510 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2140   -0.1010    0.1160 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3010    2.7740    3.8590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5190    2.7540    2.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3930   -2.7920    0.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6600    2.9610    4.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0940   -4.2920    0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2060    3.3970    5.3570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4060   -5.0750    0.1530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1070   -6.5750    0.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  2  0
  1  5  1  0
  2  6  1  0
  5  7  2  0
  5  8  1  0
  6  9  1  0
  6 10  2  0
  7 11  1  0
  8 12  2  0
  9 13  1  0
 11 14  2  0
 12 14  1  0
 13 15  1  0
 14 16  1  0
 15 17  1  0
 17 18  1  0
M  END
>  <Name>  (350) 
Tolbutamide

>  <InChIKey>  (350) 
JLRGJRBPOGGCBT-UHFFFAOYSA-N

>  <PubChem_CID>  (350) 
5505

>  <CYP1A2>  (350) 


>  <CYP2A6>  (350) 


>  <CYP2B6>  (350) 


>  <CYP2C8>  (350) 
<15,H;Hydroxylation;R1>

>  <CYP2C9>  (350) 
<15,H;Hydroxylation;R1>

>  <CYP2C19>  (350) 
<15,H;Hydroxylation;R1>

>  <CYP2D6>  (350) 


>  <CYP2E1>  (350) 


>  <CYP3A4>  (350) 


>  <References>  (350) 
Wester MR, Lasker JM, Johnson EF, Raucy JL: CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes. Drug Metab Dispos. 2000 Mar;28(3):354-9. (PMID: 10681382)
Komatsu K, Ito K, Nakajima Y, Kanamitsu Si, Imaoka S, Funae Y, Green CE, Tyson CA, Shimada N, Sugiyama Y: Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments. Drug Metab Dispos. 2000 Apr;28(4):475-81. (PMID: 10725317)
Veronese ME, Mackenzie PI, Doecke CJ, McManus ME, Miners JO, Birkett DJ: Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9. Biochem Biophys Res Commun. 1991 Mar 29;175(3):1112-8. doi: 10.1016/0006-291x(91)91680-b. (PMID: 2025243)

>  <Comments>  (350) 


$$$$
CC02199
     RDKit          3D

 24 25  0  0  0  0  0  0  0  0999 V2000
    1.9170   -0.5310    0.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5970    0.1190    0.6680 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.7240   -1.0100    1.3640 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9370   -1.6130    1.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3370   -1.7350   -0.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5300   -1.2560   -1.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3210   -0.6550   -0.9720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3290   -0.8890    2.6590 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9690   -1.3900   -2.7060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6450    1.5750    0.2810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5210   -0.5790   -0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6340    2.5510    1.2600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6780    3.8860    0.9050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7320    4.2460   -0.4290 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7420    3.2700   -1.4070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7050    1.9340   -1.0520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8610    0.0810    0.2200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9130   -0.4980   -0.6260 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2120   -1.8280   -0.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1160    0.3210   -0.4240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2260   -0.1630   -1.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5810    0.1950    1.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4330   -2.8880   -0.8590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8010   -1.8760    1.3960 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  7  1  0
  2 10  1  0
  2 11  1  6
  3  4  1  0
  3  8  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  6  9  1  0
 10 12  2  0
 10 16  1  0
 11 17  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 19 23  1  0
 19 24  1  0
 20 21  1  0
 20 22  1  0
M  END
>  <Name>  (351) 
Tolterodine

>  <InChIKey>  (351) 
OOGJQPCLVADCPB-HXUWFJFHSA-N

>  <PubChem_CID>  (351) 
443879

>  <CYP1A2>  (351) 


>  <CYP2A6>  (351) 


>  <CYP2B6>  (351) 


>  <CYP2C8>  (351) 


>  <CYP2C9>  (351) 
<10,11;Cleavage;R1>
<11,H;Oxidation;R1>
<10,14;Cleavage;R2>
<14,H;Oxidation;R2>

>  <CYP2C19>  (351) 
<10,11;Cleavage;R1>
<11,H;Oxidation;R1>
<10,14;Cleavage;R2>
<14,H;Oxidation;R2>

>  <CYP2D6>  (351) 
<0,H;Hydroxylation;R1>

>  <CYP2E1>  (351) 


>  <CYP3A4>  (351) 
<10,11;Cleavage;R1>
<11,H;Oxidation;R1>
<10,14;Cleavage;R2>
<14,H;Oxidation;R2>

>  <References>  (351) 
Postlind H, DanielsonA, Lindgren A, Andersson SH: Tolterodine, a new muscarinic receptor antagonist, is metabolized by cytochromes P450 2D6 and 3A in human liver microsomes. Drug Metab Dispos. 1998 Apr;26(4):289-93. (PMID: 9531513)

>  <Comments>  (351) 


$$$$
CC02200
     RDKit          3D

 22 24  0  0  0  0  0  0  0  0999 V2000
   -0.0990    1.3420   -0.1400 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4650   -0.0030   -0.3790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1560    1.9910   -0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2400    2.2370    0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3730   -0.9510   -0.9790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7520   -0.4480   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3980    1.3420   -0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1960    3.3860    0.1650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9970    2.5280   -1.2050 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.7540   -0.6440   -1.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0700   -2.2630   -1.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1940   -1.7510   -0.2280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5810   -0.1230   -0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5930    2.0670    0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3790    4.1080    0.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3170    3.1780   -0.8400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1960    3.4030   -2.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3460   -2.6660   -0.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5890    3.4410    0.2390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1680    3.4570   -1.9830 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5910    2.1970   -2.5720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3630    4.1070   -1.4760 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  7 13  1  0
  7 14  1  0
  8 15  2  0
  9 16  1  0
  9 17  1  6
 10 13  1  0
 11 18  2  0
 12 18  1  0
 14 19  2  0
 15 19  1  0
 16 20  1  0
 20 21  1  0
 20 22  1  0
M  END
>  <Name>  (352) 
Trimipramine

>  <InChIKey>  (352) 
ZSCDBOWYZJWBIY-MRXNPFEDSA-N

>  <PubChem_CID>  (352) 
5282594

>  <CYP1A2>  (352) 


>  <CYP2A6>  (352) 


>  <CYP2B6>  (352) 


>  <CYP2C8>  (352) 


>  <CYP2C9>  (352) 


>  <CYP2C19>  (352) 
<3,4;Cleavage;R1>
<4,H;Oxidation;R1>
<3,5;Cleavage;R2>
<5,H;Oxidation;R2>

>  <CYP2D6>  (352) 
<11,H;Hydroxylation;R1>
<14,H;Hydroxylation;R2>
<18,H;Hydroxylation;R3>
<15,H;Hydroxylation;R4>

>  <CYP2E1>  (352) 


>  <CYP3A4>  (352) 


>  <References>  (352) 
Eap CB, Bender S, Gastpar M, Fischer W, Haarmann C, Powell K, Jonzier-Perey M, Cochard N, Baumann P: Steady state plasma levels of the enantiomers of trimipramine and of its metabolites in CYP2D6-, CYP2C19- and CYP3A4/5-phenotyped patients. Ther Drug Monit. 2000 Apr;22(2):209-14. (PMID: 10774635)
Zhou SF: Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin Pharmacokinet. 2009;48(12):761-804. doi: 10.2165/11318070-000000000-00000. (PMID: 19902987)

>  <Comments>  (352) 
The first reference from Xenosite is not valid. Is site 18 and 19 symmetric?

$$$$
CC02201
     RDKit          3D

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0290    1.4140   -0.0910 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.1330   -0.1070   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4450    1.9100   -0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6830    2.0860   -1.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8540    2.6680    1.0530 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3570    1.6410   -1.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1310    1.9910   -1.2350 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1720   -0.7120   -1.2720 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0670    2.8770    0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6620    2.1220   -0.9940 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1590    3.1480    1.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3650    3.3060    0.0930 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7610   -0.7270    1.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5560   -0.4890    0.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6320    2.8390   -0.1670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6100    2.5620   -2.4820 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6720    4.0590    1.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6640   -2.2350    1.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7900   -1.9830    0.3660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7520   -2.7650    1.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  6
  2  8  1  0
  2 13  1  0
  2 14  1  0
  3  5  2  0
  3  6  1  0
  4  7  1  0
  5 11  1  0
  6 10  2  0
  7 15  1  0
  7 16  1  0
  9 10  1  0
  9 11  2  0
  9 12  1  0
 12 17  1  0
 13 18  1  0
 14 19  1  0
 18 20  1  0
 19 20  1  0
M  END
>  <Name>  (353) 
Venlafaxine

>  <InChIKey>  (353) 
PNVNVHUZROJLTJ-MRXNPFEDSA-N

>  <PubChem_CID>  (353) 
11846746

>  <CYP1A2>  (353) 


>  <CYP2A6>  (353) 


>  <CYP2B6>  (353) 


>  <CYP2C8>  (353) 


>  <CYP2C9>  (353) 
<8,9;Cleavage;R1>
<9,H;Oxidation;R1>
<8,10;Cleavage;R2>
<10,H;Oxidation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>

>  <CYP2C19>  (353) 
<8,9;Cleavage;R1>
<9,H;Oxidation;R1>
<8,10;Cleavage;R2>
<10,H;Oxidation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>

>  <CYP2D6>  (353) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (353) 


>  <CYP3A4>  (353) 
<8,9;Cleavage;R1>
<9,H;Oxidation;R1>
<8,10;Cleavage;R2>
<10,H;Oxidation;R2>

>  <References>  (353) 
Fogelman SM, Schmider J, Venkatakrishnan K, von Moltke LL, Harmatz JS, Shader RI, Greenblatt DJ: O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressants. Neuropsychopharmacology. 1999 May;20(5):480-90. doi: 10.1016/S0893-133X(98)00113-4. (PMID: 10192828)
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (353) 
The rate of <17,12> is very low for CYP2C9 and 2C19. Need to confirm.

$$$$
CC02202
     RDKit          3D

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.0000    1.3440   -0.2270 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.2560   -0.1420   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3660    2.0440   -0.3390 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.8040    1.9180    0.9450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7240    1.5540   -1.4370 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9240   -0.6080    1.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1640   -1.0860   -0.9660 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3970    3.5120   -0.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0710    1.7840   -1.6560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1530    1.4390    1.0810 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1680   -1.9630    1.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3330    0.2700    2.0470 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0720   -2.4460   -0.7780 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2910    3.9950    0.8860 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5440    4.3230   -0.7080 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5660    0.3260    1.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1790    2.1170    0.5540 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7370   -2.8710    0.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2750    5.3510    1.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1300    3.1870    1.5450 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.6110    5.6370   -0.4150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8740    0.2380    1.6510 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2120    1.3470    0.9180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9650   -4.1790    0.5500 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.4450    6.2000    0.4760 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  6
  2  6  2  0
  2  7  1  0
  3  8  1  0
  3  9  1  6
  4 10  1  0
  6 11  1  0
  6 12  1  0
  7 13  2  0
  8 14  2  0
  8 15  1  0
 10 16  1  0
 10 17  1  0
 11 18  2  0
 13 18  1  0
 14 19  1  0
 14 20  1  0
 15 21  2  0
 16 22  2  0
 17 23  2  0
 18 24  1  0
 19 25  2  0
 21 25  1  0
 22 23  1  0
M  END
>  <Name>  (354) 
Voriconazole

>  <InChIKey>  (354) 
BCEHBSKCWLPMDN-MGPLVRAMSA-N

>  <PubChem_CID>  (354) 
71616

>  <CYP1A2>  (354) 


>  <CYP2A6>  (354) 


>  <CYP2B6>  (354) 


>  <CYP2C8>  (354) 


>  <CYP2C9>  (354) 
<5,N;N-Oxidation;R1>

>  <CYP2C19>  (354) 
<5,N;N-Oxidation;R1>

>  <CYP2D6>  (354) 


>  <CYP2E1>  (354) 


>  <CYP3A4>  (354) 
<0,H;Hydroxylation;R1>
<5,N;N-Oxidation;R2>

>  <References>  (354) 
Hyland R, Jones BC, Smith DA: Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole. Drug Metab Dispos. 2003 May;31(5):540-7. doi: 10.1124/dmd.31.5.540. (PMID: 12695341)
Murayama N, Imai N, Nakane T, Shimizu M, Yamazaki H: Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes. Biochem Pharmacol. 2007 Jun 15;73(12):2020-6. doi: 10.1016/j.bcp.2007.03.012. Epub 2007 Mar 19. (PMID: 17433262)

>  <Comments>  (354) 


$$$$
CC02203
     RDKit          3D

 23 25  0  0  1  0  0  0  0  0999 V2000
    0.8670    0.8510    3.8690 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4410    0.2240    5.5000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2280    4.7490    4.9420 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9690    3.5700    9.5000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8200    2.9890    6.3680 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.9190    2.5100    5.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6730    2.2220    7.6660 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2360    3.2220    5.9380 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1370    3.5750    4.6080 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7320    1.2370    4.8810 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2400    3.1610    3.5290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9060    3.1200    8.8460 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6320    4.5130    5.5800 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1680    2.1820    5.8790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1500    1.8130    3.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5120    4.1070    2.8350 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9400    4.7620    5.1710 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4760    2.4290    5.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3280    3.4340    9.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6980    1.3970    2.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8620    3.7190    5.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3600    3.6900    1.8130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4530    2.3370    1.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  1  0
  1 15  1  0
  2 10  1  0
  3  9  2  0
  4 12  2  0
  5  6  1  0
  5  7  1  1
  5  8  1  0
  6  9  1  0
  6 10  2  0
  7 12  1  0
  8 13  2  0
  8 14  1  0
  9 11  1  0
 11 15  2  0
 11 16  1  0
 12 19  1  0
 13 17  1  0
 14 18  2  0
 15 20  1  0
 16 22  2  0
 17 21  2  0
 18 21  1  0
 20 23  2  0
 22 23  1  0
M  END
>  <Name>  (355) 
(S)-Warfarin

>  <InChIKey>  (355) 
QTXVAVXCBMYBJW-HNNXBMFYSA-N

>  <PubChem_CID>  (355) 


>  <CYP1A2>  (355) 


>  <CYP2A6>  (355) 


>  <CYP2B6>  (355) 


>  <CYP2C8>  (355) 
<8,H;Hydroxylation;R1>
<18,H;Hydroxylation;R2>

>  <CYP2C9>  (355) 
<8,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>
<18,H;Hydroxylation;R3>

>  <CYP2C19>  (355) 
<8,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>
<18,H;Hydroxylation;R3>

>  <CYP2D6>  (355) 


>  <CYP2E1>  (355) 


>  <CYP3A4>  (355) 
<3,H;Hydroxylation;R1>
<8,H;Hydroxylation;R2>

>  <References>  (355) 
Rendic S: Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448. doi: 10.1081/DMR-120001392. (PMID: 11996015)
Kaminsky LS, de Morais SM, Faletto MB, Dunbar DA, Goldstein JA: Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe. Mol Pharmacol. 1993 Feb;43(2):234-9. (PMID: 8429826)

>  <Comments>  (355) 


$$$$
CC02204
     RDKit          3D

 14 15  0  0  0  0  0  0  0  0999 V2000
   -1.2240   -0.0140   -0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1640   -0.0360   -0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5930    1.3240   -0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1560   -1.0540    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5550    1.2670   -0.1340 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0080   -1.2850   -0.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5740    2.0680   -0.1130 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9420    1.6780   -0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5180   -0.7140    0.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7770   -0.9160   -0.0860 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8850    0.6420    0.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5980   -2.3910   -0.1420 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1380   -0.2600    1.1300 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2010   -0.1500   -1.2230 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  5  7  1  0
  6 10  1  0
  8 11  2  0
  9 11  1  0
 10 12  1  0
 10 13  2  0
 10 14  2  0
M  END
>  <Name>  (356) 
Zonisamide

>  <InChIKey>  (356) 
UBQNRHZMVUUOMG-UHFFFAOYSA-N

>  <PubChem_CID>  (356) 
5734

>  <CYP1A2>  (356) 


>  <CYP2A6>  (356) 


>  <CYP2B6>  (356) 


>  <CYP2C8>  (356) 


>  <CYP2C9>  (356) 


>  <CYP2C19>  (356) 
<5,6;Cleavage;R1>
<6,7;Cleavage;R1>

>  <CYP2D6>  (356) 


>  <CYP2E1>  (356) 


>  <CYP3A4>  (356) 
<5,6;Cleavage;R1>
<6,7;Cleavage;R1>

>  <References>  (356) 
Nakasa H, Nakamura H, Ono S, Tsutsui M, Kiuchi M, Ohmori S, Kitada M: Prediction of drug-drug interactions of zonisamide metabolism in humans from in vitro data. Eur J Clin Pharmacol. 1998 Apr;54(2):177-83. (PMID: 9626925)
Nakasa H, Komiya M, Ohmori S, Rikihisa T, Kiuchi M, Kitada M: Characterization of human liver microsomal cytochrome P450 involved in the reductive metabolism of zonisamide. Mol Pharmacol. 1993 Jul;44(1):216-21. (PMID: 8341274)

>  <Comments>  (356) 
The metabolic pathway is not identified.

$$$$
CC02205
     RDKit          3D

 27 30  0  0  0  0  0  0  0  0999 V2000
    0.1960    1.1820    0.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2250   -0.2020    0.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3580   -0.8570    0.2700 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4800   -0.1900    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4430    1.2010   -0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3080    1.8510    0.0700 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8720   -0.6340   -0.2110 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2440   -1.7900   -0.1910 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6670    0.4260   -0.4390 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8540    1.6460   -0.3840 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.0370    0.3740   -0.6880 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7560    1.4850   -0.6330 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0550    1.4810   -0.8610 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7160    0.3060   -1.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9980   -0.8810   -1.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6380   -0.8440   -0.9840 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4260    0.3150   -1.4670 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.9030    2.3370   -1.6600 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8800    3.2300   -1.9050 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0140    3.7620   -3.1360 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0740    4.7400   -3.4290 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1080    3.3790   -4.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8000    4.2990   -4.7040 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9560    3.0220   -5.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8300    4.1510   -5.7960 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5920    3.7510   -6.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6420    3.5560   -1.0160 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  7  1  0
  5  6  2  0
  5 10  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
  9 11  1  0
 10 18  1  6
 11 12  2  0
 11 16  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 17  1  0
 15 16  2  0
 18 19  1  0
 19 20  1  0
 19 27  2  0
 20 21  1  0
 20 22  1  0
 21 23  1  0
 22 24  1  0
 23 25  1  0
 24 25  1  0
 25 26  1  0
M  END
>  <Name>  (357) 
Zopiclone

>  <InChIKey>  (357) 
GBBSUAFBMRNDJC-INIZCTEOSA-N

>  <PubChem_CID>  (357) 
969472

>  <CYP1A2>  (357) 


>  <CYP2A6>  (357) 


>  <CYP2B6>  (357) 


>  <CYP2C8>  (357) 
<1,N;N-Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2C9>  (357) 
<1,N;N-Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2C19>  (357) 
<1,N;N-Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2D6>  (357) 
<1,N;N-Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2E1>  (357) 


>  <CYP3A4>  (357) 
<1,N;N-Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <References>  (357) 
Becquemont L, Mouajjah S, Escaffre O, Beaune P, Funck-Brentano C, Jaillon P: Cytochrome P-450 3A4 and 2C8 are involved in zopiclone metabolism. Drug Metab Dispos. 1999 Sep;27(9):1068-73. (PMID: 10460808)

>  <Comments>  (357) 


$$$$
CC02207
     RDKit          3D

 32 36  0  0  0  0  0  0  0  0999 V2000
    3.1480    3.1490   -2.8940 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1850    2.9580   -2.0220 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5160    1.8590   -1.2750 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6710    1.4150   -1.7160 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1280    2.1960   -2.7500 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3290    2.0530   -3.4970 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6290    2.9610   -4.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8240    2.8100   -5.2680 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6820    1.7600   -4.9530 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4100    0.8470   -3.9320 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2200    1.0090   -3.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7550    1.8400   -5.8120 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6090    2.9070   -6.6650 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4170    3.5250   -6.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6260    3.2300   -7.7130 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7340    4.1300   -7.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8510    4.3970   -8.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3640    5.0290   -9.4210 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.3380    4.8680  -10.5150 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6550    5.6640  -10.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5310    6.8680   -9.5080 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.6270    7.8130   -9.7590 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8320    8.8430   -8.6330 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3090    8.2280   -7.3390 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3900    7.7390   -6.4010 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8440    7.1560   -5.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9560    6.6880   -4.3350 F   0  0  0  0  0  0  0  0  0  0  0  0
   16.2030    7.0480   -4.9510 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1250    7.5280   -5.8780 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6810    8.1130   -7.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1960    7.4550   -9.6640 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0750    6.4690   -9.2390 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  5  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6 11  1  0
  7  8  1  0
  8  9  2  0
  8 14  1  0
  9 10  1  0
  9 12  1  0
 10 11  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 32  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 31  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 24 30  1  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
 28 29  1  0
 29 30  2  0
 31 32  1  0
M  END
>  <Name>  (358) 
L-775606

>  <InChIKey>  (358) 
HYDKUVPEVOHALC-UHFFFAOYSA-N

>  <PubChem_CID>  (358) 


>  <CYP1A2>  (358) 


>  <CYP2A6>  (358) 


>  <CYP2B6>  (358) 


>  <CYP2C8>  (358) 
<7,8;Cleavage;R1>
<7,H;Oxidation;R1>
<6,H;Hydroxylation;R2>

>  <CYP2C9>  (358) 


>  <CYP2C19>  (358) 


>  <CYP2D6>  (358) 


>  <CYP2E1>  (358) 


>  <CYP3A4>  (358) 
<7,8;Cleavage;R1>
<7,H;Oxidation;R1>
<6,H;Hydroxylation;R2>

>  <References>  (358) 
Prueksaritanont T, Lu P, Gorham L, Sternfeld F, Vyas KP: Interspecies comparison and role of human cytochrome P450 and flavin-containing monooxygenase in hepatic metabolism of L-775,606, a potent 5-HT(1D) receptor agonist. Xenobiotica. 2000 Jan;30(1):47-59. (PMID: 10659950)

>  <Comments>  (358) 


$$$$
CC02208
     RDKit          3D

 62 68  0  0  0  0  0  0  0  0999 V2000
    1.9660    2.0200   -0.5540 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.1990    0.5540   -0.7620 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.8050    2.8120    0.4580 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.5360    2.5300   -0.7730 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.4580   -0.0330   -1.9990 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.4240    0.3200   -1.6930 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0700   -0.3660    0.3360 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8940    2.1690    1.8630 C   0  0  1  0  0  0  0  0  0  0  0  0
    4.1810    2.8640   -0.0620 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4210    2.3990    0.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0670    1.9490   -2.0560 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.6370    4.0570   -1.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4790    0.5980   -2.7580 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0290    0.4350   -2.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2740   -1.6780    0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5420    2.3240    2.5950 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4790    0.8010    2.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7860    3.0570    2.6000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9700    3.9180    0.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4740    1.2370    1.3130 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.2580    3.2960    0.5150 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6010    2.5200   -3.1860 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9630   -2.6610    1.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7070   -2.0710   -0.9160 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7180    1.1460    2.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8160    2.2530    4.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9220    3.6900    2.3690 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6520   -0.1670    2.8480 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.3510    3.9700   -0.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5460    4.8240    0.9130 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6670    1.3350    2.1460 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1730   -0.0500    2.5240 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0830   -1.5330    2.5500 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1720    5.0600   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8430    2.9260   -1.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8150    0.7680    1.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3250   -1.3000    2.4400 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4430   -2.3560    3.5470 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4600    5.1020   -0.4920 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1340    2.9810   -1.5680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0480    0.8690    2.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8600    0.1760    0.6920 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9060   -3.7560    3.2380 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.3950   -1.9750    4.6920 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.9400    4.0670   -1.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1640   -3.6970    2.3690 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.2010   -4.4400    4.4570 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6270   -5.0980    2.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2210   -2.9810    3.0870 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3290   -5.6700    0.8380 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3560   -5.8070    2.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2040   -2.3650    2.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7540   -6.9550    0.5540 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7810   -7.0910    2.7130 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2700   -1.6420    3.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2140   -2.4050    1.1870 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4780   -7.6660    1.4930 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2900   -1.0040    2.4190 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2580   -1.5900    4.5210 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2820   -0.3310    3.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2560   -0.9130    5.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2680   -0.2880    4.4850 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  1
  1  4  1  0
  2  5  1  0
  2  6  1  0
  2  7  1  1
  3  8  1  0
  3  9  1  6
  4 10  1  0
  4 11  1  0
  4 12  1  6
  5 13  1  0
  5 14  1  6
  6 13  1  0
  7 15  1  0
  8 16  1  0
  8 17  1  0
  8 18  1  1
  9 19  1  0
 10 20  1  0
 10 21  2  0
 11 14  1  0
 11 22  1  6
 15 23  1  0
 15 24  2  0
 16 25  1  0
 16 26  1  0
 16 27  1  0
 17 28  1  0
 19 29  1  0
 19 30  2  0
 20 25  1  0
 20 31  1  1
 25 32  2  0
 28 32  1  0
 28 33  1  6
 29 34  2  0
 29 35  1  0
 31 36  1  0
 32 37  1  0
 33 38  1  0
 34 39  1  0
 35 40  2  0
 36 41  1  0
 36 42  2  0
 38 43  1  0
 38 44  2  0
 39 45  2  0
 40 45  1  0
 43 46  1  0
 43 47  1  1
 46 48  1  0
 46 49  1  1
 48 50  2  0
 48 51  1  0
 49 52  1  0
 50 53  1  0
 51 54  2  0
 52 55  1  0
 52 56  2  0
 53 57  2  0
 54 57  1  0
 55 58  2  0
 55 59  1  0
 58 60  1  0
 59 61  2  0
 60 62  2  0
 61 62  1  0
M  END
>  <Name>  (359) 
Taxol

>  <InChIKey>  (359) 
RCINICONZNJXQF-YUKVPPSFSA-N

>  <PubChem_CID>  (359) 
14060306

>  <CYP1A2>  (359) 


>  <CYP2A6>  (359) 


>  <CYP2B6>  (359) 


>  <CYP2C8>  (359) 
<11,H;Hydroxylation;R1>

>  <CYP2C9>  (359) 


>  <CYP2C19>  (359) 


>  <CYP2D6>  (359) 


>  <CYP2E1>  (359) 


>  <CYP3A4>  (359) 
<53,H;Hydroxylation;R2>

>  <References>  (359) 
Sonnichsen DS, Liu Q, Schuetz EG, Schuetz JD, Pappo A, Relling MV: Variability in human cytochrome P450 paclitaxel metabolism. J Pharmacol Exp Ther. 1995 Nov;275(2):566-75. (PMID: 7473140)
Harris JW, Rahman A, Kim BR, Guengerich FP, Collins JM: Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme. Cancer Res. 1994 Aug 1;54(15):4026-35. (PMID: 7913410)

>  <Comments>  (359) 


$$$$
CC02209
     RDKit          3D

 34 40  0  0  0  0  0  0  0  0999 V2000
   -2.8360   -3.7360   -0.9330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7780   -3.9960   -0.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0530   -2.8870    0.3960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4970   -1.6420    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4890   -1.3640   -0.9120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1800   -2.4670   -1.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4640   -5.2620    0.3200 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1170   -2.7830    1.0570 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6500   -0.5940    0.6710 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.7000    0.0560   -1.3110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5320    0.9920   -0.9940 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.2650    0.2850   -0.5290 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.5280   -1.4100    1.2030 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.7360   -1.0890    0.3190 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.8470    1.2330   -0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0380    0.4110    0.4020 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.2680    0.7260   -0.4510 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.9480    0.5470   -1.8330 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4100   -0.2160   -0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6980    2.1750   -0.2110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8670    2.4140    1.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0270    2.4370   -0.9220 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6300    3.1220   -0.7620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4240   -1.4600   -1.1310 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8690   -1.8340    0.7700 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0200   -1.5540    2.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2490   -0.6310   -1.6480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3640    0.1890    1.7430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9750    1.8960    0.0890 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5020    1.0200    1.1450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1160    2.6580   -0.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4050    3.8440    0.4850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5670    4.7650    0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7020    3.8090    1.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  2  7  1  0
  3  4  1  0
  3  8  1  0
  4  5  2  0
  4  9  1  0
  5  6  1  0
  5 10  1  0
 13  8  1  6
  9 12  1  0
  9 13  1  0
  9 28  1  1
 11 10  1  1
 11 12  1  0
 11 29  1  0
 12 15  1  1
 12 27  1  0
 13 14  1  0
 14 16  1  0
 14 24  1  0
 14 25  1  1
 16 15  1  6
 16 17  1  0
 17 18  1  0
 17 19  1  1
 17 20  1  0
 20 21  1  0
 20 22  1  0
 20 23  1  0
 24 27  1  0
 25 26  1  0
 28 30  1  0
 29 30  1  0
 29 31  1  0
 31 32  1  0
 32 33  1  0
 32 34  1  0
 33 34  1  0
M  END
>  <Name>  (360) 
Buprenorphine

>  <InChIKey>  (360) 
RMRJXGBAOAMLHD-LDFHUFRKSA-N

>  <PubChem_CID>  (360) 
40473187

>  <CYP1A2>  (360) 


>  <CYP2A6>  (360) 


>  <CYP2B6>  (360) 


>  <CYP2C8>  (360) 
<27,2;Cleavage;R1>
<28,H;Oxidation;R1>

>  <CYP2C9>  (360) 


>  <CYP2C19>  (360) 


>  <CYP2D6>  (360) 


>  <CYP2E1>  (360) 


>  <CYP3A4>  (360) 
<18,H;Hydroxylation;R1>
<19,H;Hydroxylation;R2>
<27,28;Cleavage;R3>
<28,H;Oxidation;R3>

>  <References>  (360) 
Picard N, Cresteil T, Djebli N, Marquet P: In vitro metabolism study of buprenorphine: evidence for new metabolic pathways. Drug Metab Dispos. 2005 May;33(5):689-95. doi: 10.1124/dmd.105.003681. Epub 2005  Mar 2. (PMID: 15743975)

>  <Comments>  (360) 
<31,29;Cleavage> may also be BoM for 2C9. Need to confirm.

$$$$
CC02210
     RDKit          3D

 33 34  0  0  0  0  0  0  0  0999 V2000
   -1.1450    1.6170   -0.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8450    0.3140   -0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6130    2.0510   -1.3360 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0330    3.2670   -1.4080 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1550    4.0580   -0.2770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3710    3.6310    0.9320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0200    2.4170    1.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7880    5.2490   -0.3520 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1810   -0.8880   -0.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8840   -2.0880   -0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1450   -2.1000    0.1140 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7960   -0.9940    0.4220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1800    0.2390    0.3640 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2320   -0.8760   -0.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1950   -3.3850   -0.6060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0380   -1.8520   -0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2390   -1.0800    0.8510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9390    1.4900    0.7250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3290   -1.8060    2.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2070   -4.3030    0.6170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9300   -4.0660   -1.7630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1440   -1.5360   -0.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5860   -1.5240   -0.5230 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.4500   -0.9200    0.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9140   -0.9070    0.1430 C   0  0  2  0  0  0  0  0  0  0  0  0
    5.7770   -0.3040    1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2200   -0.2910    0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1650    0.1980    1.6340 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5260   -0.7210   -0.2710 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7180   -0.7390   -1.7100 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0460   -0.1220   -1.0440 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6780    1.9430   -0.4100 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3720    3.1250   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  7  1  0
  2  9  2  0
  2 13  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  8  1  0
  6  7  2  0
  9 10  1  0
  9 14  1  0
 10 11  2  0
 10 15  1  0
 11 12  1  0
 12 13  2  0
 12 17  1  0
 13 18  1  0
 14 22  2  0
 15 20  1  0
 15 21  1  0
 16 17  1  0
 17 19  1  0
 18 32  1  0
 22 23  1  0
 23 24  1  0
 23 30  1  6
 24 25  1  0
 25 26  1  0
 25 31  1  6
 26 27  1  0
 27 28  1  0
 27 29  2  0
 32 33  1  0
M  END
>  <Name>  (361) 
Cerivastatin

>  <InChIKey>  (361) 
SEERZIQQUAZTOL-ANMDKAQQSA-N

>  <PubChem_CID>  (361) 
446156

>  <CYP1A2>  (361) 


>  <CYP2A6>  (361) 


>  <CYP2B6>  (361) 


>  <CYP2C8>  (361) 
<6,H;Hydroxylation;R1>
<7,H;Hydroxylation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>

>  <CYP2C9>  (361) 


>  <CYP2C19>  (361) 


>  <CYP2D6>  (361) 


>  <CYP2E1>  (361) 


>  <CYP3A4>  (361) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (361) 
Muck W: Clinical pharmacokinetics of cerivastatin. Clin Pharmacokinet. 2000 Aug;39(2):99-116. doi: 10.2165/00003088-200039020-00002. (PMID: 10976657)
Boberg M, Angerbauer R, Fey P, Kanhai WK, Karl W, Kern A, Ploschke J, Radtke M: Metabolism of cerivastatin by human liver microsomes in vitro. Characterization of primary metabolic pathways and of cytochrome P450 isozymes involved. Drug Metab Dispos. 1997 Mar;25(3):321-31. (PMID: 9172950)

>  <Comments>  (361) 
Reference is updated.

$$$$
CC02211
     RDKit          3D

 22 23  0  0  0  0  0  0  0  0999 V2000
    0.1960    0.7540   -0.8400 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1980   -0.6500   -0.9970 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4300    1.4350   -0.8260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0290    1.4310   -0.7070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3290   -1.3580   -1.1290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0190   -1.3140   -1.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5980    0.6910   -0.9750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4490    2.8340   -0.6630 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2380    0.7480   -0.7290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4970   -0.6800   -1.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2220   -0.6280   -0.8860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7510    3.4870   -0.6650 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.7010   -1.4950   -0.9200 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.5660    4.9500   -1.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3400    3.4070    0.7270 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0970    5.1450   -2.4270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8950    6.6210   -2.6900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4320    6.8610   -4.0490 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1050    6.2800   -4.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3320    8.2990   -4.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3850    6.3860   -5.6190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6980    8.9490   -4.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  6 11  2  0
  7 10  2  0
  8 12  1  0
  9 11  1  0
 11 13  1  0
 12 14  1  0
 12 15  1  1
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 19 21  1  0
 20 22  1  0
M  END
>  <Name>  (362) 
Chloroquine

>  <InChIKey>  (362) 
WHTVZRBIWZFKQO-CQSZACIVSA-N

>  <PubChem_CID>  (362) 
444810

>  <CYP1A2>  (362) 


>  <CYP2A6>  (362) 


>  <CYP2B6>  (362) 


>  <CYP2C8>  (362) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2C9>  (362) 


>  <CYP2C19>  (362) 


>  <CYP2D6>  (362) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2E1>  (362) 


>  <CYP3A4>  (362) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <References>  (362) 
Projean D, Baune B, Farinotti R, Flinois JP, Beaune P, Taburet AM, Ducharme J: In vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation. Drug Metab Dispos. 2003 Jun;31(6):748-54. doi: 10.1124/dmd.31.6.748. (PMID: 12756207)

>  <Comments>  (362) 


$$$$
CC02212
     RDKit          3D

 29 31  0  0  0  0  0  0  0  0999 V2000
   -0.4500    0.3020   -1.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3000    1.1100   -2.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1280    2.4820   -2.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7860    3.0500   -1.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5310    2.2510   -0.3230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3580    0.8770   -0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0790    0.0570    0.5410 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4130   -0.8410    1.2770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0860   -0.8210    1.3320 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.6820   -1.7220    0.2410 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.2710   -1.4490   -1.2880 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5340    0.1840    0.6570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2090   -0.7520   -0.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6680   -0.6250   -0.2310 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0090    0.7360   -0.6690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2520   -1.5440   -1.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0260   -1.6780    1.9050 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5530    0.5400    1.1340 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7250    1.3500    2.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2100    2.7620    1.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4900    0.9480    3.3050 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1270   -1.3620    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1140   -2.3090    0.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4400   -1.9820    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7810   -0.7000   -0.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7890    0.2480   -0.6020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4640   -0.0860   -0.3990 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0850   -0.3750   -0.6060 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1100    0.9940   -1.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1 11  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  7 12  1  0
  8  9  1  0
  8 17  2  0
  9 10  1  0
  9 18  1  6
 10 11  1  0
 10 22  1  6
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 22 23  2  0
 22 27  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 25 28  1  0
 26 27  2  0
 28 29  1  0
M  END
>  <Name>  (363) 
Diltiazem

>  <InChIKey>  (363) 
HSUGRBWQSSZJOP-RTWAWAEBSA-N

>  <PubChem_CID>  (363) 
39186

>  <CYP1A2>  (363) 


>  <CYP2A6>  (363) 


>  <CYP2B6>  (363) 


>  <CYP2C8>  (363) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>
<17,19;Cleavage;R2>
<19,H;Oxidation;R2>

>  <CYP2C9>  (363) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>
<17,19;Cleavage;R2>
<19,H;Oxidation;R2>

>  <CYP2C19>  (363) 


>  <CYP2D6>  (363) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (363) 


>  <CYP3A4>  (363) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>
<17,19;Cleavage;R2>
<19,H;Oxidation;R2>

>  <References>  (363) 
Sutton D, Butler AM, Nadin L, Murray M: Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites. J Pharmacol Exp Ther. 1997 Jul;282(1):294-300. (PMID: 9223567)
Molden E, Asberg A, Christensen H: CYP2D6 is involved in O-demethylation of diltiazem. An in vitro study with transfected human liver cells. Eur J Clin Pharmacol. 2000 Nov;56(8):575-9. (PMID: 11151747)

>  <Comments>  (363) 


$$$$
CC02213
     RDKit          3D

 22 21  0  0  0  0  0  0  0  0999 V2000
   -1.2110   -1.1420   -0.5300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0530   -2.2640   -1.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0640   -0.1730   -0.4050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3150   -2.6600   -1.6820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5030    1.1890   -0.8790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6430   -4.0470   -1.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2890    2.2430   -0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0160   -4.9710   -2.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5280    2.1190    1.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2860   -4.6080   -3.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6690    3.1380    1.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6570   -5.0960   -3.8720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4970    3.0120    2.3800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8020   -5.8600   -4.9270 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6220    4.0150    2.3510 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6270   -6.1280   -5.8320 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4840    4.0870    3.3780 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7470    4.7550    1.4040 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0230   -5.8610   -7.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8670   -6.7920   -8.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2920   -8.1310   -7.7830 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0780   -8.4370   -8.6630 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  2  4  1  0
  3  5  1  0
  4  6  1  0
  5  7  2  0
  6  8  2  0
  7  9  1  0
  8 10  1  0
  9 11  1  0
 10 12  1  0
 11 13  1  0
 12 14  2  0
 13 15  1  0
 14 16  1  0
 15 17  1  0
 15 18  2  0
 16 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
M  END
>  <Name>  (364) 
Eicosapentaenoic acid

>  <InChIKey>  (364) 
JAZBEHYOTPTENJ-JLNKQSITSA-N

>  <PubChem_CID>  (364) 
446284

>  <CYP1A2>  (364) 


>  <CYP2A6>  (364) 


>  <CYP2B6>  (364) 


>  <CYP2C8>  (364) 
<11,12;EpOxidation;R1>
<8,9;EpOxidation;R2>
<5,6;EpOxidation;R3>
<2,3;EpOxidation;R4>

>  <CYP2C9>  (364) 
<11,12;EpOxidation;R1>
<8,9;EpOxidation;R2>
<5,6;EpOxidation;R3>
<2,3;EpOxidation;R4>

>  <CYP2C19>  (364) 


>  <CYP2D6>  (364) 


>  <CYP2E1>  (364) 


>  <CYP3A4>  (364) 


>  <References>  (364) 
Barbosa-Sicard E, Markovic M, Honeck H, Christ B, Muller DN, Schunck WH: Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily. Biochem Biophys Res Commun. 2005 Apr 22;329(4):1275-81. doi: 10.1016/j.bbrc.2005.02.103. (PMID: 15766564)

>  <Comments>  (364) 
Xenosite reported <21,22> rather than <1,2>. I think it's wrong. Needs to be double checked.

$$$$
CC02214
     RDKit          3D

 30 32  0  0  0  0  0  0  0  0999 V2000
   -0.1530    1.6490    0.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3100    0.1890    0.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1560    1.9190    0.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1930    2.6350    0.9560 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9380   -0.3250    0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3780   -0.6770    0.7600 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8020    0.7360   -0.0380 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7600    3.2560    0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3020    2.8230    0.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    3.3760    2.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0890   -1.7010   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2080   -2.0240    0.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2040    0.6220   -0.4460 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2160    4.1930   -0.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2690    3.7430    0.4760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0450    4.2940    2.4690 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0220   -2.5380    0.2190 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9650   -0.2270    0.5740 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2810   -0.0440   -1.8220 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7650    5.5970   -0.5880 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.1410    4.4810    1.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2500    5.9720   -1.9890 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7390    6.5040   -0.1800 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0910    5.3810    1.9760 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.9200    7.3470   -1.9460 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.5150    7.6680   -3.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9500    8.3390   -1.6040 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2800    8.9640   -3.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8920    9.4460   -4.3370 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3420    9.5700   -2.2000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5  7  1  0
  5 11  1  0
  6 12  2  0
  7 13  1  0
  8 14  2  0
  9 15  1  0
 10 16  2  0
 11 17  2  0
 12 17  1  0
 13 18  1  0
 13 19  1  0
 14 20  1  0
 15 21  2  0
 16 21  1  0
 20 22  1  0
 20 23  1  6
 21 24  1  0
 22 25  1  0
 25 26  1  0
 25 27  1  6
 26 28  1  0
 28 29  1  0
 28 30  2  0
M  END
>  <Name>  (365) 
Fluvastatin

>  <InChIKey>  (365) 
FJLGEFLZQAZZCD-JUFISIKESA-N

>  <PubChem_CID>  (365) 
1548972

>  <CYP1A2>  (365) 


>  <CYP2A6>  (365) 


>  <CYP2B6>  (365) 


>  <CYP2C8>  (365) 
<26,H;Hydroxylation;R1>

>  <CYP2C9>  (365) 
<27,H;Hydroxylation;R1>
<1,3;Cleavage;R2>
<1,H;oxidation;R2>
<26,H;Hydroxylation;R3>

>  <CYP2C19>  (365) 


>  <CYP2D6>  (365) 
<26,H;Hydroxylation;R1>

>  <CYP2E1>  (365) 


>  <CYP3A4>  (365) 
<26,H;Hydroxylation;R1>

>  <References>  (365) 
Fischer V, Johanson L, Heitz F, Tullman R, Graham E, Baldeck JP, Robinson WT: The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin: effect on human cytochrome P-450 and implications for metabolic drug interactions. Drug Metab Dispos. 1999 Mar;27(3):410-6. (PMID: 10064574)

>  <Comments>  (365) 


$$$$
CC02216
     RDKit          3D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4170    2.0320   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7470    2.0020   -1.2110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5220   -0.6100   -0.9020 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6020   -0.6730    1.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8810    2.7810   -1.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2790    1.6860   -2.4720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5490    3.2380   -2.1890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9480    2.1440   -3.5920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0840    2.9180   -3.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8130    3.4170   -4.6710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2440    4.7750   -5.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8970    5.2240   -6.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5340    5.8050   -3.9920 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  6
  1  4  1  0
  2  5  2  0
  2  6  1  0
  4  7  2  0
  4  8  1  0
  7  9  1  0
  8 10  2  0
  9 11  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
M  END
>  <Name>  (366) 
Ibuprofen

>  <InChIKey>  (366) 
HEFNNWSXXWATRW-JTQLQIEISA-N

>  <PubChem_CID>  (366) 
39912

>  <CYP1A2>  (366) 


>  <CYP2A6>  (366) 


>  <CYP2B6>  (366) 


>  <CYP2C8>  (366) 
<0,H;Hydroxylation;R1>
<1,H;Hydroxylation;R2>
<2,H;Hydroxylation;R3>

>  <CYP2C9>  (366) 
<0,H;Hydroxylation;R1>
<1,H;Hydroxylation;R2>
<2,H;Hydroxylation;R3>

>  <CYP2C19>  (366) 


>  <CYP2D6>  (366) 


>  <CYP2E1>  (366) 


>  <CYP3A4>  (366) 


>  <References>  (366) 
Hamman MA, Thompson GA, Hall SD: Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C. Biochem Pharmacol. 1997 Jul 1;54(1):33-41. doi: 10.1016/s0006-2952(97)00143-3. (PMID: 9296349)

>  <Comments>  (366) 


$$$$
CC02217
     RDKit          3D

 38 42  0  0  1  0  0  0  0  0999 V2000
    0.2500    1.8670    0.0870 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.8930    4.5720    0.0020 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7510    5.5530    1.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8760    5.0650    2.1740 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.4710    3.5810    1.3440 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1710    0.6100   -0.2820 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.2480   -0.1230    0.3920 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5780    0.9640   -0.4670 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3140   -1.3460    0.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9980   -0.6750    0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0000    1.2640   -0.4190 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6520   -0.9070    0.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3720    0.3200    1.8340 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6160   -0.4500   -0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0050    0.3440   -0.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9440    2.6800   -0.8570 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1180   -2.1980    0.6470 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5980    0.7060   -0.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7730   -2.9920    1.5930 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9390   -2.6710    0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8170    3.6190    0.3110 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0390    1.4820   -1.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7880    0.2870    1.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2560   -4.2340    1.9560 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4190   -3.9120    0.4270 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6930    1.8400   -1.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4410    0.6380    1.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0780   -4.6930    1.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9040    1.4160    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6240    4.6010    1.6600 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7460    4.1260    2.6800 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.2900    2.9780    3.3190 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4600    5.2190    3.6980 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.5960    4.7390    4.7150 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7650    5.6930    4.2980 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.5360    6.7250    5.2430 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7150    6.1650    3.2170 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.2010    7.3350    2.5900 O   0  0  0  0  0  0  0  0  0  0  0  0
  1 29  1  0
  2  3  1  0
  2 21  1  0
  4  3  1  6
  4 30  1  0
  4 37  1  0
  5 21  2  0
  6  8  1  0
  6 10  1  0
  6 11  1  0
  7  8  1  0
  7  9  1  0
  7 13  1  0
  7 14  1  0
  9 10  1  0
 10 12  2  0
 11 15  2  0
 11 16  1  0
 12 15  1  0
 12 17  1  0
 15 18  1  0
 16 21  1  0
 17 19  2  0
 17 20  1  0
 18 22  2  0
 18 23  1  0
 19 24  1  0
 20 25  2  0
 22 26  1  0
 23 27  2  0
 24 28  2  0
 25 28  1  0
 26 29  2  0
 27 29  1  0
 30 31  1  0
 31 32  1  1
 31 33  1  0
 33 34  1  1
 33 35  1  0
 35 36  1  1
 35 37  1  0
 37 38  1  6
M  END
>  <Name>  (367) 
Licofelone-M1

>  <InChIKey>  (367) 
YXNIWVFDFGNCED-NNVCNDCRSA-N

>  <PubChem_CID>  (367) 


>  <CYP1A2>  (367) 


>  <CYP2A6>  (367) 


>  <CYP2B6>  (367) 


>  <CYP2C8>  (367) 
<0,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>

>  <CYP2C9>  (367) 
<0,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>

>  <CYP2C19>  (367) 


>  <CYP2D6>  (367) 


>  <CYP2E1>  (367) 


>  <CYP3A4>  (367) 


>  <References>  (367) 
Albrecht W, Unger A, Nussler AK, Laufer S: In vitro metabolism of 2-[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl] acetic acid (licofelone, ML3000), an inhibitor of cyclooxygenase-1 and -2 and 5-lipoxygenase. Drug Metab Dispos. 2008 May;36(5):894-903. doi: 10.1124/dmd.108.020347. Epub 2008 Feb 11. (PMID: 18268076)

>  <Comments>  (367) 


$$$$
CC02218
     RDKit          3D

 33 37  0  0  0  0  0  0  0  0999 V2000
    6.4580   -2.3280   -0.9600 S   0  0  0  0  0  0  0  0  0  0  0  0
   12.9250    0.1800   -0.6840 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.2470    0.7460    0.8480 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2320    2.1730   -0.6640 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8470    4.9180   -0.1460 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1930    0.0420   -0.7750 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0000   -1.8810   -0.0400 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7410   -1.6120    0.8030 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2450   -3.2860    1.6170 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3650   -4.6140    1.7530 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3800    1.7040    1.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4190    2.5230    0.3420 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8360    1.3890    1.2300 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5050    0.7900    0.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4550    2.7370   -1.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1530    3.0960   -0.3800 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8980    3.9140   -0.3290 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6780    4.2670    0.4490 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1380    0.8210   -0.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1490    0.0120    0.3910 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3350    5.8890    0.8150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9850    0.2700    0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9780    0.0860    1.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1830   -0.7690   -0.7610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9470   -1.0980    0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0860   -1.2760   -0.5430 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8680   -1.3910   -0.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8460   -0.6180    0.7420 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0460   -1.4680   -1.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4230   -2.8990    1.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2830   -4.0150    0.9240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5680   -5.1040    1.3520 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8980   -6.5340    1.4210 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 26  1  0
  1 27  1  0
  2 14  2  0
  3 14  1  0
  3 20  1  0
  4 15  1  0
  4 16  1  0
  4 19  1  0
  5 17  1  0
  5 18  1  0
  5 21  1  0
  6 19  2  0
  6 26  1  0
  7 25  1  0
  7 26  2  0
  8 25  1  0
  8 30  1  0
  9 10  1  0
  9 30  2  0
 10 32  1  0
 11 12  1  0
 11 13  1  0
 11 14  1  0
 12 13  1  0
 15 17  1  0
 16 18  1  0
 19 22  1  0
 20 23  2  0
 20 24  1  0
 22 25  2  0
 23 28  1  0
 24 29  2  0
 27 28  2  0
 27 29  1  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
M  END
>  <Name>  (368) 
MK-0457

>  <InChIKey>  (368) 
GCIKSSRWRFVXBI-UHFFFAOYSA-N

>  <PubChem_CID>  (368) 
5494449

>  <CYP1A2>  (368) 


>  <CYP2A6>  (368) 


>  <CYP2B6>  (368) 


>  <CYP2C8>  (368) 
<11,12;Cleavage;R1>
<12,H;Oxidation;R1>

>  <CYP2C9>  (368) 


>  <CYP2C19>  (368) 


>  <CYP2D6>  (368) 


>  <CYP2E1>  (368) 


>  <CYP3A4>  (368) 
<11,12;Cleavage;R1>
<12,H;Oxidation;R1>
<11,N;N-Oxidation;R2>

>  <References>  (368) 
Ballard JE, Prueksaritanont T, Tang C: Hepatic metabolism of MK-0457, a potent aurora kinase inhibitor: interspecies comparison and role of human cytochrome P450 and flavin-containing monooxygenase. Drug Metab Dispos. 2007 Sep;35(9):1447-51. doi: 10.1124/dmd.107.015438. Epub 2007 May 30. (PMID: 17537870)

>  <Comments>  (368) 


$$$$
CC02219
     RDKit          3D

 21 25  0  0  0  0  0  0  0  0999 V2000
    1.4330    1.8100   -2.6160 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2980    2.1540   -1.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3430    1.1820   -1.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1600   -0.1060   -1.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3160   -0.4460   -1.8340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9490    0.5080   -2.5920 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0770    0.2190   -3.2900 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3660   -1.2470   -0.4140 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.8110   -2.2020   -0.5310 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.7220   -1.7300   -1.5670 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6390   -0.6720    0.9560 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.5100   -1.6940    2.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5320   -2.5400    1.9450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5070   -2.4660    0.8020 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.2490   -3.6680    0.7050 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4560    1.4640   -0.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8150    0.2930    0.8440 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.6100   -1.8940   -1.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8080   -1.0650   -0.9910 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9430   -1.9140   -1.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0280   -0.4660    0.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  3 16  1  0
  4  5  1  0
  4  8  1  0
  5  6  2  0
  5 10  1  0
  6  7  1  0
  8  9  1  0
  8 11  1  0
  8 18  1  6
  9 10  1  6
  9 14  1  0
 11 12  1  1
 11 17  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  6
 17 16  1  6
 17 21  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
M  END
>  <Name>  (369) 
Morphine

>  <InChIKey>  (369) 
ICXVGHUORQNRQF-NOSXKOESSA-N

>  <PubChem_CID>  (369) 


>  <CYP1A2>  (369) 


>  <CYP2A6>  (369) 


>  <CYP2B6>  (369) 


>  <CYP2C8>  (369) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C9>  (369) 


>  <CYP2C19>  (369) 


>  <CYP2D6>  (369) 


>  <CYP2E1>  (369) 


>  <CYP3A4>  (369) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (369) 
Projean D, Morin PE, Tu TM, Ducharme J: Identification of CYP3A4 and CYP2C8 as the major cytochrome P450 s responsible for morphine N-demethylation in human liver microsomes. Xenobiotica. 2003 Aug;33(8):841-54. doi: 10.1080/0049825031000121608. (PMID: 12936704)

>  <Comments>  (369) 


$$$$
CC02220
     RDKit          3D

 27 28  0  0  0  0  0  0  0  0999 V2000
   -5.9090    0.1150   -0.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3060   -0.9810    0.1730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9320   -0.9670    0.3980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1590    0.1350    0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7800    1.2350   -0.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1570    1.2220   -0.8110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7660    0.1050   -0.7380 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -3.0380    2.3900   -0.9920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4160    3.3150   -1.3150 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7720    0.1670    0.2420 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9880   -0.8120    0.8190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4490   -0.4550    0.8990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3690   -1.8960    1.2460 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3510   -1.3850    1.4160 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7060   -1.0680    1.4990 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1620    0.1770    1.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2610    1.1050    0.5510 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9060    0.7910    0.4660 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6130    0.5110    1.1460 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5930    0.2880   -0.3270 P   0  0  0  0  0  0  0  0  0  0  0  0
    7.1030    0.6300    0.1370 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6380   -1.3130   -0.5300 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1320    1.0560   -1.5300 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3530   -1.7640   -1.6670 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2820   -3.2700   -1.6990 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4060    2.0050    0.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8440    2.1220    0.7330 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4 10  1  0
  5  6  2  0
  5  8  1  0
  8  9  3  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  2  0
 12 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 19  1  0
 17 18  2  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 20 23  2  0
 21 26  1  0
 22 24  1  0
 24 25  1  0
 26 27  1  0
M  END
>  <Name>  (370) 
NO-1886

>  <InChIKey>  (370) 
KPRTURMJVWXURQ-UHFFFAOYSA-N

>  <PubChem_CID>  (370) 
131601

>  <CYP1A2>  (370) 


>  <CYP2A6>  (370) 


>  <CYP2B6>  (370) 


>  <CYP2C8>  (370) 
<24,25;Cleavage;R1>
<25,H;Oxidation;R1>
<1,2;Cleavage;R2>
<1,H;Oxidation;R2>

>  <CYP2C9>  (370) 


>  <CYP2C19>  (370) 


>  <CYP2D6>  (370) 


>  <CYP2E1>  (370) 


>  <CYP3A4>  (370) 
<24,25;Cleavage;R1>
<25,H;Oxidation;R1>
<1,2;Cleavage;R2>
<1,H;Oxidation;R2>

>  <References>  (370) 
Morioka Y, Otsu M, Naito S, Imai T: Phosphonate O-deethylation of [4-(4-bromo-2-cyano-phenylcarbamoyl) benzyl]-phosphonic acid diethyl ester, a lipoprotein lipase-promoting agent, catalyzed by cytochrome P450 2C8 and 3A4 in human liver microsomes. Drug Metab Dispos. 2002 Mar;30(3):301-6. doi: 10.1124/dmd.30.3.301. (PMID: 11854149)

>  <Comments>  (370) 


$$$$
CC02221
     RDKit          3D

 32 33  0  0  0  0  0  0  0  0999 V2000
   -6.3400    1.9440   -0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5860    1.3130   -0.2030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6490   -0.0770   -0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4640   -0.8060    0.1030 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4420    3.1130    0.5210 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.8660    2.0760    0.0440 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8890   -0.6610   -0.0070 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7680    1.9950   -0.3330 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3910   -2.0150    1.8720 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4510   -2.5270   -0.5540 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5180   -3.7010   -0.3540 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2880   -2.0130   -1.9690 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5430    1.7510    0.3960 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8090    1.2080    0.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9500   -0.1750    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8430   -1.0130    0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5660   -0.4910    0.3700 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4410    0.8970    0.5070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3610   -1.4190    0.5130 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.0800   -0.5900    0.3680 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7850   -1.3630    0.4330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3750   -0.4130    0.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6000   -1.1870    0.3280 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6990   -0.2510    0.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9990   -1.0210    0.2230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2190   -0.1760    0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1670    1.2060   -0.0980 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1070    3.5220    0.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0890    1.3920   -0.1970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8040   -2.0700    0.1710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5550    3.3920   -0.4990 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4100   -2.4810    2.9350 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1 27  1  0
  2  3  1  0
  2  8  1  0
  3  4  2  0
  3  7  1  0
  4 26  1  0
  5 13  1  0
  5 28  1  0
  6 14  1  0
  6 29  1  0
  7 30  1  0
  8 31  1  0
 19  9  1  1
  9 32  3  0
 10 11  1  0
 10 12  1  0
 10 19  1  0
 13 14  2  0
 13 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
M  END
>  <Name>  (371) 
Norverapamil

>  <InChIKey>  (371) 
UPKQNCPKPOLASS-AREMUKBSSA-N

>  <PubChem_CID>  (371) 
15593907

>  <CYP1A2>  (371) 


>  <CYP2A6>  (371) 


>  <CYP2B6>  (371) 


>  <CYP2C8>  (371) 
<7,8;Cleavage;R1>
<7,H;Oxidation;R1>
<22,23;Cleavage;R2>
<23,H;Oxidation;R2>

>  <CYP2C9>  (371) 


>  <CYP2C19>  (371) 


>  <CYP2D6>  (371) 
<7,8;Cleavage;R1>
<7,H;Oxidation;R1>
<22,23;Cleavage;R2>
<23,H;Oxidation;R2>

>  <CYP2E1>  (371) 


>  <CYP3A4>  (371) 
<7,8;Cleavage;R1>
<7,H;Oxidation;R1>
<22,23;Cleavage;R2>
<23,H;Oxidation;R2>

>  <References>  (371) 
Tracy TS, Korzekwa KR, Gonzalez FJ, Wainer IW: Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil. Br J Clin Pharmacol. 1999 May;47(5):545-52. doi: 10.1046/j.1365-2125.1999.00923.x. (PMID: 10336579)
Wang B, Zhou SF: Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr Med Chem. 2009;16(31):4066-218. (PMID: 19754423)

>  <Comments>  (371) 
<24,23;Cleavage> for CYP2E1 can't be identified in the reference provided by Xenosite.

$$$$
CC02222
     RDKit          3D

 33 35  0  0  0  0  0  0  0  0999 V2000
   -0.0460    1.5480    1.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4170    0.2230    0.8220 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2360    1.9730    0.6520 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9540    2.4510    1.5470 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5630   -0.7600    0.2350 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.6850   -0.1940    1.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8940    2.4130    1.8880 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0660    3.1560   -0.1970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2220    2.0290    1.8940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1850   -2.1200    0.6260 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5480   -0.6450   -1.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5850    0.7060    1.7160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3090    2.9020    1.5740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4360    3.6870   -0.6250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0260   -2.8650    1.3700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5940   -1.5910   -1.8840 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2290    4.0980    0.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6380   -4.2650    1.7720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0960   -2.4100    1.7160 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4950   -1.5660   -3.4110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9910   -1.1390   -1.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7430   -4.8770    2.5930 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7420   -4.7280    3.9660 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7520   -5.5900    1.9660 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7560   -5.2890    4.7270 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7680   -6.1540    2.7070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7820   -6.0060    4.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7560   -5.1430    6.0760 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8660   -6.6070    4.8950 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5980   -4.3740    6.4080 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8500   -7.2960    4.2850 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8720   -6.4800    6.1030 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5380   -4.1720    7.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  6
  6 12  1  0
  7 13  1  0
  8 14  1  0
  9 12  2  0
 10 15  1  0
 11 16  1  0
 13 17  1  0
 14 17  1  0
 15 18  1  0
 15 19  2  0
 16 20  1  0
 16 21  1  0
 18 22  1  0
 22 23  2  0
 22 24  1  0
 23 25  1  0
 24 26  2  0
 25 27  2  0
 25 28  1  0
 26 27  1  0
 27 29  1  0
 28 30  1  0
 29 31  1  0
 29 32  2  0
 30 33  1  0
M  END
>  <Name>  (372) 
Repaglinide

>  <InChIKey>  (372) 
FAEKWTJYAYMJKF-QHCPKHFHSA-N

>  <PubChem_CID>  (372) 
65981

>  <CYP1A2>  (372) 


>  <CYP2A6>  (372) 


>  <CYP2B6>  (372) 


>  <CYP2C8>  (372) 
<21,22;Cleavage;R1>
<22,H;Oxidation;R1>
<21,26;Cleavage;R2>
<26,H;Oxdation;R2>
<23,H;Hydroxylation;R3>
<25,H;Hydroxylation;R4>
<12,H;Hydroxylation;R5>

>  <CYP2C9>  (372) 


>  <CYP2C19>  (372) 


>  <CYP2D6>  (372) 


>  <CYP2E1>  (372) 


>  <CYP3A4>  (372) 
<21,22;Cleavage;R1>
<22,H;Oxidation;R1>
<21,26;Cleavage;R2>
<26,H;Oxdation;R2>
<23,H;Hydroxylation;R3>
<25,H;Hydroxylation;R4>
<12,H;Hydroxylation;R5>
<1,2;Cleavage;R6>
<1,H;Oxidation;R6>

>  <References>  (372) 
Bidstrup TB, Bjornsdottir I, Sidelmann UG, Thomsen MS, Hansen KT: CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide. Br J Clin Pharmacol. 2003 Sep;56(3):305-14. doi: 10.1046/j.0306-5251.2003.01862.x. (PMID: 12919179)

>  <Comments>  (372) 


$$$$
CC02223
     RDKit          3D

 31 32  0  0  0  0  0  0  0  0999 V2000
   -4.0390   -0.6530   -2.8460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0930   -0.1070   -3.6440 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4170   -1.5550   -1.8330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2690   -0.8010   -0.5400 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.2380   -1.7250    0.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2390   -0.4390   -2.9410 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0850   -1.9470    2.9760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4940   -1.2490    1.8790 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.2340    0.1460   -0.5910 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0500   -1.7130    1.8930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1720   -1.0810    0.8450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2430   -1.6190    0.8840 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.2710   -3.1400    0.7070 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.2170   -0.9070   -0.0450 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.6410   -3.6920    0.5080 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5860   -1.5290   -0.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6920   -2.9440    0.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3990   -3.6220   -0.4330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1980    0.6150   -0.1770 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.5140    1.2920    0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7000    0.6460   -0.5330 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.6950   -0.8250   -0.3320 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9670    1.2410    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1850    1.2690    0.5750 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5150    2.1950   -0.1700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4530    2.9920    0.6800 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3220    4.1520    1.2780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5780    3.4990   -0.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0680    2.1400    1.7710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5230    5.0660    2.1360 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7200    2.4020   -1.3610 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  6  2  0
  3  4  1  0
  4  5  1  0
  4  9  1  6
  5  8  1  0
  8  7  1  1
  8 10  1  0
 10 11  1  0
 12 11  1  6
 12 13  1  0
 12 14  1  0
 13 15  1  0
 13 18  1  6
 14 16  1  1
 14 19  1  0
 15 17  2  0
 16 17  1  0
 16 22  2  0
 19 20  1  0
 19 24  1  1
 20 21  1  0
 21 22  1  0
 21 23  1  1
 24 25  1  0
 25 26  1  0
 25 31  2  0
 26 27  1  0
 26 28  1  0
 26 29  1  0
 27 30  1  0
M  END
>  <Name>  (373) 
Simvastatin hydroxy acid

>  <InChIKey>  (373) 
XWLXKKNPFMNSFA-SRIRLJBESA-N

>  <PubChem_CID>  (373) 
93476683

>  <CYP1A2>  (373) 


>  <CYP2A6>  (373) 


>  <CYP2B6>  (373) 


>  <CYP2C8>  (373) 
<12,H;Hydroxylation;R1>
<15,H;Hydroxylation;R1>
<10,11;Oxidation;R2>
<15,H;Hydroxylation;R3>

>  <CYP2C9>  (373) 


>  <CYP2C19>  (373) 


>  <CYP2D6>  (373) 


>  <CYP2E1>  (373) 


>  <CYP3A4>  (373) 
<12,H;Hydroxylation;R1>
<15,H;Hydroxylation;R1>
<10,11;Oxidation;R2>
<15,H;Hydroxylation;R3>

>  <References>  (373) 
Prueksaritanont T, Gorham LM, Ma B, Liu L, Yu X, Zhao JJ, Slaughter DE, Arison BH, Vyas KP: In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s. Drug Metab Dispos. 1997 Oct;25(10):1191-9. (PMID: 9321523)
Prueksaritanont T, Ma B, Yu N: The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6. Br J Clin Pharmacol. 2003 Jul;56(1):120-4. doi: 10.1046/j.1365-2125.2003.01833.x. (PMID: 12848784)

>  <Comments>  (373) 


$$$$
CC02225
     RDKit          3D

 24 25  0  0  0  0  0  0  0  0999 V2000
    0.2860    1.5710   -0.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0520    0.2000    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9180    2.1830   -0.3340 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7780    2.4420    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0980   -0.7130   -0.0860 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2580   -0.2340    0.2280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4120    1.6540   -1.8230 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7870    3.5930   -0.4490 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7390    1.5070    0.6080 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0040    1.9910    0.2250 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8710   -1.0260    1.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2650    0.7010    0.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7730    2.0720   -2.9340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9310   -1.9170    0.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5840   -0.4440    2.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1110    1.5680   -4.1370 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8900    2.9040   -2.8500 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6930   -2.2240    2.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3500   -0.7550    3.3690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4160    2.0230   -5.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4010   -1.6460    3.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8430   -3.1900    1.9120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0740    3.3040   -5.8590 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5000    0.9380   -6.4190 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  3  9  2  0
  4 10  2  0
  5 11  1  0
  6 12  2  0
  7 13  1  0
 10 12  1  0
 11 14  2  0
 11 15  1  0
 13 16  1  0
 13 17  2  0
 14 18  1  0
 15 19  2  0
 16 20  1  0
 18 21  2  0
 18 22  1  0
 19 21  1  0
 20 23  1  0
 20 24  1  0
M  END
>  <Name>  (374) 
Torasemide

>  <InChIKey>  (374) 
NGBFQHCMQULJNZ-UHFFFAOYSA-N

>  <PubChem_CID>  (374) 
41781

>  <CYP1A2>  (374) 


>  <CYP2A6>  (374) 


>  <CYP2B6>  (374) 


>  <CYP2C8>  (374) 
<0,H;Hydroxylation;R1>

>  <CYP2C9>  (374) 
<0,H;Hydroxylation;R1>

>  <CYP2C19>  (374) 


>  <CYP2D6>  (374) 


>  <CYP2E1>  (374) 


>  <CYP3A4>  (374) 


>  <References>  (374) 
Miners JO, Coulter S, Birkett DJ, Goldstein JA: Torsemide metabolism by CYP2C9 variants and other human CYP2C subfamily enzymes. Pharmacogenetics. 2000 Apr;10(3):267-70. (PMID: 10803683)
Miners JO, Rees DL, Valente L, Veronese ME, Birkett DJ: Human hepatic cytochrome P450 2C9 catalyzes the rate-limiting pathway of torsemide metabolism. J Pharmacol Exp Ther. 1995 Mar;272(3):1076-81. (PMID: 7891318)

>  <Comments>  (374) 


$$$$
CC02226
     RDKit          3D

 10 10  0  0  0  0  0  0  0  0999 V2000
    1.1480    0.3300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2940   -0.9220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1740    1.4180   -0.0010 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9830   -0.4900    0.0010 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0440    0.8520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0810    1.4830   -0.0010 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1540   -1.3710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6790   -2.0720   -0.0010 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0170    0.3880    1.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0190    0.3870   -1.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  9  1  0
  1 10  1  0
  2  4  1  0
  2  8  2  0
  3  5  1  0
  4  5  1  0
  4  7  1  0
  5  6  2  0
M  END
>  <Name>  (375) 
Trimethadione

>  <InChIKey>  (375) 
IRYJRGCIQBGHIV-UHFFFAOYSA-N

>  <PubChem_CID>  (375) 
5576

>  <CYP1A2>  (375) 


>  <CYP2A6>  (375) 


>  <CYP2B6>  (375) 


>  <CYP2C8>  (375) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C9>  (375) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (375) 


>  <CYP2D6>  (375) 


>  <CYP2E1>  (375) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP3A4>  (375) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (375) 
Tanaka E, Kurata N, Yasuhara H: Involvement of cytochrome P450 2C9, 2E1 and 3A4 in trimethadione N-demethylation in human microsomes. J Clin Pharm Ther. 2003 Dec;28(6):493-6. (PMID: 14651673)
Kurata N, Nishimura Y, Iwase M, Fischer NE, Tang BK, Inaba T, Yasuhara H: Trimethadione metabolism by human liver cytochrome P450: evidence for the involvement of CYP2E1. Xenobiotica. 1998 Nov;28(11):1041-7. doi: 10.1080/004982598238930. (PMID: 9879636)

>  <Comments>  (375) 


$$$$
CC02227
     RDKit          3D

 23 25  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.3830    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2160   -0.6760   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4050    0.0270   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4030    1.4140   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1950    2.0990    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2950    2.1320    0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3360    1.5600    0.2910 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1530    3.5780    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1550    4.2210    0.2440 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1320    4.2640   -0.2770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1420    5.5900   -0.5480 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2920    3.5700   -0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5920    4.2780   -0.5470 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.2560    3.6480   -1.7730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5760    4.3660   -2.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5050    4.2340   -0.8550 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.8410    4.8630    0.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5210    4.1450    0.6610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8240    4.9520   -1.1450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4890    4.3230   -2.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7540    4.8190    0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5500    6.4320   -1.4170 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  9  1  0
  7  8  2  0
  7 13  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 11 13  2  0
 14 13  1  1
 14 15  1  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 20  1  6
 18 19  1  0
 20 21  1  0
 20 22  1  0
 20 23  1  0
M  END
>  <Name>  (376) 
58C80

>  <InChIKey>  (376) 
NWCVRXADYNRXCT-JOCQHMNTSA-N

>  <PubChem_CID>  (376) 


>  <CYP1A2>  (376) 


>  <CYP2A6>  (376) 


>  <CYP2B6>  (376) 


>  <CYP2C8>  (376) 


>  <CYP2C9>  (376) 
<3,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>
<0,H;Hydroxylation;R3>

>  <CYP2C19>  (376) 


>  <CYP2D6>  (376) 


>  <CYP2E1>  (376) 


>  <CYP3A4>  (376) 


>  <References>  (376) 
Weaver RJ, Dickins M, Burke MD: Cytochrome P450 2C9 is responsible for hydroxylation of the naphthoquinone antimalarial drug 58C80 in human liver. Biochem Pharmacol. 1993 Oct 5;46(7):1183-97. doi: 10.1016/0006-2952(93)90467-b. (PMID: 8216369)

>  <Comments>  (376) 


$$$$
CC02228
     RDKit          3D

 26 28  0  0  0  0  0  0  0  0999 V2000
   -2.4920    1.2550    0.4750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580    0.2980   -0.4720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1080   -0.2840   -0.4130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9970    0.0800    0.5820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6410    1.0290    1.5240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3940    1.6180    1.4770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8910   -0.0990   -1.5580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1530    1.8780    0.4220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1640    1.1840    0.2880 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0280    3.2170    0.5210 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2380    3.7950    0.6100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4090    5.1570    0.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6740    5.7350    0.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7550    4.9630    0.7730 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5860    3.6180    1.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3350    3.0330    0.9840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2230    4.0680    0.5280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0220    5.2150   -0.4730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7670    5.9610   -0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7240    7.2550   -0.0840 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8650    7.9990   -0.4710 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4860    9.4700   -0.3730 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5920    9.7890   -1.5620 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6890   10.1940   -0.5890 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6550    9.5780    0.7750 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9560    2.6590    1.5310 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  8  1  0
  2  3  1  0
  2  7  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 10 17  1  0
 11 12  1  0
 11 16  2  0
 12 13  2  0
 12 19  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 26  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
 22 25  2  0
M  END
>  <Name>  (377) 
M17055

>  <InChIKey>  (377) 
QQCSUWGQBREWRO-XDJHFCHBSA-N

>  <PubChem_CID>  (377) 
6338015

>  <CYP1A2>  (377) 


>  <CYP2A6>  (377) 


>  <CYP2B6>  (377) 


>  <CYP2C8>  (377) 


>  <CYP2C9>  (377) 
<0,H;Hydroxylation;R1>

>  <CYP2C19>  (377) 


>  <CYP2D6>  (377) 


>  <CYP2E1>  (377) 


>  <CYP3A4>  (377) 
<0,H;Hydroxylation;R1>

>  <References>  (377) 
Nakajima H, Nakanishi T, Nakai K, Matsumoto S, Ida K, Ogihara T, Ohzawa N: Studies on the metabolic fate of M17055, a novel diuretic (4): species difference in metabolic pathway and identification of human CYP isoform responsible for the metabolism of M17055. Drug Metab Pharmacokinet. 2002;17(1):60-74. (PMID: 15618654)

>  <Comments>  (377) 


$$$$
CC02229
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.1250    1.7240   -0.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3130    0.3590   -0.4920 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5890   -0.1420   -0.6470 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6810    0.7050   -0.5820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5020    2.0600   -0.3620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2310    2.5730   -0.2060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2400    2.2690   -0.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7180    3.1310    0.8420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0420    3.5080    0.7870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8300    3.0160   -0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6910    1.9810   -1.1080 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.0720    0.1510   -0.7520 C   0  0  1  0  0  0  0  0  0  0  0  0
    4.7420    0.8150   -1.9560 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8790    0.4300    0.4900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3770    1.0200    1.4170 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1570    0.0250    0.5650 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8140    3.6560    1.9270 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4 12  1  0
  5  6  2  0
  7  8  2  0
  7 11  1  0
  8  9  1  0
  8 17  1  0
  9 10  2  0
 10 11  1  0
 12 13  1  6
 12 14  1  0
 14 15  2  0
 14 16  1  0
M  END
>  <Name>  (378) 
S-MTPPA

>  <InChIKey>  (378) 
DTOPKPBTCXKNFF-SNVBAGLBSA-N

>  <PubChem_CID>  (378) 
127523

>  <CYP1A2>  (378) 


>  <CYP2A6>  (378) 


>  <CYP2B6>  (378) 


>  <CYP2C8>  (378) 


>  <CYP2C9>  (378) 
<3,H;Hydroxylation;R1>

>  <CYP2C19>  (378) 


>  <CYP2D6>  (378) 


>  <CYP2E1>  (378) 


>  <CYP3A4>  (378) 


>  <References>  (378) 
Taguchi K, Konishi T, Nishikawa H, Kitamura S: Identification of human cytochrome P450 isoforms involved in the metabolism of S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid. Xenobiotica. 1999 Sep;29(9):899-907. doi: 10.1080/004982599238146. (PMID: 10548450)

>  <Comments>  (378) 


$$$$
CC02230
     RDKit          3D

 23 24  0  0  0  0  0  0  0  0999 V2000
    0.0560    1.2790    0.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2040   -0.0920    0.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1820    2.1010    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2160    1.8300   -0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5810   -0.6950    0.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9120   -0.9020    0.3110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0380    2.0220   -1.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3280    1.0130    0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0560   -0.6150    1.7750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1770   -0.3500    0.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5500    1.5960   -2.3320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3760    2.3740   -0.9730 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2650   -1.0940    2.1080 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3480   -0.1190    2.6200 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3980    1.5200   -3.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1220    1.1610   -2.5000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.2180    2.2950   -2.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9890    2.9130    0.5590 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.7220   -1.0170    3.4840 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7300    1.8660   -3.2870 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0990   -1.6190    3.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7260   -1.6580    4.7770 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6400   -2.0680    2.6070 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  1  0
  6 10  2  0
  7 11  2  0
  7 12  1  0
  8 10  1  0
  9 13  1  0
  9 14  2  0
 11 15  1  0
 11 16  1  0
 12 17  2  0
 12 18  1  0
 13 19  1  0
 15 20  2  0
 17 20  1  0
 19 21  1  0
 21 22  1  0
 21 23  2  0
M  END
>  <Name>  (379) 
Aceclofenac

>  <InChIKey>  (379) 
MNIPYSSQXLZQLJ-UHFFFAOYSA-N

>  <PubChem_CID>  (379) 
71771

>  <CYP1A2>  (379) 


>  <CYP2A6>  (379) 


>  <CYP2B6>  (379) 


>  <CYP2C8>  (379) 


>  <CYP2C9>  (379) 
<19,H;Hydroxylation;R1>

>  <CYP2C19>  (379) 


>  <CYP2D6>  (379) 


>  <CYP2E1>  (379) 


>  <CYP3A4>  (379) 


>  <References>  (379) 
Bort R, Ponsoda X, Carrasco E, Gomez-Lechon MJ, Castell JV: Metabolism of aceclofenac in humans. Drug Metab Dispos. 1996 Aug;24(8):834-41. (PMID: 8869816)

>  <Comments>  (379) 


$$$$
CC02231
     RDKit          3D

 39 42  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3940    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2380   -0.6490   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3470    0.0800   -0.0200 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2900    1.4040   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1360    2.0540    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5550    2.1810   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7120    1.5330   -0.0340 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8560    2.1940   -0.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8370    3.5810   -0.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6090    4.2260   -0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5010    3.5050   -0.0180 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1560   -0.7170    0.0100 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5040   -0.9160   -1.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6610   -1.6240   -1.6020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0130   -1.8190   -2.9270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2170   -1.3110   -3.9360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0680   -0.6080   -3.6270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7100   -0.4090   -2.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4430   -2.1240   -0.6080 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5380   -2.7890   -1.2390 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3070   -2.0040   -0.0210 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6940   -2.3480   -0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8420   -3.8700   -0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3100   -4.3940   -1.2640 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2230    2.0820    0.0190 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2320    3.7380    0.0280 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6000    4.1170   -0.0200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3070    4.1230    1.0360 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5310    4.2760   -1.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3440    4.4850   -2.5950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7950    4.9130   -3.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5670    5.1330   -3.8840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3790    4.9260   -2.7860 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8300    4.4960   -1.5920 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1650    5.5990   -5.1870 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5450    6.9410   -5.5820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6770    5.7640   -5.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8810    4.5640   -6.2780 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  1 26  1  0
  2  3  2  0
  2 13  1  0
  3  4  1  0
  3 22  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  7 12  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 13 14  1  0
 14 15  2  0
 14 19  1  0
 15 16  1  0
 15 20  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 20 21  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 26 27  1  0
 27 28  2  0
 27 29  2  0
 27 30  1  0
 30 31  2  0
 30 35  1  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 33 36  1  0
 34 35  2  0
 36 37  1  0
 36 38  1  0
 36 39  1  0
M  END
>  <Name>  (380) 
Bosentan

>  <InChIKey>  (380) 
GJPICJJJRGTNOD-UHFFFAOYSA-N

>  <PubChem_CID>  (380) 
104865

>  <CYP1A2>  (380) 


>  <CYP2A6>  (380) 


>  <CYP2B6>  (380) 


>  <CYP2C8>  (380) 


>  <CYP2C9>  (380) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<20,H;Hydroxylation;R2>
<21,H;Hydroxylation;R3>
<22,H;Hydroxylation;R4>

>  <CYP2C19>  (380) 


>  <CYP2D6>  (380) 


>  <CYP2E1>  (380) 


>  <CYP3A4>  (380) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<20,H;Hydroxylation;R2>
<21,H;Hydroxylation;R3>
<22,H;Hydroxylation;R4>

>  <References>  (380) 
van Giersbergen PL, Treiber A, Clozel M, Bodin F, Dingemanse J: In vivo and in vitro studies exploring the pharmacokinetic interaction between bosentan, a dual endothelin receptor antagonist, and glyburide. Clin Pharmacol Ther. 2002 Apr;71(4):253-62. doi: 10.1067/mcp.2002.122473. (PMID: 11956508)
van Giersbergen PL, Popescu G, Bodin F, Dingemanse J: Influence of mild liver impairment on the pharmacokinetics and metabolism of bosentan, a dual endothelin receptor antagonist. J Clin Pharmacol. 2003 Jan;43(1):15-22. (PMID: 12520623)
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (380) 


$$$$
CC02232
     RDKit          3D

 21 23  0  0  0  0  0  0  0  0999 V2000
   -0.1110    1.2680   -0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1510   -0.0980   -0.0240 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1740    1.6840   -0.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2640    2.2370    0.0450 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.1170   -0.5990   -0.1180 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0050    0.5060   -0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2780    1.7340    1.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3790    2.7510    1.2330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7630    3.5140    0.4490 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6040   -1.9040   -0.1380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3850    3.7470    0.5490 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5390    3.1460   -0.2170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3530    2.5500    2.1340 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2380    3.9230   -0.4810 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3870    0.3160   -0.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9400    2.3580   -1.3230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8370   -0.9810   -0.3290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9740   -2.0610   -0.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6790   -3.0910   -0.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5760    1.0180   -1.6980 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1530   -3.4350   -1.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  3  6  1  0
  3 12  1  0
  4  7  1  1
  4  9  1  0
  4 16  1  0
  5  6  2  0
  5 10  1  0
  6 15  1  0
  7  8  1  0
  8 11  2  0
  8 13  1  0
  9 14  1  0
 10 18  2  0
 10 19  1  0
 12 14  1  0
 15 17  2  0
 16 20  1  0
 17 18  1  0
 19 21  1  0
M  END
>  <Name>  (381) 
Etodolac

>  <InChIKey>  (381) 
NNYBQONXHNTVIJ-QGZVFWFLSA-N

>  <PubChem_CID>  (381) 
667528

>  <CYP1A2>  (381) 


>  <CYP2A6>  (381) 


>  <CYP2B6>  (381) 


>  <CYP2C8>  (381) 


>  <CYP2C9>  (381) 
<3,H;Hydroxylation;R1>
<4,H;Hydroxylation;R2>

>  <CYP2C19>  (381) 


>  <CYP2D6>  (381) 


>  <CYP2E1>  (381) 


>  <CYP3A4>  (381) 


>  <References>  (381) 
Tougou K, Gotou H, Ohno Y, Nakamura A: Stereoselective glucuronidation and hydroxylation of etodolac by UGT1A9 and CYP2C9 in man. Xenobiotica. 2004 May;34(5):449-61. doi: 10.1080/00498250410001691280. (PMID: 15370961)

>  <Comments>  (381) 


$$$$
CC02234
     RDKit          3D

 21 25  0  0  0  0  0  0  0  0999 V2000
    1.2300   -0.0770   -0.0950 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9390    1.0940   -0.1360 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9890    2.1040    0.2240 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.4520    1.4690   -0.5500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7300    3.4550   -0.4250 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.2280    1.6830   -0.4250 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4150    2.7030   -1.4550 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3760    3.2630   -1.7750 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2850    3.8340   -0.7080 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.4250    4.5990    0.3110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2650    2.2020   -1.6710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0670    3.9360   -2.9340 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3020    5.1010   -1.5640 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.3290    5.8540   -0.5670 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0150    1.8640   -2.8030 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9530    4.9320   -2.9250 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8160    3.5940   -4.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9270    6.1940   -0.8150 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9430    0.8710   -2.7690 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7670    2.5910   -3.9660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9270    7.3660   -1.7000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  2  4  1  0
  3  5  1  0
  3  6  1  6
  4  7  1  0
  5  8  1  0
  5  9  1  0
  5 10  1  1
  6 11  1  0
  9  7  1  6
  8 11  2  0
  8 12  1  0
  9 13  1  0
 10 14  1  0
 11 15  1  0
 12 16  1  0
 12 17  2  0
 13 16  1  6
 13 18  1  0
 14 18  1  0
 15 19  1  0
 15 20  2  0
 17 20  1  0
 18 21  1  0
M  END
>  <Name>  (382) 
Hydromorphone

>  <InChIKey>  (382) 
WVLOADHCBXTIJK-ZWUPXRALSA-N

>  <PubChem_CID>  (382) 
118324209

>  <CYP1A2>  (382) 


>  <CYP2A6>  (382) 


>  <CYP2B6>  (382) 


>  <CYP2C8>  (382) 


>  <CYP2C9>  (382) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (382) 


>  <CYP2D6>  (382) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (382) 


>  <CYP3A4>  (382) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (382) 
Benetton SA, Borges VM, Chang TK, McErlane KM: Role of individual human cytochrome P450 enzymes in the in vitro metabolism of hydromorphone. Xenobiotica. 2004 Apr;34(4):335-44. doi: 10.1080/00498250310001657559. (PMID: 15268978)

>  <Comments>  (382) 


$$$$
CC02235
     RDKit          3D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4180    2.0340   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7520    2.0110   -1.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7260    1.9900    1.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1850   -0.7100    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2090   -0.6780   -0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3900    3.5630   -0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7160    3.5410   -1.2510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1620    1.6060    1.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1430    2.6880    2.0420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1650   -2.0980    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2310   -2.0610   -0.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6790    4.0000   -1.2620 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6370    2.2270    2.8110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0470   -2.7720   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3320   -2.7950    0.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7520    5.4580   -1.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  2  6  2  0
  2  7  1  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  2  0
  6 12  1  0
  7 13  2  0
  8 14  1  0
  9 14  1  0
 10 15  1  0
 12 16  2  0
 12 17  1  0
 13 16  1  0
 14 18  1  0
M  END
>  <Name>  (383) 
Ketobemidone

>  <InChIKey>  (383) 
ALFGKMXHOUSVAD-UHFFFAOYSA-N

>  <PubChem_CID>  (383) 
10101

>  <CYP1A2>  (383) 


>  <CYP2A6>  (383) 


>  <CYP2B6>  (383) 


>  <CYP2C8>  (383) 


>  <CYP2C9>  (383) 
<14,15;Cleavage;R1>
<15,H;Oxidation;R1>

>  <CYP2C19>  (383) 


>  <CYP2D6>  (383) 


>  <CYP2E1>  (383) 


>  <CYP3A4>  (383) 
<14,15;Cleavage;R1>
<15,H;Oxidation;R1>

>  <References>  (383) 
Yasar U, Annas A, Svensson JO, Lazorova L, Artursson P, Al-Shurbaji A: Ketobemidone is a substrate for cytochrome P4502C9 and 3A4, but not for P-glycoprotein. Xenobiotica. 2005 Aug;35(8):785-96. doi: 10.1080/00498250500183181. (PMID: 16278191)

>  <Comments>  (383) 


$$$$
CC02236
     RDKit          3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -0.0040    1.7260   -0.3100 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.1380    0.0000    0.1140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2810   -0.6770   -0.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4470    1.2840   -1.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5700    2.1850   -0.6150 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3430   -0.0840   -1.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4800    1.8060   -2.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7620   -0.7390    0.8430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0500   -2.3180    0.2740 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5190   -2.0570    1.0910 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5050    3.1200   -2.3540 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6840    1.7760   -1.5560 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3920    2.3980    0.8800 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4730    3.6200   -3.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3490    1.0670   -2.4880 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2900    4.7970   -3.8000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2510   -0.8840   -1.7260 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0360    3.5180   -0.2270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4880   -3.1940    1.9760 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.1810    5.3070   -4.6280 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6240    2.8810   -3.4680 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3460    4.6250   -4.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5780    3.3900   -4.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  1  0
  1 12  2  0
  1 13  2  0
  2  3  2  0
  2  8  1  0
  3  6  1  0
  3  9  1  0
  4  5  1  0
  4  6  2  0
  4  7  1  0
  5 18  1  0
  6 17  1  0
  7 11  1  0
  7 15  2  0
  8 10  2  0
  9 10  1  0
 10 19  1  0
 11 14  1  0
 14 16  2  0
 14 21  1  0
 16 20  1  0
 20 22  2  0
 21 23  2  0
 22 23  1  0
M  END
>  <Name>  (384) 
Lornoxicam

>  <InChIKey>  (384) 
WLHQHAUOOXYABV-UHFFFAOYSA-N

>  <PubChem_CID>  (384) 
54690031

>  <CYP1A2>  (384) 


>  <CYP2A6>  (384) 


>  <CYP2B6>  (384) 


>  <CYP2C8>  (384) 


>  <CYP2C9>  (384) 
<9,H;Hydroxylation;R1>

>  <CYP2C19>  (384) 


>  <CYP2D6>  (384) 


>  <CYP2E1>  (384) 


>  <CYP3A4>  (384) 


>  <References>  (384) 
Iida I, Miyata A, Arai M, Hirota M, Akimoto M, Higuchi S, Kobayashi K, Chiba K: Catalytic roles of CYP2C9 and its variants (CYP2C9*2 and CYP2C9*3) in lornoxicam 5'-hydroxylation. Drug Metab Dispos. 2004 Jan;32(1):7-9. doi: 10.1124/dmd.32.1.7. (PMID: 14709614)

>  <Comments>  (384) 


$$$$
CC02237
     RDKit          3D

 30 33  0  0  0  0  0  0  0  0999 V2000
    4.5640    0.2640    1.7520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6670   -0.2030    0.7750 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1940   -0.7420   -0.4210 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5890   -0.8020   -0.5750 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4580   -0.3400    0.4090 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9430    0.2000    1.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2370   -0.1140    1.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6030    1.1300    1.1710 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2430    1.2180    1.4590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5070    0.0610    1.6590 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1180   -1.1840    1.5920 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4790   -1.2690    1.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3680   -1.2190   -1.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0810   -1.0270   -1.7520 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7820   -1.6700   -2.9270 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8570   -2.2470   -3.4390 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8480   -1.9680   -2.5800 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9690    0.1260    1.9680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7510    0.6150    0.8440 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3920    1.8260    0.7930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0090    1.8440   -0.4390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7640    0.6790   -1.1220 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0060   -0.0500   -0.3290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4730   -1.3960   -0.6340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4560   -2.4640   -0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8790   -3.8240   -0.5250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8600   -4.8920   -0.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9700    3.0930   -1.0800 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -3.3860    2.8150    1.8870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1710    3.5400    1.7890 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  2  7  1  0
  3  4  2  0
  3 13  1  0
  4  5  1  0
  5  6  2  0
  7  8  2  0
  7 12  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 18  1  0
 11 12  2  0
 13 14  2  0
 13 17  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 18 19  1  0
 19 20  1  0
 19 23  1  0
 20 21  2  0
 20 29  1  0
 21 22  1  0
 21 28  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 29 30  1  0
M  END
>  <Name>  (385) 
Losartan

>  <InChIKey>  (385) 
PSIFNNKUMBGKDQ-UHFFFAOYSA-N

>  <PubChem_CID>  (385) 
3961

>  <CYP1A2>  (385) 


>  <CYP2A6>  (385) 


>  <CYP2B6>  (385) 


>  <CYP2C8>  (385) 


>  <CYP2C9>  (385) 
<1,H;Hydroxylation;R1>
<3,H;Hydroxylation;R2>
<9,10;Oxidation;R3>

>  <CYP2C19>  (385) 


>  <CYP2D6>  (385) 


>  <CYP2E1>  (385) 


>  <CYP3A4>  (385) 
<1,H;Hydroxylation;R1>
<3,H;Hydroxylation;R2>
<9,10;Oxidation;R3>

>  <References>  (385) 
Stearns RA, Chakravarty PK, Chen R, Chiu SH: Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members. Drug Metab Dispos. 1995 Feb;23(2):207-15. (PMID: 7736913)

>  <Comments>  (385) 


$$$$
CC02238
     RDKit          3D

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.0110    1.3680    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6450    1.1710   -1.1840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2130    2.0620    0.0880 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5510    0.8690    1.2110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8540    0.4710   -1.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0630    1.7000   -2.4290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2160    3.4580    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7480    0.1840    1.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3930   -0.0210   -0.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7310    1.5720   -3.5930 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0200    2.2510   -2.4080 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4190    4.1490   -0.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0160    4.1580    0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4180    5.5290   -0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7230    3.3940   -0.0560 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0220    5.5380   -0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2220    6.2230   -0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7230    6.2800   -0.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  2  0
  6 10  1  0
  6 11  2  0
  7 12  2  0
  7 13  1  0
  8  9  1  0
 12 14  1  0
 12 15  1  0
 13 16  2  0
 14 17  2  0
 14 18  1  0
 16 17  1  0
M  END
>  <Name>  (386) 
Mefenamic acid

>  <InChIKey>  (386) 
HYYBABOKPJLUIN-UHFFFAOYSA-N

>  <PubChem_CID>  (386) 
4044

>  <CYP1A2>  (386) 


>  <CYP2A6>  (386) 


>  <CYP2B6>  (386) 


>  <CYP2C8>  (386) 


>  <CYP2C9>  (386) 
<0,H;Hydroxylation;R1>

>  <CYP2C19>  (386) 


>  <CYP2D6>  (386) 


>  <CYP2E1>  (386) 


>  <CYP3A4>  (386) 


>  <References>  (386) 
Bonnabry P, Leemann T, Dayer P: Biotransformation by hepatic P450TB (CYP2C) controls mefenamic acid elimination Clin Pharmacol Ther. 1994;55:139. doi: 10.1038/clpt.1994.20.

>  <Comments>  (386) 


$$$$
CC02239
     RDKit          3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -2.8940   -1.0630    0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4440   -1.2730   -0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4370    0.2260   -0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7920    0.4250    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6360   -0.6610    0.2360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1150   -1.9410    0.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7560   -2.1510    0.2170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3300    1.5840   -0.2670 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5220   -0.2960    0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8700    1.0430    0.3290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7670    2.6050    0.6200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1580    1.7210   -1.6710 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0020   -2.5300   -0.3010 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8520   -0.6340   -0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7850    0.3390   -0.0520 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1330    0.0080   -0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1880   -1.8020   -0.1020 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6930   -1.1860    0.0350 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5150    1.0590   -0.0450 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.0040   -1.3250    0.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7720   -0.2090    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2730   -0.0750    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0160    1.9290    1.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  7  1  0
  2  9  2  0
  2 13  1  0
  3  4  1  0
  3  8  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  8 10  1  0
  8 11  2  0
  8 12  2  0
  9 10  1  0
  9 14  1  0
 10 23  1  0
 14 15  1  0
 14 17  2  0
 15 16  1  0
 16 18  2  0
 16 19  1  0
 18 20  1  0
 19 21  1  0
 20 21  2  0
 21 22  1  0
M  END
>  <Name>  (387) 
Meloxicam

>  <InChIKey>  (387) 
ZRVUJXDFFKFLMG-UHFFFAOYSA-N

>  <PubChem_CID>  (387) 
54677470

>  <CYP1A2>  (387) 


>  <CYP2A6>  (387) 


>  <CYP2B6>  (387) 


>  <CYP2C8>  (387) 


>  <CYP2C9>  (387) 
<0,H;Hydroxylation;R1>

>  <CYP2C19>  (387) 


>  <CYP2D6>  (387) 


>  <CYP2E1>  (387) 


>  <CYP3A4>  (387) 
<0,H;Hydroxylation;R1>

>  <References>  (387) 
Chesne C, Guyomard C, Guillouzo A, Schmid J, Ludwig E, Sauter T: Metabolism of Meloxicam in human liver involves cytochromes P4502C9 and 3A4. Xenobiotica. 1998 Jan;28(1):1-13. doi: 10.1080/004982598239704. (PMID: 9493314)

>  <Comments>  (387) 


$$$$
CC02240
     RDKit          3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -0.0060    1.1520    0.6750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0050   -0.2240    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2440    1.9220    0.6440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2200    1.7850    0.9620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5390   -1.0020    0.0490 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1730   -0.9450    0.4400 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3920    1.4880    0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2450    3.1490    1.2190 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3880    1.0530    0.9820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5020    0.2270   -0.5350 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0960   -1.3810    1.3000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2950   -1.8700   -1.0490 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3690   -0.3080    0.7300 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5300    2.3340    0.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4270    0.0030   -1.6490 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7680    1.8000    0.1110 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3890    3.5440    0.1410 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8820    2.6240    0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7870    3.9730   -0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0200    2.1150    0.7010 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9010    4.7800    0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0980    2.8590    0.8520 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0770    4.2060    0.5490 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  5 11  2  0
  5 12  2  0
  6 13  2  0
  7 10  1  0
  7 14  1  0
  9 13  1  0
 10 15  1  0
 14 16  1  0
 14 17  2  0
 16 18  1  0
 18 19  2  0
 18 20  1  0
 19 21  1  0
 20 22  2  0
 21 23  2  0
 22 23  1  0
M  END
>  <Name>  (388) 
Piroxicam

>  <InChIKey>  (388) 
QYSPLQLAKJAUJT-UHFFFAOYSA-N

>  <PubChem_CID>  (388) 
54676228

>  <CYP1A2>  (388) 


>  <CYP2A6>  (388) 


>  <CYP2B6>  (388) 


>  <CYP2C8>  (388) 


>  <CYP2C9>  (388) 
<9,H;Hydroxylation;R1>

>  <CYP2C19>  (388) 


>  <CYP2D6>  (388) 


>  <CYP2E1>  (388) 


>  <CYP3A4>  (388) 


>  <References>  (388) 
Hutzler JM, Hauer MJ, Tracy TS: Dapsone activation of CYP2C9-mediated metabolism: evidence for activation of multiple substrates and a two-site model. Drug Metab Dispos. 2001 Jul;29(7):1029-34. (PMID: 11408370)

>  <Comments>  (388) 


$$$$
CC02241
     RDKit          3D

 26 28  0  0  0  0  0  0  0  0999 V2000
   -1.1880   -0.1480    1.5680 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.2350    1.3720    1.8480 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.6830   -0.5670    1.4180 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.5700   -0.8560    2.6920 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7530    1.7280    1.8410 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.5010    2.1390    0.7460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2810    0.7240    0.7560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2680   -0.4490    2.8590 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3710   -2.1900    2.4130 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3140    1.0710    3.1390 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9680    1.8110    0.7980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6730   -3.4400    1.7410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7620   -2.6610    3.6950 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2590   -1.8240    1.3650 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8530    2.7760    0.8500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3180   -4.3270    2.5820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8430   -3.5370    0.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4160    4.2090    0.6860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1370   -5.3080    2.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6620   -4.5180   -0.1540 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2350    4.8680   -0.4250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3110   -5.4020    0.6870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7910    6.3230   -0.5910 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5970    6.9730   -1.6860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3790    8.2570   -2.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4400    6.3370   -2.2740 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  1
  2  5  1  0
  2  6  1  6
  3  7  1  0
  3  8  1  1
  4  9  1  0
  5  7  1  0
  5 10  1  1
  6 11  1  0
  8 10  1  0
  9 12  1  0
  9 13  2  0
  9 14  2  0
 11 15  2  0
 12 16  2  0
 12 17  1  0
 15 18  1  0
 16 19  1  0
 17 20  2  0
 18 21  1  0
 19 22  2  0
 20 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  2  0
M  END
>  <Name>  (389) 
S-145

>  <InChIKey>  (389) 
PWTCIBWRMQFJBC-ZEMKZVSASA-N

>  <PubChem_CID>  (389) 
5312138

>  <CYP1A2>  (389) 


>  <CYP2A6>  (389) 


>  <CYP2B6>  (389) 


>  <CYP2C8>  (389) 


>  <CYP2C9>  (389) 
<11,H;Hydroxylation;R1>

>  <CYP2C19>  (389) 


>  <CYP2D6>  (389) 


>  <CYP2E1>  (389) 


>  <CYP3A4>  (389) 
<12,H;Hydroxylation;R1>

>  <References>  (389) 
Yamaguchi Y, Kirita S, Baba T, Aoyama J, Touchi A, Tukey RH, Guengerich FP, Matsubara T: Identification of rat and human cytochrome P450 forms involved in the metabolism of the thromboxane A2 receptor antagonist (+)-S-145. Drug Metab Dispos. 1997 Jan;25(1):75-80. (PMID: 9010633)

>  <Comments>  (389) 


$$$$
CC02243
     RDKit          3D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -5.1650   -0.3550   -0.4150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8180   -1.3400   -0.9830 S   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3960   -0.4230   -1.0560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4500    0.3460   -0.6040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2820    1.1830    0.4840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0580    1.2530    1.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9990    0.4870    0.6780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5390   -0.8360    0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2390   -1.5840   -0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1600   -1.1600    0.8940 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1510   -1.8510    0.5840 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0360   -0.8750    0.3040 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4560    0.3870    0.3950 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1540    0.3140    0.7410 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1400    1.5850    0.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3750   -1.1020   -0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1560   -1.9470    0.7430 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4770   -2.1690    0.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0210   -1.5520   -0.7050 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2460   -0.7100   -1.4820 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9230   -0.4880   -1.1530 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5940    2.5420   -0.6870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2710    3.7240   -0.9180 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4910    3.9530   -0.3100 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0380    3.0010    0.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3630    1.8200    0.7710 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3630   -3.0450    0.5870 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6130    1.2410    0.8980 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  7  1  0
  2  8  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 14  1  0
 11 12  1  0
 11 27  2  0
 12 13  1  0
 12 16  1  0
 13 14  1  0
 13 15  1  0
 14 28  2  0
 15 22  2  0
 15 26  1  0
 16 17  2  0
 16 21  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
M  END
>  <Name>  (390) 
Sulfinpyrazone sulfide

>  <InChIKey>  (390) 
PLGXGMUJUXKCDD-UHFFFAOYSA-N

>  <PubChem_CID>  (390) 
77327

>  <CYP1A2>  (390) 


>  <CYP2A6>  (390) 


>  <CYP2B6>  (390) 


>  <CYP2C8>  (390) 


>  <CYP2C9>  (390) 
<5,S;S-Oxidation;R1>
<9,H;Hydroxylation;R2>
<25,H;Hydroxylation;R3>
<18,H;Hydroxylation;R4>

>  <CYP2C19>  (390) 


>  <CYP2D6>  (390) 


>  <CYP2E1>  (390) 


>  <CYP3A4>  (390) 
<5,S;S-Oxidation;R1>
<9,H;Hydroxylation;R2>
<25,H;Hydroxylation;R3>
<18,H;Hydroxylation;R4>

>  <References>  (390) 
He M, Rettie AE, Neal J, Trager WF: Metabolism of sulfinpyrazone sulfide and sulfinpyrazone by human liver microsomes and cDNA-expressed cytochrome P450s. Drug Metab Dispos. 2001 May;29(5):701-11. (PMID: 11302937)

>  <Comments>  (390) 


$$$$
CC02244
     RDKit          3D

 32 34  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4780    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1800    2.1970    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2360    2.1640    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4880   -0.7160    1.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5050   -0.6910   -1.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1530    3.5830    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3690    1.5400   -0.0110 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2460    3.5500    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4060    1.4750    0.0210 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4660   -2.0960    1.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5220   -2.0710   -1.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0560    4.2540    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3930    2.5370   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4560    2.4440    0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0400   -2.7720   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0620   -4.2790   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2440   -4.8050   -0.6210 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.3640   -4.4380    0.2500 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1730   -6.3050   -0.7420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6060   -4.3260   -0.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2190   -6.8730   -1.4950 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9760   -6.9970   -0.1610 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7350   -3.9560    0.6160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7970   -4.5290   -1.4450 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4730   -4.9480    1.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0670   -2.6110    0.8040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5270   -4.5940    2.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0670   -6.6210    1.0460 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -6.1240   -2.2730    1.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1530   -1.3690    0.0060 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -6.8530   -3.2610    2.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5 11  1  0
  6 12  2  0
  7 13  2  0
  8 14  1  0
  9 13  1  0
 10 15  1  0
 11 16  2  0
 12 16  1  0
 16 17  1  0
 18 17  1  1
 18 19  1  0
 18 20  1  0
 19 21  1  0
 20 22  1  0
 20 23  2  0
 21 24  1  0
 21 25  2  0
 24 26  2  0
 24 27  1  0
 26 28  1  0
 26 29  1  0
 27 30  2  0
 27 31  1  0
 28 32  2  0
 30 32  1  0
M  END
>  <Name>  (391) 
TR-14035

>  <InChIKey>  (391) 
DRSJLVGDSNWQBI-SFHVURJKSA-N

>  <PubChem_CID>  (391) 
9912743

>  <CYP1A2>  (391) 


>  <CYP2A6>  (391) 


>  <CYP2B6>  (391) 


>  <CYP2C8>  (391) 


>  <CYP2C9>  (391) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<7,8;Cleavage;R2>
<8,H;Oxidation;R2>

>  <CYP2C19>  (391) 


>  <CYP2D6>  (391) 


>  <CYP2E1>  (391) 


>  <CYP3A4>  (391) 


>  <References>  (391) 
Tsuda-Tsukimoto M, Ogasawara Y, Kume T: Role of human liver cytochrome P450 2C9 in the metabolism of a novel alpha4beta1/alpha4beta7 dual antagonist, TR-14035. Drug Metab Pharmacokinet. 2005 Apr;20(2):127-34. (PMID: 15855725)

>  <Comments>  (391) 


$$$$
CC02245
     RDKit          3D

 22 24  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4710    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1300    2.4100    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3530    1.7600    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1930   -0.8890   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2570   -0.3650    0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3390    3.2530   -1.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0010    2.4570    1.0910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9990    0.5870    0.0150 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9760    3.1320    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1710   -2.1020    0.6720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3350   -0.5120   -0.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4090    4.1250   -1.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0680    3.3320    1.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2810   -2.9220    0.6550 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4400   -1.3400   -0.7270 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2730    4.1630   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4140   -2.5400   -0.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6370    5.2780   -0.0140 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.1200    6.6970    0.6660 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5840    4.7360    0.8960 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8870    5.5740   -1.3810 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  0
  2  6  2  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  4 10  1  0
  5 11  2  0
  5 12  1  0
  6  9  1  0
  7 13  1  0
  8 14  2  0
 11 15  1  0
 12 16  2  0
 13 17  2  0
 14 17  1  0
 15 18  2  0
 16 18  1  0
 17 19  1  0
 19 20  1  0
 19 21  2  0
 19 22  2  0
M  END
>  <Name>  (392) 
Valdecoxib

>  <InChIKey>  (392) 
LNPDTQAFDNKSHK-UHFFFAOYSA-N

>  <PubChem_CID>  (392) 
119607

>  <CYP1A2>  (392) 


>  <CYP2A6>  (392) 


>  <CYP2B6>  (392) 


>  <CYP2C8>  (392) 


>  <CYP2C9>  (392) 
<0,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>
<7,H;Hydroxylation;R3>

>  <CYP2C19>  (392) 


>  <CYP2D6>  (392) 


>  <CYP2E1>  (392) 


>  <CYP3A4>  (392) 
<0,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>
<7,H;Hydroxylation;R3>

>  <References>  (392) 
Ibrahim A, Park S, Feldman J, Karim A, Kharasch ED: Effects of parecoxib, a parenteral COX-2-specific inhibitor, on the pharmacokinetics and pharmacodynamics of propofol. Anesthesiology. 2002 Jan;96(1):88-95. doi: 10.1097/00000542-200201000-00020. (PMID: 11753007)
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (392) 
<15,H;Hydroxylation>, <16,H;Hydroxylation> are added. Need to confirm.

$$$$
CC02246
     RDKit          3D

 32 34  0  0  0  0  0  0  0  0999 V2000
    0.8140    0.5200   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0830   -0.8590   -0.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9280    1.4980   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5050    0.9630    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4800   -1.3440   -0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0260   -1.7670   -0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9280    2.5550   -0.9270 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9790    1.3660    0.8890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5400    0.0500    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8840   -2.6380   -0.0930 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5670   -0.6000   -0.0810 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2760   -1.3090   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9680    3.4620   -0.9270 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0130    2.2800    0.8800 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2890   -2.5860   -0.1160 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6160   -1.3390   -0.1080 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0100    3.3240   -0.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1420    4.3170   -0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7570    5.5010    0.7390 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1570    5.6230    2.1430 C   0  0  1  0  0  0  0  0  0  0  0  0
    4.0340    6.4790    0.1570 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5930    4.4430    2.9380 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6610    5.6200    2.2390 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5350    7.6380    0.9800 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7860    6.4260   -1.0290 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9790    4.5890    4.4110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0680    4.4250    2.8100 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2620    6.0330    3.3650 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.3250    5.2450    1.3020 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6450    8.5330    0.1150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1380    9.7100    0.9500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2480   10.6040    0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  0
  2  6  2  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  2  0
  6 12  1  0
  7 13  1  0
  8 14  2  0
  9 12  2  0
 10 15  1  0
 11 16  1  0
 13 17  2  0
 14 17  1  0
 15 16  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 20 22  1  1
 20 23  1  0
 21 24  1  0
 21 25  2  0
 22 26  1  0
 22 27  1  0
 23 28  1  0
 23 29  2  0
 24 30  1  0
 30 31  1  0
 31 32  1  0
M  END
>  <Name>  (393) 
Valsartan

>  <InChIKey>  (393) 
ACWBQPMHZXGDFX-QFIPXVFZSA-N

>  <PubChem_CID>  (393) 
60846

>  <CYP1A2>  (393) 


>  <CYP2A6>  (393) 


>  <CYP2B6>  (393) 


>  <CYP2C8>  (393) 


>  <CYP2C9>  (393) 
<1,H;Hydroxylation;R1>

>  <CYP2C19>  (393) 


>  <CYP2D6>  (393) 


>  <CYP2E1>  (393) 


>  <CYP3A4>  (393) 


>  <References>  (393) 
Nakashima A, Kawashita H, Masuda N, Saxer C, Niina M, Nagae Y, Iwasaki K: Identification of cytochrome P450 forms involved in the 4-hydroxylation of valsartan, a potent and specific angiotensin II receptor antagonist, in human liver microsomes. Xenobiotica. 2005 Jun;35(6):589-602. doi: 10.1080/00498250500158175. (PMID: 16192110)

>  <Comments>  (393) 


$$$$
CC02247
     RDKit          3D

 25 28  0  0  0  0  0  0  0  0999 V2000
   -7.6670    3.6230   -0.4730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1840    4.1960    0.6740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5090    4.5880    0.7140 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.3160    4.4080   -0.3940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7990    3.8360   -1.5410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4740    3.4430   -1.5800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2210    3.2010   -0.5180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1060    1.8470   -0.0770 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7190    1.5080   -0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0250    2.1270    0.9430 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3630    1.4440    2.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3260    0.4500    2.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6710   -0.2540    3.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0330    0.0500    4.3700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0550    1.0680    4.4100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7330    1.7450    3.2770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3450   -0.6120    5.4870 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6110   -1.2240    3.0800 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9340   -1.9000    4.2030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2580   -1.5650    5.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8760   -2.8860    4.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6160   -2.3030    6.6750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1930   -3.5730    5.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.0410   -4.4550    5.3400 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5580   -3.2710    6.5990 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 16  1  0
 12 13  1  0
 13 14  2  0
 13 18  1  0
 14 15  1  0
 14 17  1  0
 15 16  2  0
 17 20  2  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 20 22  1  0
 21 23  1  0
 22 25  2  0
 23 24  2  0
 23 25  1  0
M  END
>  <Name>  (394) 
Vivid-red

>  <InChIKey>  (394) 
UOBJOWXNMYOTGQ-UHFFFAOYSA-N

>  <PubChem_CID>  (394) 
21896394

>  <CYP1A2>  (394) 


>  <CYP2A6>  (394) 


>  <CYP2B6>  (394) 


>  <CYP2C8>  (394) 


>  <CYP2C9>  (394) 
<10,11;Cleavage;R1>
<11,12;Cleavage;R1>
<11,H;Oxidation;R1>

>  <CYP2C19>  (394) 


>  <CYP2D6>  (394) 


>  <CYP2E1>  (394) 


>  <CYP3A4>  (394) 


>  <References>  (394) 
Marks BD, Thompson DV, Goossens TA, Trubetskoy OV: High-throughput screening assays for the assessment of CYP2C9*1, CYP2C9*2, and CYP2C9*3 metabolism using fluorogenic Vivid substrates. J Biomol Screen. 2004 Aug;9(5):439-49. doi: 10.1177/1087057104263440. (PMID: 15296644)

>  <Comments>  (394) 
The metabolites cannot be identified. Suggest to remove it.

$$$$
CC02248
     RDKit          3D

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.1780    1.4080   -0.2180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2430    0.0120   -0.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2800    2.2860   -0.0400 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0540    1.9790   -0.5740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5220   -0.7340    0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9150   -0.7630   -0.2180 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770    2.0390    0.7740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2600    3.5500   -0.7610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2030    1.2070   -0.7270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7400   -1.9840   -0.6730 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4790   -0.3700    0.8910 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1280   -0.1630   -0.5290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2460    0.8350    1.6720 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3470    2.7920    0.8470 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0400    3.5670   -2.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4090   -2.0870   -2.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3360   -3.0670   -0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5330   -1.1300   -0.7030 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.5300    2.6730   -2.9430 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.9490    4.7890   -2.6400 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.3470    3.2890   -1.9060 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.6470   -3.2660   -2.7230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8740   -1.0480   -2.6820 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.5760   -4.2490   -0.7230 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2290   -4.3490   -2.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  5 11  2  0
  6 12  2  0
  7 13  1  0
  7 14  2  0
  8 15  1  0
  9 12  1  0
 10 16  2  0
 10 17  1  0
 11 13  1  0
 12 18  1  0
 15 19  1  0
 15 20  1  0
 15 21  1  0
 16 22  1  0
 16 23  1  0
 17 24  2  0
 22 25  2  0
 24 25  1  0
M  END
>  <Name>  (395) 
2-Oxoquazepam

>  <InChIKey>  (395) 
YFSXBSRGIRSXAD-UHFFFAOYSA-N

>  <PubChem_CID>  (395) 
93250

>  <CYP1A2>  (395) 


>  <CYP2A6>  (395) 


>  <CYP2B6>  (395) 


>  <CYP2C8>  (395) 


>  <CYP2C9>  (395) 
<19,20;Cleavage;R1>
<20,H;Oxidation;R1>
<2,H;Hydroxylation;R2>

>  <CYP2C19>  (395) 


>  <CYP2D6>  (395) 


>  <CYP2E1>  (395) 


>  <CYP3A4>  (395) 
<19,20;Cleavage;R1>
<20,H;Oxidation;R1>
<2,H;Hydroxylation;R2>

>  <References>  (395) 
Miura M, Ohkubo T: In vitro metabolism of quazepam in human liver and intestine and assessment of drug interactions. Xenobiotica. 2004 Nov-Dec;34(11-12):1001-11. doi: 10.1080/02772240400015214. (PMID: 15801544)

>  <Comments>  (395) 


$$$$
CC02249
     RDKit          3D

 20 21  0  0  0  0  0  0  0  0999 V2000
   -1.4980   -0.1180    0.2030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4680   -1.1350    0.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7980   -0.9320    0.4510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1910    0.2860    0.9870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2470    1.2880    1.1650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9140    1.0920    0.7880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0800   -2.6880   -0.5770 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.8350    2.3650    1.2350 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.1770   -0.4050   -0.2170 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7650    0.3990   -0.8960 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1090   -0.0110   -0.9460 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0520    0.7430   -1.6490 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6520    1.8960   -2.3100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5750    2.6290   -2.9930 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3290    2.3110   -2.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3930    1.5560   -1.5920 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5690   -1.2550   -0.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8380   -1.0670    1.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1860   -0.0340    1.7660 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6900   -2.2560    1.8510 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  9  1  0
  2  3  1  0
  2  7  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  8  1  0
  9 10  1  0
 10 11  2  0
 10 16  1  0
 11 12  1  0
 11 17  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
M  END
>  <Name>  (396) 
5-OH-Diclofenac

>  <InChIKey>  (396) 
VNQURRWYKFZKJZ-UHFFFAOYSA-N

>  <PubChem_CID>  (396) 
3052566

>  <CYP1A2>  (396) 


>  <CYP2A6>  (396) 


>  <CYP2B6>  (396) 


>  <CYP2C8>  (396) 


>  <CYP2C9>  (396) 
<16,H;Hydroxylation;R1>

>  <CYP2C19>  (396) 


>  <CYP2D6>  (396) 


>  <CYP2E1>  (396) 


>  <CYP3A4>  (396) 


>  <References>  (396) 
Bort R, Mace K, Boobis A, Gomez-Lechon MJ, Pfeifer A, Castell J: Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways. Biochem Pharmacol. 1999 Sep 1;58(5):787-96. doi: 10.1016/s0006-2952(99)00167-7. (PMID: 10449188)

>  <Comments>  (396) 


$$$$
CC02250
     RDKit          3D

 30 33  0  0  0  0  0  0  0  0999 V2000
    4.6630    0.3690    1.6690 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7420   -0.1060    0.7190 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2390   -0.6790   -0.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6300   -0.7640   -0.6510 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5240   -0.2930    0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0380    0.2800    1.4710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3190    0.0090    1.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7040    1.2640    1.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3520    1.3770    1.4460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4080    0.2340    1.6870 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1970   -1.0200    1.6280 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5490   -1.1300    1.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3870   -1.1650   -1.5580 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1030   -0.9370   -1.7700 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7690   -1.6060   -2.9200 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8180   -2.2350   -3.4260 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8290   -1.9630   -2.5890 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8590    0.3340    2.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6680    0.7110    0.8880 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2030    1.9570    0.6700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8920    1.8310   -0.5170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7920    0.5520   -1.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0530   -0.1090   -0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6610   -1.5310   -0.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7210   -2.4170    0.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2890   -3.8590    0.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3470   -4.7450    0.8850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7750    3.0450   -1.3210 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -3.0660    3.1050    1.5080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4650    3.1630    2.5710 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  2  7  1  0
  3  4  2  0
  3 13  1  0
  4  5  1  0
  5  6  2  0
  7  8  2  0
  7 12  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 18  1  0
 11 12  2  0
 13 14  2  0
 13 17  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 18 19  1  0
 19 20  1  0
 19 23  1  0
 20 21  2  0
 20 29  1  0
 21 22  1  0
 21 28  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 29 30  2  0
M  END
>  <Name>  (397) 
E3179

>  <InChIKey>  (397) 
FQZSMTSTFMNWQF-UHFFFAOYSA-N

>  <PubChem_CID>  (397) 
9802264

>  <CYP1A2>  (397) 


>  <CYP2A6>  (397) 


>  <CYP2B6>  (397) 


>  <CYP2C8>  (397) 


>  <CYP2C9>  (397) 
<9,H;Hydroxylation;R1>

>  <CYP2C19>  (397) 


>  <CYP2D6>  (397) 


>  <CYP2E1>  (397) 


>  <CYP3A4>  (397) 
<3,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>

>  <References>  (397) 
Stearns RA, Chakravarty PK, Chen R, Chiu SH: Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members. Drug Metab Dispos. 1995 Feb;23(2):207-15. (PMID: 7736913)

>  <Comments>  (397) 


$$$$
CC02252
     RDKit          3D

 26 28  0  0  0  0  0  0  0  0999 V2000
    9.1370   -0.0500    0.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7590   -0.0940   -0.9570 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.1180   -0.2330    1.1820 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.7140    1.2350    0.4130 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.7170   -4.1990    0.6400 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.3690   -1.2370   -0.3460 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1970    0.1500   -0.7570 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8690    1.0070    0.4460 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7240    2.4440    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4070    3.2900    1.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2650    4.7350    0.8090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9600    5.5740    1.9540 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6170    5.2680    2.4190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9300    6.9450    1.4770 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6640   -1.6230    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2210   -2.0490   -0.3790 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9450   -2.9200    0.4980 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2520   -3.3910    0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7330   -0.7130   -0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9930   -1.5400   -0.8360 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2480   -3.2690    0.8710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0910   -4.1720   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0320   -1.0510    0.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8390   -2.3190   -0.8830 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2850   -2.3450    0.8020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8890   -3.6420   -0.4690 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1 23  1  0
  5 17  1  0
  5 18  1  0
  6  7  1  0
  6 15  1  0
  6 16  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 15 17  2  0
 15 19  1  0
 16 18  2  0
 16 20  1  0
 17 21  1  0
 18 22  1  0
 19 23  2  0
 20 24  2  0
 21 25  2  0
 22 26  2  0
 23 25  1  0
 24 26  1  0
M  END
>  <Name>  (398) 
Chlorpromazine compound 1

>  <InChIKey>  (398) 
DVGIHSLYADPMSE-UHFFFAOYSA-N

>  <PubChem_CID>  (398) 
45138909

>  <CYP1A2>  (398) 


>  <CYP2A6>  (398) 


>  <CYP2B6>  (398) 


>  <CYP2C8>  (398) 


>  <CYP2C9>  (398) 
<15,S;S-Oxidation;R1>

>  <CYP2C19>  (398) 


>  <CYP2D6>  (398) 
<15,S;S-Oxidation;R1>
<1,N;N-Oxidation;R2>

>  <CYP2E1>  (398) 
<15,S;S-Oxidation;R1>

>  <CYP3A4>  (398) 
<15,S;S-Oxidation;R1>

>  <References>  (398) 
Cashman JR, Yang Z, Yang L, Wrighton SA: Stereo- and regioselective N- and S-oxidation of tertiary amines and sulfides in the presence of adult human liver microsomes. Drug Metab Dispos. 1993 May-Jun;21(3):492-501. (PMID: 8100507)

>  <Comments>  (398) 


$$$$
CC02253
     RDKit          3D

 32 36  0  0  0  0  0  0  0  0999 V2000
    1.2250    0.4510   -1.7660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1540   -0.4880   -1.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6500   -0.8110   -2.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5230   -1.1250   -3.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2260    0.2230   -3.2730 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5720    0.2100   -1.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2210   -0.8220   -1.1660 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8990    1.3900   -0.5350 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0950    1.5590    0.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8540    1.3240    1.7130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9190    2.2760   -0.7660 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9770    3.6820   -0.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2700    4.3750   -0.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3000    4.8830   -2.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0250    5.5860   -2.4480 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9020    1.8590   -1.4570 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5600    2.3960    2.5530 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3120    2.1760    3.9060 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3510    0.8830    4.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0780    0.6510    5.8640 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6650   -0.1830    3.5910 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9130    0.0340    2.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8440    0.9260    6.4940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6620    1.3900    5.7870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7170    0.7160    7.8750 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7750    0.2310    8.6370 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9850   -0.0570    8.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1290    0.1530    6.6540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3940    1.0360    4.4880 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7560    1.6100    4.1670 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1380    2.2650    5.2760 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3000    2.1580    6.3240 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  1  0
  1  6  1  0
  1 16  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  8 11  1  0
  9 10  1  0
 10 17  2  0
 10 22  1  0
 11 12  1  0
 11 16  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 20 23  1  0
 20 28  2  0
 21 22  2  0
 23 24  1  0
 23 25  2  0
 24 29  1  0
 24 32  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 29 30  2  0
 30 31  1  0
 31 32  1  0
M  END
>  <Name>  (399) 
Irbesartan

>  <InChIKey>  (399) 
YOSHYTLCDANDAN-UHFFFAOYSA-N

>  <PubChem_CID>  (399) 
3749

>  <CYP1A2>  (399) 


>  <CYP2A6>  (399) 


>  <CYP2B6>  (399) 


>  <CYP2C8>  (399) 


>  <CYP2C9>  (399) 
<0,H;Hydroxylation;R1>
<1,H;Hydroxylation;R2>
<8,H;Hydroxylation;R3>
<9,H;Oxidation;R4>

>  <CYP2C19>  (399) 


>  <CYP2D6>  (399) 


>  <CYP2E1>  (399) 


>  <CYP3A4>  (399) 


>  <References>  (399) 
Chando TJ, Everett DW, Kahle AD, Starrett AM, Vachharajani N, Shyu WC, Kripalani KJ, Barbhaiya RH: Biotransformation of irbesartan in man. Drug Metab Dispos. 1998 May;26(5):408-17. (PMID: 9571222)
Bourrie M, Meunier V, Berger Y, Fabre G: Role of cytochrome P-4502C9 in irbesartan oxidation by human liver microsomes. Drug Metab Dispos. 1999 Feb;27(2):288-96. (PMID: 9929518)

>  <Comments>  (399) 
<15,H;Oxidation> needs to be confirmed. <9,8;Cleavage> may also be added.

$$$$
CC02254
     RDKit          3D

 24 27  0  0  0  0  0  0  0  0999 V2000
   -2.6110   -1.5550    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8000   -0.9930   -0.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9360    0.3540   -0.5920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8680    1.2010   -0.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6620    0.6310    0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5530   -0.7630    0.3560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9750    2.5280   -0.3620 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9840    3.3230   -0.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7720    2.8280    0.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5960    1.4820    0.5820 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7050    0.9220    1.0970 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.8220    1.2200    0.0940 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.5400    0.5230   -1.1540 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4730   -0.9120   -0.9120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7960   -1.4450   -0.3640 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.7850   -0.2770   -0.2380 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.1590    0.7750    0.6870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5680   -2.0660    0.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8490   -3.3310    1.1860 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9530    0.3520   -1.6280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5840    0.8150   -2.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5080   -2.9050    0.1310 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7570   -3.4540   -0.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0200    1.5270    2.3530 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1 22  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  7  1  0
  5  6  2  0
  5 10  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 24  1  1
 12 13  1  0
 12 17  1  1
 13 14  1  0
 13 21  1  0
 14 15  1  0
 15 16  1  0
 15 18  1  1
 16 17  1  1
 16 20  1  0
 18 19  2  0
 20 21  1  0
 22 23  1  0
M  END
>  <Name>  (400) 
Quinidine

>  <InChIKey>  (400) 
LOUPRKONTZGTKE-LHHVKLHASA-N

>  <PubChem_CID>  (400) 
441074

>  <CYP1A2>  (400) 


>  <CYP2A6>  (400) 


>  <CYP2B6>  (400) 


>  <CYP2C8>  (400) 


>  <CYP2C9>  (400) 
<4,N;N-Oxidation;R1>
<2,H;Hydroxylation;R2>

>  <CYP2C19>  (400) 


>  <CYP2D6>  (400) 


>  <CYP2E1>  (400) 
<4,N;N-Oxidation;R1>

>  <CYP3A4>  (400) 
<4,N;N-Oxidation;R1>
<2,H;Hydroxylation;R2>

>  <References>  (400) 
Nielsen TL, Rasmussen BB, Flinois JP, Beaune P, Brosen K: In vitro metabolism of quinidine: the (3S)-3-hydroxylation of quinidine is a specific marker reaction for cytochrome P-4503A4 activity in human liver microsomes. J Pharmacol Exp Ther. 1999 Apr;289(1):31-7. (PMID: 10086984)

>  <Comments>  (400) 
Metabolites are also reported for CYP2D6 and 2E1. <15,H;Hydroxylation> for CYP2C9 is 6%.

$$$$
CC02255
     RDKit          3D

 13 15  0  0  0  0  0  0  0  0999 V2000
   -0.0190    1.5350    0.0100 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4280    2.0410   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6960    2.0010   -1.3090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6700    1.9850    1.1890 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7550   -0.4580   -1.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7960   -0.4750    1.2280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3750    0.9360   -0.0300 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6570    3.4410   -0.6610 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8670    2.7760    1.0500 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.1630    0.1350   -1.2280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2060    0.1100    1.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9010    3.9080    2.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  6
  1  5  1  0
  2  6  1  0
  2  7  1  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  6 11  1  0
  7 12  1  0
  8 11  1  0
  8 12  1  0
  9 10  1  0
 10 13  1  1
M  END
>  <Name>  (401) 
SNI-2011

>  <InChIKey>  (401) 
WUTYZMFRCNBCHQ-PSASIEDQSA-N

>  <PubChem_CID>  (401) 
83898

>  <CYP1A2>  (401) 


>  <CYP2A6>  (401) 


>  <CYP2B6>  (401) 


>  <CYP2C8>  (401) 


>  <CYP2C9>  (401) 
<5,S;S-Oxidation;R1>

>  <CYP2C19>  (401) 


>  <CYP2D6>  (401) 
<5,S;S-Oxidation;R1>

>  <CYP2E1>  (401) 


>  <CYP3A4>  (401) 
<5,S;S-Oxidation;R1>

>  <References>  (401) 
Washio T, Arisawa H, Kohsaka K, Yasuda H: Identification of human drug-metabolizing enzymes involved in the metabolism of SNI-2011. Biol Pharm Bull. 2001 Nov;24(11):1263-6. (PMID: 11725960)

>  <Comments>  (401) 
Metabolites also reported for CYP1A2, 2A6, 2E1 with low rate.

$$$$
CC02256
     RDKit          3D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -0.0120   -0.4510   -0.7460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2520    0.0110   -0.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3210   -0.1250    1.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0800   -0.7930    1.7810 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.8330   -0.9290    0.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1800   -1.4750    0.1450 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8060   -1.7610   -1.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8700   -1.7250    1.1310 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1760   -2.0240   -1.2200 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8030   -2.3080   -2.4310 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6990   -2.6450   -4.9380 C   0  0  2  0  0  0  0  0  0  0  0  0
    6.0570   -2.0020   -5.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0680   -2.3360   -3.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6960   -2.0830   -3.5740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0700   -1.7980   -2.3620 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8110   -4.1140   -5.2280 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1970   -4.9790   -4.4560 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4410   -4.3520   -6.5120 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  2  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  7  9  2  0
  7 15  1  0
  9 10  1  0
 10 13  2  0
 11 12  1  1
 11 13  1  0
 11 16  1  0
 13 14  1  0
 14 15  2  0
 16 17  2  0
 16 18  1  0
M  END
>  <Name>  (402) 
Suprofen

>  <InChIKey>  (402) 
MDKGKXOCJGEUJW-SECBINFHSA-N

>  <PubChem_CID>  (402) 
688581

>  <CYP1A2>  (402) 


>  <CYP2A6>  (402) 


>  <CYP2B6>  (402) 


>  <CYP2C8>  (402) 


>  <CYP2C9>  (402) 
<14,H;Hydroxylation;R1>

>  <CYP2C19>  (402) 


>  <CYP2D6>  (402) 


>  <CYP2E1>  (402) 


>  <CYP3A4>  (402) 


>  <References>  (402) 
Mancy A, Broto P, Dijols S, Dansette PM, Mansuy D: The substrate binding site of human liver cytochrome P450 2C9: an approach using designed tienilic acid derivatives and molecular modeling. Biochemistry. 1995 Aug 22;34(33):10365-75. doi: 10.1021/bi00033a007. (PMID: 7654690)
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (402) 


$$$$
CC02257
     RDKit          3D

 22 24  0  0  0  0  0  0  0  0999 V2000
   -0.7880   -2.2150   -4.3700 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0310   -2.4150   -0.2620 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.5160   -2.5030   -4.9240 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5970   -1.0940   -4.7910 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5300   -5.2620   -1.2920 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6520   -6.9720   -3.3120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7330   -3.6460   -4.3590 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6480   -6.1870   -5.3240 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2030   -8.5850   -5.3960 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4460   -1.9160   -2.7220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1680   -4.6830   -3.5130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4250   -2.9670   -1.8340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6770   -4.3700   -2.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1430   -0.6670   -2.1470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1670   -3.3910   -4.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1680   -5.9190   -4.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0980   -0.8100   -0.8070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6670   -7.4510   -5.9730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1990   -7.4610   -7.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2540   -8.6550   -7.9720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2700   -9.7310   -6.1110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7810   -9.8210   -7.3920 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  2  0
  1  4  2  0
  1  7  1  0
  1 10  1  0
  2 12  1  0
  2 17  1  0
  5 13  2  0
  6 16  1  0
  7 11  1  0
  7 15  1  0
  8 16  1  0
  8 18  1  0
  9 18  2  0
  9 21  1  0
 10 12  2  0
 10 14  1  0
 11 13  1  0
 11 16  2  0
 12 13  1  0
 14 17  2  0
 18 19  1  0
 19 20  2  0
 20 22  1  0
 21 22  2  0
M  END
>  <Name>  (403) 
Tenoxicam

>  <InChIKey>  (403) 
WZWYJBNHTWCXIM-JLHYYAGUSA-N

>  <PubChem_CID>  (403) 


>  <CYP1A2>  (403) 


>  <CYP2A6>  (403) 


>  <CYP2B6>  (403) 


>  <CYP2C8>  (403) 


>  <CYP2C9>  (403) 
<9,H;Hydroxylation;R1>

>  <CYP2C19>  (403) 


>  <CYP2D6>  (403) 


>  <CYP2E1>  (403) 


>  <CYP3A4>  (403) 


>  <References>  (403) 
Zhao J, Leemann T, Dayer P: In vitro oxidation of oxicam NSAIDS by a human liver cytochrome P450. Life Sci. 1992;51(8):575-81. doi: 10.1016/0024-3205(92)90226-f. (PMID: 1640808)

>  <Comments>  (403) 


$$$$
CC02258
     RDKit          3D

 22 24  0  0  0  0  0  0  0  0999 V2000
   -1.0400    1.0000    1.0040 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.1710    2.5190    1.0570 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.4800    0.5270    0.7940 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.5110    0.5070    2.2850 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6200    2.7590    0.6200 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.2070    3.1940    0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9150    1.5410   -0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3800    0.9290    1.9700 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7190   -0.6700    2.1670 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5600    2.4340    1.7790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2330    2.9100    0.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1510   -2.0340    1.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1360   -1.0560    3.4990 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6860   -0.2190    1.1850 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9930   -2.7770    2.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0400   -2.3640    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6710   -3.8660    1.7620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6420   -3.4560   -0.3880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4970   -4.2040    0.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1160    3.6370   -0.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4640    4.8460    0.0130 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4670    3.2120   -1.5810 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  1
  2  5  1  0
  2  6  1  6
  3  7  1  0
  3  8  1  1
  4  9  1  0
  5  7  1  0
  5 10  1  1
  6 11  1  0
  8 10  1  0
  9 12  1  0
  9 13  2  0
  9 14  2  0
 11 20  1  0
 12 15  2  0
 12 16  1  0
 15 17  1  0
 16 18  2  0
 17 19  2  0
 18 19  1  0
 20 21  1  0
 20 22  2  0
M  END
>  <Name>  (404) 
Tetranor

>  <InChIKey>  (404) 
DYXPIXIKDXPQPD-DSPQJCBJSA-N

>  <PubChem_CID>  (404) 
101592321

>  <CYP1A2>  (404) 


>  <CYP2A6>  (404) 


>  <CYP2B6>  (404) 


>  <CYP2C8>  (404) 


>  <CYP2C9>  (404) 
<8,H;Hydroxylation;R1>

>  <CYP2C19>  (404) 


>  <CYP2D6>  (404) 


>  <CYP2E1>  (404) 


>  <CYP3A4>  (404) 
<7,H;Hydroxylation;R1>

>  <References>  (404) 
Yamaguchi Y, Kirita S, Baba T, Aoyama J, Touchi A, Tukey RH, Guengerich FP, Matsubara T: Identification of rat and human cytochrome P450 forms involved in the metabolism of the thromboxane A2 receptor antagonist (+)-S-145. Drug Metab Dispos. 1997 Jan;25(1):75-80. (PMID: 9010633)

>  <Comments>  (404) 


$$$$
CC02259
     RDKit          3D

 38 41  0  0  0  0  0  0  0  0999 V2000
   -2.6680    3.9040    0.4230 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2480    4.2270    0.3970 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.5560    4.2110   -0.9650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1060    5.1500   -1.8770 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3400    5.0700   -3.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8880    5.4410    1.1970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0740    5.2920    2.3190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2520    6.3980    3.0990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2300    7.6640    2.7640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0490    7.8120    1.6440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3750    6.7080    0.8640 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0940    8.8480    3.6140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9080    9.1580    4.4820 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.3230    9.9780    2.8880 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.2080    8.6740    4.3790 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0400    2.8390   -0.5070 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.4060    1.5160   -0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5610    2.6990   -0.5240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2680    2.7580    0.7500 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3370    1.7740    0.8650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7680    0.3630    0.8810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3990    2.8050    1.9140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0780    3.5540    1.7800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3080    1.9290   -0.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5140    1.0180   -0.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1540    1.1370    1.1130 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3120    1.1210    2.2950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1160    2.0330    2.1470 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.5370    1.1490    1.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.1570    1.3480    2.4810 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.2740    1.0120    0.1920 O   0  0  0  0  0  0  0  0  0  0  0  0
  -11.0640    2.5520    3.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.3620    3.7300    2.5680 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.6170    2.7430    4.3750 N   0  0  0  0  0  0  0  0  0  0  0  0
  -12.2970    1.7010    4.8880 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.4670    0.5030    4.3000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -11.8940    0.3470    3.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.0870   -0.9810    2.4340 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1 16  1  0
  1 23  1  0
  2  3  1  6
  2  6  1  0
  3  4  1  0
  4  5  1  0
  6  7  2  0
  6 11  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 12  1  0
 10 11  2  0
 12 13  1  0
 12 14  1  0
 12 15  1  0
 16 17  1  1
 16 18  1  0
 18 19  1  0
 19 20  1  0
 19 22  1  0
 20 21  1  0
 20 24  1  0
 20 28  1  0
 22 23  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 29  1  0
 27 28  1  0
 29 30  1  0
 29 31  2  0
 30 32  2  0
 30 37  1  0
 32 33  1  0
 32 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
M  END
>  <Name>  (405) 
Vicriviroc

>  <InChIKey>  (405) 
CNPVJJQCETWNEU-CYFREDJKSA-N

>  <PubChem_CID>  (405) 
3009355

>  <CYP1A2>  (405) 


>  <CYP2A6>  (405) 


>  <CYP2B6>  (405) 


>  <CYP2C8>  (405) 


>  <CYP2C9>  (405) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (405) 


>  <CYP2D6>  (405) 


>  <CYP2E1>  (405) 


>  <CYP3A4>  (405) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<28,N;N-Oxidation;R2>
<28,26;Reduction;R2>
<30,N;N-Oxidation;R3>
<3,14;Cleavage;R4>
<3,H;Oxidation;R4>
<15,14;Cleavage;R5>
<15,H;Oxidation;R5>
<16,17;Cleavage;R5>
<16,H;Oxidation;R5>

>  <References>  (405) 
Ghosal A, Ramanathan R, Yuan Y, Hapangama N, Chowdhury SK, Kishnani NS, Alton KB: Identification of human liver cytochrome P450 enzymes involved in biotransformation of vicriviroc, a CCR5 receptor antagonist. Drug Metab Dispos. 2007 Dec;35(12):2186-95. doi: 10.1124/dmd.107.017517. Epub 2007 Sep 7. (PMID: 17827338)
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (405) 
Need to confirm. Metabolite M7's structure reported in the different papers cannot match. Suggest to remove it.

$$$$
CC02261
     RDKit          3D

 12 12  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3830    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1710    2.0890    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3320    2.1190    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2140   -0.6790   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770    1.4140   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8310    2.2510    1.4600 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.3990    0.0310   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1000    3.1050    1.4830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1280    0.9170    1.9990 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1650   -0.7010    0.0100 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8180   -2.0870   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2 11  1  0
  3  6  2  0
  4  7  1  0
  5  8  2  0
  6  8  1  0
  7  9  1  6
  7 10  1  0
 11 12  1  0
M  END
>  <Name>  (406) 
2-Methoxyamphetamine

>  <InChIKey>  (406) 
VBAHFEPKESUPDE-MRVPVSSYSA-N

>  <PubChem_CID>  (406) 
7432381

>  <CYP1A2>  (406) 


>  <CYP2A6>  (406) 


>  <CYP2B6>  (406) 


>  <CYP2C8>  (406) 


>  <CYP2C9>  (406) 


>  <CYP2C19>  (406) 


>  <CYP2D6>  (406) 
<5,H;Hydroxylation;R1>
<3,H;Hydroxylation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>

>  <CYP2E1>  (406) 


>  <CYP3A4>  (406) 


>  <References>  (406) 
Bach MV, Coutts RT, Baker GB: Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives. Xenobiotica. 1999 Jul;29(7):719-32. doi: 10.1080/004982599238344. (PMID: 10456690)

>  <Comments>  (406) 


$$$$
CC02262
     RDKit          3D

 12 12  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3770    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1710    2.0860    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3320    2.1120    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2140   -0.6800   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3790    1.4140   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7710    2.3530    1.4660 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.4030    0.0330   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0400    3.2060    1.4780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0410    1.0640    2.1170 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2350   -2.0390   -0.0200 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6090   -2.4310   -0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  3  6  2  0
  4  7  1  0
  5  8  2  0
  5 11  1  0
  6  8  1  0
  7  9  1  6
  7 10  1  0
 11 12  1  0
M  END
>  <Name>  (407) 
3-Methoxyamphetamine

>  <InChIKey>  (407) 
VEJWNIYARKAHFI-MRVPVSSYSA-N

>  <PubChem_CID>  (407) 
22809970

>  <CYP1A2>  (407) 


>  <CYP2A6>  (407) 


>  <CYP2B6>  (407) 


>  <CYP2C8>  (407) 


>  <CYP2C9>  (407) 


>  <CYP2C19>  (407) 


>  <CYP2D6>  (407) 
<3,H;Hydroxylation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2E1>  (407) 


>  <CYP3A4>  (407) 


>  <References>  (407) 
Bach MV, Coutts RT, Baker GB: Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives. Xenobiotica. 1999 Jul;29(7):719-32. doi: 10.1080/004982599238344. (PMID: 10456690)

>  <Comments>  (407) 


$$$$
CC02263
     RDKit          3D

 12 12  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3780    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1700    2.0880    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3330    2.1130    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2070   -0.6800   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770    1.4180   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7710    2.3540    1.4660 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.3990    0.0300   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0410    3.2060    1.4780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0400    1.0640    2.1170 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5860   -0.6320   -0.0350 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6130    0.3610   -0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  3  6  2  0
  4  7  1  0
  5  8  2  0
  6  8  1  0
  7  9  1  6
  7 10  1  0
  8 11  1  0
 11 12  1  0
M  END
>  <Name>  (408) 
4-Methoxyamphetamine

>  <InChIKey>  (408) 
NEGYEDYHPHMHGK-MRVPVSSYSA-N

>  <PubChem_CID>  (408) 
6951129

>  <CYP1A2>  (408) 


>  <CYP2A6>  (408) 


>  <CYP2B6>  (408) 


>  <CYP2C8>  (408) 


>  <CYP2C9>  (408) 


>  <CYP2C19>  (408) 


>  <CYP2D6>  (408) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (408) 


>  <CYP3A4>  (408) 


>  <References>  (408) 
Bach MV, Coutts RT, Baker GB: Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives. Xenobiotica. 1999 Jul;29(7):719-32. doi: 10.1080/004982599238344. (PMID: 10456690)

>  <Comments>  (408) 


$$$$
CC02264
     RDKit          3D

 16 17  0  0  0  0  0  0  0  0999 V2000
   -0.0190    1.5260    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3950    2.0470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3760   -0.5120    0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2370    2.2590   -1.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1200    2.4120    1.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4630    2.7530   -0.7010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0480    2.0730   -2.5520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3590    2.8340    0.6720 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4800    3.0530   -1.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0700    2.3760   -3.4290 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2830    2.8650   -2.9500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8910    2.1970   -4.7650 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9010   -0.3370   -1.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2900   -1.9600    0.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1080    2.5930   -5.4010 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  3  5  1  0
  3  6  2  0
  4 14  1  0
  4 15  1  0
  5  7  2  0
  5  8  1  0
  6  9  1  0
  7  9  1  0
  7 10  1  0
  8 11  2  0
 10 12  2  0
 11 12  1  0
 11 13  1  0
 13 16  1  0
M  END
>  <Name>  (409) 
5-MDMT

>  <InChIKey>  (409) 
ZSTKHSQDNIGFLM-UHFFFAOYSA-N

>  <PubChem_CID>  (409) 
1832

>  <CYP1A2>  (409) 


>  <CYP2A6>  (409) 


>  <CYP2B6>  (409) 


>  <CYP2C8>  (409) 


>  <CYP2C9>  (409) 


>  <CYP2C19>  (409) 


>  <CYP2D6>  (409) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (409) 


>  <CYP3A4>  (409) 


>  <References>  (409) 
Yu AM, Idle JR, Herraiz T, Kupfer A, Gonzalez FJ: Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase. Pharmacogenetics. 2003 Jun;13(6):307-19. doi: 10.1097/01.fpc.0000054094.48725.b7. (PMID: 12777961)

>  <Comments>  (409) 


$$$$
CC02265
     RDKit          3D

 14 15  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4020    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3850    1.8270   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2360    2.0840    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3250   -0.3920   -0.0130 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1990   -0.7060    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1330    0.7120   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8920    3.2460    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4170    1.3690    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3950   -0.0240    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9580    3.7610    1.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6070    2.0270    0.0620 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4520    5.1440    1.4430 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6300    1.0300    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  5  7  1  0
  6 10  2  0
  8 11  1  0
  9 10  1  0
  9 12  1  0
 11 13  1  0
 12 14  1  0
M  END
>  <Name>  (410) 
5-Methoxytryptamine

>  <InChIKey>  (410) 
JTEJPPKMYBDEMY-UHFFFAOYSA-N

>  <PubChem_CID>  (410) 
1833

>  <CYP1A2>  (410) 


>  <CYP2A6>  (410) 


>  <CYP2B6>  (410) 


>  <CYP2C8>  (410) 


>  <CYP2C9>  (410) 


>  <CYP2C19>  (410) 


>  <CYP2D6>  (410) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (410) 


>  <CYP3A4>  (410) 


>  <References>  (410) 
Yu AM, Idle JR, Byrd LG, Krausz KW, Kupfer A, Gonzalez FJ: Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6. Pharmacogenetics. 2003 Mar;13(3):173-81. doi: 10.1097/01.fpc.0000054066.98065.7b. (PMID: 12618595)

>  <Comments>  (410) 


$$$$
CC02266
     RDKit          3D

 14 15  0  0  0  0  0  0  0  0999 V2000
   -0.0130    1.0860    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6820    1.5470    1.1840 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0180    1.0680    2.2470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4000    1.3560    3.5380 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3070    0.8650    4.6190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4350    0.0820    4.4120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8520   -0.2060    3.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1450    0.2860    2.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1520   -0.4150    5.5070 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2720   -1.1910    4.9600 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1730   -1.6660    6.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7540   -0.5060    6.7870 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6340    0.2700    7.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7320    0.7460    6.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  8  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  6  9  1  0
  7  8  2  0
  9 10  1  0
  9 14  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
M  END
>  <Name>  (411) 
MEOPP

>  <InChIKey>  (411) 
MRDGZSKYFPGAKP-UHFFFAOYSA-N

>  <PubChem_CID>  (411) 
269722

>  <CYP1A2>  (411) 


>  <CYP2A6>  (411) 


>  <CYP2B6>  (411) 


>  <CYP2C8>  (411) 


>  <CYP2C9>  (411) 


>  <CYP2C19>  (411) 


>  <CYP2D6>  (411) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (411) 


>  <CYP3A4>  (411) 


>  <References>  (411) 
Staack RF, Theobald DS, Paul LD, Springer D, Kraemer T, Maurer HH: In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step. Xenobiotica. 2004 Feb;34(2):179-92. doi: 10.1080/00498250310001644544. (PMID: 14985146)

>  <Comments>  (411) 


$$$$
CC02267
     RDKit          3D

 13 13  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3830    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1710    2.0890    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3320    2.1200    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2140   -0.6790   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1650   -0.7010    0.0100 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770    1.4140   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8310    2.2510    1.4600 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.3990    0.0320   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8180   -2.0870   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9060    3.0980    2.2240 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2230    2.8870    1.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0510    2.7170    3.6350 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  4  8  1  0
  5  9  2  0
  6 10  1  0
  7  9  1  0
  8 11  1  0
  8 12  1  6
 11 13  1  0
M  END
>  <Name>  (412) 
Methoxyphenamine

>  <InChIKey>  (412) 
OEHAYUOVELTAPG-VIFPVBQESA-N

>  <PubChem_CID>  (412) 
6918906

>  <CYP1A2>  (412) 


>  <CYP2A6>  (412) 


>  <CYP2B6>  (412) 


>  <CYP2C8>  (412) 


>  <CYP2C9>  (412) 


>  <CYP2C19>  (412) 


>  <CYP2D6>  (412) 
<7,H;Hydroxylation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP2E1>  (412) 


>  <CYP3A4>  (412) 


>  <References>  (412) 
Coutts RT, Bolaji OO, Su P, Baker GB: Metabolism of methoxyphenamine in vitro by a CYP2D6 microsomal preparation. Drug Metab Dispos. 1994 Sep-Oct;22(5):756-60. (PMID: 7835228)

>  <Comments>  (412) 


$$$$
CC02268
     RDKit          3D

 22 25  0  0  0  0  0  0  0  0999 V2000
   -0.0340    1.5290    0.0330 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.0120    0.0310    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3740    2.1250    0.0410 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.8040    2.0260    1.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7230    1.9630   -1.1410 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1400   -0.5680   -0.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9120   -0.8300    0.5560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2540    1.6470   -1.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2950    3.5910   -0.0050 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7860    3.5570    1.2820 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.0090    1.3410   -1.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2720    0.1400   -1.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3830   -1.9430   -0.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7040   -2.2070    0.4850 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6660    4.0390    1.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6770    4.0880    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4570    4.0600    2.5630 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1040   -0.8050   -1.5210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5890   -2.0590   -1.2290 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4160   -2.8000   -0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5440    5.4860    2.5260 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2480   -3.3280   -1.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  6
  2  6  2  0
  2  7  1  0
  3  8  1  6
  3  9  1  0
  4 10  1  0
  5 11  1  0
  6 12  1  0
  6 13  1  0
  7 14  2  0
  8 12  1  0
  9 15  1  0
  9 16  1  0
 10 15  1  0
 10 17  1  1
 12 18  2  0
 13 19  1  0
 13 20  2  0
 14 20  1  0
 17 21  1  0
 18 19  1  0
 19 22  1  0
M  END
>  <Name>  (413) 
MMDL

>  <InChIKey>  (413) 
LVXVIPZBNJSUKL-NJAPINKUSA-N

>  <PubChem_CID>  (413) 
9796365

>  <CYP1A2>  (413) 


>  <CYP2A6>  (413) 


>  <CYP2B6>  (413) 


>  <CYP2C8>  (413) 


>  <CYP2C9>  (413) 


>  <CYP2C19>  (413) 


>  <CYP2D6>  (413) 
<14,15;Cleavage;R1>
<15,H;Oxidation;R1>

>  <CYP2E1>  (413) 


>  <CYP3A4>  (413) 


>  <References>  (413) 
Bottiger Y, Dostert P, Benedetti MS, Bani M, Fiorentini F, Casati M, Poggesti I, Alm C, Alvan G, Bertilsson L: Involvement of CYP2D6 but not CYP2C19 in nicergoline metabolism in humans. Br J Clin Pharmacol. 1996 Dec;42(6):707-11. doi: 10.1046/j.1365-2125.1996.00471.x. (PMID: 8971425)

>  <Comments>  (413) 


$$$$
CC02270
     RDKit          3D

 34 38  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3810    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2820    1.8040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2080    2.2340    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3570   -0.3760   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9840   -0.9790    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0860    0.7700   -0.0140 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6860    3.1220    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6090    2.5190    1.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6980   -1.7310   -0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6300   -2.3130   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1130    3.4510   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0960    3.6240    2.0990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4940    1.6790    2.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7050   -2.6860   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3140    4.8440   -0.6140 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6520    3.4500    1.4250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4620    3.8860    3.4050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8630    1.9400    3.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7920    5.2260   -0.5190 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1120    3.9050    1.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3440    3.0420    4.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2030    5.2710    0.8890 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7040    3.2980    5.3360 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.6260    5.6350    0.9020 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0600    5.9440    2.3360 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5200    6.3180    2.3490 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8960    7.6400    2.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4810    5.3390    2.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2330    7.9850    2.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8200    5.6790    2.5340 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2000    7.0040    2.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5160    7.3400    2.3860 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.2510    6.1290    2.5720 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5  7  1  0
  5 10  2  0
  6 11  1  0
  8 12  1  0
  9 13  2  0
  9 14  1  0
 10 15  1  0
 11 15  2  0
 12 16  1  0
 12 17  1  0
 13 18  1  0
 14 19  2  0
 16 20  1  0
 17 21  1  0
 18 22  2  0
 19 22  1  0
 20 23  1  0
 21 23  1  0
 22 24  1  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 28 30  1  0
 29 31  2  0
 30 32  2  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
M  END
>  <Name>  (414) 
Astemizole

>  <InChIKey>  (414) 
GXDALQBWZGODGZ-UHFFFAOYSA-N

>  <PubChem_CID>  (414) 
2247

>  <CYP1A2>  (414) 


>  <CYP2A6>  (414) 


>  <CYP2B6>  (414) 


>  <CYP2C8>  (414) 


>  <CYP2C9>  (414) 


>  <CYP2C19>  (414) 


>  <CYP2D6>  (414) 
<18,H;Hydroxylation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2E1>  (414) 


>  <CYP3A4>  (414) 
<18,H;Hydroxylation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <References>  (414) 
Matsumoto S, Yamazoe Y: Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine. Br J Clin Pharmacol. 2001 Feb;51(2):133-42. doi: 10.1111/j.1365-2125.2001.01292.x. (PMID: 11259984)

>  <Comments>  (414) 


$$$$
CC02271
     RDKit          3D

 23 23  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3830    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1760    2.0910    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2020    2.0480    0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2080   -0.6770   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3800    1.4130   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8930    3.4430    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3960    0.0300   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1920    4.2520    0.0360 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.7110   -0.7070   -0.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8630    5.7410    0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9030    4.0280   -1.1830 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1140   -0.9330   -1.3890 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1100    6.5080    0.2980 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3590   -1.6310   -1.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7260    7.9200    0.4210 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8490   -1.9060   -2.7610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5340    8.5190   -0.9740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8260    8.6860    1.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1360   -0.6680   -3.4130 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5870   -0.9890   -4.7300 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2120    0.1430   -5.6880 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1060   -1.1670   -4.7210 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  3  6  2  0
  4  7  1  0
  5  8  2  0
  6  8  1  0
  7  9  1  0
  8 10  1  0
  9 11  1  0
  9 12  1  6
 10 13  1  0
 11 14  1  0
 13 15  1  0
 14 16  1  0
 15 17  1  0
 16 18  1  0
 16 19  1  0
 17 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
M  END
>  <Name>  (415) 
Bisoprolol

>  <InChIKey>  (415) 
VHYCDWMUTMEGQY-QGZVFWFLSA-N

>  <PubChem_CID>  (415) 
6604464

>  <CYP1A2>  (415) 


>  <CYP2A6>  (415) 


>  <CYP2B6>  (415) 


>  <CYP2C8>  (415) 


>  <CYP2C9>  (415) 


>  <CYP2C19>  (415) 


>  <CYP2D6>  (415) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>

>  <CYP2E1>  (415) 


>  <CYP3A4>  (415) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>

>  <References>  (415) 
Horikiri Y, Suzuki T, Mizobe M: Stereoselective metabolism of bisoprolol enantiomers in dogs and humans. Life Sci. 1998;63(13):1097-108. doi: 10.1016/s0024-3205(98)00371-3. (PMID: 9763205)

>  <Comments>  (415) 


$$$$
CC02272
     RDKit          3D

 18 20  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4000    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3920    1.8120   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2320    2.0850    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2000   -0.7030    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2960   -0.3870   -0.0120 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1120    0.6820   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4160    1.3740    0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3960   -0.0180    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1930   -2.5940    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    3.6170    0.6180   -0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6040    2.0350    0.0330 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1110   -0.1320    1.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0860   -0.1310   -1.2810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6300    1.0400    0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6310   -0.2920    1.1310 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6070   -0.2910   -1.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9840   -1.0800   -0.0540 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  4  8  2  0
  5  9  2  0
  5 10  1  0
  6  7  1  0
  7 11  1  0
  8  9  1  0
  8 12  1  0
 11 13  1  0
 11 14  1  0
 12 15  1  0
 13 16  1  0
 14 17  1  0
 16 18  1  0
 17 18  1  0
M  END
>  <Name>  (416) 
Brofaromine

>  <InChIKey>  (416) 
WZXHSWVDAYOFPE-UHFFFAOYSA-N

>  <PubChem_CID>  (416) 
44571

>  <CYP1A2>  (416) 


>  <CYP2A6>  (416) 


>  <CYP2B6>  (416) 


>  <CYP2C8>  (416) 


>  <CYP2C9>  (416) 


>  <CYP2C19>  (416) 


>  <CYP2D6>  (416) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (416) 


>  <CYP3A4>  (416) 


>  <References>  (416) 
Feifel N, Kucher K, Fuchs L, Jedrychowski M, Schmidt E, Antonin KH, Bieck PR, Gleiter CH: Role of cytochrome P4502D6 in the metabolism of brofaromine. A new selective MAO-A inhibitor. Eur J Clin Pharmacol. 1993;45(3):265-9. (PMID: 8276052)

>  <Comments>  (416) 


$$$$
CC02273
     RDKit          3D

 18 18  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3970    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1470    2.0950    0.0020 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    2.0680    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2030   -0.7110    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2490   -0.7070   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7980    3.4810    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4140    1.3570    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4000   -0.0280    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2390   -1.2650   -0.0270 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0730    4.3270    0.0060 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.7010    5.8070   -0.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7960    4.1100    1.2190 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9240    6.6110   -0.2360 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4990    8.0130   -0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7200    8.4050    0.9150 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7310    8.9100   -0.4780 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6050    8.1840   -1.5710 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  2  0
  6 10  3  0
  7 11  1  0
  8  9  1  0
 11 12  1  0
 11 13  1  1
 12 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 15 18  1  0
M  END
>  <Name>  (417) 
Bunitrolol

>  <InChIKey>  (417) 
VCVQSRCYSKKPBA-GFCCVEGCSA-N

>  <PubChem_CID>  (417) 
72710712

>  <CYP1A2>  (417) 


>  <CYP2A6>  (417) 


>  <CYP2B6>  (417) 


>  <CYP2C8>  (417) 


>  <CYP2C9>  (417) 


>  <CYP2C19>  (417) 


>  <CYP2D6>  (417) 
<13,H;Hydroxylation;R1>

>  <CYP2E1>  (417) 


>  <CYP3A4>  (417) 


>  <References>  (417) 
Narimatsu S, Kato R, Horie T, Ono S, Tsutsui M, Yabusaki Y, Ohmori S, Kitada M, Ichioka T, Shimada N, Kato R, Ishikawa T: Enantioselectivity of bunitrolol 4-hydroxylation is reversed by the change of an amino acid residue from valine to methionine at position 374 of cytochrome P450-2D6. Chirality. 1999;11(1):1-9. doi: 10.1002/(SICI)1520-636X(1999)11:1<1::AID-CHIR1>3.0.CO;2-E. (PMID: 9914647)

>  <Comments>  (417) 


$$$$
CC02274
     RDKit          3D

 22 26  0  0  0  0  0  0  0  0999 V2000
   -0.0930   -0.2350   -0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2410   -1.1590    0.8730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7890   -1.9770    1.3010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0670   -1.8100    0.7910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4000   -0.8350   -0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3660   -0.0070   -0.5960 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8240    0.7690   -0.7400 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.9290    1.0890    0.2410 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.5700   -0.2200    0.6760 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.6440   -1.1910    1.3870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1710    1.8740   -1.0720 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.6110    2.6110    0.1990 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.4060    2.6570    1.2800 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4750    1.9500    1.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6710   -0.6970   -0.6090 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7800    1.9690    0.7110 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3430    1.0540   -1.4350 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1850   -0.8540   -0.4980 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4480    0.1130   -1.9750 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1540   -1.1620   -1.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7330   -2.1400   -0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4600   -1.6910    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  1  7  1  0
  2  3  2  0
  2 10  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5 15  1  0
  6 17  1  0
  7  8  1  0
  7 11  1  0
  7 19  1  6
  8  9  1  0
  8 14  1  1
  9 10  1  6
  9 18  1  0
 11 12  1  0
 11 17  1  1
 12 13  1  0
 12 16  1  1
 13 14  2  0
 15 22  1  0
 18 20  1  0
 18 21  1  0
 19 20  1  0
M  END
>  <Name>  (418) 
Codeine

>  <InChIKey>  (418) 
OROGSEYTTFOCAN-DNJOTXNNSA-N

>  <PubChem_CID>  (418) 
5284371

>  <CYP1A2>  (418) 


>  <CYP2A6>  (418) 


>  <CYP2B6>  (418) 


>  <CYP2C8>  (418) 


>  <CYP2C9>  (418) 


>  <CYP2C19>  (418) 


>  <CYP2D6>  (418) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (418) 


>  <CYP3A4>  (418) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>

>  <References>  (418) 
Caraco Y, Tateishi T, Guengerich FP, Wood AJ: Microsomal codeine N-demethylation: cosegregation with cytochrome P4503A4 activity. Drug Metab Dispos. 1996 Jul;24(7):761-4. (PMID: 8818573)
Venhorst J, ter Laak AM, Commandeur JN, Funae Y, Hiroi T, Vermeulen NP: Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities. J Med Chem. 2003 Jan 2;46(1):74-86. doi: 10.1021/jm0209578. (PMID: 12502361)

>  <Comments>  (418) 


$$$$
CC02275
     RDKit          3D

 32 35  0  0  0  0  0  0  0  0999 V2000
    2.1380    0.1070    2.1180 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9150   -1.1790    2.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0220   -1.2000    1.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8310    0.1000    1.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9300    1.2180    0.9390 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6580    1.2390    1.5080 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8690    0.1640    2.6730 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9500    2.3610    1.4560 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1620    1.3560    2.5960 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7410    2.4430    1.9730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0190    3.7420    1.8860 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8250    4.8680    2.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0540    6.1860    2.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8610    7.2640    2.9770 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8160    8.1020    2.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3720    9.0610    3.3080 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6720    8.6610    4.5370 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8430    7.6450    4.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1380    7.1180    5.0990 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8520    9.2750    5.8550 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.0460   10.5460    5.9310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1200   10.7170    6.9430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6160   11.8840    7.0180 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4260   12.8840    6.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5040   12.7110    5.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2380   11.5420    4.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3320    9.5960    6.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1220    8.3140    6.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5600    7.2520    5.9910 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4520    8.3510    6.2980 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1490   14.0330    6.1480 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7300   14.8530    5.0560 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  1  7  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  8  1  0
  7  9  2  0
  8 10  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 18  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 20  1  0
 18 19  2  0
 20 21  1  0
 20 27  1  6
 21 22  2  0
 21 26  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 24 31  1  0
 25 26  2  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 31 32  1  0
M  END
>  <Name>  (419) 
Compound A

>  <InChIKey>  (419) 
HGFOOLONGOBCMP-IBGZPJMESA-N

>  <PubChem_CID>  (419) 
9853559

>  <CYP1A2>  (419) 


>  <CYP2A6>  (419) 


>  <CYP2B6>  (419) 


>  <CYP2C8>  (419) 


>  <CYP2C9>  (419) 


>  <CYP2C19>  (419) 


>  <CYP2D6>  (419) 
<25,H;Hydroxylation;R1>
<27,H;Hydroxylation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>

>  <CYP2E1>  (419) 


>  <CYP3A4>  (419) 
<25,H;Hydroxylation;R1>
<27,H;Hydroxylation;R2>

>  <References>  (419) 
Cui D, Subramanian R, Shou M, Yu X, Wallace MA, Braun MP, Arison BH, Yergey JA, Prueksaritanont T: In vitro and in vivo metabolism of a potent and selective integrin alpha v beta 3 antagonist in rats, dogs, and monkeys. Drug Metab Dispos. 2004 Aug;32(8):848-61. doi: 10.1124/dmd.32.8.848. (PMID: 15258111)

>  <Comments>  (419) 


$$$$
CC02276
     RDKit          3D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -1.3200   -0.0980   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3340   -1.5050   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0300    0.7020    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5370    0.5920    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0560   -2.3070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5480   -2.1990   -0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2400   -0.0540    0.0160 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7590   -0.1020    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2810   -1.5270    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7640   -1.4980    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4020    0.6080    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5680   -0.0390   -0.0070 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4180    1.9400    0.0110 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  1  0
  6 10  2  0
  7  9  1  0
  7 11  1  0
  8 10  1  0
 11 12  1  0
 11 13  2  0
M  END
>  <Name>  (420) 
Debrisoquine

>  <InChIKey>  (420) 
JWPGJSVJDAJRLW-UHFFFAOYSA-N

>  <PubChem_CID>  (420) 
2966

>  <CYP1A2>  (420) 


>  <CYP2A6>  (420) 


>  <CYP2B6>  (420) 


>  <CYP2C8>  (420) 


>  <CYP2C9>  (420) 


>  <CYP2C19>  (420) 


>  <CYP2D6>  (420) 
<12,H;Hydroxylation;R1>
<5,H;Hydroxylation;R2>
<4,H;Hydroxylation;R3>

>  <CYP2E1>  (420) 


>  <CYP3A4>  (420) 


>  <References>  (420) 
Bapiro TE, Hasler JA, Ridderstrom M, Masimirembwa CM: The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant. Potential implications for CYP2D6 phenotyping studies and the clinical use of CYP2D6 substrate drugs in some African populations. Biochem Pharmacol. 2002 Nov 1;64(9):1387-98. doi: 10.1016/s0006-2952(02)01351-5. (PMID: 12392820)
Eiermann B, Edlund PO, Tjernberg A, Dalen P, Dahl ML, Bertilsson L: 1- and 3-hydroxylations, in addition to 4-hydroxylation, of debrisoquine are catalyzed by cytochrome P450 2D6 in humans. Drug Metab Dispos. 1998 Nov;26(11):1096-101. (PMID: 9806952)

>  <Comments>  (420) 
SoMs 4,6,8,10 need to be confirmed. They are not reported clearly.

$$$$
CC02277
     RDKit          3D

 32 35  0  0  0  0  0  0  0  0999 V2000
   -6.7620   -2.4570    1.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6030   -1.1870    0.1700 S   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4320   -1.4080   -1.2230 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8610   -0.8370    0.7310 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6900    0.1680    0.4420 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3350    0.1800    0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5760    1.3090    0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7560   -0.9520   -0.4830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4250   -0.9560   -0.8310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2190    1.3170   -0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6420    0.1740   -0.6100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1950    2.2890    0.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3160    0.4590   -0.8480 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0560    1.7470   -0.4240 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2470    2.4250   -0.5050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3770    1.7000   -0.6250 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3050    3.6390   -0.4640 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6740    2.3510   -0.8700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3540    0.2330   -0.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6920    1.7900    0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4570   -0.1930    0.4650 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7460    0.3280    0.0060 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7010   -0.1150    0.9190 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8320   -0.7960    0.4620 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7740   -1.2300    1.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5500   -0.9680    2.7310 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4090   -0.2900    3.1080 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5320    0.1180    2.2100 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0130   -1.0370   -0.9050 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1370   -1.8580   -1.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7510   -2.5780   -2.6540 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3510   -0.9630   -1.6190 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  7 10  1  0
  8  9  2  0
  9 11  1  0
 10 11  2  0
 10 12  1  0
 11 13  1  0
 12 14  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  1  0
 16 19  1  0
 18 20  1  0
 19 21  1  0
 20 22  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 23 28  1  0
 24 25  1  0
 24 29  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 29 30  1  0
 30 31  1  0
 30 32  1  0
M  END
>  <Name>  (421) 
Delavirdine

>  <InChIKey>  (421) 
WHBIGIKBNXZKFE-UHFFFAOYSA-N

>  <PubChem_CID>  (421) 
5625

>  <CYP1A2>  (421) 


>  <CYP2A6>  (421) 


>  <CYP2B6>  (421) 


>  <CYP2C8>  (421) 


>  <CYP2C9>  (421) 


>  <CYP2C19>  (421) 


>  <CYP2D6>  (421) 
<1,3;Cleavage;R1>
<1,H;Oxidation;R1>

>  <CYP2E1>  (421) 


>  <CYP3A4>  (421) 
<1,3;Cleavage;R1>
<1,H;Oxidation;R1>
<7,H;Oxidation;R2>
<3,4;Oxidation;R2>

>  <References>  (421) 
Voorman RL, Maio SM, Hauer MJ, Sanders PE, Payne NA, Ackland MJ: Metabolism of delavirdine, a human immunodeficiency virus type-1 reverse transcriptase inhibitor, by microsomal cytochrome P450 in humans, rats, and other species: probable involvement of CYP2D6 and CYP3A. Drug Metab Dispos. 1998 Jul;26(7):631-9. (PMID: 9660845)

>  <Comments>  (421) 


$$$$
CC02279
     RDKit          3D

 35 39  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.5000    0.0100 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3420    2.0390    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7880    2.0210   -1.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1160   -0.7080    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1250   -0.6870   -0.4290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2360    3.4860    0.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0290    1.4740    1.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8800    3.5490   -1.1160 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.1060   -2.0930    0.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3570    0.0080    0.8840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1400   -2.0700   -0.4460 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5320    4.1280   -0.9840 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.5410    4.0960   -2.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0170   -2.7790   -0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2480   -2.7360   -0.8700 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3250    3.8350   -2.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9900    3.6080   -2.4520 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.0230   -4.1390   -0.0440 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2140   -1.7450   -1.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6910    4.5190   -2.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5980    4.0470   -3.7580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7390    4.1570   -1.3200 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2560   -4.5630    0.4350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9040    4.4840   -3.8340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8180    4.0040   -4.9040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1330    3.7210   -1.4850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4360    4.8800   -5.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7750    4.5430   -2.6040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3420    4.3990   -6.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6610    4.8390   -6.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5730    4.3560   -7.2420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1850    5.2290   -7.3900 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2910    3.8670   -6.8440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5360    5.6210   -7.1390 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  6
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  7 13  1  0
  8 11  1  0
  9 13  1  0
  9 14  1  6
 10 15  2  0
 12 15  1  0
 12 16  1  0
 13 17  1  6
 18 14  1  6
 15 19  1  0
 16 20  1  0
 17 21  1  0
 18 22  1  0
 18 23  1  0
 19 24  1  0
 22 25  2  0
 22 26  1  0
 23 27  1  0
 25 28  1  0
 25 29  1  0
 26 30  2  0
 27 29  1  0
 28 31  2  0
 30 31  1  0
 30 32  1  0
 31 33  1  0
 32 34  1  0
 33 35  1  0
M  END
>  <Name>  (422) 
Emetine

>  <InChIKey>  (422) 
AUVVAXYIELKVAI-UWBTVBNJSA-N

>  <PubChem_CID>  (422) 
11865425

>  <CYP1A2>  (422) 


>  <CYP2A6>  (422) 


>  <CYP2B6>  (422) 


>  <CYP2C8>  (422) 


>  <CYP2C9>  (422) 


>  <CYP2C19>  (422) 


>  <CYP2D6>  (422) 
<10,11;Cleavage;R1>
<11,H;Oxidation;R1>
<28,29;Cleavage;R2>
<29,H;Oxidation;R2>

>  <CYP2E1>  (422) 


>  <CYP3A4>  (422) 
<10,11;Cleavage;R1>
<11,H;Oxidation;R1>
<28,29;Cleavage;R2>
<29,H;Oxidation;R2>
<13,14;Cleavage;R3>
<14,H;Oxidation;R3>

>  <References>  (422) 
Asano T, Kushida H, Sadakane C, Ishihara K, Wakui Y, Yanagisawa T, Kimura M, Kamei H, Yoshida T: Metabolism of ipecac alkaloids cephaeline and emetine by human hepatic microsomal cytochrome P450s, and their inhibitory effects on P450 enzyme activities. Biol Pharm Bull. 2001 Jun;24(6):678-82. (PMID: 11411558)

>  <Comments>  (422) 


$$$$
CC02280
     RDKit          3D

 34 38  0  0  0  0  0  0  0  0999 V2000
    2.9730   -1.3970   -0.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7920   -2.7640   -0.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8870   -3.6060   -0.4120 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1650   -3.0820   -0.3440 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3460   -1.7150   -0.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2500   -0.8720   -0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7790   -0.4780   -0.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6240    0.1050    1.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3910    0.5670    1.5440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2490    1.1020    2.8100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3400    1.1750    3.6560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5730    0.7130    3.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7140    0.1720    1.9710 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9830    0.6530   -1.2690 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.6290    1.2800   -1.5980 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.6690    2.7690   -1.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8130    3.4240   -2.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1190    2.7090   -1.6660 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8970    1.6370   -0.7050 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9860    2.8720    0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3390    2.1800    0.5250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4260    0.6050   -0.8300 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6030    0.5300   -1.7060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7300   -0.1560   -0.9760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9210    0.5090   -0.7640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9550   -0.1190   -0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7990   -1.4140    0.3650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6090   -2.0830    0.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5720   -1.4570   -0.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4030   -2.1160   -0.7350 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5490   -3.4150   -0.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2540    0.6090    0.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3960   -0.1600   -0.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5200    0.7130    1.6400 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  7  8  1  0
 14  7  1  1
  8  9  2  0
  8 13  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 14 15  1  0
 14 19  1  0
 15 16  1  0
 15 22  1  1
 16 17  1  0
 16 20  1  0
 17 18  1  0
 18 19  1  0
 19 21  1  0
 20 21  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 24 29  1  0
 25 26  1  0
 26 27  2  0
 26 32  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  1  0
 32 33  1  0
 32 34  1  0
M  END
>  <Name>  (423) 
Ezlopitant

>  <InChIKey>  (423) 
XPNMCDYOYIKVGB-CONSDPRKSA-N

>  <PubChem_CID>  (423) 
188927

>  <CYP1A2>  (423) 


>  <CYP2A6>  (423) 


>  <CYP2B6>  (423) 


>  <CYP2C8>  (423) 


>  <CYP2C9>  (423) 


>  <CYP2C19>  (423) 


>  <CYP2D6>  (423) 
<6,H;Hydroxylation;R1>
<6,7;Dehydrogenation;R2>
<6,8;Dehydrogenation;R3>

>  <CYP2E1>  (423) 


>  <CYP3A4>  (423) 
<6,H;Hydroxylation;R1>
<6,7;Dehydrogenation;R2>
<6,8;Dehydrogenation;R3>

>  <References>  (423) 
Obach RS: Metabolism of ezlopitant, a nonpeptidic substance P receptor antagonist, in liver microsomes: enzyme kinetics, cytochrome P450 isoform identity, and in vitro-in vivo correlation. Drug Metab Dispos. 2000 Sep;28(9):1069-76. (PMID: 10950851)

>  <Comments>  (423) 


$$$$
CC02281
     RDKit          3D

 30 33  0  0  0  0  0  0  0  0999 V2000
   -0.0370    1.5230   -0.3530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0320    0.1240   -0.2120 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0160    2.2070   -0.9820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1030    2.2930    0.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9920   -0.7590   -0.6040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2060   -0.4810    0.4030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4430    1.3980   -1.6690 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.9830    3.6010   -1.0980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1440    3.6840    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1490   -0.3080   -1.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8900   -2.1370   -0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2150   -0.8420   -0.6620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0860    4.3360   -0.5980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2920    4.4570    0.5910 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1490   -1.2140   -1.6330 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8860   -3.0370   -0.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3740   -1.5740   -0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2040    4.5950    1.9430 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3920    5.7220    0.0950 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4970    3.8680    0.3500 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.0210   -2.5730   -1.3650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3540   -1.9300   -1.0370 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3510   -2.7900   -0.4130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9920   -0.7190   -1.5410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5460   -3.0760   -1.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2250   -0.9740   -2.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2070   -1.8660   -1.7860 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1890   -2.2560   -2.7850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1380   -1.1420   -3.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4870   -0.2200   -4.0530 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  1  0
  5 10  2  0
  5 11  1  0
  6 12  1  0
  7 10  1  0
  8 13  1  0
  9 13  2  0
  9 14  1  0
 10 15  1  0
 11 16  2  0
 12 17  1  0
 14 18  1  0
 14 19  1  0
 14 20  1  0
 15 21  2  0
 16 21  1  0
 17 22  1  0
 22 23  1  0
 22 24  1  0
 23 25  1  0
 24 26  1  0
 25 27  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
M  END
>  <Name>  (424) 
Fluphenazine

>  <InChIKey>  (424) 
PLDUPXSUYLZYBN-UHFFFAOYSA-N

>  <PubChem_CID>  (424) 
3372

>  <CYP1A2>  (424) 


>  <CYP2A6>  (424) 


>  <CYP2B6>  (424) 


>  <CYP2C8>  (424) 


>  <CYP2C9>  (424) 


>  <CYP2C19>  (424) 


>  <CYP2D6>  (424) 
<17,S;S-Oxidation;R1>
<2,3;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2E1>  (424) 


>  <CYP3A4>  (424) 


>  <References>  (424) 
Bapiro TE, Hasler JA, Ridderstrom M, Masimirembwa CM: The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant. Potential implications for CYP2D6 phenotyping studies and the clinical use of CYP2D6 substrate drugs in some African populations. Biochem Pharmacol. 2002 Nov 1;64(9):1387-98. doi: 10.1016/s0006-2952(02)01351-5. (PMID: 12392820)

>  <Comments>  (424) 


$$$$
CC02282
     RDKit          3D

 21 24  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.5150    0.0100 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.2930   -0.3650   -0.4030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0820    0.7120   -0.6160 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4720    1.8570   -0.0020 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.9850   -0.9110    0.2270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7300    1.9970   -1.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3610    0.3140    1.8550 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6750    2.0320    1.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8090    3.1330   -0.7250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3520   -0.6730    0.7940 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6270   -1.7130   -0.5810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2130    2.7420   -2.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6600   -2.2550   -0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6060   -2.6380   -0.3980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1200    1.6360    1.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1990    3.2310   -2.1080 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.8880   -2.0990   -0.9150 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9770    2.4470   -3.0150 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7180    0.3140    2.4190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8720   -3.5240   -1.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  4  1  0
  1  5  1  0
  1  7  1  0
  1  9  1  1
  2  3  1  0
  2  4  2  0
  2 12  1  0
  3  5  1  0
  4  6  1  0
  5 10  1  6
  6 11  1  0
  6 14  2  0
  7 13  2  0
  8 11  1  0
  8 16  1  0
  8 20  1  0
  9 16  1  0
 10 17  1  0
 12 15  2  0
 12 18  1  0
 13 17  1  0
 14 15  1  0
 17 19  1  6
 18 21  1  0
M  END
>  <Name>  (425) 
Galantamine

>  <InChIKey>  (425) 
ASUTZQLVASHGKV-JDFRZJQESA-N

>  <PubChem_CID>  (425) 
9651

>  <CYP1A2>  (425) 


>  <CYP2A6>  (425) 


>  <CYP2B6>  (425) 


>  <CYP2C8>  (425) 


>  <CYP2C9>  (425) 


>  <CYP2C19>  (425) 


>  <CYP2D6>  (425) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<18,19;Cleavage;R2>
<19,H;Oxidation;R2>

>  <CYP2E1>  (425) 


>  <CYP3A4>  (425) 


>  <References>  (425) 
Bachus R, Bickel U, Thomsen T, Roots I, Kewitz H: The O-demethylation of the antidementia drug galanthamine is catalysed by cytochrome P450 2D6. Pharmacogenetics. 1999 Dec;9(6):661-8. (PMID: 10634129)
Zhou SF: Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin Pharmacokinet. 2009;48(12):761-804. doi: 10.2165/11318070-000000000-00000. (PMID: 19902987)
Mannens GS, Snel CA, Hendrickx J, Verhaeghe T, Le Jeune L, Bode W, van Beijsterveldt L, Lavrijsen K, Leempoels J, Van Osselaer N, Van Peer A, Meuldermans W: The metabolism and excretion of galantamine in rats, dogs, and humans. Drug Metab Dispos. 2002 May;30(5):553-63. doi: 10.1124/dmd.30.5.553. (PMID: 11950787)

>  <Comments>  (425) 


$$$$
CC02283
     RDKit          3D

 33 36  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4640    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1130   -0.0700    1.2440 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0190    5.4920   -1.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0550    6.2350   -0.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0090    6.0340   -2.5020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9210    7.0140   -2.8470 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8820    5.5550   -3.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6690    7.2500    0.5640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3910    5.8970   -0.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0930    1.3980    1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140   -0.5160    1.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3810    1.9090   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9570    7.5970    1.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0600    7.0280   -5.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3470    4.1020   -1.1280 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6180    7.9310    1.3010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3420    6.5770    0.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9480    7.5110   -4.1360 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8580    6.0510   -4.7340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0850    7.5140   -6.3420 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.8860    8.2620    1.9040 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6050    1.8850   -1.2690 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7000   -0.4920    2.5230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8870    3.3880   -1.2300 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9660   -3.9290    4.1890 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5260   -2.0020    2.6910 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1370   -2.4410    4.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9380   -4.7930    3.7220 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8380   -4.4290    4.8130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7810   -6.1580    3.8740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6800   -5.7940    4.9650 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6500   -6.6590    4.4930 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  1  0
  1 13  1  0
  1 23  1  0
  2 11  1  0
  2 12  1  0
  2 24  1  0
  3  4  1  0
  3  5  1  0
  3 16  1  0
  4  8  2  0
  4  9  1  0
  5  6  2  0
  5  7  1  0
  6 19  1  0
  7 20  2  0
  8 17  1  0
  9 18  2  0
 10 12  1  0
 11 13  1  0
 14 17  2  0
 14 18  1  0
 14 22  1  0
 15 19  2  0
 15 20  1  0
 15 21  1  0
 16 25  1  0
 23 25  1  0
 24 27  1  0
 26 28  1  0
 26 29  2  0
 26 30  1  0
 27 28  1  0
 29 31  1  0
 30 32  2  0
 31 33  2  0
 32 33  1  0
M  END
>  <Name>  (426) 
GBR-12909

>  <InChIKey>  (426) 
NAUWTFJOPJWYOT-UHFFFAOYSA-N

>  <PubChem_CID>  (426) 
3455

>  <CYP1A2>  (426) 


>  <CYP2A6>  (426) 


>  <CYP2B6>  (426) 


>  <CYP2C8>  (426) 


>  <CYP2C9>  (426) 


>  <CYP2C19>  (426) 


>  <CYP2D6>  (426) 
<15,H;Hydroxylation;R1>
<19,H;Hydroxylation;R2>
<12,13;Cleavage;R3>
<13,H;Oxidation;R3>

>  <CYP2E1>  (426) 


>  <CYP3A4>  (426) 


>  <References>  (426) 
de Groot MJ, Bijloo GJ, Hansen KT, Vermeulen NP: Computer prediction and experimental validation of cytochrome P4502D6-dependent oxidation of GBR 12909. Drug Metab Dispos. 1995 Jun;23(6):667-9. (PMID: 7587951)

>  <Comments>  (426) 
<2,24;Cleavage> is atypical reaction. Followed Xenosite. Need to be confirmed.

$$$$
CC02284
     RDKit          3D

 31 34  0  0  0  0  0  0  0  0999 V2000
   -0.0040    1.3910    0.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2360    2.0780    0.2190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1880    2.0950    0.4900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1670   -0.5980   -0.2220 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2610    3.4590    0.4480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1730   -0.7290    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1400    3.4420    0.7110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0820    4.1290    0.6890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0990   -4.1680   -0.9050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3560    1.3780   -0.0200 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1380   -2.7910   -0.7940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0980    3.5330    1.4000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3010    0.0850   -0.2300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1360   -2.1220   -0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0640   -4.8820   -0.3230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6060    4.2710    0.1930 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0660   -4.2170    0.3700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3520   -5.0050   -1.7670 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.0960   -2.8400    0.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0330   -6.2280   -0.4230 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2900    4.1240    0.9560 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1040    5.4690    0.9120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8210    2.8550    1.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6830    3.8770    1.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1600    2.5610    1.1080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2190    4.6020    0.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5220    3.2510    1.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6040    5.2410    0.4980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3530    3.1700    0.9160 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4700    5.8790    0.8260 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  2  0
  2  7  1  0
  3  6  2  0
  3 11  1  0
  4  8  1  0
  5 14  1  0
  6  9  1  0
  7 15  1  0
  8  9  2  0
  8 22  1  0
  9 23  1  0
 10 12  2  0
 10 16  1  0
 10 19  1  0
 11 14  2  0
 12 15  1  0
 13 24  1  0
 13 26  1  0
 13 27  1  0
 15 20  2  0
 16 18  2  0
 16 21  1  0
 17 28  1  0
 17 29  1  0
 18 20  1  0
 22 30  1  0
 23 31  1  0
 24 25  1  0
 25 30  1  0
 26 28  1  0
 27 29  1  0
M  END
>  <Name>  (427) 
Gefitinib

>  <InChIKey>  (427) 
XGALLCVXEZPNRQ-UHFFFAOYSA-N

>  <PubChem_CID>  (427) 
123631

>  <CYP1A2>  (427) 


>  <CYP2A6>  (427) 


>  <CYP2B6>  (427) 


>  <CYP2C8>  (427) 


>  <CYP2C9>  (427) 


>  <CYP2C19>  (427) 


>  <CYP2D6>  (427) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (427) 


>  <CYP3A4>  (427) 
<13,14;Oxidation;R1>

>  <References>  (427) 
McKillop D, McCormick AD, Millar A, Miles GS, Phillips PJ, Hutchison M: Cytochrome P450-dependent metabolism of gefitinib. Xenobiotica. 2005 Jan;35(1):39-50. doi: 10.1080/00498250400026464. (PMID: 15788367)

>  <Comments>  (427) 


$$$$
CC02285
     RDKit          3D

 26 28  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3800    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3840    1.8210   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5820    1.7870    1.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1450   -0.6660    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1670   -0.6350   -0.0180 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4440    3.3430    0.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5210    3.3090    1.4330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1630   -1.9890    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2200   -1.9570   -0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8790    3.7500    1.4220 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0380   -2.6810   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8590    5.2190    1.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5170    5.7170    2.8360 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4970    7.2470    2.8440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1540    7.7440    4.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1350    9.2090    4.2580 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0180    9.8390    3.9880 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2690    9.8670    4.5410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1080   11.3430    3.9930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0080    9.1860    3.7350 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3110   11.3720    4.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2790    9.2380    4.7710 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2560   11.9290    3.6120 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6040   11.5270    2.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2090   13.4540    3.7210 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  4  8  1  0
  5  9  1  0
  6 10  2  0
  7 11  1  0
  8 11  1  0
  9 12  2  0
 10 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 18 20  1  0
 18 21  2  0
 19 22  1  0
 19 23  2  0
 20 24  1  0
 22 24  1  0
 24 25  1  0
 24 26  1  0
M  END
>  <Name>  (428) 
Gepirone

>  <InChIKey>  (428) 
QOIGKGMMAGJZNZ-UHFFFAOYSA-N

>  <PubChem_CID>  (428) 
55191

>  <CYP1A2>  (428) 


>  <CYP2A6>  (428) 


>  <CYP2B6>  (428) 


>  <CYP2C8>  (428) 


>  <CYP2C9>  (428) 


>  <CYP2C19>  (428) 


>  <CYP2D6>  (428) 
<3,H;Hydroxylation;R1>
<25,H;Hydroxylation;R2>
<18,H;Hydroxylation;R3>

>  <CYP2E1>  (428) 


>  <CYP3A4>  (428) 
<3,H;Hydroxylation;R1>
<25,H;Hydroxylation;R2>
<18,H;Hydroxylation;R3>
<10,11;Cleavage;R4>
<10,H;Oxidation;R4>

>  <References>  (428) 
Mathew SJ, Garakani A, Reinhard JF Jr, Oshana S, Donahue S: Short-term tolerability of a nonazapirone selective serotonin 1A agonist in adults with generalized anxiety disorder: a 28-day, open-label study. Clin Ther. 2008 Sep;30(9):1658-66. doi: 10.1016/j.clinthera.2008.09.006. (PMID: 18840371)
von Moltke LL, Greenblatt DJ, Grassi JM, Granda BW, Fogelman SM, Harmatz JS, Kramer SJ, Fabre LF, Shader RI: Gepirone and 1-(2-pyrimidinyl)-piperazine in vitro: human cytochromes mediating transformation and cytochrome inhibitory effects. Psychopharmacology (Berl). 1998 Dec;140(3):293-9. (PMID: 9877009)

>  <Comments>  (428) 
Xenosite recorded 3,4 as SoMs but it is not able to be identified in the reference, so removed.

$$$$
CC02286
     RDKit          3D

 22 26  0  0  0  0  0  0  0  0999 V2000
   -0.2940    1.5470   -0.1680 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.5160    0.0620   -0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2090    1.7270   -0.0160 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.1640    1.8480    1.0420 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.7710    2.2670   -1.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6920   -0.2610    0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3400   -0.8350   -0.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8700    1.1380   -1.2620 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.7020    1.0060    1.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2070    0.8330    0.9350 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4410    1.6050    2.3340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0070    1.6840   -2.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1160   -1.5940    0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6560   -0.3550   -1.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0940   -2.1490   -0.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4340    1.8770   -2.4490 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0510    1.6530    2.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0940    1.3580    3.3200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2960   -2.5020   -0.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2750   -1.9870    0.8920 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0870    1.2470   -3.6040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3980   -3.3930    0.6690 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  6
  2  6  2  0
  2  7  1  0
  3  8  1  0
  3  9  1  1
  4 10  1  1
  4 11  1  0
  5 12  1  0
  6 10  1  0
  6 13  1  0
  7 14  1  0
  7 15  2  0
  8 14  1  6
  8 16  1  0
  9 17  1  0
 11 17  1  0
 11 18  2  0
 12 16  1  0
 13 19  2  0
 13 20  1  0
 15 19  1  0
 16 21  1  0
 20 22  1  0
M  END
>  <Name>  (429) 
Hydrocodone

>  <InChIKey>  (429) 
LLPOLZWFYMWNKH-CMKMFDCUSA-N

>  <PubChem_CID>  (429) 
5284569

>  <CYP1A2>  (429) 


>  <CYP2A6>  (429) 


>  <CYP2B6>  (429) 


>  <CYP2C8>  (429) 


>  <CYP2C9>  (429) 


>  <CYP2C19>  (429) 


>  <CYP2D6>  (429) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (429) 


>  <CYP3A4>  (429) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>

>  <References>  (429) 
Hutchinson MR, Menelaou A, Foster DJ, Coller JK, Somogyi AA: CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes. Br J Clin Pharmacol. 2004 Mar;57(3):287-97. doi: 10.1046/j.1365-2125.2003.02002.x. (PMID: 14998425)

>  <Comments>  (429) 


$$$$
CC02288
     RDKit          3D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3920    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1760    2.1050    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2280    2.0720    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3980   -0.4450    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5920   -0.4250    1.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1540    3.4860    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2430    3.4540    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4560   -1.9690    0.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5330   -1.9490    1.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0530    4.1600    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8670   -2.3900    1.4060 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7560    4.3050    0.0380 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  1  0
  6 10  1  0
  7 11  2  0
  8 11  1  0
  8 13  1  0
  9 12  1  0
 10 12  1  0
M  END
>  <Name>  (430) 
m-Chlorophenylpiperazine

>  <InChIKey>  (430) 
VHFVKMTVMIZMIK-UHFFFAOYSA-N

>  <PubChem_CID>  (430) 
1355

>  <CYP1A2>  (430) 


>  <CYP2A6>  (430) 


>  <CYP2B6>  (430) 


>  <CYP2C8>  (430) 


>  <CYP2C9>  (430) 


>  <CYP2C19>  (430) 


>  <CYP2D6>  (430) 
<2,H;Hydroxylation;R1>

>  <CYP2E1>  (430) 


>  <CYP3A4>  (430) 


>  <References>  (430) 
Rotzinger S, Fang J, Coutts RT, Baker GB: Human CYP2D6 and metabolism of m-chlorophenylpiperazine. Biol Psychiatry. 1998 Dec 1;44(11):1185-91. (PMID: 9836023)

>  <Comments>  (430) 
11 (C for Aromatic hydroxylation).

$$$$
CC02289
     RDKit          3D

 11 11  0  0  0  0  0  0  0  0999 V2000
   -0.7260   -1.1270   -0.6160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8760   -0.2740   -0.0200 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.6310   -0.5350   -0.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1760   -0.7610   -0.5100 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8600   -0.3430    1.5250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7140   -1.3700    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8180    0.8520   -0.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2390    0.1230   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9730   -0.8200    0.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0760    1.4050   -0.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1490    0.5670    0.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  2  5  1  1
  3  6  2  0
  3  7  1  0
  4  8  1  0
  6  9  1  0
  7 10  2  0
  9 11  2  0
 10 11  1  0
M  END
>  <Name>  (431) 
Methamphetamine

>  <InChIKey>  (431) 
MYWUZJCMWCOHBA-VIFPVBQESA-N

>  <PubChem_CID>  (431) 
10836

>  <CYP1A2>  (431) 


>  <CYP2A6>  (431) 


>  <CYP2B6>  (431) 


>  <CYP2C8>  (431) 


>  <CYP2C9>  (431) 


>  <CYP2C19>  (431) 


>  <CYP2D6>  (431) 
<8,H;Hydroxylation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2E1>  (431) 


>  <CYP3A4>  (431) 


>  <References>  (431) 
Lin LY, Di Stefano EW, Schmitz DA, Hsu L, Ellis SW, Lennard MS, Tucker GT, Cho AK: Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6. Drug Metab Dispos. 1997 Sep;25(9):1059-64. (PMID: 9311621)

>  <Comments>  (431) 


$$$$
CC02290
     RDKit          3D

 22 24  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4790    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1830    2.1970    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1740    2.1280    0.0190 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1940   -0.7200    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2170   -0.6870   -0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1130    3.5780    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2370    3.4100    0.0260 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1690   -2.1000    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2300   -2.0670   -0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1520    4.1700    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3630    4.4190    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0400   -2.7720   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2710    5.5550    0.0350 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5990    6.1750    0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4500    7.6980    0.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7810    8.3200    0.0740 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5740    9.7520    0.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4830    7.7840    1.2470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9270   10.4360    0.5260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8130    8.5170    1.4260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5700    9.9000    1.6820 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  1  0
  6 10  2  0
  7 11  2  0
  7 12  1  0
  8 11  1  0
  9 13  2  0
 10 13  1  0
 11 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 18 20  1  0
 19 21  1  0
 20 22  1  0
 21 22  1  0
M  END
>  <Name>  (432) 
Minaprine

>  <InChIKey>  (432) 
LDMWSLGGVTVJPG-UHFFFAOYSA-N

>  <PubChem_CID>  (432) 
4199

>  <CYP1A2>  (432) 


>  <CYP2A6>  (432) 


>  <CYP2B6>  (432) 


>  <CYP2C8>  (432) 


>  <CYP2C9>  (432) 


>  <CYP2C19>  (432) 


>  <CYP2D6>  (432) 
<7,H;Hydroxylation;R1>

>  <CYP2E1>  (432) 


>  <CYP3A4>  (432) 


>  <References>  (432) 
Marre F, Fabre G, Lacarelle B, Bourrie M, Catalin J, Berger Y, Rahmani R, Cano JP: Involvement of the cytochrome P-450IID subfamily in minaprine 4-hydroxylation by human hepatic microsomes. Drug Metab Dispos. 1992 Mar-Apr;20(2):316-21. (PMID: 1352227)

>  <Comments>  (432) 
13 (C for Aromatic hydroxylation).

$$$$
CC02291
     RDKit          3D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4650    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7240   -0.4240    1.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8280   -0.4080   -1.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6340   -1.9470    1.3350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1340   -1.8760   -1.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0500   -2.5760    0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3720   -4.0190    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6700   -4.4400   -0.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3820   -4.9640    0.2680 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9650   -5.7870   -0.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6900   -6.3090    0.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9770   -6.7200   -0.0560 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  3  5  1  0
  4  6  1  0
  5  7  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
  9 11  1  0
 10 12  2  0
 11 13  2  0
 12 13  1  0
M  END
>  <Name>  (433) 
MPTP

>  <InChIKey>  (433) 
PLRACCBDVIHHLZ-UHFFFAOYSA-N

>  <PubChem_CID>  (433) 
1388

>  <CYP1A2>  (433) 


>  <CYP2A6>  (433) 


>  <CYP2B6>  (433) 


>  <CYP2C8>  (433) 


>  <CYP2C9>  (433) 


>  <CYP2C19>  (433) 


>  <CYP2D6>  (433) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<8,H;Hydroxylation;R2>

>  <CYP2E1>  (433) 


>  <CYP3A4>  (433) 


>  <References>  (433) 
Modi S, Gilham DE, Sutcliffe MJ, Lian LY, Primrose WU, Wolf CR, Roberts GC: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as a substrate of cytochrome P450 2D6: allosteric effects of NADPH-cytochrome P450 reductase. Biochemistry. 1997 Apr 15;36(15):4461-70. doi: 10.1021/bi962633p. (PMID: 9109653)

>  <Comments>  (433) 
13 (C for Aromatic hydroxylation). 1 (N for N-Demethylation).

$$$$
CC02292
     RDKit          3D

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.0360    1.5020    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0500   -0.0050    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2260    2.2050    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1680    2.1820    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0590   -0.5230    1.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2130    3.5870    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1810    3.5640    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0730   -1.9880    1.4350 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0090    4.2670    0.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0820   -2.6820    2.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0220   -4.0580    2.6160 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1900   -2.0410    3.7500 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0240   -4.7450    1.4210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0060   -6.1190    1.4180 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0440   -4.0920    0.2940 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  3  6  1  0
  4  7  2  0
  5  8  1  0
  6  9  2  0
  7  9  1  0
  8 10  1  0
 10 11  1  0
 10 12  2  0
 11 13  1  0
 13 14  1  0
 13 15  2  0
M  END
>  <Name>  (434) 
Phenformin

>  <InChIKey>  (434) 
ICFJFFQQTFMIBG-UHFFFAOYSA-N

>  <PubChem_CID>  (434) 
8249

>  <CYP1A2>  (434) 


>  <CYP2A6>  (434) 


>  <CYP2B6>  (434) 


>  <CYP2C8>  (434) 


>  <CYP2C9>  (434) 


>  <CYP2C19>  (434) 


>  <CYP2D6>  (434) 
<12,H;Hydroxylation;R1>

>  <CYP2E1>  (434) 


>  <CYP3A4>  (434) 


>  <References>  (434) 
Venhorst J, ter Laak AM, Commandeur JN, Funae Y, Hiroi T, Vermeulen NP: Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities. J Med Chem. 2003 Jan 2;46(1):74-86. doi: 10.1021/jm0209578. (PMID: 12502361)

>  <Comments>  (434) 


$$$$
CC02293
     RDKit          3D

 15 17  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4510    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3330    1.8520   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0280    2.4170    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2940   -0.3950   -0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1500   -0.9760   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1010    0.7040   -0.0130 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6470    3.2060    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6940    3.7560    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7060   -1.8480   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5860   -2.3530   -0.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6420    4.1470    0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6750    4.6980    0.0340 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5760   -2.6620    0.4560 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0260    5.9700    0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  1  0
  5  7  1  0
  5 10  1  0
  6 11  1  0
  8 12  1  0
  9 12  2  0
  9 13  1  0
 10 14  1  0
 11 14  1  0
 13 15  1  0
M  END
>  <Name>  (435) 
Pinoline

>  <InChIKey>  (435) 
QYMDEOQLJUUNOF-UHFFFAOYSA-N

>  <PubChem_CID>  (435) 
1868

>  <CYP1A2>  (435) 


>  <CYP2A6>  (435) 


>  <CYP2B6>  (435) 


>  <CYP2C8>  (435) 


>  <CYP2C9>  (435) 


>  <CYP2C19>  (435) 


>  <CYP2D6>  (435) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (435) 


>  <CYP3A4>  (435) 


>  <References>  (435) 
Yu AM, Idle JR, Herraiz T, Kupfer A, Gonzalez FJ: Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase. Pharmacogenetics. 2003 Jun;13(6):307-19. doi: 10.1097/01.fpc.0000054094.48725.b7. (PMID: 12777961)

>  <Comments>  (435) 
13 (O for O-Demethylation).

$$$$
CC02294
     RDKit          3D

 21 22  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3770    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1700    2.0860    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3320    2.1120    0.0200 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.2130   -0.6800   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3790    1.4140   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2460    3.2820   -0.8640 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6480    2.5720    1.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4030    0.0340   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2340   -2.0390   -0.0200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6170    3.5880   -1.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6080   -2.4300   -0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6010    4.8030   -2.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0290    5.1220   -2.6720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0140    6.3190   -3.5870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7680    6.1530   -4.9380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2500    7.5820   -3.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7540    7.2530   -5.7780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4780    4.5670   -5.5800 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -4.2360    8.6800   -3.9160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9850    8.5160   -5.2660 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  3  6  2  0
  4  7  1  0
  4  8  1  1
  5  9  2  0
  5 10  1  0
  6  9  1  0
  7 11  1  0
 10 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 16 18  1  0
 16 19  1  0
 17 20  2  0
 18 21  2  0
 20 21  1  0
M  END
>  <Name>  (436) 
R-568

>  <InChIKey>  (436) 
ZVQUCWXZCKWZBP-CQSZACIVSA-N

>  <PubChem_CID>  (436) 
158797

>  <CYP1A2>  (436) 


>  <CYP2A6>  (436) 


>  <CYP2B6>  (436) 


>  <CYP2C8>  (436) 


>  <CYP2C9>  (436) 


>  <CYP2C19>  (436) 


>  <CYP2D6>  (436) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (436) 


>  <CYP3A4>  (436) 


>  <References>  (436) 
McConnachie L, Bodor M, Kowdley K, Levy A, Tung B, Thummel K, Phillips B, Bajpai M, Chi V, Esmay JD, Shen DD, Ho RJ: Human liver cytochrome P450 2D6 genotype, full-length messenger ribonucleic acid, and activity assessed with a novel cytochrome P450 2D6 substrate. Clin Pharmacol Ther. 2004 Apr;75(4):282-97. doi: 10.1016/j.clpt.2003.12.003. (PMID: 15060507)

>  <Comments>  (436) 
10 (O as O-Demethylation).

$$$$
CC02295
     RDKit          3D

 24 28  0  0  0  0  0  0  0  0999 V2000
    0.9900    0.2470   -1.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1610    1.1540   -0.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0940    0.7240    0.0910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4630   -0.6060   -0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6480   -1.5290   -0.7850 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5890   -1.0700   -1.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1690    1.3640    0.7930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1430    0.4010    0.9760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7060   -0.7650    0.4250 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2490    2.7450    1.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4220    3.0210    1.8780 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5020    4.3690    2.3160 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.3550    3.5630    1.0520 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9500    4.8380    2.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1970    6.0020    3.2090 C   0  0  2  0  0  0  0  0  0  0  0  0
   -3.9690    6.8130    3.2770 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9890    6.0500    4.0920 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.9170    4.5720    3.6960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2910    8.0680    3.9810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0890    7.8240    5.2670 C   0  0  1  0  0  0  0  0  0  0  0  0
   -6.4600    8.1090    5.0420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9040    6.3580    5.6760 C   0  0  1  0  0  0  0  0  0  0  0  0
   -5.5640    5.4710    4.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3870    6.1140    5.5760 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  2  3  2  0
  3  4  1  0
  3  7  1  0
  4  5  2  0
  4  9  1  0
  5  6  1  0
  7  8  2  0
  7 10  1  0
  8  9  1  0
 10 11  1  0
 10 13  2  0
 12 11  1  1
 12 14  1  0
 12 18  1  0
 15 14  1  6
 15 16  1  0
 15 23  1  0
 16 17  1  0
 16 19  1  0
 17 18  1  6
 17 24  1  0
 19 20  1  0
 20 21  1  6
 20 22  1  0
 22 23  1  6
 22 24  1  0
M  END
>  <Name>  (437) 
Reduced dolasetron

>  <InChIKey>  (437) 
MLWGAEVSWJXOQJ-XYLOAFBBSA-N

>  <PubChem_CID>  (437) 


>  <CYP1A2>  (437) 


>  <CYP2A6>  (437) 


>  <CYP2B6>  (437) 


>  <CYP2C8>  (437) 


>  <CYP2C9>  (437) 


>  <CYP2C19>  (437) 


>  <CYP2D6>  (437) 
<21,H;Hydroxylation;R1>
<20,H;Hydroxylation;R2>
<19,H;Hydroxylation;R3>

>  <CYP2E1>  (437) 


>  <CYP3A4>  (437) 
<20,H;Hydroxylation;R1>
<11,N;N-Oxidation;R2>

>  <References>  (437) 
Sanwald P, David M, Dow J: Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of dolasetron. Comparison with other indole-containing 5-HT3 antagonists. Drug Metab Dispos. 1996 May;24(5):602-9. (PMID: 8723743)

>  <Comments>  (437) 
1 (Aromatic Hydroxylation). 5 (Aromatic Hydroxylation). 6 (Aromatic Hydroxylation). 16 (N for N-Oxidation).

$$$$
CC02297
     RDKit          3D

 17 20  0  0  0  0  0  0  0  0999 V2000
    7.8740   11.0440   10.7520 C   0  0  1  0  0  0  0  0  0  0  0  0
    7.7680    9.5490   10.4700 C   0  0  2  0  0  0  0  0  0  0  0  0
    9.3450   11.4070   10.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2380   11.9900    9.7410 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5220    9.0360    9.3370 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3200    9.1090   10.4130 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9770   11.0320    9.4890 C   0  0  1  0  0  0  0  0  0  0  0  0
    8.0640   12.4520    8.6350 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9030    9.5100    9.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5450    7.5860    9.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1670    7.6110   10.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1540   11.5560    8.3110 C   0  0  1  0  0  0  0  0  0  0  0  0
    7.2160   12.6280    7.4720 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1480    7.0160    9.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0430   12.0810    7.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9850   13.2390    6.3190 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2570   12.4920    5.9810 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  6
  2  5  1  0
  2  6  1  6
  3  7  1  0
  4  8  1  0
  5  9  1  0
  5 10  1  0
  6 11  1  0
  7  9  1  6
  7 12  1  0
  8 12  1  0
  8 13  1  0
 10 14  1  0
 11 14  1  0
 12 15  1  6
 13 16  1  0
 15 17  1  0
 16 17  1  0
M  END
>  <Name>  (438) 
Sparteine

>  <InChIKey>  (438) 
SLRCCWJSBJZJBV-ZQDZILKHSA-N

>  <PubChem_CID>  (438) 
644020

>  <CYP1A2>  (438) 


>  <CYP2A6>  (438) 


>  <CYP2B6>  (438) 


>  <CYP2C8>  (438) 


>  <CYP2C9>  (438) 


>  <CYP2C19>  (438) 


>  <CYP2D6>  (438) 
<9,N;N-Oxidation;R1>
<3,N;N-Oxidation;R2>

>  <CYP2E1>  (438) 


>  <CYP3A4>  (438) 


>  <References>  (438) 
Bapiro TE, Hasler JA, Ridderstrom M, Masimirembwa CM: The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant. Potential implications for CYP2D6 phenotyping studies and the clinical use of CYP2D6 substrate drugs in some African populations. Biochem Pharmacol. 2002 Nov 1;64(9):1387-98. doi: 10.1016/s0006-2952(02)01351-5. (PMID: 12392820)

>  <Comments>  (438) 
Assume N-oxide is detectable and the reaction can occur on the other N atom also.

$$$$
CC02298
     RDKit          3D

 27 30  0  0  0  0  0  0  0  0999 V2000
   -0.0230    1.7580    0.0100 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9480    2.2720   -1.2290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3450    2.1270   -0.3560 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6390    2.1470    1.2060 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9550   -0.6830    0.7410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9360   -0.7020   -0.7410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9810   -2.0610    0.7390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9240   -2.0800   -0.7530 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0400   -2.7740   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0610   -4.2430   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8670   -5.0780    0.5280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4610   -6.4670    0.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6970   -6.4960   -0.4020 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1080   -5.1280   -0.6440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0790   -7.4470    0.6510 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0860   -4.6510    1.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3470   -4.9360    0.7310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4790   -4.5420    1.4130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3650   -3.8640    2.6160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1140   -3.5780    3.1390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9760   -3.9680    2.4650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4770   -3.4790    3.2800 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.2310   -4.8510   -2.1470 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4860   -4.8560   -0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4750   -5.0200   -1.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6910   -4.4120   -2.3910 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  1  5  2  0
  2  6  2  0
  2  7  1  0
  6  8  1  0
  7  9  2  0
  8 10  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 15  1  0
 12 13  1  0
 12 17  1  0
 13 14  1  0
 13 16  2  0
 14 15  1  0
 15 24  1  0
 15 25  1  0
 17 18  2  0
 17 22  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 23  1  0
 21 22  2  0
 24 27  1  0
 25 26  1  0
 26 27  1  0
M  END
>  <Name>  (439) 
Spirosulfonamide

>  <InChIKey>  (439) 
YOSANFHYUVSQIJ-UHFFFAOYSA-N

>  <PubChem_CID>  (439) 
15516719

>  <CYP1A2>  (439) 


>  <CYP2A6>  (439) 


>  <CYP2B6>  (439) 


>  <CYP2C8>  (439) 


>  <CYP2C9>  (439) 


>  <CYP2C19>  (439) 


>  <CYP2D6>  (439) 
<22,H;Hydroxylation;R1>

>  <CYP2E1>  (439) 


>  <CYP3A4>  (439) 


>  <References>  (439) 
Guengerich FP, Miller GP, Hanna IH, Martin MV, Leger S, Black C, Chauret N, Silva JM, Trimble LA, Yergey JA, Nicoll-Griffith DA: Diversity in the oxidation of substrates by cytochrome P450 2D6: lack of an obligatory role of aspartate 301-substrate electrostatic bonding. Biochemistry. 2002 Sep 10;41(36):11025-34. doi: 10.1021/bi020341k. (PMID: 12206675)

>  <Comments>  (439) 
27 (Cycloalkane Ring for Aliphatic Hydroxylation).

$$$$
CC02299
     RDKit          3D

 28 29  0  0  0  0  0  0  0  0999 V2000
    2.0830    1.4830   -1.5350 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5540    1.2680   -2.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9660    1.6990   -0.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3620    1.4750   -1.1620 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.9340    1.2830   -3.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6490    1.0630   -3.8320 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3420    1.7060   -0.6980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2280    2.6970   -2.2020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1660    0.1850   -1.5600 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2070    1.9450    0.2030 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8210    1.5000   -1.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2850    0.8210   -5.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3320    1.9160    0.4010 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8250    1.6040    1.7940 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.1890    2.7770    2.3840 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9930    1.1900    2.6610 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4040    2.3980    3.5530 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1980    1.5240    3.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6080    0.2300    2.8210 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5330   -0.4880    2.3650 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7580   -1.4490    1.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2480   -0.3090    2.8820 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6870   -2.2140    0.9050 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0350   -1.5760    0.8860 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8140   -1.0760    2.4090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5940   -2.0300    1.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0910   -2.4820   -0.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4740   -2.4040   -0.8080 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  4  8  1  0
  4  9  2  0
  4 10  2  0
  5 11  2  0
  6 12  1  0
  7 11  1  0
  7 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  1
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 21 23  1  0
 21 24  1  0
 22 25  2  0
 23 26  2  0
 24 27  1  0
 25 26  1  0
 27 28  1  0
M  END
>  <Name>  (440) 
Tamsulosin

>  <InChIKey>  (440) 
DRHKJLXJIQTDTD-OAHLLOKOSA-N

>  <PubChem_CID>  (440) 
129211

>  <CYP1A2>  (440) 


>  <CYP2A6>  (440) 


>  <CYP2B6>  (440) 


>  <CYP2C8>  (440) 


>  <CYP2C9>  (440) 


>  <CYP2C19>  (440) 


>  <CYP2D6>  (440) 
<6,H;Hydroxylation;R1>
<20,21;Cleavage;R2>
<21,H;Oxidation;R2>

>  <CYP2E1>  (440) 


>  <CYP3A4>  (440) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<11,12;Cleavage;R2>
<11,H;Oxidation;R2>

>  <References>  (440) 
Kamimura H, Oishi S, Matsushima H, Watanabe T, Higuchi S, Hall M, Wood SG, Chasseaud LF: Identification of cytochrome P450 isozymes involved in metabolism of the alpha1-adrenoceptor blocker tamsulosin in human liver microsomes. Xenobiotica. 1998 Oct;28(10):909-22. doi: 10.1080/004982598238985. (PMID: 9849639)

>  <Comments>  (440) 
6 (O for O-Dealkylation). 25 (Aromatic Hydroylation).

$$$$
CC02300
     RDKit          3D

 35 38  0  0  0  0  0  0  0  0999 V2000
   -5.7960   -1.0630    0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8700    0.0030   -0.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8780   -0.0240   -1.8740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3330    1.3540    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4500   -0.2590    0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9050   -1.4400   -0.6520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7510   -2.4210   -0.1710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4890   -3.0260    1.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3800   -2.6490    1.7780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5330   -1.6680    1.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2310    2.0850   -0.7200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6560    3.3250   -0.2800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1830    3.8330    0.9160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2860    3.1010    1.6710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8660    1.8590    1.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5060    0.8200   -0.4780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9750   -1.6300   -0.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5160   -1.8350   -0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    0.4870   -0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6750   -0.8050   -0.6370 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7020   -1.0600   -0.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6370   -0.0160   -0.8040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0710   -0.2820   -0.3400 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0070    0.7620   -0.9530 C   0  0  1  0  0  0  0  0  0  0  0  0
    5.4190    0.5010   -0.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2410   -0.3320   -1.2330 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5360   -0.5720   -0.8140 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0090    0.0200    0.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1870    0.8530    1.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8940    1.0980    0.6570 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4210   -0.2420    0.8010 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6880    0.5280    2.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6060   -1.7400    1.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4010    0.2200   -0.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9450    0.6790   -2.3790 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  1 10  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  4 11  2  0
  4 15  1  0
  5 16  1  0
  5 17  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 16 19  1  0
 17 18  1  0
 18 20  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 35  1  6
 25 26  2  0
 25 30  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 28 31  1  0
 29 30  2  0
 31 32  1  0
 31 33  1  0
 31 34  1  0
M  END
>  <Name>  (441) 
Terfenadine

>  <InChIKey>  (441) 
GUGOEEXESWIERI-PMERELPUSA-N

>  <PubChem_CID>  (441) 
6604035

>  <CYP1A2>  (441) 


>  <CYP2A6>  (441) 


>  <CYP2B6>  (441) 


>  <CYP2C8>  (441) 


>  <CYP2C9>  (441) 


>  <CYP2C19>  (441) 


>  <CYP2D6>  (441) 
<0,H;Hydroxylation;R1>
<3,H;Hydroxylation;R2>
<2,H;Hydroxylation;R3>

>  <CYP2E1>  (441) 


>  <CYP3A4>  (441) 
<0,H;Hydroxylation;R1>
<3,H;Hydroxylation;R2>
<2,H;Hydroxylation;R3>
<12,13;Cleavage;R4>
<12,H;Oxidation;R4>

>  <References>  (441) 
Jones BC, Hyland R, Ackland M, Tyman CA, Smith DA: Interaction of terfenadine and its primary metabolites with cytochrome P450 2D6. Drug Metab Dispos. 1998 Sep;26(9):875-82. (PMID: 9733666)

>  <Comments>  (441) 
32 (Aliphatic Hydroxylation). 21 (N for N-Dealkylation).

$$$$
CC02301
     RDKit          3D

 21 22  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3790    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1710    2.1220    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1930    1.9720    0.0180 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1750   -0.6930   -0.0120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1560   -0.6290    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8170    1.8720   -1.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7830    3.5380    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2820    0.6560    0.0160 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.8380   -2.0820   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0340    2.7860   -1.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0260    4.4100   -0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1200   -2.9170   -0.0320 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.6150    4.1500   -1.4420 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7610   -4.3990   -0.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8400   -2.7070    1.1840 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9910   -5.2010   -0.1780 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5780   -6.6050   -0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7920   -6.7900   -1.6040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8180   -7.5020   -0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6950   -6.9860    0.8850 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  6  9  1  0
  7 11  1  0
  8 12  1  0
 10 13  1  0
 11 14  1  0
 12 14  1  0
 13 15  1  0
 13 16  1  1
 15 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 18 21  1  0
M  END
>  <Name>  (442) 
Timolol

>  <InChIKey>  (442) 
BLJRIMJGRPQVNF-JTQLQIEISA-N

>  <PubChem_CID>  (442) 
33624

>  <CYP1A2>  (442) 


>  <CYP2A6>  (442) 


>  <CYP2B6>  (442) 


>  <CYP2C8>  (442) 


>  <CYP2C9>  (442) 


>  <CYP2C19>  (442) 
<17,H;Hydroxylation;R1>
<19,H;Hydroxylation;R2>

>  <CYP2D6>  (442) 
<17,H;Hydroxylation;R1>
<19,H;Hydroxylation;R2>

>  <CYP2E1>  (442) 


>  <CYP3A4>  (442) 


>  <References>  (442) 
Bapiro TE, Hasler JA, Ridderstrom M, Masimirembwa CM: The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant. Potential implications for CYP2D6 phenotyping studies and the clinical use of CYP2D6 substrate drugs in some African populations. Biochem Pharmacol. 2002 Nov 1;64(9):1387-98. doi: 10.1016/s0006-2952(02)01351-5. (PMID: 12392820)
Volotinen M, Turpeinen M, Tolonen A, Uusitalo J, Maenpaa J, Pelkonen O: Timolol metabolism in human liver microsomes is mediated principally by CYP2D6. Drug Metab Dispos. 2007 Jul;35(7):1135-41. doi: 10.1124/dmd.106.012906. Epub 2007 Apr 12. (PMID: 17431033)

>  <Comments>  (442) 
The paper says the M1 metabolites are hydroxy metabolites.

$$$$
CC02302
     RDKit          3D

 24 26  0  0  0  0  0  0  0  0999 V2000
   -0.3960    1.6010   -0.4720 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1930    3.8410   -2.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1160    0.1890   -0.1800 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.4270   -0.5340    0.1380 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.6860    3.7180   -1.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4990    3.0760   -2.0910 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8960    2.2370   -0.7530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1740    1.6290   -1.7150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1050    0.1440    1.3010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4990    5.2930   -2.5850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0510    1.1260    1.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7850   -0.2210    2.5950 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4910    3.2870   -3.4500 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1500   -1.8950    0.4760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3510    1.3890    3.4340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4060    0.3990    3.6630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6740    1.7490    2.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9630    2.0000    4.4820 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8240    0.0940    1.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3360    6.0410   -3.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6160    5.8770   -2.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0550    7.3730   -3.6340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8970    7.2090   -2.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0600    7.9580   -3.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0
  1  7  1  0
  1  8  1  0
  2  5  1  0
  2  6  1  0
  2 10  1  0
  2 13  1  0
  3  4  1  0
  3 19  1  1
  4  9  1  0
  4 14  1  1
  5  7  1  0
  6  8  1  0
  9 11  2  0
  9 12  1  0
 10 20  2  0
 10 21  1  0
 11 17  1  0
 12 16  2  0
 15 16  1  0
 15 17  2  0
 15 18  1  0
 20 22  1  0
 21 23  2  0
 22 24  2  0
 23 24  1  0
M  END
>  <Name>  (443) 
Traxoprodil

>  <InChIKey>  (443) 
QEMSVZNTSXPFJA-HNAYVOBHSA-N

>  <PubChem_CID>  (443) 
219101

>  <CYP1A2>  (443) 


>  <CYP2A6>  (443) 


>  <CYP2B6>  (443) 


>  <CYP2C8>  (443) 


>  <CYP2C9>  (443) 


>  <CYP2C19>  (443) 


>  <CYP2D6>  (443) 
<6,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>

>  <CYP2E1>  (443) 


>  <CYP3A4>  (443) 


>  <References>  (443) 
Johnson K, Shah A, Jaw-Tsai S, Baxter J, Prakash C: Metabolism, pharmacokinetics, and excretion of a highly selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in human cytochrome P450 2D6 extensive and poor metabolizers. Drug Metab Dispos. 2003 Jan;31(1):76-87. doi: 10.1124/dmd.31.1.76. (PMID: 12485956)

>  <Comments>  (443) 
16 (Aromatic Hydroylation).

$$$$
CC02303
     RDKit          3D

 21 24  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4700    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3270    1.8730   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0320    2.4240    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1610   -0.8990    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3160   -0.3720   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1010    0.7310   -0.0140 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6330    3.2300    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7100    3.7640    0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9840   -2.2350   -0.0010 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2850   -0.4340    0.0210 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6190    4.1630    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1350   -3.1200    0.0050 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.7830   -4.4180   -0.7270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5290   -3.4330    1.4510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9550   -5.4030   -0.5860 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.6510   -4.4840    1.4440 C   0  0  2  0  0  0  0  0  0  0  0  0
   -3.0850   -5.7290    0.8590 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2570   -4.6390   -0.9220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7170   -4.0320    0.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1280   -6.7580    0.9670 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  2  0
  4  9  1  0
  5 10  1  0
  5 11  2  0
  6  7  1  0
  8 12  1  0
  9 12  2  0
 13 10  1  1
 13 14  1  0
 13 15  1  0
 16 14  1  1
 17 15  1  6
 16 18  1  0
 16 19  1  0
 17 18  1  0
 17 20  1  0
 18 21  1  0
 19 20  1  0
M  END
>  <Name>  (444) 
Tropisetron

>  <InChIKey>  (444) 
ZNRGQMMCGHDTEI-CLLJXQQHSA-N

>  <PubChem_CID>  (444) 


>  <CYP1A2>  (444) 


>  <CYP2A6>  (444) 


>  <CYP2B6>  (444) 


>  <CYP2C8>  (444) 


>  <CYP2C9>  (444) 


>  <CYP2C19>  (444) 


>  <CYP2D6>  (444) 
<17,H;Hydroxylation;R1>
<16,H;Hydroxylation;R2>

>  <CYP2E1>  (444) 


>  <CYP3A4>  (444) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (444) 
Firkusny L, Kroemer HK, Eichelbaum M: In vitro characterization of cytochrome P450 catalysed metabolism of the antiemetic tropisetron. Biochem Pharmacol. 1995 Jun 16;49(12):1777-84. doi: 10.1016/0006-2952(95)00021-q. (PMID: 7598739)

>  <Comments>  (444) 


$$$$
CC02304
     RDKit          3D

 10 10  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3780    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1700    2.0880    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3330    2.1130    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2070   -0.6800   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770    1.4180   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7710    2.3540    1.4660 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3990    0.0300   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0540    3.0690    1.4760 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5860   -0.6320   -0.0350 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  3  6  2  0
  4  7  1  0
  5  8  2  0
  6  8  1  0
  7  9  1  0
  8 10  1  0
M  END
>  <Name>  (445) 
Tyramine

>  <InChIKey>  (445) 
DZGWFCGJZKJUFP-UHFFFAOYSA-N

>  <PubChem_CID>  (445) 
5610

>  <CYP1A2>  (445) 


>  <CYP2A6>  (445) 


>  <CYP2B6>  (445) 


>  <CYP2C8>  (445) 


>  <CYP2C9>  (445) 


>  <CYP2C19>  (445) 


>  <CYP2D6>  (445) 
<5,H;Hydroxylation;R1>
<8,H;Hydroxylation;R2>

>  <CYP2E1>  (445) 


>  <CYP3A4>  (445) 


>  <References>  (445) 
Hiroi T, Imaoka S, Funae Y: Dopamine formation from tyramine by CYP2D6. Biochem Biophys Res Commun. 1998 Aug 28;249(3):838-43. doi: 10.1006/bbrc.1998.9232. (PMID: 9731223)

>  <Comments>  (445) 
5 (Aromatic Hydroylation).

$$$$
CC02306
     RDKit          3D

 21 24  0  0  0  0  0  0  0  0999 V2000
    1.4160    0.8030    0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1910    1.4050    0.3510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9360    0.5850    0.5670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8710   -0.8020    0.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3420   -1.4040    0.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4590   -0.6030    0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6540    1.3970   -0.1470 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0310    2.6390   -0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3790    2.8850   -0.4300 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1630    3.8100   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8070    3.7960    0.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0580    2.7790    0.4350 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5810    5.1730   -0.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6180    6.1190   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7340    7.5890   -0.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1410    5.3900    0.3670 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.2800    1.7730   -0.7000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3800    1.7290    0.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1060    2.9840    0.5280 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1920    4.1190    0.6270 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0880    4.1460   -0.4210 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  1  7  1  0
  2  3  2  0
  2 12  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
  9 17  1  0
  9 21  1  0
 10 11  2  0
 10 13  1  0
 11 12  1  0
 11 16  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
M  END
>  <Name>  (446) 
4-Demethylolanzapine

>  <InChIKey>  (446) 
FHPIXVHJEIZKJW-UHFFFAOYSA-N

>  <PubChem_CID>  (446) 
135446209

>  <CYP1A2>  (446) 
<0,H;Hydroxylation;R1>

>  <CYP2A6>  (446) 


>  <CYP2B6>  (446) 


>  <CYP2C8>  (446) 


>  <CYP2C9>  (446) 


>  <CYP2C19>  (446) 


>  <CYP2D6>  (446) 
<0,H;Hydroxylation;R1>

>  <CYP2E1>  (446) 


>  <CYP3A4>  (446) 


>  <References>  (446) 
Ring BJ, Catlow J, Lindsay TJ, Gillespie T, Roskos LK, Cerimele BJ, Swanson SP, Hamman MA, Wrighton SA: Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine. J Pharmacol Exp Ther. 1996 Feb;276(2):658-66. (PMID: 8632334)
Kassahun K, Mattiuz E, Nyhart E Jr, Obermeyer B, Gillespie T, Murphy A, Goodwin RM, Tupper D, Callaghan JT, Lemberger L: Disposition and biotransformation of the antipsychotic agent olanzapine in humans. Drug Metab Dispos. 1997 Jan;25(1):81-93. (PMID: 9010634)

>  <Comments>  (446) 
Xenosite reports 21, 17 as SoM but they cannot be identified in the reference. 15 can be identified in the second reference.

$$$$
CC02307
     RDKit          3D

 31 35  0  0  1  0  0  0  0  0999 V2000
    0.0380    1.4130   -0.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0440    0.0120    0.1190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1820    2.3370    0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1840    1.8620   -0.3900 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2680   -0.3620   -0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9870   -0.9720    0.4510 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5410    3.0020   -1.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0270    3.3250    1.1820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0010    0.7420   -0.4140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7480   -1.6670   -0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5490   -2.2980    0.5350 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6600    4.0050   -1.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1750    4.3090    1.2230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7860   -2.6240    0.2950 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3420    4.9840   -0.0570 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1610   -3.9080    0.3870 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.4700    5.8980    0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1760    7.0410    0.9830 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2830    8.0350    1.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5440    7.6520    1.6750 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1890    9.2760    0.5180 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5230    8.6310    1.7010 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6780    6.5320    2.1630 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1940   10.2040    0.5640 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9230    9.7230   -0.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3010    9.8770    1.1540 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7450    8.2620    2.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4430   10.8850    1.1860 C   0  0  1  0  0  0  0  0  0  0  0  0
    7.0020   12.2130    1.3640 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.9250    9.1640    2.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4930   10.6010    2.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5  9  1  0
  5 10  1  0
  6 11  2  0
  7 12  1  0
  8 13  1  0
 10 14  2  0
 11 14  1  0
 12 15  1  0
 13 15  1  0
 14 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 20 22  1  0
 20 23  2  0
 21 24  1  0
 21 25  1  0
 22 26  1  0
 22 27  1  0
 24 26  2  0
 26 28  1  0
 27 30  1  0
 28 29  1  1
 28 31  1  0
 30 31  1  0
M  END
>  <Name>  (447) 
9-OH-Risperidone

>  <InChIKey>  (447) 
PMXMIIMHBWHSKN-IBGZPJMESA-N

>  <PubChem_CID>  (447) 
9823781

>  <CYP1A2>  (447) 


>  <CYP2A6>  (447) 


>  <CYP2B6>  (447) 


>  <CYP2C8>  (447) 


>  <CYP2C9>  (447) 


>  <CYP2C19>  (447) 


>  <CYP2D6>  (447) 
<27,H;Hydroxylation;R1>

>  <CYP2E1>  (447) 


>  <CYP3A4>  (447) 


>  <References>  (447) 
Shen WW: The metabolism of atypical antipsychotic drugs: an update. Ann Clin Psychiatry. 1999 Sep;11(3):145-58. (PMID: 10482125)

>  <Comments>  (447) 
30 (Cycloalkane ring for Aliphatic hydroxylation).

$$$$
CC02308
     RDKit          3D

 27 29  0  0  0  0  0  0  0  0999 V2000
    0.8320    0.4480   -1.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4050    1.0770   -1.1180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2900    1.1050   -0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6340    1.7630   -0.1290 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.9240    0.4890    1.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3120   -0.1410    1.2810 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1900   -0.1600    0.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5990    3.2460   -0.5130 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.8970    4.0940    0.4420 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4940    4.1720    0.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2910    5.0660    0.9600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0000    3.8180   -0.5870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9140    2.9590   -1.4230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8670    1.5070   -1.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5210    0.9660   -0.9740 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2830    4.5570    1.8020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5040    3.2070    1.7590 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5220    2.8160    2.6730 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9980    5.4290    2.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7310    6.7960    2.6120 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7470    7.3090    1.7720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5540    8.6600    1.8270 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4790    9.1700    0.9940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6770    8.6390    1.3180 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2140    8.9420   -0.3100 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5540   10.5070    1.1760 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0370    6.4400    0.9480 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  7  1  0
  2  3  1  0
  4  3  1  6
  3  5  2  0
  4  8  1  0
  4 15  1  0
  5  6  1  0
  6  7  2  0
  8  9  1  1
  8 12  1  0
  9 10  1  0
 10 11  1  0
 11 16  2  0
 11 27  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 16 17  1  0
 16 19  1  0
 17 18  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 21 27  2  0
 22 23  1  0
 23 24  1  0
 23 25  1  0
 23 26  1  0
M  END
>  <Name>  (448) 
CP-122-721

>  <InChIKey>  (448) 
ZIWFCOIGUNPHPM-MJGOQNOKSA-N

>  <PubChem_CID>  (448) 


>  <CYP1A2>  (448) 


>  <CYP2A6>  (448) 


>  <CYP2B6>  (448) 


>  <CYP2C8>  (448) 


>  <CYP2C9>  (448) 


>  <CYP2C19>  (448) 


>  <CYP2D6>  (448) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (448) 


>  <CYP3A4>  (448) 
<14,15;Cleavage;R1>
<15,H;Oxidation;R1>

>  <References>  (448) 
Obach RS, Margolis JM, Logman MJ: In vitro metabolism of CP-122,721 ((2S,3S)-2-phenyl-3-[(5-trifluoromethoxy-2-methoxy)benzylamino]piperidine), a non-peptide antagonist of the substance P receptor. Drug Metab Pharmacokinet. 2007 Oct;22(5):336-49. (PMID: 17965517)

>  <Comments>  (448) 
17 (O for O-Demethylation). 9 (N for N-Dealkylation).

$$$$
CC02309
     RDKit          3D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -0.1880    1.0110    0.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1130   -0.2220   -0.4900 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9830    1.6210    0.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5300    1.6560    0.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1300   -0.8060   -0.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2310    1.0130    0.5010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6800    2.6140    1.4660 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.2680   -0.2060   -0.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9180    3.4520    1.2600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8610    1.8710    2.7030 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3860   -1.9950   -1.2290 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8150   -2.0800   -1.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3840   -0.9430   -0.3810 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  3  6  2  0
  4  7  1  0
  5  8  2  0
  5 11  1  0
  6  8  1  0
  7  9  1  6
  7 10  1  0
  8 13  1  0
 11 12  1  0
 12 13  1  0
M  END
>  <Name>  (449) 
MDA

>  <InChIKey>  (449) 
NGBBVGZWCFBOGO-SSDOTTSWSA-N

>  <PubChem_CID>  (449) 
3046161

>  <CYP1A2>  (449) 


>  <CYP2A6>  (449) 


>  <CYP2B6>  (449) 


>  <CYP2C8>  (449) 


>  <CYP2C9>  (449) 


>  <CYP2C19>  (449) 


>  <CYP2D6>  (449) 
<11,12;Cleavage;R1>
<10,11;Cleavage;R1>
<11,H;Oxidation;R1>

>  <CYP2E1>  (449) 


>  <CYP3A4>  (449) 
<11,12;Cleavage;R1>
<10,11;Cleavage;R1>
<11,H;Oxidation;R1>

>  <References>  (449) 
Maurer HH, Bickeboeller-Friedrich J, Kraemer T, Peters FT: Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy'). Toxicol Lett. 2000 Mar 15;112-113:133-42. (PMID: 10720722)

>  <Comments>  (449) 
11 (O for O-Demethylenation). 13 (O for O-Demethylenation).

$$$$
CC02310
     RDKit          3D

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.6160    1.0720    1.8610 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9590    1.4140    1.3680 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0300    1.6010   -0.1460 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6000    0.3340   -0.8840 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5880   -0.4860   -0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2270    0.4000    0.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0660    2.2380    2.4490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2920    1.8790    3.2650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4790    2.6090    3.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5900    2.2970    3.9120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5200    1.2570    4.8390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3450    0.5160    4.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4060   -0.4720    5.9330 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3460   -1.4270    5.9890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2180   -0.9830    6.9220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6830   -0.5450    8.3110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2340    0.8400    4.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3190   -1.5800    8.9230 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  7  8  1  0
  8  9  2  0
  8 17  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 17  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 18  1  0
M  END
>  <Name>  (450) 
ROX-M-5

>  <InChIKey>  (450) 
JACPUZOKPSTMTK-UHFFFAOYSA-N

>  <PubChem_CID>  (450) 
10444765

>  <CYP1A2>  (450) 


>  <CYP2A6>  (450) 


>  <CYP2B6>  (450) 


>  <CYP2C8>  (450) 


>  <CYP2C9>  (450) 


>  <CYP2C19>  (450) 


>  <CYP2D6>  (450) 
<14,13;Cleavage;R1>
<14,H;Oxidation;R1>
<16,H;Oxidation;R2>

>  <CYP2E1>  (450) 


>  <CYP3A4>  (450) 


>  <References>  (450) 
Sasaki M, Nakayama M, Numazawa S, Oguro T, Honma S, Iwamura S, Tsukamoto K, Yoshida T: Cytochrome P450 enzymes involved in the metabolic pathway of the histamine 2 (H2)-receptor antagonist roxatidine acetate by human liver microsomes. Arzneimittelforschung. 2001;51(8):651-8. doi: 10.1055/s-0031-1300096. (PMID: 11556126)

>  <Comments>  (450) 
Don't have the access to the reference. Use Xenosite's SoMs.

$$$$
CC02311
     RDKit          3D

 34 38  0  0  0  0  0  0  0  0999 V2000
    2.8190   -1.0180   -0.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1810   -2.1610   -0.6490 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8870   -3.0960   -1.4030 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2380   -2.8940   -1.6720 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8820   -1.7590   -1.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1750   -0.8250   -0.4360 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0320   -0.0400    0.6430 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3550    0.0510    2.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6080   -0.7020    3.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8880   -0.6420    4.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9190    0.1700    4.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6700    0.9220    3.9320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3890    0.8620    2.5690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5800    1.2450   -0.0270 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.5950    1.0160   -1.1910 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.5060    2.3390   -1.9800 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8540    2.5120   -2.6940 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9720    2.0370   -1.7570 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5940    2.2720   -0.3470 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4740    3.4390   -0.9050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8910    3.5740   -0.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6830    0.5810   -0.6470 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5540    0.2220   -1.7580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8510   -0.3600   -1.2990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8990    0.4980   -0.9510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1360    0.0060   -0.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3010   -1.3790   -0.4470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2650   -2.2450   -0.7940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0370   -1.7430   -1.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9840   -2.5370   -1.5930 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2930   -3.9180   -1.4400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2360    0.9050   -0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5290    0.3150    0.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1040    2.2330   -0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  7  8  1  0
 14  7  1  6
  8  9  2  0
  8 13  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 14 15  1  0
 14 19  1  0
 15 16  1  0
 15 22  1  1
 16 17  1  0
 16 20  1  0
 17 18  1  0
 18 19  1  0
 19 21  1  0
 20 21  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 24 29  1  0
 25 26  1  0
 26 27  2  0
 26 32  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  1  0
 32 33  1  0
 32 34  2  0
M  END
>  <Name>  (451) 
CJ-12 458

>  <InChIKey>  (451) 
CVTMENNEXOZZEZ-IOWSJCHKSA-N

>  <PubChem_CID>  (451) 


>  <CYP1A2>  (451) 


>  <CYP2A6>  (451) 


>  <CYP2B6>  (451) 


>  <CYP2C8>  (451) 


>  <CYP2C9>  (451) 


>  <CYP2C19>  (451) 


>  <CYP2D6>  (451) 
<0,1;EpOxidation;R1>
<0,1;Reduction;R2>
<0,H;Hydroxylation;R2>

>  <CYP2E1>  (451) 


>  <CYP3A4>  (451) 
<0,1;EpOxidation;R1>
<0,1;Reduction;R2>
<0,H;Hydroxylation;R2>

>  <References>  (451) 
Obach RS: Cytochrome P450-catalyzed metabolism of ezlopitant alkene (CJ-12,458), a pharmacologically active metabolite of ezlopitant: enzyme kinetics and mechanism of an alkene hydration reaction. Drug Metab Dispos. 2001 Jul;29(7):1057-67. (PMID: 11408374)

>  <Comments>  (451) 


$$$$
CC02312
     RDKit          3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -4.1960   -0.6820    0.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3980   -0.3610    1.5520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0200   -0.1970    1.4120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6280   -0.8470   -0.8190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2620   -0.6830   -0.9390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4680   -0.3600    0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6040   -0.8370    0.6130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7500   -0.9620    0.7500 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4230   -0.7910   -2.1570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0630   -0.6780   -1.6730 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0460   -0.2320   -0.2890 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.8280   -1.1890    0.5170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4620    1.1960   -0.2180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1990    2.1030   -1.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1590    1.6550    0.9070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6290    3.4260   -1.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5940    2.9760    0.9940 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3240    3.8490   -0.0530 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0460   -1.6890   -0.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8260   -2.6300    0.6570 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9830   -3.1000   -0.0810 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7070   -4.0060    0.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7350    5.1220    0.0280 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  4  1  0
  1  7  1  0
  2  3  1  0
  3  6  2  0
  4  5  2  0
  5  6  1  0
  5  9  1  0
  6 11  1  0
  7  8  3  0
  9 10  1  0
 10 11  1  0
 11 12  1  1
 11 13  1  0
 12 19  1  0
 13 14  2  0
 13 15  1  0
 14 16  1  0
 15 17  2  0
 16 18  2  0
 17 18  1  0
 18 23  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
M  END
>  <Name>  (452) 
Demethylcitalopram

>  <InChIKey>  (452) 
PTJADDMMFYXMMG-IBGZPJMESA-N

>  <PubChem_CID>  (452) 
11255350

>  <CYP1A2>  (452) 


>  <CYP2A6>  (452) 


>  <CYP2B6>  (452) 


>  <CYP2C8>  (452) 


>  <CYP2C9>  (452) 


>  <CYP2C19>  (452) 


>  <CYP2D6>  (452) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (452) 


>  <CYP3A4>  (452) 


>  <References>  (452) 
Olesen OV, Linnet K: Studies on the stereoselective metabolism of citalopram by human liver microsomes and cDNA-expressed cytochrome P450 enzymes. Pharmacology. 1999 Dec;59(6):298-309. doi: 10.1159/000028333. (PMID: 10575324)

>  <Comments>  (452) 


$$$$
CC02313
     RDKit          3D

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.8860    0.3390   -1.2170 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0220    0.3570   -0.2180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3950    0.1380   -0.5380 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3190    0.5650   -0.9560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7150   -1.2250   -0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0700    1.3420   -0.2270 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4000    0.5800    0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7060   -1.6800    0.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0030   -2.2170   -1.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3850    1.4160    0.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4140    2.5740   -0.4340 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6330    0.7810   -0.7260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5480   -0.7790    1.3800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9440   -3.0540    0.7110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2350   -3.5810   -0.8780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2510    0.2340    0.5180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9890    2.6600    0.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0070    3.8090   -0.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2170   -4.0020    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3070    3.8510    0.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  3  5  1  0
  3  6  1  0
  4  7  1  0
  5  8  2  0
  5  9  1  0
  6 10  2  0
  6 11  1  0
  7 12  1  0
  8 13  1  0
  8 14  1  0
  9 15  2  0
 10 16  1  0
 10 17  1  0
 11 18  2  0
 13 16  1  0
 14 19  2  0
 15 19  1  0
 17 20  2  0
 18 20  1  0
M  END
>  <Name>  (453) 
Desimipramine

>  <InChIKey>  (453) 
HCYAFALTSJYZDH-UHFFFAOYSA-N

>  <PubChem_CID>  (453) 
2995

>  <CYP1A2>  (453) 


>  <CYP2A6>  (453) 


>  <CYP2B6>  (453) 


>  <CYP2C8>  (453) 


>  <CYP2C9>  (453) 


>  <CYP2C19>  (453) 


>  <CYP2D6>  (453) 
<16,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>

>  <CYP2E1>  (453) 


>  <CYP3A4>  (453) 


>  <References>  (453) 
von Moltke LL, Greenblatt DJ, Cotreau-Bibbo MM, Duan SX, Harmatz JS, Shader RI: Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo. J Pharmacol Exp Ther. 1994 Mar;268(3):1278-83. (PMID: 8138941)

>  <Comments>  (453) 
19,20 (C for Aromatic Hydroxylation).

$$$$
CC02315
     RDKit          3D

 33 35  0  0  0  0  0  0  0  0999 V2000
   -0.2040    1.6830    0.0760 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.3710    0.1820    0.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9340    2.1560    0.9600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5040    2.4140    0.3350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7460   -0.4870    1.2890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1390   -0.5570   -1.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7080    3.0090    1.9770 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2670    1.6670    0.5810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6300    3.2440    1.3870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6220    2.2030   -0.6000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8940   -1.8760    1.3190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2820   -1.9410   -1.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5590    3.5250    2.2280 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7740    3.5280    2.8820 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0100    1.3680    1.6720 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6050    1.5010   -0.5820 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8890    3.9720    1.7210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1300    2.0400   -1.8530 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8020    2.1910   -0.2850 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6570   -2.5910    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2690   -2.5320    2.4970 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2740    0.8340    1.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1760    1.8390   -2.7990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5190   -1.8960    3.6950 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4350   -3.8960    2.6080 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0180    0.4770    2.5280 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5060   -0.7460    2.7360 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2380   -1.1360    3.9290 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6900   -2.4530    4.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5030   -0.2550    4.9800 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3980   -2.8860    5.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2100   -0.6850    6.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6580   -2.0010    6.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  1
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5 11  1  0
  6 12  2  0
  7 13  1  0
  7 14  1  0
  8 15  1  0
  8 16  2  0
  9 13  1  0
  9 17  1  0
 10 18  1  0
 10 19  2  0
 11 20  2  0
 11 21  1  0
 12 20  1  0
 15 22  1  0
 18 23  1  0
 21 24  1  0
 21 25  2  0
 22 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 29 31  1  0
 30 32  2  0
 31 33  2  0
 32 33  1  0
M  CHG  2  21   1  24  -1
M  END
>  <Name>  (454) 
Pranidipine

>  <InChIKey>  (454) 
XTFPDGZNWTZCMF-HDFUYHJRSA-N

>  <PubChem_CID>  (454) 
29986496

>  <CYP1A2>  (454) 


>  <CYP2A6>  (454) 


>  <CYP2B6>  (454) 


>  <CYP2C8>  (454) 


>  <CYP2C9>  (454) 


>  <CYP2C19>  (454) 


>  <CYP2D6>  (454) 
<7,H;Oxidation;R1>
<23,H;Oxidation;R1>

>  <CYP2E1>  (454) 


>  <CYP3A4>  (454) 
<7,H;Oxidation;R1>
<23,H;Oxidation;R1>

>  <References>  (454) 
Kudo S, Okumura H, Miyamoto G, Ishizaki T: Cytochrome P-450 isoforms involved in carboxylic acid ester cleavage of Hantzsch pyridine ester of pranidipine. Drug Metab Dispos. 1999 Feb;27(2):303-8. (PMID: 9929520)

>  <Comments>  (454) 
13 (N for Dehydration).

$$$$
CC02316
     RDKit          3D

 34 38  0  0  0  0  0  0  0  0999 V2000
    0.4140    1.2050   -1.4210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0520    0.6640   -2.6440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7930    0.5530   -3.7470 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1020    0.9810   -3.6400 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6090    1.5220   -2.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7420    1.6250   -1.3600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9260    0.8710   -4.7220 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1300    2.2530    0.1840 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.5610    1.9510    0.8060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2780    1.4230   -0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6870    1.0790    0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1190   -0.0390   -0.2230 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6210    2.1140    0.5370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8270    1.7100    1.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7250    2.6650    1.5810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4240    4.0230    1.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2220    4.4230    0.8960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3230    3.4720    0.4230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3630    4.8850    1.9740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9640    6.2410    1.8010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9790    7.1740    2.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9370    7.2040    3.8920 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9730    8.1240    4.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0230    8.2340    5.8400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6820    8.5790    6.4510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5470    7.7950    5.8310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6430    7.7130    4.3230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3050    2.2330    2.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3550    1.2900    3.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6200    1.5480    4.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2190    2.7600    4.9070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4390    3.7140    4.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6990    3.4460    2.8020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4770    3.0180    6.2190 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1 10  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  7  1  0
  5  6  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
  9 28  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 13 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 19  1  0
 17 18  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 27  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 28 29  2  0
 28 33  1  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 31 34  1  0
 32 33  2  0
M  END
>  <Name>  (455) 
Raloxifene

>  <InChIKey>  (455) 
GZUITABIAKMVPG-UHFFFAOYSA-N

>  <PubChem_CID>  (455) 
5035

>  <CYP1A2>  (455) 


>  <CYP2A6>  (455) 


>  <CYP2B6>  (455) 


>  <CYP2C8>  (455) 


>  <CYP2C9>  (455) 


>  <CYP2C19>  (455) 


>  <CYP2D6>  (455) 
<31,H;Hydroxylation;R1>
<28,H;Hydroxylation;R2>
<24,H;Hydroxylation;R3>
<21,H;Hydroxylation;R4>

>  <CYP2E1>  (455) 


>  <CYP3A4>  (455) 


>  <References>  (455) 
Chen Q, Ngui JS, Doss GA, Wang RW, Cai X, DiNinno FP, Blizzard TA, Hammond ML, Stearns RA, Evans DC, Baillie TA, Tang W: Cytochrome P450 3A4-mediated bioactivation of raloxifene: irreversible enzyme inhibition and thiol adduct formation. Chem Res Toxicol. 2002 Jul;15(7):907-14. (PMID: 12119000)

>  <Comments>  (455) 


$$$$
CC02317
     RDKit          3D

 31 35  0  0  0  0  0  0  0  0999 V2000
    0.9050   -0.0370    1.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3390    0.5380    1.7940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4260    0.2610    0.9790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9460    0.9810    1.3210 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.3090   -0.5940   -0.1150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0620   -1.1870   -0.3960 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0310   -0.9000    0.4340 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3860   -2.0820   -1.4110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3970   -2.6720   -2.5190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7180   -2.3090   -1.1670 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1240   -1.6040   -0.0590 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4460   -1.6340    0.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4040   -2.4160   -0.2070 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7110   -2.4590    0.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0480   -1.7180    1.3990 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3050   -1.7580    1.8610 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.1030   -0.9360    2.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7980   -0.8960    1.5740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9110   -1.6320   -3.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7900   -2.2470   -4.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8790   -3.0160   -3.9720 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6580   -3.5600   -5.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8610   -4.3990   -4.6660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9370   -3.6650   -4.0470 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3350   -4.1110   -3.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4880   -3.6000   -2.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8000   -2.3890   -3.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2230   -1.8720   -3.4760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0030   -3.0800   -3.3300 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2360   -4.1500   -3.8580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6310   -5.2830   -4.0890 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  7  1  0
  2  3  1  0
  3  4  1  0
  3  5  2  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  7 11  1  0
  8  9  1  0
  8 10  2  0
  9 19  1  0
  9 26  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 18  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 25  1  0
 22 23  1  0
 23 24  1  0
 24 27  1  0
 24 30  1  0
 25 26  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  2  0
M  END
>  <Name>  (456) 
Sertindole

>  <InChIKey>  (456) 
GZKLJWGUPQBVJQ-UHFFFAOYSA-N

>  <PubChem_CID>  (456) 
60149

>  <CYP1A2>  (456) 


>  <CYP2A6>  (456) 


>  <CYP2B6>  (456) 


>  <CYP2C8>  (456) 


>  <CYP2C9>  (456) 


>  <CYP2C19>  (456) 


>  <CYP2D6>  (456) 
<3,H;Hydroxylation;R1>
<4,H;Hydroxylation;R2>

>  <CYP2E1>  (456) 


>  <CYP3A4>  (456) 
<7,8;Cleavage;R1>
<7,H;Oxidation;R1>

>  <References>  (456) 
Shen WW: The metabolism of atypical antipsychotic drugs: an update. Ann Clin Psychiatry. 1999 Sep;11(3):145-58. (PMID: 10482125)

>  <Comments>  (456) 


$$$$
CC02318
     RDKit          3D

  7  6  0  0  0  0  0  0  0  0999 V2000
    0.1610    0.3970   -0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3500   -0.9880    0.2830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7040   -1.0260    0.2710 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0580   -1.3940    1.5050 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0730   -1.9080   -0.6150 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.9390    0.4550   -0.1350 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.4430    1.6380    1.0540 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
M  END
>  <Name>  (457) 
1,1-Dichloro-2,2,2-trifluoroethane

>  <InChIKey>  (457) 
OHMHBGPWCHTMQE-UHFFFAOYSA-N

>  <PubChem_CID>  (457) 
9385

>  <CYP1A2>  (457) 


>  <CYP2A6>  (457) 


>  <CYP2B6>  (457) 


>  <CYP2C8>  (457) 


>  <CYP2C9>  (457) 


>  <CYP2C19>  (457) 


>  <CYP2D6>  (457) 


>  <CYP2E1>  (457) 
<4,H;Oxidation;R1>
<4,5;Cleavage;R1>
<0,H;Oxidation;R2>
<4,6;Cleavage;R2>

>  <CYP3A4>  (457) 


>  <References>  (457) 
Urban G, Speerschneider P, Dekant W: Metabolism of the chlorofluorocarbon substitute 1,1-dichloro-2,2,2-trifluoroethane by rat and human liver microsomes: the role of cytochrome P450 2E1. Chem Res Toxicol. 1994 Mar-Apr;7(2):170-6. (PMID: 8199305)

>  <Comments>  (457) 


$$$$
CC02319
     RDKit          2D

 10 10  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0360    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.4860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1020   -0.5220    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1020   -0.5220    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2300    2.1960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2300    3.6160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    4.3260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    5.7020    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    3.6160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    2.1960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2 10  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
M  CHG  2   1   1   4  -1
M  END
>  <Name>  (458) 
4-Nitrophenol

>  <InChIKey>  (458) 
BTJIUGUIPKRLHP-UHFFFAOYSA-N

>  <PubChem_CID>  (458) 
980

>  <CYP1A2>  (458) 


>  <CYP2A6>  (458) 


>  <CYP2B6>  (458) 


>  <CYP2C8>  (458) 


>  <CYP2C9>  (458) 


>  <CYP2C19>  (458) 


>  <CYP2D6>  (458) 


>  <CYP2E1>  (458) 
<5,H;Hydroxylation;R1>
<8,H;Hydroxylation;R2>

>  <CYP3A4>  (458) 


>  <References>  (458) 
Tassaneeyakul W, Veronese ME, Birkett DJ, Gonzalez FJ, Miners JO: Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. Biochem Pharmacol. 1993 Dec 3;46(11):1975-81. doi: 10.1016/0006-2952(93)90639-e. (PMID: 8267647)

>  <Comments>  (458) 
6 (C for Aromatic Hydroxylation). 9 (C for Aromatic Hydroxylation).

$$$$
CC02320
     RDKit          3D

  3  2  0  0  0  0  0  0  0  0999 V2000
    0.0140   -0.8670    0.1390 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4740   -1.5050   -0.9780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3210   -1.9620   -1.7760 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
M  END
>  <Name>  (459) 
Acetaldehyde

>  <InChIKey>  (459) 
IKHGUXGNUITLKF-UHFFFAOYSA-N

>  <PubChem_CID>  (459) 
177

>  <CYP1A2>  (459) 


>  <CYP2A6>  (459) 


>  <CYP2B6>  (459) 


>  <CYP2C8>  (459) 


>  <CYP2C9>  (459) 


>  <CYP2C19>  (459) 


>  <CYP2D6>  (459) 


>  <CYP2E1>  (459) 
<1,H;Hydroxylation;R1>

>  <CYP3A4>  (459) 


>  <References>  (459) 
Bell-Parikh LC, Guengerich FP: Kinetics of cytochrome P450 2E1-catalyzed oxidation of ethanol to acetic acid via acetaldehyde. J Biol Chem. 1999 Aug 20;274(34):23833-40. doi: 10.1074/jbc.274.34.23833. (PMID: 10446146)

>  <Comments>  (459) 
2 (C for Aliphatic Hydroxylation).

$$$$
CC02321
     RDKit          3D

  4  3  0  0  0  0  0  0  0  0999 V2000
    0.1620    0.1040   -0.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8270   -1.0310   -0.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1390   -2.2080   -0.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5400   -3.3820   -0.2470 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  3  0
M  END
>  <Name>  (460) 
Acrylonitrile

>  <InChIKey>  (460) 
NLHHRLWOUZZQLW-UHFFFAOYSA-N

>  <PubChem_CID>  (460) 
7855

>  <CYP1A2>  (460) 


>  <CYP2A6>  (460) 


>  <CYP2B6>  (460) 


>  <CYP2C8>  (460) 


>  <CYP2C9>  (460) 


>  <CYP2C19>  (460) 


>  <CYP2D6>  (460) 


>  <CYP2E1>  (460) 
<0,1;EpOxidation;R1>

>  <CYP3A4>  (460) 


>  <References>  (460) 
Kedderis GL, Batra R, Koop DR: Epoxidation of acrylonitrile by rat and human cytochromes P450. Chem Res Toxicol. 1993 Nov-Dec;6(6):866-71. (PMID: 8117926)

>  <Comments>  (460) 
1,2 (Epoxidation).

$$$$
CC02322
     RDKit          2D

  7  7  0  0  0  0  0  0  0  0999 V2000
    1.2300    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4400    1.4090    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2300   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  7  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
M  END
>  <Name>  (461) 
Aniline

>  <InChIKey>  (461) 
PAYRUJLWNCNPSJ-UHFFFAOYSA-N

>  <PubChem_CID>  (461) 
6115

>  <CYP1A2>  (461) 


>  <CYP2A6>  (461) 


>  <CYP2B6>  (461) 


>  <CYP2C8>  (461) 


>  <CYP2C9>  (461) 


>  <CYP2C19>  (461) 


>  <CYP2D6>  (461) 


>  <CYP2E1>  (461) 
<4,H;Hydroxylation;R1>

>  <CYP3A4>  (461) 


>  <References>  (461) 
Yamazaki H, Nakano M, Gillam EM, Bell LC, Guengerich FP, Shimada T: Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes. Biochem Pharmacol. 1996 Jul 26;52(2):301-9. doi: 10.1016/0006-2952(96)00208-0. (PMID: 8694855)

>  <Comments>  (461) 
5 (C for Aromatic Hydroxylation).

$$$$
CC02324
     RDKit          3D

  3  2  0  0  0  0  0  0  0  0999 V2000
    0.0080   -0.0020    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7810    0.0090    0.0190 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.5970    1.1760    1.1880 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
M  END
>  <Name>  (462) 
Dichloromethane

>  <InChIKey>  (462) 
YMWUJEATGCHHMB-UHFFFAOYSA-N

>  <PubChem_CID>  (462) 
6344

>  <CYP1A2>  (462) 


>  <CYP2A6>  (462) 


>  <CYP2B6>  (462) 


>  <CYP2C8>  (462) 


>  <CYP2C9>  (462) 


>  <CYP2C19>  (462) 


>  <CYP2D6>  (462) 


>  <CYP2E1>  (462) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<1,H;Oxidation;R2>
<0,1;Cleavage;R2>

>  <CYP3A4>  (462) 


>  <References>  (462) 
Pankow D, Jagielki S: Effect of methanol or modifications of the hepatic glutathione concentration on the metabolism of dichloromethane to carbon monoxide in rats. Hum Exp Toxicol. 1993 May;12(3):227-31. doi: 10.1177/096032719301200305. (PMID: 8100433)

>  <Comments>  (462) 
1 (C for Aliphatic Hydroxylation).

$$$$
CC02325
     RDKit          3D

  5  4  0  0  0  0  0  0  0  0999 V2000
    0.0550    0.3950   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3110   -0.2950    0.0800 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7520   -1.0720   -1.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0770   -0.2190    1.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8270    0.4000    2.2310 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
M  END
>  <Name>  (463) 
Dimethylformamide

>  <InChIKey>  (463) 
ZMXDDKWLCZADIW-UHFFFAOYSA-N

>  <PubChem_CID>  (463) 
6228

>  <CYP1A2>  (463) 


>  <CYP2A6>  (463) 


>  <CYP2B6>  (463) 


>  <CYP2C8>  (463) 


>  <CYP2C9>  (463) 


>  <CYP2C19>  (463) 


>  <CYP2D6>  (463) 


>  <CYP2E1>  (463) 
<0,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>

>  <CYP3A4>  (463) 


>  <References>  (463) 
Mraz J, Jheeta P, Gescher A, Hyland R, Thummel K, Threadgill MD: Investigation of the mechanistic basis of N,N-dimethylformamide toxicity. Metabolism of N,N-dimethylformamide and its deuterated isotopomers by cytochrome P450 2E1. Chem Res Toxicol. 1993 Mar-Apr;6(2):197-207. (PMID: 8477011)

>  <Comments>  (463) 
The hydroxyl metabolite is detectable.

$$$$
CC02326
     RDKit          3D

 10  9  0  0  0  0  0  0  0  0999 V2000
   -1.9950    0.8000   -1.0720 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3180   -0.1190   -1.7980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4610    0.2360   -3.0980 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0440    0.0150   -1.4810 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4460   -0.7950   -0.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0120   -2.0560   -0.5870 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.8030   -0.8750   -0.5060 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.1140   -0.2640    1.0070 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.5740   -0.5790    1.4920 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.9180   -0.8780    1.9220 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  5  8  1  0
  8  9  1  0
  8 10  1  1
M  END
>  <Name>  (464) 
Enflurane

>  <InChIKey>  (464) 
JPGQOUSTVILISH-SFOWXEAESA-N

>  <PubChem_CID>  (464) 
11052326

>  <CYP1A2>  (464) 


>  <CYP2A6>  (464) 


>  <CYP2B6>  (464) 


>  <CYP2C8>  (464) 


>  <CYP2C9>  (464) 


>  <CYP2C19>  (464) 


>  <CYP2D6>  (464) 


>  <CYP2E1>  (464) 
<7,9;Cleavage;R1>
<7,H;Hydroxylation;R1>

>  <CYP3A4>  (464) 


>  <References>  (464) 
Garton KJ, Yuen P, Meinwald J, Thummel KE, Kharasch ED: Stereoselective metabolism of enflurane by human liver cytochrome P450 2E1. Drug Metab Dispos. 1995 Dec;23(12):1426-30. (PMID: 8689955)

>  <Comments>  (464) 
8 (C for Aliphatic Hydroxylation).

$$$$
CC02327
     RDKit          3D

 10 10  0  0  0  0  0  0  0  0999 V2000
   -1.2730   -0.2720    1.8000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1450   -0.9000    0.4160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0990   -0.2540   -0.5170 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.3250   -0.2520    0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6130    1.1950    0.3550 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6050    1.6210    0.9230 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6040    1.9490   -0.1540 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4030    1.2210   -0.7110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3920    1.6860   -1.2530 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1200   -0.9520   -1.8810 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  8  1  0
  3 10  1  6
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
M  END
>  <Name>  (465) 
Ethosuximide

>  <InChIKey>  (465) 
HAPOVYFOVVWLRS-SSDOTTSWSA-N

>  <PubChem_CID>  (465) 
6603844

>  <CYP1A2>  (465) 


>  <CYP2A6>  (465) 


>  <CYP2B6>  (465) 


>  <CYP2C8>  (465) 


>  <CYP2C9>  (465) 


>  <CYP2C19>  (465) 


>  <CYP2D6>  (465) 


>  <CYP2E1>  (465) 
<1,H;Hydroxylation;R1>

>  <CYP3A4>  (465) 
<1,H;Hydroxylation;R1>

>  <References>  (465) 
Bachmann K, He Y, Sarver JG, Peng N: Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of ethosuximide by human hepatic microsomal enzymes. Xenobiotica. 2003 Mar;33(3):265-76. doi: 10.1080/0049825021000061606. (PMID: 12637244)

>  <Comments>  (465) 


$$$$
CC02328
     RDKit          2D

  5  5  0  0  0  0  0  0  0  0999 V2000
    0.9770    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3730    1.1490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2080    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3730   -1.1490    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9770   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  2  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
M  END
>  <Name>  (466) 
Furan

>  <InChIKey>  (466) 
YLQBMQCUIZJEEH-UHFFFAOYSA-N

>  <PubChem_CID>  (466) 
8029

>  <CYP1A2>  (466) 


>  <CYP2A6>  (466) 


>  <CYP2B6>  (466) 


>  <CYP2C8>  (466) 


>  <CYP2C9>  (466) 


>  <CYP2C19>  (466) 


>  <CYP2D6>  (466) 


>  <CYP2E1>  (466) 
<0,1;Oxidation;R1>
<0,4;Reduction;R1>
<1,2;Reduction;R1>
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>
<4,4;Oxidation;R1>
<0,1;Oxidation;R2>
<0,4;Reduction;R2>
<1,2;Reduction;R2>
<3,4;Cleavage;R2>
<4,H;Oxidation;R2>
<2,3;Oxidation;R2>

>  <CYP3A4>  (466) 


>  <References>  (466) 
Kedderis GL, Carfagna MA, Held SD, Batra R, Murphy JE, Gargas ML: Kinetic analysis of furan biotransformation by F-344 rats in vivo and in vitro. Toxicol Appl Pharmacol. 1993 Dec;123(2):274-82. doi: 10.1006/taap.1993.1246. (PMID: 8248934)
Lu D, Peterson LA: Identification of furan metabolites derived from cysteine-cis-2-butene-1,4-dial-lysine cross-links. Chem Res Toxicol. 2010 Jan;23(1):142-51. doi: 10.1021/tx9003215. (PMID: 20043645)

>  <Comments>  (466) 


$$$$
CC02329
     RDKit          3D

  4  3  0  0  0  0  0  0  0  0999 V2000
    0.0550    0.4020    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3090   -0.2960    0.0740 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0720   -0.2180    1.2070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8230    0.4010    2.2310 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
M  END
>  <Name>  (467) 
Methylformamide

>  <InChIKey>  (467) 
ATHHXGZTWNVVOU-UHFFFAOYSA-N

>  <PubChem_CID>  (467) 
31254

>  <CYP1A2>  (467) 


>  <CYP2A6>  (467) 


>  <CYP2B6>  (467) 


>  <CYP2C8>  (467) 


>  <CYP2C9>  (467) 


>  <CYP2C19>  (467) 


>  <CYP2D6>  (467) 


>  <CYP2E1>  (467) 
<1,2;Oxidation;R1>

>  <CYP3A4>  (467) 


>  <References>  (467) 
Hyland R, Gescher A, Thummel K, Schiller C, Jheeta P, Mynett K, Smith AW, Mraz J: Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1. Mol Pharmacol. 1992 Feb;41(2):259-66. (PMID: 1538706)

>  <Comments>  (467) 
The Phase II metabolites are involed.

$$$$
CC02330
     RDKit          3D

 16 15  0  0  0  0  0  0  0  0999 V2000
   -4.0250    2.2670    6.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5080    1.5490    5.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0280    2.2720    3.8150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5150    3.7190    3.8250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9890    3.7180    3.8200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4760    2.9950    2.5690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9910    3.7100    1.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4790    5.1640    1.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0570    5.1620    1.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5610    4.4430    0.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0450    5.1610   -1.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5640    6.6020   -1.1820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0900    6.5990   -1.1740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5450    5.9610   -2.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7660    5.5000   -3.0860 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8580    5.8350   -2.4930 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
M  END
>  <Name>  (468) 
Myristic acid

>  <InChIKey>  (468) 
TUNFSRHWOTWDNC-UHFFFAOYSA-N

>  <PubChem_CID>  (468) 
11005

>  <CYP1A2>  (468) 


>  <CYP2A6>  (468) 


>  <CYP2B6>  (468) 


>  <CYP2C8>  (468) 


>  <CYP2C9>  (468) 


>  <CYP2C19>  (468) 


>  <CYP2D6>  (468) 


>  <CYP2E1>  (468) 
<1,H;Hydroxylation;R1>

>  <CYP3A4>  (468) 


>  <References>  (468) 
Adas F, Salaun JP, Berthou F, Picart D, Simon B, Amet Y: Requirement for omega and (omega;-1)-hydroxylations of fatty acids by human cytochromes P450 2E1 and 4A11. J Lipid Res. 1999 Nov;40(11):1990-7. (PMID: 10553002)

>  <Comments>  (468) 
2 (C for Aliphatic Hydroxylation).

$$$$
CC02331
     RDKit          3D

  8  8  0  0  0  0  0  0  0  0999 V2000
    1.9430    5.2230    0.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5810    5.2320    0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1010    4.0550    0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5840    2.8770    0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9410    2.8730    0.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6940    1.5640    0.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6290    4.0500    0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1310    4.0590    0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  7  8  1  0
M  END
>  <Name>  (469) 
o-Xylene

>  <InChIKey>  (469) 
CTQNGGLPUBDAKN-UHFFFAOYSA-N

>  <PubChem_CID>  (469) 
7237

>  <CYP1A2>  (469) 


>  <CYP2A6>  (469) 


>  <CYP2B6>  (469) 


>  <CYP2C8>  (469) 


>  <CYP2C9>  (469) 


>  <CYP2C19>  (469) 


>  <CYP2D6>  (469) 


>  <CYP2E1>  (469) 
<2,H;Hydroxylation;R1>
<3,H;Hydroxylation;R2>
<4,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>
<0,H;Hydroxylation;R5>
<7,H;Hydroxylation;R6>

>  <CYP3A4>  (469) 


>  <References>  (469) 
Tassaneeyakul W, Birkett DJ, Edwards JW, Veronese ME, Tassaneeyakul W, Tukey RH, Miners JO: Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene. J Pharmacol Exp Ther. 1996 Jan;276(1):101-8. doi: 10.1163/2211730x96x00063. (PMID: 8558417)

>  <Comments>  (469) 
Ring hydroxylated metabolites are 5%.

$$$$
CC02333
     RDKit          3D

  8  8  0  0  0  0  0  0  0  0999 V2000
    1.9430    5.2230    0.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5810    5.2320    0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1010    4.0550    0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5870    4.0540    0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5840    2.8770    0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9410    2.8730    0.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6290    4.0500    0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1310    4.0590    0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  7  1  0
  2  3  1  0
  3  4  1  0
  3  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
M  END
>  <Name>  (470) 
p-Xylene

>  <InChIKey>  (470) 
URLKBWYHVLBVBO-UHFFFAOYSA-N

>  <PubChem_CID>  (470) 
7809

>  <CYP1A2>  (470) 


>  <CYP2A6>  (470) 


>  <CYP2B6>  (470) 


>  <CYP2C8>  (470) 


>  <CYP2C9>  (470) 


>  <CYP2C19>  (470) 


>  <CYP2D6>  (470) 


>  <CYP2E1>  (470) 
<3,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>
<0,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>
<6,H;Hydroxylation;R5>
<7,H;Hydroxylation;R6>

>  <CYP3A4>  (470) 


>  <References>  (470) 
Tassaneeyakul W, Birkett DJ, Edwards JW, Veronese ME, Tassaneeyakul W, Tukey RH, Miners JO: Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene. J Pharmacol Exp Ther. 1996 Jan;276(1):101-8. doi: 10.1163/2211730x96x00063. (PMID: 8558417)

>  <Comments>  (470) 
Ring hydroxylated metabolites are less than 5%.

$$$$
CC02334
     RDKit          3D

 18 17  0  0  0  0  0  0  0  0999 V2000
   -3.9720    1.2040    6.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4550    0.4850    4.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9750    1.2090    3.7360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4620    2.6550    3.7450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9360    2.6550    3.7400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4230    1.9310    2.4890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9380    2.6460    1.2460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4250    4.1000    1.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1100    4.0980    1.2470 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6140    3.3790   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0990    4.0970   -1.2600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6180    5.5380   -1.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430    5.5360   -1.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6550    4.8170   -2.5060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1500    5.5360   -3.7580 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5940    6.8160   -3.7570 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3020    7.2160   -2.8430 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2800    7.6400   -4.7640 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
M  END
>  <Name>  (471) 
Palmitic acid

>  <InChIKey>  (471) 
IPCSVZSSVZVIGE-UHFFFAOYSA-N

>  <PubChem_CID>  (471) 
985

>  <CYP1A2>  (471) 


>  <CYP2A6>  (471) 


>  <CYP2B6>  (471) 


>  <CYP2C8>  (471) 


>  <CYP2C9>  (471) 


>  <CYP2C19>  (471) 


>  <CYP2D6>  (471) 


>  <CYP2E1>  (471) 
<1,H;Hydroxylation;R1>

>  <CYP3A4>  (471) 


>  <References>  (471) 
Adas F, Salaun JP, Berthou F, Picart D, Simon B, Amet Y: Requirement for omega and (omega;-1)-hydroxylations of fatty acids by human cytochromes P450 2E1 and 4A11. J Lipid Res. 1999 Nov;40(11):1990-7. (PMID: 10553002)

>  <Comments>  (471) 
1 (C for Aliphatic Hydroxylation).

$$$$
CC02335
     RDKit          3D

  7  7  0  0  0  0  0  0  0  0999 V2000
    0.6250   -0.0310   -0.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7370   -0.0220   -0.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4190   -1.1990   -0.3420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7340   -2.3770   -0.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6240   -2.3810   -0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3120   -1.2040   -0.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6390   -1.2090   -0.3340 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
M  END
>  <Name>  (472) 
Phenol

>  <InChIKey>  (472) 
ISWSIDIOOBJBQZ-UHFFFAOYSA-N

>  <PubChem_CID>  (472) 
996

>  <CYP1A2>  (472) 


>  <CYP2A6>  (472) 


>  <CYP2B6>  (472) 


>  <CYP2C8>  (472) 


>  <CYP2C9>  (472) 


>  <CYP2C19>  (472) 


>  <CYP2D6>  (472) 


>  <CYP2E1>  (472) 
<2,H;Hydroxylation;R1>
<4,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>

>  <CYP3A4>  (472) 


>  <References>  (472) 
Seaton MJ, Schlosser PM, Bond JA, Medinsky MA: Benzene metabolism by human liver microsomes in relation to cytochrome P450 2E1 activity. Carcinogenesis. 1994 Sep;15(9):1799-806. doi: 10.1093/carcin/15.9.1799. (PMID: 7923572)

>  <Comments>  (472) 
3 (C for Aromatic Hydroxylation). 1 (C for Aromatic Hydroxylation). 5 (C for Aromatic Hydroxylation).

$$$$
CC02336
     RDKit          3D

 10 10  0  0  0  0  0  0  0  0999 V2000
   -0.1620    0.2560    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5670   -0.9420    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9540   -0.9020    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6120    0.3110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8950    1.4970   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5170    1.4770   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6350    0.2270    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2220   -0.8380    0.0120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3320    1.3800   -0.0060 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0800   -2.1340    0.0320 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  2 10  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  7  8  2  0
  7  9  1  0
M  END
>  <Name>  (473) 
Salicylate

>  <InChIKey>  (473) 
YGSDEFSMJLZEOE-UHFFFAOYSA-N

>  <PubChem_CID>  (473) 
338

>  <CYP1A2>  (473) 


>  <CYP2A6>  (473) 


>  <CYP2B6>  (473) 


>  <CYP2C8>  (473) 


>  <CYP2C9>  (473) 


>  <CYP2C19>  (473) 


>  <CYP2D6>  (473) 


>  <CYP2E1>  (473) 
<5,H;Hydroxylation;R1>

>  <CYP3A4>  (473) 
<5,H;Hydroxylation;R1>

>  <References>  (473) 
Dupont I, Berthou F, Bodenez P, Bardou L, Guirriec C, Stephan N, Dreano Y, Lucas D: Involvement of cytochromes P-450 2E1 and 3A4 in the 5-hydroxylation of salicylate in humans. Drug Metab Dispos. 1999 Mar;27(3):322-6. (PMID: 10064561)

>  <Comments>  (473) 
5 (C for Aromatic Hydroxylation).

$$$$
CC02337
     RDKit          3D

 20 19  0  0  0  0  0  0  0  0999 V2000
   -4.5850    0.9220    6.8240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0680    0.2040    5.5680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5880    0.9270    4.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0750    2.3730    4.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5490    2.3730    4.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0360    1.6490    3.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5510    2.3640    1.8280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0380    3.8180    1.8200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5030    3.8160    1.8290 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0010    3.0970    0.5670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5140    3.8150   -0.6780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0050    5.2560   -0.6800 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5300    5.2540   -0.6720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0420    4.5350   -1.9240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5370    5.2540   -3.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0380    6.6950   -3.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5780    6.6980   -3.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0320    6.0600   -4.2890 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2420    5.6000   -5.0820 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3460    5.9300   -4.4880 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
M  END
>  <Name>  (474) 
Stearic acid

>  <InChIKey>  (474) 
QIQXTHQIDYTFRH-UHFFFAOYSA-N

>  <PubChem_CID>  (474) 
5281

>  <CYP1A2>  (474) 


>  <CYP2A6>  (474) 


>  <CYP2B6>  (474) 


>  <CYP2C8>  (474) 


>  <CYP2C9>  (474) 


>  <CYP2C19>  (474) 


>  <CYP2D6>  (474) 


>  <CYP2E1>  (474) 
<1,H;Hydroxylation;R1>

>  <CYP3A4>  (474) 


>  <References>  (474) 
Adas F, Salaun JP, Berthou F, Picart D, Simon B, Amet Y: Requirement for omega and (omega;-1)-hydroxylations of fatty acids by human cytochromes P450 2E1 and 4A11. J Lipid Res. 1999 Nov;40(11):1990-7. (PMID: 10553002)

>  <Comments>  (474) 
2 (C for Aliphatic Hydroxylation).

$$$$
CC02338
     RDKit          3D

  5  4  0  0  0  0  0  0  0  0999 V2000
    1.7110    4.8270    1.5520 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.3180    3.9800    0.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7080    4.8320   -1.4010 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.1160    3.9890    0.0780 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.7980    2.5440    0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
M  END
>  <Name>  (475) 
Trichloroethane

>  <InChIKey>  (475) 
UOCLXMDMGBRAIB-UHFFFAOYSA-N

>  <PubChem_CID>  (475) 
6278

>  <CYP1A2>  (475) 


>  <CYP2A6>  (475) 


>  <CYP2B6>  (475) 


>  <CYP2C8>  (475) 


>  <CYP2C9>  (475) 


>  <CYP2C19>  (475) 


>  <CYP2D6>  (475) 


>  <CYP2E1>  (475) 
<0,H;Hydroxylation;R1>

>  <CYP3A4>  (475) 


>  <References>  (475) 
Guengerich FP, Kim DH, Iwasaki M: Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol. 1991 Mar-Apr;4(2):168-79. (PMID: 1664256)

>  <Comments>  (475) 
5 (C for Aliphatic Hydroxylation).

$$$$
CC02339
     RDKit          3D

 11 12  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4610    0.0100 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.8890   -0.2890   -1.2470 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8720    0.9090   -1.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4230    1.7270   -0.0020 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.8250    3.2040   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9130   -0.3020    1.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8960    0.8960    1.2280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3680   -0.6860    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1310   -0.2940    1.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1600   -0.2410   -1.2280 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  1  0
  2  3  1  0
  2  7  1  0
  2  9  1  6
  3  4  1  0
  4  5  1  0
  5  6  1  6
  5  8  1  0
  7  8  1  0
  9 10  1  0
  9 11  1  0
M  END
>  <Name>  (476) 
1,4-Cineole

>  <InChIKey>  (476) 
RFFOTVCVTJUTAD-AOOOYVTPSA-N

>  <PubChem_CID>  (476) 


>  <CYP1A2>  (476) 


>  <CYP2A6>  (476) 


>  <CYP2B6>  (476) 


>  <CYP2C8>  (476) 


>  <CYP2C9>  (476) 


>  <CYP2C19>  (476) 


>  <CYP2D6>  (476) 


>  <CYP2E1>  (476) 


>  <CYP3A4>  (476) 
<5,H;Hydroxylation;R1>
<8,H;Hydroxylation;R2>

>  <References>  (476) 
Miyazawa M, Shindo M, Shimada T: Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, a monoterpene cyclic ether, by rat and human liver microsomes. Xenobiotica. 2001 Oct;31(10):713-23. doi: 10.1080/00498250110065595. (PMID: 11695850)

>  <Comments>  (476) 
8 (C for Aliphatic Hydroxylation). 4 (C for Aliphatic Hydroxylation).

$$$$
CC02340
     RDKit          3D

 11 12  0  0  0  0  0  0  0  0999 V2000
   -1.2120   -0.4330    1.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0010   -1.3730    1.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8310   -1.1000    0.0380 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.0050   -1.4750   -1.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2350   -0.5590   -1.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1800    0.3820   -0.0150 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.4020    1.3030   -0.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1700    0.3900   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9950    0.7570    1.2190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0020    0.6650   -1.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0180    1.1940   -0.0630 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  3  2  1  1
  3  4  1  0
  3  8  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  1
  6 11  1  0
  8  9  1  0
  8 10  1  0
  8 11  1  0
M  END
>  <Name>  (477) 
1,8-Cineole

>  <InChIKey>  (477) 
WEEGYLXZBRQIMU-WAAGHKOSSA-N

>  <PubChem_CID>  (477) 


>  <CYP1A2>  (477) 


>  <CYP2A6>  (477) 


>  <CYP2B6>  (477) 


>  <CYP2C8>  (477) 


>  <CYP2C9>  (477) 


>  <CYP2C19>  (477) 


>  <CYP2D6>  (477) 


>  <CYP2E1>  (477) 


>  <CYP3A4>  (477) 
<10,H;Hydroxylation;R1>
<6,H;Hydroxylation;R2>

>  <References>  (477) 
Miyazawa M, Shindo M, Shimada T: Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, a monoterpene cyclic ether, by rat and human liver microsomes. Xenobiotica. 2001 Oct;31(10):713-23. doi: 10.1080/00498250110065595. (PMID: 11695850)

>  <Comments>  (477) 
5 (C for Aliphatic Hydroxylation). 1 (C for Aliphatic Hydroxylation).

$$$$
CC02342
     RDKit          3D

 20 22  0  0  0  0  0  0  0  0999 V2000
    1.5850    0.5620   -0.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9240    0.8930   -0.9240 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6720    0.5360    0.1890 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0710   -0.1540    1.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7320   -0.4830    1.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9880   -0.1210    0.0530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3270    0.7570    0.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4530    1.6510   -0.9070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2390    2.7790   -0.7620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8970    3.0140    0.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7710    2.1210    1.4780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9860    0.9920    1.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4750   -0.4760   -0.0200 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.8170   -1.4780    1.0040 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2530   -2.5670    0.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2390   -2.4020   -0.9820 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7900   -1.1750   -1.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6640   -0.7270   -2.4470 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6190   -3.5870    0.8960 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9900    0.8600    0.2570 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  3 20  1  0
  4  5  1  0
  5  6  2  0
 13  6  1  6
  7  8  2  0
  7 12  1  0
  7 13  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 13 14  1  0
 13 17  1  0
 14 15  1  0
 15 16  1  0
 15 19  2  0
 16 17  1  0
 17 18  2  0
M  END
>  <Name>  (478) 
4-HPPH

>  <InChIKey>  (478) 
XEEDURHPFVXALT-HNNXBMFYSA-N

>  <PubChem_CID>  (478) 
719423

>  <CYP1A2>  (478) 


>  <CYP2A6>  (478) 


>  <CYP2B6>  (478) 


>  <CYP2C8>  (478) 


>  <CYP2C9>  (478) 
<14,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>

>  <CYP2C19>  (478) 
<14,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>

>  <CYP2D6>  (478) 


>  <CYP2E1>  (478) 


>  <CYP3A4>  (478) 
<14,H;Hydroxylation;R1>
<17,H;Hydroxylation;R2>

>  <References>  (478) 
Komatsu T, Yamazaki H, Asahi S, Gillam EM, Guengerich FP, Nakajima M, Yokoi T: Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9, 2C19, and 3A4. Drug Metab Dispos. 2000 Nov;28(11):1361-8. (PMID: 11038165)

>  <Comments>  (478) 
<2,H;Hydroxylation> (2C9-minor;2C19-minor). <4,H;Hydroxylation> (2C9-minor;2C19-minor).

$$$$
CC02343
     RDKit          3D

 29 31  0  0  0  0  0  0  0  0999 V2000
   -0.0590    1.3520   -0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0050    0.0160    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1850    2.1300   -0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3720    2.0300   -0.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2980   -0.6810    0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2500   -0.7540    0.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4460    2.7390   -1.5240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0970    2.2610    0.7520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7390    2.9340    0.8350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2460    1.7720   -1.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8440   -1.2680    1.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9850   -0.7650   -1.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4070   -0.8590    1.9620 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6060    3.4640   -1.6990 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2540    2.9870    0.5700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9640    3.5640    0.7760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4690    2.4060   -1.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0570   -1.9200    1.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1970   -1.4200   -1.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5130    3.5880   -0.6550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8320    3.3000   -0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7330   -1.9930   -0.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6550    4.3020   -0.8310 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3720    4.2460    0.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6760    5.0350    0.2730 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3700    6.4570    0.0660 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9680    6.9960    1.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6340    7.1140   -0.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0390    3.9220   -0.3290 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5 11  2  0
  5 12  1  0
  6 13  1  0
  7 14  1  0
  8 15  2  0
  9 16  1  0
 10 17  2  0
 11 18  1  0
 12 19  2  0
 14 20  2  0
 15 20  1  0
 16 21  2  0
 17 21  1  0
 18 22  2  0
 19 22  1  0
 20 23  1  0
 21 29  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  1  0
M  END
>  <Name>  (479) 
4-Hydroxytamoxifen

>  <InChIKey>  (479) 
TXUZVZSFRXZGTL-QPLCGJKRSA-N

>  <PubChem_CID>  (479) 
449459

>  <CYP1A2>  (479) 


>  <CYP2A6>  (479) 


>  <CYP2B6>  (479) 


>  <CYP2C8>  (479) 


>  <CYP2C9>  (479) 


>  <CYP2C19>  (479) 


>  <CYP2D6>  (479) 


>  <CYP2E1>  (479) 


>  <CYP3A4>  (479) 
<6,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>

>  <References>  (479) 
Dehal SS, Kupfer D: Cytochrome P-450 3A and 2D6 catalyze ortho hydroxylation of 4-hydroxytamoxifen and 3-hydroxytamoxifen (droloxifene) yielding tamoxifen catechol: involvement of catechols in covalent binding to hepatic proteins. Drug Metab Dispos. 1999 Jun;27(6):681-8. (PMID: 10348797)

>  <Comments>  (479) 
17 (C for Aromatic Hydroxylation). 16 (C for Aromatic Hydroxylation).

$$$$
CC02344
     RDKit          3D

 31 33  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4030    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1450    2.0910    0.0020 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2340    2.0670    0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2930   -0.6960   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2000   -0.7210    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3310    1.4630   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4140    1.3420    0.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4240    0.0560   -0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3890   -0.0520    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3530    2.1250   -0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3640   -2.2010   -0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7030   -2.6050   -0.0380 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.7380   -2.7040    1.1230 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.7150   -2.6920   -1.1610 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6050    1.9940    0.0650 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6240    0.9920    0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9780    1.6530    0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0740    3.0310    0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3160    3.6380    0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4620    2.8650    0.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3660    1.4860    0.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1240    0.8800    0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0200   -0.6240    0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3030   -1.1800    0.0980 F   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3440   -1.0320   -1.0670 F   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3150   -1.0540    1.2170 F   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4210    5.1410    0.1390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4720    5.6150   -1.1760 F   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5830    5.5230    0.8180 F   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3040    5.6820    0.7860 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  2  0
  5 12  1  0
  6 10  2  0
  7  9  1  0
  7 11  2  0
  8 10  1  0
  8 16  1  0
 12 13  1  0
 12 14  1  0
 12 15  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 23  1  0
 19 20  1  0
 20 21  2  0
 20 28  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 24 27  1  0
 28 29  1  0
 28 30  1  0
 28 31  1  0
M  END
>  <Name>  (480) 
BFBFC

>  <InChIKey>  (480) 
PCBGILKQGDYJAY-UHFFFAOYSA-N

>  <PubChem_CID>  (480) 
101149749

>  <CYP1A2>  (480) 


>  <CYP2A6>  (480) 


>  <CYP2B6>  (480) 


>  <CYP2C8>  (480) 


>  <CYP2C9>  (480) 


>  <CYP2C19>  (480) 


>  <CYP2D6>  (480) 


>  <CYP2E1>  (480) 


>  <CYP3A4>  (480) 
<12,13;Cleavage;R1>
<13,H;Oxidation;R1>

>  <References>  (480) 
Renwick AB, Lewis DF, Fulford S, Surry D, Williams B, Worboys PD, Cai X, Wang RW, Price RJ, Lake BG, Evans DC: Metabolism of 2,5-bis(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin by human hepatic CYP isoforms: evidence for selectivity towards CYP3A4. Xenobiotica. 2001 Apr;31(4):187-204. doi: 10.1080/00498250110043526. (PMID: 11465405)

>  <Comments>  (480) 
17 (O for O-Dealklyation).

$$$$
CC02345
     RDKit          3D

 52 54  0  0  0  0  0  0  0  0999 V2000
    2.0300    1.3480    1.9550 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.5960   -0.0780    2.0390 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.9480    2.2390    1.1220 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.7340    1.3010    1.3530 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7520   -0.0930    3.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0400   -0.4780    0.7410 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4650   -1.0050    2.4930 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1590    3.5700    1.8500 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.2950    2.5150   -0.2360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2170    1.3110    2.4200 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.1640   -1.4920    3.4670 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.8760   -0.5710   -0.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2650    4.5490    1.3140 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6010    4.0410    1.6590 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.5900    0.9040    1.8810 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.2870    2.6210    2.9800 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1440   -1.3890    4.6120 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8030   -2.2660    2.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7450    4.8760    0.0090 C   0  0  2  0  0  0  0  0  0  0  0  0
    5.3790    3.8090    2.9290 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6100    5.5350    1.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0050    1.8830    0.7770 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.5200   -0.4190    1.3450 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5200    3.5360    1.9100 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.5570   -0.9110    4.4030 C   0  0  1  0  0  0  0  0  0  0  0  0
    4.7820   -1.7030    5.7250 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7340    6.3960   -0.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9070    4.2660   -0.9710 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4810    3.0450    2.9060 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0060    4.3110    3.9630 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9180    3.3100    1.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3840    1.6000    0.3590 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4120    4.9690    2.4340 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6960    0.5090    4.9520 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.5020   -1.8430    5.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2820    6.7370   -1.5620 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.5180    4.4640   -2.2450 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.2340    2.7990    4.1210 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.2590    2.0720    1.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6560    2.4520   -0.8060 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6930    1.3340    4.1420 C   0  0  1  0  0  0  0  0  0  0  0  0
    7.1350    0.4450    6.3140 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4880    5.9490   -2.6100 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.6620    6.3760   -1.6350 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1260    8.2370   -1.8210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7560    3.6640   -3.3030 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4630    3.7100    4.1570 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0770    1.2650    4.7950 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7780    0.8600    2.7990 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0770    6.1370   -3.8980 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3670    7.2580   -0.7590 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0140    5.1690    4.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  6
  2  5  1  0
  2  6  1  0
  2  7  1  1
  3  8  1  0
  3  9  1  6
 10  4  1  6
  5 11  1  0
  6 12  1  0
  8 13  1  6
  8 14  1  0
 10 15  1  0
 10 16  1  0
 11 17  1  0
 11 18  1  6
 19 13  1  1
 14 20  1  0
 14 21  1  1
 15 22  1  0
 15 23  1  6
 16 24  1  0
 17 25  1  0
 17 26  2  0
 19 27  1  0
 19 28  1  0
 20 29  1  0
 20 30  2  0
 22 31  1  0
 22 32  1  1
 24 31  1  0
 24 33  1  1
 25 34  1  0
 25 35  1  1
 27 36  1  0
 28 37  1  0
 29 38  1  0
 32 39  1  0
 32 40  1  0
 34 41  1  0
 34 42  1  1
 36 43  1  0
 36 44  1  0
 36 45  1  6
 37 43  1  0
 37 46  1  6
 38 41  1  0
 38 47  1  6
 41 48  1  1
 41 49  1  0
 43 50  1  6
 44 51  1  0
 47 52  1  0
M  END
>  <Name>  (481) 
Clarithromycin

>  <InChIKey>  (481) 
AGOYDEPGAOXOCK-WIQGUNGHSA-N

>  <PubChem_CID>  (481) 


>  <CYP1A2>  (481) 


>  <CYP2A6>  (481) 


>  <CYP2B6>  (481) 


>  <CYP2C8>  (481) 


>  <CYP2C9>  (481) 


>  <CYP2C19>  (481) 


>  <CYP2D6>  (481) 


>  <CYP2E1>  (481) 


>  <CYP3A4>  (481) 
<31,33;Cleavage;R1>
<33,H;Oxidation;R1>
<41,32;Cleavage;R2>
<42,H;Oxidation;R2>
<1,H;Hydroxylation;R3>

>  <References>  (481) 
Rodrigues AD, Roberts EM, Mulford DJ, Yao Y, Ouellet D: Oxidative metabolism of clarithromycin in the presence of human liver microsomes. Major role for the cytochrome P4503A (CYP3A) subfamily. Drug Metab Dispos. 1997 May;25(5):623-30. (PMID: 9152603)

>  <Comments>  (481) 
39 (N for N-demethylation). 40 (N for N-demethylation). 47 (C for Aliphatic hydroxylation).

$$$$
CC02346
     RDKit          3D

 26 29  0  0  0  0  0  0  0  0999 V2000
   -0.1280    1.5320   -0.0750 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.0070    0.0100   -0.2180 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.2440    2.2040    0.0820 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.7640    1.7900    1.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9940   -0.3820   -1.2890 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.4070   -0.5310   -0.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7010    1.8490    1.5030 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.2310    1.7620   -0.9750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0720    3.7210   -0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4100    1.5880    2.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1920   -1.9030   -1.3240 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.3630    0.2410   -0.9750 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.3900   -1.8590   -1.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4650    2.9990    2.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5150    0.6750    1.4800 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0970   -2.5790   -0.9430 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2930   -2.2980   -0.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5950   -2.3320   -2.7360 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3090   -0.1570   -1.9690 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9510    3.1160    1.8830 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8870    3.8270    2.7690 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1060   -3.7730   -0.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4650   -3.8200   -0.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4430    4.2800    2.5510 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1420   -4.4690   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1130   -5.5690    0.4620 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  1
  2  5  1  0
  2  6  1  6
  3  7  1  0
  3  8  1  0
  3  9  1  1
  4 10  1  0
  5 11  1  0
  5 12  1  1
  6 13  1  0
  7 10  1  0
  7 14  1  0
  7 15  1  6
  8 12  1  0
 11 16  1  0
 11 17  1  0
 11 18  1  6
 12 19  1  6
 13 16  1  0
 14 20  1  0
 14 21  2  0
 16 22  2  0
 17 23  1  0
 20 24  1  0
 22 25  1  0
 23 25  1  0
 25 26  2  0
M  END
>  <Name>  (482) 
Cortisol

>  <InChIKey>  (482) 
JYGXADMDTFJGBT-FFICGRQZSA-N

>  <PubChem_CID>  (482) 
40469545

>  <CYP1A2>  (482) 


>  <CYP2A6>  (482) 


>  <CYP2B6>  (482) 


>  <CYP2C8>  (482) 


>  <CYP2C9>  (482) 


>  <CYP2C19>  (482) 


>  <CYP2D6>  (482) 


>  <CYP2E1>  (482) 


>  <CYP3A4>  (482) 
<8,H;Hydroxylation;R1>

>  <References>  (482) 
Tran JQ, Kovacs SJ, McIntosh TS, Davis HM, Martin DE: Morning spot and 24-hour urinary 6 beta-hydroxycortisol to cortisol ratios: intraindividual variability and correlation under basal conditions and conditions of CYP 3A4 induction. J Clin Pharmacol. 1999 May;39(5):487-94. (PMID: 10234596)

>  <Comments>  (482) 
13 (C for Aliphatic Hydroxylation).

$$$$
CC02347
     RDKit          3D

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.0130    1.3780    0.0590 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.0740   -0.1220    0.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4100    1.9290    0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7470    1.9450    1.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4930   -0.9240   -0.7860 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7020   -0.6960    1.2770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9550    2.5410    1.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1690    1.7990   -1.1700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1160    2.5570    2.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1560    1.8310    1.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4360   -2.3020   -0.6670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2760   -0.2020   -2.1580 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.7590   -2.0730    1.3960 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2460    2.6910    2.2420 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3640    3.0700    0.9970 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1430    0.8690   -1.2490 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9440    2.5270   -2.1190 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9180    3.1020    3.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7450    0.9350    2.0720 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8380    2.5420    0.5390 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1880   -2.8750    0.4270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1470   -3.3100   -1.8880 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.7190    0.9840   -2.5520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1550    1.0580    1.8750 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8360   -0.0490   -2.7090 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  1
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5 11  1  0
  5 12  1  0
  6 13  2  0
  7 14  1  0
  7 15  1  0
  8 16  1  0
  8 17  2  0
  9 14  1  0
  9 18  1  0
 10 19  1  0
 10 20  2  0
 11 21  2  0
 11 22  1  0
 13 21  1  0
 16 23  1  0
 19 24  1  0
 23 25  1  0
M  END
>  <Name>  (483) 
Felodipine

>  <InChIKey>  (483) 
RZTAMFZIAATZDJ-HNNXBMFYSA-N

>  <PubChem_CID>  (483) 
941699

>  <CYP1A2>  (483) 


>  <CYP2A6>  (483) 


>  <CYP2B6>  (483) 


>  <CYP2C8>  (483) 


>  <CYP2C9>  (483) 


>  <CYP2C19>  (483) 


>  <CYP2D6>  (483) 


>  <CYP2E1>  (483) 


>  <CYP3A4>  (483) 
<8,H;Oxidation;R1>
<16,H;Oxidation;R1>

>  <References>  (483) 
Walsky RL, Obach RS: Validated assays for human cytochrome P450 activities. Drug Metab Dispos. 2004 Jun;32(6):647-60. doi: 10.1124/dmd.32.6.647. (PMID: 15155557)

>  <Comments>  (483) 
We recorded the site where the first reaction happens. The metabolic pathway needs to be identified.

$$$$
CC02348
     RDKit          3D

 30 32  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3780    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2080   -0.6790   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3960    0.0280   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770    1.4110   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1710    2.0860    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7110   -0.7070   -0.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1060   -0.9290   -1.3600 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.6820    0.0590    0.6170 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.5670   -1.9350    0.6190 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3320    2.1140    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7520    2.3450    1.4040 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9070    2.9900    1.6600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6010    3.3810    0.7410 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3290    3.2230    3.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5350    2.7760    4.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9330    3.0010    5.4130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1170    3.6690    5.6750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9120    4.1160    4.6380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5270    3.8990    3.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3070    4.3370    2.3040 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4400    4.9760    2.8960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5410    3.9100    7.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9760    5.2470    7.5830 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.1430    5.1980    7.6910 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0030    5.4800    9.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2790    5.5930    9.8600 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3160    5.4980    9.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4590    5.6030    9.4360 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9900    5.5510   10.1190 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1 11  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  7  1  0
  5  6  2  0
  7  8  1  0
  7  9  1  0
  7 10  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 15 20  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 23  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 24 23  1  1
 24 25  1  0
 24 28  1  0
 25 26  1  0
 26 27  1  0
 26 30  2  0
 27 28  1  0
 28 29  2  0
M  END
>  <Name>  (484) 
MK-0767

>  <InChIKey>  (484) 
RXRULMGJKSLDFM-INIZCTEOSA-N

>  <PubChem_CID>  (484) 
87173364

>  <CYP1A2>  (484) 


>  <CYP2A6>  (484) 


>  <CYP2B6>  (484) 


>  <CYP2C8>  (484) 


>  <CYP2C9>  (484) 


>  <CYP2C19>  (484) 


>  <CYP2D6>  (484) 


>  <CYP2E1>  (484) 


>  <CYP3A4>  (484) 
<6,H;Hydroxylation;R1>
<7,S;S-Oxidation;R2>

>  <References>  (484) 
Liu DQ, Karanam BV, Doss GA, Sidler RR, Vincent SH, Hop CE: In vitro metabolism of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)-ph enyl] methyl]benzamide], a peroxisome proliferator-activated receptor alpha/gamma agonist. II. Identification of metabolites by liquid chromatography-tandem mass spectrometry. Drug Metab Dispos. 2004 Sep;32(9):1023-31. doi: 10.1124/dmd.104.000059. (PMID: 15319345)

>  <Comments>  (484) 
21 (O for O-demethylation). 24 (C for O-demethylation). 25 (S for S-Oxidation).

$$$$
CC02349
     RDKit          3D

  7  6  0  0  0  0  0  0  0  0999 V2000
   -0.0160    1.3440    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0400   -0.6250    0.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2420    2.0930    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2950    2.0590    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6670    2.3620   -1.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7330    2.3000    1.4650 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  1  5  1  0
  2  3  2  0
  4  6  1  0
  5  7  1  0
M  END
>  <Name>  (485) 
N,N-Diethylformamide

>  <InChIKey>  (485) 
SUAKHGWARZSWIH-UHFFFAOYSA-N

>  <PubChem_CID>  (485) 
12051

>  <CYP1A2>  (485) 


>  <CYP2A6>  (485) 


>  <CYP2B6>  (485) 


>  <CYP2C8>  (485) 


>  <CYP2C9>  (485) 


>  <CYP2C19>  (485) 


>  <CYP2D6>  (485) 


>  <CYP2E1>  (485) 
<1,H;Hydroxylation;R1>
<5,H;Hydroxylation;R2>

>  <CYP3A4>  (485) 
<1,H;Hydroxylation;R1>
<5,H;Hydroxylation;R2>

>  <References>  (485) 
Amato G, Grasso E, Longo V, Gervasi PG: Oxidation of N,N-dimethylformamide and N,N-diethylformamide by human liver microsomes and human recombinant P450s. Toxicol Lett. 2001 Oct 15;124(1-3):11-9. (PMID: 11684354)

>  <Comments>  (485) 


$$$$
CC02351
     RDKit          3D

 19 18  0  0  0  0  0  0  0  0999 V2000
   -0.0120    0.0070   -0.1170 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2580   -0.7350   -0.1520 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.2600   -0.0610   -1.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9340    0.2550   -2.2200 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9440   -2.1540   -0.6630 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4490   -3.1220   -0.9220 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.4190    0.1720   -0.6490 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7700   -0.0060    0.9780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3950   -0.5790    2.0270 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2460   -4.8490   -1.1890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0190   -5.3650   -1.1520 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.3570   -5.7160   -1.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7080   -5.0430   -1.5390 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4130   -5.4500   -2.8040 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.5460   -5.3980   -0.3400 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.1150   -6.9550   -1.4780 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9910   -8.0890   -1.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2600   -9.2430   -1.4850 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1360    0.6310    0.9080 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  8  1  0
  2  3  1  0
  2  5  1  6
  3  4  2  0
  3  7  1  0
  5  6  1  0
  6 10  1  0
  8  9  2  0
  8 19  1  0
 10 11  1  0
 10 12  2  0
 12 13  1  0
 12 16  1  0
 13 14  1  0
 13 15  1  0
 16 17  1  0
 17 18  1  0
M  END
>  <Name>  (486) 
N-Ac-FFVC

>  <InChIKey>  (486) 
JAZJDNUIJLZFSZ-GZNKVARCSA-N

>  <PubChem_CID>  (486) 


>  <CYP1A2>  (486) 


>  <CYP2A6>  (486) 


>  <CYP2B6>  (486) 


>  <CYP2C8>  (486) 


>  <CYP2C9>  (486) 


>  <CYP2C19>  (486) 


>  <CYP2D6>  (486) 


>  <CYP2E1>  (486) 


>  <CYP3A4>  (486) 
<6,S;S-Oxidation;R1>

>  <References>  (486) 
Altuntas TG, Park SB, Kharasch ED: Sulfoxidation of cysteine and mercapturic acid conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A). Chem Res Toxicol. 2004 Mar;17(3):435-45. doi: 10.1021/tx034254k. (PMID: 15025515)

>  <Comments>  (486) 
6 (S for S-Oxidation).

$$$$
CC02352
     RDKit          3D

 16 15  0  0  0  0  0  0  0  0999 V2000
    0.0500   -0.0280    0.1930 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3160   -0.7500   -0.0050 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.0860   -0.1170   -1.1540 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5330    0.0370   -2.2660 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9610   -2.2270   -0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3870   -3.1420   -0.9110 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.2680    0.2660   -0.9900 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1330   -4.8480   -1.2730 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6050   -5.5330   -0.9110 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.1530   -5.6770   -1.8640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8070   -7.3320   -2.1410 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.5130   -5.1630   -2.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5910   -4.1660   -3.3880 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.4850   -5.1680   -1.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9480   -4.3220   -1.7040 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.3070   -6.0320    0.0710 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6
  2  3  1  0
  2  5  1  0
  3  4  2  0
  3  7  1  0
  5  6  1  0
  6  8  1  0
  8  9  1  0
  8 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 14 16  1  0
M  END
>  <Name>  (487) 
N-Ac-PCBC

>  <InChIKey>  (487) 
GEAIQETWXSVTMO-CBABADBVSA-N

>  <PubChem_CID>  (487) 


>  <CYP1A2>  (487) 


>  <CYP2A6>  (487) 


>  <CYP2B6>  (487) 


>  <CYP2C8>  (487) 


>  <CYP2C9>  (487) 


>  <CYP2C19>  (487) 


>  <CYP2D6>  (487) 


>  <CYP2E1>  (487) 


>  <CYP3A4>  (487) 
<3,S;S-Oxidation;R1>

>  <References>  (487) 
Werner M, Guo Z, Birner G, Dekant W, Guengerich FP: The sulfoxidation of the hexachlorobutadiene metabolite N-acetyl-S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine is catalyzed by human cytochrome P450 3A enzymes. Chem Res Toxicol. 1995 Oct-Nov;8(7):917-23. (PMID: 8555406)

>  <Comments>  (487) 
6 (S for S-Oxidation) .

$$$$
CC02353
     RDKit          3D

 24 26  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4840    0.0100 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.4690    1.8610   -0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5660    2.4300    0.9830 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2660   -0.3170   -0.8630 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1250   -0.5360    1.3450 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8050    1.1030   -1.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1480    3.2940   -0.3110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1240    3.5690    0.8060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6630    2.1780    1.9840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2200   -1.8100    1.6150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1380    1.3870    3.0820 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2520   -2.2930    3.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5070   -2.5640    0.7060 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8620    1.1990    4.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0420   -1.3550    4.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5440   -3.5680    3.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2920    0.3910    5.3340 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.9680    1.6770    4.2860 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2400   -1.0840    4.9330 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.8390   -4.5090    2.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1810    0.5530    6.5690 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0270    0.8520    5.6320 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4540   -1.4200    4.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  1
  1  4  1  0
  2  5  1  6
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5  7  1  0
  6 11  1  0
  8  9  1  0
 10 12  1  0
 11 13  1  0
 11 14  2  0
 12 15  1  0
 13 16  1  0
 13 17  2  0
 15 18  1  0
 15 19  2  0
 16 20  1  0
 17 21  1  0
 18 20  1  0
 18 22  1  1
 18 23  1  0
 20 24  1  6
M  END
>  <Name>  (488) 
Senecionine

>  <InChIKey>  (488) 
HKODIGSRFALUTA-RCDLFFMESA-N

>  <PubChem_CID>  (488) 
12299899

>  <CYP1A2>  (488) 


>  <CYP2A6>  (488) 


>  <CYP2B6>  (488) 


>  <CYP2C8>  (488) 


>  <CYP2C9>  (488) 


>  <CYP2C19>  (488) 


>  <CYP2D6>  (488) 


>  <CYP2E1>  (488) 


>  <CYP3A4>  (488) 
<16,N;N-Oxidation;R1>
<9,11;Cleavage;R2>
<20,21;Cleavage;R3>

>  <References>  (488) 
Miranda CL, Reed RL, Guengerich FP, Buhler DR: Role of cytochrome P450IIIA4 in the metabolism of the pyrrolizidine alkaloid senecionine in human liver. Carcinogenesis. 1991 Mar;12(3):515-9. doi: 10.1093/carcin/12.3.515. (PMID: 2009596)

>  <Comments>  (488) 
Don't know why Xenosite reported site 1 and 8 as SoM. Metabolic pathway to DHP. BoM needs to be confirmed.

$$$$
CC02354
     RDKit          3D

 46 49  0  0  0  0  0  0  0  0999 V2000
   -0.6300    0.6390   -0.6100 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1020   -0.5870   -0.2840 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.0310    1.8060   -0.6590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0660    0.5660   -0.8820 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0920   -0.8880   -1.3800 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8480   -0.3990    1.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5760    2.9690   -0.9400 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2270    1.8090   -0.4400 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7220    1.8930   -0.4840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6420   -2.1150   -1.4730 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3920   -0.0270   -2.1790 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1360    0.0550    2.1190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4880   -1.7250    1.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0100    3.0300   -1.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6030   -2.4080   -2.5380 C   0  0  1  0  0  0  0  0  0  0  0  0
    4.0240   -2.3420   -1.9760 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3390   -3.8100   -3.0930 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3420   -0.9240   -1.5780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9660   -3.8400   -3.7670 C   0  0  1  0  0  0  0  0  0  0  0  0
    4.1920   -0.5240   -0.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7890   -0.0240   -2.5270 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7530   -5.2030   -4.4290 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.0510   -3.6240   -2.7870 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4830    0.7770    0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0800    1.2780   -2.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6200   -5.2340   -5.1030 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8220   -6.2560   -3.4130 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9250    1.6780   -0.8490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7800   -6.5280   -5.8590 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1670   -7.5110   -3.7650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3200   -7.6340   -5.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3900   -6.6080   -7.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2380   -8.5940   -2.7200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4200   -7.7680   -4.9230 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4670   -8.8210   -5.9220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5370   -7.7960   -7.8760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6210   -9.8250   -3.3350 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0730   -8.9030   -7.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6680  -10.7590   -2.3490 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5370  -11.5000   -2.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8490  -10.9780   -1.6550 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5870  -12.4480   -1.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7460  -11.2690   -2.7950 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8950  -11.9280   -0.6530 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0820  -10.1800   -1.9940 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7640  -12.6600   -0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  1
  3  7  1  0
  3  8  2  0
  4  9  1  0
  5 10  1  0
  5 11  2  0
  6 12  1  0
  6 13  1  0
  7 14  1  0
  9 14  1  0
 10 15  1  0
 15 16  1  1
 15 17  1  0
 16 18  1  0
 17 19  1  0
 18 20  2  0
 18 21  1  0
 19 22  1  0
 19 23  1  1
 20 24  1  0
 21 25  2  0
 22 26  1  1
 22 27  1  0
 24 28  2  0
 25 28  1  0
 26 29  1  0
 27 30  1  0
 29 31  2  0
 29 32  1  0
 30 33  1  0
 30 34  2  0
 31 35  1  0
 32 36  2  0
 33 37  1  0
 35 38  2  0
 36 38  1  0
 37 39  1  0
 39 40  2  0
 39 41  1  0
 40 42  1  0
 40 43  1  0
 41 44  2  0
 41 45  1  0
 42 46  2  0
 44 46  1  0
M  END
>  <Name>  (489) 
ABT-378

>  <InChIKey>  (489) 
KJHKTHWMRKYKJE-UQJYGFKOSA-N

>  <PubChem_CID>  (489) 
6850809

>  <CYP1A2>  (489) 


>  <CYP2A6>  (489) 


>  <CYP2B6>  (489) 


>  <CYP2C8>  (489) 


>  <CYP2C9>  (489) 


>  <CYP2C19>  (489) 


>  <CYP2D6>  (489) 


>  <CYP2E1>  (489) 


>  <CYP3A4>  (489) 
<42,H;Oxidation;R1>

>  <References>  (489) 
Kumar GN, Dykstra J, Roberts EM, Jayanti VK, Hickman D, Uchic J, Yao Y, Surber B, Thomas S, Granneman GR: Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction. Drug Metab Dispos. 1999 Aug;27(8):902-8. (PMID: 10421617)

>  <Comments>  (489) 
14 (C for Aliphatic Hydroxylation).

$$$$
CC02355
     RDKit          3D

 30 32  0  0  0  0  0  0  0  0999 V2000
    4.9110    1.9610   -0.2040 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9030    1.3200   -0.5700 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6560   -0.0490   -0.4090 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4090   -0.1790    0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9200    1.0720    0.2320 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5960    1.4330    0.7430 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8390   -1.2200    0.3690 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5800   -1.1400   -0.7280 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4360   -1.4590    0.4990 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6010    1.4980   -0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2730    1.8600    0.0950 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6280    1.9040   -1.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0410    2.2700   -0.6030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5510    1.1980    0.3640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5540    1.0540    1.5180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1660    0.7510    0.9490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9160    1.6130    0.9160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6720   -0.0810   -0.3410 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4430    0.5590    1.7250 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7120    1.0050    2.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4060   -0.1610   -1.4690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0270   -1.2180    0.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4750   -1.4590   -2.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3070   -1.2610   -3.5010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4170   -1.7640    1.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7770   -2.8870    1.8610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7500   -3.4670    1.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3590   -2.9260   -0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9990   -1.8070   -0.5680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0110    0.8110   -1.8690 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  5  1  0
  2  3  1  0
  3  4  1  0
  3  8  1  0
  4  5  1  0
  4  7  2  0
  5  6  1  0
  6 10  1  0
  8  9  1  0
 10 11  1  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 17  1  0
 14 18  1  0
 15 16  1  0
 17 19  1  0
 18 21  1  0
 18 22  1  0
 19 20  1  0
 21 23  1  0
 21 30  2  0
 22 25  2  0
 22 29  1  0
 23 24  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
M  END
>  <Name>  (490) 
Alfentanil

>  <InChIKey>  (490) 
IDBPHNDTYPBSNI-UHFFFAOYSA-N

>  <PubChem_CID>  (490) 
51263

>  <CYP1A2>  (490) 


>  <CYP2A6>  (490) 


>  <CYP2B6>  (490) 


>  <CYP2C8>  (490) 


>  <CYP2C9>  (490) 


>  <CYP2C19>  (490) 


>  <CYP2D6>  (490) 


>  <CYP2E1>  (490) 


>  <CYP3A4>  (490) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>
<4,11;Cleavage;R2>
<11,H;Oxidation;R2>

>  <References>  (490) 
Klees TM, Sheffels P, Dale O, Kharasch ED: Metabolism of alfentanil by cytochrome p4503a (cyp3a) enzymes. Drug Metab Dispos. 2005 Mar;33(3):303-11. doi: 10.1124/dmd.104.002709. Epub 2004  Nov 22. (PMID: 15557344)

>  <Comments>  (490) 


$$$$
CC02356
     RDKit          3D

 38 44  0  0  1  0  0  0  0  0999 V2000
    1.2510    2.1300    0.6080 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.1710    2.7920   -0.2790 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9410    0.8360    0.9800 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0200    1.8580   -0.1560 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0460    3.0340    1.8430 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2440    1.8860   -0.5760 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.0910    0.7530    0.3320 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5190   -0.0290    1.7830 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2170    1.4990    0.1890 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3780    3.3350    2.5600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4230    4.3680    1.3940 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5710    2.5120   -0.1410 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.2210    1.4860   -1.9500 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1200   -0.3000    0.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0960    1.2160   -1.0030 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.6220    1.4020    1.3730 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6720    1.5500   -0.1520 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1000    3.6280   -1.0530 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5040    0.2620    0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5540    0.8390   -0.6800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4560    0.0570   -1.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9490    2.1890   -0.5060 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5580    3.6850   -0.5620 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4970   -0.4950    0.1740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6380   -0.5450   -0.0140 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.5120   -1.1950   -1.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0840   -0.9340    0.1110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9140   -1.6070   -0.8660 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.7680   -2.2390   -1.7220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3860   -2.2870    0.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1620   -0.0560    0.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0160   -3.0070   -0.2020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4840   -3.3230   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6560   -2.8160    0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4670   -0.5730    0.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2270   -4.5100    0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5500   -4.1770    0.2580 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7480   -1.9520    0.3910 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  6
  1  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6  7  1  0
  6 12  1  0
  6 13  1  6
  7 14  1  0
 15  9  1  1
  9 16  2  0
 12 17  1  0
 12 18  1  6
 14 19  1  0
 15 20  1  0
 15 21  1  0
 17 19  1  0
 17 22  1  0
 18 23  1  0
 19 24  2  0
 25 20  1  6
 21 26  1  0
 22 23  1  0
 25 27  1  0
 25 28  1  0
 26 28  1  0
 26 29  1  0
 27 30  2  0
 27 31  1  0
 28 32  1  1
 30 33  1  0
 30 34  1  0
 31 35  2  0
 32 33  1  0
 33 36  2  0
 34 37  1  0
 34 38  2  0
 35 38  1  0
 36 37  1  0
M  END
>  <Name>  (491) 
alpha-Dihydroergocryptine

>  <InChIKey>  (491) 
YJUGYRAWLRIQHU-JJCPZVKWSA-N

>  <PubChem_CID>  (491) 


>  <CYP1A2>  (491) 


>  <CYP2A6>  (491) 


>  <CYP2B6>  (491) 


>  <CYP2C8>  (491) 


>  <CYP2C9>  (491) 


>  <CYP2C19>  (491) 


>  <CYP2D6>  (491) 


>  <CYP2E1>  (491) 


>  <CYP3A4>  (491) 
<29,H;Hydroxylation;R1>
<30,H;Hydroxylation;R2>

>  <References>  (491) 
Althaus M, Retzow A, Castell JV, Gomez-Lechon MJ, Amalou Z, Rose T, Appel K: In vitro identification of the cytochrome P450 isoform responsible for the metabolism of alpha-dihydroergocryptine. Xenobiotica. 2000 Nov;30(11):1033-45. doi: 10.1080/00498250010002261. (PMID: 11197065)

>  <Comments>  (491) 
It has both mono-hydroxy and dihydroxy metabolites.

$$$$
CC02357
     RDKit          3D

 11 12  0  0  0  0  0  0  0  0999 V2000
    0.1310    1.2360   -0.9370 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.2500   -0.2520   -0.5420 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.6070   -0.8820   -0.9170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3900   -0.3510    0.5120 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.8390    1.1010    0.7680 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5540    1.5980   -0.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8560    2.0580   -0.0980 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3020    2.2350   -1.3290 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3020   -1.4010    1.6400 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7450   -1.7400    2.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4950   -0.9210    2.8680 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  1  7  1  1
  2  3  1  6
  2  4  1  0
  3  4  1  0
  4  5  1  0
  4  9  1  1
  5  6  1  0
  6  8  2  0
  9 10  1  0
  9 11  1  0
M  END
>  <Name>  (492) 
alpha-Thujone

>  <InChIKey>  (492) 
USMNOWBWPHYOEA-MRTMQBJTSA-N

>  <PubChem_CID>  (492) 
261491

>  <CYP1A2>  (492) 


>  <CYP2A6>  (492) 


>  <CYP2B6>  (492) 


>  <CYP2C8>  (492) 


>  <CYP2C9>  (492) 


>  <CYP2C19>  (492) 


>  <CYP2D6>  (492) 


>  <CYP2E1>  (492) 


>  <CYP3A4>  (492) 
<1,H;Hydroxylation;R1>
<7,H;Hydroxylation;R2>
<0,1;Dehydrogenation;R3>
<1,2;Dehydrogenation;R4>

>  <References>  (492) 
Hold KM, Sirisoma NS, Casida JE: Detoxification of alpha- and beta-Thujones (the active ingredients of absinthe): site specificity and species differences in cytochrome P450 oxidation in vitro and in vivo. Chem Res Toxicol. 2001 May;14(5):589-95. (PMID: 11368559)

>  <Comments>  (492) 


$$$$
CC02358
     RDKit          3D

 22 25  0  0  1  0  0  0  0  0999 V2000
   -0.0160    1.3930    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1590    2.1450    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2310    2.0690    0.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2390   -0.7860   -0.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2140   -0.6980    0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3120    1.8270    0.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3850    3.3360   -0.6140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4190    1.3710    0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1870   -1.9700   -0.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3650   -0.5700    0.4860 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4080   -0.0140    0.1250 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5550    0.5520    1.4110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1500    2.8040    0.4440 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6040    3.6960   -0.3060 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4170    4.0940   -1.4840 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2670   -2.0180   -2.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0610   -3.0370   -0.7880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9040   -0.8900    0.2160 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.2230   -3.1240   -2.8630 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0080   -4.1370   -1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0890   -4.1820   -2.6530 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  2  0
  6 12  1  0
  7 13  1  0
  7 14  2  0
  8 15  2  0
  8 16  1  0
  9 12  2  0
 10 17  2  0
 10 18  1  0
 11 13  1  0
 12 19  1  0
 14 15  1  0
 17 20  1  0
 18 21  2  0
 20 22  2  0
 21 22  1  0
M  END
>  <Name>  (493) 
Alprazolam

>  <InChIKey>  (493) 
VREFGVBLTWBCJP-UHFFFAOYSA-N

>  <PubChem_CID>  (493) 
2118

>  <CYP1A2>  (493) 


>  <CYP2A6>  (493) 


>  <CYP2B6>  (493) 


>  <CYP2C8>  (493) 


>  <CYP2C9>  (493) 


>  <CYP2C19>  (493) 


>  <CYP2D6>  (493) 


>  <CYP2E1>  (493) 


>  <CYP3A4>  (493) 
<21,H;Hydroxylation;R1>

>  <References>  (493) 
Hirota N, Ito K, Iwatsubo T, Green CE, Tyson CA, Shimada N, Suzuki H, Sugiyama Y: In vitro/in vivo scaling of alprazolam metabolism by CYP3A4 and CYP3A5 in humans. Biopharm Drug Dispos. 2001 Mar;22(2):53-71. (PMID: 11745908)

>  <Comments>  (493) 
13 (C for Aliphatic Hydroxylation).

$$$$
CC02360
     RDKit          3D

 21 24  0  0  0  0  0  0  0  0999 V2000
    0.8340    2.0020   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140    0.4800   -0.1640 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.2140   -0.0390    1.1680 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.7360    0.2330   -0.3800 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6060    0.1180   -1.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4090   -1.2550    1.6060 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.7060   -0.3260    1.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6970   -0.3280    0.6270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2550    0.5370   -1.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0830    0.5640   -2.6770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0850   -1.9820    2.7400 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.0240   -0.8060    1.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2260   -0.6600    2.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3520    1.0020   -2.6490 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1120   -1.1270    3.4710 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.2160   -2.4540    3.9120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7730    1.7560   -3.5220 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4790    0.0570    4.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5440   -2.1240    4.5450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2680   -2.8120    4.9730 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6660   -2.3000    4.9410 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  2  4  1  0
  2  5  1  0
  3  6  1  0
  3  7  1  6
  4  8  1  0
  4  9  2  0
  5 10  1  0
  6 11  1  0
  6 12  1  1
  7 13  1  0
  8 12  1  0
  9 14  1  0
 10 14  1  0
 11 15  1  0
 11 16  1  1
 13 15  1  0
 14 17  2  0
 15 18  1  1
 15 19  1  0
 16 20  1  0
 19 20  1  0
 19 21  2  0
M  END
>  <Name>  (494) 
Androstenedione

>  <InChIKey>  (494) 
AEMFNILZOJDQLW-LHHMMCJZSA-N

>  <PubChem_CID>  (494) 
124905398

>  <CYP1A2>  (494) 


>  <CYP2A6>  (494) 


>  <CYP2B6>  (494) 


>  <CYP2C8>  (494) 


>  <CYP2C9>  (494) 


>  <CYP2C19>  (494) 


>  <CYP2D6>  (494) 


>  <CYP2E1>  (494) 


>  <CYP3A4>  (494) 
<8,H;Hydroxylation;R1>

>  <References>  (494) 
Waxman DJ, Lapenson DP, Aoyama T, Gelboin HV, Gonzalez FJ, Korzekwa K: Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch Biochem Biophys. 1991 Oct;290(1):160-6. doi: 10.1016/0003-9861(91)90602-f. (PMID: 1898086)

>  <Comments>  (494) 
8 (C for Aliphatic Hydroxylation).

$$$$
CC02361
     RDKit          3D

 30 33  0  0  0  0  0  0  0  0999 V2000
   -0.0380    1.3560   -0.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0190   -0.0320   -0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1560    2.0640   -0.1530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2590    2.0370   -0.1690 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1860   -0.7080   -0.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3160   -0.7980   -0.2730 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3620    1.3820   -0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3920    1.3970    0.1730 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3750   -0.0050   -0.2130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3710   -0.0570    0.5490 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5330    2.0720   -0.1330 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4450    1.9990    0.1700 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7380    1.3050   -0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9430    2.2480   -0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2340    1.4260   -0.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4380    2.3690   -0.0810 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6780    1.5810   -0.0970 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.8490    2.4450   -0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6210    0.5310   -1.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1220    1.5990   -0.2270 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8940   -0.3160   -1.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0660    0.5480   -1.2540 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.2450   -0.2020   -1.2690 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4410    0.3890   -1.6600 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2250   -1.5370   -0.8880 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6050   -0.3570   -1.6730 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4720    2.0600   -2.1310 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   14.3920   -2.2760   -0.9030 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5800   -1.6890   -1.2980 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1000    0.3780   -2.1620 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  4  8  1  0
  5  9  1  0
  6 10  1  0
  7  9  2  0
  7 11  1  0
  8 10  1  0
  8 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 18 20  1  0
 19 21  1  0
 20 22  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 24 26  1  0
 24 27  1  0
 25 28  2  0
 26 29  2  0
 26 30  1  0
 28 29  1  0
M  END
>  <Name>  (495) 
Aripiprazole

>  <InChIKey>  (495) 
CEUORZQYGODEFX-UHFFFAOYSA-N

>  <PubChem_CID>  (495) 
60795

>  <CYP1A2>  (495) 


>  <CYP2A6>  (495) 


>  <CYP2B6>  (495) 


>  <CYP2C8>  (495) 


>  <CYP2C9>  (495) 


>  <CYP2C19>  (495) 


>  <CYP2D6>  (495) 


>  <CYP2E1>  (495) 


>  <CYP3A4>  (495) 
<2,3;Dehydrogenation;R1>

>  <References>  (495) 
Kubo M, Mizooku Y, Hirao Y, Osumi T: Development and validation of an LC-MS/MS method for the quantitative determination of aripiprazole and its main metabolite, OPC-14857, in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Aug 5;822(1-2):294-9. doi: 10.1016/j.jchromb.2005.06.023. (PMID: 16005688)

>  <Comments>  (495) 
10,6 (H for Dehydrogenation).

$$$$
CC02362
     RDKit          3D

 30 34  0  0  0  0  0  0  0  0999 V2000
   -0.0190    1.5260    0.0100 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.4410    2.0200   -0.0010 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.6020    1.9890    1.3640 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.7440    2.0240   -1.0850 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2320   -0.4920   -0.5270 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0700   -0.5120   -0.7780 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0720    1.6140   -1.3400 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.1860    1.2850    1.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1130    1.8590    1.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0710    1.2090    2.4800 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.1240    1.5660   -1.0780 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5260    0.2340   -1.7180 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.2440    0.2610   -0.5270 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.5940    1.5480   -1.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5610    1.5820    2.4830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4740    0.3920    0.9880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5580    1.5810    3.8240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5060   -0.4750   -2.4800 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4510   -0.4310   -1.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8640   -1.6460   -2.9890 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8490   -2.4420   -3.8070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6250   -3.4120   -3.1970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9680   -2.2040   -5.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5270   -4.1460   -3.9390 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8670   -2.9300   -5.9190 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6570   -3.9070   -5.3090 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6220   -4.6870   -6.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7440   -4.4540   -7.4310 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3040   -5.5390   -5.5780 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  6
  2  6  1  6
  2  7  1  0
  3  8  1  0
  3  9  1  1
  4 10  1  6
  4 11  1  0
  5 12  1  0
  6 13  1  0
  7 14  1  0
  8 13  1  0
  8 15  1  1
  9 16  1  0
 10 17  1  0
 11 16  1  0
 11 18  1  1
 12 14  1  0
 13 19  1  1
 14 17  1  0
 14 20  1  6
 19 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 23 25  1  0
 24 26  2  0
 25 27  2  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  2  0
M  END
>  <Name>  (496) 
Artelinic acid

>  <InChIKey>  (496) 
UVNHKOOJXSALHN-ILQPJIFQSA-N

>  <PubChem_CID>  (496) 
10341948

>  <CYP1A2>  (496) 


>  <CYP2A6>  (496) 


>  <CYP2B6>  (496) 


>  <CYP2C8>  (496) 


>  <CYP2C9>  (496) 


>  <CYP2C19>  (496) 


>  <CYP2D6>  (496) 


>  <CYP2E1>  (496) 


>  <CYP3A4>  (496) 
<3,4;Cleavage;R1>
<4,H;Oxidation;R1>

>  <References>  (496) 
Grace JM, Skanchy DJ, Aguilar AJ: Metabolism of artelinic acid to dihydroqinqhaosu by human liver cytochrome P4503A. Xenobiotica. 1999 Jul;29(7):703-17. doi: 10.1080/004982599238335. (PMID: 10456689)

>  <Comments>  (496) 
19 (O for O-Debenzylation).

$$$$
CC02363
     RDKit          3D

 41 44  0  0  0  0  0  0  0  0999 V2000
   -1.1270   -1.1000   -0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1990   -0.6380    0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9240    0.0630   -0.2800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5180   -2.4970    0.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1620    0.7180    0.1670 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4980   -1.3650    0.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0960    1.1820   -0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3010    0.0860   -0.7330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8560   -2.8530    0.3680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6160   -3.5740    0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3480    1.5680    0.3600 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9670   -2.0780   -0.9120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2590   -1.3430    1.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2950    2.6840   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1850    0.9880   -0.2760 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6270   -0.7780   -1.5800 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2890   -4.1650    0.5710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0070   -4.9040    0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9360    1.9400   -1.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2020   -2.7370   -0.8670 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4980   -1.9900    1.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1670    3.0900    1.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8180    3.1500   -1.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5340    0.9950   -0.3800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3520   -5.1980    0.5430 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3520    2.5200   -0.8430 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.9740   -2.6830    0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3820    0.0630   -1.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1780    2.0490    0.2860 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2170    1.4020   -0.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2630    3.6950   -0.0290 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1580   -3.2860    0.3480 F   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7820    0.1370   -0.9810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5760    2.1540    0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7450    1.6730   -0.3070 C   0  0  2  0  0  0  0  0  0  0  0  0
   -8.3840    1.1960   -0.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5210    0.3530   -0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1750    2.6360    0.6660 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0140    0.5250   -0.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8440    0.1990    0.5710 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4290    0.9730   -1.4060 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5  7  1  0
  5 11  1  0
  6 12  2  0
  6 13  1  0
  7 14  1  0
  8 15  1  0
  8 16  2  0
  9 17  1  0
 10 18  2  0
 11 19  1  0
 12 20  1  0
 13 21  2  0
 14 22  1  0
 14 23  1  0
 15 24  1  0
 17 25  2  0
 18 25  1  0
 19 26  1  0
 20 27  2  0
 21 27  1  0
 24 28  2  0
 24 29  1  0
 26 30  1  0
 26 31  1  1
 27 32  1  0
 28 33  1  0
 29 34  2  0
 30 35  1  0
 33 36  2  0
 34 36  1  0
 35 37  1  0
 35 38  1  1
 37 39  1  0
 39 40  1  0
 39 41  2  0
M  END
>  <Name>  (497) 
Atorvastatin

>  <InChIKey>  (497) 
XUKUURHRXDUEBC-KAYWLYCHSA-N

>  <PubChem_CID>  (497) 
60823

>  <CYP1A2>  (497) 


>  <CYP2A6>  (497) 


>  <CYP2B6>  (497) 


>  <CYP2C8>  (497) 


>  <CYP2C9>  (497) 


>  <CYP2C19>  (497) 


>  <CYP2D6>  (497) 


>  <CYP2E1>  (497) 


>  <CYP3A4>  (497) 
<9,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>
<13,H;Hydroxylation;R3>

>  <References>  (497) 
Jacobsen W, Kuhn B, Soldner A, Kirchner G, Sewing KF, Kollman PA, Benet LZ, Christians U: Lactonization is the critical first step in the disposition of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin. Drug Metab Dispos. 2000 Nov;28(11):1369-78. (PMID: 11038166)

>  <Comments>  (497) 
36 (C for Aromatic Hydroxylation). 28 (C for Aromatic Hydroxylation). 29 (C for Aromatic Hydroxylation).

$$$$
CC02364
     RDKit          3D

 11 12  0  0  0  0  0  0  0  0999 V2000
   -0.0190    1.5390    0.0100 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.0340   -0.7080   -0.8820 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3690   -0.4140    0.5820 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.1040    0.9030    0.9110 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4530    1.9370   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7270    2.0710   -1.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9780    2.8510   -0.5920 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5290   -1.5760    1.5640 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0010   -1.7100    1.9600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6870   -1.3090    2.8130 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  1  7  1  6
  2  3  1  6
  2  4  1  0
  3  4  1  0
  4  5  1  0
  4  9  1  1
  5  6  1  0
  6  8  2  0
  9 10  1  0
  9 11  1  0
M  END
>  <Name>  (498) 
beta-Thujone

>  <InChIKey>  (498) 
USMNOWBWPHYOEA-XKSSXDPKSA-N

>  <PubChem_CID>  (498) 
91456

>  <CYP1A2>  (498) 


>  <CYP2A6>  (498) 


>  <CYP2B6>  (498) 


>  <CYP2C8>  (498) 


>  <CYP2C9>  (498) 


>  <CYP2C19>  (498) 


>  <CYP2D6>  (498) 


>  <CYP2E1>  (498) 


>  <CYP3A4>  (498) 
<7,H;Hydroxylation;R1>
<1,H;Hydroxylation;R2>
<0,1;Dehydrogenation;R3>
<1,2;Dehydrogenation;R4>

>  <References>  (498) 
Hold KM, Sirisoma NS, Casida JE: Detoxification of alpha- and beta-Thujones (the active ingredients of absinthe): site specificity and species differences in cytochrome P450 oxidation in vitro and in vivo. Chem Res Toxicol. 2001 May;14(5):589-95. (PMID: 11368559)

>  <Comments>  (498) 


$$$$
CC02365
     RDKit          3D

 43 49  0  0  1  0  0  0  0  0999 V2000
   -0.0690    0.9690    0.1290 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2690   -0.4630    0.1530 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.0640    1.6850    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4360    1.4940    0.2220 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.3960   -1.0670    1.3930 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.6870   -0.5880    0.2300 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2270   -1.1000   -1.0260 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2320    0.7330    0.1260 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.1360    2.8890   -0.0830 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3090    0.4960    0.9370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9850    1.7370   -1.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8210   -0.6770    1.3790 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4130   -2.6090    1.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0540    0.8420   -1.0820 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0760    1.0500    1.3620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4800    0.7560    1.1180 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1740    2.8410   -1.8650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6140   -1.8030    1.8930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6370   -2.9690    2.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6930    1.9950   -1.3600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2270    0.8610    2.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2800    0.1080    1.4130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6410    2.9980   -3.3140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3780    4.1600   -1.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4910    2.1260   -2.6320 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.6270    2.9270   -0.5870 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5880    1.0930   -2.6550 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1530    3.5090   -2.6900 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7660    1.3690   -3.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9480    3.5930   -3.9150 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8160    0.3320   -3.1740 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0910    2.6960   -3.8220 C   0  0  2  0  0  0  0  0  0  0  0  0
    6.4870    4.9590   -3.9750 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8130    0.4940   -4.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9700   -0.7560   -2.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7490    2.5780   -5.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8540    1.5560   -5.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9220   -0.3370   -4.3360 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0650   -1.6010   -2.5110 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9610    1.3300   -5.8580 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6110    0.2020   -5.3820 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0490   -1.4280   -3.4770 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5610    2.3950   -7.3010 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  2  7  1  6
  3  8  1  0
  3  9  2  0
  4 10  1  0
  4 11  1  6
  5 12  1  0
  5 13  1  6
  6  8  1  0
  8 14  1  6
  8 15  1  0
 10 12  1  0
 10 16  2  0
 11 17  1  0
 12 18  1  0
 13 19  1  0
 14 20  1  0
 15 21  1  0
 15 22  1  0
 17 23  1  0
 17 24  1  0
 18 19  1  0
 25 20  1  1
 20 26  2  0
 25 27  1  0
 25 28  1  0
 27 29  2  0
 28 30  1  0
 29 31  1  0
 29 32  1  0
 30 32  1  0
 30 33  1  0
 31 34  2  0
 31 35  1  0
 32 36  1  6
 34 37  1  0
 34 38  1  0
 35 39  2  0
 36 37  1  0
 37 40  2  0
 38 41  1  0
 38 42  2  0
 39 42  1  0
 40 41  1  0
 40 43  1  0
M  END
>  <Name>  (499) 
Bromocriptine

>  <InChIKey>  (499) 
OZVBMTJYIDMWIL-AYFBDAFISA-N

>  <PubChem_CID>  (499) 
31101

>  <CYP1A2>  (499) 


>  <CYP2A6>  (499) 


>  <CYP2B6>  (499) 


>  <CYP2C8>  (499) 


>  <CYP2C9>  (499) 


>  <CYP2C19>  (499) 


>  <CYP2D6>  (499) 


>  <CYP2E1>  (499) 


>  <CYP3A4>  (499) 
<9,H;Hydroxylation;R1>
<8,H;Hydroxylation;R2>

>  <References>  (499) 
Althaus M, Retzow A, Castell JV, Gomez-Lechon MJ, Amalou Z, Rose T, Appel K: In vitro identification of the cytochrome P450 isoform responsible for the metabolism of alpha-dihydroergocryptine. Xenobiotica. 2000 Nov;30(11):1033-45. doi: 10.1080/00498250010002261. (PMID: 11197065)

>  <Comments>  (499) 
Both mono-hydroxy and dihydroxy metabolites are detectable.

$$$$
CC02366
     RDKit          3D

 22 25  0  0  1  0  0  0  0  0999 V2000
    1.5420    3.5400    1.8180 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2660    2.8640    0.6820 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5000    3.0820    0.3060 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7960    2.3240   -0.6930 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7720    1.5850   -1.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6630    0.5430   -2.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3240   -0.7500   -1.4880 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2130   -0.9720   -0.8640 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9490   -2.3650   -0.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7620   -3.3690   -1.3810 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5170   -4.6640   -0.9730 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4550   -4.9680    0.3760 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6390   -3.9770    1.3230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8910   -2.6780    0.9270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1290   -1.4360    2.1170 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.1820    0.0400   -0.5420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2430   -0.2480   -0.5530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1150    0.7200   -0.2270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0030    0.6270   -0.1520 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -1.0590    2.1150    0.1200 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.5080    1.3490   -0.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7650    1.9100   -0.1400 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2 22  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5 22  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 16  1  0
  9 10  2  0
  9 14  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 16 17  1  0
 16 21  2  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
M  END
>  <Name>  (500) 
Brotizolam

>  <InChIKey>  (500) 
UMSGKTJDUHERQW-UHFFFAOYSA-N

>  <PubChem_CID>  (500) 
2451

>  <CYP1A2>  (500) 


>  <CYP2A6>  (500) 


>  <CYP2B6>  (500) 


>  <CYP2C8>  (500) 


>  <CYP2C9>  (500) 


>  <CYP2C19>  (500) 


>  <CYP2D6>  (500) 


>  <CYP2E1>  (500) 


>  <CYP3A4>  (500) 
<0,H;Hydroxylation;R1>
<21,H;Hydroxylation;R2>

>  <References>  (500) 
Senda C, Kishimoto W, Sakai K, Nagakura A, Igarashi T: Identification of human cytochrome P450 isoforms involved in the metabolism of brotizolam. Xenobiotica. 1997 Sep;27(9):913-22. doi: 10.1080/004982597240082. (PMID: 9381732)

>  <Comments>  (500) 
1 (C for Aliphatic Hydroxylation). 6 (C for Aliphatic Hydroxylation).

$$$$
CC02367
     RDKit          3D

 31 35  0  0  0  0  0  0  0  0999 V2000
    4.1320    0.6060    1.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2600   -0.0230    1.5740 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3960    0.4500   -0.0020 C   0  0  1  0  0  0  0  0  0  0  0  0
    4.0060   -0.5580   -0.9310 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1330   -1.2020   -0.6610 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8600   -0.9430    0.5930 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9170   -1.4990    0.8270 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2840   -0.8570   -2.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8260   -1.1930   -1.9010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2050   -0.0520   -1.0930 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.9370    0.0610    0.2540 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.4000    1.8050   -0.7130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2570   -0.3530   -0.8160 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.2830    1.1130    1.1450 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.2180    0.8420    1.3350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8460    0.8760   -0.0740 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.1590   -0.4550   -2.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9230    1.1050    2.4220 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3500    0.6470   -0.1510 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.4760    2.1590   -0.8210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5740   -0.1690   -1.4780 C   0  0  2  0  0  0  0  0  0  0  0  0
   -3.1150    1.9460   -0.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7720   -0.2480    0.8950 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1340   -1.4210   -1.0310 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6580    2.9190   -0.6930 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4500    2.0300    0.5500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9720    3.3530    0.4200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7150   -1.1360    0.2570 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.8580   -2.4300    1.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8600   -3.3540    0.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0030   -4.6480    1.1710 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  2  6  1  0
  3  4  1  0
  3 11  1  0
  3 12  1  6
  4  5  2  0
  4  8  1  0
  5  6  1  0
  6  7  2  0
  8  9  1  0
 10  9  1  6
 10 11  1  0
 10 13  1  0
 11 14  1  1
 13 16  1  0
 13 17  1  6
 14 15  1  0
 14 18  1  1
 15 16  1  0
 16 19  1  0
 16 20  1  6
 21 17  1  1
 19 21  1  0
 19 22  1  6
 19 23  1  0
 21 24  1  0
 22 25  2  0
 22 26  1  0
 23 28  1  0
 24 28  1  0
 26 27  1  0
 28 29  1  1
 29 30  1  0
 30 31  1  0
M  END
>  <Name>  (501) 
Budesonide

>  <InChIKey>  (501) 
VOVIALXJUBGFJZ-CMVRJZLVSA-N

>  <PubChem_CID>  (501) 
93233157

>  <CYP1A2>  (501) 


>  <CYP2A6>  (501) 


>  <CYP2B6>  (501) 


>  <CYP2C8>  (501) 


>  <CYP2C9>  (501) 


>  <CYP2C19>  (501) 


>  <CYP2D6>  (501) 


>  <CYP2E1>  (501) 


>  <CYP3A4>  (501) 
<3,30;Cleavage;R1>
<3,H;Oxidation;R1>
<10,H;Hydroxylation;R2>

>  <References>  (501) 
Jonsson G, Astrom A, Andersson P: Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver. Drug Metab Dispos. 1995 Jan;23(1):137-42. (PMID: 7720517)

>  <Comments>  (501) 
8 (C for Aliphatic Hydroxylation).

$$$$
CC02369
     RDKit          3D

 22 24  0  0  0  0  0  0  0  0999 V2000
   -3.4790    0.8920    1.0780 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8110    0.4850    0.0050 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.6370   -0.6390    0.6370 C   0  0  2  0  0  0  0  0  0  0  0  0
   -4.9280    1.0750    0.9170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0850    1.5040   -1.2030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8220    1.9430    0.2560 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.3090    1.8410    0.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2440   -1.9590    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0690   -2.6260   -0.5540 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0220   -2.3940    0.1250 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4000   -3.6660   -0.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5860    0.3180    0.3670 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5540    0.7370   -0.4720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9740    0.5670   -0.1030 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2580    1.2540   -1.5300 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9800    1.0000   -0.9700 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3040    0.8380   -0.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6370    0.2480    0.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6460   -0.1840    1.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3170   -0.0220    1.1150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1270   -0.3690    0.3720 C   0  0  2  0  0  0  0  0  0  0  0  0
   -3.2870   -0.0240   -1.1260 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  4  1  0
  1  6  1  0
  1 21  1  0
  2  3  1  0
  2  7  1  0
  2 12  1  1
  3  8  1  6
  3 21  1  0
  6  5  1  6
  5 22  1  0
  6  7  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 14 16  2  0
 14 20  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 21 22  1  6
M  END
>  <Name>  (502) 
Cocaine

>  <InChIKey>  (502) 
ZPUCINDJVBIVPJ-LXTVHRRPSA-N

>  <PubChem_CID>  (502) 
644018

>  <CYP1A2>  (502) 


>  <CYP2A6>  (502) 


>  <CYP2B6>  (502) 


>  <CYP2C8>  (502) 


>  <CYP2C9>  (502) 


>  <CYP2C19>  (502) 


>  <CYP2D6>  (502) 


>  <CYP2E1>  (502) 


>  <CYP3A4>  (502) 
<20,21;Cleavage;R1>
<21,H;Oxidation;R1>

>  <References>  (502) 
Rendic S, Di Carlo FJ: Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev. 1997 Feb-May;29(1-2):413-580. (PMID: 9187528)

>  <Comments>  (502) 


$$$$
CC02370
     RDKit          3D

 29 31  0  0  0  0  0  0  0  0999 V2000
   -2.9100    0.7560    1.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7130    0.1070    0.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1520   -0.7630   -0.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7810   -0.9830   -0.5330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9780   -0.3230    0.4030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5470    0.5430    1.3290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0550    0.3240    0.3950 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3250    1.2510    1.4480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9450   -1.3990   -1.4360 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2560   -2.6800   -0.8840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2240   -1.8320   -1.4370 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9970   -1.0760   -2.6280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6750    1.2310    2.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0750    2.3840    1.6860 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6410    1.9670    0.3430 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.3080    0.6080    0.4110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5000   -0.5390    0.3920 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6500    0.6070    0.4940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9330   -1.8390    0.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1580   -2.3960    0.3620 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5770   -0.3960    0.5450 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3700   -1.7850    0.4600 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7380   -0.0380    0.6960 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4680   -2.5790    0.4610 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0140   -3.9110    0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6270    2.9610   -0.0890 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8240    3.1880   -1.4030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8390    4.2100   -1.8470 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1850    2.5690   -2.2280 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  2  7  1  0
  3  4  2  0
  3  9  1  0
  4  5  1  0
  4 11  1  0
  5  6  2  0
  5 17  1  0
  6 13  1  0
  7  8  1  0
  9 10  1  0
 11 12  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 26  1  1
 16 17  1  0
 16 18  2  0
 17 19  2  0
 18 21  1  0
 19 20  1  0
 20 22  2  0
 21 22  1  0
 21 23  2  0
 22 24  1  0
 24 25  1  0
 26 27  1  0
 27 28  1  0
 27 29  2  0
M  END
>  <Name>  (503) 
Colchicine

>  <InChIKey>  (503) 
IAKHMKGGTNLKSZ-MRXNPFEDSA-N

>  <PubChem_CID>  (503) 
53278

>  <CYP1A2>  (503) 


>  <CYP2A6>  (503) 


>  <CYP2B6>  (503) 


>  <CYP2C8>  (503) 


>  <CYP2C9>  (503) 


>  <CYP2C19>  (503) 


>  <CYP2D6>  (503) 


>  <CYP2E1>  (503) 


>  <CYP3A4>  (503) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<10,11;Cleavage;R2>
<11,H;Oxidation;R2>

>  <References>  (503) 
Tateishi T, Soucek P, Caraco Y, Guengerich FP, Wood AJ: Colchicine biotransformation by human liver microsomes. Identification of CYP3A4 as the major isoform responsible for colchicine demethylation. Biochem Pharmacol. 1997 Jan 10;53(1):111-6. doi: 10.1016/s0006-2952(96)00693-4. (PMID: 8960070)

>  <Comments>  (503) 
9 (O for O-Demethylation). 8 (O for O-Demethylation).

$$$$
CC02371
     RDKit          3D

 43 47  0  0  0  0  0  0  0  0999 V2000
   -0.3110    1.6970    0.1040 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3660    0.3800    0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7920   -0.3760    0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0190    0.2680    0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0360    1.6550    0.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8390    2.3440    0.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3450    2.4020    0.0420 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.2000    3.5950   -0.7300 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7500    2.7660    1.4720 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0260    3.4930    1.4500 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3540    3.8110    2.8460 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6800    4.5740    2.8970 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0170    4.9000    4.3290 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7640    4.0120    5.0810 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0800    4.3100    6.3920 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6460    5.5040    6.9550 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8950    6.3930    6.1970 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5830    6.0890    4.8870 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9630    5.8090    8.2810 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5330    7.3140    8.6710 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.6130    8.2350    8.1010 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.8870    7.2480   10.0460 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.0460    7.5460    7.7980 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0440    8.2020    6.5800 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2250    8.3930    5.8930 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4260    7.9220    6.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4200    7.2600    7.6640 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2310    7.0770    8.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6910    8.1210    5.7050 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8450    8.7150    4.5580 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.1350    8.7500    4.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9640    8.1580    5.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0720    7.6810    6.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5790    9.3690    2.8690 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6480    9.9620    2.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0670   10.5420    0.8380 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4080   10.5340    0.4980 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3360    9.9460    1.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9280    9.3640    2.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8600   11.1670   -0.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1640   12.5140   -0.5690 F   0  0  0  0  0  0  0  0  0  0  0  0
   17.9970   10.5040   -1.2650 F   0  0  0  0  0  0  0  0  0  0  0  0
   15.8360   11.0720   -1.7420 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  6
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 19  1  0
 17 18  2  0
 19 20  1  0
 20 21  2  0
 20 22  2  0
 20 23  1  0
 23 24  2  0
 23 28  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 26 29  1  0
 27 28  2  0
 29 30  2  0
 29 33  1  0
 30 31  1  0
 31 32  2  0
 31 34  1  0
 32 33  1  0
 34 35  2  0
 34 39  1  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 37 40  1  0
 38 39  2  0
 40 41  1  0
 40 42  1  0
 40 43  1  0
M  END
>  <Name>  (504) 
Compound 1

>  <InChIKey>  (504) 
ODRPZOGBOVWNQM-HKBQPEDESA-N

>  <PubChem_CID>  (504) 


>  <CYP1A2>  (504) 


>  <CYP2A6>  (504) 


>  <CYP2B6>  (504) 


>  <CYP2C8>  (504) 


>  <CYP2C9>  (504) 


>  <CYP2C19>  (504) 


>  <CYP2D6>  (504) 


>  <CYP2E1>  (504) 


>  <CYP3A4>  (504) 
<18,N;N-Oxidation;R1>
<10,11;Cleavage;R2>
<11,H;Oxidation;R2>

>  <References>  (504) 
Tang W, Stearns RA, Miller RR, Ngui JS, Mathvink RJ, Weber AE, Kwei GY, Strauss JR, Keohane CA, Doss GA, Chiu SH, Baillie TA: Metabolism of a thiazole benzenesulfonamide derivative, a potent and elective agonist of the human beta3-adrenergic receptor, in rats: identification of a novel isethionic acid conjugate. Drug Metab Dispos. 2002 Jul;30(7):778-87. doi: 10.1124/dmd.30.7.778. (PMID: 12065436)

>  <Comments>  (504) 
1 (N for N-Oxidation). 9 (N for N-Dealkylation).

$$$$
CC02372
     RDKit          3D

 31 34  0  0  0  0  0  0  0  0999 V2000
    0.0070    1.3460   -0.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7310    3.3620   -0.5530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1970   -0.9800   -2.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7410    1.4800    1.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7170    3.6030   -1.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0790    4.0350   -0.6660 C   0  0  1  0  0  0  0  0  0  0  0  0
    4.9810    5.1620   -1.7000 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.3040    2.0490   -0.2680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4750    0.5440   -1.1520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6800   -0.1130   -1.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8230    4.4640   -2.5030 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2400    2.3220    2.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5000    2.9380   -1.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5340    2.4770    0.4970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9600    0.8120    1.1870 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1810    4.6160   -2.8900 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3820    5.5720   -2.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3310    1.8220    0.6470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4180    0.0180    0.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7590    2.9950    2.0110 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7290   -2.2870   -1.9610 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5960   -0.9790   -2.1100 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7470   -0.4760   -3.3540 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.4500    4.5790    0.6020 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8920    2.3450    3.3450 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2820    6.7600   -3.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3280    8.0410   -2.5630 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1490    6.5680   -4.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2360    9.1310   -3.4090 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0570    7.6580   -5.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0980    8.9400   -4.7710 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  4  2  0
  1  8  1  0
  1  9  1  0
  2  5  2  0
  2  6  1  0
  2 14  1  0
  3 10  1  0
  3 21  1  0
  3 22  1  0
  3 23  1  0
  4 12  1  0
  4 15  1  0
  5 11  1  0
  5 13  1  0
  6  7  1  0
  6 24  1  1
  7 16  1  0
  7 17  1  6
  8 13  2  0
  8 18  1  0
  9 10  2  0
 10 19  1  0
 11 16  1  0
 12 20  2  0
 12 25  1  0
 14 18  2  0
 15 19  2  0
 17 26  1  0
 26 27  2  0
 26 28  1  0
 27 29  1  0
 28 30  2  0
 29 31  2  0
 30 31  1  0
M  END
>  <Name>  (505) 
CP-195543

>  <InChIKey>  (505) 
NZQDWKCNBOELAI-KSFYIVLOSA-N

>  <PubChem_CID>  (505) 
9823886

>  <CYP1A2>  (505) 


>  <CYP2A6>  (505) 


>  <CYP2B6>  (505) 


>  <CYP2C8>  (505) 


>  <CYP2C9>  (505) 


>  <CYP2C19>  (505) 


>  <CYP2D6>  (505) 


>  <CYP2E1>  (505) 


>  <CYP3A4>  (505) 
<22,H;Hydroxylation;R1>
<26,H;Hydroxylation;R2>

>  <References>  (505) 
Khojasteh-Bakht SC, Rossulek MI, Fouda HG, Prakash C: Identification of the human cytochrome P450s responsible for the in vitro metabolism of a leukotriene B4 receptor antagonist, CP-195,543. Xenobiotica. 2003 Dec;33(12):1201-10. doi: 10.1080/00498250310001646362. (PMID: 14742142)

>  <Comments>  (505) 
The aromatic hydroxylated metabolites are not confirmed. Followed Xenosite.

$$$$
CC02373
     RDKit          3D

 41 45  0  0  0  0  0  0  0  0999 V2000
   -0.6110    0.7280    0.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6470   -0.4690    1.0560 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6610    1.5660    0.3340 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.7650    1.1840   -0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4560   -0.8900    1.7030 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8210   -1.2320    1.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9750    0.7550    0.5700 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.7780    2.2320   -0.9210 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9550    0.4410   -0.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7700   -0.6390    1.2020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9560   -0.7670    0.4490 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7330    0.5920   -0.7820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1880    0.7280   -0.7050 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1130   -0.0520   -0.6510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0440   -0.3670   -0.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2910   -1.4400   -0.7880 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2220    0.7630   -0.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5450   -0.1780   -0.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5450   -2.0220   -0.5800 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2840   -2.2610   -1.1160 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4990    0.2040   -0.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3110    0.9550   -0.1900 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5680   -1.5620   -0.2550 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.6260   -1.1950   -0.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5220   -3.6650   -1.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5260    1.0490    0.0870 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6600    0.6970   -0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.0110   -0.6550   -0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0870    0.6610    0.2890 S   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6810    1.6460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.3190   -1.1230   -0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1080    2.1400    0.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6030   -0.1160   -0.8030 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.2330   -0.0670    1.5080 O   0  0  0  0  0  0  0  0  0  0  0  0
  -11.0100    1.2000    0.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.3320   -0.1670    0.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4260    1.7660    0.5130 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.7820    2.7750    1.6320 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.9060    2.9880   -0.5920 F   0  0  0  0  0  0  0  0  0  0  0  0
  -11.9880    2.0930    0.1800 F   0  0  0  0  0  0  0  0  0  0  0  0
  -12.6010   -0.5530    0.1490 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  1  6
  4  9  2  0
  5 10  1  0
  6 11  2  0
  7 10  1  0
  7 12  1  6
  9 11  1  0
  9 13  1  0
 12 14  1  0
 13 15  1  0
 14 16  2  0
 14 17  1  0
 15 18  1  0
 16 19  1  0
 16 20  1  0
 17 21  2  0
 18 22  2  0
 18 23  1  0
 19 24  2  0
 20 25  1  0
 21 24  1  0
 21 26  1  0
 22 27  1  0
 23 28  1  0
 26 29  1  0
 27 28  2  0
 27 30  1  0
 28 31  1  0
 29 32  1  0
 29 33  2  0
 29 34  2  0
 30 35  2  0
 31 36  2  0
 32 37  1  0
 32 38  1  0
 32 39  1  0
 35 36  1  0
 35 40  1  0
 36 41  1  0
M  END
>  <Name>  (506) 
CP-199331

>  <InChIKey>  (506) 
OFYJBLBCZNRWLC-DLUDVSRJSA-N

>  <PubChem_CID>  (506) 
9895247

>  <CYP1A2>  (506) 


>  <CYP2A6>  (506) 


>  <CYP2B6>  (506) 


>  <CYP2C8>  (506) 


>  <CYP2C9>  (506) 


>  <CYP2C19>  (506) 


>  <CYP2D6>  (506) 


>  <CYP2E1>  (506) 


>  <CYP3A4>  (506) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (506) 
Kuperman AV, Kalgutkar AS, Marfat A, Chambers RJ, Liston TE: Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue. Drug Metab Dispos. 2001 Nov;29(11):1403-9. (PMID: 11602515)

>  <Comments>  (506) 
20 (O for O-Demethylation).

$$$$
CC02374
     RDKit          3D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -2.1660   -1.0100   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8690   -0.2640    0.0860 C   0  0  2  0  0  0  0  0  0  0  0  0
   -3.3300   -0.2680    0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6390   -0.7640    0.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8010   -2.1230   -0.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6460   -2.8620   -0.2990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3570   -2.3310   -0.2600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3880    1.1660    0.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4400    0.3070    0.4390 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6750    1.4490    0.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9020    0.2580    0.5170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4960    0.5210   -0.8680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0970    1.9400    0.5580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0480    1.2010   -0.3140 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.1500   -0.9120   -0.8590 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2320    1.9110   -0.1960 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1500    1.3370   -1.1840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4500   -0.1040   -0.8280 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.0150    3.3000   -0.6060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0370   -0.1700    0.5130 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5510   -0.8090    0.7240 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.6030    0.1080   -0.1680 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8850   -0.5670    2.0840 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5230   -2.0840    0.0980 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2510    1.2750    0.4350 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8860   -0.2490   -1.5610 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5700    0.8490    1.0810 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3810   -0.5320   -1.7210 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  7  1  0
  2 14  1  0
  2 15  1  6
  3  4  1  0
  3  8  1  0
  4  5  2  0
  4  9  1  0
  5  6  1  0
  6  7  2  0
  8 10  2  0
  8 13  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 14 13  1  1
 14 16  1  0
 15 18  1  0
 16 17  1  0
 16 19  1  0
 17 18  1  0
 18 20  1  1
 20 21  1  0
 21 22  1  0
 21 23  2  0
 21 24  2  0
 22 25  1  0
 22 26  1  0
 25 27  1  0
 26 28  1  0
M  END
>  <Name>  (507) 
CQA 206-291

>  <InChIKey>  (507) 
ARTRTLXKTHJPRW-ILZDJORESA-N

>  <PubChem_CID>  (507) 
9953076

>  <CYP1A2>  (507) 


>  <CYP2A6>  (507) 


>  <CYP2B6>  (507) 


>  <CYP2C8>  (507) 


>  <CYP2C9>  (507) 


>  <CYP2C19>  (507) 


>  <CYP2D6>  (507) 


>  <CYP2E1>  (507) 


>  <CYP3A4>  (507) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <References>  (507) 
Ball SE, Maurer G, Zollinger M, Ladona M, Vickers AE: Characterization of the cytochrome P-450 gene family responsible for the N-dealkylation of the ergot alkaloid CQA 206-291 in humans. Drug Metab Dispos. 1992 Jan-Feb;20(1):56-63. (PMID: 1346997)

>  <Comments>  (507) 
22 (N for N-Dealkylation). 22 (N for N-Dealkylation).

$$$$
CC02375
     RDKit          3D

 85 85  0  0  0  0  0  0  0  0999 V2000
    4.7480   -0.6320    3.7590 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5950   -1.8820    3.4900 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7240   -3.8750    2.5640 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6920    0.3050    3.1100 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.8420   -3.9620    3.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0070   -5.1100    3.3770 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.5280   -5.2640    2.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2550   -4.9270    0.4590 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9250    1.0190    2.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0690    0.9880   -4.8180 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.0180    1.8900   -5.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5680   -5.3150    3.5390 C   0  0  1  0  0  0  0  0  0  0  0  0
   10.8640   -4.6130    1.8070 C   0  0  1  0  0  0  0  0  0  0  0  0
   10.9790    3.0380   -4.8080 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.2120    4.3850   -3.1210 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.4280   -5.7120    0.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3100    4.1350   -4.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2820   -2.5340    2.1780 C   0  0  1  0  0  0  0  0  0  0  0  0
   14.1330   -1.0840   -3.7130 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2510    5.3570   -2.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3260    2.2370    1.5140 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6310    4.4310   -1.4750 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.7980   -0.4090   -5.0020 C   0  0  1  0  0  0  0  0  0  0  0  0
   12.4230    2.9080   -4.3470 C   0  0  1  0  0  0  0  0  0  0  0  0
    8.8730    4.3060   -4.5220 C   0  0  1  0  0  0  0  0  0  0  0  0
    5.7680    3.7900   -0.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7670   -2.3830   -3.7660 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.0570   -4.7890   -1.1000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.1400   -4.1620   -2.2860 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1790   -5.8830   -0.8420 C   0  0  1  0  0  0  0  0  0  0  0  0
    5.0230    2.5040    0.1170 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.6020    5.5620   -1.6540 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3040    1.3170    4.0750 C   0  0  1  0  0  0  0  0  0  0  0  0
   15.1200   -3.0470   -2.5460 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.9320   -2.5800    4.1780 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4510   -2.9780    3.5860 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.9660   -5.8760    1.3570 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.7490    1.8970   -6.4440 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8550    0.5010    1.5890 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.6280   -3.0660    1.8880 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8290   -6.3000    1.3650 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1310   -5.7630    4.9500 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9830    5.0180   -3.7520 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.9240   -0.6130   -2.5870 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9100    5.9860   -3.9780 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6060    4.2040    0.5120 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.2740   -0.6780   -5.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2110    3.1410   -5.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4670   -4.5360   -3.1890 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2610   -2.5960    1.0520 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4020    2.3820   -2.9020 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1150   -0.1080    4.9850 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2520    3.7280    3.6950 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9170   -5.0500    2.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2390    5.0360    3.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8050   -4.9220    4.6460 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6220   -4.5140   -0.6820 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2600    1.5520   -4.3630 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5250    1.9700    3.4230 C   0  0  1  0  0  0  0  0  0  0  0  0
    8.6240    3.5360   -2.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3380    2.3220    4.3890 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5380    4.0740   -2.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5450    1.3160   -0.8190 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9850   -7.2300   -0.8210 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1270    2.9990    4.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6550   -6.1640    4.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9500   -2.3360    1.6480 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7480    3.4850   -5.6120 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0830   -2.1540   -5.6930 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5680   -3.5700   -2.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3650    5.7660    2.9390 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9840    3.5080   -1.9550 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4030    1.2280   -2.7940 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7250   -1.1900    0.7730 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9260   -3.1480   -0.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5680    0.8970    3.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6990   -0.8270    1.6030 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9230   -2.6570    2.7850 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4880   -7.4380    4.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6820    4.7030   -6.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0660    2.2940   -6.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1700   -6.4200    6.3510 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5940   -2.4420   -5.8920 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8400   -2.4660   -6.9850 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0150    1.0290   -0.5060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  4  1  1  1
  1 52  1  0
  2 18  1  0
  2 35  2  0
  3  5  1  0
  3 18  1  0
  3 54  1  0
  4  9  1  0
  4 33  1  0
  5 12  1  0
  5 36  2  0
  6  7  1  0
  6 12  1  0
  6 56  1  0
  7 13  1  0
  7 37  2  0
  8 13  1  0
  8 16  1  0
  8 57  1  0
  9 21  1  0
  9 39  2  0
 10 11  1  0
 10 23  1  0
 10 58  1  0
 11 24  1  0
 11 38  2  0
 12 42  1  1
 13 40  1  6
 14 17  1  0
 14 24  1  0
 15 20  1  0
 15 25  1  0
 15 60  1  0
 16 30  1  0
 16 41  2  0
 17 25  1  0
 17 43  2  0
 18 50  1  6
 19 23  1  0
 19 27  1  0
 19 44  2  0
 20 32  1  0
 20 45  2  0
 21 31  1  0
 22 26  1  0
 22 32  1  0
 22 62  1  0
 23 47  1  1
 24 51  1  1
 25 48  1  1
 26 31  1  0
 26 46  2  0
 27 34  1  0
 28 29  1  0
 28 30  1  0
 29 34  1  0
 29 49  2  0
 30 64  1  1
 31 63  1  6
 33 59  1  0
 33 61  1  6
 34 70  1  6
 40 67  1  0
 42 66  1  0
 47 69  1  0
 48 68  1  0
 50 74  1  0
 50 75  1  0
 51 72  1  0
 51 73  1  0
 53 55  2  0
 53 65  1  0
 55 71  1  0
 59 65  1  0
 59 76  1  1
 63 85  1  0
 66 79  1  0
 66 82  1  0
 67 77  1  0
 67 78  1  0
 68 80  1  0
 68 81  1  0
 69 83  1  0
 69 84  1  0
M  END
>  <Name>  (508) 
Cyclosporine A

>  <InChIKey>  (508) 
PMATZTZNYRCHOR-UITTWSBISA-N

>  <PubChem_CID>  (508) 


>  <CYP1A2>  (508) 


>  <CYP2A6>  (508) 


>  <CYP2B6>  (508) 


>  <CYP2C8>  (508) 


>  <CYP2C9>  (508) 


>  <CYP2C19>  (508) 


>  <CYP2D6>  (508) 


>  <CYP2E1>  (508) 


>  <CYP3A4>  (508) 
<0,H;Hydroxylation;R1>
<22,23;Cleavage;R2>
<23,H;Oxidation;R2>
<61,H;Hydroxylation;R3>

>  <References>  (508) 
Dai Y, Iwanaga K, Lin YS, Hebert MF, Davis CL, Huang W, Kharasch ED, Thummel KE: In vitro metabolism of cyclosporine A by human kidney CYP3A5. Biochem Pharmacol. 2004 Nov 1;68(9):1889-902. doi: 10.1016/j.bcp.2004.07.012. (PMID: 15450954)

>  <Comments>  (508) 
AM1, Am9, and AM4N are all metabolites for CYP3A4.

$$$$
CC02376
     RDKit          3D

 36 39  0  0  0  0  0  0  0  0999 V2000
    0.6140    1.4710    1.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6630    0.0710    1.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9410    1.9310    1.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5790    2.0900    0.9140 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5470   -0.6550    0.9680 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9800   -0.2790    1.1680 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7370    0.8990    1.2100 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3720    3.3750    1.1380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6920    1.4030    0.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7040    0.0350    0.8610 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5470   -1.8740    0.9880 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5060   -1.6450    1.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4000    3.8880    2.5790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9730    2.1280    0.7080 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8380    5.3540    2.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9900    3.5280    0.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1730    1.4210    0.6110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1980    4.1990    0.5680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8290    4.2260    0.7720 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3660    2.1030    0.4970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3790    3.4880    0.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1740    5.6120    0.7190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8790    1.2100    0.3740 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9040    6.4580    0.8140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4440    0.9780    1.9130 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8010    2.0960   -0.2460 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5280   -0.0800   -0.1070 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2740    7.9420    0.7580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8480    2.1280    2.7270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6630    1.6420    3.9270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9980    2.8300    4.8300 C   0  0  1  0  0  0  0  0  0  0  0  0
   -9.8780    2.3930    5.9290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7080    3.3840    5.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1810    2.6280    7.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.0310    0.9380    5.7930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1610    3.7530    6.9070 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  5 11  2  0
  6  7  1  0
  6 12  1  0
  8 13  1  0
  9 10  1  0
  9 14  1  0
 13 15  1  0
 14 16  2  0
 14 17  1  0
 16 18  1  0
 16 19  1  0
 17 20  2  0
 18 21  2  0
 19 22  1  0
 20 21  1  0
 20 23  1  0
 22 24  1  0
 23 25  1  0
 23 26  2  0
 23 27  2  0
 24 28  1  0
 25 29  1  0
 29 30  1  0
 31 30  1  6
 31 32  1  0
 31 33  1  0
 32 34  1  0
 32 35  1  0
 33 36  1  0
 34 36  1  0
M  END
>  <Name>  (509) 
DA-8159

>  <InChIKey>  (509) 
IYFNEFQTYQPVOC-KRWDZBQOSA-N

>  <PubChem_CID>  (509) 
135564686

>  <CYP1A2>  (509) 


>  <CYP2A6>  (509) 


>  <CYP2B6>  (509) 


>  <CYP2C8>  (509) 


>  <CYP2C9>  (509) 


>  <CYP2C19>  (509) 


>  <CYP2D6>  (509) 


>  <CYP2E1>  (509) 


>  <CYP3A4>  (509) 
<30,31;Cleavage;R1>
<31,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>
<26,H;Hydroxylation;R3>
<28,H;Hydroxylation;R4>
<28,H;Hydroxylation;R5>
<0,H;Hydroxylation;R6>
<1,H;Hydroxylation;R7>
<2,H;Hydroxylation;R8>

>  <References>  (509) 
Ji HY, Lee HW, Kim HH, Kim DS, Yoo M, Kim WB, Lee HS: Role of human cytochrome P450 3A4 in the metabolism of DA-8159, a new erectogenic. Xenobiotica. 2004 Nov-Dec;34(11-12):973-82. doi: 10.1080/00498250400010898. (PMID: 15801542)

>  <Comments>  (509) 
Hydroxylation location is not defined, or by other any reference.

$$$$
CC02378
     RDKit          3D

 22 24  0  0  0  0  0  0  0  0999 V2000
   -3.4520    0.8540    0.5970 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.2370    0.1380   -0.0490 C   0  0  2  0  0  0  0  0  0  0  0  0
   -3.5510    2.2690   -0.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1480    1.0390   -1.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5510    1.7120   -1.4740 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.5490    0.0090   -0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3000   -1.3560   -0.3680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9030    0.9960   -1.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0200    0.3570    0.6720 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4380    0.8270    2.1380 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9850   -0.0520    0.8080 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3710    3.2170    0.2110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8780    2.9690    0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0730    0.8620   -0.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2870    1.1710    0.3800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9640   -1.7890   -1.6650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6080   -2.3220    0.6140 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2700    0.3240    1.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2440   -0.9000   -0.3630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5960   -3.6880    0.2810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9500   -3.1540   -1.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2680   -4.1120   -1.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  6  1  0
  1 10  1  1
  2  4  1  0
  2  7  1  0
  2  9  1  1
  3  5  1  0
  3 12  1  0
  3 13  1  0
  5  4  1  1
  5  8  1  0
  6  8  1  0
  7 16  2  0
  7 17  1  0
  9 14  1  0
 11 15  1  0
 11 18  1  0
 11 19  1  0
 14 15  1  0
 16 21  1  0
 17 20  2  0
 20 22  1  0
 21 22  2  0
M  END
>  <Name>  (510) 
Deramciclane

>  <InChIKey>  (510) 
QOBGWWQAMAPULA-RLLQIKCJSA-N

>  <PubChem_CID>  (510) 
119590

>  <CYP1A2>  (510) 


>  <CYP2A6>  (510) 


>  <CYP2B6>  (510) 


>  <CYP2C8>  (510) 


>  <CYP2C9>  (510) 


>  <CYP2C19>  (510) 


>  <CYP2D6>  (510) 


>  <CYP2E1>  (510) 


>  <CYP3A4>  (510) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <References>  (510) 
Laine K, Ahokoski O, Huupponen R, Hanninen J, Palovaara S, Ruuskanen J, Bjorklund H, Anttila M, Rouru J: Effect of the novel anxiolytic drug deramciclane on the pharmacokinetics and pharmacodynamics of the CYP3A4 probe drug buspirone. Eur J Clin Pharmacol. 2003 Dec;59(10):761-6. doi: 10.1007/s00228-003-0674-3. Epub 2003 Oct 18. (PMID: 14566442)

>  <Comments>  (510) 
18 (N for N-Demethylation). 19 (N for N-Demethylation).

$$$$
CC02379
     RDKit          3D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -1.6470   -0.6630    1.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6270   -0.0620   -0.0870 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.7690    1.2320   -0.0940 C   0  0  2  0  0  0  0  0  0  0  0  0
   -3.0200    0.4340   -0.4570 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.9760   -1.0350   -1.0520 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5530    0.8960    0.5750 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.6800    2.2130    0.6530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0720   -0.4140    0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1930    0.4110   -1.8760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0900    1.8900    0.0690 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.4030   -1.3910   -0.4760 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.2620   -0.1480   -0.3020 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.4100    2.1570    0.6960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5720   -1.6650   -0.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5130   -0.0910    1.2890 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4150    2.8480   -1.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2280   -2.0550    0.7770 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5640    0.4210   -1.5440 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.5740   -0.5560    0.3760 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.7190    1.8200    1.4160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5570   -2.2900    0.3620 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2230   -1.2040    1.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3920    0.6680    0.6600 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2980   -1.5690   -0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6590    0.7930    0.2870 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5600   -1.4500   -0.8230 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3290   -0.2830   -0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5020   -0.1890   -0.7680 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  2  4  1  0
  2  5  1  0
  3  6  1  0
  3  7  1  1
  4  8  1  0
  4  9  1  6
  4 10  1  0
  5 11  1  0
  6 12  1  0
  6 13  1  6
  7 10  1  0
  8 14  1  0
  8 15  2  0
 10 16  1  6
 11 12  1  0
 11 17  1  1
 12 18  1  6
 12 19  1  0
 13 20  1  0
 14 21  1  0
 19 22  1  1
 19 23  1  0
 19 24  1  0
 20 23  1  0
 23 25  2  0
 24 26  2  0
 25 27  1  0
 26 27  1  0
 27 28  2  0
M  END
>  <Name>  (511) 
Dexamethasone

>  <InChIKey>  (511) 
UREBDLICKHMUKA-CXSFZGCWSA-N

>  <PubChem_CID>  (511) 
5743

>  <CYP1A2>  (511) 


>  <CYP2A6>  (511) 


>  <CYP2B6>  (511) 


>  <CYP2C8>  (511) 


>  <CYP2C9>  (511) 


>  <CYP2C19>  (511) 


>  <CYP2D6>  (511) 


>  <CYP2E1>  (511) 


>  <CYP3A4>  (511) 
<6,H;Hydroxylation;R1>

>  <References>  (511) 
Gentile DM, Tomlinson ES, Maggs JL, Park BK, Back DJ: Dexamethasone metabolism by human liver in vitro. Metabolite identification and inhibition of 6-hydroxylation. J Pharmacol Exp Ther. 1996 Apr;277(1):105-12. (PMID: 8613906)

>  <Comments>  (511) 


$$$$
CC02380
     RDKit          3D

 25 26  0  0  0  0  0  0  0  0999 V2000
    0.5770    1.3900    0.4620 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.1590    0.6260    1.5310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9420    1.8280    0.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2360    2.6240    0.0650 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.7630    0.5380   -0.7000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0140   -0.7460    1.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9760    1.2970    2.4220 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6980    2.5510   -0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2140    3.1080   -1.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7220    2.2620    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2200   -0.2880   -1.0910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6900   -1.4460    2.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6520    0.5960    3.4030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7400    3.9330   -0.0990 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3540    1.8330   -1.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2340    4.4920   -1.5180 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0920   -1.0530   -2.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2070   -0.4180   -0.4070 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5100   -0.7760    3.4950 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4330    4.5960   -1.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0470    2.4960   -2.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4030    4.9650   -2.7550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6780    4.4350   -1.7820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3390   -1.9140   -2.5910 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0840    3.8780   -2.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  1
  1  4  1  0
  1  5  1  0
  2  6  2  0
  2  7  1  0
  3  8  1  0
  4  9  1  0
  4 10  1  6
  5 11  1  0
  6 12  1  0
  7 13  2  0
  8 14  2  0
  8 15  1  0
  9 16  1  0
 11 17  1  0
 11 18  2  0
 12 19  2  0
 13 19  1  0
 14 20  1  0
 15 21  2  0
 16 22  1  0
 16 23  1  0
 17 24  1  0
 20 25  2  0
 21 25  1  0
M  END
>  <Name>  (512) 
Dextropropoxyphene

>  <InChIKey>  (512) 
XLMALTXPSGQGBX-GCJKJVERSA-N

>  <PubChem_CID>  (512) 
10100

>  <CYP1A2>  (512) 


>  <CYP2A6>  (512) 


>  <CYP2B6>  (512) 


>  <CYP2C8>  (512) 


>  <CYP2C9>  (512) 


>  <CYP2C19>  (512) 


>  <CYP2D6>  (512) 


>  <CYP2E1>  (512) 


>  <CYP3A4>  (512) 
<22,23;Cleavage;R1>
<23,H;Oxidation;R1>
<22,24;Cleavage;R2>
<24,H;Oxidation;R2>

>  <References>  (512) 
Somogyi AA, Menelaou A, Fullston SV: CYP3A4 mediates dextropropoxyphene N-demethylation to nordextropropoxyphene: human in vitro and in vivo studies and lack of CYP2D6 involvement. Xenobiotica. 2004 Oct;34(10):875-87. doi: 10.1080/00498250400008371. (PMID: 15764408)

>  <Comments>  (512) 


$$$$
CC02381
     RDKit          3D

 21 24  0  0  0  0  0  0  0  0999 V2000
    0.7260   -0.3290    0.4520 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.3580    0.1660   -0.4890 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.9190    0.1680   -0.2550 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.9230   -1.8500    0.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5810   -0.3290    0.1890 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.4960    1.6980   -0.6120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8680    1.6840   -0.1320 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.2290   -0.2700    0.3960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3740   -2.5560    0.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5150   -1.8280    0.1860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7250    0.2230   -0.6520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5830    0.2790    1.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8330    2.2990   -1.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3000    2.0140   -0.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5320    2.1020    1.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1800    0.7840   -0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7620   -2.6080    0.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9360   -0.3460    0.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6490    3.1700   -0.3630 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9370   -1.8510   -0.2510 C   0  0  2  0  0  0  0  0  0  0  0  0
   -5.0980   -2.4050    0.3540 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  6
  2  5  1  0
  2  6  1  1
  3  7  1  0
  3  8  1  1
  4  9  1  0
  5 10  1  0
  5 11  1  0
  5 12  1  1
  6 13  1  0
  7 13  1  0
  7 14  1  0
  7 15  1  1
  8 16  1  0
  9 10  2  0
 10 17  1  0
 11 18  1  0
 14 16  1  0
 14 19  2  0
 17 20  1  0
 18 20  1  0
 20 21  1  1
M  END
>  <Name>  (513) 
DHEA

>  <InChIKey>  (513) 
FMGSKLZLMKYGDP-USOAJAOKSA-N

>  <PubChem_CID>  (513) 
5881

>  <CYP1A2>  (513) 


>  <CYP2A6>  (513) 


>  <CYP2B6>  (513) 


>  <CYP2C8>  (513) 


>  <CYP2C9>  (513) 


>  <CYP2C19>  (513) 


>  <CYP2D6>  (513) 


>  <CYP2E1>  (513) 


>  <CYP3A4>  (513) 
<9,H;Hydroxylation;R1>
<18,H;Hydroxylation;R2>

>  <References>  (513) 
Miller KK, Cai J, Ripp SL, Pierce WM Jr, Rushmore TH, Prough RA: Stereo- and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450. Drug Metab Dispos. 2004 Mar;32(3):305-13. doi: 10.1124/dmd.32.3.305. (PMID: 14977864)

>  <Comments>  (513) 


$$$$
CC02382
     RDKit          3D

 54 61  0  0  0  0  0  0  0  0999 V2000
   -1.6200    0.9950   -0.2020 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.4790   -0.5050   -0.2800 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.2790    1.7350   -0.0520 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.4220    1.4510    1.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2860    1.4660   -1.3750 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6410   -1.0560    0.8730 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.8560   -1.1730   -0.2770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7090    3.1390    0.4500 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.5620    1.1090    1.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4820    1.8080   -1.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0610    2.9490    1.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4760   -2.5680    0.7090 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.7380   -0.3900    0.8320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6900   -2.6850   -0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8660    4.0800   -0.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8520   -3.2360    0.7120 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.3620   -3.1190    1.8640 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2300   -2.8630   -0.6160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8940    3.9810   -1.8200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1290    5.1590   -0.9690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5580   -2.9460    2.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3440   -2.8290    3.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6440    5.1090   -2.7040 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6040    5.7990   -2.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7200   -3.4990    3.1930 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.1310    6.8060   -2.6880 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5630   -4.9100    3.0350 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4450   -5.4620    4.3480 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.3990   -6.9890    4.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2510   -4.9790    4.9610 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3070   -7.5720    5.6710 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.2620   -5.4040    6.3220 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.1180   -6.9260    6.3910 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.5120   -7.2900    6.3850 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9020   -4.7490    7.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1040   -7.3430    7.7580 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7630   -8.4760    7.8350 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.0790   -8.7770    9.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1240   -9.6030    7.2370 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0360   -9.9720    9.3720 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.0820  -10.6570    7.1710 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.4240  -11.1360    8.5840 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.2940   -9.6130    8.7980 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5030  -11.8220    6.3650 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3650  -12.2100    8.5100 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0880  -13.0780    9.6110 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.2300  -14.0860    9.7630 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8630  -13.7680    9.3740 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9400  -14.9900   10.9670 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.5320  -14.4800   10.5650 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.5460  -15.6030   10.7950 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.9180  -16.0300   11.0310 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5570  -13.5200   11.7560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5470  -16.4850    9.6710 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  6
  2  6  1  0
  2  7  1  1
  3  8  1  0
  3  9  1  0
  3 10  1  6
  4 11  1  0
  6 12  1  0
  6 13  1  6
  7 14  1  0
  8 11  1  0
  8 15  1  6
  9 13  1  0
 12 16  1  0
 12 17  1  0
 12 18  1  6
 16 14  1  6
 15 19  1  0
 15 20  2  0
 16 21  1  0
 17 22  1  0
 19 23  1  0
 20 24  1  0
 21 25  1  0
 22 25  1  0
 23 24  1  0
 24 26  2  0
 25 27  1  6
 28 27  1  6
 28 29  1  0
 28 30  1  0
 29 31  1  0
 30 32  1  0
 31 33  1  0
 31 34  1  1
 32 33  1  0
 32 35  1  1
 33 36  1  1
 37 36  1  1
 37 38  1  0
 37 39  1  0
 38 40  1  0
 39 41  1  0
 40 42  1  0
 40 43  1  6
 41 42  1  0
 41 44  1  6
 42 45  1  6
 46 45  1  6
 46 47  1  0
 46 48  1  0
 47 49  1  0
 48 50  1  0
 49 51  1  0
 49 52  1  6
 50 51  1  0
 50 53  1  1
 51 54  1  6
M  END
>  <Name>  (514) 
Digitoxin

>  <InChIKey>  (514) 
WDJUZGPOPHTGOT-UWWSFERISA-N

>  <PubChem_CID>  (514) 


>  <CYP1A2>  (514) 


>  <CYP2A6>  (514) 


>  <CYP2B6>  (514) 


>  <CYP2C8>  (514) 


>  <CYP2C9>  (514) 


>  <CYP2C19>  (514) 


>  <CYP2D6>  (514) 


>  <CYP2E1>  (514) 


>  <CYP3A4>  (514) 
<3,4;Cleavage;R1>
<3,H;Oxidation;R1>

>  <References>  (514) 
Eberhart DC, Gemzik B, Halvorson MR, Parkinson A: Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin. Mol Pharmacol. 1991 Nov;40(5):859-67. (PMID: 1944247)

>  <Comments>  (514) 


$$$$
CC02383
     RDKit          3D

 25 26  0  0  0  0  0  0  0  0999 V2000
    2.4540   -1.6300   -1.3280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9810   -0.7570   -0.1870 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5060   -0.8630   -0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5960    0.6410   -0.4230 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1650    0.7440   -0.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3480    0.1300   -1.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0490   -0.2290   -0.7380 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.9080   -0.6730   -1.8950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5450   -1.7420   -2.6310 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9240   -0.0680   -2.1630 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6710    0.9790   -0.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9840    2.0910   -0.8450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5540    3.1990   -0.2470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8120    3.1950    1.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4990    2.0830    1.8710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9350    0.9730    1.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9450   -1.3460    0.2680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0750   -1.7600    0.9480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9680   -2.7880    1.8720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7240   -3.3640    2.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3620   -2.8970    1.3600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2220   -1.9200    0.4860 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3060    1.4490    0.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4590    2.1960   -0.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3390    2.4580    1.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  4 23  1  0
  5  6  1  0
  7  6  1  6
  7  8  1  0
  7 11  1  0
  7 17  1  0
  8  9  1  0
  8 10  2  0
 11 12  2  0
 11 16  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 17 18  2  0
 17 22  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 23 24  1  0
 23 25  1  0
M  END
>  <Name>  (515) 
Disopyramide

>  <InChIKey>  (515) 
UVTNFZQICZKOEM-NRFANRHFSA-N

>  <PubChem_CID>  (515) 
156295

>  <CYP1A2>  (515) 


>  <CYP2A6>  (515) 


>  <CYP2B6>  (515) 


>  <CYP2C8>  (515) 


>  <CYP2C9>  (515) 


>  <CYP2C19>  (515) 


>  <CYP2D6>  (515) 


>  <CYP2E1>  (515) 


>  <CYP3A4>  (515) 
<1,3;Cleavage;R1>
<1,H;Oxidation;R1>
<3,22;Cleavage;R2>
<22,H;Oxidation;R2>

>  <References>  (515) 
Echizen H, Tanizaki M, Tatsuno J, Chiba K, Berwick T, Tani M, Gonzalez FJ, Ishizaki T: Identification of CYP3A4 as the enzyme involved in the mono-N-dealkylation of disopyramide enantiomers in humans. Drug Metab Dispos. 2000 Aug;28(8):937-44. (PMID: 10901704)

>  <Comments>  (515) 


$$$$
CC02384
     RDKit          3D

 58 63  0  0  0  0  0  0  0  0999 V2000
    1.2890    0.7440    0.7980 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.0370   -0.7410    0.6270 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.7180    1.2700    0.8660 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.1610    1.5250   -0.5280 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4660    1.3060    1.8600 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3010   -1.0010   -0.0690 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.1940   -1.6100    0.2600 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.5310    1.9330   -0.3840 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8030    0.2050    0.8840 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5530    2.6120    2.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2860   -1.7690    0.8360 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.9520    0.2940   -0.3420 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4590   -0.8520   -0.1550 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.5820   -2.6240    1.3050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9040   -2.3960   -1.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2990    3.1930    3.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3140    3.3210    1.5440 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8800   -3.2060    1.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5710   -1.0140    2.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5300   -1.8320    0.1140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7650    0.4280   -1.4080 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2530   -0.2690   -1.4360 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6620   -3.7740    1.6540 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.6620   -2.5180    1.8710 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3280   -3.1690    1.9840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0270   -3.9220    1.8510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7070   -3.9460   -0.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0330   -1.6760    3.3760 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.4170    1.7250   -1.6810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9630   -0.5180   -2.1430 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6580   -4.7890    0.6610 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2200   -2.4800    3.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7110   -0.6300    4.3480 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2610    1.8660   -2.7850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1970    2.8130   -0.8350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3450   -2.4380    4.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8000   -0.8840    5.6620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8670    3.0800   -3.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8090    4.0210   -1.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4680    0.1930    6.6630 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.1460   -1.9770    6.0440 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6400    4.1560   -2.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4790    1.3340    6.5370 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.5250   -0.3500    7.9840 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1480    2.4120    7.5370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8270    0.8240    6.7980 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4640    3.5430    7.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5320    2.2700    8.8580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8990    1.4550    6.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1600    4.5310    8.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2280    3.2580    9.7750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1380    0.9860    6.5190 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7470    2.4480    5.5950 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5400    4.3880    9.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2930    1.6670    5.9600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1900    1.6760    4.4330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5690    0.9350    6.3810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3360    3.1060    6.4770 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  1
  2  6  1  6
  2  7  1  0
  3  8  1  0
  3  9  1  6
  4  8  1  0
  5 10  1  0
  6 11  1  0
  6 12  1  1
  7 13  1  0
  7 14  1  0
  7 15  1  6
  9 13  1  0
 10 16  1  0
 10 17  2  0
 11 18  1  0
 11 19  1  0
 11 20  1  6
 12 21  1  0
 13 22  1  6
 14 23  1  0
 14 24  2  0
 18 25  1  0
 18 26  1  0
 18 27  1  0
 19 28  1  0
 21 29  1  0
 21 30  2  0
 23 25  1  0
 23 31  1  6
 25 32  2  0
 28 32  1  0
 28 33  1  1
 29 34  2  0
 29 35  1  0
 32 36  1  0
 33 37  1  0
 34 38  1  0
 35 39  2  0
 37 40  1  0
 37 41  2  0
 38 42  2  0
 39 42  1  0
 40 43  1  0
 40 44  1  1
 43 45  1  0
 43 46  1  1
 45 47  2  0
 45 48  1  0
 46 49  1  0
 47 50  1  0
 48 51  2  0
 49 52  1  0
 49 53  2  0
 50 54  2  0
 51 54  1  0
 52 55  1  0
 55 56  1  0
 55 57  1  0
 55 58  1  0
M  END
>  <Name>  (516) 
Docetaxel

>  <InChIKey>  (516) 
ZDZOTLJHXYCWBA-VCVYQWHSSA-N

>  <PubChem_CID>  (516) 
148124

>  <CYP1A2>  (516) 


>  <CYP2A6>  (516) 


>  <CYP2B6>  (516) 


>  <CYP2C8>  (516) 


>  <CYP2C9>  (516) 


>  <CYP2C19>  (516) 


>  <CYP2D6>  (516) 


>  <CYP2E1>  (516) 


>  <CYP3A4>  (516) 
<32,H;Hydroxylation;R1>
<33,H;Hydroxylation;R2>
<34,H;Hydroxylation;R3>

>  <References>  (516) 
Cresteil T, Monsarrat B, Dubois J, Sonnier M, Alvinerie P, Gueritte F: Regioselective metabolism of taxoids by human CYP3A4 and 2C8: structure-activity relationship. Drug Metab Dispos. 2002 Apr;30(4):438-45. doi: 10.1124/dmd.30.4.438. (PMID: 11901098)

>  <Comments>  (516) 


$$$$
CC02385
     RDKit          3D

 29 32  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3730    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3220    1.8060   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0380    2.3160    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1860   -0.8620    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2950   -0.4520   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1400    0.5910   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6120    3.1710    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7290    3.6590    0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1910   -1.7400   -1.2460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1600   -1.7640    1.2470 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5930    4.0820    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8380    4.6800    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3710   -2.7120   -1.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3410   -2.7340    1.1870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1880    5.0120    1.4810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2270   -3.5820   -0.0040 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1590    5.9080    1.7460 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5950    4.4730    2.3920 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3920   -4.4770    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4990    6.2310    3.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1870   -5.5740    1.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3820   -6.4920    1.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4520   -7.5450    0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4070   -6.2870    1.9600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5500   -8.3880    0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4480   -7.7500   -0.7230 F   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5030   -7.1290    1.9660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5760   -8.1770    1.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6  7  2  0
  8 12  1  0
  9 12  2  0
  9 13  1  0
 10 14  1  0
 11 15  1  0
 13 16  1  0
 14 17  1  0
 15 17  1  0
 16 18  1  0
 16 19  2  0
 17 20  1  0
 18 21  1  0
 20 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 24 26  1  0
 24 27  1  0
 25 28  2  0
 26 29  2  0
 28 29  1  0
M  END
>  <Name>  (517) 
E-2101

>  <InChIKey>  (517) 
CQEOXWCXSBFJMB-UHFFFAOYSA-N

>  <PubChem_CID>  (517) 
9908587

>  <CYP1A2>  (517) 


>  <CYP2A6>  (517) 


>  <CYP2B6>  (517) 


>  <CYP2C8>  (517) 


>  <CYP2C9>  (517) 


>  <CYP2C19>  (517) 
<17,H;Hydroxylation;R1>
<7,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<15,16;Cleavage;R4>
<16,H;Oxidation;R4>

>  <CYP2D6>  (517) 
<7,H;Hydroxylation;R1>
<6,H;Hydroxylation;R1>

>  <CYP2E1>  (517) 


>  <CYP3A4>  (517) 
<17,H;Hydroxylation;R1>
<7,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<15,16;Cleavage;R4>
<16,H;Oxidation;R4>

>  <References>  (517) 
Zhang ZY, King BM, Mollova NN, Wong YN: In vitro interactions between a potential muscle relaxant E2101 and human cytochromes P450. Drug Metab Dispos. 2002 Jul;30(7):805-13. doi: 10.1124/dmd.30.7.805. (PMID: 12065439)

>  <Comments>  (517) 
M3 is considered to be a metabolite of M2. CYP2C19 and 2D6 also metabolize it but Xenosite did not make note of this.

$$$$
CC02387
     RDKit          3D

 27 28  0  0  0  0  0  0  0  0999 V2000
    3.2080    2.2010   -0.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9630    1.5260   -0.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4070    1.4760   -0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3600    3.5410   -0.2030 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9850    0.1180   -0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7280    2.1080   -0.1620 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4050    0.0790   -0.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6450    4.1650   -0.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1880   -0.6030   -0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3600    3.4960   -0.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1750   -2.1130   -0.0930 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8140   -2.6530   -0.5620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5660   -3.9090    0.1610 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3690   -4.3260    0.5760 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0680   -5.6100    1.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5950   -3.5590    0.3710 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6260   -6.8510    0.7530 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4300   -7.9610    1.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0630   -9.1800    1.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4410   -7.8620    2.5580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8180  -10.2830    2.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6900   -8.9680    3.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0640  -10.1820    3.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4640  -11.5370    1.7980 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3220  -11.7450    0.8090 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2150  -12.4750    2.5820 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9570  -13.0670    0.6720 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  4  8  1  0
  5  9  2  0
  6 10  1  0
  7  9  1  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 19 21  1  0
 20 22  2  0
 21 23  2  0
 21 24  1  0
 22 23  1  0
 24 25  1  0
 24 26  2  0
 25 27  1  0
M  END
>  <Name>  (518) 
Ecabapide

>  <InChIKey>  (518) 
JTAGHJPZEDNHHA-UHFFFAOYSA-N

>  <PubChem_CID>  (518) 
65885

>  <CYP1A2>  (518) 


>  <CYP2A6>  (518) 


>  <CYP2B6>  (518) 


>  <CYP2C8>  (518) 


>  <CYP2C9>  (518) 


>  <CYP2C19>  (518) 


>  <CYP2D6>  (518) 


>  <CYP2E1>  (518) 


>  <CYP3A4>  (518) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>
<5,H;Hydroxylation;R2>

>  <References>  (518) 
Fujimaki Y, Arai N, Inaba T: Identification of cytochromes P450 involved in human liver microsomal metabolism of ecabapide, a prokinetic agent. Xenobiotica. 1999 Dec;29(12):1273-82. doi: 10.1080/004982599237930. (PMID: 10647912)

>  <Comments>  (518) 


$$$$
CC02388
     RDKit          3D

 30 35  0  0  0  0  0  0  0  0999 V2000
    0.0110    1.5140    0.0050 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.0120   -0.0190   -0.0040 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.3180    2.2790   -0.0100 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.2340    2.1240    0.6660 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.4780    2.1840   -1.1700 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3220   -0.4970   -0.6040 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.1960   -0.5020   -0.8030 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.6590    1.5380   -0.1190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4470    1.4750    0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2050    3.6330    0.5070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2000    1.8060    2.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4540    0.0880    0.2920 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.5370   -2.0140   -0.4510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4720   -0.0330   -0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1480    0.0780   -2.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5160    2.1620   -0.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5800    4.2470    0.7740 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6490   -0.8120   -0.0060 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.0700   -0.0110    1.7690 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0790   -2.1670   -0.4590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4220   -0.5260   -3.1470 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7620    1.0860   -2.4490 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5530    3.6220   -0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5250   -0.2090   -1.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4940   -0.9750    1.1600 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3740    0.0320   -4.4860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3280    4.2980   -0.8490 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9090   -0.0890   -0.4350 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7860   -0.9910    0.7800 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6810   -1.6080    1.3080 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  6
  2  6  1  0
  2  7  1  6
  3  5  1  0
  3  8  1  6
  4  9  1  0
  4 10  1  0
  4 11  1  1
  6 12  1  0
  6 13  1  1
  7 14  1  0
  7 15  1  6
  8 12  1  0
  9 14  1  0
  9 16  2  0
 10 17  1  0
 12 18  1  0
 12 19  1  1
 13 20  1  0
 15 21  1  0
 15 22  2  0
 16 23  1  0
 17 23  1  0
 18 20  1  6
 18 24  1  0
 18 25  1  0
 21 26  1  0
 23 27  2  0
 24 28  1  0
 25 29  1  0
 28 29  1  0
 29 30  2  0
M  END
>  <Name>  (519) 
Eplerenone

>  <InChIKey>  (519) 
JUKPWJGBANNWMW-VWBFHTRKSA-N

>  <PubChem_CID>  (519) 
443872

>  <CYP1A2>  (519) 


>  <CYP2A6>  (519) 


>  <CYP2B6>  (519) 


>  <CYP2C8>  (519) 


>  <CYP2C9>  (519) 


>  <CYP2C19>  (519) 


>  <CYP2D6>  (519) 


>  <CYP2E1>  (519) 


>  <CYP3A4>  (519) 
<5,H;Hydroxylation;R1>
<25,H;Hydroxylation;R2>

>  <References>  (519) 
Cook CS, Berry LM, Kim DH, Burton EG, Hribar JD, Zhang L: Involvement of CYP3A in the metabolism of eplerenone in humans and dogs: differential metabolism by CYP3A4 and CYP3A5. Drug Metab Dispos. 2002 Dec;30(12):1344-51. doi: 10.1124/dmd.30.12.1344. (PMID: 12433801)

>  <Comments>  (519) 


$$$$
CC02389
     RDKit          3D

 49 51  0  0  0  0  0  0  0  0999 V2000
    4.4320   -0.7040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4280   -0.4190   -1.4970 C   0  0  1  0  0  0  0  0  0  0  0  0
    4.0930    0.5160    0.8600 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.3410    0.0450    2.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0250   -0.2720   -2.0550 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.7000    1.0110   -2.7810 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.3970    1.1340    2.6460 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.9690    0.7410    2.3130 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.1900    1.1970   -3.0180 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.6630    2.1000   -2.0760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1180    1.7710    2.4450 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.0010    1.9320    1.2240 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.2920    1.5620   -1.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4390    2.5650   -0.0210 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.8760    3.3110    0.1380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8670    0.9510    0.2880 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.6800    1.6460    1.2180 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9300    0.1150    1.0280 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3990    1.1790    1.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0930   -0.5200   -0.9940 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7670    2.3930    2.1060 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5890    1.1500    4.1730 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2450    3.0860    3.1080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6000    0.6650    0.8980 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4110    0.6770   -1.8590 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3560    1.0310   -4.1730 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1360    2.1630   -2.0500 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4460   -0.1130   -3.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5380   -0.3730   -0.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8730   -0.0930   -0.7750 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.2760   -0.4440   -4.6450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7090    0.8840    0.0430 C   0  0  2  0  0  0  0  0  0  0  0  0
   -4.9150    2.0250    0.6520 C   0  0  2  0  0  0  0  0  0  0  0  0
   -4.7470    3.1780   -0.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3780    0.1630    1.0900 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5960   -1.3360   -0.8740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6430    0.4310   -2.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8770   -1.0260   -1.4250 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2840   -1.1480    1.2030 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.5140   -2.0130   -0.0380 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.8220   -1.8000    2.3520 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0330   -2.9630    2.5960 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.2110   -3.3510    0.1460 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.2410   -3.9770    1.4690 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4530   -3.5920    3.9270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0010   -1.3420   -1.1900 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1240   -4.2500   -0.9670 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5560   -4.5540   -0.8480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5970   -5.5070   -0.7260 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  5  1  0
  2 25  1  1
  3  4  1  0
  3 19  1  1
  4  7  1  0
  5  6  1  0
  5 20  1  1
  6  9  1  0
  6 26  1  6
  6 27  1  0
  7  8  1  0
  7 21  1  0
  7 22  1  1
  8 11  1  0
  8 18  1  6
  9 10  1  0
  9 28  1  1
 10 13  1  0
 11 12  1  0
 11 23  1  6
 12 14  1  0
 12 24  1  6
 13 14  1  0
 14 15  1  1
 16 17  1  0
 16 24  1  1
 16 29  1  0
 17 33  1  0
 39 18  1  6
 28 31  1  0
 29 30  1  0
 30 32  1  0
 30 36  1  0
 30 37  1  6
 32 33  1  0
 32 35  1  1
 33 34  1  6
 36 38  1  0
 39 40  1  0
 39 41  1  0
 40 43  1  0
 40 46  1  6
 41 42  1  0
 42 44  1  0
 42 45  1  1
 43 44  1  0
 43 47  1  6
 47 48  1  0
 47 49  1  0
M  END
>  <Name>  (520) 
Erythromycin

>  <InChIKey>  (520) 
PGRWHWPTHNFQEN-LQDUVHJKSA-N

>  <PubChem_CID>  (520) 


>  <CYP1A2>  (520) 


>  <CYP2A6>  (520) 


>  <CYP2B6>  (520) 


>  <CYP2C8>  (520) 


>  <CYP2C9>  (520) 


>  <CYP2C19>  (520) 


>  <CYP2D6>  (520) 


>  <CYP2E1>  (520) 


>  <CYP3A4>  (520) 
<30,31;Cleavage;R1>
<31,H;Oxidation;R1>
<30,32;Cleavage;R2>
<32,H;Oxidation;R2>

>  <References>  (520) 
Wang RW, Newton DJ, Scheri TD, Lu AY: Human cytochrome P450 3A4-catalyzed testosterone 6 beta-hydroxylation and erythromycin N-demethylation. Competition during catalysis. Drug Metab Dispos. 1997 Apr;25(4):502-7. (PMID: 9107550)

>  <Comments>  (520) 


$$$$
CC02390
     RDKit          3D

 21 24  0  0  1  0  0  0  0  0999 V2000
   -0.0160    1.3930    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1590    2.1450    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2310    2.0690    0.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2390   -0.7860   -0.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2140   -0.6980    0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3120    1.8270    0.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3850    3.3350   -0.6140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4190    1.3710    0.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1870   -1.9700   -0.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3650   -0.5700    0.4860 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4080   -0.0140    0.1250 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5550    0.5520    1.4110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1500    2.8030    0.4440 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6040    3.6960   -0.3060 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2670   -2.0180   -2.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0610   -3.0370   -0.7880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9040   -0.8900    0.2160 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.2230   -3.1230   -2.8630 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0080   -4.1370   -1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0890   -4.1820   -2.6540 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  2  0
  6 12  1  0
  7 13  1  0
  7 14  2  0
  8 15  2  0
  9 12  2  0
 10 16  2  0
 10 17  1  0
 11 13  1  0
 12 18  1  0
 14 15  1  0
 16 19  1  0
 17 20  2  0
 19 21  2  0
 20 21  1  0
M  END
>  <Name>  (521) 
Estazolam

>  <InChIKey>  (521) 
CDCHDCWJMGXXRH-UHFFFAOYSA-N

>  <PubChem_CID>  (521) 
3261

>  <CYP1A2>  (521) 


>  <CYP2A6>  (521) 


>  <CYP2B6>  (521) 


>  <CYP2C8>  (521) 


>  <CYP2C9>  (521) 


>  <CYP2C19>  (521) 


>  <CYP2D6>  (521) 


>  <CYP2E1>  (521) 


>  <CYP3A4>  (521) 
<15,H;Hydroxylation;R1>

>  <References>  (521) 
Miura M, Otani K, Ohkubo T: Identification of human cytochrome P450 enzymes involved in the formation of 4-hydroxyestazolam from estazolam. Xenobiotica. 2005 May;35(5):455-65. doi: 10.1080/00498250500111612. (PMID: 16012077)

>  <Comments>  (521) 


$$$$
CC02391
     RDKit          3D

 24 25  0  0  0  0  0  0  0  0999 V2000
   -0.8650    0.1280   -0.1910 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9690    1.4770   -0.1110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1000   -0.7520    0.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7940   -0.5950   -0.7790 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1420    2.3450   -0.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2130    2.1270    0.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2220   -2.0520   -0.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1580   -0.5000    1.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4540   -1.9120   -0.8200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0270    3.7360   -0.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7240    1.8850   -0.7660 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.3070    3.5240    0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7370    1.3810    0.3690 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.7140   -3.5340    0.0730 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3030   -2.9280   -1.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1920    4.3490    0.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3440   -3.4520    0.8670 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2380   -4.8220   -0.4050 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0300   -3.5930   -2.0140 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2910    5.8530    0.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4190   -3.2610   -0.2180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5090    6.3850   -1.0570 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3280    6.1840    1.0160 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1200    6.3490    0.6970 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  6 13  1  0
  7  9  1  0
  7 14  1  0
  9 15  1  0
 10 16  2  0
 12 16  1  0
 14 17  1  6
 14 18  2  0
 15 19  3  0
 16 20  1  0
 17 21  1  0
 20 22  1  0
 20 23  1  0
 20 24  1  0
M  END
>  <Name>  (522) 
Ethiprole

>  <InChIKey>  (522) 
FNELVJVBIYMIMC-UHFFFAOYSA-N

>  <PubChem_CID>  (522) 
9930667

>  <CYP1A2>  (522) 


>  <CYP2A6>  (522) 


>  <CYP2B6>  (522) 


>  <CYP2C8>  (522) 


>  <CYP2C9>  (522) 


>  <CYP2C19>  (522) 


>  <CYP2D6>  (522) 


>  <CYP2E1>  (522) 


>  <CYP3A4>  (522) 
<2,S;S-Oxidation;R1>

>  <References>  (522) 
Caboni P, Sammelson RE, Casida JE: Phenylpyrazole insecticide photochemistry, metabolism, and GABAergic action: ethiprole compared with fipronil. J Agric Food Chem. 2003 Nov 19;51(24):7055-61. doi: 10.1021/jf030439l. (PMID: 14611171)

>  <Comments>  (522) 
Xenosite reports 18 as SoM but it cannot be identified.

$$$$
CC02392
     RDKit          3D

 26 28  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3690    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2570    1.8110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2160    2.2110    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2320   -0.4050   -0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2110   -0.8980    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0600    0.7260   -0.0140 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6170    2.9740    0.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6260    2.4960    1.4660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7670   -2.3620   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5250    0.7300   -0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0480    0.7240    1.4100 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5780    0.7280    1.3960 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0810    0.7220    2.7770 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5260    0.9700    2.7010 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9090   -0.6460    3.2820 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1410    0.8560    4.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5250   -0.7600    4.6770 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9700   -0.5110    4.6010 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4470   -0.5180    5.9140 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4160   -1.6880    6.6600 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9600    0.6460    6.4730 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8900   -1.6910    7.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4330    0.6370    7.7710 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3950   -0.5280    8.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8510   -3.1530    8.8930 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  1  0
  5  7  1  0
  6 10  1  0
  7 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 15 17  1  0
 16 18  1  0
 17 19  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 21 23  1  0
 22 24  2  0
 23 25  2  0
 23 26  1  0
 24 25  1  0
M  END
>  <Name>  (523) 
Etoperidone

>  <InChIKey>  (523) 
IZBNNCFOBMGTQX-UHFFFAOYSA-N

>  <PubChem_CID>  (523) 
40589

>  <CYP1A2>  (523) 


>  <CYP2A6>  (523) 


>  <CYP2B6>  (523) 


>  <CYP2C8>  (523) 


>  <CYP2C9>  (523) 


>  <CYP2C19>  (523) 


>  <CYP2D6>  (523) 


>  <CYP2E1>  (523) 


>  <CYP3A4>  (523) 
<7,8;Cleavage;R1>
<7,H;Oxidation;R1>
<15,H;Hydroxylation;R2>
<1,H;Hydroxylation;R3>

>  <References>  (523) 
Yan Z, Caldwell GW, Wu WN, McKown LA, Rafferty B, Jones W, Masucci JA: In vitro identification of metabolic pathways and cytochrome P450 enzymes involved in the metabolism of etoperidone. Xenobiotica. 2002 Nov;32(11):949-62. doi: 10.1080/00498250210163298. (PMID: 12487725)

>  <Comments>  (523) 


$$$$
CC02393
     RDKit          3D

 24 26  0  0  0  0  0  0  0  0999 V2000
    3.5960   -0.8410   -0.0340 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2780   -0.6940   -0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7070    0.5880    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5500    1.7010    0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9200    1.4900    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4100    0.1940   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2350    0.7580    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4030   -1.8890   -0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5350    0.1490    1.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9050    0.3100    1.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5160    1.0750    0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7580    1.6830   -0.9560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3860    1.5330   -0.9650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2900   -1.9340   -0.8930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4880   -2.9960   -0.9180 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2530   -4.0500   -0.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8310   -4.0830    0.6990 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6820   -2.9930    0.7570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1790   -5.2360   -0.2330 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0130    2.8380    0.0510 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -4.2660    1.2770    0.0380 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5070    2.7580    1.0560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5620    1.5270   -1.3290 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7150    0.1050    0.7050 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  2  8  1  0
  3  4  2  0
  3  7  1  0
  4  5  1  0
  5  6  2  0
  5 20  1  0
  7  9  2  0
  7 13  1  0
  8 14  2  0
  8 18  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 21  1  0
 12 13  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 19  1  0
 17 18  2  0
 21 22  1  0
 21 23  2  0
 21 24  2  0
M  END
>  <Name>  (524) 
Etoricoxib

>  <InChIKey>  (524) 
MNJVRJDLRVPLFE-UHFFFAOYSA-N

>  <PubChem_CID>  (524) 
123619

>  <CYP1A2>  (524) 


>  <CYP2A6>  (524) 


>  <CYP2B6>  (524) 


>  <CYP2C8>  (524) 


>  <CYP2C9>  (524) 


>  <CYP2C19>  (524) 


>  <CYP2D6>  (524) 


>  <CYP2E1>  (524) 


>  <CYP3A4>  (524) 
<0,H;Hydroxylation;R1>

>  <References>  (524) 
Kassahun K, McIntosh IS, Shou M, Walsh DJ, Rodeheffer C, Slaughter DE, Geer LA, Halpin RA, Agrawal N, Rodrigues AD: Role of human liver cytochrome P4503A in the metabolism of etoricoxib, a novel cyclooxygenase-2 selective inhibitor. Drug Metab Dispos. 2001 Jun;29(6):813-20. (PMID: 11353749)

>  <Comments>  (524) 


$$$$
CC02394
     RDKit          3D

 68 71  0  0  1  0  0  0  0  0999 V2000
   -0.8890    1.6070   -0.3290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2040    0.1700   -0.2890 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.3690    2.0310   -0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9960    2.5720   -0.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8880   -0.2500   -1.5640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1030   -0.1110    0.9110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9300    3.3100   -0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1460    1.2540   -0.9590 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8640    2.2610    0.9630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4370   -1.3330   -2.2280 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8300    0.3760   -1.9880 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3280    0.8020    0.8740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3100    4.4660   -0.8920 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.1070    3.4520    1.1610 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0510   -1.7500   -3.4790 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.7140    4.4890   -1.1390 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8940    5.7640   -0.1850 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.6130    4.3760   -2.1390 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0320   -2.8930   -3.2100 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.9590   -2.2280   -4.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9710    5.5070   -2.0970 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.2040    6.9510   -1.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6050    5.7270    0.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0710   -2.4420   -2.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7380   -3.2760   -4.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1440   -3.6960   -4.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4300    5.4790   -2.5570 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6910    6.8820   -1.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9590   -3.6280   -1.7990 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.0140   -4.2160   -6.1440 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.3980   -4.4600   -3.8340 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8160    4.0910   -3.0450 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.1210   -4.6780   -1.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0870   -3.1470   -0.8850 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4420   -4.2860   -6.5250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6320   -5.6120   -6.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0560    4.0990   -4.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0090    3.6720   -2.3780 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0090   -5.8640   -0.6850 C   0  0  2  0  0  0  0  0  0  0  0  0
   -6.9750   -4.3330   -0.5030 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7880   -4.3170   -7.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7040    3.0700   -5.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5740    5.2420   -5.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6000    2.9040   -1.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1370   -5.3830    0.2290 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.2260   -6.8440    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2460   -4.3800   -8.1710 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.2680   -4.2720   -8.8620 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9400    2.9280   -6.5080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9660   -6.4910    0.5860 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7090   -7.7290   -0.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6130   -3.1150   -8.9460 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.4750   -5.5270   -8.9920 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3770    1.7230   -6.9190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4970   -6.2090    1.8820 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1010   -3.0540   -9.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1990   -1.9680   -8.2020 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5300    1.3310   -8.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3990   -7.3630    2.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6870   -1.9740  -10.0380 C   0  0  1  0  0  0  0  0  0  0  0  0
    4.8240   -3.8720   -8.6520 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6900   -1.0240   -9.1470 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6220    0.0180   -8.5530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6140   -8.5460    2.4870 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2090   -1.9820   -9.9490 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2650   -2.2100  -11.4900 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7400   -0.5410   -9.9400 C   0  0  2  0  0  0  0  0  0  0  0  0
    8.2080   -0.5340  -10.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  1
  3  7  1  0
  3  8  2  0
  4  9  1  0
  5 10  1  0
  5 11  2  0
  6 12  1  0
  7 13  1  0
  7 14  2  0
  9 12  1  0
 10 15  1  0
 13 16  1  0
 13 17  1  0
 13 18  1  6
 15 19  1  0
 15 20  1  6
 16 21  1  0
 17 22  1  0
 17 23  1  6
 19 24  1  0
 19 25  1  6
 20 26  1  0
 21 27  1  1
 21 28  1  0
 22 28  1  0
 29 24  1  1
 26 30  1  0
 26 31  2  0
 27 32  1  0
 29 33  1  0
 29 34  1  0
 30 35  1  0
 30 36  1  1
 32 37  1  0
 32 38  1  1
 33 39  1  0
 34 40  1  0
 35 41  2  0
 37 42  2  0
 37 43  1  0
 38 44  1  0
 39 45  1  0
 39 46  1  1
 40 45  1  0
 41 47  1  0
 41 48  1  0
 42 49  1  0
 45 50  1  6
 46 51  1  0
 47 52  1  0
 47 53  1  6
 49 54  2  0
 50 55  1  0
 52 56  1  0
 52 57  1  1
 54 58  1  0
 55 59  1  0
 56 60  1  0
 56 61  2  0
 57 62  1  0
 58 63  2  0
 59 64  1  0
 60 65  1  0
 60 66  1  6
 63 67  1  0
 65 67  1  0
 67 68  1  1
M  END
>  <Name>  (525) 
Everolimus

>  <InChIKey>  (525) 
HKVAMNSJSFKALM-GKUWKFKPSA-N

>  <PubChem_CID>  (525) 
6442177

>  <CYP1A2>  (525) 


>  <CYP2A6>  (525) 


>  <CYP2B6>  (525) 


>  <CYP2C8>  (525) 


>  <CYP2C9>  (525) 


>  <CYP2C19>  (525) 


>  <CYP2D6>  (525) 


>  <CYP2E1>  (525) 


>  <CYP3A4>  (525) 
<38,39;Cleavage;R1>
<39,H;Oxidation;R1>
<33,34;Cleavage;R2>
<34,H;Oxidation;R2>

>  <References>  (525) 
Kuhn B, Jacobsen W, Christians U, Benet LZ, Kollman PA: Metabolism of sirolimus and its derivative everolimus by cytochrome P450 3A4: insights from docking, molecular dynamics, and quantum chemical calculations. J Med Chem. 2001 Jun 7;44(12):2027-34. doi: 10.1021/jm010079y. (PMID: 11384247)

>  <Comments>  (525) 
Xenosite also reports 67, 60, 22, and 17 as SoMs but cannot be identified.

$$$$
CC02396
     RDKit          3D

 27 30  0  0  0  0  0  0  0  0999 V2000
   -4.8210   -1.9590    0.6540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6630   -1.0750   -0.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2700    0.1990   -0.3960 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9960    0.6630    0.1490 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.9680   -0.4690    0.0820 C   0  0  2  0  0  0  0  0  0  0  0  0
   -3.5220   -1.6800    0.7850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4610    1.8520   -0.6460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1470    2.3250   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1260    1.1870   -0.0300 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.6710   -0.0050    0.7410 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.1670    1.6240    0.6320 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.1720    0.4510    0.4810 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.6940   -0.6750    1.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6590   -1.1440    0.7740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9080    2.7810   -0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3690    2.5950    0.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5100    1.0870    0.8420 C   0  0  2  0  0  0  0  0  0  0  0  0
   -6.7030   -1.4880   -0.6490 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6950   -0.8200   -1.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2000   -0.0230   -0.9730 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6250    0.4350    0.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9620    0.8900   -1.0080 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2470   -0.6520    0.5620 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3300   -1.2850   -0.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8600   -2.4900    0.5870 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8010   -1.7510   -1.5520 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4610   -0.2770   -0.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  2  3  1  0
  2 18  2  0
  3  4  1  0
  4  5  1  0
  4  7  1  6
  5  6  1  0
  5 10  1  0
  5 19  1  6
  7  8  1  0
  9  8  1  1
  9 10  1  0
  9 11  1  0
 10 14  1  6
 11 12  1  0
 11 15  1  6
 12 13  1  0
 12 17  1  0
 12 20  1  6
 13 14  1  0
 15 16  1  0
 16 17  1  0
 17 21  1  6
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 24 27  1  0
M  END
>  <Name>  (526) 
Finasteride

>  <InChIKey>  (526) 
DBEPLOCGEIEOCV-WSBQPABSSA-N

>  <PubChem_CID>  (526) 
57363

>  <CYP1A2>  (526) 


>  <CYP2A6>  (526) 


>  <CYP2B6>  (526) 


>  <CYP2C8>  (526) 


>  <CYP2C9>  (526) 


>  <CYP2C19>  (526) 


>  <CYP2D6>  (526) 


>  <CYP2E1>  (526) 


>  <CYP3A4>  (526) 
<0,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>
<3,H;Hydroxyaltion;R3>

>  <References>  (526) 
Guengerich FP: Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol. 1999;39:1-17. doi: 10.1146/annurev.pharmtox.39.1.1. (PMID: 10331074)
Huskey SW, Dean DC, Miller RR, Rasmusson GH, Chiu SH: Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride. Drug Metab Dispos. 1995 Oct;23(10):1126-35. (PMID: 8654202)

>  <Comments>  (526) 


$$$$
CC02397
     RDKit          3D

 57 60  0  0  1  0  0  0  0  0999 V2000
    0.1080    1.9540   -0.1770 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.5820    0.5510   -0.5560 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.2460    2.7880    0.0290 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7200    1.8950    1.1130 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.3630    0.6290   -1.8660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5450   -0.3090   -0.7240 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8950    3.0050   -1.2200 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.5790    3.1570    1.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1630    1.8240    2.2330 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4500    1.7020   -1.7840 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.1160   -1.6260   -0.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0220    3.9910   -1.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9680    3.5660   -2.1550 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4700    3.1120    2.4450 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.0860    0.5720    2.8760 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9860    1.9460   -3.2020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7270    5.3960   -0.6110 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1630    3.6220   -1.1300 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8120    3.7600    2.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7730    3.8310    3.5980 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6470    6.3700   -0.7290 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6290    5.6550   -0.1550 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2270    4.7710    3.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5140    7.6230    0.0200 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.8000    6.1960   -1.6240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7910    6.0000    3.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1600    4.3480    4.2640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1190    8.1770   -0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5090    8.6550   -0.5350 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8710    7.3310   -2.6410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1550    7.0940    4.0240 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.6020    8.8590    0.9330 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4800    8.0160   -1.1110 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4080    8.6590   -2.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9340    8.4330    3.3680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3370    6.9800    5.3080 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2560    9.3960    0.8900 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.6220    9.1620    3.4380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8600    8.9370    2.7620 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7010    5.7050    6.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3260   10.8910    0.7050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4430    9.0780    2.2150 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.9570    9.1920    2.0600 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.7670    4.8440    6.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3090   11.4580   -0.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1280   11.7320    1.6650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0700    7.6560    2.6460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4380    8.1080    1.2660 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1400   12.9340   -0.5490 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.3050   13.1500   -1.9970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4720   13.6490   -0.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4770   14.6470   -2.2600 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.3000   15.1460   -0.5750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8550   15.3620   -2.0230 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.8930   14.8490   -3.6120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6940   16.7610   -2.2680 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6860   16.0370   -3.6270 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  1
  1  4  1  0
  2  5  1  0
  2  6  1  6
  3  7  1  0
  4  8  1  0
  4  9  1  1
  5 10  1  0
  6 11  1  0
  7 10  1  0
  7 12  1  0
  7 13  1  6
  8 14  1  0
  9 15  1  0
 10 16  1  6
 12 17  1  0
 12 18  2  0
 14 19  1  0
 14 20  1  1
 17 21  1  0
 17 22  2  0
 19 23  1  0
 21 24  1  0
 21 25  1  0
 23 26  2  0
 23 27  1  0
 24 28  1  0
 24 29  1  6
 25 30  1  0
 26 31  1  0
 28 32  1  0
 28 33  2  0
 29 34  1  0
 30 34  1  0
 31 35  1  0
 31 36  1  1
 32 37  1  0
 35 38  1  0
 35 39  2  0
 36 40  1  0
 37 41  1  1
 37 42  1  0
 38 43  1  0
 40 44  2  0
 41 45  2  0
 41 46  1  0
 42 43  1  0
 42 47  1  6
 43 48  1  6
 49 45  1  6
 49 50  1  0
 49 51  1  0
 50 52  1  0
 51 53  1  0
 52 54  1  0
 52 55  1  6
 53 54  1  0
 54 56  1  1
 55 57  1  0
M  END
>  <Name>  (527) 
FK-506

>  <InChIKey>  (527) 
QJJXYPPXXYFBGM-LFZNUXCKSA-N

>  <PubChem_CID>  (527) 
445643

>  <CYP1A2>  (527) 


>  <CYP2A6>  (527) 


>  <CYP2B6>  (527) 


>  <CYP2C8>  (527) 


>  <CYP2C9>  (527) 


>  <CYP2C19>  (527) 


>  <CYP2D6>  (527) 


>  <CYP2E1>  (527) 


>  <CYP3A4>  (527) 
<55,56;Cleavage;R1>
<56,H;Oxidation;R1>

>  <References>  (527) 
Vincent SH, Karanam BV, Painter SK, Chiu SH: In vitro metabolism of FK-506 in rat, rabbit, and human liver microsomes: identification of a major metabolite and of cytochrome P450 3A as the major enzymes responsible for its metabolism. Arch Biochem Biophys. 1992 May 1;294(2):454-60. doi: 10.1016/0003-9861(92)90711-5. (PMID: 1373595)

>  <Comments>  (527) 


$$$$
CC02398
     RDKit          2D

 16 17  0  0  0  0  0  0  0  0999 V2000
   -0.4800    0.6970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4800   -0.9440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7840    1.5230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7520    1.5230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7840   -1.7670    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7520   -1.7670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0560    0.6970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7840    3.2860    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0240    0.6970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0560   -0.9440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7840   -3.5340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0240   -0.9440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3280    1.5230    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2920   -1.7670    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.5960    0.6970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3280    3.2860    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  2  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  7 10  2  0
  7 13  1  0
  9 12  1  0
 12 14  1  0
 13 15  1  0
 13 16  2  0
M  END
>  <Name>  (528) 
Flosequinan

>  <InChIKey>  (528) 
UYGONJYYUKVHDD-UHFFFAOYSA-N

>  <PubChem_CID>  (528) 
4474062

>  <CYP1A2>  (528) 


>  <CYP2A6>  (528) 


>  <CYP2B6>  (528) 


>  <CYP2C8>  (528) 


>  <CYP2C9>  (528) 


>  <CYP2C19>  (528) 


>  <CYP2D6>  (528) 


>  <CYP2E1>  (528) 


>  <CYP3A4>  (528) 
<4,S;S-Oxidation;R1>

>  <References>  (528) 
Kashiyama E, Yokoi T, Odomi M, Funae Y, Inoue K, Kamataki T: Cytochrome P450 responsible for the stereoselective S-oxidation of flosequinan in hepatic microsomes from rats and humans. Drug Metab Dispos. 1997 Jun;25(6):716-24. (PMID: 9193873)

>  <Comments>  (528) 
Xenosite reports 13, 16 as SoMs.

$$$$
CC02399
     RDKit          3D

 30 33  0  0  1  0  0  0  0  0999 V2000
    0.6170    2.1950   -0.2770 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8130    0.7500   -0.0680 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.8150    2.9610   -0.6340 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.2660    1.9160   -1.2660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0030    0.4360   -1.3190 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.6280    0.5320   -0.2740 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.0980    2.3060   -0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6840    4.3620   -0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0220    2.6230   -1.8980 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8050    0.0070   -2.4680 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3390    2.6680   -0.8680 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2850    2.6570    1.4290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4510    5.3460   -0.5900 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8900    4.5990    0.7840 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2500   -0.7590   -3.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0560   -1.1900   -4.5830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9160   -1.0930   -3.3420 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3410   -0.4560   -5.8340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7320   -2.3710   -4.7620 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8740    0.9000   -6.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0970   -1.2610   -6.5370 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3120   -2.2990   -5.9620 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8050   -3.5220   -3.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4720    1.2420   -6.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7780    1.8410   -6.7010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9010    2.5080   -6.4210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3540    0.3370   -5.5880 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.3360    3.1030   -7.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4550    1.4290   -6.8740 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    3.4340   -6.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  6
  3  7  1  0
  3  8  1  1
  4  5  1  0
  4  9  2  0
  5 10  1  6
  6  7  1  0
  7 11  1  0
  7 12  1  0
  8 13  1  0
  8 14  2  0
 10 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  1  0
 16 19  2  0
 18 20  1  0
 18 21  2  0
 19 22  1  0
 19 23  1  0
 20 24  2  0
 20 25  1  0
 21 22  1  0
 24 26  1  0
 24 27  1  0
 25 28  2  0
 25 29  1  0
 26 30  2  0
 28 30  1  0
M  END
>  <Name>  (529) 
Flucloxacillin

>  <InChIKey>  (529) 
UIOFUWFRIANQPC-JKIFEVAISA-N

>  <PubChem_CID>  (529) 
21319

>  <CYP1A2>  (529) 


>  <CYP2A6>  (529) 


>  <CYP2B6>  (529) 


>  <CYP2C8>  (529) 


>  <CYP2C9>  (529) 


>  <CYP2C19>  (529) 


>  <CYP2D6>  (529) 


>  <CYP2E1>  (529) 


>  <CYP3A4>  (529) 
<0,H;Hydroxylation;R1>

>  <References>  (529) 
Lakehal F, Dansette PM, Becquemont L, Lasnier E, Delelo R, Balladur P, Poupon R, Beaune PH, Housset C: Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes. Chem Res Toxicol. 2001 Jun;14(6):694-701. (PMID: 11409940)

>  <Comments>  (529) 


$$$$
CC02400
     RDKit          3D

 23 26  0  0  0  0  0  0  0  0999 V2000
    5.0230   -1.7940   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7480   -0.6100   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6560   -1.7720   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1060    0.6090   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9870   -0.5520    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7160    0.6540    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5810   -0.1270    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7840    1.6600    0.0060 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5900    1.1880    0.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3940   -1.0020    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1090    3.0880    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5300   -2.2110    0.0060 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8410   -0.4630    0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0190   -1.3310    0.0140 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.8640   -1.1370   -1.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8790   -1.1110    1.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6940    0.1710    1.1720 C   0  0  2  0  0  0  0  0  0  0  0  0
   -3.6760    0.1500   -1.1810 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.5260    0.2440   -0.0110 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7710    1.3840    1.2690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7540    1.3650   -1.2870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7040    2.1880   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4850   -0.8490   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  2  4  1  0
  3  5  2  0
  4  6  2  0
  5  6  1  0
  5  7  1  0
  6  8  1  0
  7  9  2  0
  7 10  1  0
  8  9  1  0
  8 11  1  0
 10 12  2  0
 10 13  1  0
 14 13  1  6
 14 15  1  0
 14 16  1  0
 18 15  1  1
 17 16  1  6
 17 19  1  0
 17 20  1  0
 18 19  1  0
 18 21  1  0
 19 23  1  0
 20 22  1  0
 21 22  1  0
M  END
>  <Name>  (530) 
Granisetron

>  <InChIKey>  (530) 
MFWNKCLOYSRHCJ-BTTYYORXSA-N

>  <PubChem_CID>  (530) 


>  <CYP1A2>  (530) 


>  <CYP2A6>  (530) 


>  <CYP2B6>  (530) 


>  <CYP2C8>  (530) 


>  <CYP2C9>  (530) 


>  <CYP2C19>  (530) 


>  <CYP2D6>  (530) 


>  <CYP2E1>  (530) 


>  <CYP3A4>  (530) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (530) 
Bloomer JC, Baldwin SJ, Smith GJ, Ayrton AD, Clarke SE, Chenery RJ: Characterisation of the cytochrome P450 enzymes involved in the in vitro metabolism of granisetron. Br J Clin Pharmacol. 1994 Dec;38(6):557-66. doi: 10.1111/j.1365-2125.1994.tb04397.x. (PMID: 7888294)

>  <Comments>  (530) 
The paper says <3,H;Hydroxylation> is involved with other enzymes.

$$$$
CC02401
     RDKit          3D

 37 41  0  0  0  0  0  0  0  0999 V2000
    0.3020    1.4730   -0.0810 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3630    0.0050   -0.0980 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0620   -0.4590   -1.3790 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4100    0.1220   -1.4360 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3490    1.5900   -1.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6510    2.0540   -0.1390 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1410   -0.3620   -2.6160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4290    1.9560    1.0980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6840    3.4350    0.9590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8420    3.8790    0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0850    5.2310    0.2200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1600    6.1520    0.7140 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0060    5.6970    1.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2370    4.3420    1.4510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4130    7.6020    0.5830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4290    7.9960    0.0430 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5170    8.4890    1.0610 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7000    9.8570    0.8370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1830   10.7830    1.7320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3610   12.1400    1.5030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0560   12.5670    0.3780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5690   11.6430   -0.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3930   10.2920   -0.2870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2490   14.0410    0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1570   13.0760    2.4020 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3790   12.7170    3.7280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0270   11.5350    4.1620 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1700   11.1520    5.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8150   11.9910    6.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2520   13.2360    5.8970 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0300   13.6030    4.5810 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3020    9.8180    5.8620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9520    8.9620    4.9700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3680    7.7250    5.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1290    7.3800    6.7500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5130    8.2100    7.5690 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0990    9.3960    7.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  1  8  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  7  1  0
  5  6  1  0
  8  9  1  0
  9 10  2  0
  9 14  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 15  1  0
 13 14  2  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 18 23  1  0
 19 20  1  0
 20 21  2  0
 20 25  1  0
 21 22  1  0
 21 24  1  0
 22 23  2  0
 25 26  1  0
 26 27  2  0
 26 31  1  0
 27 28  1  0
 28 29  2  0
 28 32  1  0
 29 30  1  0
 30 31  2  0
 32 33  2  0
 32 37  1  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
M  END
>  <Name>  (531) 
Imatinib

>  <InChIKey>  (531) 
KTUFNOKKBVMGRW-UHFFFAOYSA-N

>  <PubChem_CID>  (531) 
5291

>  <CYP1A2>  (531) 


>  <CYP2A6>  (531) 


>  <CYP2B6>  (531) 


>  <CYP2C8>  (531) 


>  <CYP2C9>  (531) 


>  <CYP2C19>  (531) 


>  <CYP2D6>  (531) 


>  <CYP2E1>  (531) 


>  <CYP3A4>  (531) 
<16,17;Cleavage;R1>
<17,H;Oxidation;R1>

>  <References>  (531) 
Cohen MH, Williams G, Johnson JR, Duan J, Gobburu J, Rahman A, Benson K, Leighton J, Kim SK, Wood R, Rothmann M, Chen G, U KM, Staten AM, Pazdur R: Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. Clin Cancer Res. 2002 May;8(5):935-42. (PMID: 12006504)
Novartis Pharmaceuticals (2018) Gleevec(imatinib mesylate) full prescribing information [https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/gleevec_tabs.pdf]

>  <Comments>  (531) 


$$$$
CC02402
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    0.0040    1.3160   -0.0420 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0470   -0.0700   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1270    2.2080   -0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3610    1.8020   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2780   -0.4940   -0.2120 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1200   -0.7610    0.2070 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5230    2.5810   -1.4240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0460    0.6460   -0.7310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9090   -2.0870    0.2080 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9800    3.6970   -2.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4480    1.8220   -2.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9990   -2.7020   -0.8650 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6750   -2.6480    1.2890 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3690    4.0190   -3.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8550    2.1020   -3.3760 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3000    3.1920   -3.9490 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8340    3.5210   -5.5440 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  4  8  1  0
  5  8  1  0
  6  9  1  0
  7 10  2  0
  7 11  1  0
  9 12  1  0
  9 13  2  0
 10 14  1  0
 11 15  2  0
 14 16  2  0
 15 16  1  0
 16 17  1  0
M  CHG  2   9   1  12  -1
M  END
>  <Name>  (532) 
Imidacloprid

>  <InChIKey>  (532) 
YWTYJOPNNQFBPC-UHFFFAOYSA-N

>  <PubChem_CID>  (532) 
86418

>  <CYP1A2>  (532) 


>  <CYP2A6>  (532) 


>  <CYP2B6>  (532) 


>  <CYP2C8>  (532) 


>  <CYP2C9>  (532) 


>  <CYP2C19>  (532) 


>  <CYP2D6>  (532) 


>  <CYP2E1>  (532) 


>  <CYP3A4>  (532) 
<1,2;Reduction;R1>
<7,H;Hydroxylation;R2>

>  <References>  (532) 
Schulz-Jander DA, Leimkuehler WM, Casida JE: Neonicotinoid insecticides: reduction and cleavage of imidacloprid nitroimine substituent by liver microsomal and cytosolic enzymes. Chem Res Toxicol. 2002 Sep;15(9):1158-65. (PMID: 12230409)

>  <Comments>  (532) 
P450 3A4 with NADPH by imidazolidine hydroxylation and dehydrogenation to give 5-hydroxyimidacloprid and olefin, respectively, and by nitroimine reduction and cleavage to yield the nitrosoimine, guanidine, and urea derivatives.

$$$$
CC02403
     RDKit          3D

 45 49  0  0  0  0  0  0  0  0999 V2000
   -1.0880    2.3650    1.5340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4930    0.9850    1.7090 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.2140    3.3170    2.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3010    2.7580    0.9920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6340    1.1590    2.7490 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.5070    0.0540    2.2090 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0280    2.6400    2.5650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5530    4.6580    1.9700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6360    4.0960    0.9360 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1450    0.9240    4.0710 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3180   -0.5880    1.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7600    5.0480    1.4240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3820   -1.5230    1.8610 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.1930   -0.4130    0.1510 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7640   -2.8950    2.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4900   -1.6620    0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7100   -2.7680    3.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6500   -2.4660    1.4060 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.0680   -2.8330    4.5390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3860   -2.5910    2.8520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8200   -2.4720    0.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2240   -3.8080    1.6480 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1010   -2.7160    5.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5810   -2.4740    3.8340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9740   -3.1420    1.0350 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2230   -2.5340    5.1670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1210   -2.9030    0.1490 C   0  0  1  0  0  0  0  0  0  0  0  0
   -7.6970   -4.5830    0.9940 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.3370   -3.6750    0.6630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.4360   -1.4300    0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9130   -5.3550    1.5080 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.0600   -5.1160    0.6230 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.4580   -0.9720   -0.6280 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7710   -0.6560    0.7780 O   0  0  0  0  0  0  0  0  0  0  0  0
  -11.2140   -5.7860    1.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.7650    0.4600   -0.6530 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.1120   -7.2720    1.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5500    1.2320   -1.1710 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.9600    0.7090   -1.5750 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.1050    0.9330    0.7620 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.4550   -8.0780    1.9270 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.6780   -7.8490   -0.1110 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.3860   -9.4400    1.6770 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.5940   -9.1490   -0.3150 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.9710   -9.9460    0.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  0
  2  6  1  1
  3  7  1  0
  3  8  2  0
  4  9  1  0
  5  7  1  0
  5 10  1  1
  6 11  1  0
  8 12  1  0
  9 12  2  0
 11 13  1  0
 11 14  2  0
 13 15  1  6
 13 16  1  0
 15 17  1  0
 16 18  1  0
 17 19  2  0
 17 20  1  0
 18 21  1  0
 18 22  1  6
 19 23  1  0
 20 24  2  0
 21 25  1  0
 23 26  2  0
 24 26  1  0
 25 27  1  0
 25 28  1  0
 27 29  1  0
 27 30  1  1
 28 31  1  0
 29 32  1  0
 30 33  1  0
 30 34  2  0
 31 32  1  0
 32 35  1  0
 33 36  1  0
 35 37  1  0
 36 38  1  0
 36 39  1  0
 36 40  1  0
 37 41  2  0
 37 42  1  0
 41 43  1  0
 42 44  2  0
 43 45  2  0
 44 45  1  0
M  END
>  <Name>  (533) 
Indinavir

>  <InChIKey>  (533) 
CBVCZFGXHXORBI-PXQQMZJSSA-N

>  <PubChem_CID>  (533) 
5362440

>  <CYP1A2>  (533) 


>  <CYP2A6>  (533) 


>  <CYP2B6>  (533) 


>  <CYP2C8>  (533) 


>  <CYP2C9>  (533) 


>  <CYP2C19>  (533) 


>  <CYP2D6>  (533) 


>  <CYP2E1>  (533) 


>  <CYP3A4>  (533) 
<15,N;N-Oxidation;R1>
<9,10;Cleavage;R2>
<10,H;Oxidation;R2>
<29,H;Hydroxylation;R3>
<42,H;Hydroxylation;R4>

>  <References>  (533) 
Chiba M, Hensleigh M, Lin JH: Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes. Major role of CYP3A. Biochem Pharmacol. 1997 Apr 25;53(8):1187-95. doi: 10.1016/s0006-2952(97)00100-7. (PMID: 9175724)

>  <Comments>  (533) 
<44,N;Conjugation> is not considered in Phase 1.

$$$$
CC02405
     RDKit          2D

 10 11  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.8760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -0.8760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5210    1.7520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5170    1.7550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5170   -1.7550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5210   -1.7520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0450    0.8790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0410    0.8760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0410   -0.8760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0450   -0.8790    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  1  0
  6 10  2  0
  7  9  2  0
  8 10  1  0
M  END
>  <Name>  (534) 
Isoquinoline

>  <InChIKey>  (534) 
AWJUIBRHMBBTKR-UHFFFAOYSA-N

>  <PubChem_CID>  (534) 
8405

>  <CYP1A2>  (534) 


>  <CYP2A6>  (534) 


>  <CYP2B6>  (534) 


>  <CYP2C8>  (534) 


>  <CYP2C9>  (534) 


>  <CYP2C19>  (534) 


>  <CYP2D6>  (534) 


>  <CYP2E1>  (534) 
<5,N;N-Oxidation;R1>

>  <CYP3A4>  (534) 
<5,N;N-Oxidation;R1>

>  <References>  (534) 
Dowers TS, Rock DA, Rock DA, Perkins BN, Jones JP: An analysis of the regioselectivity of aromatic hydroxylation and N-oxygenation by cytochrome P450 enzymes. Drug Metab Dispos. 2004 Mar;32(3):328-32. doi: 10.1124/dmd.32.3.328. (PMID: 14977867)

>  <Comments>  (534) 


$$$$
CC02406
     RDKit          3D

 49 55  0  0  0  0  0  0  0  0999 V2000
   -7.0900    2.6950    0.6370 C   0  0  2  0  0  0  0  0  0  0  0  0
   -6.5960    1.4020   -0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2040    2.9580    1.7270 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4870    2.4830    1.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0410    3.8880   -0.1770 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0010    1.1940   -1.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7590    0.2840    0.8110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1180    3.5520    1.0450 C   0  0  1  0  0  0  0  0  0  0  0  0
   -9.5670    2.1020    0.3400 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8560    4.5940    0.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6290   -0.1020   -1.6820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6590    2.3860   -2.4770 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -6.3960   -1.0080    0.4120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0950    4.1940    2.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.0360    2.8300   -0.7080 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.2450    0.9810    0.4270 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8280   -1.2050   -0.8470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8900    4.5050    1.2890 O   0  0  0  0  0  0  0  0  0  0  0  0
  -11.0410    2.1360   -1.2980 N   0  0  0  0  0  0  0  0  0  0  0  0
  -11.1580    0.9820   -0.5820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3750   -2.7730   -1.3620 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.0420    3.5140    0.9360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9000    3.7640    0.1670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2990    2.2030    1.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0380    2.7080   -0.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4370    1.1510    1.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2940    1.4080    0.2860 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5800    0.4610   -0.0240 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7830    0.8960   -0.7580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4520   -0.9320    0.4650 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1000   -0.1370   -1.8480 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8520   -1.9000   -0.6690 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1550   -1.4020   -1.1270 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3590   -1.8980   -0.8440 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4640   -1.1010   -1.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5650   -3.1580   -0.2650 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7510   -1.5800   -0.8960 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8670   -3.6370   -0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9940   -2.8510   -0.3390 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2450   -3.3180   -0.1190 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4660   -2.7820   -0.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4640   -4.5320    0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3750   -3.6960    0.0590 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7560   -1.6410   -0.7490 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.7760   -4.7450    0.4830 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.8550   -3.6320    0.0550 C   0  0  2  0  0  0  0  0  0  0  0  0
   11.3680   -2.6140    1.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3660   -3.3120   -1.3640 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8950   -2.4390    0.9750 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  1
  1  5  1  0
  2  6  2  0
  2  7  1  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  6 11  1  0
  6 12  1  0
  7 13  2  0
  8 10  1  0
  8 14  1  1
  9 15  1  0
  9 16  1  0
 11 17  2  0
 13 17  1  0
 14 18  1  0
 15 19  2  0
 16 20  2  0
 17 21  1  0
 18 22  1  0
 19 20  1  0
 22 23  2  0
 22 24  1  0
 23 25  1  0
 24 26  2  0
 25 27  2  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  1  0
 29 31  1  0
 30 32  1  0
 31 33  1  0
 32 33  1  0
 33 34  1  0
 34 35  2  0
 34 36  1  0
 35 37  1  0
 36 38  2  0
 37 39  2  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 40 42  1  0
 41 43  1  0
 41 44  2  0
 42 45  2  0
 43 45  1  0
 43 46  1  0
 46 47  1  0
 46 48  1  6
 47 49  1  0
M  END
>  <Name>  (535) 
Itraconazole

>  <InChIKey>  (535) 
VHVPQPYKVGDNFY-ARROIKNCSA-N

>  <PubChem_CID>  (535) 
24867300

>  <CYP1A2>  (535) 


>  <CYP2A6>  (535) 


>  <CYP2B6>  (535) 


>  <CYP2C8>  (535) 


>  <CYP2C9>  (535) 


>  <CYP2C19>  (535) 


>  <CYP2D6>  (535) 


>  <CYP2E1>  (535) 


>  <CYP3A4>  (535) 
<1,H;Hydroxylation;R1>

>  <References>  (535) 
Isoherranen N, Kunze KL, Allen KE, Nelson WL, Thummel KE: Role of itraconazole metabolites in CYP3A4 inhibition. Drug Metab Dispos. 2004 Oct;32(10):1121-31. doi: 10.1124/dmd.104.000315. Epub 2004 Jul 8. (PMID: 15242978)

>  <Comments>  (535) 
Xenosite reports 46 as SoM as well. However 46 is the SoM for a further reaction from 47.

$$$$
CC02407
     RDKit          3D

 61 67  0  0  0  0  0  0  0  0999 V2000
    4.1560   -2.6100    0.5880 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.9880   -4.0560    0.0710 C   0  0  1  0  0  0  0  0  0  0  0  0
    5.5790   -2.0240    0.3060 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.9520   -1.9570   -0.0520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9370   -2.5630    2.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4020   -3.8760   -1.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2910   -4.8810    0.0050 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.3630   -2.7740   -0.7470 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5880   -0.5730   -0.1190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3500   -2.7660   -1.1740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4340   -0.8010    0.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2510   -4.1020   -0.8610 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8480   -5.1750    1.2990 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5760    0.3480    0.7320 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5540   -0.3310   -1.3480 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2320   -0.2020   -0.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0880   -4.8360   -1.8820 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5110    1.7360    0.3720 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.8570    1.0190    0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8670    2.2690   -0.1710 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0390    2.5270    1.6030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3440    1.7450   -0.3970 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.9410    3.7930   -0.4330 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.2900    3.2430   -0.0030 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.3600    1.6150   -1.9320 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7160    4.3170   -0.9760 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.3720    4.5130    0.8670 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9580    4.0230   -1.4200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5180    3.8850   -0.3500 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8190    4.0060   -0.7080 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5010    3.7290   -0.4850 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.9620    5.8730    0.4890 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2410    4.1670   -0.8100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1350    4.4080    0.8310 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.1090    3.7800   -0.4230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4700    5.0360   -1.7560 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2860    4.4640   -1.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3220    3.7640    1.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3220    5.5600   -0.1540 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.1740    5.4670    0.4350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7720    3.3630    1.5760 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6210    6.6420   -1.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2440    4.7890   -0.4290 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.7860    2.6860    0.8180 C   0  0  2  0  0  0  0  0  0  0  0  0
   -4.9070    3.6740    0.3960 C   0  0  2  0  0  0  0  0  0  0  0  0
   -5.2230    5.7520   -0.8210 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3110    1.5370    1.6990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9000    3.0650   -0.4440 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5930    6.7860   -1.5790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9930    2.4940    0.2900 C   0  0  1  0  0  0  0  0  0  0  0  0
   -7.7790    3.5970    1.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8660    1.8010   -0.6050 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3690    4.5940    0.0080 C   0  0  1  0  0  0  0  0  0  0  0  0
   -8.3800    2.6820   -1.6080 C   0  0  2  0  0  0  0  0  0  0  0  0
   -9.2490    3.7860   -0.9770 C   0  0  2  0  0  0  0  0  0  0  0  0
   -9.0880    5.5870    0.7580 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.2420    1.8720   -2.5930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7720    4.5740   -2.0510 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.2290    6.8350    0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9820    6.3510   -1.8710 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6640    8.0230   -0.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  1
  2  6  1  6
  2  7  1  0
  3  8  1  6
  3  9  1  0
  4 10  1  0
  4 11  2  0
  6 10  1  0
  7 12  1  0
  7 13  1  1
  8 12  2  0
  9 14  1  0
  9 15  2  0
 11 16  1  0
 12 17  1  0
 14 18  1  0
 16 19  2  0
 18 20  1  1
 18 21  1  0
 19 22  1  0
 23 20  1  1
 21 38  1  0
 22 24  1  0
 22 25  1  6
 23 26  1  0
 23 27  1  0
 23 28  1  0
 24 29  1  6
 24 30  1  0
 26 31  1  0
 27 32  1  0
 28 33  1  0
 34 29  1  6
 30 35  2  0
 30 36  1  0
 31 37  1  6
 31 38  1  0
 32 39  1  0
 33 39  1  0
 34 40  1  0
 34 41  1  0
 35 37  1  0
 39 42  1  6
 40 43  1  0
 41 44  1  0
 42 60  1  0
 42 61  1  0
 43 45  1  0
 43 46  1  1
 44 45  1  0
 44 47  1  1
 45 48  1  6
 46 49  1  0
 50 48  1  6
 50 51  1  0
 50 52  1  0
 51 53  1  0
 52 54  1  0
 53 55  1  0
 53 56  1  1
 54 55  1  0
 54 57  1  6
 55 58  1  6
 56 59  1  0
M  END
>  <Name>  (536) 
Ivermectin

>  <InChIKey>  (536) 
QSENXEKZWYFFJK-FKLTURBQSA-N

>  <PubChem_CID>  (536) 


>  <CYP1A2>  (536) 


>  <CYP2A6>  (536) 


>  <CYP2B6>  (536) 


>  <CYP2C8>  (536) 


>  <CYP2C9>  (536) 


>  <CYP2C19>  (536) 


>  <CYP2D6>  (536) 


>  <CYP2E1>  (536) 


>  <CYP3A4>  (536) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<26,H;Hydroxylation;R2>
<38,H;Hydroxylation;R3>

>  <References>  (536) 
Zeng Z, Andrew NW, Arison BH, Luffer-Atlas D, Wang RW: Identification of cytochrome P4503A4 as the major enzyme responsible for the metabolism of ivermectin by human liver microsomes. Xenobiotica. 1998 Mar;28(3):313-21. doi: 10.1080/004982598239597. (PMID: 9574819)

>  <Comments>  (536) 


$$$$
CC02408
     RDKit          3D

 41 44  0  0  0  0  0  0  0  0999 V2000
   -0.0360    1.3150   -0.0890 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.0080   -0.1850   -0.3910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3750    1.8300    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7270    2.0180   -1.1730 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4150   -0.7250   -0.3840 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2030    1.3260    0.9620 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7660    2.7000   -0.7240 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0700    2.1220   -1.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1560   -0.7400   -1.5510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9630   -1.2120    0.7880 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5750    1.8270    1.0740 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.7140    2.6620   -2.2150 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7020    1.7280   -0.2000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4460   -1.2350   -1.5450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2540   -1.7070    0.7940 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5890    3.0830    1.9480 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4470    0.7690    1.6990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1670    2.8940   -2.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9860    3.0440   -3.4350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9960   -1.7170   -0.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8060    4.1980    1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4770    0.2970    1.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4390    4.3290   -2.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3970    4.4700   -3.8170 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8200    5.4340    2.1140 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4970   -0.9400    1.7730 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8510    4.5380   -3.9700 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8300    6.3680    1.9670 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8210    5.6380    3.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3270   -2.4020    0.8050 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8350   -0.5020    1.5790 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9030   -1.2370    3.0290 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1680    5.9180   -4.3600 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8430    7.5020    2.7570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8340    6.7720    3.8370 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1760   -2.6280   -0.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3480   -3.3270    1.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8460    7.7030    3.6940 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0430   -3.7750   -1.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2150   -4.4750    0.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0600   -4.6980   -0.7130 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  6
  1  3  1  0
  1  4  1  0
  2  5  1  0
  3  6  1  0
  3  7  2  0
  4  8  1  0
  5  9  2  0
  5 10  1  0
  6 11  1  0
  8 12  1  0
  8 13  2  0
  9 14  1  0
 10 15  2  0
 11 16  1  1
 11 17  1  0
 12 18  1  0
 12 19  1  0
 14 20  2  0
 15 20  1  0
 16 21  1  0
 17 22  2  0
 18 23  1  0
 19 24  1  0
 21 25  1  0
 22 26  1  0
 23 27  1  0
 24 27  1  0
 25 28  2  0
 25 29  1  0
 26 30  1  0
 26 31  2  0
 26 32  2  0
 27 33  1  0
 28 34  1  0
 29 35  2  0
 30 36  2  0
 30 37  1  0
 34 38  2  0
 35 38  1  0
 36 39  1  0
 37 40  2  0
 39 41  2  0
 40 41  1  0
M  END
>  <Name>  (537) 
K-11777

>  <InChIKey>  (537) 
RHJLQMVZXQKJKB-FPHSVDBKSA-N

>  <PubChem_CID>  (537) 
9851116

>  <CYP1A2>  (537) 


>  <CYP2A6>  (537) 


>  <CYP2B6>  (537) 


>  <CYP2C8>  (537) 


>  <CYP2C9>  (537) 


>  <CYP2C19>  (537) 


>  <CYP2D6>  (537) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (537) 


>  <CYP3A4>  (537) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,N;N-Oxidation;R2>
<31,H;Hydroxylation;R3>

>  <References>  (537) 
Jacobsen W, Christians U, Benet LZ: In vitro evaluation of the disposition of A novel cysteine protease inhibitor. Drug Metab Dispos. 2000 Nov;28(11):1343-51. (PMID: 11038163)

>  <Comments>  (537) 


$$$$
CC02409
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.4220    1.7580    2.5420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4760    0.4240    2.9620 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6070   -0.1640    3.5740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7700    0.5590    3.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8560    1.8820    3.3810 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7420    2.5080    2.7430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6320    2.7520    1.7390 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.6280    3.8200    2.2660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5480    4.1320    1.7070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8830    5.4460    1.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0640    6.3450    1.1640 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0980    5.6560    0.5960 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4480    6.9160    0.1540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6590    7.1450   -0.2640 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5170    7.9270    0.1540 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0620    2.6200    3.6030 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0190    3.2070    3.7790 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5 16  1  0
  6  8  1  0
  7  9  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 16 17  3  0
M  END
>  <Name>  (538) 
KR-33028

>  <InChIKey>  (538) 
WGKIDCRTLNUROQ-UHFFFAOYSA-N

>  <PubChem_CID>  (538) 
11515637

>  <CYP1A2>  (538) 
<5,H;Hydroxylation;R1>

>  <CYP2A6>  (538) 


>  <CYP2B6>  (538) 


>  <CYP2C8>  (538) 


>  <CYP2C9>  (538) 


>  <CYP2C19>  (538) 


>  <CYP2D6>  (538) 


>  <CYP2E1>  (538) 


>  <CYP3A4>  (538) 
<3,H;Hydroxylation;R1>
<5,H;Hydroxylation;R2>

>  <References>  (538) 
Kim H, Yoon YJ, Kim H, Kang S, Cheon HG, Yoo SE, Shin JG, Liu KH: Characterization of the cytochrome P450 enzymes involved in the metabolism of a new cardioprotective agent KR-33028. Toxicol Lett. 2006 Oct 10;166(2):105-14. doi: 10.1016/j.toxlet.2006.06.002. Epub  2006 Jun 12. (PMID: 16857327)

>  <Comments>  (538) 


$$$$
CC02410
     RDKit          3D

 25 27  0  0  0  0  0  0  0  0999 V2000
    0.7670   -0.0440    1.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0120   -0.0440    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0440    0.6750    1.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3220   -0.7340    2.3100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4180    0.6270   -1.1220 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2240   -0.7280   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4450    1.3430    0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8130    0.6930    2.3040 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8780   -1.4090    2.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2780   -0.7400    3.7590 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.5820    1.2980   -1.1450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4180    0.6060   -2.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6510   -1.3980    1.1190 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7140    2.0790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9220    1.8760   -2.1620 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8720    1.4180   -0.1980 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7210    3.2870    0.1490 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.0880    2.1070   -0.1470 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8560   -0.0220   -0.4650 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1000    3.4920   -0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2870    1.4070   -0.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9180   -0.2620   -1.9750 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3020    4.1690    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4860    2.0900   -0.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4940    3.4690   -0.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5 11  1  0
  5 12  1  0
  6 13  2  0
  7 11  1  0
  7 14  1  0
  9 13  1  0
 11 15  2  0
 14 16  1  0
 14 17  2  0
 16 18  1  0
 16 19  1  0
 18 20  2  0
 18 21  1  0
 19 22  1  0
 20 23  1  0
 21 24  2  0
 23 25  2  0
 24 25  1  0
M  END
>  <Name>  (539) 
Laquinimod

>  <InChIKey>  (539) 
GKWPCEFFIHSJOE-UHFFFAOYSA-N

>  <PubChem_CID>  (539) 
54677946

>  <CYP1A2>  (539) 


>  <CYP2A6>  (539) 


>  <CYP2B6>  (539) 


>  <CYP2C8>  (539) 


>  <CYP2C9>  (539) 


>  <CYP2C19>  (539) 


>  <CYP2D6>  (539) 


>  <CYP2E1>  (539) 


>  <CYP3A4>  (539) 
<13,H;Hydroxylation;R1>
<12,H;Hydroxylation;R2>
<11,H;Hydroxylation;R3>
<15,16;Cleavage;R4>
<16,H;Oxidation;R4>
<22,H;Hydroxylation;R5>
<1,2;Cleavage;R6>
<1,H;Oxidation;R6>

>  <References>  (539) 
Tuvesson H, Hallin I, Persson R, Sparre B, Gunnarsson PO, Seidegard J: Cytochrome P450 3A4 is the major enzyme responsible for the metabolism of laquinimod, a novel immunomodulator. Drug Metab Dispos. 2005 Jun;33(6):866-72. doi: 10.1124/dmd.104.002238. Epub 2005  Mar 11. (PMID: 15764719)

>  <Comments>  (539) 


$$$$
CC02411
     RDKit          3D

 33 37  0  0  0  0  0  0  0  0999 V2000
    2.2430    5.9200   -0.7630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0390    5.3680   -0.1370 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1840    6.2250    0.6880 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7070    4.0240   -0.3260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4340    3.4990    0.2680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7600    2.1700    0.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0480    1.3630   -0.7010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1850    1.8820   -1.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5140    3.2120   -1.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3100   -0.0870   -0.9050 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.3360   -0.4970    0.1330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9110   -0.7760    1.5520 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.3300   -1.6570    1.4960 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.3990   -0.8960    0.6680 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.9600   -0.9430   -0.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6050   -0.5930   -0.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6730   -0.8990    0.6900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3560   -0.8200    2.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9790   -1.4760    2.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9840   -0.3290   -1.7010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0230   -1.3680   -2.1330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1420   -1.4250   -1.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8960   -1.2620    0.2470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2780   -1.6150   -1.5110 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6930   -1.6380    0.9940 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.4940   -2.2090    2.4190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0310   -1.8640    2.8450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4950    0.5540    1.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9150   -2.7570    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8000   -0.7340    0.9740 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9910   -2.7690   -0.7370 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2120   -3.8880   -1.7220 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3020   -3.3500   -3.0430 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  9  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
 10  7  1  1
  8  9  2  0
 10 11  1  0
 10 15  1  0
 11 12  1  0
 11 16  2  0
 12 13  1  0
 12 19  1  1
 13 14  1  0
 13 27  1  1
 14 15  1  0
 14 25  1  0
 14 28  1  1
 16 17  1  0
 16 20  1  0
 17 18  1  0
 17 23  2  0
 18 19  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
 25 26  1  0
 25 29  1  0
 25 30  1  1
 26 27  1  0
 29 31  2  0
 31 32  1  0
 32 33  1  0
M  END
>  <Name>  (540) 
Lilopristone

>  <InChIKey>  (540) 
RCOWGILQXUPXEW-CEBPFEQASA-N

>  <PubChem_CID>  (540) 
9868258

>  <CYP1A2>  (540) 


>  <CYP2A6>  (540) 


>  <CYP2B6>  (540) 


>  <CYP2C8>  (540) 


>  <CYP2C9>  (540) 


>  <CYP2C19>  (540) 


>  <CYP2D6>  (540) 


>  <CYP2E1>  (540) 


>  <CYP3A4>  (540) 
<1,2;Cleavage;R1>
<2,H;Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <References>  (540) 
Jang GR, Benet LZ: Cytochrome P4503A4-mediated N-demethylation of the antiprogestins lilopristone and onapristone. Drug Metab Dispos. 1997 Oct;25(10):1119-22. (PMID: 9321513)

>  <Comments>  (540) 


$$$$
CC02412
     RDKit          3D

 27 30  0  0  0  0  0  0  0  0999 V2000
   -0.1390    1.4470   -0.2310 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.1630   -0.0540   -0.4530 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.3470    1.8920   -0.3010 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.7690    2.2970   -1.3390 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5780   -0.7010    0.7270 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.6040   -0.5640   -0.4820 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2530    3.4090   -0.4220 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.0420    1.3520    0.9330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0020    1.3130   -1.5570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0890    3.6800   -1.1450 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5840   -2.2200    0.5450 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.0070   -0.1830    0.8430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6030   -2.0840   -0.6580 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4210    3.9480   -1.2510 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.8570   -2.7340    0.5090 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.3280   -2.8700    1.7140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2850   -2.5740   -0.7680 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2310    5.4480   -1.4840 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    3.7110   -0.5000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8530   -4.2530    0.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3320   -4.3890    1.5350 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3300    5.9630   -2.4160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1100   -4.9020    1.4990 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.1420    7.4410   -2.6460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7640   -4.5680    2.7240 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9960    8.1100   -3.4360 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2240    8.0230   -2.1180 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  6
  2  5  1  0
  2  6  1  1
  3  7  1  0
  3  8  1  0
  3  9  1  6
  4 10  1  0
  5 11  1  0
  5 12  1  6
  6 13  1  0
  7 10  1  6
  7 14  1  0
  8 12  1  0
 11 15  1  0
 11 16  1  0
 11 17  1  6
 15 13  1  6
 14 18  1  0
 14 19  1  1
 15 20  1  0
 16 21  1  0
 18 22  1  0
 20 23  1  0
 21 23  1  0
 22 24  1  0
 23 25  1  1
 24 26  1  0
 24 27  2  0
M  END
>  <Name>  (541) 
Lithocholic acid

>  <InChIKey>  (541) 
SMEROWZSTRWXGI-NWFSOSCSSA-N

>  <PubChem_CID>  (541) 
5283803

>  <CYP1A2>  (541) 


>  <CYP2A6>  (541) 


>  <CYP2B6>  (541) 


>  <CYP2C8>  (541) 


>  <CYP2C9>  (541) 


>  <CYP2C19>  (541) 


>  <CYP2D6>  (541) 


>  <CYP2E1>  (541) 


>  <CYP3A4>  (541) 
<13,H;Hydroxylation;R1>

>  <References>  (541) 
Araya Z, Wikvall K: 6alpha-hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes. Biochim Biophys Acta. 1999 Apr 19;1438(1):47-54. doi: 10.1016/s1388-1981(99)00031-1. (PMID: 10216279)

>  <Comments>  (541) 


$$$$
CC02414
     RDKit          3D

 35 40  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.3830    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0900    2.3570    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1060   -0.9800    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4520    1.7610    0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4260   -0.4300   -0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2040    0.6550   -0.0160 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1130    3.2870    0.1820 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4280    2.1160    0.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3290   -0.8880    0.6290 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0600   -2.0070    0.3680 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0500   -2.3220   -0.5780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9530    3.8250   -0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2410    4.3510    0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2870   -2.9260   -0.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9130    2.8760    0.1940 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8320   -1.5760   -0.0440 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5540    3.4340    0.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4100   -0.0480    1.1390 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0800    2.3290    1.2890 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6310    1.1790    0.4440 C   0  0  1  0  0  0  0  0  0  0  0  0
    7.6450    0.3330   -0.6640 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4620   -2.2220    0.7260 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1330    1.3820    0.2280 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3150   -1.0850    0.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0900   -3.0110   -1.3140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0920    4.6950   -0.4210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5240   -4.2260   -0.7510 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4350    5.7280    0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2220    0.6920   -2.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1100    0.4340   -0.6370 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3410   -4.2970   -1.7430 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1140    6.0590   -0.4080 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5560   -4.9040   -1.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3740    6.5750   -0.1470 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  5  1  0
  2  4  1  0
  2  6  1  0
  3  9  2  0
  3 13  1  0
  4 10  2  0
  4 12  1  0
  5  7  1  0
  5 16  2  0
  6  7  1  0
  6 17  2  0
  8  9  1  0
  8 14  1  0
  8 18  1  0
 10 11  1  0
 11 15  1  0
 11 23  1  0
 12 15  2  0
 12 26  1  0
 13 14  2  0
 13 27  1  0
 14 29  1  0
 15 28  1  0
 18 20  1  0
 19 21  1  0
 19 25  1  0
 20 21  1  0
 21 24  1  1
 22 24  1  0
 22 30  1  0
 22 31  1  0
 23 25  1  0
 26 32  2  0
 27 33  2  0
 28 34  2  0
 29 35  2  0
 32 34  1  0
 33 35  1  0
M  END
>  <Name>  (542) 
LY-333531

>  <InChIKey>  (542) 
ZCBUQCWBWNUWSU-SFHVURJKSA-N

>  <PubChem_CID>  (542) 
153999

>  <CYP1A2>  (542) 


>  <CYP2A6>  (542) 


>  <CYP2B6>  (542) 


>  <CYP2C8>  (542) 


>  <CYP2C9>  (542) 


>  <CYP2C19>  (542) 


>  <CYP2D6>  (542) 


>  <CYP2E1>  (542) 


>  <CYP3A4>  (542) 
<0,1;Cleavage;R1>
<0,H;Oxidaiton;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <References>  (542) 
Ring BJ, Gillespie JS, Binkley SN, Campanale KM, Wrighton SA: The interactions of a selective protein kinase C beta inhibitor with the human cytochromes P450. Drug Metab Dispos. 2002 Sep;30(9):957-61. doi: 10.1124/dmd.30.9.957. (PMID: 12167559)

>  <Comments>  (542) 


$$$$
CC02415
     RDKit          3D

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.4320    1.7020   -1.0150 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6160    0.5930   -0.4690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3290   -0.3160   -0.1260 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0060    0.3440   -0.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1610   -1.5290    0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6680   -0.0360   -0.2110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4270   -0.9130    0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9220    1.3660   -0.5730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6270   -2.7420    0.7610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4720   -1.7880    0.3570 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3540    1.1550    0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5190   -1.0240   -0.7430 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7940   -1.1950    0.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2910    1.1030   -0.4510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7790    2.3480    0.8980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7340    1.3200   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8960   -0.8730   -0.9380 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7210   -0.1760   -0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5250    0.3140   -0.5730 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  2  4  1  0
  3  5  1  0
  3  6  1  0
  4  7  2  0
  4  8  1  0
  5  9  1  0
  5 10  2  0
  6 11  2  0
  6 12  1  0
  7 10  1  0
  7 13  1  0
  8 14  2  0
 11 15  1  0
 11 16  1  0
 12 17  2  0
 13 18  2  0
 14 18  1  0
 16 19  2  0
 17 19  1  0
M  END
>  <Name>  (543) 
Methaqualone

>  <InChIKey>  (543) 
JEYCTXHKTXCGPB-UHFFFAOYSA-N

>  <PubChem_CID>  (543) 
6292

>  <CYP1A2>  (543) 


>  <CYP2A6>  (543) 


>  <CYP2B6>  (543) 


>  <CYP2C8>  (543) 


>  <CYP2C9>  (543) 


>  <CYP2C19>  (543) 


>  <CYP2D6>  (543) 


>  <CYP2E1>  (543) 


>  <CYP3A4>  (543) 
<0,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>

>  <References>  (543) 
Prost F, Thormann W: Assessment of the stereoselective metabolism of methaqualone in man by capillary electrophoresis. Electrophoresis. 2003 Aug;24(15):2598-607. doi: 10.1002/elps.200305512. (PMID: 12900872)

>  <Comments>  (543) 
15 is also a SoM.

$$$$
CC02416
     RDKit          3D

 24 27  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4860    0.0100 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.0660   -0.0020    0.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2470    2.1850   -0.0340 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7270    1.9210    1.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8050    1.9610   -1.0900 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0480   -0.7220    0.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9370   -0.6820   -0.6530 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8710    3.5500   -0.4900 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.8380    2.2800    1.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8770    2.6850    1.1840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2300    1.5520    2.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3090    3.2650   -1.4480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0760   -0.1950    1.4370 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0260   -2.1240    0.6000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9580   -2.0580   -0.7180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4180    4.4120    0.6900 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4900    1.0190    1.7040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5270    3.0840    2.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5050    3.1430   -0.3680 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.8800    1.9510    3.6560 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0380   -2.7840   -0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2230   -2.8740   -1.5830 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.5000    1.1220    2.3660 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0270    2.7190    3.5740 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  1
  1  5  1  0
  2  6  2  0
  2  7  1  0
  3  8  1  0
  3  9  1  0
  4 10  2  0
  4 11  1  0
  5 12  1  0
  6 13  1  0
  6 14  1  0
  7 15  2  0
  8 12  1  0
  8 16  1  1
  9 17  1  0
 10 18  1  0
 10 19  1  0
 11 20  2  0
 13 17  1  0
 14 21  2  0
 15 21  1  0
 15 22  1  0
 17 23  2  0
 18 24  2  0
 20 24  1  0
M  END
>  <Name>  (544) 
Mexazolam

>  <InChIKey>  (544) 
ANUCDXCTICZJRH-ZMZPIMSZSA-N

>  <PubChem_CID>  (544) 
76961231

>  <CYP1A2>  (544) 


>  <CYP2A6>  (544) 


>  <CYP2B6>  (544) 


>  <CYP2C8>  (544) 


>  <CYP2C9>  (544) 


>  <CYP2C19>  (544) 


>  <CYP2D6>  (544) 


>  <CYP2E1>  (544) 


>  <CYP3A4>  (544) 
<1,23;Cleavage;R1>
<1,H;Oxidation;R1>
<3,4;Cleavage;R1>
<4,23;Oxidation;R1>

>  <References>  (544) 
Ishigami M, Honda T, Takasaki W, Ikeda T, Komai T, Ito K, Sugiyama Y: A comparison of the effects of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors on the CYP3A4-dependent oxidation of mexazolam in vitro. Drug Metab Dispos. 2001 Mar;29(3):282-8. (PMID: 11181496)

>  <Comments>  (544) 
The observed metabolite is M-1. We mark BoM by comparing the substrate and the detectable, stable metabolite M-1. The postulated intermediate metabolites are not considered.

$$$$
CC02417
     RDKit          3D

 32 36  0  0  0  0  0  0  0  0999 V2000
   -5.7860   -2.6290   -0.7290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5560   -2.9670   -0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5560   -4.0560    0.9720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3820   -2.2520   -0.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2150   -2.5710    0.4250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0560   -1.8620    0.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0570   -0.8350   -0.7500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2170   -0.5150   -1.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3780   -1.2230   -1.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2100   -0.0630   -1.0180 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.2000   -0.3270    0.0990 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0380    0.3540    1.4340 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.7510    1.8250    1.1690 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.5200    1.8940    0.2800 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.1210    1.4350   -1.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1970   -1.1750   -0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1480   -1.5540    0.8940 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8150   -1.1980    2.3210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2660    0.2410    2.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3360   -1.8170   -1.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8190   -1.8350   -1.8960 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6330   -2.4200   -0.7740 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2980   -2.1860    0.5710 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5990   -3.1090   -1.0360 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9540    3.3540    0.3970 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.4630    3.8210    1.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3410    2.6330    2.4070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6060    0.9800    0.8520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3240    4.1590   -0.6630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3770    3.4540    0.3150 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1790    4.8010   -1.5070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8090    5.6060   -2.5660 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  9  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
 10  7  1  1
  8  9  2  0
 10 11  1  0
 10 15  1  0
 11 12  1  0
 11 16  2  0
 12 13  1  0
 12 19  1  1
 13 14  1  0
 13 27  1  1
 14 15  1  0
 14 25  1  0
 14 28  1  1
 16 17  1  0
 16 20  1  0
 17 18  1  0
 17 23  2  0
 18 19  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
 25 26  1  0
 25 29  1  0
 25 30  1  1
 26 27  1  0
 29 31  3  0
 31 32  1  0
M  END
>  <Name>  (545) 
Mifepristone

>  <InChIKey>  (545) 
VKHAHZOOUSRJNA-GCNJZUOMSA-N

>  <PubChem_CID>  (545) 
55245

>  <CYP1A2>  (545) 


>  <CYP2A6>  (545) 


>  <CYP2B6>  (545) 


>  <CYP2C8>  (545) 


>  <CYP2C9>  (545) 


>  <CYP2C19>  (545) 


>  <CYP2D6>  (545) 


>  <CYP2E1>  (545) 


>  <CYP3A4>  (545) 
<24,26;Cleavage;R1>
<26,H;Oxidation;R1>
<24,25;Cleavage;R2>
<25,H;Oxidation;R2>
<0,H;Hydroxylation;R3>

>  <References>  (545) 
Jang GR, Wrighton SA, Benet LZ: Identification of CYP3A4 as the principal enzyme catalyzing mifepristone (RU 486) oxidation in human liver microsomes. Biochem Pharmacol. 1996 Sep 13;52(5):753-61. doi: 10.1016/0006-2952(96)00357-7. (PMID: 8765473)

>  <Comments>  (545) 


$$$$
CC02418
     RDKit          3D

 63 65  0  0  0  0  0  0  0  0999 V2000
   -1.3610   -0.5520   -1.0170 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.1870   -1.8940   -0.3030 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.0270   -0.1220   -1.6300 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.7940    0.4350   -0.0780 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4400   -1.7110    1.1950 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.1450   -2.3720   -0.5060 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6460    0.9040   -0.7160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2740    0.5030   -3.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5030    1.4290   -0.8200 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.4380   -2.5530    1.9870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2810   -0.3110    1.5460 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0790   -3.7990   -0.4840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2220    2.0410   -1.5630 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.0170   -0.4770   -3.8750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9230    2.5620    0.1190 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.6580    0.8410   -1.4160 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1640   -1.8920    3.3140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9960    0.2140    2.5520 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6260    2.3880   -1.0610 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.3200    3.2720   -1.4470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5210   -0.8660   -4.9060 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6530    3.6380   -0.6920 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.7970    2.0480    1.1270 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2350    1.8120   -2.2880 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.0920   -1.5650    3.6540 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0760   -1.6560    4.0700 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7400    1.6290    3.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8460   -0.4490    3.0990 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9710    1.5000    0.1080 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6600    3.7780   -0.6400 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7970    2.9760   -1.4680 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.1980    4.6550    0.2170 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1640    2.3350   -3.2460 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3560   -0.9310    4.9330 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.6970    1.9840    4.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3810    1.6920    1.2830 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8000    4.4800   -0.7360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7770    2.4860   -0.5510 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0560    5.2320    0.9390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7470    5.7250   -0.6270 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4520    0.1240    4.7640 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0790   -0.2610    5.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7120    0.8240    2.4240 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8360    5.9220   -0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7980    3.9550   -1.1730 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0370    2.5450   -1.2220 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.1150    1.0130    3.5950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1150    1.9170   -0.3360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3670    3.9060   -1.4920 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.4560    1.9550   -1.0780 C   0  0  2  0  0  0  0  0  0  0  0  0
   -8.5320    3.9130   -2.3150 C   0  0  1  0  0  0  0  0  0  0  0  0
   -9.7320    3.3970   -1.5190 C   0  0  2  0  0  0  0  0  0  0  0  0
  -10.5150    1.5040   -0.1930 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3880    1.0460   -2.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8120    5.3410   -2.7880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.9340    4.2320   -0.3480 O   0  0  0  0  0  0  0  0  0  0  0  0
  -10.4720    0.2700    0.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.7400    5.3030   -0.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.5720   -0.1980    1.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5520   -0.4670    0.0670 O   0  0  0  0  0  0  0  0  0  0  0  0
  -10.9500    6.1700    0.7950 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.2970    5.5720   -1.4570 O   0  0  0  0  0  0  0  0  0  0  0  0
  -11.9050    7.3140    0.4470 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  1
  2  5  1  0
  2  6  1  1
  3  7  1  0
  3  8  1  6
  9  4  1  1
  5 10  1  0
  5 11  1  1
  6 12  1  0
  7 13  1  0
  8 14  1  0
  9 15  1  0
  9 16  1  0
 10 17  1  0
 11 18  1  0
 13 19  1  0
 13 20  1  1
 14 21  2  0
 15 22  1  0
 15 23  1  1
 16 24  1  0
 17 25  1  0
 17 26  2  0
 18 27  1  0
 18 28  2  0
 19 29  1  0
 19 30  1  1
 22 31  1  0
 22 32  1  1
 24 31  1  0
 24 33  1  6
 25 34  1  0
 27 35  1  0
 29 36  2  0
 30 37  1  0
 31 38  1  1
 32 39  1  0
 32 40  1  0
 34 41  1  0
 34 42  1  6
 36 43  1  0
 37 44  1  0
 37 45  2  0
 46 38  1  1
 41 47  1  0
 43 47  2  0
 46 48  1  0
 46 49  1  0
 48 50  1  0
 49 51  1  0
 50 52  1  0
 50 53  1  0
 50 54  1  6
 51 52  1  0
 51 55  1  1
 52 56  1  1
 53 57  1  0
 56 58  1  0
 57 59  1  0
 57 60  2  0
 58 61  1  0
 58 62  2  0
 61 63  1  0
M  END
>  <Name>  (546) 
Miocamycin

>  <InChIKey>  (546) 
GQNZGCARKRHPOH-QZYHRENMSA-N

>  <PubChem_CID>  (546) 


>  <CYP1A2>  (546) 


>  <CYP2A6>  (546) 


>  <CYP2B6>  (546) 


>  <CYP2C8>  (546) 


>  <CYP2C9>  (546) 


>  <CYP2C19>  (546) 


>  <CYP2D6>  (546) 


>  <CYP2E1>  (546) 


>  <CYP3A4>  (546) 
<18,19;Cleavage;R1>
<41,42;Cleavage;R2>
<46,47;Cleavage;R2>

>  <References>  (546) 
Kasahara M, Suzuki H, Komiya I: Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms. Drug Metab Dispos. 2000 Apr;28(4):409-17. (PMID: 10725309)

>  <Comments>  (546) 
Detected metabolites are Mb-2, Mb-12, and Mb-6.

$$$$
CC02419
     RDKit          3D

 23 24  0  0  0  0  0  0  0  0999 V2000
   -0.2880    0.9710   -0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0920   -0.4120   -0.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7850    1.8210   -0.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7810    1.1860   -0.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2160   -0.9210   -0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4100   -1.0560   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0820    1.3130   -0.2060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5620    3.3070   -0.3560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3840   -0.1330   -0.0620 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2920   -0.0540   -0.0980 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4230   -2.2580    0.0800 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5930   -2.2540    0.0920 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1410    2.1570   -0.2780 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6980   -0.5970   -0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4710    2.5220    1.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1600   -0.8900   -1.4650 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2920   -0.3940   -1.8990 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6720   -0.5410   -3.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2130    0.3260   -0.9480 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2490    0.7120   -4.1180 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6300    0.5640   -5.5690 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3540    1.5490   -6.4390 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1830   -0.4400   -5.9490 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6  9  1  0
  6 12  2  0
  7 10  2  0
  7 13  1  0
 10 14  1  0
 13 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
M  END
>  <Name>  (547) 
Mycophenolic acid

>  <InChIKey>  (547) 
HPNSFSBZBAHARI-RUDMXATFSA-N

>  <PubChem_CID>  (547) 
446541

>  <CYP1A2>  (547) 


>  <CYP2A6>  (547) 


>  <CYP2B6>  (547) 


>  <CYP2C8>  (547) 


>  <CYP2C9>  (547) 


>  <CYP2C19>  (547) 


>  <CYP2D6>  (547) 


>  <CYP2E1>  (547) 


>  <CYP3A4>  (547) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (547) 
Picard N, Cresteil T, Premaud A, Marquet P: Characterization of a phase 1 metabolite of mycophenolic acid produced by CYP3A4/5. Ther Drug Monit. 2004 Dec;26(6):600-8. (PMID: 15570183)

>  <Comments>  (547) 


$$$$
CC02420
     RDKit          3D

 14 15  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3860    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1800    2.0940    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3170    1.8060    0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2140   -0.6780   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2850   -0.4580    0.0120 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3860    1.4120   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1660    3.4540    0.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0910    0.6650   -0.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4010    0.0290   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5300    3.8800   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7150   -0.7080   -0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1400   -0.9470   -1.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3160   -0.5410   -1.8740 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  6  9  1  0
  7 10  2  0
  8 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
M  END
>  <Name>  (548) 
Myristicin

>  <InChIKey>  (548) 
BNWJOHGLIBDBOB-UHFFFAOYSA-N

>  <PubChem_CID>  (548) 
4276

>  <CYP1A2>  (548) 


>  <CYP2A6>  (548) 


>  <CYP2B6>  (548) 


>  <CYP2C8>  (548) 


>  <CYP2C9>  (548) 


>  <CYP2C19>  (548) 


>  <CYP2D6>  (548) 


>  <CYP2E1>  (548) 


>  <CYP3A4>  (548) 
<12,13;Cleavage;R1>
<12,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <References>  (548) 
Yun CH, Lee HS, Lee HY, Yim SK, Kim KH, Kim E, Yea SS, Guengerich FP: Roles of human liver cytochrome P450 3A4 and 1A2 enzymes in the oxidation of myristicin. Toxicol Lett. 2003 Feb 3;137(3):143-50. (PMID: 12523956)

>  <Comments>  (548) 


$$$$
CC02421
     RDKit          3D

 10 11  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4010    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1940   -0.6610   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3990    0.0380   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4200    1.3990   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2090    2.1130    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2280    2.1150    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1900    3.5180    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2070    3.4760    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0020    4.1750    0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  8  1  0
  7  9  2  0
  8 10  2  0
  9 10  1  0
M  END
>  <Name>  (549) 
Naphthalene

>  <InChIKey>  (549) 
UFWIBTONFRDIAS-UHFFFAOYSA-N

>  <PubChem_CID>  (549) 
931

>  <CYP1A2>  (549) 
<2,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>
<4,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>
<7,H;Hydroxylation;R5>
<6,H;Hydroxylation;R6>
<9,H;Hydroxylation;R7>
<1,H;Hydroxylation;R8>
<1,2;EpOxidation;;R9>
<0,9;EpOxidation;R10>
<4,5;EpOxidation;R11>
<6,7;EpOxidation;R12>

>  <CYP2A6>  (549) 
<2,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>
<4,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>
<7,H;Hydroxylation;R5>
<6,H;Hydroxylation;R6>
<9,H;Hydroxylation;R7>
<1,H;Hydroxylation;R8>
<1,2;EpOxidation;;R9>
<0,9;EpOxidation;R10>
<4,5;EpOxidation;R11>
<6,7;EpOxidation;R12>

>  <CYP2B6>  (549) 
<2,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>
<4,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>
<7,H;Hydroxylation;R5>
<6,H;Hydroxylation;R6>
<9,H;Hydroxylation;R7>
<1,H;Hydroxylation;R8>
<1,2;EpOxidation;;R9>
<0,9;EpOxidation;R10>
<4,5;EpOxidation;R11>
<6,7;EpOxidation;R12>

>  <CYP2C8>  (549) 
<2,H;Hydroxylation;R1>
<4,H;Hydroxylation;R2>
<7,H;Hydroxylation;R7>
<9,H;Hydroxylation;R8>

>  <CYP2C9>  (549) 
<2,H;Hydroxylation;R1>
<4,H;Hydroxylation;R2>
<7,H;Hydroxylation;R7>
<9,H;Hydroxylation;R8>

>  <CYP2C19>  (549) 
<2,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>
<4,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>
<7,H;Hydroxylation;R5>
<6,H;Hydroxylation;R6>
<9,H;Hydroxylation;R7>
<1,H;Hydroxylation;R8>
<1,2;EpOxidation;;R9>
<0,9;EpOxidation;R10>
<4,5;EpOxidation;R11>
<6,7;EpOxidation;R12>

>  <CYP2D6>  (549) 
<2,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>
<4,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>
<7,H;Hydroxylation;R5>
<6,H;Hydroxylation;R6>
<9,H;Hydroxylation;R7>
<1,H;Hydroxylation;R8>
<1,2;EpOxidation;;R9>
<0,9;EpOxidation;R10>
<4,5;EpOxidation;R11>
<6,7;EpOxidation;R12>

>  <CYP2E1>  (549) 
<2,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>
<4,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>
<7,H;Hydroxylation;R5>
<6,H;Hydroxylation;R6>
<9,H;Hydroxylation;R7>
<1,H;Hydroxylation;R8>
<1,2;EpOxidation;;R9>
<0,9;EpOxidation;R10>
<4,5;EpOxidation;R11>
<6,7;EpOxidation;R12>

>  <CYP3A4>  (549) 
<2,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>
<4,H;Hydroxylation;R3>
<5,H;Hydroxylation;R4>
<7,H;Hydroxylation;R5>
<6,H;Hydroxylation;R6>
<9,H;Hydroxylation;R7>
<1,H;Hydroxylation;R8>
<1,2;EpOxidation;;R9>
<0,9;EpOxidation;R10>
<4,5;EpOxidation;R11>
<6,7;EpOxidation;R12>

>  <References>  (549) 
Cho TM, Rose RL, Hodgson E: In vitro metabolism of naphthalene by human liver microsomal cytochrome P450 enzymes. Drug Metab Dispos. 2006 Jan;34(1):176-83. doi: 10.1124/dmd.105.005785. Epub 2005  Oct 21. (PMID: 16243959)

>  <Comments>  (549) 
We considered the first reaction which is EpOxidation. More CYPs are considered based on the reference. Rates of metabolites in CYP2C8 and 2C9 are low.

$$$$
CC02423
     RDKit          3D

 25 26  0  0  1  0  0  0  0  0999 V2000
   -0.7820   -1.9510   -0.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1490   -2.8680   -1.5020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9850   -2.5390   -2.8430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4580   -1.3000   -3.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0960   -0.3880   -2.2060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2510   -0.6920   -0.8460 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1400    0.3360    0.1970 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6210    0.6530    0.2200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0630    1.8990   -0.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1870    2.9500   -0.2850 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1870    2.7810   -0.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7310    1.5790    0.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5080    2.2740   -0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9790    4.0380   -0.3030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5890   -0.3720    0.6480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3880   -1.5220   -0.0380 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4570   -0.1810    1.4870 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1830    1.4430    0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4080    0.4110    1.1830 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0400    2.1510   -0.1720 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7990    0.2440    1.4470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1960   -1.9230    1.7210 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9020   -3.1580    1.1000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3140   -2.5300    0.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9740   -2.3720    0.8680 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1 25  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  7 12  1  0
  8  9  2  0
  8 15  1  0
  9 10  1  0
  9 13  1  0
 10 11  1  0
 11 12  2  0
 11 14  1  0
 12 18  1  0
 15 16  1  0
 15 17  2  0
 16 24  1  0
 18 19  1  0
 18 20  2  0
 19 21  1  0
 22 25  1  0
 23 25  2  0
M  CHG  2  22  -1  25   1
M  END
>  <Name>  (550) 
Nifedipine

>  <InChIKey>  (550) 
HYIMSNHJOBLJNT-UHFFFAOYSA-N

>  <PubChem_CID>  (550) 
4485

>  <CYP1A2>  (550) 


>  <CYP2A6>  (550) 


>  <CYP2B6>  (550) 


>  <CYP2C8>  (550) 


>  <CYP2C9>  (550) 


>  <CYP2C19>  (550) 


>  <CYP2D6>  (550) 


>  <CYP2E1>  (550) 


>  <CYP3A4>  (550) 
<7,H;Oxidation;R1>
<15,H;Oxidation;R1>

>  <References>  (550) 
Guengerich FP, Martin MV, Beaune PH, Kremers P, Wolff T, Waxman DJ: Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J Biol Chem. 1986 Apr 15;261(11):5051-60. (PMID: 3514607)

>  <Comments>  (550) 
Forms an aromatic ring.

$$$$
CC02424
     RDKit          3D

 26 27  0  0  0  0  0  0  0  0999 V2000
    0.2340    0.4850    1.9770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3420    0.8170    2.7570 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5890    0.9840    2.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7080    0.8150    0.7850 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6100    0.4850   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3590    0.3170    0.5920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8230   -0.0450   -0.2780 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.3720   -1.4200    0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6350   -1.5680    0.4840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5030   -0.4870    0.5920 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1240    0.7830    0.1710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8840    1.0360   -0.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2330   -2.8850    0.8500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2090    1.8060    0.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4940   -2.5850   -0.1650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3550   -2.3230   -1.1890 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5360   -3.6180    0.4850 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5250    2.3600   -0.8250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6100    2.2020   -1.8140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9880    3.4210   -0.4400 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2310    3.4540   -2.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0050    0.9850    0.1580 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0750    0.8170   -1.0680 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9600    1.2870    0.8850 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2350   -3.4170   -1.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1940   -3.0070   -2.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4 22  1  0
  5  6  2  0
  7  6  1  1
  7  8  1  0
  7 12  1  0
  8  9  2  0
  8 15  1  0
  9 10  1  0
  9 13  1  0
 10 11  1  0
 11 12  2  0
 11 14  1  0
 12 18  1  0
 15 16  1  0
 15 17  2  0
 16 25  1  0
 18 19  1  0
 18 20  2  0
 19 21  1  0
 22 23  1  0
 22 24  2  0
 25 26  1  0
M  CHG  2  22   1  23  -1
M  END
>  <Name>  (551) 
Nitrendipine

>  <InChIKey>  (551) 
PVHUJELLJLJGLN-MRXNPFEDSA-N

>  <PubChem_CID>  (551) 
157704

>  <CYP1A2>  (551) 


>  <CYP2A6>  (551) 


>  <CYP2B6>  (551) 


>  <CYP2C8>  (551) 


>  <CYP2C9>  (551) 


>  <CYP2C19>  (551) 


>  <CYP2D6>  (551) 


>  <CYP2E1>  (551) 


>  <CYP3A4>  (551) 
<8,H;Oxidation;R1>
<16,H;Oxidation;R1>

>  <References>  (551) 
Guengerich FP, Brian WR, Iwasaki M, Sari MA, Baarnhielm C, Berntsson P: Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4. J Med Chem. 1991 Jun;34(6):1838-44. doi: 10.1021/jm00110a012. (PMID: 2061924)

>  <Comments>  (551) 
Xenosite reports sites 7 and 10 as SoMs. We use <10,H> here because we assume the reaction starts with 10.

$$$$
CC02425
     RDKit          3D

 28 29  0  0  0  0  0  0  0  0999 V2000
    0.4390    2.3970   -1.0080 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.6250    0.9020   -1.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7930    3.0810   -1.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4910    2.7950   -2.1250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1210    2.7990    0.2440 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2260    0.0940   -0.2870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6430    0.3370   -1.7630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6040    4.5990   -1.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7370    2.6770   -0.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8200    2.7580   -1.9380 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0410    3.1480   -3.1890 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0560   -1.2770   -0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8130   -1.0350   -1.7720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9590    5.2830   -1.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0920    3.3600   -0.2650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7160    3.1420   -3.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9660   -1.8420   -1.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9030    4.8790   -0.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1100    3.0150   -2.5600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4400    4.5920   -3.4150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4860    2.2270   -4.2190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2230    2.9140   -2.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6170    2.7870   -1.7450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5240    3.1760   -2.8340 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5460    2.0550   -3.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8700    3.2620   -2.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1420    2.5250   -5.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9910    4.5520   -1.4380 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  1
  2  6  2  0
  2  7  1  0
  3  8  1  0
  3  9  1  0
  4 10  1  0
  4 11  2  0
  6 12  1  0
  7 13  2  0
  8 14  1  0
  9 15  1  0
 10 16  1  0
 12 17  2  0
 13 17  1  0
 14 18  1  0
 15 18  1  0
 16 19  1  0
 16 20  1  0
 16 21  1  0
 19 22  3  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 25 27  1  0
 26 28  1  0
M  END
>  <Name>  (552) 
NS-21

>  <InChIKey>  (552) 
DMEPDNFRHUGNPT-XMMPIXPASA-N

>  <PubChem_CID>  (552) 
3075626

>  <CYP1A2>  (552) 


>  <CYP2A6>  (552) 


>  <CYP2B6>  (552) 


>  <CYP2C8>  (552) 


>  <CYP2C9>  (552) 


>  <CYP2C19>  (552) 


>  <CYP2D6>  (552) 


>  <CYP2E1>  (552) 


>  <CYP3A4>  (552) 
<2,3;Cleavage;R1>
<3,H;Oxidation;R1>
<1,2;Cleavage;R2>
<1,H;Oxidation;R2>
<25,H;Hydroxylation;R3>

>  <References>  (552) 
Nakamura A, Hirota T, Morino A, Imaoka S, Funae Y, Yamamoto Y, Tasaki T, Masuda M, Kazusaka A, Fujita S: Cytochrome P450 isoforms responsible for the N-deethylation and cyclohexane-hydroxylation of NS-21. Xenobiotica. 1999 Mar;29(3):243-52. doi: 10.1080/004982599238641. (PMID: 10219965)

>  <Comments>  (552) 


$$$$
CC02426
     RDKit          3D

 25 27  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4790    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2010    2.1270    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2130    2.1890    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6640   -0.7130   -1.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5700   -0.6950    0.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3450    1.4230    0.0280 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2320    3.5180   -0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1720    3.5710    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8570   -0.2800   -1.6730 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0280   -1.8570   -1.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2390    0.0350    2.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6900    0.8880   -1.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0470    4.2280   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4540    4.3630    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3840   -0.9960   -2.7500 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5700   -2.5560   -2.6720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6820   -0.4530    2.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8620    4.6360    1.4470 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7520   -2.1160   -3.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3350    0.2580    3.3790 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9820    5.3310    1.7030 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1820    4.2300    2.3590 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6520    1.6050    2.8880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6180   -0.4180    3.6170 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  5 10  2  0
  5 11  1  0
  6 12  1  0
  7 13  1  0
  8 14  2  0
  9 14  1  0
  9 15  1  0
 10 13  1  0
 10 16  1  0
 11 17  2  0
 12 18  1  0
 15 19  1  0
 16 20  2  0
 17 20  1  0
 18 21  1  0
 19 22  1  0
 19 23  2  0
 21 24  1  0
 21 25  1  0
M  END
>  <Name>  (553) 
Olopatadine

>  <InChIKey>  (553) 
JBIMVDZLSHOPLA-LSCVHKIXSA-N

>  <PubChem_CID>  (553) 
5281071

>  <CYP1A2>  (553) 


>  <CYP2A6>  (553) 


>  <CYP2B6>  (553) 


>  <CYP2C8>  (553) 


>  <CYP2C9>  (553) 


>  <CYP2C19>  (553) 


>  <CYP2D6>  (553) 


>  <CYP2E1>  (553) 


>  <CYP3A4>  (553) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <References>  (553) 
Kajita J, Inano K, Fuse E, Kuwabara T, Kobayashi H: Effects of olopatadine, a new antiallergic agent, on human liver microsomal cytochrome P450 activities. Drug Metab Dispos. 2002 Dec;30(12):1504-11. doi: 10.1124/dmd.30.12.1504. (PMID: 12433826)

>  <Comments>  (553) 


$$$$
CC02427
     RDKit          3D

 33 37  0  0  0  0  0  0  0  0999 V2000
    4.3200   -4.1610    1.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9150   -3.9620    0.3900 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5020   -4.7880   -0.6680 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9700   -2.9840    0.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5850   -2.7940   -1.2510 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6500   -1.8270   -1.5640 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0970   -1.0490   -0.5640 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4780   -1.2350    0.7530 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4090   -2.2040    1.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0770    0.0060   -0.9090 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.3780    1.2470   -0.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5930    1.9540    0.7800 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.9520    1.3500    0.8030 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.2570    0.6810   -0.5620 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.3240   -0.5470   -0.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5950    1.8040   -0.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8940    3.0830    0.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8040    3.9960    0.8960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5710    3.4480    0.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6550    1.1530   -1.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9830    1.1960   -0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2380    2.5940    0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1960    3.4440    0.5610 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3820    2.9990    0.2230 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7480    0.3620   -0.4690 C   0  0  2  0  0  0  0  0  0  0  0  0
   -4.3420    1.4300    0.4810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1500    2.2920    0.9550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9910    1.6580   -1.7090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9550   -1.0380    0.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3550    0.4560   -1.7590 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4520   -1.3390    0.1980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6590   -2.7390    0.7800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0570   -3.0200    0.8590 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  9  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
 10  7  1  1
  8  9  2  0
 10 11  1  0
 10 15  1  0
 11 12  1  0
 11 16  2  0
 12 13  1  0
 12 19  1  6
 13 14  1  0
 13 27  1  6
 14 15  1  0
 14 25  1  0
 14 28  1  6
 16 17  1  0
 16 20  1  0
 17 18  1  0
 17 23  2  0
 18 19  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
 25 26  1  0
 25 29  1  0
 25 30  1  6
 26 27  1  0
 29 31  1  0
 31 32  1  0
 32 33  1  0
M  END
>  <Name>  (554) 
Onapristone

>  <InChIKey>  (554) 
IEXUMDBQLIVNHZ-MKNNCVFRSA-N

>  <PubChem_CID>  (554) 


>  <CYP1A2>  (554) 


>  <CYP2A6>  (554) 


>  <CYP2B6>  (554) 


>  <CYP2C8>  (554) 


>  <CYP2C9>  (554) 


>  <CYP2C19>  (554) 


>  <CYP2D6>  (554) 


>  <CYP2E1>  (554) 


>  <CYP3A4>  (554) 
<1,2;Cleavage;R1>
<2,H;Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <References>  (554) 
Jang GR, Benet LZ: Cytochrome P4503A4-mediated N-demethylation of the antiprogestins lilopristone and onapristone. Drug Metab Dispos. 1997 Oct;25(10):1119-22. (PMID: 9321513)

>  <Comments>  (554) 


$$$$
CC02428
     RDKit          3D

 23 26  0  0  0  0  0  0  0  0999 V2000
   -0.0190    1.5500    0.0110 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.0000    1.4830   -1.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.4160   -0.5100   -1.3550 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.7840    0.0600   -1.7430 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.5500   -1.5900   -3.5230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4350    1.9850   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7800    1.7440    1.3360 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.9900   -0.1650   -3.2400 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.3780   -0.3470    0.4770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1830   -1.9610   -4.7420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8360    0.6400    1.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0690    1.5500    2.5170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4820   -2.0420   -1.3420 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7480    1.3960    3.4620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1090    0.7490   -4.0910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5010   -2.5500   -2.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1470   -0.9980   -5.8420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7210    2.3120   -2.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8970   -1.3710   -6.9690 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4170    0.4610   -5.5700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4060    3.0310    1.3690 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8060    2.1530   -1.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0
  1  7  1  0
  1  8  1  0
  1 23  1  6
  5  2  1  6
  2  7  1  0
  2 19  2  0
  3  4  1  0
  3 10  1  6
  4  5  1  0
  4 14  1  1
  5  9  1  0
  6  9  1  0
  6 11  2  0
  6 17  1  0
  8 12  1  0
  8 13  1  0
  8 22  1  6
  9 16  1  6
 10 12  2  0
 11 18  1  0
 13 15  3  0
 14 17  1  0
 16 21  1  0
 18 20  2  0
 18 21  1  0
M  END
>  <Name>  (555) 
ORG-30659

>  <InChIKey>  (555) 
YJSTYQGZKJHXLN-SSFAQJFESA-N

>  <PubChem_CID>  (555) 


>  <CYP1A2>  (555) 


>  <CYP2A6>  (555) 


>  <CYP2B6>  (555) 


>  <CYP2C8>  (555) 


>  <CYP2C9>  (555) 


>  <CYP2C19>  (555) 


>  <CYP2D6>  (555) 


>  <CYP2E1>  (555) 


>  <CYP3A4>  (555) 
<9,H;Hydroxylation;R1>

>  <References>  (555) 
Verhoeven CH, van Munster TT, Groothuis GM, Vos RM, Rietjens IM: Identification of the human P450 enzymes involved in the in vitro metabolism of the synthetic steroidal hormones Org 4060 and Org 30659. Xenobiotica. 2002 Feb;32(2):109-18. doi: 10.1080/00498250110093026. (PMID: 11871398)

>  <Comments>  (555) 


$$$$
CC02429
     RDKit          3D

 26 27  0  0  0  0  0  0  0  0999 V2000
    2.5440   -1.4420    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8060   -0.0620    0.5580 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.5930   -2.2120   -0.4550 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3530   -3.4790   -0.9520 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0630   -3.9770   -0.9830 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0140   -3.2070   -0.5170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2540   -1.9390   -0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7390    0.2920    1.5620 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0850   -0.0380    1.1950 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7860    0.9530   -0.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8950    2.3680   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4760    0.8170   -1.3660 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4560    1.8320   -2.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8750    3.3830   -1.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5660    3.2470   -1.9390 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4720    0.4730    1.1580 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5570    0.8140    2.1250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8500    0.9580    1.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8810    1.0730    0.8870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1740    1.2170    0.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5210   -0.0490   -0.4600 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8640   -1.0000    0.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1410   -0.5380    1.3110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7550    0.1950   -1.2200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1280   -1.0650   -2.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0240    0.4120    2.7300 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  7  1  0
  2  8  1  0
  2  9  1  1
  2 10  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  8 16  1  0
  8 26  2  0
 10 11  1  0
 10 12  1  0
 11 14  1  0
 12 13  1  0
 13 15  1  0
 14 15  1  0
 16 17  1  0
 17 18  1  0
 18 19  3  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 24  1  0
 22 23  1  0
 24 25  1  0
M  END
>  <Name>  (556) 
Oxybutynin

>  <InChIKey>  (556) 
XIQVNETUBQGFHX-JOCHJYFZSA-N

>  <PubChem_CID>  (556) 
206530

>  <CYP1A2>  (556) 


>  <CYP2A6>  (556) 


>  <CYP2B6>  (556) 


>  <CYP2C8>  (556) 


>  <CYP2C9>  (556) 


>  <CYP2C19>  (556) 


>  <CYP2D6>  (556) 


>  <CYP2E1>  (556) 


>  <CYP3A4>  (556) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <References>  (556) 
Yaich M, Popon M, Medard Y, Aigrain EJ: In-vitro cytochrome P450 dependent metabolism of oxybutynin to N-deethyloxybutynin in humans. Pharmacogenetics. 1998 Oct;8(5):449-51. (PMID: 9825837)

>  <Comments>  (556) 


$$$$
CC02430
     RDKit          3D

 11 11  0  0  0  0  0  0  0  0999 V2000
   -2.0170   -2.1920   -0.0230 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.7640   -1.0370   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0780    0.3280   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5760   -1.4440    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6980    0.8400    0.0020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.0350    1.2690   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9370   -3.1060    0.0190 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.6150   -0.5120    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4140    2.9300    0.0170 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.2960    0.8520    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5510    2.0020    0.0200 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  3  5  1  0
  3  6  1  0
  4  7  1  0
  4  8  2  0
  6  9  1  0
  6 10  2  0
  8 10  1  0
 10 11  1  0
M  END
>  <Name>  (557) 
Pentachlorobenzene

>  <InChIKey>  (557) 
CEOCDNVZRAIOQZ-UHFFFAOYSA-N

>  <PubChem_CID>  (557) 
11855

>  <CYP1A2>  (557) 


>  <CYP2A6>  (557) 


>  <CYP2B6>  (557) 


>  <CYP2C8>  (557) 


>  <CYP2C9>  (557) 


>  <CYP2C19>  (557) 


>  <CYP2D6>  (557) 


>  <CYP2E1>  (557) 


>  <CYP3A4>  (557) 
<2,H;Hydroxylation;R1>

>  <References>  (557) 
Mehmood Z, Williamson MP, Kelly DE, Kelly SL: Metabolism of organochlorine pesticides: the role of human cytochrome P450 3A4. Chemosphere. 1996 Aug;33(4):759-69. (PMID: 8759309)

>  <Comments>  (557) 


$$$$
CC02432
     RDKit          3D

 18 18  0  0  0  0  0  0  0  0999 V2000
   -0.0850    1.2210    0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1730    1.7530    0.1210 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2480   -0.0940   -0.3000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1410    1.9780    0.2720 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3380    3.1200    0.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9120   -0.9030   -0.6800 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.4090    3.5960    1.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4390    4.0450   -0.1820 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6140   -2.3800   -0.4130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2080   -0.7040   -2.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5370    4.9550    1.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6380    5.3880    0.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6010   -2.8120   -1.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8260   -3.2250   -0.8090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3180   -2.5790    1.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6620    5.7990    0.7880 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3770    1.4250    0.3050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4140    0.9620    0.3320 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  0
  3  6  1  0
  4 17  1  0
  5  7  2  0
  5  8  1  0
  6  9  1  0
  6 10  1  6
  7 11  1  0
  8 12  2  0
  9 13  1  0
  9 14  1  0
  9 15  1  0
 11 16  2  0
 12 16  1  0
 17 18  3  0
M  END
>  <Name>  (558) 
Pinacidil

>  <InChIKey>  (558) 
IVVNZDGDKPTYHK-SNVBAGLBSA-N

>  <PubChem_CID>  (558) 
12428581

>  <CYP1A2>  (558) 


>  <CYP2A6>  (558) 


>  <CYP2B6>  (558) 


>  <CYP2C8>  (558) 


>  <CYP2C9>  (558) 


>  <CYP2C19>  (558) 


>  <CYP2D6>  (558) 


>  <CYP2E1>  (558) 


>  <CYP3A4>  (558) 
<5,6;Reduction;R1>
<11,N;N-Oxidation;R2>

>  <References>  (558) 
Zhang Z, Li Y, Stearns RA, Ortiz De Montellano PR, Baillie TA, Tang W: Cytochrome P450 3A4-mediated oxidative conversion of a cyano to an amide group in the metabolism of pinacidil. Biochemistry. 2002 Feb 26;41(8):2712-8. doi: 10.1021/bi0119971. (PMID: 11851418)

>  <Comments>  (558) 


$$$$
CC02433
     RDKit          3D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4010    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2960    1.7970   -0.0010 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1870    2.0310    0.0290 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3020   -0.3860   -0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2280   -0.6840    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0630    0.6700   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7850    3.1780    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3150    1.3520    0.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3470    0.0320    0.0240 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2720   -2.0680    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8510    3.6930    1.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3280    5.0400    1.4440 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4270    5.6190    2.7470 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8810    4.9340    3.6070 P   0  0  1  0  0  0  0  0  0  0  0  0
    4.0100    5.5810    5.0920 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6940    3.3360    3.8380 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1090    5.1990    2.8250 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1890    5.0600    6.1540 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.8820    2.8800    4.9360 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3680    3.5430    6.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6060    5.6790    7.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6580    5.9540    8.4310 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0410    6.5160    9.6350 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3720    6.8040    9.8710 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3210    6.5300    8.9020 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9380    5.9660    7.6990 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9930    6.8920    9.1980 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5  7  2  0
  6 10  1  0
  6 11  1  0
  8 12  1  0
  9 10  2  0
 12 13  1  0
 13 14  1  0
 15 14  1  6
 15 16  1  0
 15 17  1  0
 15 18  2  0
 16 19  1  0
 17 20  1  0
 19 21  1  0
 19 22  1  1
 20 21  1  0
 22 23  2  0
 22 27  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
M  END
>  <Name>  (559) 
Pradefovir

>  <InChIKey>  (559) 
GWNHAOBXDGOXRR-POXGOYDTSA-N

>  <PubChem_CID>  (559) 
58823201

>  <CYP1A2>  (559) 


>  <CYP2A6>  (559) 


>  <CYP2B6>  (559) 


>  <CYP2C8>  (559) 


>  <CYP2C9>  (559) 


>  <CYP2C19>  (559) 


>  <CYP2D6>  (559) 


>  <CYP2E1>  (559) 


>  <CYP3A4>  (559) 
<19,27;Cleavage;R1>
<16,17;Cleavage;R2>

>  <References>  (559) 
Lin CC, Fang C, Benetton S, Xu GF, Yeh LT: Metabolic activation of pradefovir by CYP3A4 and its potential as an inhibitor or inducer. Antimicrob Agents Chemother. 2006 Sep;50(9):2926-31. doi: 10.1128/AAC.01566-05. (PMID: 16940083)

>  <Comments>  (559) 
The left/side metabolites of PMEA are not identified.

$$$$
CC02434
     RDKit          3D

 28 29  0  0  0  0  0  0  0  0999 V2000
    0.3040    0.8760    0.7280 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1420   -0.0860   -0.2800 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0350   -0.1270   -1.3510 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0890    0.7800   -1.4240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2540    1.7350   -0.4260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3640    1.7810    0.6450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6030    0.8770    1.7570 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3260    1.9030    2.7020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9280   -0.9850   -0.1800 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2620   -1.9830   -1.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7290   -2.3320   -2.0990 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4750   -2.7230   -0.5810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5980   -2.0710   -0.5980 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3630   -4.1300   -0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4640   -5.0640   -0.8530 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1090   -4.2630    1.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6530   -2.7610   -0.1000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9010   -2.0940   -0.1140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0360   -0.8160   -0.6800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2600   -0.1600   -0.6950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3590   -0.7970   -0.1330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2600   -2.0620    0.4390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0290   -2.7160    0.4510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8500   -3.9580    1.0050 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0600   -4.4760    1.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6390   -0.1250   -0.1380 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7140    0.9660   -0.7190 O   0  0  0  0  0  0  0  0  0  0  0  0
  -10.5800   -0.6860    0.4390 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  2  9  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  7  8  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 12 14  1  0
 13 17  1  0
 14 15  2  0
 14 16  1  0
 17 18  1  0
 18 19  2  0
 18 23  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 26  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 26 27  2  0
 26 28  1  0
M  CHG  2  26   1  28  -1
M  END
>  <Name>  (560) 
PY74

>  <InChIKey>  (560) 
KWEMUXODTDSRRP-HEHNFIMWSA-N

>  <PubChem_CID>  (560) 


>  <CYP1A2>  (560) 


>  <CYP2A6>  (560) 


>  <CYP2B6>  (560) 


>  <CYP2C8>  (560) 


>  <CYP2C9>  (560) 


>  <CYP2C19>  (560) 


>  <CYP2D6>  (560) 


>  <CYP2E1>  (560) 


>  <CYP3A4>  (560) 
<23,H;Hydroxylation;R1>

>  <References>  (560) 
Cui Y, Churchwell MI, Couch LH, Doerge DR, Howard PC: Metabolism of pigment yellow 74 by rat and human microsomal proteins. Drug Metab Dispos. 2005 Oct;33(10):1459-65. doi: 10.1124/dmd.104.003285. Epub 2005 Jul 13. (PMID: 16014769)

>  <Comments>  (560) 


$$$$
CC02435
     RDKit          3D

 28 30  0  0  0  0  0  0  0  0999 V2000
    0.5780    2.3420    0.8800 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7110    0.8990    0.6430 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.7960    2.9070    1.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6280    0.2110    0.9140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1240    0.6570   -0.8110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3530    3.9280    0.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5230    2.4880    2.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9800    0.3470    2.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6090    4.4920    0.7430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6720    4.3940   -0.7420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8130    3.1190    2.6110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0460    1.4800    3.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3190   -0.3410    2.6680 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2840    4.0750    1.8140 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1450    5.5130   -0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2230    5.3830   -1.5030 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5310    2.6900    3.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7880    1.1110    4.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6570   -0.2100    4.0920 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4610    5.9400   -1.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5620    5.8320   -2.6030 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0160    1.7100    4.5350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0360   -0.6460    4.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7060   -0.9540    4.9290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1910    6.8690   -3.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9120    1.1900    5.9280 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -5.0090    0.4320    3.8650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8320   -0.4890    6.3810 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  2  5  1  6
  3  6  2  0
  3  7  1  0
  4  8  1  0
  6  9  1  0
  6 10  1  0
  7 11  2  0
  7 12  1  0
  8 13  1  0
  9 14  2  0
  9 15  1  0
 10 16  2  0
 11 14  1  0
 11 17  1  0
 12 18  2  0
 13 19  1  0
 15 20  2  0
 16 20  1  0
 16 21  1  0
 17 22  2  0
 18 22  1  0
 19 23  1  0
 19 24  1  0
 21 25  1  0
 22 26  1  0
 23 27  1  0
 24 28  1  0
M  END
>  <Name>  (561) 
Quinacrine

>  <InChIKey>  (561) 
GPKJTRJOBQGKQK-MRXNPFEDSA-N

>  <PubChem_CID>  (561) 
446536

>  <CYP1A2>  (561) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2A6>  (561) 


>  <CYP2B6>  (561) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2C8>  (561) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2C9>  (561) 


>  <CYP2C19>  (561) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2D6>  (561) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <CYP2E1>  (561) 


>  <CYP3A4>  (561) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<2,3;Cleavage;R2>
<3,H;Oxidation;R2>

>  <References>  (561) 
Huang Y, Okochi H, May BC, Legname G, Prusiner SB, Benet LZ, Guglielmo BJ, Lin ET: Quinacrine is mainly metabolized to mono-desethyl quinacrine by CYP3A4/5 and its brain accumulation is limited by P-glycoprotein. Drug Metab Dispos. 2006 Jul;34(7):1136-44. doi: 10.1124/dmd.105.008664. Epub 2006 Mar 31. (PMID: 16581945)

>  <Comments>  (561) 
Rate of M-1(<2,1>) is low.

$$$$
CC02436
     RDKit          3D

 26 28  0  0  0  0  0  0  0  0999 V2000
    1.2050   -0.4330    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1520    0.1070   -0.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2980    0.4520   -0.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4300   -1.8050    0.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3500   -0.8050   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3090    1.4460   -0.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0710    1.8030   -0.2170 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5920   -0.0520    0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7090   -2.2770    0.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7040   -1.0660    1.4540 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.8200    2.2900   -0.2980 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7890   -1.4080    0.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1360    0.1850    2.0830 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8190   -2.0770    1.5290 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6570    3.4910   -0.4310 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9780    0.3620    3.4100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6490   -3.3040    1.0130 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8670   -1.7830    2.0540 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4130    1.6240    4.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4770   -0.5160    4.0850 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2510    1.8100    5.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9840    2.6360    3.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6590    2.9900    6.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3880    3.8120    3.8680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2300    3.9880    5.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7420    5.4700    5.9770 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  2  0
  4  9  1  0
 10  5  1  6
  6 11  1  0
  7 11  1  0
  8 12  1  0
  9 12  2  0
 10 13  1  0
 10 14  1  0
 11 15  2  0
 13 16  1  0
 14 17  1  0
 14 18  2  0
 16 19  1  0
 16 20  2  0
 19 21  2  0
 19 22  1  0
 21 23  1  0
 22 24  2  0
 23 25  2  0
 24 25  1  0
 25 26  1  0
M  END
>  <Name>  (562) 
Rebamipide

>  <InChIKey>  (562) 
ALLWOAVDORUJLA-MRXNPFEDSA-N

>  <PubChem_CID>  (562) 
969464

>  <CYP1A2>  (562) 


>  <CYP2A6>  (562) 


>  <CYP2B6>  (562) 


>  <CYP2C8>  (562) 


>  <CYP2C9>  (562) 


>  <CYP2C19>  (562) 


>  <CYP2D6>  (562) 


>  <CYP2E1>  (562) 


>  <CYP3A4>  (562) 
<11,H;Hydroxylation;R1>
<13,H;Hydroxylation;R2>

>  <References>  (562) 
Koyama N, Sasabe H, Miyamoto G: Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver. Xenobiotica. 2002 Jul;32(7):573-86. doi: 10.1080/00498250210130591. (PMID: 12162853)

>  <Comments>  (562) 


$$$$
CC02437
     RDKit          3D

 23 25  0  0  0  0  0  0  0  0999 V2000
    4.4990   -2.4930   -1.8760 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2210   -1.3170   -0.9390 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8110   -1.1790   -0.7520 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6270   -0.1230    0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7190    0.5760    0.5720 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5300    1.6490    1.4230 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2530    2.0260    1.7910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1580    1.3320    1.3090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3400    0.2600    0.4510 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2640   -0.4200   -0.0280 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8850    0.1000    0.6440 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.0070   -0.9410    0.6130 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.5390   -2.2140    1.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6370   -3.1890    1.3520 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0090   -3.4540   -0.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4410   -2.1490   -0.7150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3430   -1.2370   -0.7420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3470    1.3560   -0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1410    1.5130   -1.4070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5640    2.6660   -2.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1920    3.6620   -1.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3980    3.5060    0.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9810    2.3500    0.6740 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  9  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 11 10  1  6
 11 12  1  0
 11 18  1  0
 12 13  1  6
 12 17  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 18 19  2  0
 18 23  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
M  END
>  <Name>  (563) 
Reboxetine

>  <InChIKey>  (563) 
CBQGYUDMJHNJBX-OALUTQOASA-N

>  <PubChem_CID>  (563) 
65856

>  <CYP1A2>  (563) 


>  <CYP2A6>  (563) 


>  <CYP2B6>  (563) 


>  <CYP2C8>  (563) 


>  <CYP2C9>  (563) 


>  <CYP2C19>  (563) 


>  <CYP2D6>  (563) 


>  <CYP2E1>  (563) 


>  <CYP3A4>  (563) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<6,H;Hydroxylation;R2>
<5,H;Hydroxylation;R3>

>  <References>  (563) 
Wienkers LC, Allievi C, Hauer MJ, Wynalda MA: Cytochrome P-450-mediated metabolism of the individual enantiomers of the antidepressant agent reboxetine in human liver microsomes. Drug Metab Dispos. 1999 Nov;27(11):1334-40. (PMID: 10534319)

>  <Comments>  (563) 


$$$$
CC02438
     RDKit          3D

 26 28  0  0  0  0  0  0  0  0999 V2000
   -0.3260    1.4130   -0.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5770    1.7410    0.3350 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0620   -0.0500   -0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7360    2.3030    0.3560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4160    1.7780   -1.7430 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5990   -0.4930    1.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5100   -1.0090   -0.9650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4330    3.7700    0.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7000    3.2550   -1.9300 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8210   -1.8500    1.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2930   -2.3680   -0.7490 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3170    4.0800   -1.2890 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3740   -2.7800    0.3990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0590    5.4780   -1.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6430   -4.4530    0.6710 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.0780    5.9310   -2.8370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4670    7.3880   -2.8970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5080    7.9550   -4.3000 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.1930    9.4130   -4.3280 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3230    7.2500   -5.2010 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0640   10.2800   -4.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9580    9.9250   -3.7180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7950   11.6460   -5.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2330   11.2890   -3.7650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3510   12.1360   -4.4260 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6120   13.4500   -4.4710 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  3  6  2  0
  3  7  1  0
  4  8  1  0
  5  9  1  0
  6 10  1  0
  7 11  2  0
  8 12  1  0
  9 12  1  0
 10 13  2  0
 11 13  1  0
 12 14  1  0
 13 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  6
 19 21  2  0
 19 22  1  0
 21 23  1  0
 22 24  2  0
 23 25  2  0
 24 25  1  0
 25 26  1  0
M  END
>  <Name>  (564) 
Reduced haloperidol

>  <InChIKey>  (564) 
WNZBBTJFOIOEMP-FQEVSTJZSA-N

>  <PubChem_CID>  (564) 
16048564

>  <CYP1A2>  (564) 


>  <CYP2A6>  (564) 


>  <CYP2B6>  (564) 


>  <CYP2C8>  (564) 


>  <CYP2C9>  (564) 


>  <CYP2C19>  (564) 


>  <CYP2D6>  (564) 


>  <CYP2E1>  (564) 


>  <CYP3A4>  (564) 
<0,1;Oxidation;R1>
<5,N;N-Oxidation;R2>
<8,9;Reduction;R2>
<4,5;Cleavage;R3>
<4,H;Oxidation;R3>

>  <References>  (564) 
Fang J, McKay G, Song J, Remillrd A, Li X, Midha K: In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes. Drug Metab Dispos. 2001 Dec;29(12):1638-43. (PMID: 11717183)

>  <Comments>  (564) 
<1,4;Dehydrogenation>, <8,12;Dehydrogenation>, and <9,5;Dehydrogenation> are not included here because the reaction starts with <2,1;Cleavage>.

$$$$
CC02439
     RDKit          3D

 25 27  0  0  0  0  0  0  0  0999 V2000
   -0.0190    1.5390    0.0100 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.4020    2.0460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6060    1.9450   -1.3170 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3550   -0.5000    0.1470 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5420   -0.4000   -1.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4660    1.6490    0.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5650    2.9030   -0.9750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1190    0.8510   -2.2300 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2520    3.1060   -1.6870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7440   -1.1980    1.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4530    0.8040    0.3490 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0540   -1.8640    1.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0070   -1.2780    2.1920 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7390    0.8740    0.7360 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9130   -1.8930    0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4830   -2.4440    2.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7540   -0.0510    0.1130 C   0  0  2  0  0  0  0  0  0  0  0  0
    5.0790    1.6720    1.5770 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3210   -1.4740    0.3530 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6250   -2.4160    3.6120 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1240    0.1840    0.7540 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8330    0.2000   -1.2910 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1660   -2.3440    0.8510 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4700    1.5660    0.6440 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  6
  2  5  1  0
  2  6  1  6
  3  7  1  0
  3  8  2  0
  4  9  1  0
  4 10  1  0
  5 11  1  0
  6  9  1  0
  7 12  1  0
  8 10  1  0
 11 13  1  0
 11 14  2  0
 12 15  1  0
 13 16  1  0
 13 17  2  0
 15 18  1  0
 15 19  2  0
 16 20  1  0
 17 21  1  0
 18 20  1  0
 18 22  1  0
 18 23  1  6
 20 24  2  0
 22 25  1  0
M  END
>  <Name>  (565) 
Riddelliine

>  <InChIKey>  (565) 
SVCNNZDUGWLODJ-RAYFHMIRSA-N

>  <PubChem_CID>  (565) 
5281744

>  <CYP1A2>  (565) 


>  <CYP2A6>  (565) 


>  <CYP2B6>  (565) 


>  <CYP2C8>  (565) 


>  <CYP2C9>  (565) 


>  <CYP2C19>  (565) 


>  <CYP2D6>  (565) 


>  <CYP2E1>  (565) 


>  <CYP3A4>  (565) 
<12,N;N-Oxidation;R1>
<8,9;Cleavage;R2>
<16,17;Cleavage;R2>
<15,24;Oxidation;R2>
<13,14;Oxidation;R2>
<14,15;Reduction;R2>

>  <References>  (565) 
Xia Q, Chou MW, Kadlubar FF, Chan PC, Fu PP: Human liver microsomal metabolism and DNA adduct formation of the tumorigenic pyrrolizidine alkaloid, riddelliine. Chem Res Toxicol. 2003 Jan;16(1):66-73. doi: 10.1021/tx025605i. (PMID: 12693032)

>  <Comments>  (565) 
The observed stable metabolites are DHP and riddelliine N-oxide.

$$$$
CC02441
     RDKit          3D

 68 74  0  0  0  0  0  0  0  0999 V2000
   -1.2720   -0.9450   -0.7610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0520   -1.5260   -0.3530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5320   -1.5790   -0.6410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2060    0.3230   -1.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1450   -0.8030   -0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0290   -2.8220   -0.0790 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5680   -1.1760   -1.4680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1720   -2.6280    0.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0080    1.0790   -1.2470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3420    0.7600   -2.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1190    0.5670   -0.5450 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2450   -1.3420   -0.0330 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2040   -3.3820    0.1380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6510   -1.9730   -1.4200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4830   -0.0330   -2.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5950   -2.8040   -0.2600 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.7500   -3.2520    1.1320 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1230    2.2120   -1.7790 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5370    1.8880   -2.8740 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2120    1.2420   -0.1330 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3440   -2.5780    0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2910   -4.7680    0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6410    0.3820   -3.1110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6020   -2.4230    0.7080 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8100   -4.2740   -0.6520 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1990    2.4650    0.4210 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6010   -3.1840    0.2680 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5510   -5.3680    0.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1750   -5.5180    0.3530 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1650   -1.2170    1.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3210    3.3680    0.3930 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1580    2.7840    1.0400 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7080   -4.5800    0.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7300   -0.0040    0.6220 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2860    4.8090    0.5270 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6770    2.7510    0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8870   -5.1950    0.3750 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4020    1.3430    0.7910 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.2630    5.8340    0.4770 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9020   -6.6660    0.3630 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1380   -4.4520    0.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3250    2.4490    0.6640 C   0  0  1  0  0  0  0  0  0  0  0  0
   -7.3520    1.5130   -0.2760 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9680    5.5960    0.1870 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1100   -7.1680    1.1710 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2640   -5.1300    0.9610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9480    3.8680    0.5460 C   0  0  2  0  0  0  0  0  0  0  0  0
   -4.4080    2.3790    1.9010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5130    0.6910   -0.1180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3180    6.3800    0.0100 C   0  0  1  0  0  0  0  0  0  0  0  0
    7.3130   -6.5570    0.5930 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7900    4.9100    0.5760 C   0  0  1  0  0  0  0  0  0  0  0  0
   -6.8780    4.1220    1.6210 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4520    5.3220    0.0030 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.5480    7.3600    1.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5120   -7.2370    1.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9080    4.8010   -0.6960 C   0  0  2  0  0  0  0  0  0  0  0  0
   -5.3070    6.3620    0.6590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0090    4.6510    1.4400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7400    5.8310   -0.7010 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.6770    4.9280    1.3500 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7250   -7.0690    0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7430    5.0590   -1.8310 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4820    5.0140    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7480    4.8710    2.4280 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3620    6.0950   -2.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8190   -8.0620    0.6060 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3280   -5.6510    0.2180 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  4 10  2  0
  5 11  2  0
  5 12  1  0
  6 13  1  0
  7 14  1  0
  7 15  2  0
  8 16  1  0
  8 17  2  0
  9 11  1  0
  9 18  2  0
 10 15  1  0
 10 19  1  0
 11 20  1  0
 12 21  1  0
 13 21  2  0
 13 22  1  0
 14 16  1  0
 15 23  1  0
 16 24  1  0
 16 25  1  6
 20 26  1  0
 21 27  1  0
 22 28  2  0
 22 29  1  0
 24 30  1  0
 26 31  1  0
 26 32  2  0
 27 33  2  0
 28 33  1  0
 30 34  2  0
 31 35  2  0
 31 36  1  0
 33 37  1  0
 34 38  1  0
 35 39  1  0
 37 40  1  0
 37 41  1  0
 38 42  1  0
 38 43  1  6
 39 44  2  0
 40 45  1  0
 41 46  1  0
 42 47  1  0
 42 48  1  1
 43 49  1  0
 44 50  1  0
 45 51  1  0
 46 51  1  0
 47 52  1  0
 47 53  1  1
 50 54  1  0
 50 55  1  1
 51 56  1  0
 52 57  1  0
 52 58  1  6
 53 59  1  0
 54 60  1  0
 54 61  1  1
 56 62  1  0
 57 60  1  0
 57 63  1  6
 59 64  1  0
 59 65  2  0
 60 66  1  6
 62 67  1  0
 62 68  1  0
M  END
>  <Name>  (566) 
Rifalazil

>  <InChIKey>  (566) 
UEFHFKKWYKVLDC-GZBMFKKJSA-N

>  <PubChem_CID>  (566) 


>  <CYP1A2>  (566) 


>  <CYP2A6>  (566) 


>  <CYP2B6>  (566) 


>  <CYP2C8>  (566) 


>  <CYP2C9>  (566) 


>  <CYP2C19>  (566) 


>  <CYP2D6>  (566) 


>  <CYP2E1>  (566) 


>  <CYP3A4>  (566) 
<56,H;Hydroxylation;R1>

>  <References>  (566) 
Mae T, Inaba T, Konishi E, Hosoe K, Hidaka T: Identification of enzymes responsible for rifalazil metabolism in human liver microsomes. Xenobiotica. 2000 Jun;30(6):565-74. doi: 10.1080/004982500406408. (PMID: 10923859)

>  <Comments>  (566) 


$$$$
CC02442
     RDKit          3D

 23 25  0  0  0  0  0  0  0  0999 V2000
    0.0810    1.0570    0.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1580   -0.2600    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2780    1.9040    0.4830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1330    1.5480    0.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3490   -0.7600   -0.4750 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9830   -1.0590    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4650    1.3630   -0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2340    3.1720    0.9410 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2370    0.7440    1.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4680   -0.0160   -0.5030 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3950   -2.1370   -0.9720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1680   -0.5530    0.5130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6930    2.1680   -0.0530 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4980   -0.4970   -0.9400 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3240    2.4850    1.0950 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1400    2.5480   -1.1190 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5190    3.2100    1.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7580    2.0710    2.3810 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0740    3.6980    2.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1570    3.4390   -0.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2550    4.4140    2.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3380    4.1550   -0.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8840    4.6450    0.9840 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  7 10  1  0
  7 13  1  0
  9 12  1  0
 10 14  2  0
 13 15  1  0
 13 16  2  0
 15 17  1  0
 15 18  1  0
 17 19  2  0
 17 20  1  0
 19 21  1  0
 20 22  2  0
 21 23  2  0
 22 23  1  0
M  END
>  <Name>  (567) 
Roquinimex

>  <InChIKey>  (567) 
SGOOQMRIPALTEL-UHFFFAOYSA-N

>  <PubChem_CID>  (567) 
54676478

>  <CYP1A2>  (567) 


>  <CYP2A6>  (567) 


>  <CYP2B6>  (567) 


>  <CYP2C8>  (567) 


>  <CYP2C9>  (567) 


>  <CYP2C19>  (567) 


>  <CYP2D6>  (567) 


>  <CYP2E1>  (567) 


>  <CYP3A4>  (567) 
<11,H;Hydroxylation;R1>
<10,H;Hydroxylation;R2>
<9,H;Hydroxylation;R3>
<20,H;Hydroxylation;R4>
<13,14;Cleavage;R5>
<14,H;Oxidation;R5>

>  <References>  (567) 
Tuvesson H, Wienkers LC, Gunnarsson PO, Seidegard J, Persson R: Identification of cytochrome P4503A as the major subfamily responsible for the metabolism of roquinimex in man. Xenobiotica. 2000 Sep;30(9):905-14. doi: 10.1080/004982500433327. (PMID: 11055268)

>  <Comments>  (567) 


$$$$
CC02443
     RDKit          3D

 29 33  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3800    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2400    2.0210    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1950    2.0380    0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1940   -0.7370   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1310   -0.9930   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2910    3.4980    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4290    1.2880   -0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0390    3.2860    0.6650 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.9530   -2.0630   -0.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4330   -0.0820   -0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4090   -2.3030   -0.4080 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.0640    4.1630   -0.1420 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.3220    4.1230    0.1630 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3420    4.0690    0.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9860   -3.4810    0.3340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0740    5.5380    0.4680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1390    5.1570    1.6820 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8440   -3.5710    1.8320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6100   -4.4270   -0.3230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0980    5.9400    1.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9690    6.4010    0.1700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0700    7.2340    1.8340 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9980    7.6790    0.6980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0340    8.0960    1.5340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0250    8.5200    0.4040 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0220    9.3520    2.0560 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9080    7.8070   -0.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1960    9.4770    2.8600 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6 12  1  0
 13  7  1  1
  7 14  2  0
  8 11  2  0
  9 13  1  0
  9 15  1  6
 10 12  1  0
 12 16  1  1
 13 17  1  0
 15 18  1  0
 16 19  1  0
 16 20  2  0
 17 21  2  0
 17 22  1  0
 18 21  1  0
 21 23  1  0
 22 24  2  0
 23 25  2  0
 24 25  1  0
 24 26  1  0
 25 27  1  0
 26 28  1  0
 27 29  1  0
M  END
>  <Name>  (568) 
Rotenone

>  <InChIKey>  (568) 
JUVIOZPCNVVQFO-MAODMQOUSA-N

>  <PubChem_CID>  (568) 
7057975

>  <CYP1A2>  (568) 


>  <CYP2A6>  (568) 


>  <CYP2B6>  (568) 


>  <CYP2C8>  (568) 


>  <CYP2C9>  (568) 


>  <CYP2C19>  (568) 


>  <CYP2D6>  (568) 


>  <CYP2E1>  (568) 


>  <CYP3A4>  (568) 
<25,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>
<0,1;EpOxidation;R3>
<21,22;Cleavage;R4>
<22,H;Oxidation;R4>

>  <References>  (568) 
Caboni P, Sherer TB, Zhang N, Taylor G, Na HM, Greenamyre JT, Casida JE: Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease. Chem Res Toxicol. 2004 Nov;17(11):1540-8. doi: 10.1021/tx049867r. (PMID: 15540952)

>  <Comments>  (568) 


$$$$
CC02444
     RDKit          3D

 58 60  0  0  0  0  0  0  0  0999 V2000
    0.7300    2.1000   -1.2600 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.2270    1.1790   -0.4960 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.0520    1.5540   -1.2050 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7320    3.4900   -0.6280 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.9560    0.2780   -1.4900 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.5910    0.3120    0.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3450    1.0430   -2.5140 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.0370    4.4670   -1.5450 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1760    3.9490   -0.4110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5200   -1.0710   -1.3240 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4710    0.3540   -1.2880 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.7400    0.4200   -2.4940 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3140    2.1160   -3.4410 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6750    5.4800   -1.0320 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1170    4.3270   -2.7420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7930   -1.7470   -2.5500 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.9180    1.8120   -1.3100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8450   -0.2990    0.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1100   -0.3560   -2.3540 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0820   -0.1430   -3.8720 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.5120    1.6660   -4.7630 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.4560    6.3520   -1.8860 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.4710   -2.4420   -3.0540 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.8810   -2.6340   -2.4370 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4340    1.9210   -1.4490 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.7860    0.8690   -4.9710 C   0  0  1  0  0  0  0  0  0  0  0  0
    5.4930   -0.4400   -3.8970 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3240   -1.4500   -4.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2910    0.9100   -5.2860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9440    6.0050   -1.7090 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.2280    7.8090   -1.4780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8150   -3.5980   -2.1090 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.2520   -2.9460   -4.3730 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6460   -3.7790   -1.6540 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.7850    2.8520   -2.5790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0500    2.4160   -0.1360 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8960    1.7760   -5.0830 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7960   -0.8920   -5.2180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2850    4.8230   -2.6100 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.1720    5.6530   -0.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7320    7.1400   -2.0620 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2310    8.1890   -1.7400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3870   -4.5420   -2.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9860   -4.3220   -2.6270 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6250   -3.4590   -0.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7250    4.3510   -2.4330 C   0  0  1  0  0  0  0  0  0  0  0  0
   -5.1580    2.3540   -3.7040 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0980    5.2100   -3.9810 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010   -5.1380   -1.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4870   -5.2570   -3.6450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5900    4.9740   -3.5420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2330    0.9500   -3.8670 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6710    0.7120   -5.2060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7670   -0.6960   -5.4330 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9450   -1.1430   -4.7590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1080   -2.6510   -4.9630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0260   -3.3370   -4.3300 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2340   -4.7320   -4.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  1
  1  4  1  0
  2  5  1  0
  2  6  1  1
  7  3  1  1
  4  8  1  0
  4  9  1  6
  5 10  1  1
  5 11  1  0
  7 12  1  0
  7 13  1  0
  8 14  1  0
  8 15  2  0
 16 10  1  1
 11 17  1  0
 11 18  1  1
 11 19  1  0
 12 20  1  0
 13 21  1  0
 14 22  1  0
 16 23  1  0
 16 24  1  0
 17 25  1  0
 20 26  1  0
 20 27  1  0
 20 28  1  6
 21 26  1  0
 21 29  1  1
 22 30  1  0
 22 31  1  1
 23 32  1  0
 23 33  1  6
 24 34  1  0
 25 35  1  0
 25 36  1  1
 26 37  1  1
 27 38  1  0
 30 39  1  0
 30 40  1  1
 30 41  1  0
 31 42  1  0
 32 43  1  0
 32 44  1  6
 34 43  1  0
 34 45  1  1
 35 46  1  0
 35 47  2  0
 39 46  1  0
 39 48  1  6
 44 49  1  0
 44 50  1  0
 46 51  1  6
 47 52  1  0
 52 53  1  0
 53 54  1  0
 54 55  1  0
 55 56  1  0
 56 57  1  0
 57 58  1  0
M  END
>  <Name>  (569) 
Roxithromycin

>  <InChIKey>  (569) 
RXZBMPWDPOLZGW-FZWLNVMRSA-N

>  <PubChem_CID>  (569) 


>  <CYP1A2>  (569) 


>  <CYP2A6>  (569) 


>  <CYP2B6>  (569) 


>  <CYP2C8>  (569) 


>  <CYP2C9>  (569) 


>  <CYP2C19>  (569) 


>  <CYP2D6>  (569) 


>  <CYP2E1>  (569) 


>  <CYP3A4>  (569) 
<31,33;Cleavage;R1>
<33,H;Oxidation;R1>
<31,32;Cleavage;R2>
<32,H;Oxidation;R2>

>  <References>  (569) 
Yamazaki H, Shimada T: Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin. Drug Metab Dispos. 1998 Nov;26(11):1053-7. (PMID: 9806945)

>  <Comments>  (569) 


$$$$
CC02445
     RDKit          3D

 31 35  0  0  0  0  0  0  0  0999 V2000
   -1.9160    1.2630   -0.0580 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.3090   -0.1350   -0.0420 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.9660   -3.6470   -0.8540 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.2060   -2.3470   -1.1420 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.0820    0.0720   -0.6980 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.4160   -3.4740   -1.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8980   -1.1790   -0.4260 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.7050    2.2370    0.0320 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.5070    1.5340   -1.3440 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2440   -2.5040   -0.6930 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.0330   -1.1950   -0.8510 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5680    1.3470   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7520    2.9900   -1.1980 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3100   -1.0070   -0.9930 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1410   -2.2490   -0.6610 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.1170   -4.3490   -1.9080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1220    2.8930   -1.6420 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.2950   -4.7920   -1.5920 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4740   -5.5680   -2.4110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0840    1.5050    1.3080 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.2310   -2.1000   -2.5190 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.9290   -6.1890   -3.3490 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1360   -0.6080    1.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8550   -3.9370    0.6440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2110   -6.0100   -1.6980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2660   -2.8990    0.6810 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3970   -2.1490   -1.2690 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2150    3.1560   -3.1460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7090    3.1580    0.8990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9240    4.6320   -3.4250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0170    4.8950   -4.9290 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  8  1  0
  1  9  1  0
  1 20  1  1
  2  5  1  0
  2 11  1  0
  2 23  1  1
  3  4  1  0
  3  6  1  0
  3 18  1  0
  3 24  1  1
  4  7  1  0
  4 10  1  0
  4 21  1  6
  5  7  1  0
  5 12  1  1
  6 15  1  0
  6 16  2  0
  7 14  1  6
  8 12  1  6
  8 13  1  0
  9 17  1  0
 10 11  1  0
 10 26  1  1
 13 17  1  0
 14 15  1  0
 15 27  1  6
 16 19  1  0
 17 28  1  6
 18 25  1  0
 19 22  2  0
 19 25  1  0
 20 29  1  0
 28 30  1  0
 30 31  1  0
M  END
>  <Name>  (570) 
RPR-106541

>  <InChIKey>  (570) 
QGBIFMJAQARMNQ-QISPFCDLSA-N

>  <PubChem_CID>  (570) 
9846880

>  <CYP1A2>  (570) 


>  <CYP2A6>  (570) 


>  <CYP2B6>  (570) 


>  <CYP2C8>  (570) 


>  <CYP2C9>  (570) 


>  <CYP2C19>  (570) 


>  <CYP2D6>  (570) 


>  <CYP2E1>  (570) 


>  <CYP3A4>  (570) 
<28,S;S-Oxidation;R1>

>  <References>  (570) 
Stevens JC, Domanski TL, Harlow GR, White RB, Orton E, Halpert JR: Use of the steroid derivative RPR 106541 in combination with site-directed mutagenesis for enhanced cytochrome P-450 3A4 structure/function analysis. J Pharmacol Exp Ther. 1999 Aug;290(2):594-602. (PMID: 10411567)

>  <Comments>  (570) 


$$$$
CC02446
     RDKit          3D

 30 31  0  0  0  0  0  0  0  0999 V2000
    9.3840    0.8820   -0.1380 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9510   -0.0980   -0.9400 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1940    0.6330    0.5190 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3210   -1.3270   -1.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5660   -0.5900    0.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1320   -1.5710   -0.4210 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1210    0.1450   -1.5880 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.0680    2.2150    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2980    3.0450    0.8930 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2690   -0.8600    1.0920 C   0  0  1  0  0  0  0  0  0  0  0  0
    5.0970   -0.4400    0.2020 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1680   -2.2540    1.3860 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8330   -0.7030    0.9020 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7540   -0.2800   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4010   -0.5270    0.6690 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2780   -0.0870   -0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0750   -0.3330    0.3980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1980    0.1070   -0.5430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5510   -0.1400    0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6000    0.2710   -0.7520 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8320    0.0170   -0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0020    0.4370   -0.9640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3200    0.1650   -0.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.4910    0.5850   -1.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.7890    0.3160   -0.4120 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.3510    1.2920    0.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.4220   -0.9040   -0.5620 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.5420    1.0460    1.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.6130   -1.1500    0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.1710   -0.1760    0.9030 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  8  1  0
  2  4  1  0
  2  7  1  0
  3  5  2  0
  4  6  2  0
  5  6  1  0
  5 10  1  0
  8  9  1  0
 10 11  1  0
 10 12  1  6
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 26 28  1  0
 27 29  2  0
 28 30  2  0
 29 30  1  0
M  END
>  <Name>  (571) 
Salmeterol

>  <InChIKey>  (571) 
GIIZNNXWQWCKIB-RUZDIDTESA-N

>  <PubChem_CID>  (571) 
9812133

>  <CYP1A2>  (571) 


>  <CYP2A6>  (571) 


>  <CYP2B6>  (571) 


>  <CYP2C8>  (571) 


>  <CYP2C9>  (571) 


>  <CYP2C19>  (571) 


>  <CYP2D6>  (571) 


>  <CYP2E1>  (571) 


>  <CYP3A4>  (571) 
<19,H;Hydroxylation;R1>

>  <References>  (571) 
Manchee GR, Eddershaw PJ, Ranshaw LE, Herriott D, Park GR, Bayliss MK, Tarbit MH: The aliphatic oxidation of salmeterol to alpha-hydroxysalmeterol in human liver microsomes is catalyzed by CYP3A. Drug Metab Dispos. 1996 May;24(5):555-9. (PMID: 8723736)

>  <Comments>  (571) 


$$$$
CC02447
     RDKit          3D

 49 53  0  0  0  0  0  0  0  0999 V2000
   -1.6550    0.7110    0.5420 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1690   -0.6300    0.8370 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.2290    0.5760    0.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3220    1.1570   -0.6880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5080   -1.1750    2.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6610   -0.5610    1.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5310    0.1100    1.4710 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.1670    2.6730   -0.8310 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.0030   -1.2670    1.8810 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.4100   -1.6750    0.9240 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1880    0.4980    1.3100 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2860    1.1110    2.6030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9850    3.1580   -2.0290 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.7890    2.9940   -1.0340 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6940   -1.7350    3.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8600   -1.6080    1.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9970    0.6370    3.8720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4040    2.5690   -3.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9340    4.6210   -2.0950 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4420   -0.7280    4.2830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4700   -0.6440    0.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4660   -3.0000    0.9340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1580   -1.1090    2.5370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2820    2.9460   -4.4820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9250    5.3030   -2.7020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0380    4.1140   -5.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3260    2.1220   -4.8570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8720    6.8080   -2.7700 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.8600    4.7070   -3.1940 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8420    4.4600   -6.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1310    2.4690   -5.9260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0560    7.3070   -3.4740 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8430    7.3820   -1.3520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8900    3.6390   -6.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0020    7.5400   -4.8010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6860    8.8790   -1.4190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2080    8.0200   -5.5180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9660    7.3580   -5.4080 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5450    9.5930   -0.2850 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6880    9.4410   -2.4940 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3250    8.2130   -4.8440 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1330    8.2640   -6.8980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4330    8.6430   -5.4470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2360    8.7050   -7.5700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4250    8.9030   -6.8420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6220    8.8460   -4.7210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5970    9.3540   -7.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.7380    9.2840   -5.3630 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.7270    9.5380   -6.7340 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  1
  7  3  1  6
  4  8  1  0
  9  5  1  1
  6 10  1  0
  6 11  2  0
  7  9  1  0
  7 12  1  0
  8 13  1  0
  8 14  1  6
  9 15  1  0
 10 16  1  0
 12 17  1  0
 13 18  1  6
 13 19  1  0
 15 20  1  0
 16 21  1  0
 16 22  1  0
 16 23  1  0
 17 20  1  0
 18 24  1  0
 19 25  1  0
 24 26  2  0
 24 27  1  0
 25 28  1  0
 25 29  2  0
 26 30  1  0
 27 31  2  0
 28 32  1  0
 28 33  1  1
 30 34  2  0
 31 34  1  0
 32 35  1  0
 33 36  1  0
 35 37  1  0
 35 38  2  0
 36 39  1  0
 36 40  2  0
 37 41  2  0
 37 42  1  0
 41 43  1  0
 42 44  2  0
 43 45  2  0
 43 46  1  0
 44 45  1  0
 45 47  1  0
 46 48  2  0
 47 49  2  0
 48 49  1  0
M  END
>  <Name>  (572) 
Saquinavir

>  <InChIKey>  (572) 
QWAXKHKRTORLEM-UGJKXSETSA-N

>  <PubChem_CID>  (572) 
441243

>  <CYP1A2>  (572) 


>  <CYP2A6>  (572) 


>  <CYP2B6>  (572) 


>  <CYP2C8>  (572) 


>  <CYP2C9>  (572) 


>  <CYP2C19>  (572) 


>  <CYP2D6>  (572) 


>  <CYP2E1>  (572) 


>  <CYP3A4>  (572) 
<13,H;Hydroxylation;R1>

>  <References>  (572) 
Fitzsimmons ME, Collins JM: Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism. Drug Metab Dispos. 1997 Feb;25(2):256-66. (PMID: 9029057)

>  <Comments>  (572) 


$$$$
CC02448
     RDKit          3D

 89 89  0  0  0  0  0  0  0  0999 V2000
    6.3920   -2.5080   -0.8920 C   0  0  2  0  0  0  0  0  0  0  0  0
    6.6500   -1.2140   -1.6250 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9610   -2.5490   -0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4930   -2.9140    0.1300 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.6680    0.1090   -1.3280 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9410   -1.4390   -3.0530 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0650   -2.7360   -1.3500 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6170   -2.3380    0.8000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4860   -4.4270    0.4800 C   0  0  1  0  0  0  0  0  0  0  0  0
    8.7650   -2.6880   -0.4870 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4100    0.9020   -0.0370 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.9210    0.8340   -2.3200 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5960   -2.6820   -1.3690 C   0  0  2  0  0  0  0  0  0  0  0  0
    8.8980   -4.8430    0.9450 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5220   -4.7670    1.6490 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0070    1.4010    0.0420 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8780    0.0890    1.2020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8340   -3.8020   -0.6840 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2650   -2.7220   -2.8740 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9250   -6.3210    1.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7730    2.5810    0.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9240    0.5720   -0.5080 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4100    0.2130    1.2800 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3150    0.5440    2.5660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9430   -3.4670    0.2530 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9910   -4.9940   -1.0300 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7610   -2.5440   -3.1450 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0420   -6.9140    1.7270 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4600    3.1460    1.1890 C   0  0  1  0  0  0  0  0  0  0  0  0
    5.7640    3.3180    0.8310 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0490   -4.4200    0.8020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9610   -2.0870    0.7510 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0340   -8.3900    2.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5990    3.8690    0.2160 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7160    1.9940    1.9110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4500   -3.8180    0.7770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8730    4.9280    0.6030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4930    3.4310   -1.1840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8030    2.4310    3.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1680   -3.8280   -0.3540 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9180   -3.2720    1.8040 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8220    5.5880   -0.2840 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.0430    5.4120    1.7420 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6550    3.1090    4.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1350    1.1850    3.6770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4800   -3.1450   -0.4690 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.6400   -4.5220   -1.5430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4770    4.8560   -0.3060 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6380    7.0620    0.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6620   -4.0780   -0.1980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5070   -2.5470   -1.8960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3560    4.6160    0.6850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8310    4.2930   -1.6190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2580    7.8180   -0.8620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9360   -3.7100   -0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4670   -5.3140   -0.1640 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3380   -1.2550   -1.9270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4510    3.6140    0.3660 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.3140    5.1120    1.8350 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4550    9.2670   -0.3780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4170    7.8280   -2.2460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6760   -2.4260    0.0210 C   0  0  2  0  0  0  0  0  0  0  0  0
   -4.1950   -0.5720   -3.3010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8130   -0.3210   -0.8260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8310    4.1090    0.4760 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3770    2.4260    1.3560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3580   -1.5370    1.2130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1760   -2.7940    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6810    3.6580   -0.4470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1310    1.7490    1.2120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8730   -0.3120    1.3710 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5960   -1.9440    2.1160 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4790   -3.5830   -1.2830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5390   -3.6560    1.2270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1820    3.8630   -0.3240 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.2030    3.0210   -1.4110 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0480    1.3190   -0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7760    0.3500    0.3940 C   0  0  2  0  0  0  0  0  0  0  0  0
   -6.5060    0.3920    2.6090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8380    2.6780    0.2820 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4160    5.0800    0.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3750    0.8620   -0.4770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1480    1.5290   -0.3360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.0600    0.8170    1.1110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4270    0.5670   -1.8730 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9480    1.3840   -1.5630 O   0  0  0  0  0  0  0  0  0  0  0  0
  -10.1230    1.2700    0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.3720    1.7720    0.8350 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.5090    0.0810   -0.8140 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  1
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  1  0
  4 10  1  6
  5 11  1  0
  5 12  2  0
  7 13  1  0
  9 14  1  0
  9 15  1  1
 11 16  1  0
 11 17  1  1
 13 18  1  0
 13 19  1  6
 14 20  1  0
 16 21  1  0
 16 22  1  0
 17 23  1  0
 17 24  1  0
 18 25  1  0
 18 26  2  0
 19 27  1  0
 20 28  2  0
 21 29  1  0
 21 30  2  0
 25 31  1  0
 25 32  1  0
 28 33  1  0
 29 34  1  0
 29 35  1  6
 31 36  1  0
 34 37  1  0
 34 38  1  0
 35 39  1  0
 36 40  1  0
 36 41  2  0
 37 42  1  0
 37 43  2  0
 39 44  1  0
 39 45  1  0
 40 46  1  0
 40 47  1  0
 42 48  1  0
 42 49  1  1
 46 50  1  0
 46 51  1  6
 48 52  1  0
 48 53  1  0
 49 54  1  0
 50 55  1  0
 50 56  2  0
 51 57  1  0
 52 58  1  0
 52 59  2  0
 54 60  1  0
 54 61  1  0
 55 62  1  0
 57 63  1  0
 57 64  1  0
 58 65  1  0
 58 66  1  1
 62 67  1  0
 62 68  1  1
 65 69  1  0
 66 70  1  0
 67 71  1  0
 67 72  2  0
 68 73  1  0
 68 74  1  0
 69 75  1  0
 69 76  2  0
 70 77  1  0
 71 78  1  0
 71 79  1  0
 75 80  1  0
 75 81  1  1
 77 82  1  0
 78 83  1  0
 78 84  1  1
 80 83  1  0
 82 85  1  0
 83 86  2  0
 84 87  1  0
 87 88  1  0
 87 89  1  0
M  END
>  <Name>  (573) 
SDZ IMM 125

>  <InChIKey>  (573) 
XZDDMPMZGYEESG-VNHFGJPGSA-N

>  <PubChem_CID>  (573) 
6436153

>  <CYP1A2>  (573) 


>  <CYP2A6>  (573) 


>  <CYP2B6>  (573) 


>  <CYP2C8>  (573) 


>  <CYP2C9>  (573) 


>  <CYP2C19>  (573) 


>  <CYP2D6>  (573) 


>  <CYP2E1>  (573) 


>  <CYP3A4>  (573) 
<0,H;Hydroxylation;R1>
<65,H;Hydroxylation;R2>
<22,23;Cleavage;R3>
<23,H;Oxidation;R3>

>  <References>  (573) 
Vickers AE, Meyer E, Dannecker R, Keller B, Tynes RE, Maurer G: Human liver cytochrome P4503A biotransformation of the cyclosporin derivative SDZ IMM 125. Drug Metab Dispos. 1995 Mar;23(3):321-6. (PMID: 7628296)

>  <Comments>  (573) 


$$$$
CC02450
     RDKit          3D

 30 32  0  0  0  0  0  0  0  0999 V2000
   -3.8620   -0.9020   -1.3490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0440   -1.5850   -0.6960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9200   -1.4200    0.8230 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.5450   -1.9240    1.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0110   -0.1490   -2.2820 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6330   -1.1600   -0.8470 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4530   -1.0920    0.5930 C   0  0  2  0  0  0  0  0  0  0  0  0
   -5.0610   -0.0400    1.1670 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0780   -1.6490    0.9670 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0130   -0.7960    0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3790   -1.4400    0.5620 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.2590   -2.9600    0.4430 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.3780   -0.9400   -0.4850 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.6030   -3.6210    0.4290 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7140   -1.5520   -0.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -3.0000    0.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5220   -3.3030   -0.8530 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4010    0.5680   -0.5670 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.5690    1.1640    0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8750    0.5940   -0.3550 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.8440   -0.8690   -0.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0700    1.1910    0.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1580    1.0900   -0.0290 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7580    2.3320   -0.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5240    2.8800    0.2270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6360    4.3690   -0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7140    2.1310   -0.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5240    2.6960    1.7460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9380    4.9250    0.4750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4260    3.0100   -1.0900 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  2  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  3  8  1  6
  4  7  1  0
  6  7  1  0
  7  9  1  6
  9 10  1  0
 11 10  1  6
 11 12  1  0
 11 13  1  0
 12 14  1  0
 12 17  1  6
 13 15  1  1
 13 18  1  0
 14 16  2  0
 15 16  1  0
 15 21  2  0
 18 19  1  0
 18 23  1  1
 19 20  1  0
 20 21  1  0
 20 22  1  1
 23 24  1  0
 24 25  1  0
 24 30  2  0
 25 26  1  0
 25 27  1  0
 25 28  1  0
 26 29  1  0
M  END
>  <Name>  (574) 
Simvastatin

>  <InChIKey>  (574) 
RYMZZMVNJRMUDD-HGQWONQESA-N

>  <PubChem_CID>  (574) 
54454

>  <CYP1A2>  (574) 


>  <CYP2A6>  (574) 


>  <CYP2B6>  (574) 


>  <CYP2C8>  (574) 


>  <CYP2C9>  (574) 


>  <CYP2C19>  (574) 


>  <CYP2D6>  (574) 


>  <CYP2E1>  (574) 


>  <CYP3A4>  (574) 
<10,11;Dehydrogenation;R1>
<15,H;Hydroxylation;R2>
<10,12;Oxidation;R2>
<12,13;Reduction;R2>
<13,14;Oxidation;R2>
<14,15;Reduction;R2>
<15,H;Hydroxylation;R3>
<12,H;Hydroxylation;R3>
<12,13;Reduction;R3>
<13,14;Oxidation;R3>
<14,15;Reduction;R3>

>  <References>  (574) 
Prueksaritanont T, Gorham LM, Ma B, Liu L, Yu X, Zhao JJ, Slaughter DE, Arison BH, Vyas KP: In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s. Drug Metab Dispos. 1997 Oct;25(10):1191-9. (PMID: 9321523)

>  <Comments>  (574) 


$$$$
CC02451
     RDKit          3D

 65 68  0  0  1  0  0  0  0  0999 V2000
   -0.8890    1.6060   -0.3290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2050    0.1700   -0.2890 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.3690    2.0300   -0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9960    2.5710   -0.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8880   -0.2510   -1.5650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1030   -0.1120    0.9110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9300    3.3090   -0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1450    1.2530   -0.9590 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8640    2.2600    0.9630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4370   -1.3330   -2.2280 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8300    0.3760   -1.9880 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3280    0.8010    0.8740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3110    4.4650   -0.8910 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.1070    3.4500    1.1620 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0520   -1.7500   -3.4790 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.7140    4.4880   -1.1380 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8940    5.7640   -0.1840 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.6140    4.3760   -2.1380 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0330   -2.8930   -3.2110 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.9590   -2.2280   -4.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9710    5.5060   -2.0960 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.2050    6.9500   -1.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6050    5.7260    0.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0710   -2.4420   -2.1820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7380   -3.2760   -4.5130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1450   -3.6960   -4.7360 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4300    5.4780   -2.5560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6910    6.8810   -1.4780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9590   -3.6280   -1.8000 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.0140   -4.2150   -6.1450 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.3990   -4.4600   -3.8350 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8160    4.0900   -3.0450 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.1220   -4.6780   -1.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0880   -3.1470   -0.8860 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4410   -4.2860   -6.5260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6320   -5.6120   -6.2330 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0570    4.0990   -4.5350 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0090    3.6710   -2.3780 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0100   -5.8640   -0.6860 C   0  0  2  0  0  0  0  0  0  0  0  0
   -6.9760   -4.3340   -0.5050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7880   -4.3170   -7.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7040    3.0700   -5.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5740    5.2420   -5.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6000    2.9030   -1.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1380   -5.3830    0.2280 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.2270   -6.8440   -0.0020 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2450   -4.3800   -8.1720 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.2680   -4.2710   -8.8630 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9400    2.9270   -6.5080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9670   -6.4910    0.5840 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8140   -8.1150   -0.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6130   -3.1150   -8.9460 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.4750   -5.5270   -8.9920 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3780    1.7220   -6.9180 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1010   -3.0540   -9.1700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1990   -1.9670   -8.2020 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5300    1.3300   -8.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6870   -1.9740  -10.0380 C   0  0  1  0  0  0  0  0  0  0  0  0
    4.8240   -3.8720   -8.6520 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6900   -1.0240   -9.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6220    0.0180   -8.5530 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2090   -1.9820   -9.9490 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2650   -2.2100  -11.4900 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7400   -0.5410   -9.9400 C   0  0  2  0  0  0  0  0  0  0  0  0
    8.2080   -0.5340  -10.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  1
  3  7  1  0
  3  8  2  0
  4  9  1  0
  5 10  1  0
  5 11  2  0
  6 12  1  0
  7 13  1  0
  7 14  2  0
  9 12  1  0
 10 15  1  0
 13 16  1  0
 13 17  1  0
 13 18  1  6
 15 19  1  0
 15 20  1  6
 16 21  1  0
 17 22  1  0
 17 23  1  6
 19 24  1  0
 19 25  1  6
 20 26  1  0
 21 27  1  1
 21 28  1  0
 22 28  1  0
 29 24  1  1
 26 30  1  0
 26 31  2  0
 27 32  1  0
 29 33  1  0
 29 34  1  0
 30 35  1  0
 30 36  1  1
 32 37  1  0
 32 38  1  1
 33 39  1  0
 34 40  1  0
 35 41  2  0
 37 42  2  0
 37 43  1  0
 38 44  1  0
 39 45  1  0
 39 46  1  1
 40 45  1  0
 41 47  1  0
 41 48  1  0
 42 49  1  0
 45 50  1  6
 46 51  1  0
 47 52  1  0
 47 53  1  6
 49 54  2  0
 52 55  1  0
 52 56  1  1
 54 57  1  0
 55 58  1  0
 55 59  2  0
 56 60  1  0
 57 61  2  0
 58 62  1  0
 58 63  1  6
 61 64  1  0
 62 64  1  0
 64 65  1  1
M  END
>  <Name>  (575) 
Sirolimus

>  <InChIKey>  (575) 
QFJCIRLUMZQUOT-HPLJOQBZSA-N

>  <PubChem_CID>  (575) 
5284616

>  <CYP1A2>  (575) 


>  <CYP2A6>  (575) 


>  <CYP2B6>  (575) 


>  <CYP2C8>  (575) 


>  <CYP2C9>  (575) 


>  <CYP2C19>  (575) 


>  <CYP2D6>  (575) 


>  <CYP2E1>  (575) 


>  <CYP3A4>  (575) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<35,36;Cleavage;R2>
<36,H;Oxidation;R2>
<54,H;Hydroxylation;R3>
<55,H;Hydroxylation;R4>
<53,H;Hydroxylation;R5>
<6,H;Hydroxylation;R6>
<7,H;Hydroxylation;R7>

>  <References>  (575) 
Cummins CL, Jacobsen W, Christians U, Benet LZ: CYP3A4-transfected Caco-2 cells as a tool for understanding biochemical absorption barriers: studies with sirolimus and midazolam. J Pharmacol Exp Ther. 2004 Jan;308(1):143-55. doi: 10.1124/jpet.103.058065. Epub  2003 Oct 20. (PMID: 14569063)

>  <Comments>  (575) 


$$$$
CC02452
     RDKit          3D

 29 32  0  0  0  0  0  0  0  0999 V2000
   -4.9970   -0.0880    0.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6850   -1.1650    0.9020 S   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8870   -0.4740   -0.5560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9200    0.3680   -0.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0610    1.5970   -0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1710    1.9840    0.6770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1390    1.1410    1.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3980   -0.6210   -0.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1260   -1.4390   -0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0400   -0.9800   -1.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2460   -1.7430   -0.7610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1710   -0.8270   -0.4180 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6400    0.4590   -0.4040 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3330    0.4640   -0.7390 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3720    1.6080   -0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5020   -1.1310   -0.1130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7950   -2.1460    0.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1100   -2.4440    1.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1350   -1.7330    0.4900 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8470   -0.7220   -0.4080 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5340   -0.4230   -0.7150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3190    2.7210   -0.9100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0420    3.8540   -0.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8190    3.8790    0.5530 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8750    2.7720    1.3800 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1490    1.6390    1.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4100   -2.9410   -0.8580 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3980    1.4290   -0.8150 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2170   -2.4080    0.4670 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  7  1  0
  2  8  1  6
  2 29  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 14  1  0
 11 12  1  0
 11 27  2  0
 12 13  1  0
 12 16  1  0
 13 14  1  0
 13 15  1  0
 14 28  2  0
 15 22  2  0
 15 26  1  0
 16 17  2  0
 16 21  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
M  END
>  <Name>  (576) 
Sulfinpyrazone

>  <InChIKey>  (576) 
MBGGBVCUIVRRBF-LJAQVGFWSA-N

>  <PubChem_CID>  (576) 
25273605

>  <CYP1A2>  (576) 


>  <CYP2A6>  (576) 


>  <CYP2B6>  (576) 


>  <CYP2C8>  (576) 


>  <CYP2C9>  (576) 
<5,6;Reduction;R1>

>  <CYP2C19>  (576) 


>  <CYP2D6>  (576) 


>  <CYP2E1>  (576) 


>  <CYP3A4>  (576) 
<5,S;S-Oxidation;R1>
<5,6;Reduction;R2>

>  <References>  (576) 
He M, Rettie AE, Neal J, Trager WF: Metabolism of sulfinpyrazone sulfide and sulfinpyrazone by human liver microsomes and cDNA-expressed cytochrome P450s. Drug Metab Dispos. 2001 May;29(5):701-11. (PMID: 11302937)

>  <Comments>  (576) 
The location of hydroxylation is not confirmed.

$$$$
CC02453
     RDKit          3D

 22 23  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3830    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1760    2.0910    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4310   -1.8120    1.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4270   -1.4040    2.2060 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1700   -0.9640    1.3990 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.3960    0.0300   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7870    0.5850    2.1900 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2920   -0.7760    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1600    3.5980    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3800    1.4130   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2080   -0.6770   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2660   -0.1690    2.9950 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7110   -0.7070   -0.0380 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5250   -2.8230    0.7660 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2020    2.0480    0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9920   -2.2760   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0880   -0.4240    1.2680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1110   -0.4110   -1.2300 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5960    4.1240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4210    4.1070   -1.2280 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4450    4.0920    1.2700 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1 16  1  0
  2  9  1  0
  2 12  1  0
  3 10  1  0
  3 11  2  0
  4  5  1  0
  4  6  1  0
  4 15  2  0
  5 13  1  0
  6  8  1  0
  6 14  1  6
  7 11  1  0
  7 12  2  0
  7 14  1  0
  8 13  1  0
  9 17  1  0
  9 18  1  0
  9 19  1  0
 10 20  1  0
 10 21  1  0
 10 22  1  0
M  END
>  <Name>  (577) 
Tazofelone

>  <InChIKey>  (577) 
ILMMRHUILQOQGP-AWEZNQCLSA-N

>  <PubChem_CID>  (577) 
10969297

>  <CYP1A2>  (577) 


>  <CYP2A6>  (577) 


>  <CYP2B6>  (577) 


>  <CYP2C8>  (577) 


>  <CYP2C9>  (577) 


>  <CYP2C19>  (577) 


>  <CYP2D6>  (577) 


>  <CYP2E1>  (577) 


>  <CYP3A4>  (577) 
<9,S;S-Oxidation;R1>

>  <References>  (577) 
Surapaneni SS, Clay MP, Spangle LA, Paschal JW, Lindstrom TD: In vitro biotransformation and identification of human cytochrome P450 isozyme-dependent metabolism of tazofelone. Drug Metab Dispos. 1997 Dec;25(12):1383-8. (PMID: 9394028)

>  <Comments>  (577) 


$$$$
CC02454
     RDKit          3D

 46 53  0  0  0  0  0  0  0  0999 V2000
   -4.5400   -2.3810    2.2890 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4440   -2.2830    1.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6880   -1.0060    1.5750 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.6850   -3.3090    1.3400 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5030    0.2100    1.1880 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.8030   -1.3680    0.3400 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.4410   -2.8090    0.7370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5390    1.2930    0.7340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4420   -0.1420    0.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6560   -0.3750    0.3540 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.2410    1.0250    0.3570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0420    2.5960    0.7180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7450   -0.5110    0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0020   -0.0900   -1.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1300   -0.5610    1.5330 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3800    2.0490   -0.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1950    3.6150    0.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6130   -0.8360   -0.6870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8640   -0.4120   -2.2820 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4680   -0.1850    1.2010 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.8710    3.3430   -0.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4150    4.9450    0.2100 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8940   -1.1990   -0.4090 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1720   -0.7900   -2.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4290   -0.3600   -3.5700 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9400   -1.0070    0.1330 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3630   -0.3560    2.4300 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.2670    4.5050   -0.3990 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1060    5.5480    0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0390   -1.1500    1.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0210   -1.1080   -3.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0620    0.0550   -3.5280 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2010   -0.4860   -0.2750 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.8740    0.4630    3.4930 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7950    0.0640    2.0760 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.2320   -0.7160    0.8360 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.6880   -1.1900   -1.5440 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6690   -0.2390    3.1660 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5070   -0.2620    0.3860 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0020   -0.7190   -1.8570 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8460   -1.0440   -0.7590 C   0  0  1  0  0  0  0  0  0  0  0  0
    7.2790   -0.7760   -1.1380 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0060   -1.3010   -2.1540 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4590    0.3210   -0.3680 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.3210   -0.9040   -2.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8430    0.0000   -1.4490 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  3  2  1  6
  2  4  1  0
  3  5  1  0
  3  6  1  0
  4  7  1  0
  5  8  1  0
  5  9  1  6
  6  7  1  1
  6 10  1  0
  8 11  2  0
  8 12  1  0
  9 13  2  0
  9 14  1  0
 10 11  1  0
 10 15  1  1
 11 16  1  0
 12 17  2  0
 13 18  1  0
 14 19  2  0
 20 15  1  1
 16 21  2  0
 17 21  1  0
 17 22  1  0
 18 23  1  0
 18 24  2  0
 19 24  1  0
 19 25  1  0
 20 26  1  0
 20 27  1  0
 21 28  1  0
 22 29  1  0
 23 30  1  0
 24 31  1  0
 25 32  1  0
 26 33  1  0
 27 34  1  1
 27 35  1  0
 28 29  1  0
 33 36  1  0
 33 37  1  6
 35 36  1  0
 35 38  1  1
 36 39  1  6
 37 40  1  0
 39 41  1  0
 40 41  1  0
 41 42  1  6
 42 43  2  0
 42 44  1  0
 43 45  1  0
 44 46  1  0
 45 46  2  0
M  END
>  <Name>  (578) 
Teniposide

>  <InChIKey>  (578) 
NRUKOCRGYNPUPR-QBPJDGROSA-N

>  <PubChem_CID>  (578) 
452548

>  <CYP1A2>  (578) 


>  <CYP2A6>  (578) 


>  <CYP2B6>  (578) 


>  <CYP2C8>  (578) 


>  <CYP2C9>  (578) 


>  <CYP2C19>  (578) 


>  <CYP2D6>  (578) 


>  <CYP2E1>  (578) 


>  <CYP3A4>  (578) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<42,43;Cleavage;R2>
<43,H;Oxidation;R2>

>  <References>  (578) 
Brown CM, Reisfeld B, Mayeno AN: Cytochromes P450: a structure-based summary of biotransformations using representative substrates. Drug Metab Rev. 2008;40(1):1-100. doi: 10.1080/03602530802309742. (PMID: 18259985)

>  <Comments>  (578) 


$$$$
CC02455
     RDKit          3D

 30 31  0  0  0  0  0  0  0  0999 V2000
    4.5410   -2.3570   -2.5970 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4120   -1.4350   -2.3320 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.9020    0.0010   -2.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4250    0.8190   -3.1350 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7460   -1.7600   -0.9800 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8510    0.3970   -1.4710 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4810    1.7190   -1.6260 C   0  0  2  0  0  0  0  0  0  0  0  0
    6.7730    1.4600   -2.3930 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8710    2.0730   -3.4810 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6280    2.4250   -0.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1390    3.8620   -0.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1130    4.6530   -1.2980 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3170    4.5380    0.9080 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7150    0.5880   -1.9720 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.2590   -0.4770   -2.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7010   -1.1060   -3.7600 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3250   -0.5870   -4.8360 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.3270   -1.0680   -1.8220 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2900   -2.1210   -2.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0820   -2.4230   -0.8870 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4960   -2.8410   -3.1890 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0470   -3.4330   -0.9550 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4630   -3.8520   -3.2660 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2410   -4.1510   -2.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3930   -2.3820   -3.5250 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3410   -3.1330   -4.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9900   -2.5270   -3.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2760   -2.1330   -4.8020 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1910   -2.9670   -1.4210 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1650    0.6190   -0.5720 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1 27  1  0
  1 29  1  0
  2  3  1  0
  2  5  1  1
  3  4  2  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  7 10  1  1
  8  9  2  0
  8 14  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 14 15  1  0
 14 30  1  0
 15 16  1  0
 15 18  2  0
 16 17  2  0
 16 25  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 20 22  1  0
 21 23  2  0
 22 24  2  0
 23 24  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
M  END
>  <Name>  (579) 
Tentoxin

>  <InChIKey>  (579) 
SIIRBDOFKDACOK-YQMBXKBSSA-N

>  <PubChem_CID>  (579) 
6442695

>  <CYP1A2>  (579) 


>  <CYP2A6>  (579) 


>  <CYP2B6>  (579) 


>  <CYP2C8>  (579) 


>  <CYP2C9>  (579) 


>  <CYP2C19>  (579) 


>  <CYP2D6>  (579) 


>  <CYP2E1>  (579) 


>  <CYP3A4>  (579) 
<10,11;Cleavage;R1>
<11,H;Oxidation;R1>

>  <References>  (579) 
Delaforge M, Andre F, Jaouen M, Dolgos H, Benech H, Gomis JM, Noel JP, Cavelier F, Verducci J, Aubagnac JL, Liebermann B: Metabolism of tentoxin by hepatic cytochrome P-450 3A isozymes. Eur J Biochem. 1997 Nov 15;250(1):150-7. doi: 10.1111/j.1432-1033.1997.00150.x. (PMID: 9432003)

>  <Comments>  (579) 


$$$$
CC02456
     RDKit          3D

 37 42  0  0  0  0  0  0  0  0999 V2000
   -0.0190    0.9850    0.4540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0180   -0.4080    0.5540 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2330   -1.0680    0.5680 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4210   -0.3440    0.4820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3860    1.0440    0.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1740    1.7080    0.3680 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5380   -2.3960    0.6550 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4680   -1.2200    0.5160 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9020   -2.5080    0.2110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5460    1.7480    0.3000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1870    3.1280    0.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3150    1.6900    0.4330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4550    0.9800    0.5100 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6510    1.5930    0.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7290    2.9850    0.3520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5740    3.7350    0.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3380    3.0450    0.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6720    0.9290    0.5400 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5350    5.0750    0.2060 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0910    3.6360    0.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7310    5.6020   -0.3900 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.9060    5.1470    0.4690 C   0  0  1  0  0  0  0  0  0  0  0  0
   -6.2070    5.8920    0.1960 C   0  0  2  0  0  0  0  0  0  0  0  0
   -3.5950    7.1270   -0.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9720    7.4050    0.2620 C   0  0  1  0  0  0  0  0  0  0  0  0
   -5.4340    7.7160    1.5700 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9170    7.7940   -0.7720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8020    5.0930   -1.8290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5400    5.3530    1.8560 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1970    5.5700    1.3100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2450    8.2190    0.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0040    4.6830    2.1070 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4120    6.3920    1.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4340    7.5750    0.7580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8450    5.4720   -1.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5640    8.5370   -1.3490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0250    9.5680    0.8310 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1 12  1  0
  2  3  1  0
  3  4  2  0
  3  7  1  0
  4  5  1  0
  4  8  1  0
  5  6  2  0
  5 10  1  0
  7  9  1  0
  8  9  1  0
 10 11  1  0
 12 13  1  0
 12 17  2  0
 13 14  1  0
 14 15  1  0
 14 18  2  0
 15 16  2  0
 15 20  1  0
 16 17  1  0
 16 19  1  0
 19 21  1  0
 20 22  1  0
 21 22  1  0
 21 24  1  0
 21 28  1  6
 22 23  1  0
 22 29  1  1
 23 25  1  0
 23 30  1  0
 23 35  1  6
 24 27  1  0
 25 26  1  1
 25 27  1  0
 25 31  1  0
 30 32  2  0
 30 33  1  0
 31 34  1  0
 31 36  1  0
 31 37  1  0
 33 34  2  0
M  END
>  <Name>  (580) 
Territrem A

>  <InChIKey>  (580) 
LCJHAHVVYAVVPA-JUDWXZBOSA-N

>  <PubChem_CID>  (580) 
44559227

>  <CYP1A2>  (580) 


>  <CYP2A6>  (580) 


>  <CYP2B6>  (580) 


>  <CYP2C8>  (580) 


>  <CYP2C9>  (580) 
<22,H;Hydroxylation;R1>
<23,H;Hydroxylation;R2>

>  <CYP2C19>  (580) 


>  <CYP2D6>  (580) 
<22,H;Hydroxylation;R1>
<23,H;Hydroxylation;R2>

>  <CYP2E1>  (580) 


>  <CYP3A4>  (580) 
<22,H;Hydroxylation;R1>
<23,H;Hydroxylation;R2>

>  <References>  (580) 
Peng FC, Tseng HY, Tsai JC, Lin C, Doehmer J: Role of human hepatic cytochrome P-450s in territrem A metabolism. J Toxicol Environ Health A. 2003 Jul 11;66(13):1237-48. doi: 10.1080/15287390306408. (PMID: 12851121)

>  <Comments>  (580) 
Rate of metabolites for CYP2C9 and 2D6 is low.

$$$$
CC02457
     RDKit          3D

  9  9  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3910    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2080   -0.6750   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3960    0.0330   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3840    1.4170   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1850    2.0990    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3050    2.1160    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3200    3.4410    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6330    4.1800    0.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  7  8  2  0
  8  9  1  0
M  END
>  <Name>  (581) 
trans-Phenylpropene

>  <InChIKey>  (581) 
QROGIFZRVHSFLM-QHHAFSJGSA-N

>  <PubChem_CID>  (581) 
252325

>  <CYP1A2>  (581) 


>  <CYP2A6>  (581) 


>  <CYP2B6>  (581) 


>  <CYP2C8>  (581) 


>  <CYP2C9>  (581) 


>  <CYP2C19>  (581) 


>  <CYP2D6>  (581) 


>  <CYP2E1>  (581) 


>  <CYP3A4>  (581) 
<1,2;EpOxidation;R1>
<0,H;Hydroxylation;R2>

>  <References>  (581) 
Sanga M, Younis IR, Tirumalai PS, Bland TM, Banaszewska M, Konat GW, Tracy TS, Gannett PM, Callery PS: Epoxidation of the methamphetamine pyrolysis product, trans-phenylpropene, to trans-phenylpropylene oxide by CYP enzymes and stereoselective glutathione adduct formation. Toxicol Appl Pharmacol. 2006 Mar 1;211(2):148-56. doi: 10.1016/j.taap.2005.06.017. Epub 2005 Jul 20. (PMID: 16038959)

>  <Comments>  (581) 


$$$$
CC02459
     RDKit          3D

 23 26  0  0  1  0  0  0  0  0999 V2000
    0.7650   -3.0580    0.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6990   -2.0440    0.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3530   -0.7550   -0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0460   -0.4770   -0.5720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8890   -1.5230   -0.6080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5270   -2.7970   -0.2330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6950   -4.0800   -0.2920 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.4110    0.8690   -0.9340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3480    0.2240   -0.1780 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3770    0.3760    0.6970 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0920    1.3850    0.2720 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6420   -0.4580    1.9240 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5670    1.8750   -0.7970 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4880    1.2130   -1.0980 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5260    1.4880   -2.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2080    1.7510   -1.6370 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7480    1.2600   -0.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7940    1.4870   -1.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9670    1.3980    0.9420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0370    1.8500   -0.8480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2160    1.7620    1.4050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2480    1.9900    0.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6730    1.1110    2.0630 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  3  9  1  0
  4  5  1  0
  4  8  1  0
  5  6  2  0
  6  7  1  0
  8 16  2  0
  8 17  1  0
  9 10  1  0
  9 14  1  0
 10 11  2  0
 10 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 17 18  2  0
 17 19  1  0
 18 20  1  0
 19 21  2  0
 19 23  1  0
 20 22  2  0
 21 22  1  0
M  END
>  <Name>  (582) 
Triazolam

>  <InChIKey>  (582) 
JOFWLTCLBGQGBO-UHFFFAOYSA-N

>  <PubChem_CID>  (582) 
5556

>  <CYP1A2>  (582) 


>  <CYP2A6>  (582) 


>  <CYP2B6>  (582) 


>  <CYP2C8>  (582) 


>  <CYP2C9>  (582) 


>  <CYP2C19>  (582) 


>  <CYP2D6>  (582) 


>  <CYP2E1>  (582) 


>  <CYP3A4>  (582) 
<22,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>

>  <References>  (582) 
Perloff MD, von Moltke LL, Court MH, Kotegawa T, Shader RI, Greenblatt DJ: Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms. J Pharmacol Exp Ther. 2000 Feb;292(2):618-28. (PMID: 10640299)

>  <Comments>  (582) 


$$$$
CC02460
     RDKit          3D

 40 44  0  0  0  0  0  0  0  0999 V2000
    2.6900    0.3300    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6180    1.6980   -0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8000    0.4220   -0.0170 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.6040   -0.4180    0.1120 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8850    2.1980   -0.0770 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3870    0.1160    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7330    1.1870   -0.0150 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0410    0.0170    0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2690    1.4460   -0.0170 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3200    2.2730   -0.0830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8130   -0.6800    0.1140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1220   -0.6160   -0.3410 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2840   -0.4780    0.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9960    0.0850    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2090    1.1310   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0270    1.1310    1.2050 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6960    1.3670   -1.0810 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8040   -1.6310    0.0760 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4770   -1.4560    0.8170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3060    0.1770   -0.7080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9300   -2.0920    0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1690    3.5080   -0.1760 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4110    2.1540    0.0340 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3790   -1.8580    0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2210   -2.6280    0.2690 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0700    2.3790    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6230   -2.4200    0.4530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4660   -0.7720   -1.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6540   -1.3530    0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1050   -3.0450    0.2400 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.9240   -2.5120   -0.2860 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3150    3.1700    0.0410 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6050    3.7020   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2650   -3.4990    0.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6840   -1.8280    1.5610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9110   -3.3320   -1.1710 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.1570   -1.6460   -0.6330 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8840    4.5000    0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0770   -4.0560   -2.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5120    4.7680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  1  8  2  0
  2  5  2  0
  2 10  1  0
  3 12  1  0
  3 13  1  0
  3 16  2  0
  3 17  2  0
  4  6  2  0
  5  7  1  0
  6  9  1  0
  6 11  1  0
  7  8  1  0
  7 15  1  0
  8 29  1  0
  9 10  1  0
 10 22  2  0
 11 14  2  0
 11 21  1  0
 12 19  1  0
 12 20  1  0
 13 14  1  0
 13 24  2  0
 15 26  1  0
 18 27  1  0
 18 28  1  0
 18 31  1  0
 19 27  1  0
 20 28  1  0
 21 25  2  0
 21 30  1  0
 23 26  2  0
 23 32  1  0
 24 25  1  0
 26 33  1  0
 29 35  1  0
 30 34  1  0
 31 37  1  0
 32 38  2  0
 33 40  2  0
 34 36  1  0
 36 39  1  0
 38 40  1  0
M  END
>  <Name>  (583) 
UK-343664

>  <InChIKey>  (583) 
NIBCDDKWFDEBEP-UHFFFAOYSA-N

>  <PubChem_CID>  (583) 
135430996

>  <CYP1A2>  (583) 


>  <CYP2A6>  (583) 


>  <CYP2B6>  (583) 


>  <CYP2C8>  (583) 


>  <CYP2C9>  (583) 


>  <CYP2C19>  (583) 


>  <CYP2D6>  (583) 


>  <CYP2E1>  (583) 


>  <CYP3A4>  (583) 
<14,15;Cleavage;R1>
<15,H;Oxidation;R1>

>  <References>  (583) 
Abel S, Beaumont KC, Crespi CL, Eve MD, Fox L, Hyland R, Jones BC, Muirhead GJ, Smith DA, Venn RF, Walker DK: Potential role for P-glycoprotein in the non-proportional pharmacokinetics of UK-343,664 in man. Xenobiotica. 2001 Aug-Sep;31(8-9):665-76. doi: 10.1080/00498250110052779. (PMID: 11569532)

>  <Comments>  (583) 


$$$$
CC02461
     RDKit          3D

 86 86  0  0  0  0  0  0  0  0999 V2000
   -0.0410    3.4040    0.2760 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.1030    2.4080    0.0230 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2940    2.8550   -0.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0040    3.7180    1.7510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6410    2.4080   -1.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5340    1.4900    1.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2570    3.7350   -0.5620 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5090    1.6650   -0.1490 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5090    5.0580    2.2200 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.3640    2.8960    2.5550 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8400    1.5700   -1.5630 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.1310    3.1050   -2.0850 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6030    3.1960   -0.8140 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.0940    5.3790    3.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0350    5.0180    2.3320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5800    2.2260   -2.6740 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3890    0.1830   -2.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6460    4.2220   -0.4820 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7380    2.6920   -2.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3120    6.7700    4.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9740    3.5090   -2.4470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8430    1.4960   -3.9160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4460   -0.4260   -0.9930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6120   -0.7210   -2.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6960    5.4630   -1.0360 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5100    3.9220    0.3360 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1870    2.2720   -2.5060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8140    1.4910   -2.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6020    7.6510    4.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6790    4.3070   -3.5080 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.7330    4.0220   -1.3660 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6510    6.3890   -0.3780 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9110    5.8900   -2.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1960    9.0420    4.7380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8360    5.0180   -2.9430 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6950    5.3100   -4.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9650    7.5450   -1.2830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2000    6.2020   -3.4660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6230    4.4060   -1.8550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2690    5.8530   -5.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2010    8.6700   -1.2980 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9430    7.4740   -2.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8150    7.5510   -2.9520 C   0  0  1  0  0  0  0  0  0  0  0  0
   -6.9120    6.1550   -4.4760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3460    6.9420   -5.9800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3780    4.7160   -6.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5920    9.7210   -2.2610 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.0510    8.8510   -0.4080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8810    8.5260   -3.2640 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5880    7.5220   -1.4380 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9080   11.0130   -1.9090 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2420    9.2790   -3.6810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5770    9.6160   -4.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2530    8.3290   -2.7600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0260    8.8700   -0.9810 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9400   11.5460   -2.7000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2400   11.6010   -0.8920 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1830    8.1510   -4.1110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1670    9.9960   -4.3800 C   0  0  2  0  0  0  0  0  0  0  0  0
   -7.4920   10.3220   -4.4140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0120    8.9240    0.5480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6010    9.0350   -1.5110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3320   12.8210   -2.2340 C   0  0  2  0  0  0  0  0  0  0  0  0
    5.8480    7.7240   -5.5410 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6300    8.6440   -4.0520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9840   11.4320   -4.0800 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9620    9.7620   -5.8810 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9220   12.8820   -2.7630 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1500   13.9830   -2.8040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7270   11.9460   -4.1190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1470   13.9790   -2.5980 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4700   11.8890   -3.3130 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6260   15.3030   -2.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6210   13.8100   -2.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5160   13.4030   -3.7990 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.7760   11.2450   -4.3970 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1680   14.3260   -3.6430 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.2440   14.8080   -1.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1770   13.8340   -4.2490 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5780   14.2480   -4.5150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1260   13.5970   -3.4120 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7240   14.0250   -5.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2370   12.8040   -2.5000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9160   14.9420   -5.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5940   14.5110   -6.6190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4300   16.3860   -5.4470 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  1
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  1  0
  4 10  2  0
  5 11  1  0
  5 12  2  0
  7 13  1  0
  9 14  1  0
  9 15  1  1
 11 16  1  0
 11 17  1  6
 13 18  1  0
 13 19  1  6
 14 20  1  0
 16 21  1  0
 16 22  1  0
 17 23  1  0
 17 24  1  0
 18 25  1  0
 18 26  2  0
 19 27  1  0
 19 28  1  0
 20 29  2  0
 21 30  1  0
 21 31  2  0
 25 32  1  0
 25 33  1  0
 29 34  1  0
 30 35  1  0
 30 36  1  1
 32 37  1  0
 35 38  1  0
 35 39  1  0
 36 40  1  0
 37 41  1  0
 37 42  2  0
 38 43  1  0
 38 44  2  0
 40 45  1  0
 40 46  1  0
 41 47  1  0
 41 48  1  0
 43 49  1  0
 43 50  1  1
 47 51  1  0
 47 52  1  6
 49 53  1  0
 49 54  1  0
 50 55  1  0
 51 56  1  0
 51 57  2  0
 52 58  1  0
 53 59  1  0
 53 60  2  0
 55 61  1  0
 55 62  1  0
 56 63  1  0
 58 64  1  0
 58 65  1  0
 59 66  1  0
 59 67  1  6
 63 68  1  0
 63 69  1  6
 66 70  1  0
 68 71  1  0
 68 72  2  0
 69 73  1  0
 69 74  1  0
 70 75  1  0
 70 76  2  0
 71 77  1  0
 71 78  1  0
 75 79  1  0
 75 80  1  6
 77 81  1  0
 77 82  1  6
 79 81  1  0
 81 83  2  0
 82 84  1  0
 84 85  1  0
 84 86  1  0
M  END
>  <Name>  (584) 
Valspodar

>  <InChIKey>  (584) 
YJDYDFNKCBANTM-QCWCSKBGSA-N

>  <PubChem_CID>  (584) 
5281884

>  <CYP1A2>  (584) 


>  <CYP2A6>  (584) 


>  <CYP2B6>  (584) 


>  <CYP2C8>  (584) 


>  <CYP2C9>  (584) 


>  <CYP2C19>  (584) 


>  <CYP2D6>  (584) 


>  <CYP2E1>  (584) 


>  <CYP3A4>  (584) 
<63,H;Hydroxylation;R1>
<64,H;Hydroxylation;R2>

>  <References>  (584) 
Fischer V, Rodriguez-Gascon A, Heitz F, Tynes R, Hauck C, Cohen D, Vickers AE: The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A. Implications for drug-drug interactions and pharmacological activity of the main metabolite. Drug Metab Dispos. 1998 Aug;26(8):802-11. (PMID: 9698296)

>  <Comments>  (584) 


$$$$
CC02462
     RDKit          3D

 29 31  0  0  0  0  0  0  0  0999 V2000
   -0.0450    1.6490    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0690    0.1220    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8790   -0.4460    1.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2680    0.1180    1.0260 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.0990    1.6510    1.2290 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.3920    2.1980    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1760   -0.2410    2.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2080    0.9220    2.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5160    2.1230    1.5140 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.2380    1.9010    2.4690 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5020   -1.3790    1.9220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8690   -1.8940    1.8980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2510   -2.8380    2.7820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6600   -3.3970    2.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1650   -3.4150    4.2360 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.2210   -4.2480    5.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8560   -3.5580    5.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3140   -3.3820    3.7870 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9440   -3.6980    3.4780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4740   -3.9860    4.2750 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2340    2.4660    0.2070 C   0  0  1  0  0  0  0  0  0  0  0  0
    5.6350    2.9970    0.5190 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3440    1.2290   -0.6460 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7970    1.2020   -1.8360 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9070   -0.0350   -2.6890 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.5060   -0.5660   -3.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6250    0.3080   -3.9950 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0260    0.8390   -3.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7370   -0.9480   -4.8610 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  3 11  2  0
  4  5  1  0
  4  7  1  1
  5  6  1  0
  5  9  1  0
  5 10  1  1
  7  8  1  0
  9  8  1  6
  9 21  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 18  1  0
 14 15  1  0
 15 16  1  0
 15 20  1  6
 16 17  1  0
 17 18  1  0
 18 19  2  0
 21 22  1  1
 21 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  6
 25 27  1  0
 27 28  1  0
 27 29  1  0
M  END
>  <Name>  (585) 
Vitamin D2

>  <InChIKey>  (585) 
MECHNRXZTMCUDQ-PXQSPDBHSA-N

>  <PubChem_CID>  (585) 


>  <CYP1A2>  (585) 


>  <CYP2A6>  (585) 


>  <CYP2B6>  (585) 


>  <CYP2C8>  (585) 


>  <CYP2C9>  (585) 


>  <CYP2C19>  (585) 


>  <CYP2D6>  (585) 


>  <CYP2E1>  (585) 


>  <CYP3A4>  (585) 
<24,H;Hydroxylation;R1>
<26,H;Hydroxylation;R2>

>  <References>  (585) 
Gupta RP, He YA, Patrick KS, Halpert JR, Bell NH: CYP3A4 is a vitamin D-24- and 25-hydroxylase: analysis of structure function by site-directed mutagenesis. J Clin Endocrinol Metab. 2005 Feb;90(2):1210-9. doi: 10.1210/jc.2004-0966. Epub 2004 Nov 16. (PMID: 15546903)

>  <Comments>  (585) 


$$$$
CC02463
     RDKit          3D

 41 45  0  0  0  0  0  0  0  0999 V2000
   -0.1680    1.6380    0.8190 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2980    0.0020    0.5960 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0380   -7.1300    1.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3450   -8.1550    2.6340 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3900   -7.2140    0.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0780   -7.7110    2.3700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1730   -7.8650    1.5700 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2250   -0.8450    1.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1930   -6.6920   -3.1840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5430    2.0480    0.7240 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1690   -6.5150    0.5010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2120   -2.3020    1.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1840   -5.0320    0.7650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7710    2.2330   -0.3210 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5470    1.8750    2.1680 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7360   -4.5440    1.9410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8950   -6.6250   -2.0360 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7520   -3.1810    2.1870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5230   -8.0930    1.3210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9670   -6.8010   -0.6020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7100   -6.1870   -4.3200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3090   -7.0370   -0.8310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0930   -7.2070   -3.1940 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7070   -0.4130    2.5320 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3470   -2.8020    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570   -4.1610   -0.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2280    1.8860   -0.4660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0830   -7.6830    0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7590   -8.8380    3.8610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2610   -5.4050    2.8530 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9540   -6.2590   -5.5570 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2000    2.5370    1.8380 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5100    1.3580   -1.6820 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5700    2.2080   -0.5410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7440   -4.6120    3.9390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9130   -6.3480   -6.7570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1280   -4.9700   -5.7480 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5420    2.8590    1.7630 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2280    2.6920    0.5740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6370   -5.1100   -7.6350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1870   -4.7030   -7.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1 10  1  0
  1 14  2  0
  1 15  2  0
  2  8  1  0
  3  5  1  0
  3  6  2  0
  3 11  1  0
  4  6  1  0
  4  7  1  0
  4 29  1  0
  5  7  2  0
  5 20  1  0
  7 19  1  0
  8 12  1  0
  8 24  2  0
  9 17  1  0
  9 21  1  0
  9 23  2  0
 10 27  2  0
 10 32  1  0
 11 13  1  0
 12 18  2  0
 12 25  1  0
 13 16  2  0
 13 26  1  0
 16 18  1  0
 16 30  1  0
 17 22  1  0
 19 28  2  0
 20 22  2  0
 21 31  1  0
 22 28  1  0
 25 26  2  0
 27 33  1  0
 27 34  1  0
 30 35  1  0
 31 36  1  0
 31 37  1  0
 32 38  2  0
 34 39  2  0
 36 40  1  0
 37 41  1  0
 38 39  1  0
 40 41  1  0
M  END
>  <Name>  (586) 
Zafirlukast

>  <InChIKey>  (586) 
YEEZWCHGZNKEEK-UHFFFAOYSA-N

>  <PubChem_CID>  (586) 
5717

>  <CYP1A2>  (586) 


>  <CYP2A6>  (586) 


>  <CYP2B6>  (586) 


>  <CYP2C8>  (586) 


>  <CYP2C9>  (586) 


>  <CYP2C19>  (586) 


>  <CYP2D6>  (586) 


>  <CYP2E1>  (586) 


>  <CYP3A4>  (586) 
<21,H;Hydroxylation;R1>
<25,H;Hydroxylation;R2>

>  <References>  (586) 
Kassahun K, Skordos K, McIntosh I, Slaughter D, Doss GA, Baillie TA, Yost GS: Zafirlukast metabolism by cytochrome P450 3A4 produces an electrophilic alpha,beta-unsaturated iminium species that results in the selective mechanism-based inactivation of the enzyme. Chem Res Toxicol. 2005 Sep;18(9):1427-37. doi: 10.1021/tx050092b. (PMID: 16167835)

>  <Comments>  (586) 
Metabolites (M1 and M4) on ring cannot be identfied.

$$$$
CC02464
     RDKit          3D

 23 25  0  0  1  0  0  0  0  0999 V2000
    0.2650    1.3080   -1.7110 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4510    1.9870   -1.8980 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5820    1.6210   -1.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5310    0.5670   -0.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3450   -0.1220   -0.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2020    0.2510   -0.8000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0690   -0.4740   -0.5920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1540   -1.8300   -0.8420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3700   -2.4820   -0.6350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4190   -1.8120   -0.2070 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3510   -0.5030    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1840    0.1870   -0.1410 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3050    0.4280    0.4930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6590    1.6750    0.5640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4120    1.5240    0.1990 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6720    0.1570    0.8190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7570   -0.0580    1.0780 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6790    0.2010    0.4250 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4620   -0.7980   -0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7590   -1.1150    0.6730 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1240   -1.4420   -0.9980 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0280    0.9030    1.6620 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4150    0.1690    2.8560 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4 18  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7 12  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 15  1  0
 13 14  1  0
 13 16  1  0
 14 15  2  0
 16 17  3  0
 18 19  1  0
 18 22  1  0
 19 20  1  0
 19 21  2  0
 22 23  1  0
M  END
>  <Name>  (587) 
Zaleplon

>  <InChIKey>  (587) 
HUNXMJYCHXQEGX-UHFFFAOYSA-N

>  <PubChem_CID>  (587) 
5719

>  <CYP1A2>  (587) 


>  <CYP2A6>  (587) 


>  <CYP2B6>  (587) 


>  <CYP2C8>  (587) 


>  <CYP2C9>  (587) 


>  <CYP2C19>  (587) 


>  <CYP2D6>  (587) 


>  <CYP2E1>  (587) 


>  <CYP3A4>  (587) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <References>  (587) 
Renwick AB, Mistry H, Ball SE, Walters DG, Kao J, Lake BG: Metabolism of Zaleplon by human hepatic microsomal cytochrome P450 isoforms. Xenobiotica. 1998 Apr;28(4):337-48. doi: 10.1080/004982598239452. (PMID: 9604298)

>  <Comments>  (587) 


$$$$
CC02465
     RDKit          3D

 24 27  0  0  0  0  0  0  0  0999 V2000
   -0.0100    1.3840   -0.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0100   -0.0040   -0.1970 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2100    2.0780   -0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2800    1.8610   -0.2740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4300   -0.4670   -0.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1970   -0.6950   -0.1030 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2230    3.5530   -0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4080    1.3690   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1430    0.8280   -0.7790 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3990   -0.0100   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3930    4.2170   -0.0040 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1790    4.1700   -0.1750 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5350    0.9300   -0.1530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2310    0.8930   -2.3050 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8920   -0.8890    0.1130 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.4050    5.6820   -0.0010 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.0300    6.1840    1.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2240    6.1860   -1.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5130    5.7800    1.3340 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.6930    5.7820   -0.9940 C   0  0  1  0  0  0  0  0  0  0  0  0
    5.1860    6.4930    0.2160 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6040    4.2870    0.9420 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7240    4.2890   -0.5960 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6200    6.1930    0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  3  8  2  0
  4  9  1  0
  5  9  1  0
  6 10  2  0
  7 11  1  0
  7 12  2  0
  8 10  1  0
  9 13  1  0
  9 14  1  0
 10 15  1  0
 16 11  1  1
 16 17  1  0
 16 18  1  0
 19 17  1  6
 20 18  1  1
 19 21  1  0
 19 22  1  0
 20 21  1  0
 20 23  1  0
 21 24  1  0
 22 23  1  0
M  END
>  <Name>  (588) 
Zatosetron

>  <InChIKey>  (588) 
SPKBYQZELVEOLL-QDMKHBRRSA-N

>  <PubChem_CID>  (588) 
5282379

>  <CYP1A2>  (588) 


>  <CYP2A6>  (588) 


>  <CYP2B6>  (588) 


>  <CYP2C8>  (588) 


>  <CYP2C9>  (588) 


>  <CYP2C19>  (588) 


>  <CYP2D6>  (588) 


>  <CYP2E1>  (588) 


>  <CYP3A4>  (588) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,N;N-Oxidation;R2>
<22,H;Hydroxylation;R3>

>  <References>  (588) 
Ring BJ, Parli CJ, George MC, Wrighton SA: In vitro metabolism of zatosetron. Interspecies comparison and role of CYP 3A. Drug Metab Dispos. 1994 May-Jun;22(3):352-7. (PMID: 8070310)

>  <Comments>  (588) 
CYP3A4 is reported because it may also be partly responsible for the formation of the N-desmethyl and hydroxyl metabolites.

$$$$
CC02466
     RDKit          3D

 28 32  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3800    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2030   -0.6860   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4060    0.0180   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3730    1.4070   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1750    2.0840    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4920   -0.8880    0.0120 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.7260   -0.4340   -0.0340 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8130    1.8660   -0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6100    0.5790   -0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8180    0.4800   -0.0460 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3310    2.1170    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9050    2.1560   -1.3980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1860    2.8760   -1.3880 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5600    3.0900   -2.7910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8270    3.9430   -2.8610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5630    5.2670   -2.2830 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1890    5.0520   -0.8800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9220    4.1990   -0.8100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7800    5.9500   -2.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8510    7.3070   -1.7540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1540    7.8530   -1.8240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0940    6.5370   -2.5480 S   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8550    5.3770   -2.7340 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4340    9.1290   -1.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8430    8.1310   -1.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4290    9.8980   -0.8590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1390    9.3870   -0.7780 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1 12  1  0
  2  3  1  0
  2  7  1  0
  3  4  2  0
  4  5  1  0
  4  8  1  0
  5  6  2  0
  5  9  1  0
  8 10  1  0
  9 10  1  0
 10 11  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 20  1  0
 18 19  1  0
 20 21  1  0
 20 24  2  0
 21 22  2  0
 21 26  1  0
 22 23  1  0
 22 25  1  0
 23 24  1  0
 25 27  2  0
 26 28  2  0
 27 28  1  0
M  END
>  <Name>  (589) 
Ziprasidone

>  <InChIKey>  (589) 
MVWVFYHBGMAFLY-UHFFFAOYSA-N

>  <PubChem_CID>  (589) 
60854

>  <CYP1A2>  (589) 


>  <CYP2A6>  (589) 


>  <CYP2B6>  (589) 


>  <CYP2C8>  (589) 


>  <CYP2C9>  (589) 


>  <CYP2C19>  (589) 


>  <CYP2D6>  (589) 


>  <CYP2E1>  (589) 


>  <CYP3A4>  (589) 
<14,S;S-Oxidation;R1>
<7,8;Cleavage;R2>
<7,H;Oxidation;R2>

>  <References>  (589) 
Prakash C, Kamel A, Cui D, Whalen RD, Miceli JJ, Tweedie D: Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions. Br J Clin Pharmacol. 2000;49 Suppl 1:35S-42S. doi: 10.1046/j.1365-2125.2000.00151.x. (PMID: 10771452)

>  <Comments>  (589) 


$$$$
CC02468
     RDKit          3D

 18 19  0  0  0  0  0  0  0  0999 V2000
    1.3230    0.6550    0.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1450    1.3800   -0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0660    0.6950   -0.1730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1850    1.4680   -0.3140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3630    0.6710   -0.3700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5460    1.5930   -0.5240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8150    0.7810   -0.5870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9990    1.7020   -0.7410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2680    0.8900   -0.8040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.4520    1.8110   -0.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0810   -0.7010   -0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1090   -1.4160    0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3180   -0.7320    0.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5720   -1.4400    0.2660 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7100   -0.7520    0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7490    0.7110    0.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8140    1.3150    0.3030 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5330    1.3720    0.1020 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1 13  1  0
  1 18  1  0
  2  3  1  0
  3  4  1  0
  3 11  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
M  END
>  <Name>  (590) 
7-Hexoxycoumarin

>  <InChIKey>  (590) 
HYKWMZVCUBUWMM-UHFFFAOYSA-N

>  <PubChem_CID>  (590) 
53903022

>  <CYP1A2>  (590) 


>  <CYP2A6>  (590) 


>  <CYP2B6>  (590) 


>  <CYP2C8>  (590) 


>  <CYP2C9>  (590) 


>  <CYP2C19>  (590) 


>  <CYP2D6>  (590) 


>  <CYP2E1>  (590) 


>  <CYP3A4>  (590) 
<1,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>
<3,H;Hydroxylation;R3>
<5,6;Cleavage;R4>
<5,H;Oxidation;R4>

>  <References>  (590) 
Khan KK, Halpert JR: Structure-function analysis of human cytochrome P450 3A4 using 7-alkoxycoumarins as active-site probes. Arch Biochem Biophys. 2000 Jan 15;373(2):335-45. doi: 10.1006/abbi.1999.1578. (PMID: 10620357)

>  <Comments>  (590) 


$$$$
CC02469
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    1.3210    0.6530    0.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1430    1.3790   -0.1080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0700    0.6950   -0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1890    1.4690   -0.3190 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3680    0.6740   -0.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5500    1.5990   -0.5330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8200    0.7890   -0.5990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0020    1.7130   -0.7550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2700    0.9000   -0.8210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0840   -0.7010   -0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1060   -1.4150    0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3160   -0.7330    0.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5720   -1.4340    0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7230   -0.7630    0.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7550    0.7070    0.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8070    1.3350    0.3050 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5330    1.3630    0.1030 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1 12  1  0
  1 17  1  0
  2  3  1  0
  3  4  1  0
  3 10  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
M  END
>  <Name>  (591) 
7-Pentoxycoumarin

>  <InChIKey>  (591) 
AUCNGVTWAHBDRJ-UHFFFAOYSA-N

>  <PubChem_CID>  (591) 
23274496

>  <CYP1A2>  (591) 


>  <CYP2A6>  (591) 


>  <CYP2B6>  (591) 


>  <CYP2C8>  (591) 


>  <CYP2C9>  (591) 


>  <CYP2C19>  (591) 


>  <CYP2D6>  (591) 


>  <CYP2E1>  (591) 


>  <CYP3A4>  (591) 
<1,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>
<4,5;Cleavage;R3>
<4,H;Oxidation;R3>

>  <References>  (591) 
Khan KK, Halpert JR: Structure-function analysis of human cytochrome P450 3A4 using 7-alkoxycoumarins as active-site probes. Arch Biochem Biophys. 2000 Jan 15;373(2):335-45. doi: 10.1006/abbi.1999.1578. (PMID: 10620357)

>  <Comments>  (591) 


$$$$
CC02470
     RDKit          3D

 15 15  0  0  1  0  0  0  0  0999 V2000
   -2.0554   -2.7547    0.1603 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4568    2.0650    0.7210 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4706    0.0608    0.0642 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9550    1.6591    0.9114 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0696    1.2975   -0.1681 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1618   -1.8354   -0.0892 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1553   -0.7426    0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2196   -1.6678    0.5624 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.5189   -0.9694   -0.3374 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9194   -0.3805    0.1932 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1570   -0.0758   -1.1299 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3238    0.4926    1.1735 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7806   -0.2050   -0.5465 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8040    1.1154   -1.4394 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1793    1.9408   -0.3917 C   0  0  0  0  0  0  0  0  0  0  0  0
  8  1  1  6
  2  5  2  0
  3  5  1  0
  3  9  1  0
  3 13  1  0
  4 12  2  0
  4 15  1  0
  6  7  1  0
  6  8  1  0
  7  9  1  0
  8 10  1  0
 10 11  2  0
 10 12  1  0
 11 14  1  0
 14 15  2  0
M  END
>  <Name>  (592) 
NNAL

>  <InChIKey>  (592) 
OGRXKBUCZFFSTL-JTQLQIEISA-N

>  <PubChem_CID>  (592) 
40508062

>  <CYP1A2>  (592) 


>  <CYP2A6>  (592) 


>  <CYP2B6>  (592) 


>  <CYP2C8>  (592) 


>  <CYP2C9>  (592) 


>  <CYP2C19>  (592) 


>  <CYP2D6>  (592) 


>  <CYP2E1>  (592) 


>  <CYP3A4>  (592) 
<11,N;N-Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<5,6;Oxidation;R3>

>  <References>  (592) 
Staretz ME, Murphy SE, Patten CJ, Nunes MG, Koehl W, Amin S, Koenig LA, Guengerich FP, Hecht SS: Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N'- nitrosonornicotine in human hepatic microsomes. Drug Metab Dispos. 1997 Feb;25(2):154-62. (PMID: 9029045)

>  <Comments>  (592) 
The structure recorded in Xenosite was wrong.

$$$$
CC02471
     RDKit          3D

 30 32  0  0  0  0  0  0  0  0999 V2000
   -2.2350   -2.6480    0.4680 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5550   -5.0020   -0.2470 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.6360   -5.5140   -5.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0490   -9.5090   -3.9700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3090   -3.7030   -0.5360 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.9830   -6.3140   -4.3360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3350   -8.2340   -3.6430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1500   -4.8620   -0.4270 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3890   -6.6020   -1.9980 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3000   -7.4930   -4.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2830   -7.7810   -2.3230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0160   -5.8720   -3.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8680   -5.4870    1.0590 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4210   -6.1580   -0.5640 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.2070   -3.2200   -1.9440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6990   -4.7830   -4.9810 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1140   -6.2790   -6.4420 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.7790   -4.6220   -5.9890 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3220   -9.5340   -3.4870 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1560   -9.7460   -5.3070 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4280  -10.6030   -3.4480 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3030   -3.3810   -2.7950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0410   -2.6190   -2.4310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3690   -3.2150    1.8030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0710   -2.3530   -4.5830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5590   -4.4830    2.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9700   -2.1840   -3.7520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2380   -2.9480   -4.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0090   -1.9320   -5.8530 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.8520   -6.0840   -0.0810 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  1 24  1  0
  2  5  1  0
  2  8  1  1
  2 13  1  0
  3  6  1  0
  3 16  1  0
  3 17  1  0
  3 18  1  0
  4  7  1  0
  4 19  1  0
  4 20  1  0
  4 21  1  0
  5 15  1  6
  6 10  2  0
  6 12  1  0
  7 10  1  0
  7 11  2  0
  8 14  1  0
  9 11  1  0
  9 12  2  0
  9 14  1  0
 13 26  1  0
 14 30  1  6
 15 22  2  0
 15 23  1  0
 22 28  1  0
 23 27  2  0
 24 26  1  0
 25 27  1  0
 25 28  2  0
 25 29  1  0
M  END
>  <Name>  (593) 
Aprepitant M1

>  <InChIKey>  (593) 
AFBDSAJOMZYQAI-CNOZUTPLSA-N

>  <PubChem_CID>  (593) 
10113945

>  <CYP1A2>  (593) 


>  <CYP2A6>  (593) 


>  <CYP2B6>  (593) 


>  <CYP2C8>  (593) 


>  <CYP2C9>  (593) 


>  <CYP2C19>  (593) 


>  <CYP2D6>  (593) 


>  <CYP2E1>  (593) 


>  <CYP3A4>  (593) 
<7,8;DeHydrogenation;R1>

>  <References>  (593) 
Sanchez RI, Wang RW, Newton DJ, Bakhtiar R, Lu P, Chiu SH, Evans DC, Huskey SE: Cytochrome P450 3A4 is the major enzyme involved in the metabolism of the substance P receptor antagonist aprepitant. Drug Metab Dispos. 2004 Nov;32(11):1287-92. doi: 10.1124/dmd.104.000216. Epub 2004 Aug 10. (PMID: 15304427)

>  <Comments>  (593) 


$$$$
CC02472
     RDKit          3D

 60 64  0  0  1  0  0  0  0  0999 V2000
    3.8630   -6.1950   -0.6390 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2680   -4.5910    1.8980 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9350   -3.5390   -1.1070 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0060   -0.9030   -1.5490 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9390   -2.7200    0.7540 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6950    0.7930    0.2940 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2470   -1.6000    2.5660 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1720    2.1820   -2.1580 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8320   -4.8730    3.4000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0520   -5.9570    1.3870 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.3000   -2.9430    0.6410 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8570    1.6150    2.2730 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6660    3.8250   -2.4980 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6100    1.5170   -0.1900 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8450    3.0680    2.9680 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6850    5.1130    2.3470 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5020    3.1400    1.4790 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6790   -3.1740    0.0710 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.7290   -4.6150    0.5550 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.3290   -2.3810    0.2800 C   0  0  1  0  0  0  0  0  0  0  0  0
    5.9590   -2.6560   -0.6220 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.4000   -5.3900    0.4580 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.1700   -1.1760   -0.7220 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.2240   -3.3220    0.8350 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.1740   -4.6190    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1390   -0.5410    0.7090 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1950   -5.6740   -0.4660 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4010   -1.2710    1.3780 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1720   -0.3110   -1.4930 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1210    0.5490    0.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7670   -1.8470   -1.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7330    0.2330    1.0790 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.5980    1.1450   -1.3870 C   0  0  1  0  0  0  0  0  0  0  0  0
    5.4530    1.4750   -0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9840   -1.4650    1.9040 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4900    0.0480    1.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5710    2.6030   -0.8240 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4390   -5.2300    2.1530 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0750   -3.5850   -0.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8020    1.4660    1.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2290    2.9300   -1.7770 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0230   -4.5350   -0.9620 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8550    2.6440   -0.4510 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7190    2.0180    0.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5730    3.6440    0.6450 C   0  0  2  0  0  0  0  0  0  0  0  0
    8.7210   -5.2450   -2.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2490   -4.7240   -0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1000   -5.4300    3.7220 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8200    4.0790    1.4260 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6470   -6.1420   -2.6490 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1740   -5.6220   -0.8530 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8730   -6.3300   -2.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5540    5.3060    2.2690 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9340    4.4540    0.4670 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3350    2.9830    2.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6840    3.8910    2.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8660    3.6590    3.8380 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8790    4.4940    3.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1170    2.5140    4.4810 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5200    4.4680    4.9350 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 22  1  0
  1 27  1  0
 19  2  1  1
  2 38  1  0
 21  3  1  1
  3 39  1  0
 23  4  1  6
 24  5  1  6
 32  6  1  6
  6 40  1  0
  7 28  2  0
 33  8  1  1
  8 41  1  0
  9 38  1  0
  9 48  1  0
 10 38  2  0
 11 39  2  0
 12 40  2  0
 13 41  2  0
 14 43  1  0
 15 56  1  0
 15 57  1  0
 16 56  2  0
 45 17  1  1
 17 56  1  0
 18 19  1  0
 18 20  1  0
 18 21  1  6
 19 22  1  0
 19 27  1  0
 20 24  1  0
 20 28  1  0
 20 31  1  6
 21 23  1  0
 22 25  1  6
 23 26  1  0
 23 29  1  0
 24 25  1  0
 26 30  1  0
 26 35  1  0
 26 36  1  0
 28 32  1  0
 29 33  1  0
 30 32  1  0
 30 34  2  0
 33 34  1  0
 34 37  1  0
 39 42  1  0
 40 44  1  0
 41 43  1  0
 42 46  2  0
 42 47  1  0
 43 45  1  0
 45 49  1  0
 46 50  1  0
 47 51  2  0
 49 53  1  0
 49 54  1  0
 49 55  1  0
 50 52  2  0
 51 52  1  0
 57 58  1  0
 57 59  1  0
 57 60  1  0
M  END
>  <Name>  (594) 
BMS-275183

>  <InChIKey>  (594) 
AHXICHPPXIGCBN-TYVWMPTDSA-N

>  <PubChem_CID>  (594) 


>  <CYP1A2>  (594) 


>  <CYP2A6>  (594) 


>  <CYP2B6>  (594) 


>  <CYP2C8>  (594) 


>  <CYP2C9>  (594) 


>  <CYP2C19>  (594) 


>  <CYP2D6>  (594) 


>  <CYP2E1>  (594) 


>  <CYP3A4>  (594) 
<36,H;Hydroxylation;R1>
<37,H;Hydroxylation;R2>
<38,H;Hydroxylation;R3>
<40,H;Hydroxylation;R4>
<41,H;Hydroxylation;R5>
<42,H;Hydroxylation;R6>

>  <References>  (594) 
Zhang D, Ly VT, Lago M, Tian Y, Gan J, Humphreys WG, Comezoglu SN: CYP3A4-mediated ester cleavage as the major metabolic pathway of the oral taxane 3'-tert-butyl-3'-N-tert-butyloxycarbonyl-4-deacetyl-3'-dephenyl-3'-N-debenzoyl-4- O-methoxycarbonyl-paclitaxel (BMS-275183). Drug Metab Dispos. 2009 Apr;37(4):710-8. doi: 10.1124/dmd.108.024398. Epub 2009 Jan 21. (PMID: 19158314)

>  <Comments>  (594) 


$$$$
CC02473
     RDKit          3D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -0.7200   -0.4530   -1.7640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8480   -0.2420   -0.2580 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.1890   -1.0600    0.5030 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.1610   -0.8200    0.2790 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.6320    1.2180    0.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5900   -0.7680    0.0270 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.3990   -2.4440    0.3600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3410   -0.9300   -0.6600 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.7630   -2.1310    0.9640 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7840    1.6590   -0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8820    0.7200    0.2160 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.6590   -1.6080    0.6980 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.4340   -2.9920    0.5210 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5120   -1.6140    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7430    0.4290   -1.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2690    1.1210   -0.2810 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.0530   -1.2730    0.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6850   -1.7790   -0.9290 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2960    1.0410   -1.8020 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3270    0.2070    0.3150 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.5710    2.5530    0.1520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7770   -2.4950   -0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7580    0.5390   -0.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0320    2.9660    0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6970   -1.9500    0.3860 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6090   -3.8360   -0.2970 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9120    1.9440   -0.5760 C   0  0  1  0  0  0  0  0  0  0  0  0
    7.2650    2.3340   -0.5790 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6
  2  3  1  0
  2  4  1  0
  2  5  1  0
  3  6  1  0
  3  7  1  6
  4  8  1  0
  4  9  1  6
  5 10  1  0
  6 11  1  0
  6 12  1  1
  7  9  1  0
  8 14  1  0
  8 15  1  1
 11 10  1  6
 11 16  1  0
 12 13  1  6
 12 17  1  0
 14 18  1  0
 16 19  1  6
 16 20  1  0
 16 21  1  0
 20 17  1  6
 18 22  1  0
 20 23  1  0
 21 24  1  0
 22 25  2  0
 22 26  1  0
 23 27  1  0
 24 27  1  0
 27 28  1  1
M  END
>  <Name>  (595) 
Chenodeoxycholic acid

>  <InChIKey>  (595) 
RUDATBOHQWOJDD-SHOXBNBYSA-N

>  <PubChem_CID>  (595) 
5283828

>  <CYP1A2>  (595) 


>  <CYP2A6>  (595) 


>  <CYP2B6>  (595) 


>  <CYP2C8>  (595) 


>  <CYP2C9>  (595) 


>  <CYP2C19>  (595) 


>  <CYP2D6>  (595) 


>  <CYP2E1>  (595) 


>  <CYP3A4>  (595) 
<17,18;Oxidation;R1>
<14,H;Hydroxylation;R2>

>  <References>  (595) 
Deo AK, Bandiera SM: Identification of human hepatic cytochrome p450 enzymes involved in the biotransformation of cholic and chenodeoxycholic acid. Drug Metab Dispos. 2008 Oct;36(10):1983-91. doi: 10.1124/dmd.108.022194. Epub 2008 Jun 26. (PMID: 18583509)

>  <Comments>  (595) 


$$$$
CC02474
     RDKit          3D

 29 32  0  0  0  0  0  0  0  0999 V2000
   -0.8210   -0.2490   -1.7180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9150   -0.0610   -0.2050 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.1110   -0.9310    0.5190 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.2490   -0.6090    0.3430 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.6010    1.3730    0.1790 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.5150   -0.6980    0.0220 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.5420   -2.2880    0.4390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3780   -0.8520   -0.6410 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.8460   -1.8760    1.1090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5120    2.2880   -0.4000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8080    1.7530   -0.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8780    0.7750    0.2260 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.5580   -1.5960    0.6580 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.2640   -2.9650    0.4660 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5380   -1.5640    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8440    0.4380   -1.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2700    1.1150   -0.3030 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.9560   -1.3180    0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6470   -1.8730   -0.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2590    1.0490   -1.8250 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2990    0.1470    0.2610 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.6480    2.5270    0.1360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6960   -2.6690   -0.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7350    0.4170   -0.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1250    2.8720    0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6970   -2.1990    0.2660 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3860   -3.9870   -0.2760 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9440    1.8190   -0.6470 C   0  0  1  0  0  0  0  0  0  0  0  0
    7.3140    2.1450   -0.6750 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6
  2  3  1  0
  2  4  1  0
  2  5  1  0
  3  6  1  0
  3  7  1  6
  4  8  1  0
  4  9  1  6
  5 10  1  6
  5 11  1  0
  6 12  1  0
  6 13  1  1
  7  9  1  0
  8 15  1  0
  8 16  1  1
 12 11  1  6
 12 17  1  0
 13 14  1  6
 13 18  1  0
 15 19  1  0
 17 20  1  6
 17 21  1  0
 17 22  1  0
 21 18  1  6
 19 23  1  0
 21 24  1  0
 22 25  1  0
 23 26  2  0
 23 27  1  0
 24 28  1  0
 25 28  1  0
 28 29  1  1
M  END
>  <Name>  (596) 
Cholic acid

>  <InChIKey>  (596) 
BHQCQFFYRZLCQQ-JWQTVRMOSA-N

>  <PubChem_CID>  (596) 
5283878

>  <CYP1A2>  (596) 


>  <CYP2A6>  (596) 


>  <CYP2B6>  (596) 


>  <CYP2C8>  (596) 


>  <CYP2C9>  (596) 


>  <CYP2C19>  (596) 


>  <CYP2D6>  (596) 


>  <CYP2E1>  (596) 


>  <CYP3A4>  (596) 
<17,18;Oxidation;R1>

>  <References>  (596) 
Deo AK, Bandiera SM: Identification of human hepatic cytochrome p450 enzymes involved in the biotransformation of cholic and chenodeoxycholic acid. Drug Metab Dispos. 2008 Oct;36(10):1983-91. doi: 10.1124/dmd.108.022194. Epub 2008 Jun 26. (PMID: 18583509)

>  <Comments>  (596) 


$$$$
CC02475
     RDKit          3D

 56 59  0  0  1  0  0  0  0  0999 V2000
    1.1360    1.2530   -0.4550 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.3520    0.9620   -0.4180 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.4570    2.6490   -0.3110 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0890    1.4190    0.8240 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.7520    0.8150   -1.7650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0000    1.4390   -1.5870 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4940    2.9720   -1.2510 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.6140    2.8330    0.7510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4700    1.0820    2.0450 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0140    1.6250   -1.7250 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.6310    3.7650   -0.6250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9620    3.7100   -2.3370 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3210    3.3750    1.9730 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.5460   -0.3250    2.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7020    1.6290   -3.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2640    5.0940   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8110    3.4280   -0.6100 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9020    4.7180    1.5870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3940    3.5130    3.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4200    6.2080   -0.8160 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9100    5.1180    1.1610 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7610    5.3710    2.6110 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1860    7.5230   -0.2460 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.8550    6.1120   -2.1970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2590    6.3640    3.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1810    4.9390    2.6840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7260    7.9360   -0.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0200    8.5990   -0.9120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4430    7.3130   -3.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9700    7.2260    4.3260 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.5520    8.7900    0.8570 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8630    7.6110   -0.9950 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9100    8.6220   -2.4230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7900    8.6560    3.8640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4150    7.0930    5.7280 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2150    9.2860    0.9280 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.3810    9.1920    3.7800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7550    9.3740    3.6000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8700    5.8510    6.4030 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2180   10.7550    0.6330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3810    8.9780    2.2960 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.8500    9.3630    2.3710 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.0160    4.9340    6.8590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5420   11.2390   -0.3560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0810   11.6290    1.4760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1580    7.5210    2.6550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5930    8.6450    1.4040 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6450   12.6640   -0.7510 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.1730   12.8650   -2.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0490   13.1750   -0.5160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3180   14.3080   -2.6060 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.2580   14.5840   -1.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7580   14.7720   -2.4370 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.1290   14.3950   -3.9520 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9200   16.1350   -2.7880 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5210   15.7330   -4.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  5  1  6
  2  4  1  0
  2  6  1  6
  3  7  1  0
  4  8  1  0
  4  9  1  1
  5 10  1  0
  7 10  1  0
  7 11  1  0
  7 12  1  6
  8 13  1  0
  9 14  1  0
 10 15  1  6
 11 16  1  0
 11 17  2  0
 13 18  1  0
 13 19  1  1
 16 20  1  0
 16 21  2  0
 18 22  1  0
 20 23  1  0
 20 24  1  0
 22 25  2  0
 22 26  1  0
 23 27  1  0
 23 28  1  6
 24 29  1  0
 25 30  1  0
 27 31  1  0
 27 32  2  0
 28 33  1  0
 29 33  1  0
 30 34  1  0
 30 35  1  1
 31 36  1  0
 34 37  1  0
 34 38  2  0
 35 39  1  0
 36 40  1  1
 36 41  1  0
 37 42  1  0
 39 43  2  0
 40 44  2  0
 40 45  1  0
 41 42  1  0
 41 46  1  6
 42 47  1  6
 48 44  1  6
 48 49  1  0
 48 50  1  0
 49 51  1  0
 50 52  1  0
 51 53  1  0
 51 54  1  6
 52 53  1  0
 53 55  1  1
 54 56  1  0
M  END
>  <Name>  (597) 
FK-506-M1

>  <InChIKey>  (597) 
OKRZOXIQNKYTBL-ZNPYSLGISA-N

>  <PubChem_CID>  (597) 


>  <CYP1A2>  (597) 


>  <CYP2A6>  (597) 


>  <CYP2B6>  (597) 


>  <CYP2C8>  (597) 


>  <CYP2C9>  (597) 


>  <CYP2C19>  (597) 


>  <CYP2D6>  (597) 


>  <CYP2E1>  (597) 


>  <CYP3A4>  (597) 
<12,13;Cleavage;R1>
<13,H;Oxidation;R1>

>  <References>  (597) 
Vincent SH, Karanam BV, Painter SK, Chiu SH: In vitro metabolism of FK-506 in rat, rabbit, and human liver microsomes: identification of a major metabolite and of cytochrome P450 3A as the major enzymes responsible for its metabolism. Arch Biochem Biophys. 1992 May 1;294(2):454-60. doi: 10.1016/0003-9861(92)90711-5. (PMID: 1373595)

>  <Comments>  (597) 


$$$$
CC02477
     RDKit          3D

 27 30  0  0  0  0  0  0  0  0999 V2000
    1.5800    0.2350   -0.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5050    0.7810   -1.6220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7680    0.2470   -1.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9570   -0.8300   -0.5970 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1210   -1.3810    0.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4130   -0.8550   -0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2090   -2.8000    1.1300 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.9000   -3.9190    0.3030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2700   -3.6760    0.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9510   -2.5030    0.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0890   -2.7280    1.5530 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5400   -1.2660    0.6650 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3470   -5.0670   -0.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1420   -5.9580   -0.9880 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5000   -5.7060   -1.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0620   -4.5690   -0.5700 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6100   -4.0310    1.9260 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0970   -4.1210    1.5850 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9240   -3.0410    2.1280 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9810   -3.0940    3.5850 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2670   -4.4590    4.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5550   -4.9230    3.8140 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.7430   -6.2420    4.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7400   -7.2540    3.7750 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5410   -7.1000    2.3800 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3310   -1.7600    1.7390 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8510   -1.6100    2.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  6 12  1  0
  7  8  1  0
  8  9  2  0
  8 13  1  0
  9 10  1  0
  9 16  1  0
 10 11  1  0
 10 12  2  0
 11 17  1  0
 11 27  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 26  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 26 27  1  0
M  END
>  <Name>  (598) 
Quetiapine

>  <InChIKey>  (598) 
URKOMYMAXPYINW-UHFFFAOYSA-N

>  <PubChem_CID>  (598) 
5002

>  <CYP1A2>  (598) 


>  <CYP2A6>  (598) 


>  <CYP2B6>  (598) 


>  <CYP2C8>  (598) 


>  <CYP2C9>  (598) 


>  <CYP2C19>  (598) 


>  <CYP2D6>  (598) 
<15,H;Hydroxylation;R1>

>  <CYP2E1>  (598) 


>  <CYP3A4>  (598) 
<2,3;Cleavage;R1>
<2,H;Oxidation;R1>
<5,6;Cleavage;R2>
<5,H;Oxidation;R2>
<18,S;S-Oxidation;R3>
<15,H;Hydroxylation;R4>

>  <References>  (598) 
Shen WW: The metabolism of atypical antipsychotic drugs: an update. Ann Clin Psychiatry. 1999 Sep;11(3):145-58. (PMID: 10482125)

>  <Comments>  (598) 


$$$$
CC02478
     RDKit          3D

 46 53  0  0  1  0  0  0  0  0999 V2000
   -4.6510    0.6350    9.6650 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4040   11.8830    9.7180 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2010    2.2960    7.2040 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5780    2.6690    6.1330 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6070    1.8570    6.3160 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1790    2.1440    2.2840 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7680    1.0440    6.5120 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9700    1.5950    4.4050 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8800    3.9170    9.6910 C   0  0  1  0  0  0  0  0  0  0  0  0
   -6.0200    4.6490   10.3760 C   0  0  2  0  0  0  0  0  0  0  0  0
   -5.6450    2.7490    9.0740 C   0  0  2  0  0  0  0  0  0  0  0  0
   -5.5660    5.8530   11.1730 C   0  0  1  0  0  0  0  0  0  0  0  0
   -6.7050    3.5260   11.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8380    2.4870   10.0060 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.2660    4.8610    8.6720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5830    6.6970   10.3760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7970    6.6340   11.6060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8200    3.4680   10.6890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2670    8.0670   10.9550 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.0350    6.2290    9.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8450    1.4930    8.8050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1280    2.6720    9.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4570    7.9540   12.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5470    8.7460   11.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3980    7.8590   12.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2910    1.3470    7.4070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4660    8.9360   10.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9200    9.9670   10.9850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8060   10.1580    9.6140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0690   10.7590   10.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9530    2.3460    5.7600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0060    1.7480    7.8630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7160    3.1620    5.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7350    2.5410    7.5650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6100    2.3220    5.5420 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7690    2.4340    4.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9750    2.0570    3.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7630    1.5080    5.7300 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4270    1.7500    1.6490 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2310    2.6220    1.2890 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6890    0.8950    7.9520 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0660    0.6310    6.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9540    1.5990    0.1970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1880    2.9090    0.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8640   -0.0670    8.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8740    0.6780    7.3210 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 21  2  0
  2 30  2  0
  3 26  1  0
  3 31  1  0
  3 32  1  0
  4 33  1  0
  4 34  1  0
  4 35  1  0
  5 35  2  0
  5 38  1  0
  6 37  1  0
  6 39  1  0
  6 40  1  0
  7 38  1  0
  7 41  1  0
  7 42  1  0
  8 37  1  0
  8 38  2  0
  9 10  1  0
  9 11  1  0
  9 15  1  0
  9 18  1  1
 10 12  1  0
 10 13  1  1
 11 14  1  0
 11 21  1  1
 12 16  1  0
 12 17  1  6
 13 14  1  0
 14 22  1  6
 15 20  1  0
 16 19  1  0
 16 20  2  0
 17 23  1  0
 19 24  1  0
 19 25  1  1
 19 27  1  0
 21 26  1  0
 23 24  1  0
 24 28  2  0
 27 29  2  0
 28 30  1  0
 29 30  1  0
 31 33  1  0
 32 34  1  0
 35 36  1  0
 36 37  2  0
 39 43  1  0
 40 44  1  0
 41 45  1  0
 42 46  1  0
 43 44  1  0
 45 46  1  0
M  END
>  <Name>  (599) 
Tirilazad

>  <InChIKey>  (599) 
RBKASMJPSJDQKY-RBFSKHHSSA-N

>  <PubChem_CID>  (599) 
104903

>  <CYP1A2>  (599) 


>  <CYP2A6>  (599) 


>  <CYP2B6>  (599) 


>  <CYP2C8>  (599) 


>  <CYP2C9>  (599) 


>  <CYP2C19>  (599) 


>  <CYP2D6>  (599) 


>  <CYP2E1>  (599) 


>  <CYP3A4>  (599) 
<6,H;Hydroxylation;R1>

>  <References>  (599) 
Wienkers LC, Steenwyk RC, Sanders PE, Pearson PG: Biotransformation of tirilazad in human: 1. Cytochrome P450 3A-mediated hydroxylation of tirilazad mesylate in human liver microsomes. J Pharmacol Exp Ther. 1996 May;277(2):982-90. (PMID: 8627581)

>  <Comments>  (599) 
The hydroxylated metabolite on the pyrrolidine is not recorded because the exact location cannot be identified.

$$$$
CC02479
     RDKit          3D

 29 32  0  0  1  0  0  0  0  0999 V2000
   -5.0370    0.5370    0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9330   -0.5930    1.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7280   -1.2810    1.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6030   -0.8360    0.4620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6840    0.2960   -0.3440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8930    0.9790   -0.4680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9890   -1.0250    1.7260 F   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2740    1.2890    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3890    2.6070    0.0670 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7150    2.9340   -0.0990 N   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3850    1.8140   -0.2470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5220    0.7440   -0.1890 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7480    1.5330   -0.4530 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.1880    0.2720   -0.6040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1120   -0.7600   -0.5390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8460   -0.5720   -0.3480 N   0  0  0  0  0  0  0  0  0  0  0  0
  -11.6340   -0.0770   -0.8240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6230   -2.0030   -0.6990 O   0  0  0  0  0  0  0  0  0  0  0  0
  -12.5310    1.1480   -0.8500 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.8190   -0.7820   -2.1520 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.1450   -0.9680    0.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6290   -3.0310   -0.6920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3410   -4.3230   -0.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.4690   -5.2540   -1.5090 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.1960   -6.2320   -0.8760 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.5170   -5.9570    0.3940 N   0  0  0  0  0  0  0  0  0  0  0  0
   -9.9630   -4.7470    0.5490 N   0  0  0  0  0  0  0  0  0  0  0  0
  -10.0840   -4.0500    1.8080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9370   -4.4090    2.7230 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  8  1  0
  2  3  1  0
  2  7  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  8  9  2  0
  8 12  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 12 16  1  0
 13 14  2  0
 14 15  1  0
 14 17  1  0
 15 16  2  0
 15 18  1  0
 17 19  1  0
 17 20  1  0
 17 21  1  0
 18 22  1  0
 22 23  1  0
 23 24  2  0
 23 27  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
M  END
>  <Name>  (600) 
TPA023

>  <InChIKey>  (600) 
QKIWQBLNTSQOLY-UHFFFAOYSA-N

>  <PubChem_CID>  (600) 
9908684

>  <CYP1A2>  (600) 


>  <CYP2A6>  (600) 


>  <CYP2B6>  (600) 


>  <CYP2C8>  (600) 


>  <CYP2C9>  (600) 


>  <CYP2C19>  (600) 


>  <CYP2D6>  (600) 


>  <CYP2E1>  (600) 


>  <CYP3A4>  (600) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>
<18,H;Hydroxylation;R2>
<20,H;Hydroxylation;R3>
<19,H;Hydroxylation;R4>

>  <References>  (600) 
Ma B, Polsky-Fisher SL, Vickers S, Cui D, Rodrigues AD: Cytochrome P450 3A-dependent metabolism of a potent and selective gamma-aminobutyric acid Aalpha2/3 receptor agonist in vitro: involvement of cytochrome P450 3A5 displaying biphasic kinetics. Drug Metab Dispos. 2007 Aug;35(8):1301-7. doi: 10.1124/dmd.107.014753. Epub 2007  Apr 25. (PMID: 17460031)

>  <Comments>  (600) 


$$$$
